Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.7985438851000937,-2.300525597693854,0.0,0.0,0.0,52/141,9.84%,RPS2;RPL29;RPL15;TRIR;RPL23A;UTP11;IMP3;RPL10;RPLP1;RPL7A;POP4;RPL10A;RPS19;RPL18;WDR18;RPL13;RPS24;RPL35A;NIFK;EBNA1BP2;RPS16;EXOSC8;PIH1D1;RPL8;RPS15;NOL11;RPS28;RPS7;RPL19;NOP56;DDX54;RPLP0;RPL23;RPL41;RPS9;UBA52;RPL37;RPL13A;RPL3;RPL31;RPL34;NOP14;RPL35;RPL21;RPL4;RPL11;RPL38;RPL6;NOL6;POP5;RPL36;RPF1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8165260981828237,-2.2344882132954984,0.0,0.0,0.0,47/83,11.55%,RPS2;RPL29;RPL15;RPL23A;RPL10;RPLP1;RPL7A;RPS27A;SRP14;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;RPL8;RPS15;RPS28;RPS7;RPL19;RPLP0;RPL23;RPL41;RPS9;UBA52;RPL37;RPL13A;RPL3;RPS15A;RPL31;RPL34;RPL35;SEC61B;RPL21;RPL4;RPL11;RPL38;RPS3A;RPL6;RPL36;RPS11;RPS13;RPS5;RPL30;RPL9
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.7785823333829155,-2.211784157352568,0.0,0.0,0.0,52/154,9.84%,RPS2;RPL29;RPL15;RPL23A;UTP11;IMP3;RPL10;RPLP1;RPL7A;POP4;RPL10A;RPS19;RPL18;WDR18;RPL13;RPS24;RPL35A;EBNA1BP2;RPS16;EXOSC8;PIH1D1;RPL8;RPS15;NOL11;RPS28;RPS7;RPL19;NHP2;NOP56;DDX54;RPLP0;RPL23;RIOK2;RPL41;RPS9;UBA52;RPL37;RPL13A;RPL3;RPL31;RPL34;NOP14;RPL35;RPL21;RPL4;RPL11;RPL38;RPL6;NOL6;POP5;RPL36;RPF1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.756120815737182,-2.2115136422100026,0.0,0.0,0.0,67/170,12.71%,RPS2;RPL29;RPL15;RPL23A;UTP11;IMP3;ZNF658;MRPL36;RPL10;RPLP1;RPL7A;POP4;RAN;RPL10A;RPS19;RPL18;WDR18;RPL13;RPS24;RPL35A;EBNA1BP2;RPS16;EXOSC8;PIH1D1;RPL8;RPS15;NOL11;LTV1;RPS28;RPS7;RPL19;NOP56;DDX54;RPLP0;RPL23;RIOK2;RPL41;RPS9;UBA52;RPL37;RPL13A;RPL3;RPL31;RPL34;NOP14;RPL35;METTL17;RPL21;RPL4;RPF2;LSG1;RPL11;RPL38;NOC2L;RPL6;NOL6;POP5;RPL36;RPF1;NIP7;RPL30;RPL9;CUL4B;SBDS;MRTO4;LTO1;NPM1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8112693104864401,-2.1850542994085767,0.0,0.0,0.0,49/94,11.55%,RPS2;SPCS2;RPL29;RPL15;RPL23A;RPL10;RPLP1;RPL7A;RPS27A;SRP14;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;SEC61G;RPL8;RPS15;RPS28;RPS7;RPL19;RPLP0;RPL23;RPL41;RPS9;UBA52;RPL37;RPL13A;RPL3;RPS15A;RPL31;RPL34;RPL35;RPL21;RPL4;RPL11;RPL38;RPS3A;RPL6;GET3;RPL36;RPS11;RPS13;RPS5;RPL30;RPL9
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.7502387889579014,-2.176633432604476,0.0,0.0,0.0,53/175,9.84%,RPS2;RPL29;RPL15;RPL23A;UTP11;IMP3;RPL10;RPLP1;RPL7A;POP4;RPL10A;MRPL44;RPS19;RPL18;WDR18;RPL13;RPS24;RPL35A;EBNA1BP2;RPS16;EXOSC8;PIH1D1;RPL8;RPS15;NOL11;RPS28;RPS7;RPL19;NOP56;DDX54;RPLP0;RPL23;RPL41;RPS9;UBA52;RPL37;RPL13A;RPL3;RPL31;RPL34;NOP14;RPL35;SARS1;RPL21;RPL4;AARS1;RPL11;RPL38;RPL6;NOL6;POP5;RPL36;RPF1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.786041686176309,-2.1541229907510187,0.0,0.0,0.0,52/102,11.93%,RPS2;RPL29;RBM8A;RPL15;RPL23A;RPL10;RPLP1;RPL7A;RPS27A;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;PNRC2;RPL8;RPS15;RPS28;RPS7;RPL19;RPLP0;RPL23;RPL41;RPS9;GSPT2;UBA52;RPL37;RPL13A;RPL3;RPS15A;RPL31;RPL34;RPL35;RPL21;RPL4;RPL11;RPL38;RPS3A;RPL6;RPL36;RPS11;MAGOH;RPS13;EIF4A3;RPS5;RPL30;DCP1A;RPL9;GSPT1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8128674057512572,-2.1518149788275855,0.0,0.0,0.0,47/86,11.55%,RPS2;RPL29;RPL15;RPL23A;RPL10;RPLP1;RPL7A;RPS27A;SRP14;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;RPL8;RPS15;RPS28;RPS7;RPL19;RPLP0;RPL23;RPL41;RPS9;UBA52;RPL37;SSR2;RPL13A;RPL3;RPS15A;RPL31;RPL34;RPL35;RPL21;RPL4;RPL11;RPL38;RPS3A;RPL6;RPL36;RPS11;RPS13;RPS5;RPL30;RPL9
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8105943312975987,-2.14068221098514,0.0,0.0,0.0,50/84,11.93%,TMA7;RPS2;RPL29;RPL15;RPL23A;RPL10;RPLP1;RPL7A;RPS27A;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;RPL8;RPS15;RPS28;RPS7;RPL19;RPLP0;RPL23;RWDD1;RPL41;RPS9;GSPT2;UBA52;RPL37;RPL13A;RPL3;RPS15A;RPL31;RPL34;RPL35;RPL21;RPL4;RPL22L1;RPL11;RPL38;RPS3A;RPL6;RPL36;RPS11;RPS13;RPS5;RPL30;RPL9;GSPT1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.7948840945497949,-2.1312923057761193,0.0,0.0011209135796691084,0.01,37/74,15.40%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;MRPL27;MRPL10;MRPS7;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;MRPL52;MRPL28;MTRF1L;MRPS11;MRPS12;MRPL21;MRPL48;MRPS10;MRPL32;MRPS18B;MRPL24;MRPL16;MRPL13;MRPS22;MRPS2;MRPL9;MRPS23;MRPS14;MRPL34;MRPL4;MRPS18A;MRPL51
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.7859022218156027,-2.1225820503490174,0.0,0.0010190123451537347,0.01,41/80,15.40%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;TRMT112;MRPL36;MRPL27;MRPL10;MRPS7;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;MRPL52;MRPL28;GSPT2;MTRF1L;MRPS11;MRPS12;MRPL21;APEH;MRPL48;MRPS10;MRPL32;GSPT1;MRPS18B;MRPL24;MRPL16;MRPL13;MRPS22;MRPS2;MRPL9;MRPS23;MRPS14;MRPL34;MRPL4;MRPS18A;MRPL51
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.7725693057055142,-2.113227237450104,0.0,0.0009340946497242568,0.01,40/88,15.40%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;MRPL27;MRPL10;MRPS7;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;MRPL52;MRPL28;MTRF1L;MRPS11;MRPS12;TUFM;MRPL21;MRPL48;MRPS10;MRPL32;MRPS18B;MTIF3;MRPL24;MRPL16;MRPL13;GATC;MRPS22;MRPS2;MRPL9;MRPS23;MRPS14;MRPL34;MRPL4;MRPS18A;MRPL51
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.8004393744772942,-2.1047254740166146,0.0,0.0008622412151300833,0.01,37/73,15.40%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;MRPL27;MRPL10;MRPS7;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;MRPL52;MRPL28;MRPS11;MRPS12;TUFM;MRPL21;MRPL48;MRPS10;MRPL32;MRPS18B;MRPL24;MRPL16;MRPL13;MRPS22;MRPS2;MRPL9;MRPS23;MRPS14;MRPL34;MRPL4;MRPS18A;MRPL51
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.718989594506881,-2.0994347698679583,0.0,0.0008006525569065058,0.01,62/174,13.20%,HSD17B10;UQCR10;ISCA1;IDH1;SURF1;GPX4;ATP5MC1;NDUFA6;NDUFB1;NDUFB7;MRPL15;OAT;NDUFS6;TIMM8B;COX6C;ISCU;UQCRQ;COX7C;ATP6V0E1;NDUFA1;COX7A2;ATP6V1F;ATP5PD;ATP5F1A;COX5B;SLC25A6;ATP6V1G1;CYB5R3;NDUFS8;UQCRC1;NDUFA3;ATP5F1E;COX6B1;TIMM13;NDUFA5;VDAC2;MRPS11;MRPS12;PHB2;COX11;SLC25A4;NDUFS3;COX4I1;DLD;COX17;ATP5PB;AIFM1;SLC25A5;COX5A;NDUFB2;GRPEL1;NDUFAB1;CYC1;ATP5ME;ATP5F1D;UQCRH;UQCRB;NDUFB3;PDHB;SUCLA2;MRPS22;SLC25A20
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7331413421480114,-2.0813583674579874,0.0,0.0007472757197794054,0.01,79/136,16.73%,RPS2;RPL29;RPL15;RPL23A;MRPS33;MRPL36;MRPL27;RPL10;MRPL10;RPLP1;RPL7A;RPS27A;MRPS7;RPS23;MRPS16;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;EEF1A1;MRPL52;RPL8;RPS15;RPS28;RPS7;RPL19;MRPL28;RPLP0;RPL23;RPL41;RPS9;GSPT2;RPL37;MRPS11;RPL13A;RPL3;MRPS12;RPS15A;RPL31;RPL34;RPL35;SARS1;RPL21;RPL4;RPL11;RPL38;MRPL32;RPS3A;RPL6;RPL36;RPS11;EIF4EBP2;RPS13;RPS5;RPL30;RPL9;FURIN;GSPT1;MRPS18B;MRPL24;MRPL13;RPL18A;MRPL9;RPS8;MRPS14;MRPL34;RPS14;MRPS18A;MRPL51;RPS26;RPS12;RPS18;RPSA;RPL27;RSL24D1;RPL32
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.8030903247277843,-2.05805117326437,0.0,0.0021017129618795777,0.02,29/52,12.76%,NDUFB11;UQCR10;NDUFA6;NDUFB1;NDUFB7;NDUFA12;NDUFS6;COX6C;UQCRQ;COX7C;COA6;NDUFA1;COX5B;NDUFS8;NDUFB10;UQCRC1;NDUFA3;COX6B1;NDUFA5;NDUFS3;COX4I1;NDUFS5;COX5A;NDUFB2;NDUFAB1;CYC1;UQCRH;UQCRB;NDUFB3
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.8004647254415057,-2.0561082807097475,0.0,0.0019780827876513677,0.02,28/51,12.76%,NDUFB11;UQCR10;NDUFA6;NDUFB1;NDUFB7;NDUFA12;NDUFS6;COX6C;UQCRQ;COX7C;NDUFA1;COX5B;NDUFS8;NDUFB10;UQCRC1;NDUFA3;COX6B1;NDUFA5;NDUFS3;COX4I1;NDUFS5;COX5A;NDUFB2;NDUFAB1;CYC1;UQCRH;UQCRB;NDUFB3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7026225813486641,-2.0463911608830627,0.0,0.0018681892994485136,0.02,60/154,12.14%,RPS2;RPL29;RBM8A;RPL15;RPL23A;RPL10;RPLP1;RPL7A;RPS27A;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;POLR2G;LSM1;PNRC2;EXOSC8;RPL8;RPS15;ZFP36L1;RPS28;RPS7;RPL19;RPLP0;RPL23;RPL41;RPS9;GSPT2;UBA52;RPL37;RPL13A;RPL3;DXO;RPS15A;RPL31;RPL34;RPL35;RPL21;RPL4;RPL11;RPL38;RPS3A;RPL6;RPL36;RPS11;MAGOH;DDX5;RPS13;EIF4A3;RPS5;DCPS;RPL30;DCP1A;RPL9;GSPT1;MRTO4
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.6622734354307924,-1.984090973805731,0.0,0.008259363218614481,0.1,87/303,12.90%,RPS2;RPL29;RBM8A;SRSF7;RPL15;NOX4;PTMA;RPL23A;MRPS33;CPSF1;POLR2L;MRPL36;POLR2J;MRPL27;RPL10;MRPL10;RPLP1;RPL7A;RPS27A;MRPS7;RPS23;MRPS16;RPL10A;MRPL44;RPS19;RPL18;NUP42;POLR2I;RPL13;RPS24;RPL35A;RPS16;EEF1A1;POLR2G;MRPL52;RPL8;RPS15;RPS28;RPS7;RPL19;MRPL28;DDX54;PAX8;RPLP0;RPL23;RPL41;RPS9;GSPT2;U2AF1;RPL37;MRPS11;RPL13A;RPL3;MRPS12;RPS15A;RPL31;RPL34;RPL35;SARS1;RPL21;RPL4;RPL11;RPL38;STUB1;MRPL32;RBM15B;RPS3A;RPL6;RPL36;RPS11;MAGOH;SLU7;EIF4EBP2;RPS13;EIF4A3;RPS5;POLR2K;RPL30;NUP155;RPL9;GSPT1;POLR2E;MRPS18B;MRPL24;MRPL13;NOVA1;SRSF9
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.8420343176608708,-1.9348726006341994,0.0,0.019615987644209396,0.17,15/30,10.26%,NDUFB11;NDUFA6;NDUFB1;NDUFB7;NDUFA12;NDUFS6;NDUFA1;NDUFS8;NDUFB10;NDUFA3;NDUFA5;NDUFS3;NDUFS5;NDUFB2;NDUFAB1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.7711168930723228,-1.9262265699539007,0.0,0.020889753075651565,0.21,22/50,13.76%,NDUFB11;NDUFAF8;NDUFA6;NDUFB1;NDUFB7;NDUFA12;NDUFS6;NDUFA1;NDUFS8;NDUFB10;NDUFA3;NDUFA5;NDUFS3;NDUFS5;BCS1L;NDUFB2;NDUFAB1;TIMM21;TMEM126B;NDUFB3;NDUFAF3;DMAC2
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.7711168930723228,-1.9262265699539007,0.0,0.020889753075651565,0.21,22/50,13.76%,NDUFB11;NDUFAF8;NDUFA6;NDUFB1;NDUFB7;NDUFA12;NDUFS6;NDUFA1;NDUFS8;NDUFB10;NDUFA3;NDUFA5;NDUFS3;NDUFS5;BCS1L;NDUFB2;NDUFAB1;TIMM21;TMEM126B;NDUFB3;NDUFAF3;DMAC2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.7313002562508297,-1.909684390977798,0.0,0.02875387008716408,0.28,31/72,14.03%,NDUFB11;NDUFAF8;SURF1;NDUFA6;NDUFB1;NDUFB7;NDUFA12;NDUFS6;NDUFA1;COX19;NDUFS8;NDUFB10;NDUFA3;NDUFA5;COX18;SMIM20;NDUFS3;COX17;NDUFS5;AIFM1;BCS1L;SLC25A33;NDUFB2;NDUFAB1;TIMM21;TMEM126B;SDHAF4;NDUFB3;NDUFAF3;DMAC2;COA5
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.676651761317951,-1.8879550691109637,0.0,0.038297880638694534,0.31,43/111,17.27%,LSM4;RPL23A;RPL10;MRPS7;SNRPB;SNRPD2;RPS19;EIF5;RPS15;RPS28;NOL3;RPLP0;SF3A2;MRPS11;RPL3;SNRPG;PUF60;RPF2;RPL11;RPL38;HSP90AB1;BRIX1;EIF4H;RPL6;SNRPD1;COIL;RPS5;DDX1;SNRNP200;PRMT5;SRSF9;DHX29;PRPF18;SNRPE;SRSF10;CDC73;RPS14;PRPF19;RPSA;ERAL1;RSL24D1;SF1;SRPK1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.6591823886090044,-1.886389174133798,0.0,0.037662696276882034,0.31,85/186,14.35%,TMA7;RPS2;RPL29;RPL15;RPL23A;MRPS33;TRMT112;MRPL36;MRPL27;RPL10;MRPL10;RPLP1;RPL7A;RPS27A;MRPS7;RPS23;MRPS16;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;MRPL47;RPS16;EEF1A1;MRPL52;RPL8;RPS15;RPS28;EEF2;RPS7;RPL19;MRPL28;RPLP0;RPL23;RWDD1;RPL41;RPS9;GSPT2;FARSA;UBA52;QARS1;RPL37;WARS2;MRPS11;RPL13A;RPL3;MRPS12;RPS15A;RPL31;RPL34;TUFM;RPL35;APEH;SARS1;RPL21;RPL4;RPL22L1;AARS1;RPL11;RPL38;MRPL32;RPS3A;RPL6;RPL36;RPS11;EEF1B2;EIF4EBP2;RPS13;RPS5;RPL30;RPL9;GSPT1;MRPS18B;MRPL24;MRPL16;MRPL13;GATC;MRPS2;RPL18A;MRPL9;RPS8;MRPS14;MRPL34
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6144692049740297,-1.8712269099742116,0.0,0.04526766379432937,0.36,85/302,11.67%,RPS2;SPCS2;RPL29;RPL15;MMP2;RPL23A;TMEM208;MRPS33;NCSTN;UBL5;MRPL36;MRPL27;RPL10;SCG3;MRPL10;RPLP1;RPL7A;CKAP4;RPS27A;MRPS7;NUCB1;RPS23;MRPS16;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;IGFBP7;ICMT;RPS16;EEF1A1;MRPL52;RPL8;RPS15;RPS28;CHGB;APH1A;RPS7;RPL19;MSRB2;MRPL28;RCN1;RPLP0;RPL23;VWA1;SEC11C;RPL41;RPS9;GSPT2;UBE2L6;UBA52;RPL37;MRPS11;RPL13A;RPL3;MRPS12;RPS15A;RPL31;RPL34;RPL35;SARS1;RPL21;RPL4;RPL11;RPL38;MRPL32;SEC11A;RPS3A;RPL6;RPL36;RPS11;EIF4EBP2;FN1;RPN1;MFGE8;RPS13;CST3;HM13;RPS5;MAN2B1;RPL30;RPL9;FURIN
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.658568541879204,-1.8528227280050908,0.0,0.058121444871731535,0.41,79/176,18.28%,RPS2;SRSF7;ILF2;APEX1;PSMD8;RAN;SNRPD2;ODC1;VBP1;RPL18;LSM7;EIF1AX;RANBP1;ERH;PPIA;CCT5;PSMA7;HDGF;NHP2;H2AZ1;NOP56;RPLP0;EIF3D;U2AF1;KPNA2;CANX;YWHAQ;PRPF31;CCT3;CSTF2;PA2G4;RPL34;TUFM;PHB2;SNRPG;SET;HSP90AB1;EIF4H;SRM;RPL6;CNBP;EEF1B2;COX5A;EIF3J;NDUFAB1;CYC1;SNRPD1;RPS5;GSPT1;MRPS18B;TARDBP;NPM1;PRDX4;RACK1;MRPL9;MCM4;RUVBL2;PCBP1;IMPDH2;PSMD3;CCT7;HNRNPA2B1;DEK;SERBP1;SNRPB2;PSMB2;BUB3;RSL1D1;POLD2;PRDX3;SRPK1;TRIM28;COPS5;PSMC4;SNRPA;CBX3;PGK1;EIF4G2;HNRNPR
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.660245077321992,-1.7820915191948763,0.0,0.13130701933266697,0.69,23/80,15.37%,AURKAIP1;SRSF7;SNRPB;HNRNPA0;PCBP3;TBRG4;ERN1;U2AF1;PRPF8;SF3A2;KIN;DXO;NUDT16L1;SNRPG;RNH1;DDX5;SF3B2;SRSF9;PRPF18;SNRPE;HNRNPA2B1;NONO;PRKACA
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.8089100351242499,-1.7811327734697058,0.0,0.12948484454798317,0.71,8/24,12.20%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;CTDP1;POLR2K;POLR2E
prerank,PanglaoDB_Augmented_2021__B Cells,0.7897583946628313,1.7766111527619228,0.0,0.2712128809404424,0.22,6/35,11.53%,EBF1;PTPRC;BCL11A;TRAF3IP3;CD27;PXK
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.6450722476640651,-1.772146625944288,0.0,0.13936692173885912,0.73,10/74,5.85%,SOX4;EIF5A;PIWIL2;TRMT10C;POLR2G;PCIF1;EEF2;FXR2;RPS9;EIF3D
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.9669327844561,-1.7677313927084086,0.0,0.1410181600228878,0.75,1/8,0.67%,SIRT2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.9036482592668345,1.756990518784514,0.0,0.23053094879937602,0.34,3/15,2.05%,CHRM3;HTR2C;HTR1F
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7727008014320598,-1.7522726977225045,0.0,0.1611313270774343,0.85,19/37,16.53%,MRPS7;RPS19;RPS24;RPS16;RPS15;NOL11;LTV1;RPS28;RPS7;RIOK2;MRPS11;NOP14;METTL17;RPS5;TSR3;NPM1;RPS14;RPSA;ERAL1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.7591528034663364,-1.7520009288729397,0.0,0.15658823037195724,0.85,12/32,13.85%,LSM4;SNRPB;SNRPD2;PRPF8;PRPF31;SNRPG;SNRPD1;COIL;CD2BP2;PRMT5;SNRPE;SRSF10
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.6745780269560218,-1.7482071439129112,0.0,0.15890598394132652,0.88,15/63,12.33%,POLR2L;ELOB;POLR2J;GTF2F1;POLR2I;POLR2G;ELOC;TCEA1;ADRM1;CCNK;CTDP1;TCEA2;POLR2K;POLR2E;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.6808624996033155,-1.7418020284453768,0.0,0.1636533826316898,0.88,14/51,9.23%,PPIF;PTTG1IP;TMBIM6;RTKN2;PPIA;NOL3;CXCL12;DNAJA1;SELENOS;CREB3;CLU;NDUFS3;TMEM161A;NOC2L
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.8705766492869733,-1.7402881085603306,0.0,0.16222110416877927,0.88,3/15,3.66%,SOX4;BAD;NLGN2
prerank,PanglaoDB_Augmented_2021__NK Cells,0.8069982012432219,1.7401973832283153,0.0,0.2380646399366105,0.5,10/28,13.68%,PTPRC;ITGA2;AHR;HSD11B1;ZBTB16;CD247;TRAF3IP3;CD27;AOAH;HMBOX1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.683291848028657,-1.7322192760866166,0.0,0.17025768426325374,0.92,24/53,14.81%,PPP1R14B;EIF5A;TUBA1C;AGRN;RPL8;NR2F6;HDGF;KDELR1;HNRNPAB;CCT3;SAPCD2;TUBG1;LAMA5;NOC2L;SLC25A1;GIPC1;FKBP4;PYCR1;DHCR7;PRMT5;PRDX4;MRPS2;PSMD3;TRAF4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.7057263836520853,-1.730253807399064,0.0,0.1690219687237892,0.92,23/54,12.71%,ZNF658;MRPL36;RPS19;RPS24;RPL35A;EBNA1BP2;RPS16;RPS15;LTV1;RPS28;RPS7;RIOK2;NOP14;METTL17;RPF2;RPL11;RPL38;NOC2L;NIP7;CUL4B;MRTO4;LTO1;NPM1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.6556181296557433,-1.7209241595066678,0.0,0.18107065517731746,0.96,41/87,15.40%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;MRPL27;MRPL10;MRPS7;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;EEF1A1;MRPS26;MRPL52;EEF2;MRPL28;MRPS11;MRPS12;TUFM;MRPL21;MRPL48;MRPS10;MRPL32;EEF1B2;MRPS18B;MRPL24;MRPL16;MRPL13;MRPS22;MRPS2;RACK1;MRPL9;MRPS23;MRPS14;MRPL34;MRPL4;MRPS18A;MRPL51
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.841989980193101,-1.720886326696575,0.02127659574468085,0.17682411719280183,0.96,7/15,11.18%,ATP5MC1;ATP5PD;ATP5F1A;ATP5F1E;ATP5PB;ATP5ME;ATP5F1D
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.7057274070472302,1.720565951012282,0.0,0.26217245157576097,0.63,22/50,21.99%,SLC6A15;SLC6A11;SLC6A17;SCN8A;SLC24A2;SLC4A4;HCN3;HCN1;SLC6A6;SLC12A1;SCN2A;NALCN;SLC6A7;SLC8A1;SLC8A2;SLC6A8;SLC6A1;SLC9A9;PKD2;KCNK1;SLC4A8;SLC24A3
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.8993906721106324,1.7187986686260188,0.0,0.21516221887941758,0.65,2/14,1.11%,HEY2;SOX9
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.6708066510617904,-1.7182891400569036,0.0,0.17606545007485505,0.96,14/62,12.33%,POLR2L;ELOB;POLR2J;GTF2F1;POLR2I;POLR2G;ELOC;TCEA1;ADRM1;CCNK;CTDP1;POLR2K;POLR2E;GTF2H2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.6658674594298581,-1.7179784781933858,0.0,0.17214029973489875,0.96,19/69,10.08%,UBB;PSMB6;ELOB;PSMD8;RPS27A;ATF4;PSMB4;UBC;ELOC;BAG3;STOX1;PSMA7;UBA52;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.7272038772869509,-1.7046077683036502,0.0,0.19055530854374841,0.98,10/35,12.20%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;LARP7;IFITM3;CTDP1;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.8375638779610645,-1.703288644323943,0.025,0.18851728385344094,0.98,1/8,2.31%,WDR18
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.7318627348548881,-1.702137693251836,0.0,0.1863207461316651,0.98,9/33,7.58%,TSR1;RPS19;RPS16;NOL11;RPS28;NGDN;RIOK2;MRPS11;NOP14
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.57439599373178,-1.7016945772357177,0.0,0.18324500258938464,0.98,80/249,12.70%,RPS2;RPL29;RPL15;PTMA;RPL23A;MRPS33;POLR2L;MRPL36;POLR2J;MRPL27;RPL10;MRPL10;RPLP1;RPL7A;RPS27A;MRPS7;RPS23;MRPS16;RPL10A;RPS19;RPL18;POLR2I;RPL13;RPS24;RPL35A;RPS16;EEF1A1;POLR2G;MRPL52;RPL8;RPS15;RPS28;EEF2;RPS7;PIF1;RPL19;MRPL28;PAX8;RPLP0;RPL23;RPL41;RPS9;GSPT2;RPL37;KIN;MRPS11;RPL13A;RPL3;MRPS12;RPS15A;RPL31;RPL34;TUFM;RPL35;SARS1;RPL21;RPL4;PTMS;SET;RPL11;RPL38;MRPL32;RPS3A;RPL6;RPL36;RPS11;EEF1B2;EIF4EBP2;RPS13;RPS5;GAL3ST4;POLR2K;RPL30;RPL9;GSPT1;POLR2E;MRPS18B;MRPL24;RAD17;MRPL13
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.6694771791023492,-1.7016821670358397,0.0,0.1793461727470573,0.98,19/54,15.66%,PSMB6;CALR;PSMD8;PSMB4;PSMA7;HLA-B;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2;ITGB5;B2M;PSMD3;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7649266374954419,-1.7008255607841554,0.0,0.17724445978517772,0.98,8/24,9.84%,RPL7A;RPL10A;NIFK;NHP2;RPL35;RPF2;ZNHIT3;RPF1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.8292083923972847,-1.6984215509115168,0.0196078431372549,0.17418997028057942,0.98,4/17,3.33%,POLR2L;POLR2J;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.8292083923972847,-1.6984215509115168,0.0196078431372549,0.17418997028057942,0.98,4/17,3.33%,POLR2L;POLR2J;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7630480951647646,-1.6969311189087217,0.0,0.17560979414816028,1.0,7/23,12.33%,UBB;RPS27A;UBC;PARP1;UBA52;CUL4B;GTF2H2
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.5695010629970507,-1.696752076299431,0.0,0.17244824302601663,1.0,61/244,13.85%,LSM4;RBM8A;SRSF7;CPSF1;UBL5;POLR2L;POLR2J;SF3B5;PPWD1;RBM22;GTF2F1;SNRPB;SNRPD2;POLR2I;LSM7;DNAJC8;HSPA8;HNRNPA0;POLR2G;SMU1;SF3B6;ZMAT2;SCNM1;U2AF1;PRPF8;SF3A2;PRPF31;CSTF2;CWC15;CSTF2T;SNRPG;PUF60;RBM15B;BUD13;CACTIN;MAGOH;SLU7;DDX5;SNRPD1;COIL;SYF2;EIF4A3;SMNDC1;POLR2K;DCPS;DDX1;CD2BP2;YBX1;POLR2E;PDCD7;SNRNP200;SF3B2;SNIP1;NOVA1;PRMT5;SRSF9;BUD31;PRPF38A;SNRPE;WBP11;SRSF10
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.9039812015848894,-1.6964374620158627,0.0,0.17025196823276076,1.0,2/9,1.90%,SMYD2;CSKMT
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.8508091905123393,-1.6860349365506921,0.022222222222222223,0.18495074064540284,1.0,7/14,11.18%,ATP5MC1;ATP5PD;ATP5F1A;ATP5F1E;ATP5PB;ATP5ME;ATP5F1D
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.7094097747708122,-1.6798060186930281,0.0,0.19565037026951704,1.0,19/51,15.66%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;UBA52;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;MCM4;PSMD3;PSMD4;PSMB2
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.793981452443244,-1.6791524425058535,0.0,0.19255693993601466,1.0,5/22,6.23%,UBB;RPS27A;DERL2;UBC;UBA52
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.708141933137741,-1.6780907049202243,0.0,0.19212852058538923,1.0,19/47,12.71%,RPL23A;RPL10;RPL7A;RPL10A;RPL35A;EBNA1BP2;NHP2;RPLP0;RPL3;RPF2;RPL11;BRIX1;NOC2L;RPL6;RPF1;NIP7;MRTO4;LTO1;NPM1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7137737812953142,-1.6780053518823015,0.0,0.18939574277167687,1.0,23/39,17.17%,RPL23A;RPL10;MRPS7;RPS19;RPS15;RPS28;RPLP0;MRPS11;RPL3;RPF2;RPL11;BRIX1;RPL6;RPS5;SBDS;NPM1;DHX29;MRPS2;RPS14;RPSA;ERAL1;RSL24D1;MTERF3
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.8398281648691965,1.677964121082993,0.0,0.39476541559108835,0.88,5/19,8.37%,HEY2;ROBO2;SOX9;SLIT3;EFNA1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.6918076501971586,1.677280095856926,0.0,0.34482780576713384,0.89,19/63,14.28%,HEY2;CORO6;FABP3;EDNRA;CKMT2;ZFPM2;SYNPO2;SORBS1;PDE1A;LAMA2;CAV3;TTN;RYR2;MYOM1;TPM1;SGCA;ADIPOR2;PRKG1;MYOM2
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.7647252719589512,-1.6755478484012303,0.027777777777777776,0.1905553085437484,1.0,9/28,9.03%,UBB;SIRT2;RPS27A;UBC;CDC26;NPM2;UBA52;PHB2;ANAPC11
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6119140655152129,1.6747800458416384,0.0,0.31867513510501977,0.89,32/136,13.18%,GABRA4;UNC13C;CHRM3;GLRA1;GABRG3;GLRA2;GRIN2A;SYT1;HTR2C;HTR1F;KCNQ3;PCDHB5;KCNC4;APBA2;PRKAR1B;GRM3;GRIN1;NRGN;CHRNB3;GABRB1;SNAP25;GABRG2;AKAP5;PRKAR2A;GPR176;GABRA2;CPLX1;DLG4;GRM1;CAMK1;KCNMB4;RPS6KA2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.6756109447215681,-1.6728211711671013,0.0,0.1901816706838587,1.0,18/63,10.08%,UBB;SIRT2;PSMB6;ELOB;PSMD8;RPS27A;PSMB4;UBC;ELOC;STOX1;PSMA7;UBA52;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.77014526627322,-1.6725230661052979,0.022222222222222223,0.1870639383775659,1.0,2/17,2.82%,TRMT112;BUD23
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.6566806413960574,-1.6718556138971474,0.0,0.18495074064540284,1.0,19/56,15.66%,PSMB6;CALR;PSMD8;PSMB4;PSMA7;HLA-B;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2;ITGB5;B2M;PSMD3;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.6213889489715377,-1.6683257420860447,0.0,0.18877608063951168,1.0,23/97,10.08%,UBB;SIRT2;PSMB6;ELOB;PSMD8;RPS27A;BAD;PSMB4;UBC;ELOC;MT3;STOX1;ZFP36L1;PSMA7;SFRP1;UBA52;PSMC3;PSMC1;PSMD10;PSMD12;STUB1;PSMB9;PSME3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.7124120633619108,1.6679475651696178,0.0,0.32143748852200577,0.9,19/50,14.78%,SLC6A15;NEDD4L;SLC6A11;SLC6A17;SCN8A;SLC24A2;SLC4A4;HCN3;HCN1;SLC6A6;SLC9B2;SLC12A1;SGK1;SCN2A;NALCN;SLC6A7;SLC8A1;SLC8A2;SLC6A8
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.5930676030572377,-1.6665435133441393,0.0,0.1888038810755154,1.0,32/115,15.80%,MRPL40;POLR2J;SURF1;GPX4;EIF1B;VPS37B;GTF2F1;POLR2I;VPS28;TMED2;NME3;POLR2G;MPC2;DAD1;ADRM1;GTF2A2;EDF1;POLR1D;MPG;COX17;ADCY6;POLR2K;TAF6;GMPR2;POLR2E;DGCR8;RFC5;IMPDH2;DGUOK;PRIM1;NT5C;POLD3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.853718594297922,-1.6644283206784163,0.0,0.18917572259954024,1.0,4/13,9.48%,PPIF;BAD;SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.8609963673038175,-1.6643891524896541,0.023809523809523808,0.18630942377227452,1.0,5/11,8.88%,PPIF;GPX1;NOL3;CLU;PSMD10
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.8494239454768187,-1.6593113130073798,0.0,0.19206101335225914,1.0,5/17,6.23%,UBB;RPS27A;DERL2;UBC;UBA52
prerank,PanglaoDB_Augmented_2021__Macrophages,0.673621112099256,1.6590433230276784,0.0,0.3408241870484892,0.93,7/36,8.97%,PTPRC;AHR;EGLN3;NR4A3;SPI1;NAAA;RAB20
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.7937141381750112,-1.6555323983999028,0.0,0.1966543971390068,1.0,4/17,3.66%,MT1E;JUN;MT2A;MT3
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.573209322747232,-1.6524101425130913,0.0,0.20241424931416072,1.0,56/225,13.85%,LSM4;RBM8A;SRSF7;CPSF1;UBL5;POLR2L;POLR2J;SF3B5;PPWD1;RBM22;GTF2F1;SNRPB;SNRPD2;POLR2I;LSM7;DNAJC8;HSPA8;HNRNPA0;POLR2G;SMU1;SF3B6;ZMAT2;U2AF1;PRPF8;SF3A2;PRPF31;CSTF2;CWC15;CSTF2T;SNRPG;PUF60;RBM15B;BUD13;CACTIN;MAGOH;SLU7;DDX5;SNRPD1;SYF2;EIF4A3;SMNDC1;POLR2K;CD2BP2;YBX1;POLR2E;PDCD7;SNRNP200;SF3B2;SNIP1;NOVA1;SRSF9;BUD31;PRPF38A;SNRPE;WBP11;SRSF10
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.6358180674965128,-1.6491794266684405,0.023255813953488372,0.207369012238785,1.0,26/94,14.69%,LSM4;IMP3;YIF1A;CALR;POP4;BANF1;ATF4;LSM1;BAG3;EEF2;NHP2;ERN1;NOP56;NOP14;TUBB2A;SEC11A;PSAT1;EIF4A3;DCP1A;ATP6V0D1;NPM1;FKBP14;HSPA9;HSPA5;HSP90B1;RPS14
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.6469080138867467,-1.6485227230012254,0.02127659574468085,0.20571132314209126,1.0,12/60,7.06%,POLR2L;POLR2J;RAN;GTF2F1;POLR2I;HNRNPA0;POLR2G;LSM1;NT5E;DDX54;KPNA2;DXO
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.8684567318271235,-1.6484831154993385,0.0,0.20285422143178444,1.0,4/12,7.71%,CALR;CXCL12;MOSPD2;CREB3
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.766593485586067,-1.645918075922365,0.0,0.20713868753063383,1.0,10/24,10.54%,OST4;DDOST;MAGT1;DAD1;UBE2J1;OSTC;DPM2;STT3A;ALG8;RPN1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.790743463075564,1.644225370177481,0.0,0.41668160799031595,0.96,5/20,7.07%,CDH9;PCDHB5;CDH7;CDH8;CDH12
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.9234429743659671,1.6427146364902434,0.0,0.39325867736364145,0.97,2/9,3.35%,ITGA2;ITGA8
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.7372676911716762,1.6415524030366533,0.0,0.3727438568822489,0.97,7/36,5.87%,GLRA1;AKR1C2;AHR;GLRA2;GRAMD1C;KLF9;ADCY5
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.7855045649865838,-1.6360832109349814,0.0,0.2290299097918502,1.0,3/19,1.90%,TRMT112;SMYD2;CSKMT
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.7687355103441338,1.6340419757114657,0.0,0.3803437782712394,0.98,6/27,10.34%,PTPRC;GPR18;FOXP1;SLC12A1;DOCK8;TRAF3IP3
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7946707755375549,-1.6337999954776585,0.023255813953488372,0.23120710769974806,1.0,9/15,16.53%,MRPS7;RPS19;RPS15;RPS28;MRPS11;RPS5;RPS14;RPSA;ERAL1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.7942713011587884,-1.6314953246393376,0.0,0.2343594313281859,1.0,4/19,4.93%,NOP10;TRMT112;BUD23;NHP2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7768112139434528,-1.6285130721471777,0.0,0.23801216918947948,1.0,7/19,12.33%,UBB;RPS27A;UBC;PARP1;UBA52;CUL4B;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.715075956543746,-1.6256255814977927,0.024390243902439025,0.2418586608439883,1.0,6/24,7.95%,UBXN1;TMBIM6;ALOX5;SELENOS;CREB3;CLU
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.6285998542467812,-1.6231514876380297,0.0,0.2466009875272038,1.0,16/62,10.08%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;CDC26;PSMA7;UBA52;PSMC3;PSMC1;PSMD10;PSMD12;ANAPC11;PSMB9;PSME3
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.6181333649145172,-1.6225175079488214,0.0,0.24562018814499337,1.0,17/74,9.64%,NOX4;GPX1;GSTP1;SIRT2;PRDX5;ATF4;PRDX1;LRRC8D;MT3;STOX1;PPIA;PARP1;SELENOS;SLC25A24;TMEM161A;CHCHD2;CAV1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.5787112406900282,1.6207199147536608,0.0,0.4550349446889644,1.0,47/178,13.89%,GABRA4;UNC13C;CHRM3;GLRA1;GABRG3;GLRA2;GRIN2A;SYT1;HTR2C;SHISA6;HTR1F;KCNQ3;PCDHB5;RAB3A;KCNC4;GRIK5;CBLN2;APBA2;CDH8;PRKAR1B;GRM3;GRIN1;SYN3;NRGN;GRIK3;CHRNB3;GABRB1;SNAP25;GABRG2;NAAA;AKAP5;SLC1A4;PRKAR2A;GPR176;NAPB;GABRA2;CPLX1;LIN7A;DLG4;GRM1;CAMK1;STXBP3;KCNMB4;STX1A;RPS6KA2;SNCA;ERC1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.7950697159358715,-1.61813258918768,0.0,0.2547656666877566,1.0,4/16,3.66%,MT1E;JUN;MT2A;MT3
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.8144327380606877,-1.6164007511775216,0.0,0.25348852879986944,1.0,3/14,6.73%,CD320;CUBN;MMACHC
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.8144327380606877,-1.6164007511775216,0.0,0.25348852879986944,1.0,3/14,6.73%,CD320;CUBN;MMACHC
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.9222205421518814,-1.61623239815862,0.0,0.2507376924045541,1.0,1/8,0.56%,NOX4
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.6049610544611578,-1.615977325184343,0.029411764705882353,0.2481834537573249,1.0,10/75,5.85%,SOX4;AURKAIP1;PIWIL2;BAD;PTTG1IP;PCIF1;EEF2;FXR2;VPS35;EIF3D
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.7860202987647813,1.6136705332188608,0.017857142857142856,0.47801270265752965,1.0,7/21,10.34%,PTPRC;AHR;IL5;STAT6;CD247;RORA;TRAF3IP3
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.7007366292031557,-1.6132308430770588,0.045454545454545456,0.25129318390721406,1.0,8/37,9.07%,CNPPD1;CDKN2C;CCND1;ACTB;STOX1;CDC37;CCNK;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.8412515611982379,-1.611696589017943,0.02564102564102564,0.25291417895292634,1.0,3/10,5.54%,TRMT112;BUD23;RIOK2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.7446475165123051,-1.6116676848925209,0.02127659574468085,0.2500401541920977,1.0,10/25,10.54%,OST4;DDOST;MAGT1;DAD1;UBE2J1;OSTC;DPM2;STT3A;ALG8;RPN1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.7583981299931827,1.611532508433644,0.0,0.46744337715029183,1.0,4/19,5.97%,RASGRF1;MMD2;RELN;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.937480214983011,1.6112807994323723,0.0,0.44398553102102045,1.0,2/6,0.47%,PTPRC;AHR
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.6538573506101312,-1.6093731262667519,0.0,0.2531501455207761,1.0,16/51,15.66%,PSMB6;PSMD8;ODC1;PSMB4;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;CAV1;PSMB9;PSME3;PSMD2;PSMD3;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.7118032870898654,-1.6082044297669544,0.0,0.2550701123513704,1.0,19/47,10.93%,PPIF;BAD;AIP;TIMM8B;TSPO;SLC25A6;TIMM13;TOMM7;TIMM23;SLC25A4;DNAJC19;COX18;TIMM44;SLC25A24;SLC25A5;BCS1L;TIMM22;STARD3;MFF
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.6993985897649957,-1.6080845043116212,0.0,0.2527598533495615,1.0,2/26,2.93%,COPZ1;GABARAPL2
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.8909831366082954,1.6059724800255073,0.0,0.459634461383276,1.0,3/11,5.39%,FOXO1;SOX9;GLDC
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.5635214395499472,-1.6054077968918272,0.0,0.2569572542958858,1.0,30/136,13.40%,NR0B1;TAF9B;POLR2L;POLR2J;GTF2F1;POLR2I;ESRRB;POLR1F;POLR2G;NR2F6;YAP1;NR2E1;SMARCA5;MED23;GTF2A2;POLR1A;TAF7;TAF11;RRN3;HNF4G;NAT14;RXRB;TAF4B;POLR2K;TAF6;ESRRA;POLR2E;GTF2H2;AR;TAF1A
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.9637072072076062,1.6052162768079168,0.0,0.44298103886938917,1.0,2/8,1.11%,HEY2;SOX9
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.8659976201491342,1.6035050151636938,0.0,0.43437110614112123,1.0,5/16,8.37%,HEY2;ROBO2;SOX9;SLIT3;EFNA1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.85269747339052,1.6033720811188277,0.0,0.41544882216785944,1.0,6/14,9.69%,PTPRC;ITPR1;HTR2C;RYR2;ITPR2;RYR3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.8241493407524731,-1.6028352435321183,0.023809523809523808,0.2620286152903915,1.0,3/13,8.81%,JUN;TAF11;CTDP1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.8877936636602626,1.6024102414601382,0.0,0.40288869994775856,1.0,2/12,0.78%,HEY2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.7604201894490497,-1.599782259713511,0.047619047619047616,0.26687282886164515,1.0,8/18,16.06%,SRSF7;TMBIM6;SAP18;PCBP4;RPS13;SRSF9;SRSF10;RPS26
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6992633662542895,-1.5997155903521505,0.022727272727272728,0.2642996229956634,1.0,8/25,11.18%,ATP5MC1;ATP5PD;ATP5F1A;ATP5F1E;MICOS13;ATP5PB;ATP5ME;ATP5F1D
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.8576689473072314,-1.5985986539943264,0.021739130434782608,0.26469907136561127,1.0,2/11,3.60%,TRIR;EXOSC8
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.5926801282561818,-1.595280680199299,0.0,0.2724860021504904,1.0,27/99,11.09%,SPCS2;ZDHHC1;VPS37B;SRP14;AIP;ZDHHC6;NACA;AP4M1;TIMM8B;ICMT;TSPO;SEC61G;SLC25A6;ZDHHC4;GOLGA7;TIMM13;TOMM7;CDC37;TIMM23;YIF1B;DNAJC19;TIMM44;RPL11;GIPC1;TIMM22;MFF;MICALL1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.938296517056258,1.5923537087628352,0.0,0.45767173658699656,1.0,1/9,0.26%,VSIR
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.76035461375918,-1.5913515500230613,0.08888888888888889,0.27558622756713225,1.0,5/15,6.23%,UBB;RPS27A;UBC;IRF3;UBA52
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.76035461375918,-1.5913515500230613,0.08888888888888889,0.27558622756713225,1.0,5/15,6.23%,UBB;RPS27A;UBC;IRF3;UBA52
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.8670492416551174,-1.59098456572636,0.023809523809523808,0.27395127887113,1.0,2/8,5.90%,DHFR;APOD
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.563891873471168,-1.5884387911735554,0.0,0.2783417086940716,1.0,30/156,12.90%,AURKAIP1;LSM4;RBM8A;SRSF7;PIWIL2;SNRPB;SNRPD2;MRPL44;HNRNPA0;LSM1;SMU1;NOL3;DDX54;SCNM1;U2AF1;PRPF8;SF3A2;KIN;SNRPG;TSEN34;MAGOH;SLU7;SNRPD1;YJU2;PDCD7;SF3B2;TARDBP;PPP2R1A;NOVA1;SRSF9
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.5506773087086989,-1.5880022699071699,0.0,0.27671180329478573,1.0,38/145,16.64%,UBB;SIRT2;PSMB6;PSMD8;RPS27A;SSNA1;PSMB4;UBC;ZFP36L1;CDC26;TUBA1A;PSMA7;NPM2;RIOK2;UBA52;TUBG1;PSMC3;PSMC1;PSMD10;PSMD12;TUBB4B;ANAPC11;PSMB9;PSME3;ODF2;PRKAR2B;PSMD2;PPP2R1A;HAUS8;KNTC1;PSMD3;PSMD4;PRKACA;PSMB2;UBE2S;DCTN3;BUB3;DYNLL1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.8129291512368274,-1.5876053553124965,0.04,0.27522237310516257,1.0,5/18,11.85%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V0E2;ATP6V0D1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.6360894767327379,-1.5872625687056592,0.0,0.2733304651962364,1.0,15/57,15.10%,CPSF1;POLR2L;SNRPB;POLR1F;CSTF2;POLR1A;CSTF2T;SNRPG;POLR2K;POLR2E;GTF2H2;PRMT5;TAF1A;SNRPE;POLR1G
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.8607686898945557,1.5871170687974014,0.0,0.4842053967723364,1.0,5/10,10.52%,ADAMTS9;PKP2;TGFBR3;PROX1;TPM1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.8241445925226543,-1.5840996476174964,0.022222222222222223,0.2789473508262266,1.0,3/14,0.80%,THNSL2;HSD17B10;HPD
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.7120498578188577,-1.5836973031444166,0.022222222222222223,0.27716174455780496,1.0,2/32,0.60%,PPIF;GPX1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.6034823405825059,-1.583489865380155,0.0,0.27499048099358964,1.0,12/66,12.20%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;NABP2;GTF2A2;CCNK;TAF11;POLR2K;TAF6;POLR2E
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.6043612694430462,-1.5834743304125203,0.0,0.27244427283624156,1.0,12/65,12.20%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;NABP2;GTF2A2;CCNK;TAF11;POLR2K;TAF6;POLR2E
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.8509722686855479,1.5834347014652663,0.0196078431372549,0.49270340037513694,1.0,6/13,10.34%,PTPRC;IL5;CD247;CYLD;RORA;TRAF3IP3
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6307216958557404,1.5809156065535086,0.01639344262295082,0.49688878434026723,1.0,25/88,17.34%,HOOK1;ABLIM1;BAIAP3;RAPGEF5;KIAA1671;NEBL;SORBS1;ARFGEF3;ADCY5;SYBU;SH3BGRL2;SRCIN1;USP54;AQP4;SHC2;RAI2;PDE9A;NDRG2;SLC22A23;ASAP3;PPP1R13B;MTUS1;CHDH;SLC6A1;PRKCZ
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7749416150131674,-1.5805240098980273,0.0,0.27878868940210577,1.0,8/28,11.40%,LSM4;LSM7;POLR2G;LSM1;EXOSC8;EDC3;DCPS;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.8686176667375872,-1.5796247799361287,0.02631578947368421,0.2785979751650311,1.0,3/9,5.15%,BTC;SIRT2;NPM2
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.5669508448686941,-1.579458511246746,0.0,0.27618906670225324,1.0,36/179,13.43%,GTF3C6;GMEB2;PTMA;TAF9B;POLR2L;ELOB;POLR2J;GTF2F1;ATF4;POLR2I;POLR2G;ELOC;TCEA1;PARP1;PAX8;SMARCA5;DRAP1;GTF2A2;BTF3;CCNK;TAF7;TAF11;CTDP1;NAT14;COPS2;SLC25A33;TAF4B;DDX5;TCEA2;POLR2K;TAF6;POLR2E;GTF2H2;PRMT5;TAF1A;RO60
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.860828298424519,1.57891869516783,0.0,0.4956092526709274,1.0,6/13,9.69%,PTPRC;ITPR1;HTR2C;RYR2;ITPR2;RYR3
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.5771971788335564,-1.5785119819918019,0.023809523809523808,0.277025784689651,1.0,13/112,5.25%,LAGE3;POLR2L;POLR2J;GTF2F1;RNASEH2C;MRPL44;POLR2I;HNRNPA0;POLR2G;LSM1;PCBP3;TBRG4;DDX54
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.6944992141378589,-1.5779196215207687,0.0,0.2762605592370324,1.0,7/24,9.32%,CALR;RARRES2;CXCL12;MOSPD2;VEGFB;CREB3;PTN
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.5365150855786815,-1.5777748137571084,0.0,0.2748204785241366,1.0,62/265,13.85%,AURKAIP1;LSM4;RBM8A;SRSF7;CPSF1;UBL5;POLR2L;POLR2J;SF3B5;PPWD1;RBM22;GTF2F1;SNRPB;SNRPD2;POLR2I;LSM7;DNAJC8;HSPA8;HNRNPA0;POLR2G;SMU1;SF3B6;TBRG4;ERN1;ZMAT2;U2AF1;PRPF8;SF3A2;KIN;PRPF31;CSTF2;CWC15;CSTF2T;SNRPG;PUF60;RBM15B;BUD13;CACTIN;MAGOH;SLU7;DDX5;SNRPD1;SYF2;EIF4A3;SMNDC1;POLR2K;CD2BP2;YBX1;POLR2E;PDCD7;SNRNP200;GTF2H2;SF3B2;SNIP1;NOVA1;SRSF9;BUD31;PRPF38A;PRPF18;SNRPE;WBP11;SRSF10
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.7401006712832938,-1.576645513357111,0.02127659574468085,0.27564726985254245,1.0,5/21,12.99%,TRMT112;SMYD2;PRMT5;PRMT6;PRMT1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.7832404056536235,-1.575772737430361,0.0,0.27559013182899106,1.0,9/20,17.53%,PTTG1IP;CXCL12;CLU;TMEM161A;PSMD10;CD44;YJU2;TPT1;CDKN2D
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.8454781368738995,-1.5755459122377884,0.0,0.2739052926729898,1.0,4/9,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.7425856379837509,1.574077942557532,0.0,0.5174866463921084,1.0,11/28,17.35%,UNC13C;SYT1;PCLO;RAB3A;SNAP25;CPLX1;STX1A;SNCA;SYT2;UNC13A;STX1B
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.6782533385844096,-1.5740751849753118,0.022727272727272728,0.27728362195373957,1.0,6/45,3.66%,RRAGA;SIRT2;DAPL1;KIF25;LZTS1;MT3
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.7932459274396139,1.5724319778604372,0.018518518518518517,0.514099083204883,1.0,9/24,9.69%,PTPRC;ITPR1;GRIN2A;HTR2C;SLC24A2;GRIN1;RYR2;ITPR2;RYR3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.8796720448927995,1.5693799480955377,0.037037037037037035,0.5249281566589207,1.0,3/11,3.46%,TPCN2;EDNRA;MYLK
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.9640423496617494,-1.5690570475753653,0.0,0.2925678637354832,1.0,1/5,1.90%,ATF4
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.5305967217671993,-1.5684664960535502,0.0,0.2918111685738578,1.0,35/129,18.06%,BTG1;CUL7;PSMB6;PSMD8;PSMB4;TRIM35;BTG3;CDC26;PSMA7;DUSP3;CUL9;PSMC3;PSMC1;PSMD10;PSMD12;ANAPC11;PSMB9;PSME3;BRINP1;AFAP1L2;CDKN1C;PSMD2;GAS1;PRMT5;SMAD3;PSMD3;HECA;PSMD4;PSMB2;UBE2S;BUB3;ANAPC2;PSMC4;PSMD11;PIN1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.6838202032089236,-1.5680933164963309,0.0,0.291252255742122,1.0,16/45,15.66%,PSMB6;PSMD8;ODC1;PSMB4;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;BHMT;PSMD2;PSMD3;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.6338493223282586,-1.567708914873453,0.0,0.28996748011768075,1.0,17/50,18.01%,PSMB6;PSMD8;PSMB4;PSMA7;NABP2;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PSMD3;PSMD4;PSMB2;PSMC4;PSMD11
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.688628091318026,-1.563733790976269,0.0,0.30045951806252436,1.0,17/42,18.01%,PSMB6;PSMD8;ODC1;PSMB4;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PSMD3;PSMD4;PSMB2;PSMC4;PSMD11
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.6066982732515718,-1.563642304718111,0.06382978723404255,0.2984884387151125,1.0,11/78,8.15%,CNPPD1;CDKN2C;CCND1;THY1;CALM1;ACTB;SYAP1;PIH1D1;CDC37;CCNK;CALM3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.5304380390758362,-1.563443161788198,0.0,0.2966385697236328,1.0,43/258,12.33%,NR0B1;GMEB2;TAF9B;CPSF1;POLR2L;ELOB;POLR2J;GTF2F1;SNRPB;ATF4;PRRX1;POLR2I;ESRRB;POLR2G;ELOC;TCEA1;NR2F6;PARP1;YAP1;NABP2;NR2E1;DRAP1;MED23;ADRM1;GTF2A2;CSTF2;BTF3;CCNK;TAF7;CSTF2T;SNRPG;TAF11;CTDP1;HNF4G;RXRB;COPS2;TAF4B;DDX5;POLR2K;TAF6;ESRRA;POLR2E;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.8826726475137991,-1.5618199411576716,0.0,0.2991771720973977,1.0,3/9,3.57%,JUN;SIRT2;BAG3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.7288691921386901,-1.5595923328060497,0.023809523809523808,0.3036175365402939,1.0,4/18,11.33%,CALM1;PDGFD;CALM3;RAP2C
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.7766539518675999,-1.5595883125496672,0.05555555555555555,0.30124552453607284,1.0,7/15,17.53%,TAF9B;CXCL12;CLU;TMEM161A;CD44;TPT1;CDKN2D
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.731312279990423,1.558945093800115,0.0,0.5989284454101437,1.0,6/27,10.70%,HEY2;SOX9;TTN;RYR2;TGFBR3;HES1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.8215649151079794,-1.5559370785717777,0.03508771929824561,0.31159659664290096,1.0,7/13,11.85%,ATP6V0A4;PPT1;TMEM9;ATP6V0E1;GRN;ATP6V0E2;ATP6V0D1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.7252025093659089,-1.5545276062592568,0.0,0.31394202642886326,1.0,7/24,8.61%,TSR1;RPS19;RPS16;NGDN;MRPS11;NOP14;KRI1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.6187155596937236,-1.5539057621346346,0.0,0.3138558023073503,1.0,14/57,10.08%,PPIF;GPX1;GSTP1;TMBIM6;RTKN2;PIH1D1;NOL3;QARS1;CLU;NDUFS3;PSMD10;NOC2L;SLC25A5;PSME3
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8328051284608251,-1.5517256134681856,0.045454545454545456,0.320734135637138,1.0,5/11,12.38%,H1-4;BANF1;NOC2L;AIFM1;H1-10
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.9371321003297481,-1.5513857504544049,0.0,0.31891255529833873,1.0,2/6,3.53%,UBB;MAP1S
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.7797873924883534,1.5512242185324236,0.0,0.6607732008367142,1.0,3/18,0.92%,SCEL;AHR;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.8879810656605521,1.5506500411781563,0.018867924528301886,0.6477201744812918,1.0,5/8,8.69%,DOCK5;NR4A3;FGF9;DOCK7;DOCK4
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),-0.9767738438176599,-1.5488623432559985,0.0,0.32464668676834396,1.0,1/5,0.67%,SIRT2
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.9275858518853107,1.5472564719534998,0.0,0.6620177274765274,1.0,2/9,1.86%,PON1;PON3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7202121755609955,-1.5467939894122034,0.05357142857142857,0.32929950051612467,1.0,6/16,6.32%,EIF5A;UBB;RPS15;RPS7;RPL23;RPL37
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.8936083145631136,-1.5462300939583644,0.038461538461538464,0.32910352379549623,1.0,2/6,3.66%,ATF4;MT3
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.9233738032466272,-1.5462292239844337,0.0,0.3267013082933393,1.0,3/8,2.86%,HSD17B10;TRMT5;TRMT10C
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.9264653092804673,1.5450781987525324,0.0,0.6612069588112821,1.0,2/9,2.70%,INTU;WNT7A
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.529274972155267,1.544619455601473,0.0,0.6462685316103334,1.0,108/354,21.22%,EEF2K;CTBP1;IGF1R;NUAK1;TLK1;VRK1;NEK3;AKT2;GRK4;CAMK1D;ALK;DAPK1;MERTK;PAK1;RPS6KB2;RELN;DAPK2;BCR;FAM20C;CAMK2B;CDC42BPB;PRKX;PRKAR1B;PNCK;TSSK3;CDKL1;PRKCA;TGFBR3;CDK19;MAK;RIPK1;LIMK1;TYRO3;PAK2;CDK14;OXSR1;ATM;CDK6;JAK1;SGK1;CDK7;MAP3K9;GRK5;TNKS;EPHA4;MAPK10;TOP1;PXK;RARA;TTBK2;TAF1;MAST4;PRKAA2;PDPK1;CAMK1;STK11;MAPK12;PIK3CD;TNIK;RPS6KA2;CIT;PLK2;PRKG1;AKT3;ACVR1C;MAPKAPK5;ERC1;FAM20A;LMTK2;SIK3;STK3;NIM1K;MASTL;CSNK1G1;PRKAA1;CAMK2D;MAP3K5;DAPK3;ADAM10;CSNK1D;CDC7;VRK2;CDK13;PRKCE;SRPK2;MKNK1;CDK17;STK17A;PRKCZ;STK17B;CDK12;RYK;DCLK1;NEK4;NEK7;ABL2;ABL1;NEK11;MAML1;ACVR1B;FER;MAPK1;CSNK1G2;TAOK1;STK24;BRSK1;TGFB2;PRKD2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.7136640937096826,-1.5445012539339347,0.0,0.32993847540695054,1.0,15/35,11.25%,AIP;ROMO1;TIMM8B;TSPO;SLC25A6;TIMM13;TOMM7;TIMM23;DNAJC19;TIMM44;AIFM1;TIMM22;GRPEL1;MFF;TIMM21
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.8203051072530656,1.5439650417206274,0.0,0.6347333038150001,1.0,3/14,3.98%,SOX9;FABP3;NR4A3
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.8917469586199127,1.5421916586359672,0.017241379310344827,0.6365389496260297,1.0,1/7,1.30%,MCCC1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8544058250203959,-1.5407751577776458,0.023255813953488372,0.3387739531071887,1.0,4/8,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6976497371837788,-1.540305792977498,0.0,0.3377953137588548,1.0,10/40,10.38%,BGN;STAB2;BCAN;HSPG2;AGRN;GPC4;GUSB;GALNS;SGSH;CD44
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.9696510507114414,1.5398276861415428,0.0,0.640062399019444,1.0,2/6,1.86%,PON1;PON3
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.7074961412723572,-1.5378727940866987,0.044444444444444446,0.3421568827585703,1.0,6/19,16.47%,AP4M1;HSPA8;CLU;AP3M1;SCARB2;NCOA4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.7570561355990852,1.5371910459543718,0.0,0.647382941822064,1.0,5/22,5.24%,CHRM3;NEDD4L;KCNJ13;KCNJ11;AHCYL1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.6322685414920798,-1.5365868607804694,0.021739130434782608,0.3447203945362673,1.0,13/55,8.35%,MT1E;SLC22A17;MT2A;FTL;ISCU;SLC30A10;MT3;ATP6V1G1;COX19;CYBRD1;SLC31A1;ABCG2;CYB561A3
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.7981181822947323,-1.5361916043749517,0.07317073170731707,0.3434071603168086,1.0,2/11,15.10%,NIFK;POLR1G
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.8895586110557513,-1.5356136595195102,0.0,0.3441360372025783,1.0,3/8,2.86%,HSD17B10;POP4;TRMT10C
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.6655747419053735,-1.5353180847696692,0.0,0.3424584246851137,1.0,14/48,14.57%,MMP2;COPS9;ATF4;PARP1;OPN3;SMPD1;MAPK13;TMEM161A;NOC2L;CUL4B;NPM1;CASP9;RUVBL2;TIMP1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.7356420075269118,-1.5339527781950557,0.018867924528301886,0.3444889884914581,1.0,1/16,0.04%,NR0B1
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.8227517392866782,1.5314012726857376,0.03225806451612903,0.6855658934883405,1.0,2/11,10.00%,GRAMD1C;RORA
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.6952948297519757,1.5306067035409092,0.019230769230769232,0.6769809896342824,1.0,3/22,5.11%,PON1;PON3;DDO
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.8835661461580075,1.529819706004844,0.03773584905660377,0.66940270159391,1.0,2/8,2.42%,MREG;USP13
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.7659352330581781,-1.5290528624068878,0.04,0.3596836296121893,1.0,7/26,11.40%,LSM4;LSM7;LSM1;EXOSC8;EDC3;DCPS;DCP1A
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.6659532444465538,-1.5287263011075447,0.0,0.35823792106992447,1.0,14/33,16.72%,MRPS7;MRPS16;MRPL47;MRPS11;MRPS12;SLC25A33;MRPS18B;MRPL16;GATC;MRPS2;MRPS14;MRPS18A;MRPL51;TFB2M
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.8199694539277613,1.5283895122029652,0.017857142857142856,0.6707998588593608,1.0,2/13,0.57%,RASGRF1;CALB1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.753148542681515,-1.5283567012050268,0.0,0.35673638891214166,1.0,12/22,17.54%,UBB;RPS27A;UBC;PARP1;UBA52;COPS7B;COPS2;CUL4B;COPS6;COPS8;GPS1;COPS5
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.787509270013862,1.5282449018276345,0.0,0.6571999085977095,1.0,5/21,13.58%,KIF1C;TRAK1;RAB1A;FBXW11;FYCO1
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.8412520449901959,1.528135769116288,0.0,0.6443710291847389,1.0,3/11,7.17%,SGO2;IHO1;FMN2
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.8203745609926882,1.5272821890734087,0.03389830508474576,0.6392336929943482,1.0,1/14,0.26%,VSIR
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.7258316286808479,-1.5262014043591812,0.020833333333333332,0.3627276343809234,1.0,6/25,7.74%,UBB;RPS27A;CCDC88C;UBC;UBA52;MAPK13
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.9171302956739351,1.5258454757188398,0.0,0.6368890238138822,1.0,1/6,0.27%,PTPRC
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.8479710012164953,-1.5256288488570815,0.02040816326530612,0.36329477211262357,1.0,3/10,1.22%,BGN;BCAN;DSEL
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.8003596566289862,1.5255047376563087,0.05660377358490566,0.6266825635597155,1.0,1/11,0.26%,VSIR
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.7688222799220561,1.5249986264169577,0.034482758620689655,0.6170536199697254,1.0,6/17,7.35%,GLRA1;GRIN2A;ABCA2;GRIN1;SLIT3;TGFBR3
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.6158458824466386,1.5247909084081115,0.0,0.6060564762553731,1.0,18/66,14.34%,RASGRF1;TBC1D4;TBC1D10B;BCR;TBC1D13;NTRK3;TIAM1;ARHGAP24;RANGAP1;DOCK7;SGSM1;BCAS3;RAP1GAP2;TBC1D22B;TBC1D8;TSC1;TBC1D1;SIPA1L1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.8930022262518804,1.5216424362378476,0.03571428571428571,0.6200369951059799,1.0,5/6,8.69%,DOCK5;NR4A3;FGF9;DOCK7;DOCK4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.9242734805487076,-1.5213711175876483,0.02631578947368421,0.37609600370476653,1.0,4/7,4.47%,EIF5A;UBB;PTTG1IP;RPS7
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.8762293841526536,-1.5213706998940593,0.0625,0.3736378598897027,1.0,2/6,6.29%,NR0B1;ASAH1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6984176486565123,-1.5187532767795322,0.023255813953488372,0.3821296294326505,1.0,7/18,12.07%,UQCR10;SURF1;NDUFS8;UQCRC1;ATP5F1D;UQCRH;UQCRB
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.8761332872984705,1.5178496371225876,0.0,0.6415356541751699,1.0,2/10,3.26%,PTPRC;LMBR1L
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.7417615096976117,1.517398102996853,0.043478260869565216,0.6339806556286584,1.0,11/18,21.12%,ZFPM2;LRP2;PKP2;RYR2;TGFBR3;PROX1;TPM1;NRG1;SMAD4;ENG;TGFB2
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.843566158706633,-1.5170957168967785,0.02857142857142857,0.3859558564318729,1.0,1/7,6.72%,LYN
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.7139649981188639,-1.5156380775564073,0.0196078431372549,0.3894456155004209,1.0,4/16,6.58%,S100A10;THY1;SFRP1;LIMS1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.9670905611536923,1.5143925062314003,0.0,0.6450992096654807,1.0,1/6,0.78%,ROBO2
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.8152240162715237,-1.513025718657337,0.023255813953488372,0.39831699751426464,1.0,5/9,11.67%,SPCS2;SEC11C;SEC11A;HM13;FURIN
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.6904126415012585,-1.5126921640390183,0.0,0.3969311062182696,1.0,7/28,13.69%,PPIF;BAD;MICOS13;SLC25A4;SLC25A5;MTX3;HSPA9
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5772477439760048,-1.5123859560154331,0.022727272727272728,0.3959151360642586,1.0,23/90,11.95%,COL9A3;MMP2;BGN;PODN;THY1;ATF4;PRRX1;FIBIN;IGFBP7;COL12A1;CHAD;SCRG1;THBS2;PDGFRA;SFRP1;CXCL12;HAS2;AEBP1;FN1;SEMA5A;ADAMTS2;HAPLN1;GAS1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6304626543664569,-1.512086093352202,0.0,0.3940011232536916,1.0,10/41,12.54%,H1-4;POLR2L;POLR2J;POLR2I;POLR2G;MAGEF1;POLR2K;POLR2E;H1-10;UBQLN4
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.57844308064426,1.510531088142483,0.0,0.6670885246991232,1.0,37/113,18.75%,CALB1;GRIN2A;OLFM3;STMN2;KCNQ3;MMD2;ATP2B3;DAB1;OXTR;KCNB2;KCNC2;GFAP;GRM3;PSD2;NRGN;SNAP25;SATB2;GABRG2;KCND3;ADGRB3;CALY;DLG4;GRM1;CLVS2;CDH20;ACTL6B;SLC8A2;ASTN1;LRRTM1;GAD2;GRIN2B;SLC6A1;STX1B;PCP4;SNCB;SPINK8;SEZ6L
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.6789166831262756,1.5089856799264691,0.018518518518518517,0.6697711203454488,1.0,14/51,11.75%,GRIN2A;SHISA6;CNIH2;DAPK1;CACNG2;RELN;CAMK2B;GRIN1;BEGAIN;GSG1L;NEFL;MAPK8IP2;CACNG8;DLG4
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.641759289701672,-1.5081611067218088,0.023255813953488372,0.4077758283305569,1.0,7/46,5.90%,JUN;GPX1;GSTP1;PRDX5;ROMO1;PDGFRA;APOD
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.8701049062244198,1.507757380654815,0.017543859649122806,0.6683788625210223,1.0,4/10,5.96%,GLRA1;GLRA2;GRIN2A;GRIN1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.8772360344868466,-1.5071071107951775,0.04081632653061224,0.40968699414943144,1.0,4/9,11.35%,PTTG1IP;PSMD10;CD44;YJU2
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.9641784859104677,-1.5065438396867994,0.0,0.40930537583990995,1.0,2/5,3.35%,LAGE3;OSGEP
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.573385794692342,-1.5062812397087213,0.0,0.40776648879914024,1.0,17/94,9.53%,JUN;NOX4;GPX1;GSTP1;SIRT2;PRDX5;ATF4;ROMO1;PRDX1;MT3;PPIA;PARP1;PDGFRA;SELENOS;SLC25A24;TMEM161A;CHCHD2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.6234494839184161,-1.5055716323779778,0.04878048780487805,0.4082163454685861,1.0,7/38,10.51%,TRMT112;RBM22;BUD23;ERN1;RIOK2;DXO;DDX5
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.9316534904728746,1.5052563299185275,0.01694915254237288,0.6772788332373825,1.0,2/8,3.47%,SPRED2;NNMT
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.834928502649858,-1.5048850194007874,0.021739130434782608,0.4084582074348455,1.0,6/11,10.04%,COX6C;COX7C;COX5B;COX6B1;COX4I1;COX5A
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.9342008572964522,1.5045967491830181,0.017857142857142856,0.6734378857887269,1.0,1/5,4.40%,CFAP69
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7972401978802551,1.5044794882286445,0.10204081632653061,0.6641799315503845,1.0,3/11,5.42%,CHRM3;SRF;KCNB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6408835624534225,-1.5041890229258634,0.0,0.40869717285061075,1.0,16/46,18.01%,PSMB6;PSMD8;PSMB4;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PSMD3;PSMD4;PSMB2;PSMC4;PSMD11
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.5078710366456077,-1.5034864956497684,0.0,0.40926689867204225,1.0,25/150,12.71%,EIF1;SOX4;MIF4GD;PIWIL2;RPL10;EIF1B;CALR;GAPDH;EIF5;PCIF1;DHFR;EEF2;FXR2;EIF3D;RPL13A;EIF4H;EIF2B2;EIF4A3;SHFL;NCL;DDX1;GSPT1;YBX1;MRPL13;NPM1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.6839431868114333,1.5028539523999218,0.05172413793103448,0.6691352718652289,1.0,8/33,11.17%,GABRA4;GLRA1;GABRG3;GLRA2;GABRB1;GABRG2;SLC12A1;GABRA2
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.8952013495689002,1.5014861349256459,0.0,0.6722406772893569,1.0,2/10,0.78%,HEY2;ROBO2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.9216171413796017,1.5009342059649324,0.0,0.6657928518266141,1.0,4/5,7.32%,WNT7A;COL5A1;ARHGAP24;PLET1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.8213575980495424,1.5000824272245687,0.0,0.6633757486841224,1.0,4/13,4.61%,SYT1;NEDD4L;RNF157;CPNE5
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8988395070248341,1.4979956438469046,0.0,0.6635409258694842,1.0,2/7,6.25%,SEMA3A;SLIT3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8988395070248341,1.4979956438469046,0.0,0.6635409258694842,1.0,2/7,6.25%,SEMA3A;SLIT3
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.8862136234496578,-1.49742827077245,0.02,0.4299930613606407,1.0,1/10,3.21%,ERH
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.9658787794736273,1.497247420746041,0.0,0.6590341986137319,1.0,2/5,2.05%,HTR2C;HTR1F
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.8924107290905223,1.4969595611868263,0.0,0.652977298111846,1.0,1/5,1.30%,MCCC1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.587959536719336,1.4945032163420688,0.0,0.6621159534696245,1.0,15/70,11.33%,PTPRC;IGF1R;EPHA7;ALK;MMD2;MERTK;RELN;NTRK3;CACUL1;ZNF16;TYRO3;ZNF622;ROR1;MMD;EPHA4
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6146782825928159,1.4942630835475492,0.0,0.6545521983067251,1.0,23/73,20.01%,KCNJ13;KCNQ3;KCNJ11;KCNH7;KCNC4;SLC24A2;HCN3;KCNN3;KCNB2;KCNC2;KCNQ5;HCN1;KCND3;SLC12A1;NALCN;KCNAB2;ABCC8;KCNH1;SLC9A9;SLC12A5;PKD2;KCNQ1;KCNK1
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.8935200266800916,-1.4935638262337583,0.04081632653061224,0.4434202248985148,1.0,1/6,0.60%,GPX1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.7316390180931212,-1.4935329661606536,0.021739130434782608,0.4410237756733193,1.0,5/22,9.07%,NOP10;PPIA;PIF1;NHP2;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.711715026710752,-1.4924314876287137,0.0,0.44439009882346797,1.0,5/20,6.58%,S100A10;THY1;SFRP1;DUSP3;LIMS1
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.7993137974110925,1.492250273533356,0.0,0.6626758565809622,1.0,5/16,6.30%,PTPRC;KLF6;SOX9;CAMK2B;SPI1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.6800769528096986,-1.4913857128260033,0.02702702702702703,0.446032894938852,1.0,5/30,10.51%,NR0B1;CALR;RNF6;UFL1;DDX5
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.9177377810381125,1.4913427829709744,0.0,0.6610508553012313,1.0,1/8,1.63%,GRAMD1C
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.6352436997571262,-1.4906273894918631,0.023809523809523808,0.4463039816061829,1.0,6/58,3.33%,EIF1;MIF4GD;EIF1B;ATF4;EIF5;POLR2G
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6416114212241361,-1.4901966814987477,0.08,0.44567523927643743,1.0,5/37,2.92%,HSPG2;AGRN;RBP1;GPC4;RARRES2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.8507983705948772,-1.4901091827283113,0.04,0.4438435645860236,1.0,3/6,9.76%,PIH1D1;PRPF31;ZNHIT3
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.8262078110249241,-1.4899899573803714,0.06382978723404255,0.4415892876289656,1.0,4/9,13.10%,GSTP1;SELENOS;TAF7;AR
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.8077801988944624,-1.4899375051104826,0.027777777777777776,0.4392343942804511,1.0,6/15,13.67%,RBM22;CWC15;CACTIN;DCPS;SNRNP200;WBP11
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.8362764928932257,-1.4894928991748004,0.04,0.43834609260803115,1.0,3/11,1.22%,BGN;BCAN;DSEL
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.7609044880113814,-1.4886280243120142,0.07894736842105263,0.4393358502536422,1.0,5/13,13.85%,SRSF7;SAP18;PCBP4;SRSF9;SRSF10
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8514167854128749,1.4882391137950675,0.045454545454545456,0.6777911242347143,1.0,4/8,11.17%,GABRA4;GABRG3;GABRG2;GABRA2
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.779481341892956,1.488194790544024,0.06779661016949153,0.6688728199684681,1.0,3/9,12.52%,RNF152;ATM;STK11
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6355410171873807,1.4879883847625341,0.03125,0.6622995070930888,1.0,7/41,7.40%,DOCK5;SOX9;PTPRR;ENPP2;MACF1;EMP2;SASH1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.713973252591474,1.4874329952445111,0.061224489795918366,0.6577491877508592,1.0,5/28,4.06%,EFNA5;PTPRR;MDGA1;EPHA7;TENM3
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.5871705610089305,-1.4869916872508566,0.0,0.44514512766085906,1.0,10/62,9.64%,RPS2;UBB;PTTG1IP;CENPX;MALT1;PEF1;PRICKLE1;PSMD10;STUB1;CAV1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.8438023271674827,1.486692315262265,0.0196078431372549,0.6554883468467738,1.0,2/9,7.22%,VRK1;PRKCA
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.8377689696558581,-1.4861589344724841,0.0,0.44602506285514737,1.0,5/9,11.18%,ATP5MC1;ATP5PD;ATP5F1A;ATP5PB;ATP5F1D
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.8775525016524814,-1.486071800557691,0.02,0.4440777842951385,1.0,5/7,11.39%,GAPDH;RPS19;ROMO1;HMGN2;RPL30
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.7226184882761653,-1.4858724245202024,0.0,0.4422125910227205,1.0,2/25,1.00%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.7713402857119691,-1.485511729386203,0.0625,0.4410946410806004,1.0,3/13,1.22%,BGN;BCAN;DSEL
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.7172541847260487,-1.4850928202137992,0.06382978723404255,0.4406516179860494,1.0,9/24,16.95%,HSBP1;BAG3;STUB1;HSP90AB1;SLU7;ZFAND1;PRKACA;VCP;SUMO1
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.892433264441981,-1.483900642534211,0.044444444444444446,0.443510137752499,1.0,1/6,2.02%,CALM1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.8266943372668651,-1.4836359665248773,0.058823529411764705,0.4427012409065494,1.0,1/11,0.09%,PPIF
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.8085407043751962,1.4830962197364128,0.0,0.6763371218452281,1.0,4/15,7.86%,PTPRC;TESPA1;FOXP1;RAB29
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.7332297417748065,1.482883954693034,0.0,0.6704427060943364,1.0,8/27,11.75%,GRIN2A;DAPK1;RELN;CAMK2B;GRIN1;NEFL;MAPK8IP2;DLG4
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.5226393021848227,1.482621875354491,0.0,0.663699814333928,1.0,92/297,21.22%,CTBP1;NUAK1;TLK1;VRK1;NEK3;GRK4;EPHA7;ALK;DAPK1;MERTK;PAK1;DAPK2;BCR;FAM20C;CAMK2B;CDC42BPB;DGKG;PRKAR1B;TSSK3;CDKL1;PRKCA;CDK19;MAK;LIMK1;PAK2;CDK14;OXSR1;ATM;CDK6;JAK1;SGK1;CDK7;MAP3K9;GRK5;DGKZ;MAPK10;TOP1;PXK;RARA;TAF1;PRKAA2;PDPK1;CAMK1;STK11;PIK3CD;TNIK;PLK2;AGK;PRKG1;AKT3;ACVR1C;FAM20A;LMTK2;SIK3;STK3;NIM1K;PRKAA1;CAMK2D;MAP3K5;DAPK3;ADAM10;CSNK1D;VRK2;CDK13;PRKCE;SRPK2;MKNK1;CDK17;STK17A;PRKCZ;STK17B;CDK12;RYK;DCLK1;NEK4;CERK;NEK7;ABL1;NEK11;MAML1;ACVR1B;FER;DGKI;MAPK1;STAT3;CSNK1G2;TAOK1;DGKD;STK24;BRSK1;TGFB2;PRKD2
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.8206678353073187,1.4823979972489272,0.0,0.6573372435644858,1.0,4/14,4.61%,SYT1;NEDD4L;RNF157;CPNE5
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.7441153010879259,-1.4823855182394365,0.02,0.44534074443044097,1.0,8/18,9.42%,RPL23A;RPL10;RPLP0;RPL3;RPF2;RPL11;BRIX1;RPL6
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.6798647799081614,-1.4822791289004376,0.043478260869565216,0.4432918230333515,1.0,2/26,1.34%,TRMT112;SMYD2
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.8395264939042018,-1.4822278690325745,0.0425531914893617,0.4410296100111701,1.0,5/8,11.40%,LSM1;PNRC2;EDC3;DCPS;DCP1A
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.5752970779930074,1.4820886537559357,0.0,0.6524176524845086,1.0,18/79,17.73%,SYNJ2;INPP4B;PIP4K2C;PIP5K1B;PLEKHA4;PITPNM2;CDS1;PIP4P1;INPP4A;INPP5E;PLEKHA2;PIP4K2A;PIK3CD;PGAP1;MTMR7;MTMR3;IMPA1;PLAAT3
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.8532909363321912,-1.4816935722754487,0.023255813953488372,0.44130134107910357,1.0,3/8,7.71%,CXCL12;MOSPD2;CREB3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.5549610853635624,-1.4813945547362264,0.0,0.44035060938089005,1.0,23/112,12.33%,NR0B1;TAF9B;POLR2L;POLR2J;GTF2F1;POLR2I;ESRRB;POLR2G;NR2F6;YAP1;NR2E1;MED23;GTF2A2;TAF7;TAF11;HNF4G;RXRB;TAF4B;POLR2K;TAF6;ESRRA;POLR2E;GTF2H2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.756579737551538,1.4811288133295222,0.02127659574468085,0.651761778197267,1.0,3/19,7.22%,HOOK1;EMP2;WDR91
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.7713477615955999,-1.4809387046970715,0.043478260869565216,0.43975635334338053,1.0,6/11,14.71%,RPS19;ROMO1;RARRES2;TNFRSF14;RPL30;OPTN
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.8544212785422196,-1.4804440848001894,0.0625,0.43957057147331646,1.0,3/7,7.56%,KIF25;RANBP1;CEP85
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6885676797985815,-1.4803765436911533,0.044444444444444446,0.43772819075445685,1.0,5/25,6.23%,UBB;RPS27A;UBC;PARP1;UBA52
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.8234492266293951,1.479620445366291,0.058823529411764705,0.6535389460491201,1.0,2/14,1.11%,HEY2;SOX9
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.8764791355925632,-1.4794641410964342,0.13953488372093023,0.43726951966485816,1.0,1/6,0.67%,SIRT2
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.8764791355925632,-1.4794641410964342,0.13953488372093023,0.43726951966485816,1.0,1/6,0.67%,SIRT2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.8815367861663146,1.4792948453136239,0.0,0.6494561325202164,1.0,1/7,0.35%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.7970494463834594,-1.4790872638023667,0.08,0.4367620048620233,1.0,2/9,6.16%,GSTP1;DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.7035970397227149,-1.478500812285715,0.025,0.4372123417499357,1.0,3/21,5.39%,NR0B1;CALR;SFRP1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7742464734030899,1.4782885082975985,0.018867924528301886,0.649369931978991,1.0,6/16,10.49%,UNC13C;GRIK5;CDH8;GRIK3;SLC1A4;NAPB
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.8669553335755824,1.477565083093214,0.015151515151515152,0.6489809349544892,1.0,3/11,2.35%,PTPRC;ITGA2;SHTN1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6468693789458821,-1.477218726236812,0.0196078431372549,0.4408369078250896,1.0,6/33,5.27%,PTMA;POLR2L;POLR2J;POLR2I;POLR2G;PAX8
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.708510353151877,1.4769976047121185,0.0196078431372549,0.6452857582079267,1.0,12/31,15.69%,ITPR1;KCNJ11;ATP2B3;AHCYL1;RYR2;ATP2B2;ITPR2;RYR3;NOS1;SLC8A1;SLC8A2;ANK2
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.8617204237681436,1.4765364352884023,0.0,0.642069175647648,1.0,1/6,5.95%,WRN
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6352767513963585,1.4760731275715233,0.03225806451612903,0.6384311911123384,1.0,4/45,0.65%,GABRA4;GLRA1;GABRG3;GLRA2
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.9213102723494787,-1.4758382801922147,0.0,0.44420362402233715,1.0,2/5,4.93%,NOP10;NHP2
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.7137915883930511,-1.4757909274212493,0.057692307692307696,0.44212586366554424,1.0,2/15,3.05%,GTF3C6;NIFK
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.6079201389885142,-1.475660633935008,0.023809523809523808,0.44056299420524064,1.0,8/43,9.64%,SOX4;COPS9;UBXN1;VPS28;DNAJA1;RPL11;UFL1;CAV1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.8159359076513064,-1.475414835827597,0.046511627906976744,0.4390700509630702,1.0,6/10,12.07%,UQCR10;UQCRQ;UQCRC1;CYC1;UQCRH;UQCRB
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.6093856584340063,-1.4748464356268092,0.0,0.4390607608907783,1.0,11/52,12.13%,UBB;VEPH1;RPS27A;PMEPA1;UBC;BAMBI;UBA52;STUB1;CAV1;SPRY1;SLC2A10
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.6876078906752271,-1.4747322995536116,0.0784313725490196,0.43758949938676633,1.0,2/18,3.66%,ATF4;MT3
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.6235083636090566,1.474251567985751,0.04918032786885246,0.6437174543324765,1.0,4/45,0.65%,GABRA4;GLRA1;GABRG3;GLRA2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.5388297468611537,-1.4740407543980063,0.0,0.43909633880499493,1.0,24/104,11.85%,UBB;PSMB6;APEX1;PSMD8;RPS27A;PSMB4;UBC;HSPA8;EXOSC8;ZFP36L1;PSMA7;FXR2;UBA52;PSMC3;PSMC1;SET;PSMD10;PSMD12;PCBP4;PSMB9;PSME3;YWHAB;DCP1A;PSMD2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.7040038664661286,1.4728294912704103,0.03773584905660377,0.6473524473794743,1.0,6/23,11.33%,CALB1;FAM107A;RELN;AKAP5;SHANK3;EPHA4
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.9211290857708017,-1.471488455192239,0.0,0.4469709939216434,1.0,2/8,1.00%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6451038861347871,-1.4704680743231842,0.03333333333333333,0.4483120550305162,1.0,14/41,13.69%,ATP5MC1;ROMO1;TIMM8B;ATP5PD;ATP5F1A;ATP5F1E;MICOS13;TIMM13;ATP5PB;TIMM22;ATP5ME;ATP5F1D;MTX3;HSPA9
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5454409250601167,1.4701474060100752,0.0,0.664138489853806,1.0,29/134,15.69%,FSTL5;OLFM3;IGF2BP3;PCLO;EFNA5;SHISA6;STMN2;ARHGAP26;SULT4A1;ATP2B3;FAM13C;KCNIP1;SNAP25;GCNT2;CRMP1;TAFA5;ADGRB3;GPR22;NMNAT2;LSAMP;MAPK10;TTBK2;CLVS2;SNX21;ACTL6B;ASTN1;KIF1B;LRRTM1;ANK2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.7083562375457919,-1.4679515504774043,0.02040816326530612,0.457130869812923,1.0,15/23,19.16%,TM7SF2;SQLE;ARV1;SC5D;PMVK;MSMO1;IDI1;ACLY;ACAT2;HMGCS1;DHCR7;ACAA2;FDPS;LBR;HSD17B7
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.922689989936753,1.4673587429858306,0.041666666666666664,0.6772788332373825,1.0,2/5,4.77%,SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6103392504961394,1.4669855899540225,0.030303030303030304,0.6738381887283156,1.0,22/66,20.01%,KCNJ13;KCNQ3;KCNJ11;KCNH7;KCNC4;SLC24A2;HCN3;KCNN3;KCNB2;KCNC2;KCNQ5;HCN1;KCND3;NALCN;KCNMB4;KCNAB2;ABCC8;KCNH1;SLC9A9;PKD2;KCNQ1;KCNK1
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5738520344234811,1.466685280092525,0.0,0.6696375179410445,1.0,20/99,11.53%,LIFR;PCLO;SHISA6;STMN2;CNTN3;ADGRL2;FAM13C;LMO3;PLCXD3;UNC5C;CADPS2;SYBU;SNAP25;ARX;AQP4;PROX1;SHC2;FGF14;MAPK10;PXK
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.7153090425937344,-1.4666010377067438,0.07317073170731707,0.45957456766433435,1.0,2/13,3.46%,GPX1;NT5E
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.6504101756207338,-1.4666007048943355,0.08333333333333333,0.45741694058609805,1.0,9/25,13.68%,ATP6V0A4;TMEM9;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;ATP6V0E2;ATP6V0D1;CLCN3
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.9011275010938946,-1.4665090779302024,0.0,0.45373538994698825,1.0,4/5,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.9011275010938946,-1.4665090779302024,0.0,0.45373538994698825,1.0,4/5,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.7740388289569187,-1.4654000367268505,0.0425531914893617,0.45573440077102356,1.0,5/13,8.65%,STAB2;ROMO1;RARRES2;PPP1R11;TNFRSF14
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.8964311682609334,-1.4653480235441876,0.0,0.45389251726048174,1.0,2/6,3.58%,NDUFA12;COA6
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.6064101300918405,-1.4649006035092351,0.047619047619047616,0.4540728358742154,1.0,7/55,8.88%,CNPPD1;CDKN2C;CCND1;ACTB;CDC37;CCNK;PSMD10
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.8521321323525649,-1.464786642210249,0.02,0.45246009334588655,1.0,3/7,5.83%,CCND1;MMP2;OPN3
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.67066413006389,-1.4645289800089052,0.06,0.4512696170513314,1.0,5/31,2.92%,HSPG2;AGRN;RBP1;GPC4;RARRES2
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.5363210863687236,-1.4643334373696528,0.0,0.45003919422642524,1.0,24/94,14.91%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;PARP1;SMARCA5;UBA52;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;CENPV;PSMD2;CUL4B;GTF2H2;NPM1;MCM4;PSMD3;PSMD4
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.7175666424862444,-1.4642924205297465,0.023255813953488372,0.4481634654568921,1.0,2/16,1.90%,SMYD2;CSKMT
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.7137524221141256,-1.4635062435402557,0.0625,0.44911940961181535,1.0,6/20,12.32%,HSPG2;AGRN;GPC4;GUSB;SGSH;GPC1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.8632388481340298,-1.46320357387854,0.08888888888888889,0.4483153910828366,1.0,1/7,2.11%,CHAMP1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.861009570193688,-1.462861002015448,0.0784313725490196,0.44731924585995214,1.0,1/7,0.34%,ATP6V0A4
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.827629649597205,-1.4614100225053326,0.020833333333333332,0.4516388963038451,1.0,4/8,12.13%,ITM2A;ITM2B;ITM2C;SLC2A10
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.8425324302207633,1.461094937352523,0.02040816326530612,0.710541221076627,1.0,5/9,9.45%,HEY2;MYLK;TTN;TGFBR3;PROX1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.8620091659234214,1.460450652931354,0.08,0.7075040020799673,1.0,4/5,13.81%,SLC6A15;SLC6A17;SLC1A4;SLC6A7
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.6387716350690817,-1.4588224091206383,0.027777777777777776,0.46046339781561385,1.0,8/26,18.60%,NOL3;SF3A2;PUF60;SLU7;SRSF9;SRSF10;SF1;LUC7L2
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.607711006826936,-1.4577466309265006,0.046511627906976744,0.46247517736610966,1.0,10/52,8.24%,G0S2;FAHD1;PLIN2;PMEPA1;SLC30A10;FERMT1;CBR1;CYBRD1;GBA3;ABCG2
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.8513296518755201,-1.457244424502026,0.05555555555555555,0.4622177699919384,1.0,2/7,3.31%,UGDH;LRRC8D
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8776082514705288,1.4571896992945708,0.05172413793103448,0.7270832448446248,1.0,1/6,0.41%,CHRM3
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6403712350754345,-1.4562692734169034,0.075,0.4639120158639235,1.0,10/41,13.89%,UBB;RPS27A;UBC;PIF1;PARP1;UBA52;DDX1;CUL4B;GTF2H2;MCM4
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.7166507515764394,1.4556760482966713,0.016666666666666666,0.7320975152183182,1.0,7/23,11.78%,FOXO1;KAT2B;ING5;NAA50;NAA16;ESCO1;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.9745498293396285,1.4554198136892367,0.0,0.7277106782774135,1.0,1/5,0.26%,VSIR
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.8416694990742386,-1.455412275464096,0.02564102564102564,0.4643784830057734,1.0,2/8,5.27%,NR0B1;PAX8
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.9483010134937934,1.4552721221810323,0.0,0.7213219506550611,1.0,2/6,3.09%,CLDN12;CLDN18
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.6309793596104172,1.4552366398565075,0.02127659574468085,0.7150549130826584,1.0,10/34,9.64%,RTN4IP1;NEDD4L;CAMK1D;RAB17;ALK;KIAA0319;NSMF;BCL11A;ADGRB3;BMP7
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.7081039450641209,-1.4552094805510423,0.043478260869565216,0.46319821070205774,1.0,6/14,20.25%,TMBIM6;SELENOS;CREB3;PARK7;HSPA1A;TXNDC12
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.9366642643387073,-1.4545384917385558,0.075,0.4638561688913966,1.0,2/6,2.82%,TRMT112;BUD23
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.655039351958884,1.4542442684411616,0.017857142857142856,0.7180318379363473,1.0,8/51,7.97%,ACACB;HIF3A;CKMT2;KCNJ11;SORBS1;CECR2;RYR2;SYCP2L
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.6647603804736663,1.4541195645146183,0.05263157894736842,0.7121661599523328,1.0,8/23,11.46%,SHISA6;CNIH2;CACNG2;RELN;GSG1L;SHANK3;MAPK8IP2;CACNG8
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.8836229946524065,-1.453990506461789,0.045454545454545456,0.46493962411403267,1.0,5/5,11.67%,LAPTM4B;CDH3;HSP90AB1;FN1;FURIN
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.762373378592165,-1.4531456194893064,0.05263157894736842,0.4659184615407595,1.0,4/13,10.38%,STAB2;GUSB;HAS2;CD44
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.653910796531365,-1.4530710915694804,0.0,0.4644666904908563,1.0,17/41,13.35%,AIP;ROMO1;TIMM8B;TSPO;SLC25A6;TIMM13;TOMM7;TIMM23;DNAJC19;TIMM44;AIFM1;TIMM22;GRPEL1;MFF;TIMM21;HSPA4;FIS1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.8397320967712021,-1.4530204607201749,0.044444444444444446,0.4627906910152837,1.0,2/9,10.51%,ATF4;DDX5
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.8223165482926331,1.4527702240756601,0.06349206349206349,0.7157006580372784,1.0,5/11,11.91%,HEY2;TMSB4X;PSEN1;SIN3A;TAF1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.8118958395558524,-1.4506862467643227,0.023255813953488372,0.46894691230106345,1.0,3/11,3.82%,SIRT2;MT3;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.8256193902344972,1.4494032932901384,0.04081632653061224,0.7397393532439771,1.0,3/9,8.27%,SOX9;SRF;NFATC3
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.783442689780743,-1.4487938625699928,0.125,0.47547371843872044,1.0,4/7,19.77%,RHOG;MADCAM1;ZP3;CD81
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.7132338983409733,-1.4487064244494927,0.09302325581395349,0.4743332631299776,1.0,8/15,22.06%,POLR2L;ATF4;POLR2K;WDR43;DHX33;LYAR;MAF1;UBTF
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.8087970415678801,1.4486190621528185,0.0967741935483871,0.7324376691583778,1.0,2/9,6.54%,SYNJ2;INPP5A
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.8087970415678801,1.4486190621528185,0.0967741935483871,0.7324376691583778,1.0,2/9,6.54%,SYNJ2;INPP5A
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6784317031945692,-1.4486098992236527,0.0,0.4725046081269074,1.0,4/22,10.08%,EIF5A;IRF3;IFI6;VWCE
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.7826856662640459,-1.4484130189974522,0.0,0.4716637595772946,1.0,2/10,3.46%,GPX1;NT5E
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6725859697842971,1.4480775987234058,0.1111111111111111,0.7299339530786965,1.0,5/22,9.18%,AKT2;NR4A3;SORBS1;CLTCL1;C2CD5
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.802316254715292,-1.4477738790185881,0.0851063829787234,0.47272108495674986,1.0,3/10,3.66%,MT1E;MT2A;MT3
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.7443192375018105,1.4477619176881655,0.034482758620689655,0.7196657586358229,1.0,8/17,17.35%,SLC4A4;PSEN1;PRXL2C;PFKFB3;GAPDHS;PRKAA2;PRKAA1;PFKFB1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.7443192375018105,1.4477619176881655,0.034482758620689655,0.7196657586358229,1.0,8/17,17.35%,SLC4A4;PSEN1;PRXL2C;PFKFB3;GAPDHS;PRKAA2;PRKAA1;PFKFB1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7855578747220393,1.4471960803785697,0.05555555555555555,0.7175742542679298,1.0,1/10,0.35%,HEY2
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.660009599076082,1.4469198436875055,0.09259259259259259,0.7128690292994904,1.0,3/28,9.30%,GCA;DNM1;HACE1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.6857101952023358,-1.446784432466776,0.022727272727272728,0.4753776115744234,1.0,14/25,17.63%,TM7SF2;SQLE;ARV1;SC5D;PMVK;MSMO1;IDI1;ACLY;ACAT2;HMGCS1;DHCR7;ACAA2;FDPS;LBR
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.6726069973145433,-1.4463973376639383,0.07894736842105263,0.47494709675693925,1.0,4/22,13.10%,ACTB;GPC4;GPC1;AR
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.8078263367421529,-1.4463668391530489,0.041666666666666664,0.4731075486871687,1.0,4/11,10.42%,COL9A3;ZNF830;FSHR;EIF2B2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6698208261795302,-1.4462058479231006,0.10638297872340426,0.47187285025908454,1.0,7/19,11.85%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;ATP6V0E2;ATP6V0D1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6756365305852051,1.4461254689238627,0.08196721311475409,0.7131121590311518,1.0,8/29,18.88%,GRIN2A;GRM3;GRIN1;GRIK3;GRM1;GRIN2B;CPEB4;GRIK1
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.8411564182321511,1.4460450579422888,0.09259259259259259,0.7077583599231092,1.0,2/7,7.46%,LRRC19;OCIAD2
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.7103927444014991,1.4443338354115411,0.08,0.7170807796069567,1.0,3/13,6.25%,BCL2L11;FAM107A;SLIT3
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.9160663402929113,1.4439731231040611,0.017241379310344827,0.7139679090757146,1.0,1/5,4.54%,GCLC
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.7240850413161882,1.443754320161557,0.03636363636363636,0.7098604908581662,1.0,6/19,14.13%,GRIN2A;IGF1R;PSEN1;GRIN1;EPHA4;GJA1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.8125121899172116,1.4437441181650867,0.04,0.7041901660046513,1.0,1/11,0.35%,HEY2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.7048771890959745,-1.4433072957047943,0.06976744186046512,0.48276120743732837,1.0,10/26,18.21%,BTC;BTG1;IL20RA;WNT5A;AR;CD9;DDR1;PROM1;ERBB3;ATP7B
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.733832093960278,1.4424146956850492,0.057971014492753624,0.7082404663257731,1.0,1/17,0.27%,PTPRC
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6812077511118135,1.4423849823704,0.02127659574468085,0.70274756972713,1.0,7/25,14.97%,SHISA6;RAB3A;CAMK2B;NSMF;DLG4;SLC8A2;SHISA9
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.86220242082127,-1.4418446458250775,0.0,0.4866745666587441,1.0,3/7,5.49%,HSD17B10;TRMT10C;TRMT10A
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.9070783106909056,1.4418340550868896,0.05,0.7004524671755158,1.0,1/5,0.35%,HEY2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.8197187952918312,-1.4412163806122729,0.046511627906976744,0.4874628975265018,1.0,2/10,1.10%,SOX4;ASCL1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.8544271724089065,1.4403153299352542,0.04918032786885246,0.7064449803543903,1.0,1/6,9.52%,PAK2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.6258721322530878,-1.4393443031126136,0.05,0.49297868549670465,1.0,11/32,14.67%,AURKAIP1;BTG1;TRIM35;BTG3;ZFP36L1;NABP2;BRINP1;CDKN1C;GAS1;SMAD3;HECA
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.8236228327692553,-1.439256396011722,0.057692307692307696,0.491378266452565,1.0,3/8,11.56%,NOP10;NHP2;TSR3
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.8509052487825278,1.4386419976549287,0.018518518518518517,0.7141939198098315,1.0,2/7,7.35%,LRP2;TGFBR3
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.9270242775871778,-1.438331687393039,0.0,0.4936450239001266,1.0,2/7,1.00%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.7439779662466262,-1.4375779897609906,0.10204081632653061,0.4953643673931393,1.0,6/15,18.86%,S100A1;DHFR;CDH3;SCARB1;PARK7;AKT1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6839158569235195,1.4369901049559064,0.07547169811320754,0.7218924104406931,1.0,11/23,19.76%,HEY2;ADAMTS9;TTN;BMP7;SGCZ;GJA1;NRG1;SMAD4;AKAP13;SMAD5;MAML1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.8003473756571161,-1.4364283155604793,0.07317073170731707,0.49808124593061437,1.0,3/8,3.07%,GPX1;PRDX5;PRDX1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6825045061073058,1.4363406615146466,0.0784313725490196,0.7206413578063486,1.0,11/22,18.06%,SOX9;CRIM1;NBR1;CDK6;RANBP3L;HDAC7;SUFU;CHRD;RORB;SEMA4D;PPARG
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.9000135065645529,-1.4362860216270001,0.021739130434782608,0.4967486156775794,1.0,3/6,7.57%,ITM2A;ITM2B;ITM2C
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.6300219912356886,-1.435964900587395,0.030303030303030304,0.49638589300444047,1.0,9/28,13.60%,SNRPB;SNRPD2;MALT1;SNRPG;LSG1;RBM15B;SNRPD1;NPM1;SNRPE
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.6692807034007664,1.4359397347395053,0.017857142857142856,0.7181578003774227,1.0,9/25,11.69%,GABRA4;GLRA1;GABRG3;GRIN2A;GRIN1;GABRG2;MAPK8IP2;GABRA2;ARRB2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.6068294235981968,-1.4356859829534552,0.06060606060606061,0.49537428819330126,1.0,9/54,11.08%,RBM8A;SRSF7;CPSF1;U2AF1;CSTF2;CSTF2T;MAGOH;SLU7;EIF4A3
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.85294415936449,1.4356269761547957,0.01818181818181818,0.7151600725663625,1.0,1/8,2.27%,ACSS3
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.8890443004824015,1.435124433162863,0.018518518518518517,0.7145363603160695,1.0,3/6,9.10%,ITPK1;RIPK1;CYLD
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.8674112709868608,-1.4350058686784797,0.0851063829787234,0.4967940919313395,1.0,2/5,2.86%,HSD17B10;TRMT10C
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.6224036364877694,-1.4341978105655293,0.08333333333333333,0.4984616464667011,1.0,11/37,14.05%,COPS9;ATF4;PARP1;OPN3;SMPD1;MAPK13;TMEM161A;NOC2L;NPM1;CASP9;RUVBL2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.673832498594699,-1.4340015562640234,0.02857142857142857,0.49758255686001096,1.0,5/26,7.97%,CPSF1;SNRPB;CSTF2;CSTF2T;SNRPG
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.5801198424861188,-1.4336862545113522,0.05128205128205128,0.4971380074715663,1.0,5/47,3.66%,RRAGA;SIRT2;DAPL1;KIF25;MT3
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.6004755732428892,1.433042796968767,0.0,0.7262251679117008,1.0,20/56,20.34%,CALCB;CALB1;EDNRA;TRPC4;ATP2B3;ADCY5;CAV3;RYR2;ATP2B2;DLG4;ACKR4;SLC8A1;SLC8A2;KNG1;SPPL3;ABL2;ABL1;FPR3;LPAR1;ATP2B1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.8732265379285798,-1.4323649747472404,0.038461538461538464,0.5013424501006738,1.0,2/5,2.86%,HSD17B10;TRMT10C
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7812399403033559,-1.4318906871835504,0.1111111111111111,0.5016937445973554,1.0,5/13,16.96%,PTTG1IP;PSMD10;CD44;YJU2;ARMC10
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.699480536719324,-1.431862108306099,0.02,0.49984285928112643,1.0,14/22,19.16%,TM7SF2;SQLE;ARV1;PMVK;MSMO1;IDI1;ACLY;ACAT2;HMGCS1;DHCR7;ACAA2;FDPS;LBR;HSD17B7
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.7418602594133951,1.4317184144510744,0.05357142857142857,0.7314651878498198,1.0,8/14,21.22%,SLCO1A2;RXRA;NCOA1;SLC51A;AKR1C1;NCOA2;SLCO2B1;ATP8B1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.6738647937553476,1.4316286227520354,0.041666666666666664,0.7266496224900593,1.0,4/22,16.12%,SYNJ2;PIP4P1;MTMR7;MTMR3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.6754305379588117,-1.431463618680634,0.022727272727272728,0.4991857994270773,1.0,6/24,9.48%,PPIF;GPX1;NOL3;CLU;PSMD10;SLC25A5
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.7409974343519031,1.4312997750743246,0.05084745762711865,0.7234337704104985,1.0,4/24,6.13%,PTPRC;KLF6;HDAC4;PTPRJ
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.7439725969049867,-1.4302817299154518,0.058823529411764705,0.5021021128405444,1.0,7/15,12.92%,CPSF1;RTRAF;ERN1;CSTF2;TSEN34;DDX1;C2ORF49
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.6318278820234884,1.4296353889099012,0.07407407407407407,0.7311529734355479,1.0,11/36,14.11%,ITPR1;HTR2C;KCNJ11;G6PC2;KCNC2;PRKCA;SNAP25;ITPR2;CLOCK;STX1A;ENSA
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.5298293904999635,-1.4294359036865005,0.0,0.5033236573782854,1.0,18/78,13.85%,RBM8A;SRSF7;SAP18;JMJD6;SMU1;FXR2;LARP7;PUF60;C9ORF78;RBM15B;PCBP4;MAGOH;DDX5;NCL;NOVA1;SRSF9;RBM23;SRSF10
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.8133104081124897,-1.4288056503747841,0.06666666666666667,0.5042861019016932,1.0,3/9,8.61%,TSR1;NOP14;KRI1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.8581642804377229,1.4287132833924507,0.03636363636363636,0.7333229442626357,1.0,3/6,11.57%,SEPTIN9;CEP135;MAP4
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.7691365543808772,-1.4286510439742448,0.06666666666666667,0.5029995900470708,1.0,2/10,9.31%,VPS37B;CHMP2A
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.7991266716314113,1.4280542432744654,0.05357142857142857,0.7218237857275414,1.0,2/9,13.75%,WRN;XRCC3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.7991266716314113,1.4280542432744654,0.05357142857142857,0.7218237857275414,1.0,2/9,13.75%,WRN;XRCC3
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.7991266716314113,1.4280542432744654,0.05357142857142857,0.7218237857275414,1.0,2/9,13.75%,WRN;XRCC3
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.6623076608227869,1.428040873101221,0.0784313725490196,0.7167405196308685,1.0,5/25,11.18%,SHTN1;SEMA3A;CAMK2B;NSMF;PHACTR1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.6214153519976648,-1.4280084027445976,0.0196078431372549,0.5039561274792773,1.0,9/36,18.70%,HSPA8;GABARAPL2;RPL23;MAP1LC3A;CAV1;MAP1LC3B2;VCP;GABARAPL1;LIX1L
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.8201013259062947,1.4276827877701441,0.10714285714285714,0.7153318759536377,1.0,1/7,0.35%,HEY2
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.9591001004207285,-1.4271265657457846,0.0,0.5060183031160654,1.0,1/5,1.90%,ATF4
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.9483937101003012,1.427012649355062,0.0,0.7153239734804168,1.0,1/5,0.11%,HOOK1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6993332147040909,-1.4269535091028356,0.08333333333333333,0.5046985245894754,1.0,4/21,9.07%,NOP10;PIF1;NHP2;HSP90AB1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.9499781281975274,1.4267188109878959,0.018867924528301886,0.7124481817256172,1.0,2/6,3.35%,ITGA2;ITGA8
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.6296714039214252,1.42618964586116,0.07407407407407407,0.7109740408580272,1.0,9/40,13.73%,FOXO1;CTBP1;AKT2;NR4A3;STEAP4;TMEM120B;OSBPL11;BBS7;PRDM16
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.7350896660883148,1.4258992302008469,0.045454545454545456,0.7085359640169697,1.0,5/12,10.52%,PKP2;TTN;TGFBR3;PROX1;TPM1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.7065311312579579,1.4256466968812476,0.0851063829787234,0.7053367423917315,1.0,4/24,6.76%,MSL3;MRGBP;KAT2B;NAA50
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5506701522501682,1.425595128941131,0.017857142857142856,0.7012096789773361,1.0,30/108,17.05%,UNC5D;LIFR;PCLO;SHISA6;STMN2;RGS4;SULT4A1;FAM13C;PHYHIP;KCNIP1;SNAP25;ARNT2;CRMP1;ADGRB3;LSAMP;MAPK10;CLVS2;NCS1;AKAP12;STX1A;ACTL6B;SLC8A2;ASTN1;KIF1B;NOVA2;LRRTM1;ANK2;ITSN1;UNC13A;ERC2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.6087825320368017,-1.4255481416687052,0.047619047619047616,0.5096474954568522,1.0,7/40,14.49%,GSTP1;SIRT2;SELENOS;WNT5A;CACTIN;NFKBIL1;CDC73
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.521048351969755,-1.42550825806648,0.06896551724137931,0.5079980343060398,1.0,29/117,11.81%,PPIF;BTG1;PPT1;E2F5;CLTB;EIF5;TMBIM6;CNP;BTG3;SELENOW;ATP6V1F;WIZ;HSPA13;UROD;DNAJA1;LYN;GRINA;SLC25A4;SIGMAR1;PSMC3;PDLIM3;RXRB;PARP2;GRPEL1;STARD3;RPN1;FKBP4;FURIN;CDKN1C
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.7268656486484758,-1.4254530032396542,0.047619047619047616,0.5062386873396896,1.0,2/14,3.86%,SOX4;HES5
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.6080326898271039,1.425404127802914,0.05660377358490566,0.698403303186188,1.0,11/48,10.62%,TPD52L1;TNFRSF19;WNT7A;SEMA3A;GADD45A;DUSP22;SH3RF1;RIPK1;ZNF622;TIRAP;CD27
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.716134335595044,1.4247280264755107,0.016666666666666666,0.6986276175924993,1.0,8/18,17.35%,SLC4A4;PSEN1;PRXL2C;PFKFB3;GAPDHS;PRKAA2;PRKAA1;PFKFB1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.5005751317923135,-1.424407514015679,0.0,0.5094693851275838,1.0,17/108,7.77%,EIF1;G0S2;CCND1;BTG1;JUN;PANX1;MARCKS;PMEPA1;BTG3;SAT1;IER2;IFIT2;LDLR;TIPARP;TRIP10;PHLDA1;TUBB2A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.8414218208929949,1.4242927947507376,0.020833333333333332,0.6967673026792286,1.0,7/9,13.63%,DOCK5;NR4A3;FGF9;DOCK7;DOCK4;TPM1;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6774482001822106,1.4240408395580468,0.07407407407407407,0.6945767789662093,1.0,3/22,6.33%,STMN2;PAK1;CAV3
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.7946764631450687,-1.4237747593553138,0.04878048780487805,0.5102979231759797,1.0,2/9,9.32%,DHFR;PTN
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.7019281377687394,1.4235769142828383,0.0847457627118644,0.6929430403941518,1.0,9/21,15.69%,HEY2;NEBL;CAV3;TTN;HES1;SGCZ;DYSF;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.6982128802176271,1.423063198473573,0.05555555555555555,0.6917969851257176,1.0,4/22,9.52%,CLDN18;TBCD;PARD3;PAK2
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.6734580133294777,1.4229655871358944,0.07936507936507936,0.6884634670026614,1.0,2/25,1.25%,HOOK1;TPCN2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.5255909627043344,1.4224339694496237,0.017857142857142856,0.687821202300124,1.0,38/125,18.32%,CALCB;OLFM3;NKAIN2;SHISA6;STMN2;SULT4A1;MMD2;ATP2B3;FAM13C;TLN2;PRKX;PARM1;VAMP1;CREBRF;SNAP25;GCNT2;CRMP1;ADGRB3;AQP4;DGKZ;LSAMP;MAPK10;SCN2A;CLVS2;RUFY2;ACTL6B;ASTN1;KIF1B;PIEZO2;KCNAB2;LRRTM1;MAGI2;ANK2;CCDC92;ERC2;SLC6A1;GDAP1;DCLK1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.6657287438405881,-1.4216946093383718,0.06,0.5179504612578546,1.0,2/24,1.72%,RPS2;GORASP1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.6809154024524406,-1.4210540434102261,0.05405405405405406,0.5177820085514374,1.0,6/25,9.20%,UBB;RPS27A;UBC;DYNLL2;UBA52;ACBD5
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.8948166266804138,1.420919940391737,0.017857142857142856,0.6935382552487557,1.0,3/6,5.94%,ASXL2;LMO3;PLIN5
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5492640472726406,-1.4209173704842153,0.02631578947368421,0.5162185990924529,1.0,15/62,19.85%,JUN;GTF2F1;ACTB;TMBIM6;IFIT2;CAV1;ZNF304;RACK1;PARK7;SUMO1;PIN1;BAX;AKT1;GOLGA2;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.6355708567394104,1.419745769930892,0.061224489795918366,0.6990128214427251,1.0,9/27,17.55%,RNF152;ATM;UBR1;TSC1;PRKAA2;STK11;MAPKAPK5;PRKAA1;TNFAIP8L1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.6772637998312965,-1.4194792435362895,0.061224489795918366,0.5210658197121397,1.0,14/25,18.95%,HSPA8;TMBIM6;BAG3;ERN1;HSPA13;STUB1;HSPA14;DNAJB12;HSPA9;HSPA5;OPTN;BAX;DNAJC18;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.7992660007788761,1.4194154297312216,0.09090909090909091,0.6971866120675246,1.0,1/9,0.27%,PTPRC
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.9182879010765715,1.4193071595418896,0.061224489795918366,0.6932493225860666,1.0,1/5,0.27%,PTPRC
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.8229764595422011,-1.4191954874888741,0.0425531914893617,0.520492061852712,1.0,2/10,0.99%,BGN;BCAN
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.6088826852504912,1.4189220987500357,0.07142857142857142,0.6920950924739436,1.0,9/46,10.22%,ITGA2;SCEL;FMO5;EMILIN2;SLC25A48;CDKL1;CDKN2A;ITPR2;BRCA1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.5806736569800239,-1.418286663087335,0.04,0.5225272845506804,1.0,15/50,15.95%,CPSF1;TRMT10C;RTRAF;TRMT10A;CSTF2;ADAT2;TSEN34;SARS1;AARS1;POP5;PUS3;DDX1;C2ORF49;THUMPD1;TYW5
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.846525227844489,-1.4179116257982782,0.1346153846153846,0.518276069763382,1.0,2/5,3.66%,SNX17;MT3
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.846525227844489,-1.4179116257982782,0.1346153846153846,0.518276069763382,1.0,2/5,3.66%,SNX17;MT3
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.846525227844489,-1.4179116257982782,0.1346153846153846,0.518276069763382,1.0,2/5,3.66%,SNX17;MT3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5425404610015427,-1.4171028694268522,0.045454545454545456,0.5200961168443852,1.0,19/69,15.66%,CDKN2C;PSMB6;PSMD8;PSMB4;ZFP36L1;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;CDK2AP2;PSME3;PSMD2;BRD7;PSMD3;CDC73;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5742224396695264,-1.4169918077221515,0.02702702702702703,0.5188394794198498,1.0,21/77,16.67%,UBB;RPS27A;UBC;PHF1;FAM50A;PARP1;HDAC11;UBA52;RFWD3;COPS7B;COPS2;CENPV;HMGN2;NUP155;CUL4B;COPS6;HDAC3;BAHD1;COPS8;H3-3A;GPS1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.7742474488036718,-1.4166847785371885,0.0,0.5187897264247852,1.0,6/11,18.21%,MT2A;COX19;SLC31A1;PRNP;COMMD1;ATP7B
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.8982167586766452,-1.4166402694596285,0.0,0.5171610213277473,1.0,1/6,0.29%,GTF3C6
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.772872411202016,-1.4161972299417376,0.07142857142857142,0.5170405823480555,1.0,2/9,9.40%,ODC1;SRM
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.7166288411087041,-1.4157826558465378,0.05128205128205128,0.5169209654774399,1.0,1/14,0.34%,ATP6V0A4
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.7956170062057402,-1.4157373256026866,0.0625,0.5153533624621542,1.0,3/8,12.38%,H1-4;SMARCA5;H1-10
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.6843860866894514,-1.4157003649537951,0.07142857142857142,0.5136823960524296,1.0,6/20,16.07%,ATF4;PIH1D1;NOL11;NCL;WDR43;DHX33
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.8734971805623428,1.4153202778694212,0.038461538461538464,0.7120863350499671,1.0,3/6,8.27%,HEY2;FGF9;NFATC3
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.8444447909176034,1.4151547919047747,0.0,0.7091224594345226,1.0,3/5,13.01%,UBASH3B;FOXP1;PRXL2A
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.6847253225121981,1.41495494815027,0.05454545454545454,0.7061397191031155,1.0,7/27,12.82%,RAB3A;NR4A3;PLEKHM1;BORCS5;SYTL4;PIP4P1;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.8375342217072497,-1.4145296629786321,0.027777777777777776,0.5169077825163286,1.0,1/8,0.62%,GSTP1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.890335188768972,1.4144248291121435,0.09803921568627451,0.7013640889150442,1.0,1/5,0.35%,HEY2
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.890335188768972,1.4144248291121435,0.09803921568627451,0.7013640889150442,1.0,1/5,0.35%,HEY2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.555969864742732,-1.4143818316003418,0.022222222222222223,0.5163373294091943,1.0,21/74,15.66%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;UBA52;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2;TOLLIP;PSMD3;PELI1;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.8215159776973298,1.4130880489773419,0.038461538461538464,0.7057992353997703,1.0,2/9,6.25%,HEY2;EMP2
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5570070739952241,-1.4124562556114557,0.043478260869565216,0.5231807711281082,1.0,15/71,10.08%,PSMB6;PSMD8;PSMB4;ESRRB;HES5;PSMA7;PDGFRA;YAP1;PSMC3;PSMC1;PSMD10;PSMD12;PTN;PSMB9;PSME3
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.9085643761497536,1.412165336245878,0.03508771929824561,0.7083631103379364,1.0,1/5,0.26%,VSIR
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.7087094408068673,-1.411553592423569,0.05,0.5253298325051242,1.0,4/23,8.39%,PPIF;RNF112;MAPK13;SIGMAR1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8478725253815546,1.411446330488376,0.04,0.709301452153651,1.0,1/7,0.53%,NDST3
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.8002897794818672,-1.4112638868320726,0.09090909090909091,0.5250732845029993,1.0,3/10,11.27%,PIH1D1;NOL11;NCL
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.7151654153956198,-1.4111386008128899,0.14634146341463414,0.524259846331618,1.0,5/12,13.44%,DERL2;UBE2J1;YOD1;OS9;ERLEC1
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.8360491175440763,-1.4111201673814797,0.10526315789473684,0.5225610029192509,1.0,3/7,12.61%,JUN;PSMC3;TARDBP
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6169798535461445,-1.4109568622731241,0.10638297872340426,0.5217982191825997,1.0,5/25,12.38%,H1-4;BANF1;SET;AIFM1;H1-10
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.6895089910016419,1.410283586038975,0.038461538461538464,0.7128193516023362,1.0,4/25,5.22%,PON1;YJEFN3;ABCA2;RXRA
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.8693441629633163,-1.4101462385166283,0.09615384615384616,0.5239164820236302,1.0,1/5,0.62%,GSTP1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.7320601414702909,-1.4100267183669546,0.0425531914893617,0.522860245834505,1.0,3/13,3.07%,GPX1;PRDX5;PRDX1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.5469704489933687,-1.4097703361743943,0.12195121951219512,0.5221772247772266,1.0,13/65,11.42%,RBM8A;SRSF7;CALR;RAN;NUP42;MALT1;U2AF1;WASHC4;LSG1;MAGOH;SLU7;EIF4A3;NUP155
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.7585556669997507,-1.4096700371067077,0.10714285714285714,0.5209874875667265,1.0,3/11,10.38%,STAB2;GUSB;CD44
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.8573731523802707,1.4093643979570367,0.05357142857142857,0.7144567229890374,1.0,1/7,2.27%,ACSS3
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.7933835885476616,-1.4091679403237838,0.0975609756097561,0.5214795676324236,1.0,4/8,13.50%,MT2A;COX19;SLC31A1;PRNP
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.8709431406903593,-1.4090966294084597,0.06666666666666667,0.5201909622153725,1.0,3/7,3.66%,MT1E;MT2A;MT3
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.7511279654334853,1.4089626453968946,0.07272727272727272,0.7134100675527782,1.0,4/15,3.63%,BCL2L11;SGO2;BRME1;TDRD9
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5945662497663068,-1.4087483342993623,0.10810810810810811,0.5199231084536163,1.0,11/36,12.52%,UQCR10;SURF1;NDUFS8;UQCRC1;NDUFA5;ETFRF1;COQ10A;ATP5F1D;UQCRH;UQCRB;SDHAF4
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.6461179358198081,-1.4085533625103366,0.11538461538461539,0.5187559212918802,1.0,9/21,14.71%,HSPA8;TMBIM6;BAG3;ERN1;HSPA13;HSPA14;HSPA9;HSPA5;OPTN
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.92704083834076,1.4080125503291758,0.06521739130434782,0.7171554397741238,1.0,2/5,1.64%,FABP3;HTR2C
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.9125030798983697,1.4078437907788812,0.019230769230769232,0.7139872814243531,1.0,1/5,4.22%,RELN
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.9043956733259472,-1.4074799199989696,0.10416666666666667,0.5214763015672149,1.0,2/5,6.72%,CXCL12;LYN
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7543003781790604,-1.4072924760484662,0.125,0.5207771653529767,1.0,3/10,13.33%,CRAT;ACOX1;CROT
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.8283379286571257,1.4071418794322057,0.04918032786885246,0.7145021162654457,1.0,3/7,16.02%,AHR;IL6ST;IRF1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.8731638518632445,1.4061755490597048,0.043478260869565216,0.7181267619628287,1.0,2/7,2.73%,OTUD7B;USP30
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.8588800745431757,-1.4061732406532212,0.041666666666666664,0.5247232072470134,1.0,2/6,9.80%,POP4;POP5
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.768425995831211,1.4057014212695116,0.10714285714285714,0.7174444112667956,1.0,3/12,6.17%,SHTN1;SEMA3A;NSMF
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.8537764964718256,-1.4055224413557545,0.06818181818181818,0.5252992464468373,1.0,4/8,10.44%,CALM1;SRI;CALM3;NIPSNAP2
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.6618457102500573,-1.4051554718754808,0.02631578947368421,0.5250557850082955,1.0,13/27,22.47%,POLR2L;POLR1F;POLR1A;POLR2K;POLR2E;GTF2H2;TAF1A;POLR1G;TBP;GTF2H1;UBTF;POLR2F;GTF2H5
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.7956013540008045,-1.4048498281776325,0.06382978723404255,0.5247784995542345,1.0,1/11,0.09%,PPIF
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.5212414538733238,1.4044328745429335,0.03125,0.7233858647504573,1.0,48/135,19.77%,CALB1;OLFM3;SHISA6;STMN2;GNG4;SULT4A1;MMD2;CACNG2;ATP2B3;SLC24A2;PDE1A;NRIP3;GRM3;GRIN1;PSD2;GRIK3;HCN1;PRKCA;SNAP25;GABRG2;SLC22A15;ATP2B2;ADGRB3;HIVEP2;CNTNAP2;CALY;PDE9A;CPLX1;DLG4;CLVS2;ACTL6B;PRKG1;SLC8A2;ASTN1;LRRTM1;SYT2;GAD2;SLC6A1;PCP4;SNCB;CTNND2;SEZ6L;SLC12A5;CERK;ABAT;SYP;PLP1;GABRA1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6086537428114179,1.4044206190840272,0.017857142857142856,0.7195177282134773,1.0,9/43,14.34%,NEDD9;PAK1;CDC42BPB;MKLN1;THSD7B;PHACTR1;TNIK;DMTN;SIPA1L1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.6323410780177258,-1.4043494980099267,0.04878048780487805,0.5250316908544455,1.0,8/31,15.01%,HSPG2;AGRN;UGDH;GPC4;XYLT2;GPC1;B4GAT1;B3GALT2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.8365162742808491,1.403460208974428,0.07142857142857142,0.7213363584791654,1.0,1/8,0.46%,AKR1C2
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.7289887641037185,-1.4032719157214648,0.1875,0.528516023567494,1.0,5/10,10.38%,ARV1;LDLR;CAV1;LCAT;STARD3
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.912246752588925,1.4029487246441366,0.018867924528301886,0.7210984235553849,1.0,4/6,7.28%,HDAC4;CAMTA2;TTN;RYR2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.8784399152730586,1.4027894791048778,0.05263157894736842,0.7183436250919805,1.0,2/6,3.09%,INTU;COL5A1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.75559005622108,-1.4024080375812833,0.06818181818181818,0.5313830938618866,1.0,4/10,9.40%,ODC1;SAT1;SAT2;SRM
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.5421204684196766,-1.4022619147347326,0.023255813953488372,0.530111808503325,1.0,14/64,16.29%,SOX4;PIWIL2;PCIF1;EEF2;FXR2;EIF3D;CLU;SPHK2;EIF4A3;NPM1;RACK1;PLXNB2;SMPD3;CHRNA7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.5014114685469435,1.4005292855941711,0.0,0.7308499282588913,1.0,41/210,17.61%,FHDC1;ABLIM1;INTU;SHTN1;FAM161A;RPGR;SEPTIN6;RAB17;MYLK;RAB8B;IFT172;EMP2;RABL2B;CCDC57;WDR19;CFAP221;MAK;ARHGEF6;VCL;RAB1A;BBS7;INPP5E;TTBK2;P2RY12;TNIK;DNAH5;RAP1B;PCNT;DMTN;ASAP1;RILPL1;TMEM138;KIAA0586;CEP41;IFT52;BBS4;ARHGEF7;CEP131;EHD1;TMEM216;ARHGEF4
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.8716057978493024,1.4001062636509414,0.09803921568627451,0.7299780208087078,1.0,2/5,10.22%,KAT2B;BRCA1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.5337926900887077,1.3996029251264386,0.016129032258064516,0.7291154887074509,1.0,33/106,19.27%,ROBO2;NKX6-2;PCSK2;UNC5D;EFNA5;SHISA6;STMN2;G6PC2;SULT4A1;CAMK2B;KCNB2;KCNIP1;EDARADD;TGFBR3;SNAP25;ADGRB3;PROX1;LSAMP;MAPK10;CLVS2;ACTL6B;SLC8A2;ASTN1;DPP6;NOVA2;LRRTM1;GAD2;ABCC8;PCP4;CTNND2;SEZ6L;SYP;UNC79
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5999674406395448,-1.3993799781455571,0.04878048780487805,0.5406493417963019,1.0,8/35,10.38%,GPX1;BEX3;MT3;PIH1D1;NOL3;NGF;IFI6;CD44
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.7731671242763043,1.398812417285981,0.0784313725490196,0.7299058959783955,1.0,5/12,13.63%,PTPRC;CD247;TRAF3IP3;CD27;AOAH
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5063063536660026,-1.3980334469843034,0.05,0.5439380633973251,1.0,31/103,18.01%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;UBA52;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;GINS3;MCM4;RFC5;PSMD3;PSMD4;PRIM1;PSMB2;POLD3;WDHD1;POLD2;DBF4;REV3L;RFC3;PSMC4;POLG;PSMD11
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.6073277459703889,-1.3977163205836436,0.10714285714285714,0.5435392978451037,1.0,12/37,14.71%,HSPA8;TMBIM6;BAG3;ERN1;HSPA13;DNAJA1;HSP90AB1;HSPA14;HSPA4;HSPA9;HSPA5;OPTN
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6894071609494361,1.3968388908092972,0.03508771929824561,0.7396321492455574,1.0,6/20,12.22%,CAMK2B;PSEN1;FOXO6;SHANK3;CAMK1;CPEB3
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.7158570613473862,1.396494148842672,0.03278688524590164,0.738397397368185,1.0,3/16,6.30%,PTPRC;AHR;SPI1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.8592526610458371,1.3955150152461315,0.057692307692307696,0.7418861823900662,1.0,3/6,8.93%,PKP2;GFAP;NEFL
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.6217280704143429,1.3948743685783225,0.12280701754385964,0.7422145176312525,1.0,6/33,8.97%,HOOK1;ARFGEF2;EPS15;PLEKHF1;SORT1;DNM1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.5357114492528965,-1.3948475605158739,0.05128205128205128,0.5547659978146956,1.0,11/84,11.42%,RBM8A;SRSF7;CPSF1;RAN;NUP42;U2AF1;RBM15B;MAGOH;SLU7;EIF4A3;NUP155
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.7861941658013502,-1.39461190486476,0.043478260869565216,0.5534768678507249,1.0,4/11,7.89%,CPSF1;ERN1;CSTF2;CSTF2T
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.8110082110372985,-1.3945139301664342,0.14583333333333334,0.5520927863654636,1.0,1/5,0.60%,GPX1
prerank,PanglaoDB_Augmented_2021__Myocytes,0.5778964091352796,1.3935217022609585,0.037037037037037035,0.7473892463832711,1.0,17/54,13.63%,DOCK5;FABP3;EDNRA;CKMT2;MEF2D;ARHGAP26;SYNPO2;LAMA2;CAV3;WASHC1;TTN;SULF1;NBR1;TPM1;CLOCK;SGCA;PRKG1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.5988796646615385,-1.3932221548059247,0.05,0.5555015316317486,1.0,5/38,6.54%,GPX4;NDUFA6;FTL;PRDX1;SELENOS
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.8701140428720023,1.3927789445463565,0.06382978723404255,0.7483882899456731,1.0,1/5,0.84%,BCL2L11
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.8961081192554363,1.3924643657340399,0.0392156862745098,0.7472334271271466,1.0,1/6,4.16%,KAT2B
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.919401103176924,1.3919988873304576,0.034482758620689655,0.7466467431702264,1.0,1/5,0.26%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.7180739597699709,-1.3911655478038512,0.1111111111111111,0.5619558839836556,1.0,5/14,13.85%,SRSF7;SAP18;PCBP4;SRSF9;SRSF10
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.6435107881073189,-1.3910693545153068,0.0851063829787234,0.560456789834554,1.0,7/28,8.80%,UBB;RPS27A;UBC;S100A1;TLR1;UBA52;CNPY3
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.6243847001340365,1.3909290132615302,0.10526315789473684,0.7494792691158584,1.0,9/38,7.93%,MAP3K19;TMCO5A;DNAH7;NEBL;FUT2;SHROOM3;ARFGEF3;CHST9;CDS1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.8959567820004057,-1.390893248995556,0.06382978723404255,0.5592715337835444,1.0,1/6,0.09%,PPIF
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.8764612328611343,-1.3897372183192547,0.0,0.5626851120110047,1.0,3/8,6.88%,CHRNA4;NIPSNAP1;P2RX4
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6186380381270624,-1.389504763782941,0.047619047619047616,0.5618368936413539,1.0,11/38,16.17%,UBB;RPS27A;UBC;CENPX;UBA52;RFWD3;MUS81;RNF168;RNF8;FAN1;VCP
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7987450918181817,1.389009798165832,0.09433962264150944,0.7584323660410645,1.0,2/10,6.54%,SYNJ2;INPP5A
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.8430647714542074,1.388916557954863,0.016666666666666666,0.7552411218242184,1.0,2/9,2.56%,PTPRC;GPI
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5804706771422482,-1.3888929191271853,0.04,0.5631416127798693,1.0,14/57,12.20%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;ZFP36L1;SFRP1;RAB14;CD44;ANOS1;FLRT3;DSTYK;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6453136808714672,-1.388380741472952,0.10869565217391304,0.5637693404132778,1.0,7/25,18.70%,CALM1;GABARAPL2;MAP1LC3A;MAP1LC3B2;VCP;GABARAPL1;LIX1L
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.5588902426751273,-1.3872791836343294,0.046511627906976744,0.566695207673784,1.0,23/72,18.74%,PSMB6;PSMD8;PSMB4;CDC26;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;ANAPC11;PSMB9;PSME3;PSMD2;PSMD3;PSMD4;PSMB2;UBE2S;BUB3;DBF4;ANAPC2;PSMC4;PSMD11;DBF4B
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.5205651822226325,-1.3870798574065506,0.027777777777777776,0.5660447269676225,1.0,24/88,13.85%,LSM4;RBM8A;SRSF7;SNRPB;SNRPD2;LSM1;SMU1;NOL3;SCNM1;U2AF1;PRPF8;SNRPG;MAGOH;SLU7;SNRPD1;SMNDC1;YJU2;PDCD7;SF3B2;TARDBP;PPP2R1A;NOVA1;PRPF18;SRSF10
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.7951473474981322,1.3870418479620175,0.02,0.7649838697078909,1.0,1/9,0.27%,PTPRC
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5285484498119677,1.3865137143644315,0.03278688524590164,0.7645039092242836,1.0,27/99,17.16%,GRIN2A;OLFM3;STMN2;MEIS2;MMD2;ATP2B3;NTRK3;TMEM132B;KCNC2;GRM3;GRIN1;PSD2;SNAP25;GABRG2;GABRA2;LSAMP;SCN2A;GRM1;CLVS2;ACTL6B;SLC8A2;ASTN1;MAGI2;UNC13A;GAD2;GRIN2B;SLC6A1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.796490159391428,-1.3864235462058945,0.13333333333333333,0.5672552301846182,1.0,2/11,2.35%,TAF9B;PTTG1IP
prerank,PanglaoDB_Augmented_2021__Podocytes,0.4892452206339901,1.3862193918004606,0.03571428571428571,0.7622296340460493,1.0,27/141,13.36%,DOCK5;LIFR;NUAK1;CHST3;EDNRA;ADAMTS13;KIAA1217;ADGRL2;KITLG;MERTK;NEBL;ARHGAP24;ARHGEF17;HSPA12A;TEAD1;CADPS2;FKBP9;ETF1;SULF1;COL4A5;TPM1;PLSCR4;MID1;RBFOX2;PTPRG;APBB2;NAV2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.6108969346910593,-1.3856531966455143,0.05555555555555555,0.5686900488710617,1.0,6/21,11.54%,RAN;CHAMP1;KIF25;SMC1A;TUBG1;KIF18B
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.7947837416736743,1.3853009257908715,0.1111111111111111,0.7649903917351453,1.0,2/10,3.47%,CTBP1;NNMT
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.5665850278442561,1.3845307373797628,0.04081632653061224,0.7672340743582826,1.0,15/75,10.62%,TPD52L1;IGF1R;TNFRSF19;WNT7A;SEMA3A;GADD45A;DUSP22;SH3RF1;TGFBR3;RIPK1;CYLD;MAPK8IP2;ZNF622;TIRAP;CD27
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.851985342305253,1.3842581626091466,0.0851063829787234,0.7655116512034643,1.0,2/5,6.47%,VSIR;SH3RF1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.593672862872391,-1.3839126838592022,0.10526315789473684,0.5751605385560958,1.0,16/47,15.14%,H1-4;POLR2L;ACTB;POLR1F;SMARCA5;WBP2;POLR1A;SPHK2;POLR2K;POLR2E;H1-10;MYBBP1A;TAF1A;DEK;POLR1G;SMARCD1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.6144027977150328,-1.3833482226905323,0.07317073170731707,0.576300788233396,1.0,6/47,7.74%,PPIF;JUN;PRDX5;ROMO1;PDGFRA;MAPK13
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.7212504152217374,-1.3830516945274145,0.044444444444444446,0.5754350794810097,1.0,5/14,15.89%,SLITRK2;GPC4;PTPRF;SLITRK1;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.7145748471398037,1.382545433890434,0.11290322580645161,0.7731992587851667,1.0,1/16,0.27%,PTPRC
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.6644565480319916,-1.3823708408783963,0.07407407407407407,0.5772214739852903,1.0,4/22,10.08%,UBB;GPX1;CTSC;PSME3
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7993087176781937,1.3816648951188732,0.058823529411764705,0.7747560194373091,1.0,2/10,8.18%,DPYD;CRMP1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.889803767951699,1.3814784356061471,0.044444444444444446,0.7724544646044451,1.0,1/5,0.35%,HEY2
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.49358265845203714,-1.3809448467793664,0.029411764705882353,0.5818975205154342,1.0,29/137,12.42%,HSD17B10;AIP;TIMM8B;TSPO;PTCD2;HAX1;COX7A2;PARP1;SLC25A6;IFIT2;CHCHD10;ATCAY;TIMM13;TOMM7;TIMM23;PHB2;SLC25A4;DNAJC19;TIMM44;AIFM1;CHCHD2;BCS1L;SLC25A33;TIMM22;NIPSNAP2;MFF;ATP5F1D;ESRRA;MTX3
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.8365946770248354,1.3808338094997783,0.0,0.7731740286938348,1.0,2/9,1.55%,UNC13C;SYT1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5160219888898786,-1.380737511060717,0.09090909090909091,0.5811530782475751,1.0,16/95,13.00%,PPP1R14B;ZDHHC1;S100B;RARRES2;TRIM35;MALT1;LYN;PHB2;SMPD1;IFITM3;IFI6;IKBKB;SHFL;NLRP1;RNF187;B2M
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.7034631651274433,1.3803798658985165,0.15217391304347827,0.7729783385017073,1.0,8/19,20.49%,STAT4;STAT6;STAT5B;NMI;STAT2;PKD2;FER;STAT3
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.8253864362462058,1.3794860821815809,0.0784313725490196,0.7757118891533065,1.0,1/6,0.35%,HEY2
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.8226267422075775,-1.379086764672009,0.09803921568627451,0.5861146960512573,1.0,3/6,9.40%,SAT1;SAT2;SRM
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.7857722078765307,1.3788026177980508,0.16393442622950818,0.7765771669898132,1.0,1/10,0.27%,PTPRC
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.7594122180042601,1.376969566809756,0.05660377358490566,0.785323335754589,1.0,1/12,0.08%,FHDC1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.6670398240668892,-1.3766891701714572,0.10869565217391304,0.5957962554298856,1.0,2/15,3.68%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7402910006117481,1.376476438936901,0.1,0.784734734852557,1.0,2/15,0.65%,GLRA1;GLRA2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8926843195437815,1.3763938725432892,0.12244897959183673,0.7814479550835363,1.0,1/5,0.26%,VSIR
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.49834598927143137,-1.3761289645646553,0.0,0.5965643795704468,1.0,26/109,15.76%,BICD2;SCG3;CALR;GABARAPL2;SEC61G;WASHC2A;VPS35;DNAJA1;ARL1;LAMP5;SEC61B;AUP1;RPL11;RAB33B;MICALL1;CEP68;DCP1A;DDX1;YBX1;TOLLIP;LAMP1;IFT20;PRNP;OPTN;WDR35;ISG15
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.8625410207038151,-1.3756541086824288,0.12195121951219512,0.5974565733239183,1.0,2/5,12.97%,ULK3;VPS11
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.7001062461910431,-1.3755072576001022,0.12244897959183673,0.5963900765885182,1.0,3/13,9.31%,VPS37B;KPNA2;CHMP2A
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.8185591397047663,-1.375162260016397,0.04878048780487805,0.5963196374120017,1.0,3/6,9.38%,PPT1;TMEM9;GRN
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.7404965519525925,-1.375133581144486,0.11363636363636363,0.5947847682119206,1.0,2/11,10.75%,IDH1;AADAT
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.7319670941756938,1.3749615704945721,0.07142857142857142,0.7882413435828733,1.0,5/13,17.13%,GRIN2A;GRIN1;RYR2;SLC8A1;GRIN2B
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.513655756049771,-1.3747937462997495,0.047619047619047616,0.5947827835915599,1.0,10/69,8.14%,BGN;BCAN;HSPG2;DSEL;AGRN;UGDH;GPC4;CHST7;XYLT2;HAS2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.678668436912308,-1.3744893935296991,0.1111111111111111,0.5945274963804287,1.0,4/17,9.98%,PSMB6;PSMB4;PSMA7;PSMB9
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.5488851987295266,-1.374301660216984,0.14634146341463414,0.5920690716881436,1.0,5/51,3.33%,POLR2L;POLR2J;NUP42;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.5488851987295266,-1.374301660216984,0.14634146341463414,0.5920690716881436,1.0,5/51,3.33%,POLR2L;POLR2J;NUP42;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.791388362111213,1.3742147214305378,0.057692307692307696,0.7899493695786898,1.0,4/7,15.69%,UBASH3B;RYR2;DIAPH1;ANK2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7250833375168507,1.3740738988176746,0.09259259259259259,0.7870172863050532,1.0,5/13,17.13%,GRIN2A;GRIN1;MAPK8IP2;ARRB2;GRIN2B
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.7913331789259449,1.3739723922063587,0.06382978723404255,0.7839876932995509,1.0,4/12,9.45%,HEY2;ADAMTS9;MYLK;PROX1
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.8827056851424481,1.3736546310411673,0.041666666666666664,0.782678268284747,1.0,1/5,0.45%,GLRA1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.8465482609595183,1.372797824851109,0.04,0.7846270831328496,1.0,2/7,7.22%,VRK1;PRKCA
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.5055537622098646,1.372757178946856,0.03225806451612903,0.7813630827818084,1.0,44/170,22.45%,FHDC1;ABLIM1;INTU;FAM161A;RPGR;SEPTIN6;RAB17;RAB8B;IFT172;RABL2B;CCDC57;WDR19;CFAP221;MAK;RAB1A;CCP110;BBS7;INPP5E;TTBK2;DNAH5;PCNT;ASAP1;RILPL1;TMEM138;KIAA0586;CEP41;IFT52;BBS4;CEP131;EHD1;TMEM216;DYNC2I1;CEP290;DZIP1;PKD2;RFX3;IFT140;DISC1;CDC14A;ARL13B;CC2D2A;CEP250;TTLL3;CDC14B
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.5596729983230484,-1.3718868276543938,0.07142857142857142,0.6009289916326909,1.0,11/54,12.20%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;PPIA;KPNA2;CTDP1;POLR2K;RAD23A;POLR2E
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.6340580528093849,-1.3718537756554363,0.04878048780487805,0.5993130399007375,1.0,4/31,8.31%,JUN;SIRT2;NGF;EDF1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7953840714580229,1.3715543942831903,0.10638297872340426,0.7854585657025905,1.0,2/7,7.28%,HEY2;RYR2
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.6853420418784065,-1.371324295344934,0.15384615384615385,0.5994858141962919,1.0,1/19,1.16%,PPT1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.6609457281961788,1.3713135789821334,0.10714285714285714,0.7839227920396613,1.0,6/21,13.63%,PTPRC;ZBTB16;CD247;RORA;TRAF3IP3;AOAH
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.6299528686699702,-1.3708539260911576,0.125,0.599906720541242,1.0,6/32,9.09%,GPX1;GSTP1;GPX4;ALOX5;FADS3;FADS1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.7590604349895758,1.3703864658752118,0.07272727272727272,0.7860734050709816,1.0,3/9,5.83%,BCL2L11;FAM107A;KLF9
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8981702051472586,1.3702434969479063,0.06666666666666667,0.7833431595281282,1.0,2/5,0.41%,DOCK5;CHRM3
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.8188876531302904,-1.3702119956556431,0.13333333333333333,0.6008531490353716,1.0,4/6,17.86%,SLC25A4;SLC25A24;SLC25A5;SLC25A42
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.6777845426811779,-1.3701317679918044,0.08108108108108109,0.5996268361959193,1.0,2/17,9.03%,BTC;ANAPC11
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.853956273686754,-1.3698292725503327,0.10638297872340426,0.5991175006264473,1.0,3/6,12.03%,COX11;SLC7A8;UNC80
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.8377149630892011,-1.3690790152508874,0.0392156862745098,0.6005818006672148,1.0,2/7,0.60%,NOX4;GPX1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.7746598251871679,1.3690648567168096,0.10909090909090909,0.7871973870246262,1.0,1/12,8.20%,STN1
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.8691627716123725,-1.3689112182730692,0.023809523809523808,0.6000419296754713,1.0,2/9,4.33%,PPIF;COX7A2
prerank,PanglaoDB_Augmented_2021__Neurons,0.4884967615381138,1.3688851168486242,0.0,0.784804850486396,1.0,43/237,13.25%,RASGRF1;NWD2;CALB1;PCSK2;OLFM3;PCLO;STMN2;NRSN2;SULT4A1;SLC6A17;SCN8A;MMD2;CACNG2;ATP2B3;PDE1A;NMT1;VSNL1;GRM3;RBFOX3;SLC30A9;PNCK;PSD2;NRGN;RB1CC1;RYR2;SNAP25;GABRG2;ADGRB3;RERE;PROX1;SGIP1;RORA;KMT2C;CNTNAP2;CALY;CPLX1;ARID4A;DLG4;SCN2A;CLVS2;STX1A;ACTL6B;CAMK2N1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.7061358371132962,-1.3686454870569305,0.13157894736842105,0.599413130636169,1.0,3/15,11.45%,FBLN5;HAS2;LTBP3
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.7391918024783309,-1.367618844323631,0.14893617021276595,0.6025139560254087,1.0,6/14,19.21%,EMC6;GET3;EMC10;MMGT1;EMC4;EMC7
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7501085258923552,1.3675389671767846,0.16666666666666666,0.7913944284634925,1.0,5/10,23.23%,TRAK1;SYBU;NEFL;ACTR10;MAPT
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.4783515272382311,-1.3674599940716525,0.029411764705882353,0.6017904780848525,1.0,16/147,8.37%,COPZ1;YIF1A;GORASP1;RANGRF;TMED2;RAB1B;PEF1;TMEM115;DYNLL2;KDELR1;CTSC;TRAPPC2L;LMAN2;YIF1B;TRAPPC6A;TMED9
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.8390469963162133,1.3672458556148999,0.10526315789473684,0.7897545390412736,1.0,2/7,8.18%,DPYD;CRMP1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.8992011242667826,1.3665740342653478,0.08163265306122448,0.7907624259072202,1.0,2/5,7.22%,VRK1;PRKCA
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.8302437701611107,-1.3664838603867038,0.14285714285714285,0.6039871193647934,1.0,1/6,0.67%,SIRT2
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.8487247168705296,-1.3663873992225877,0.1111111111111111,0.6027788512074661,1.0,1/5,1.24%,IDH1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.8241731778594021,1.366003664026551,0.0,0.7913702259013975,1.0,4/10,10.62%,PTPRC;CD247;TRAF3IP3;CD27
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.6340103791213875,-1.3656558484006238,0.08333333333333333,0.6040545875559159,1.0,8/25,11.85%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;MCOLN1;ATP6V0E2;ATP6V0D1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7272385130835043,-1.365623399054624,0.09615384615384616,0.6026115774140455,1.0,6/14,12.92%,CPSF1;RTRAF;CSTF2;TSEN34;DDX1;C2ORF49
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.482105705975387,-1.365211634672537,0.024390243902439025,0.6024084079905346,1.0,28/117,16.64%,CCND1;PSMB6;PSMD8;SSNA1;PSMB4;STOX1;TUBA1A;PSMA7;TUBG1;PSMC3;PSMC1;RCC2;PSMD10;PSMD12;TUBB4B;PSMB9;PSME3;ODF2;PRKAR2B;PSMD2;PPP2R1A;HAUS8;PSMD3;PSMD4;PRKACA;PSMB2;DCTN3;DYNLL1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6054525374896705,-1.3651634083414805,0.11627906976744186,0.600947545078751,1.0,8/32,12.25%,HSD17B10;TM7SF2;SQLE;SC5D;PMVK;MSMO1;PSAT1;DHCR7
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.8049129743167034,-1.3649202429291374,0.16279069767441862,0.6003613132707744,1.0,4/6,16.45%,ISCU;PRELID1;VCP;PARK7
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.6620112294595412,-1.3646847611787425,0.09090909090909091,0.5998676343112179,1.0,7/31,10.86%,S100A6;GSTP1;PDGFRA;SFRP1;WNT5A;FN1;MORC3
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.7616757348434755,-1.3645533698082755,0.1,0.5989008550470782,1.0,7/12,19.16%,TSPO;STARD3;DHCR7;FDX1;HSD17B14;STARD3NL;HSD17B7
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7831184516808631,1.3644455008374117,0.1590909090909091,0.7984024019524029,1.0,4/8,15.43%,KLF15;DIP2B;PRKAA2;PRKAA1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6168435275444046,-1.3641078275918692,0.03125,0.5993625733405296,1.0,6/26,12.38%,H1-4;PPP4C;USP51;KPNA2;FIGNL1;H1-10
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.8014075966089057,1.364031014418616,0.16666666666666666,0.7978081914016274,1.0,1/6,2.59%,AKT2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.6035555896267244,-1.363718116827248,0.0784313725490196,0.5992599195581918,1.0,8/37,10.14%,HSPG2;AGRN;UGDH;B3GAT2;GPC4;GUSB;XYLT2;SGSH
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.9019381600340655,1.363578817299828,0.03225806451612903,0.7977985742763725,1.0,2/5,3.88%,ITGA2;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8288140053856846,-1.3633098449297132,0.12244897959183673,0.5980853585588792,1.0,2/7,10.38%,TAF9B;CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8288140053856846,-1.3633098449297132,0.12244897959183673,0.5980853585588792,1.0,2/7,10.38%,TAF9B;CD44
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.7047117802908996,1.3632440829316494,0.14583333333333334,0.7964425920723374,1.0,5/17,11.24%,STAT4;STAT6;STAT5B;NMI;STAT2
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.7961353652854324,1.363074250549023,0.16666666666666666,0.7944085769693352,1.0,3/10,10.02%,PON1;RXRA;SGK1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.7966388998353922,1.362941079983558,0.06,0.7917051116622899,1.0,8/10,19.31%,NEDD4L;PKP2;SNTA1;CAV3;RYR2;ANK2;GPD1L;KCNQ1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.730471971911729,1.3625940555706613,0.07272727272727272,0.7909236144176319,1.0,2/15,8.96%,HEY2;SIN3A
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.845686116122571,-1.3620126210607741,0.08,0.6025350640032845,1.0,1/7,1.40%,APEX1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.5698523445001992,-1.3617954290689507,0.06666666666666667,0.6017813322495092,1.0,12/57,11.85%,RRAGA;DAPL1;ATF4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;TFEB;MLST8;ATP6V0E2;LAMTOR4;ATP6V0D1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.5894756739713822,1.3616516575165307,0.0392156862745098,0.7940447415204694,1.0,7/33,4.36%,PON1;CYP2E1;HSD11B1;SLC4A4;SLC13A3;LRP2;SORD
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.8535418437054034,1.3616328828939464,0.09615384615384616,0.7908492271311927,1.0,2/5,6.25%,MYLK;EMP2
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.6421094547842353,1.361284118461739,0.09836065573770492,0.7903060823863403,1.0,2/27,1.25%,HOOK1;TPCN2
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.8681438297128812,-1.3611646455469328,0.06666666666666667,0.6026078109033612,1.0,3/6,12.02%,DCP1A;DDX1;YBX1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.5093303907229455,-1.3608460603754213,0.08823529411764706,0.6027021302007847,1.0,27/116,13.11%,G0S2;S100A10;HSD17B10;IDH1;APEX1;PCBD1;ODC1;UGDH;CRAT;H2AZ1;CBR1;UBE2L6;UROD;ERP29;OSTC;IDI1;ALAD;DLD;ACAT2;CRYZ;HMGCS1;AADAT;UROS;ACOX1;PDHB;SUCLA2;GRHPR
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.812833551651901,-1.360411621234227,0.15555555555555556,0.6029701960686363,1.0,1/7,0.66%,HSD17B10
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.881601022764019,-1.3599266896476843,0.023255813953488372,0.603497554159833,1.0,2/7,8.01%,MRPL44;HENMT1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.8384871388472228,-1.3591053579946586,0.13043478260869565,0.6052933330213184,1.0,4/7,9.22%,PPIF;DNAJC30;PHB2;SPHK2
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.7771430466302554,1.3590969180473278,0.1,0.802468856126948,1.0,3/10,5.49%,APOLD1;SOX9;PRKX
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.6939146563057064,1.3590034370456525,0.05357142857142857,0.7999849902417466,1.0,6/17,17.77%,GNA12;DMTN;ITGB1BP1;ARHGEF7;PRKCE;APPL2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.6943834617610538,-1.3587965501725547,0.13333333333333333,0.604889919393674,1.0,7/22,14.49%,MMP2;COL8A1;COL12A1;FN1;ITGB5;ITGA4;CDC73
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5922610777889685,1.358748038885335,0.08955223880597014,0.7983366045934033,1.0,12/47,11.38%,RGS4;TULP3;GNG4;GRK4;SLC39A14;RNF157;NMT1;MRAP;GNG7;CAMKMT;GRK5;RGS12
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.8075757106566742,-1.358531501105152,0.1111111111111111,0.6046035400492143,1.0,1/7,4.49%,PIF1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5637419309032252,-1.3583519004810973,0.06818181818181818,0.603802603963958,1.0,25/67,17.54%,UBB;POLR2L;POLR2J;RPS27A;POLR2I;UBC;POLR2G;TCEA1;ZNF830;UBA52;COPS7B;COPS2;POLR2K;CUL4B;POLR2E;GTF2H2;COPS6;RFC5;POLD3;COPS8;PRPF19;GPS1;POLD2;RFC3;COPS5
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.7635056397764484,1.3581923096414235,0.15517241379310345,0.7986942595858333,1.0,1/10,1.49%,CTBP1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.6858536328516622,1.3581067296214056,0.10344827586206896,0.7960722800720681,1.0,2/13,6.69%,ADAMTS13;CHAC2
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.7129397275986165,1.3575674156880269,0.06896551724137931,0.7966192110214209,1.0,5/13,10.34%,CAMK1D;DAPK2;RIPOR2;MPP1;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.8518033874025398,-1.3575506451671724,0.15217391304347827,0.6061225803124002,1.0,1/5,10.81%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.6274993568535955,-1.3575110177306058,0.14893617021276595,0.6047514155146082,1.0,6/30,10.91%,AURKAIP1;BAD;CSTB;STUB1;CAV1;CST3
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.8740456061497419,-1.3569074723762446,0.1111111111111111,0.6062321692682494,1.0,2/5,8.15%,CALM1;CALM3
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.5320168670813746,1.3565873558643915,0.034482758620689655,0.8003696255280043,1.0,21/76,14.47%,GRIN2A;OPALIN;TNS1;PLXDC2;FAM107A;SHISA6;MMD2;ENPP2;TMEM132C;RTN1;GFAP;KCND3;AQP4;BAALC;GALNT15;NDRG2;P2RY12;CDH20;SPP1;SLC6A7;SLC8A1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.792117485597754,-1.3565410701491638,0.06521739130434782,0.6061162822317084,1.0,2/7,3.37%,CALM1;DHFR
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.5875461718443211,-1.3559624122880882,0.07547169811320754,0.6073030518131494,1.0,15/42,12.25%,TM7SF2;SNX17;SQLE;MT3;ARV1;SOAT1;PMVK;MSMO1;IDI1;ACLY;ACAT2;LCAT;HMGCS1;STARD3;DHCR7
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.7203292709662577,1.3556977597242772,0.1509433962264151,0.8029280939756203,1.0,6/14,15.69%,UBASH3B;CAV3;NOS1;CAMK2D;DIAPH1;ANK2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6483051231378089,1.355095221506024,0.11864406779661017,0.8038026556725537,1.0,9/23,20.07%,SRF;CCDC39;RYR2;MICAL2;HES1;BBS7;BBS4;PKD2;ENG
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.54352526120287,-1.3550765463349947,0.024390243902439025,0.6091897076811253,1.0,13/72,14.05%,CCND1;GPX1;COPS9;ATF4;PARP1;SMPD1;MAPK13;TMEM161A;NOC2L;GTF2H2;NPM1;CASP9;RUVBL2
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.7176174245513739,1.3549599393206035,0.125,0.8015727311194614,1.0,2/15,3.26%,PTPRC;LMBR1L
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.565615959249063,-1.352809070601698,0.05405405405405406,0.6174318695247704,1.0,2/26,2.42%,RNASEH2C;ADPRM
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.7683333061275166,-1.3526611702414362,0.1,0.6165305618901816,1.0,6/10,17.54%,COPS7B;COPS2;COPS6;COPS8;GPS1;COPS5
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.8410739606801766,-1.3522953131899302,0.05,0.6164464231390261,1.0,3/6,10.91%,ASCL1;MYT1L;POU3F2
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.7486397304788304,1.351344715073988,0.2,0.8211364592388605,1.0,3/9,10.22%,KAT2B;CENATAC;BRCA1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.520987860996304,-1.3511709747332927,0.06060606060606061,0.6196332000130953,1.0,14/87,9.64%,SOX4;UBB;UBXN1;PTTG1IP;CENPX;VPS28;MALT1;PRICKLE1;DNAJA1;PSMD10;STUB1;HSP90AB1;UFL1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.6489162718574164,-1.3508626704374391,0.11363636363636363,0.6197369458140696,1.0,3/22,3.66%,SOX4;BAD;NLGN2
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.8638675611268914,1.3507892892482427,0.1206896551724138,0.8220716125053779,1.0,1/6,5.38%,GUK1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5460410653621467,-1.3501779899569473,0.06666666666666667,0.6207858606609138,1.0,13/60,5.75%,MMP2;BGN;PODN;THY1;PRRX1;FBLN2;KRT10;FIBIN;COL12A1;THBS2;PDGFRA;CXCL12;DYNLT1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5887250340176333,-1.3501106409248178,0.0967741935483871,0.6195544612379006,1.0,15/40,18.60%,SNRPD2;NOL3;SF3A2;SNRPG;PUF60;SNRPD1;DDX1;SNRNP200;SRSF9;SNRPE;SRSF10;PRPF19;SF1;SRPK1;LUC7L2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6575983629925205,1.3492054631197614,0.11320754716981132,0.8298331127462485,1.0,9/18,28.66%,NEDD4L;CAV3;WWP2;ANK2;CACNA1D;ATP1B1;CAB39;DLG1;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.7073759933661323,-1.348671788121382,0.16326530612244897,0.6235323959596379,1.0,2/11,3.86%,ESRRB;HES5
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.692331047147487,1.3484442224070774,0.14,0.8314004275731129,1.0,3/17,5.76%,AKT2;SORBS1;CLTCL1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6618859847617911,-1.348302253650619,0.10526315789473684,0.623377037323862,1.0,8/25,10.93%,PPIF;GPX1;BAD;NOL3;PDCD5;CLU;PSMD10;MFF
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.8046985356963039,1.3482903542423588,0.1206896551724138,0.8291062524374618,1.0,2/9,8.85%,KAT2B;ESCO1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.7042382263100262,1.3481994455936497,0.10344827586206896,0.8267595772688997,1.0,2/17,6.41%,TMSB4X;SSH2
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5259408453541445,-1.348195731272089,0.021739130434782608,0.6224512976437718,1.0,29/92,17.54%,UBB;POLR2L;POLR2J;RPS27A;POLR2I;UBC;POLR2G;TCEA1;PARP1;ZNF830;UBA52;COPS7B;COPS2;POLR2K;RAD23A;CUL4B;POLR2E;GTF2H2;COPS6;RFC5;COMMD1;POLD3;COPS8;FAN1;PRPF19;GPS1;POLD2;RFC3;COPS5
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.8521450742124641,1.347711012797046,0.018518518518518517,0.8267087209338316,1.0,1/6,0.95%,FOXO1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.8505915542635959,-1.347419851801557,0.20930232558139536,0.6243873265965643,1.0,4/5,11.40%,PNRC2;ZFP36L1;EDC3;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.5740223429051698,-1.3472709453926424,0.09090909090909091,0.6235184560159384,1.0,6/39,6.12%,PPIF;BAD;ZDHHC6;CHCHD10;VPS35;PDCD5
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.52222404691538,-1.3471651116884755,0.0425531914893617,0.6222710728499652,1.0,9/63,11.08%,RBM8A;SRSF7;CPSF1;U2AF1;CSTF2;CSTF2T;MAGOH;SLU7;EIF4A3
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.561486255889055,-1.3471559448129893,0.11363636363636363,0.6207570313101843,1.0,6/35,12.42%,RNASEH2C;ERN1;DXO;NUDT16L1;RNH1;ISG20
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.6155672895815385,-1.3468676883955761,0.1111111111111111,0.620338605097945,1.0,3/27,0.59%,AURKAIP1;BTC;CUL7
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.7048459287746925,1.3466815268355434,0.18181818181818182,0.8299393397838994,1.0,5/15,19.99%,KIF1C;NEFL;FBXW11;DST;ACTR10
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.5971610422019006,-1.346063287623484,0.043478260869565216,0.6221748886279572,1.0,4/28,4.47%,EIF5A;UBB;BAD;RPS7
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7696498838680839,1.3459609644286774,0.1320754716981132,0.8311283965537685,1.0,4/8,17.17%,NEDD4L;CAMK2D;PRKCE;HECW2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.6815676966996287,-1.3458969369063927,0.14285714285714285,0.6212677052919651,1.0,2/12,4.75%,BICD2;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.48315421452330015,-1.345467375957318,0.04,0.6214182825890885,1.0,26/123,12.02%,UBB;PSMB6;APEX1;PSMD8;RPS27A;PSMB4;UBC;HSPA8;EXOSC8;ZFP36L1;PSMA7;TBRG4;FXR2;UBA52;PSMC3;PSMC1;SET;PSMD10;PSMD12;PCBP4;PSMB9;PSME3;YWHAB;DCP1A;PSMD2;YBX1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5976239371587396,-1.345207278120548,0.09803921568627451,0.6211100703113609,1.0,9/37,13.00%,SLC22A17;FTL;ISCU;ATP6V1G1;CYBRD1;ABCG2;CYB561A3;ATP6V0D1;B2M
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6731610854245316,1.344755543367957,0.12962962962962962,0.8358760207988194,1.0,9/19,19.31%,NEDD4L;PKP2;SNTA1;CAV3;RYR2;GJA1;ANK2;GPD1L;KCNQ1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.8948730325929959,1.3446194981964619,0.06557377049180328,0.8339278507084747,1.0,1/5,0.75%,TMSB4X
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.8230017985327018,1.3444954192796035,0.07142857142857142,0.8318569985752478,1.0,2/9,10.76%,XRCC4;LIG3
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.8096137809055586,-1.3444610077215882,0.12195121951219512,0.6226043245154887,1.0,1/7,0.66%,HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.8068453558543481,-1.3443891732442201,0.10638297872340426,0.621383001629009,1.0,1/5,0.62%,GSTP1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.8638850747752178,1.3428686458129553,0.08163265306122448,0.8389449962323102,1.0,2/5,7.04%,CAV3;TTN
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.5702838834816437,-1.342649331492018,0.1111111111111111,0.6269357933065764,1.0,10/42,20.98%,HSD17B10;CRAT;ACAT2;ACOX1;CROT;ACADS;ACAA2;ABCD2;MECR;ECHDC1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.790886068574433,-1.3425868760713158,0.18181818181818182,0.6256832848038707,1.0,1/5,1.61%,PCBD1
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.8123791213779712,1.3423796788646647,0.1,0.8390883043536002,1.0,2/7,6.30%,PTPRC;SPI1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.5641523480830626,-1.3421764719534324,0.1111111111111111,0.6262206031785611,1.0,6/33,5.60%,ATP6V0A4;CCND1;AMOTL2;FERMT1;CDH3;YAP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7212311314213877,1.3418731995104634,0.15,0.8390606020874236,1.0,2/10,7.35%,ZFPM2;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.794069808581704,1.3418395352672832,0.13793103448275862,0.8360534901599754,1.0,1/7,0.75%,TMSB4X
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.678886281038722,1.3416308717118504,0.0784313725490196,0.8344181371819381,1.0,2/24,0.65%,GLRA1;GLRA2
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.8410953826280645,-1.3414928305113232,0.024390243902439025,0.6274725472161929,1.0,3/7,5.49%,TRMT10C;TBRG4;TRMT10A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.8589100182081679,-1.34128404136269,0.0392156862745098,0.6268636321667239,1.0,2/5,4.44%,TMBIM6;NOL3
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.8624773731334413,1.3411722696719637,0.0967741935483871,0.83410563718226,1.0,1/7,0.72%,KIF1C
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.7018154841386498,1.3407017142785798,0.1206896551724138,0.8344316303600943,1.0,2/14,6.25%,SRF;EMP2
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.5920036987751147,1.3403359749720853,0.05,0.833554275037987,1.0,13/47,13.53%,UNC13C;GABRG3;MGAT4C;CDH7;SLC24A2;RBFOX3;MCF2L2;HCN1;SLC6A6;PDE10A;CREM;SV2C;CATSPERG
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.7679870330196394,1.3400410619826353,0.1206896551724138,0.8326501339852894,1.0,2/10,11.44%,PEX5L;PEX16
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.7925827545619153,1.3398588680303,0.061224489795918366,0.8307591629002293,1.0,4/11,13.63%,PTPRC;CD247;TRAF3IP3;AOAH
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.7785646515892487,1.3394452977404303,0.07017543859649122,0.8307296735180606,1.0,2/11,3.88%,GLRA1;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.65570254146145,1.3394301232927526,0.037037037037037035,0.8278074612074278,1.0,7/21,12.22%,RELN;CAMK2B;PSEN1;FOXO6;SHANK3;CAMK1;CPEB3
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.6727910600618535,1.339351251087985,0.1,0.8251684657791817,1.0,9/25,17.35%,TMSB4X;SLC4A4;PSEN1;PRXL2C;PFKFB3;GAPDHS;PRKAA2;PRKAA1;PFKFB1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.6952928945609891,-1.3392131996675305,0.125,0.633739158769525,1.0,4/14,9.35%,PPT1;PPCS;ACLY;SLC25A1
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.8114847592676486,1.3391766583605127,0.10344827586206896,0.8233970846265248,1.0,3/7,7.22%,SLC39A14;MRAP;PRKCA
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7900780626567864,1.3390235511848652,0.034482758620689655,0.8213457714523684,1.0,1/7,1.60%,IGF1R
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.562556750711309,-1.3383671088787656,0.06818181818181818,0.6357558079511495,1.0,12/58,11.85%,RRAGA;DAPL1;ATF4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;TFEB;MLST8;ATP6V0E2;LAMTOR4;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.7245155085009325,-1.3379521445054903,0.14705882352941177,0.635973737572825,1.0,5/9,13.44%,DERL2;UBE2J1;YOD1;OS9;ERLEC1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.5167019868843267,-1.3378139394528716,0.08888888888888889,0.6350093557891271,1.0,14/58,15.12%,RBM8A;SRSF7;RTRAF;ZFP36L1;U2AF1;MAGOH;SLU7;EIF4A3;NUP155;YBX1;SRSF9;FLOT1;HNRNPA2B1;TGFBR2
prerank,PanglaoDB_Augmented_2021__Interneurons,0.4748446603669385,1.3375960282581543,0.03125,0.8283819953694634,1.0,53/235,15.19%,GABRA4;CALB1;PCSK2;OLFM3;SYT1;SHISA6;STMN2;CALN1;GNG4;NRSN2;ADGRL2;SULT4A1;SCN8A;MMD2;CACNG2;ATP2B3;PDE1A;RELN;CPNE5;NRIP3;LMO3;PARM1;KCNC2;KCNQ5;GRM3;PSD2;HSPA12A;NRGN;SNAP25;GABRG2;SLC22A15;ARX;ADGRB3;SRGAP3;AQP4;HIVEP2;RORA;FBXW11;FRYL;CPLX1;ZIC4;NOS1;GRM1;CLVS2;HPCAL4;RORB;ACTL6B;OXR1;FBXO11;SLC8A2;SHISA9;ASTN1;LRRTM1
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.6644033356774465,1.337385513199152,0.08,0.8267795526478461,1.0,5/25,11.22%,OTUD7B;USP13;CYLD;ZRANB1;BABAM2
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7955385808811091,-1.3373054230197465,0.09259259259259259,0.6352542006648105,1.0,2/7,12.67%,ZNF830;RAD17
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.8132645267073555,1.3369398655742146,0.07407407407407407,0.826121513260816,1.0,2/9,3.88%,GLRA1;UBASH3B
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.8049964109355073,-1.3366535839426517,0.05714285714285714,0.6366998160693899,1.0,3/7,5.35%,FBLN5;DHFR;ALOX5
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6892856683297814,-1.3358997449057572,0.15217391304347827,0.6385297240463907,1.0,5/12,13.99%,CALM1;CALM3;HSP90AB1;PPP1R15B;BMP2
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.762891376561571,1.3358952855987751,0.08771929824561403,0.8303089381037183,1.0,6/14,18.16%,PTPRC;CD247;TRAF3IP3;AOAH;IL6R;BCL6
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7456524232818862,1.3356292585697076,0.10909090909090909,0.8287805633826664,1.0,3/15,4.32%,ROBO2;ZFPM2;LRP2
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.5205759187929344,-1.3348423275008927,0.05555555555555555,0.641313409769386,1.0,11/86,11.42%,RBM8A;SRSF7;CPSF1;NUP42;ZFP36L1;U2AF1;RBM15B;MAGOH;SLU7;EIF4A3;NUP155
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.7151666793083035,1.3348117402198703,0.12,0.831655836555164,1.0,2/11,5.11%,ASPA;DDO
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.5540532891791277,1.3342454904223082,0.14285714285714285,0.8325125216703988,1.0,10/52,15.58%,FHDC1;SORBS1;CDC42BPB;TTN;TMOD3;TPM1;PHACTR1;CIT;MYOM2;ARRB1
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.8670350259508606,1.3340740392064951,0.04081632653061224,0.8308344245499519,1.0,2/5,11.39%,CYP2E1;NOS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6510268308980528,1.3340557664290935,0.08333333333333333,0.8280340303462727,1.0,2/12,7.35%,ZFPM2;TGFBR3
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.8000901692129332,1.3338786986151252,0.07692307692307693,0.826728431172272,1.0,2/6,11.91%,SASH1;TAF1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7843775448345265,1.3337313715014105,0.16666666666666666,0.8250252043740747,1.0,3/10,14.47%,NEDD4L;SLC12A1;SLC8A1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.8068113428952433,1.3329869384539592,0.09523809523809523,0.8266693306642127,1.0,2/7,13.75%,WRN;XRCC3
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7224219844949364,1.3329828678990676,0.18867924528301888,0.8238906761214813,1.0,2/13,4.41%,CHRM3;OXTR
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7799293320758849,-1.3326404092444037,0.1,0.6493774110735826,1.0,1/7,0.75%,PIWIL2
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.7903947448454414,1.3323872887360473,0.1016949152542373,0.82456765503274,1.0,2/9,2.10%,HDAC4;SAE1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.7419660676632834,1.3323066519705435,0.10204081632653061,0.822092832739152,1.0,3/18,4.32%,HEY2;ADAMTS9;LRP2
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.792877401864072,-1.3321246529490285,0.22413793103448276,0.6499486661605611,1.0,1/6,9.37%,CAND2
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.7031591946883085,-1.3317920555725526,0.125,0.6498457736878901,1.0,5/13,14.63%,VPS28;LEPROTL1;TMEM50B;TMEM50A;SNF8
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.771672262285209,1.3316113758293218,0.10344827586206896,0.8227405717054962,1.0,2/7,13.06%,SOX9;CHRD
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5808367357685035,1.3315479808201023,0.058823529411764705,0.8202887213709402,1.0,16/28,31.31%,SPIRE1;BAIAP2;CRACD;CDC42EP3;VASP;CDC42EP4;PRKCE;FER;FCHSD2;NCK2;CARMIL1;WASHC2C;BIN1;PTK2B;CTTN;EVL
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7558985943947673,1.3308293474665165,0.15384615384615385,0.8215795605065203,1.0,3/10,5.94%,AKT2;NR4A3;PLIN5
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.6783363061033905,-1.330710913992857,0.1,0.6523201671108845,1.0,4/12,6.99%,CIAO2B;ISCA1;MAGEF1;GLRX5
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.8465919440003591,1.3305511000178465,0.10526315789473684,0.8211266752243965,1.0,2/6,8.18%,DPYD;CRMP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7320528320061028,1.3305298178304021,0.1590909090909091,0.8185532386504493,1.0,2/9,7.35%,ZFPM2;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.7548649918961734,1.3305016927539808,0.1111111111111111,0.8159365445996407,1.0,5/11,10.86%,NR4A3;AZIN2;CA2;C2CD5;ACSL1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.7484264018222048,-1.3304221018446056,0.1951219512195122,0.6519037990749903,1.0,3/7,9.32%,SIRT2;WNT5A;PTN
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.7036334636694118,1.3302690163502013,0.12307692307692308,0.814663224815991,1.0,4/13,14.33%,HDAC4;SAE1;GNL3L;PIAS4
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.7522206779963461,-1.3293890825682426,0.14893617021276595,0.6548238621366741,1.0,3/11,11.61%,S100A1;DHFR;SCARB1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5135273092748114,1.3285553003638955,0.07142857142857142,0.8212374090315079,1.0,11/100,7.07%,CDH9;CLDN12;ROBO2;UNC5D;PCDHB5;CLDN18;CDH7;TENM3;CDH8;PVR;CDH12
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.6375145416165033,1.3279967509244688,0.1346153846153846,0.8216313403059957,1.0,7/22,17.61%,ABLIM1;ARHGEF6;VCL;P2RY12;DMTN;ARHGEF7;ARHGEF4
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.7366545731403862,-1.3279832759905543,0.13333333333333333,0.6594964143395643,1.0,5/9,15.94%,CFL1;TENM4;ZBED3;RACK1;TLE6
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.857085542827049,-1.327441384030693,0.10638297872340426,0.6604964118196012,1.0,1/5,1.48%,CALR
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.5281190870987026,-1.32728265226186,0.043478260869565216,0.6594793144748683,1.0,20/65,18.95%,RBM22;TMBIM6;FAM50A;JMJD6;LARP7;ERN1;C9ORF78;RPS13;RBM23;SRSF10;AKAP17A;AFF2;RPS26;RBM39;SF1;SRPK1;CLK2;CWC22;SRSF3;HSPA1A
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.727155937289919,1.326577794417214,0.0625,0.8254149915990042,1.0,2/14,4.14%,FHDC1;SORBS1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.727155937289919,1.326577794417214,0.0625,0.8254149915990042,1.0,2/14,4.14%,FHDC1;SORBS1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6803038821320488,-1.3252224158318993,0.16666666666666666,0.6664733553855711,1.0,7/14,19.05%,SCNM1;PUF60;SLU7;DDX5;SRSF9;RBM17;RSRC1
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.823624325786684,1.3252093783155086,0.0784313725490196,0.8316305792946438,1.0,2/6,11.39%,CYP2E1;NOS1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.7736593585520972,-1.3246918343528837,0.024390243902439025,0.6672732603677279,1.0,2/11,5.58%,LSM4;EDC3
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5751300110752751,-1.3244934074629713,0.13953488372093023,0.6667538089810535,1.0,6/31,10.38%,GPX1;BEX3;MT3;NGF;IFI6;CD44
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.8183150682303114,1.3244669168620784,0.07575757575757576,0.8336398541935145,1.0,2/7,6.28%,SOX9;RFLNA
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.8008018722797005,1.3234944368760642,0.1320754716981132,0.8372851079022364,1.0,1/7,3.98%,SLC4A4
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.8330125133382744,1.3234131860575011,0.030303030303030304,0.8351536906275332,1.0,1/7,0.37%,DPYD
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.8034030719558495,-1.323020561481152,0.11666666666666667,0.6714120867409895,1.0,3/6,12.79%,SYAP1;HAS2;CORO1B
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.6446282032266946,-1.3228519851120923,0.13636363636363635,0.6705834004033931,1.0,4/17,16.83%,UGDH;MPI;GNPNAT1;UAP1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7306298402547765,1.3225151607753838,0.14545454545454545,0.8374538839308763,1.0,6/11,23.25%,CAV3;TTN;RYR2;SLC8A1;DMD;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.5633489932757247,-1.3225127451227388,0.046511627906976744,0.67061293825809,1.0,8/42,15.20%,GSTP1;SELENOS;LYN;WNT5A;CACTIN;NFKBIL1;CDC73;IL18
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.7165499283368897,-1.3223507736345557,0.16279069767441862,0.6696142129285055,1.0,2/12,3.53%,UBB;MAP1S
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.655898740846017,1.3221493216691844,0.1111111111111111,0.8368229697404294,1.0,7/27,10.34%,PTPRC;OTUD7B;TMSB4X;RAB1A;RIPK1;MAP2K5;TIRAP
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.8890499698639416,1.3219821374368241,0.04081632653061224,0.8351205634017115,1.0,2/5,6.13%,PTPRC;PTPRJ
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.6294389538983183,1.321747387363041,0.08695652173913043,0.8340085846270036,1.0,6/21,10.74%,PTPRC;CAMK1D;MERTK;PTPRJ;RAB27A;RAB31
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.5017562496916846,-1.3217217642979897,0.07692307692307693,0.6705965571940053,1.0,11/87,11.42%,RBM8A;SRSF7;CPSF1;NUP42;U2AF1;RBM15B;ENY2;MAGOH;SLU7;EIF4A3;NUP155
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.8235354774853072,-1.3214102492356106,0.13636363636363635,0.6701265750346964,1.0,2/7,8.12%,TXN2;ADO
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.770556654674044,-1.3206795435871743,0.16666666666666666,0.6721745099415751,1.0,2/10,3.39%,GSTP1;SLC30A10
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.8358351883012987,-1.320217158496647,0.08,0.6725481478014649,1.0,2/5,12.67%,ZNF830;RAD17
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.8153388199201403,1.32016900473943,0.09803921568627451,0.8408176972371904,1.0,3/8,10.34%,FOXP1;MAP2K5;TIRAP
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.6905879926513007,-1.3201592830117683,0.1875,0.6712586012053854,1.0,4/12,7.71%,CXCL12;MOSPD2;LYN;CREB3
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5388414463587897,-1.3197357699821022,0.0975609756097561,0.6715583786361943,1.0,18/56,18.01%,PSMB6;PSMD8;PSMB4;PSMA7;YAP1;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PSMD3;PSMD4;PSMB2;SETD1A;PSMC4;PSMD11
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.744406320211179,-1.3196144600299504,0.11320754716981132,0.670375451876115,1.0,7/11,21.97%,SEC61G;SEC61B;GET3;HSPA5;SEC62;SEC61A2;SEC61A1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.7666464962199692,1.3194158742840583,0.15517241379310345,0.8428328956104575,1.0,2/8,1.86%,PON1;PON3
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.8727884534965366,1.319194109908239,0.06557377049180328,0.8417644230670026,1.0,1/5,0.78%,ROBO2
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.8433243098875741,-1.318912804876239,0.125,0.671587364733177,1.0,1/5,4.66%,MSRB2
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.8036046330126521,-1.3183275078041115,0.11363636363636363,0.6724006591725611,1.0,2/5,15.20%,TMBIM1;IL18
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.7076345089494355,-1.3177102667654814,0.16,0.6732349219859449,1.0,2/11,8.82%,IDH1;ACLY
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.6081979442911537,1.3172300138391522,0.2033898305084746,0.8505155841221953,1.0,1/15,0.92%,FMO5
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.6125905689577927,1.3170854117330848,0.05555555555555555,0.8487451682090962,1.0,7/25,17.61%,ABLIM1;ARHGEF6;VCL;P2RY12;DMTN;ARHGEF7;ARHGEF4
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.6082480378054975,-1.317044619988757,0.11363636363636363,0.6743102826865343,1.0,3/17,9.78%,USP51;ATXN7L3;ENY2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.5558398582595414,-1.316103943430226,0.07272727272727272,0.6769927288798915,1.0,10/49,12.20%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;RAB14;ANOS1;FLRT3;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.5876909039985286,-1.3157712645026454,0.10638297872340426,0.6766906545089378,1.0,5/28,9.43%,BGN;BCAN;TXN2;ADO;GALNS
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.8550513323758284,1.315442105502566,0.06779661016949153,0.8567370419309404,1.0,1/5,2.50%,EGLN3
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.5068812616917336,-1.3145677095573525,0.07692307692307693,0.6803045779948369,1.0,10/82,11.42%,RBM8A;SRSF7;CPSF1;NUP42;U2AF1;RBM15B;MAGOH;SLU7;EIF4A3;NUP155
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.674402810622021,-1.3145330055419755,0.16279069767441862,0.678977630455411,1.0,4/18,9.07%,CCND1;STOX1;PSMD10;HSP90AB1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.6902235826013086,1.3144452925975343,0.14,0.8605128439786408,1.0,4/16,14.47%,YWHAH;SCN8A;SCN2A;SLC8A1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.7927102378905746,-1.3142441866187335,0.07317073170731707,0.6786248067322844,1.0,1/7,2.85%,PCGF2
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.6529769678965471,1.3142292009087109,0.16981132075471697,0.8591798057459097,1.0,7/19,13.87%,PCLO;WNT7A;RAB3A;SNAP25;CPLX1;STX1A;SNCA
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.5918436708960025,-1.3142001563459607,0.12,0.6771864108897508,1.0,9/34,12.99%,TRMT112;SNRPB;CSKMT;ICMT;BHMT;GSPT1;PRMT5;PRMT6;PRMT1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6335945547178561,1.3140815949773024,0.13725490196078433,0.857263643088902,1.0,5/24,9.52%,CLDN12;CLDN18;TBCD;PARD3;PAK2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5747877286526073,1.3140668352443816,0.12307692307692308,0.8546013336383153,1.0,12/45,15.69%,PTPRC;CHRM3;TPCN2;PTPRJ;RYR2;PDPK1;P2RY12;ACKR4;DMTN;SLC8A1;PRKAA1;ANK2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.7009354734138644,-1.3139691906833788,0.14,0.6764773717474017,1.0,4/15,10.48%,S100A6;PDGFRA;WNT5A;FN1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.8603548530801537,1.313670891761135,0.1,0.8545025031075031,1.0,2/5,6.33%,NEDD4L;CAV3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.808809266600347,1.3133859310589093,0.11538461538461539,0.8533997904900648,1.0,2/7,5.94%,SOX9;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.636470440006499,1.3132683035936072,0.10204081632653061,0.851719712975939,1.0,6/30,10.34%,PTPRC;ARFGEF2;PSEN1;PTPRJ;RIPK1;TIRAP
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.7771989712246717,-1.313241746021264,0.07547169811320754,0.6779362302445094,1.0,4/9,14.65%,CDH3;OPN3;GIPC1;ASIP
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5932896758222834,-1.313047514146207,0.13725490196078433,0.6773486342240307,1.0,5/29,5.49%,HSD17B10;TRMT112;TRMT5;TRMT10C;TRMT10A
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5614132874301831,-1.31256340253278,0.12962962962962962,0.6778653019614338,1.0,7/35,8.35%,SLC22A17;FTL;ISCU;ATP6V1G1;CYBRD1;ABCG2;CYB561A3
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.7334967571058361,1.312294499665872,0.09259259259259259,0.8551247849365522,1.0,6/15,12.10%,TMSB4X;SPI1;CYLD;BMP7;NMI;HDAC7
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.6363957373572381,1.312128114821623,0.12,0.8535050010594636,1.0,6/31,10.34%,PTPRC;ARFGEF2;PSEN1;PTPRJ;RIPK1;TIRAP
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.789872266143486,1.312046682858357,0.09803921568627451,0.8513714105050126,1.0,2/6,9.17%,SOX9;SULF1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8610539434965221,-1.311746227156897,0.12,0.6797898709281119,1.0,2/5,7.58%,XYLB;DCXR
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.6957041082926944,-1.3115783868079234,0.23404255319148937,0.6792259308292808,1.0,5/11,17.53%,CXCL12;CLU;TMEM161A;TPT1;CDKN2D
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6918264890397141,1.3115569472182504,0.07272727272727272,0.8517513343982667,1.0,3/20,5.87%,BAIAP3;EFNA5;ADCY5
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.8587673277910592,1.3106876267452727,0.10344827586206896,0.8549780607343703,1.0,3/5,5.96%,GRIN2A;SHISA6;GRIN1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.6532685418473809,-1.3106080211572124,0.17391304347826086,0.6821865766712312,1.0,5/21,12.71%,CENPX;SMARCA5;CENPV;CENPQ;NPM1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.7755813413902131,-1.3105453703445997,0.06382978723404255,0.6812637258467735,1.0,6/10,14.79%,ASAH1;GBA3;NEU1;NEU4;GM2A;NEU3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.6614582988227992,-1.3102634688184305,0.05263157894736842,0.6808898302548164,1.0,5/15,15.46%,GSTP1;SFRP1;MORC3;CDC73;FTH1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.4916466987805996,-1.3101573734040868,0.0,0.6799972570334432,1.0,17/87,11.85%,JUN;PSMB6;PSMD8;CALM1;LAT2;PSMB4;MALT1;PSMA7;LYN;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.695662212959793,1.3099222043805192,0.17307692307692307,0.8571747286439922,1.0,4/16,4.92%,VSIR;GRIN2A;NLRC4;C1RL
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5691155719897122,-1.309564622232794,0.058823529411764705,0.6804771364913348,1.0,10/37,6.23%,UBB;NCSTN;HSPG2;RPS27A;UBC;SNCAIP;APH1A;ITM2B;UBE2L6;UBA52
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7911143928492579,1.3095194765017717,0.08,0.8570708260642995,1.0,1/8,0.67%,MYRF
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6776798567703489,-1.309433897072394,0.10714285714285714,0.6795185347674746,1.0,3/16,3.47%,SPCS2;SRP14;SEC61G
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.6270665345541099,-1.309378961136375,0.1568627450980392,0.6783524592098145,1.0,4/22,4.75%,GPX1;HSPA8;MAP1S;CAMSAP3
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.8494341404616625,1.3092124593081407,0.21818181818181817,0.8562616881743296,1.0,1/5,1.49%,CTBP1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.6154424179378857,-1.3088177168961286,0.10638297872340426,0.6791141687702379,1.0,4/24,9.07%,NOP10;PIF1;NHP2;HSP90AB1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6604804045536079,-1.3087830011291082,0.15555555555555556,0.6778368005990687,1.0,5/19,12.71%,CENPX;SMARCA5;CENPV;CENPQ;NPM1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7320990199867662,1.3084138694855552,0.14035087719298245,0.8585971852606559,1.0,5/10,18.76%,SRPX2;RHOJ;HDAC7;AKT3;JCAD
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5411541173678079,1.308199519493139,0.08333333333333333,0.8572485946222976,1.0,12/60,13.77%,CALCB;GNA12;HTR1F;ADGRL2;ADCY5;GNA14;AKAP5;ADGRB3;GRK5;P2RY12;AKAP12;ADCY3
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.8134939625914013,-1.3081154287232726,0.15555555555555556,0.6790401056170485,1.0,2/5,3.66%,PRDX1;MT3
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.6183262238465403,-1.3078605972681787,0.13157894736842105,0.6786304439406258,1.0,5/16,17.59%,PCGF2;RING1;CUL4B;RNF168;BMI1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.6917622291929927,1.307795688236687,0.14545454545454545,0.8575762057752698,1.0,9/16,25.53%,GRIN2A;SLC24A2;PLK2;SLC8A2;GRIN2B;PRKCZ;GRIN2D;TSHZ3;SLC8A3
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.7600138940941517,-1.3077571152220626,0.1590909090909091,0.6777341172675689,1.0,3/10,7.89%,CPSF1;CSTF2;CSTF2T
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4977737673789875,-1.3071262546929387,0.02631578947368421,0.6784660145264261,1.0,9/67,8.37%,COPZ1;BICD2;SURF4;TMED2;RAB1B;TMEM115;KDELR1;LMAN2;TMED9
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.6662974454198052,1.3052678527904031,0.20833333333333334,0.8695444434029178,1.0,1/12,1.73%,TLK1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.7569117916570489,-1.3050362960767676,0.14285714285714285,0.6857026708025404,1.0,3/6,16.78%,GAS1;PRNP;SNX12
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5591911533898695,1.3049937676532628,0.14035087719298245,0.8685498898204127,1.0,7/40,10.03%,ABLIM1;PITPNA;RPGR;EYA4;WHRN;RABGGTB;CRYBG3
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.7953409823395637,-1.3049330219995632,0.22448979591836735,0.6847048600263299,1.0,3/6,11.40%,LSM1;DCPS;DCP1A
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.7380334998595437,1.3044603203434102,0.08928571428571429,0.8692946194705605,1.0,2/9,1.82%,BCL2L11;FAM107A
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.8116349425695769,1.3044585758511482,0.21739130434782608,0.8667378705897647,1.0,1/5,0.78%,ROBO2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6862168097781691,-1.3041131956838508,0.0975609756097561,0.686617227710892,1.0,4/14,9.76%,NIFK;RPL35;RPF2;ZNHIT3
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.6683466433755011,-1.303931542209864,0.12195121951219512,0.6860819708989071,1.0,2/13,1.21%,RHOC;CD151
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.7693070428171805,1.303808528174289,0.17857142857142858,0.8679872651016699,1.0,4/8,19.31%,SNTA1;CAV3;ANK2;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.5342818855595735,-1.3036584165971714,0.12,0.6856867250057831,1.0,9/44,6.58%,S100A10;SLITRK2;THY1;CLSTN2;NLGN2;SYNDIG1;EPHB3;SFRP1;LIMS1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.6556238978990764,1.3033745363340465,0.09230769230769231,0.8681191250453283,1.0,4/21,6.28%,NEDD9;FAM107A;BAIAP2;RFLNA
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.6168680602700065,-1.3033091199811602,0.10256410256410256,0.6854306310688276,1.0,7/23,11.25%,ROMO1;TIMM23;DNAJC19;TIMM44;AIFM1;GRPEL1;TIMM21
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.5648004296249803,1.3032808308664994,0.10344827586206896,0.866352516667866,1.0,9/47,11.84%,PTPRC;LIFR;MADD;IRAK2;RIPK1;CYLD;JAK1;TRIM44;CBFB
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.6816468190319153,-1.3029875941594709,0.14634146341463414,0.6853814644993091,1.0,9/16,14.03%,SURF1;COA6;COX19;COX18;SMIM20;COX17;BCS1L;TIMM21;COA5
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7434839938642421,1.302966963856212,0.14545454545454545,0.8660678770728951,1.0,4/11,14.75%,TTLL6;TTLL4;TTLL5;CEP41
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5589940502904771,1.302850845230668,0.0967741935483871,0.8642650472635431,1.0,13/53,12.48%,HOOK1;DNAH6;TMCO5A;PARN;SORD;ACYP1;TSSK3;CCDC30;UBE3D;BRCA1;CREM;GAPDHS;MAEL
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.8379415726386911,-1.3028226262242328,0.14545454545454545,0.6848074266666851,1.0,1/6,8.47%,MPG
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.7034063712105852,-1.302476831284543,0.20930232558139536,0.6843268535065244,1.0,6/13,11.25%,ROMO1;TIMM23;DNAJC19;TIMM44;GRPEL1;TIMM21
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6608917356527051,1.302434840286393,0.12244897959183673,0.8643016270355388,1.0,2/21,2.38%,SCEL;SVEP1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7814560574012407,1.3022558116217335,0.09803921568627451,0.8630092873345008,1.0,3/8,13.58%,IGF1R;CALCOCO2;FYCO1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.7117664151277932,-1.3019362016171319,0.2619047619047619,0.6848031664513969,1.0,4/9,17.09%,RPS19;GRN;RC3H1;ENPP3
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.7833694862376828,-1.3018979383566587,0.27906976744186046,0.6836211402483986,1.0,2/6,10.75%,HPD;AADAT
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.667442682327405,1.3015921959211934,0.1568627450980392,0.8646339383468145,1.0,4/19,10.70%,PAK1;PRKX;RYR2;HES1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.6803028058028309,-1.30120647155937,0.22,0.6847310065057473,1.0,2/10,7.29%,PPIB;CCNK
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.5771408858500255,1.3011004885135695,0.07142857142857142,0.8652131266754265,1.0,14/51,16.26%,PTPRC;PLXNA4;TBCD;GCNT2;RIPOR2;DUSP1;ADAM22;PLXNA1;DMTN;ITGB1BP1;SEMA4D;KNG1;ARHGDIG;ADAM10
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.6323048406097225,1.3006813491802436,0.18867924528301888,0.8654790477782287,1.0,4/24,10.62%,PTPRC;CD247;TRAF3IP3;CD27
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.7716092440983333,-1.3000010895804408,0.2571428571428571,0.6879381104578088,1.0,6/7,22.64%,RPS7;RPL23;RPL11;RPL5;MAD2L2;USP44
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.5758687171701583,-1.2994518274122566,0.10638297872340426,0.6889671636163363,1.0,3/29,3.53%,UBB;BICD2;MAP1S
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.7476064739499162,1.299419522597305,0.10344827586206896,0.8709977203003741,1.0,3/10,7.28%,PTPRC;PTPRJ;RYR2
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.8308445480645062,-1.2991601300769862,0.14893617021276595,0.6886415857424972,1.0,1/6,2.81%,HSPA8
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.9116764550095103,-1.2989797166435053,0.09302325581395349,0.6879803648201558,1.0,1/5,0.67%,SIRT2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.7050831551913864,-1.2989229310373234,0.21052631578947367,0.6868958416212295,1.0,3/10,7.52%,DSEL;B3GAT2;XYLT2
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.8163359877070298,-1.298316198952908,0.1111111111111111,0.6879187591633945,1.0,5/6,14.79%,GBA3;NEU1;NEU4;GM2A;NEU3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.8516163117196345,-1.2980653541104712,0.14583333333333334,0.6861640165326345,1.0,4/6,14.65%,CDH3;OPN3;GIPC1;ASIP
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.8516163117196345,-1.2980653541104712,0.14583333333333334,0.6861640165326345,1.0,4/6,14.65%,CDH3;OPN3;GIPC1;ASIP
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.49590727114715094,-1.297978491361408,0.08571428571428572,0.6852473869679542,1.0,7/61,6.23%,UBB;JUN;RPS27A;UBC;DUSP15;BAMBI;UBA52
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.7384361081297878,-1.2977073523125269,0.17142857142857143,0.6852666325767203,1.0,5/8,13.44%,DERL2;UBE2J1;YOD1;OS9;ERLEC1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.5419995640716406,1.2974925934420964,0.07142857142857142,0.8809282022970808,1.0,20/65,17.49%,GRIN2A;SHISA6;CNIH2;DAPK1;CACNG2;RELN;CAMK2B;GRIN1;GSG1L;NEFL;MAPK8IP2;FGF14;NOS1;CACNG8;DLG4;SHISA9;CAMK2D;ANK2;GRIN2B;CACNB4
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.8204618362714927,1.2974192339434045,0.08771929824561403,0.8790985223004367,1.0,1/7,2.51%,ITPK1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5707297530709119,1.2971093343827527,0.14285714285714285,0.8785305383457777,1.0,16/51,15.69%,CALCB;TPCN2;HTR2C;ATP2B3;SLC24A2;GRIN1;VAPB;RYR2;TMTC2;ATP2B2;ATP13A4;SNCA;FAM20A;SLC8A1;SLC8A2;ANK2
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.7150761783523055,1.2969630986944591,0.11666666666666667,0.8769980463687281,1.0,5/14,11.84%,LIFR;IRAK2;MAP2K5;PARP9;CBFB
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.9053968199669267,1.2969008338775472,0.08888888888888889,0.8747885133554641,1.0,1/5,7.22%,PRKCA
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.6303345338776606,-1.2968861240564324,0.1509433962264151,0.6871244548256205,1.0,7/24,13.35%,BAD;IFIT2;VPS35;CLU;IFI6;MFF;FIS1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.839638740362759,-1.2968772323950803,0.13953488372093023,0.6857912885158988,1.0,1/5,0.62%,GSTP1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.701661788679345,-1.2966033888302548,0.19607843137254902,0.6855886975176941,1.0,5/10,12.71%,RAN;RPS15;LTV1;LSG1;NPM1
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.7018494685190266,1.2959647356639963,0.18867924528301888,0.8780611982940149,1.0,5/11,13.63%,PTPRC;IL5;SPI1;TRAF3IP3;AOAH
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.5049397136360805,-1.2958745771982518,0.0625,0.6868183246113977,1.0,14/74,5.66%,MMP2;BGN;PODN;HSPG2;PRRX1;FBLN2;FIBIN;RARRES2;COL12A1;TNS2;THBS2;PDGFRA;SAT2;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.5487096469010165,1.2955138287293777,0.03508771929824561,0.8784620567295315,1.0,4/35,5.97%,RASGRF1;GPR18;MMD2;ERBIN
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.7753709037421418,-1.2954131680749157,0.12244897959183673,0.6869881521513199,1.0,1/8,0.15%,SOX4
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.5547389298876595,-1.294994399852246,0.10204081632653061,0.6870257008852538,1.0,9/44,13.93%,CUL7;YIF1A;HDGF;ERN1;TLN1;ATP6V0D1;EXTL1;FKBP14;HSPA5
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5562906021358281,1.2948109630740023,0.08333333333333333,0.8797168786233437,1.0,13/55,12.36%,DRAM1;DEPP1;ITPR1;TPCN2;PIP4K2C;USP13;DAPK1;DAPK2;WDR91;RPTOR;ATM;WDR41;PIP4K2A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5977459859322035,1.294711537719595,0.10344827586206896,0.8781270389560546,1.0,8/28,13.48%,OTUD7B;NEDD4L;SPI1;CAV3;RIPOR2;SIN3A;TTBK2;MACROH2A1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.769461425851763,-1.2935347540328297,0.18,0.6920984569156156,1.0,5/6,21.80%,B4GAT1;B3GALT2;B3GALT5;GAL3ST3;B3GNT7
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.5352803459637019,-1.2933800767289156,0.11904761904761904,0.691208190628705,1.0,8/38,11.30%,SYT11;TLR1;SELENOS;MAPK13;HLA-B;WNT5A;SPHK2;AFAP1L2
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.8084101057170039,-1.2933613402864121,0.1702127659574468,0.6898634276119177,1.0,2/5,9.48%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7173572998669544,1.2929137111980693,0.16326530612244897,0.8860121632200232,1.0,5/11,19.12%,SHISA6;RAB3A;SLC8A2;SHISA9;SYP
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6386822271342556,-1.2929017478146807,0.07317073170731707,0.6903086425783579,1.0,1/19,0.39%,CCND1
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.8209851334692415,1.2928491396720923,0.1016949152542373,0.8839392192345265,1.0,4/6,17.05%,PCLO;RAB3A;ERC1;ERC2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7841876110828181,1.2926757104231437,0.15,0.882500315530264,1.0,3/8,16.65%,GALNTL6;GALNT16;GALNT13
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.8722312239283552,-1.2922407036519472,0.12195121951219512,0.6918382884748403,1.0,2/5,5.77%,EYS;GNA11
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.8760331475074289,1.2922344227441513,0.10526315789473684,0.8827333529656778,1.0,2/5,6.98%,ENPP2;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5263709264950452,-1.2919382939100852,0.11627906976744186,0.6918443390182059,1.0,15/51,19.85%,GTF2F1;ACTB;TMBIM6;IFIT2;CAV1;PTPRF;ITGA4;B2M;RACK1;PARK7;PIN1;BAX;AKT1;GOLGA2;IFIT1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.7055545757956371,-1.2917556918814974,0.14,0.6912228277098518,1.0,7/13,19.59%,BAD;CLU;IFI6;MFF;FIS1;BAX;TIMM50
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.506860379852047,-1.2909370594283924,0.07142857142857142,0.6931522240057874,1.0,17/89,10.91%,SOX4;OLIG1;ASCL1;PPT1;UGDH;OLIG2;MYT1L;WNT3;IER2;USH2A;RNF112;TENM4;ITM2C;WNT5A;EPHA5;ANOS1;POU3F2
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.607708632294366,-1.2908775267990515,0.08888888888888889,0.6920779113241612,1.0,4/19,10.89%,NOX4;TXN2;ADO;BHMT
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.5474692458003856,-1.290789305684739,0.1111111111111111,0.6911583252758177,1.0,10/35,12.25%,TM7SF2;SQLE;ARV1;SC5D;SOAT1;PMVK;MSMO1;LCAT;STARD3;DHCR7
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.8008821563932618,-1.2903757411318335,0.22916666666666666,0.6911656204752794,1.0,3/5,15.50%,CXCL12;VEGFB;SCG2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7557737447592242,1.290291702256003,0.18867924528301888,0.8912872621590701,1.0,1/9,0.26%,VSIR
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.7594961579779329,1.290089807153502,0.12,0.8901611842742861,1.0,4/9,15.72%,RYR2;RYR3;SLC8A1;GSTM2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.7678668966998506,1.2900015209206406,0.1276595744680851,0.8882776100556177,1.0,1/10,0.26%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.786187113805505,-1.2898532286524576,0.15555555555555556,0.6921159125861283,1.0,3/8,19.06%,DUSP3;PIN1;FRMD5
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.8508524230798166,-1.2898207039354375,0.16279069767441862,0.6909234295750482,1.0,1/5,0.15%,SOX4
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4921348693330166,1.2898055556451613,0.07142857142857142,0.8869692994886478,1.0,45/116,24.67%,EEF2K;IGF1R;VRK1;ALK;DAPK1;PAK1;DAPK2;CAMK2B;PRKX;MAK;RIPK1;TYRO3;PAK2;OXSR1;ATM;MAP3K9;GRK5;EPHA4;TAF1;PDPK1;STK11;TNIK;MAPKAPK5;LMTK2;CAMK2D;DAPK3;VRK2;MKNK1;STK17B;CDK12;ABL1;ACVR1B;FER;TAOK1;STK24;PRKD2;EIF2AK3;MAPK3;ATR;MAP3K10;MAP3K12;ULK2;AATK;ERBB4;INSR
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.7088629369665119,-1.2897614525064256,0.10869565217391304,0.6898208922957947,1.0,3/12,16.00%,CHMP2A;SNF8;SMPD3
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5106416302157505,1.2894628929236982,0.08620689655172414,0.8862805752502713,1.0,30/86,21.73%,IQSEC2;BAIAP3;SYT1;GRIK5;RELN;BCR;GRM3;SYN3;BEGAIN;GRIK3;TPRG1L;MAPK8IP2;DGKZ;CPLX1;PXK;DLG4;GRM1;NRG3;KCNMB4;SLC8A2;UNC13A;STX1B;GRIK1;CACNG5;BTBD9;DGKI;NPTX2;USP46;SLC4A8;HOMER1
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.820472271082311,1.2893354048362224,0.12,0.8850091676165552,1.0,3/5,12.16%,CAMK2B;SHANK3;CAMK1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.8380026269189425,1.2893343702076772,0.13725490196078433,0.8826236981620632,1.0,2/5,10.76%,XRCC4;LIG3
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6320895874666907,1.289142173745327,0.11475409836065574,0.8811988407616883,1.0,2/20,2.04%,ADAMTS9;PTPRR
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6664124646496321,-1.289000733449164,0.1320754716981132,0.6914076253301181,1.0,2/11,2.31%,CFL1;PPIB
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.5271142291839963,1.2889767874040656,0.1,0.8799270458036424,1.0,11/61,6.25%,THBS3;ITGA2;ADAMTS9;ADAMTS13;ITGA8;ITGBL1;SORBS1;BCR;TIAM1;MKLN1;EMP2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.6559833330279982,1.2888084676313452,0.125,0.8785170182619819,1.0,8/21,20.07%,SRF;MMP21;CCDC39;MICAL2;BBS7;BBS4;PKD2;ENG
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.5932897353396717,-1.2883257739473712,0.075,0.6929883366071957,1.0,7/25,19.77%,AP4M1;LAMTOR4;AP3M1;SCARB2;LAMTOR5;NCOA4;CD81
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.4587575326932797,-1.2882807648453765,0.09302325581395349,0.6918881529355286,1.0,23/137,10.86%,SOX4;TAF9B;CALR;GAPDH;PPIB;BAG3;MT3;RABL3;CCT5;WIZ;RPS7;RPL23;GOLGA7;CCT3;CDC37;PHB2;GBA3;CLU;RPL11;HSP90AB1;GRN;ZBED3;MORC3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5394360617153052,1.2881028480808006,0.10344827586206896,0.8803208498152173,1.0,2/46,0.40%,HOOK1;KATNAL2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7265437546668612,1.2880174466921728,0.20754716981132076,0.8787970565933659,1.0,5/11,18.57%,TAFA5;TPM1;PRKG1;PPARG;PDCD4
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.8044625981480195,1.2879873348313668,0.1896551724137931,0.876705829105444,1.0,1/6,0.48%,JADE2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.7189834772403151,-1.2871277348978591,0.18867924528301888,0.6948604729317404,1.0,3/8,9.22%,TNFRSF14;WNT5A;SPHK2
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.8380323585008207,1.286985785695151,0.125,0.8803177885058028,1.0,1/5,7.23%,RHCE
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.8358448845328663,1.2868899906379936,0.1346153846153846,0.8786629447952625,1.0,2/5,14.13%,IL5;ASAP1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5529932177462695,1.2864265155473473,0.15384615384615385,0.8793244993368148,1.0,10/58,8.05%,CALCB;TPCN2;HTR2C;NEDD4L;ATP2B3;SLC24A2;VAPB;RYR2;LETM2;ATP2B2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5303441517255829,-1.2855505307314,0.04081632653061224,0.6995558202776432,1.0,21/54,18.44%,UBB;RPS27A;UBC;PNRC2;PARP1;EDC3;UBA52;DXO;DCP1A;DDX1;CUL4B;MUS81;GTF2H2;ISG20;RFC5;POLD3;FAN1;POLD2;RFC3;EXD2;RNASE1
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.7497682899370084,1.2854078860812574,0.15789473684210525,0.8827350478343252,1.0,4/8,17.93%,PARP9;HMBOX1;MED25;DTX3L
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.5009079639631366,1.2852614066594872,0.06666666666666667,0.8813708649200659,1.0,21/96,16.53%,SYNJ2;INPP4B;PIP4K2C;PIP5K1B;PLEKHA4;PITPNM2;SOCS4;CDS1;INPP4A;ITPKB;INPP5E;PLEKHA2;PIP4K2A;PIGH;PIK3CD;ITPKC;MTMR7;MPPE1;MTMR3;IMPA1;EFR3A
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6479213164466019,-1.2847770371000646,0.17391304347826086,0.7015103593138193,1.0,7/13,22.53%,PRPF8;PRPF31;CD2BP2;SRSF10;PRPF19;PRPF6;LSM2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.5240236576835544,1.2847669689413834,0.12727272727272726,0.8816897077257044,1.0,19/85,15.69%,CALCB;CALB1;TPCN2;HTR2C;TRPC4;ATP2B3;SLC24A2;PSEN1;VAPB;CAV3;RYR2;ATP2B2;C19ORF12;ATP13A4;SLC8A1;SLC8A2;PACS2;CAMK2D;ANK2
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.7250451982690955,-1.2847659703877994,0.20408163265306123,0.7001917308188685,1.0,2/8,7.06%,EXOSC8;DXO
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.7779811431880231,1.2842153787018176,0.3,0.8825012883726112,1.0,3/6,20.04%,CCDC39;PROX1;SRP54
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.6510931639169194,-1.2841835552333594,0.14285714285714285,0.7012544711832348,1.0,3/15,3.66%,SIRT2;SLC30A10;MT3
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7468154724624987,1.2841660412678213,0.22413793103448276,0.8805143384852561,1.0,2/11,3.47%,AKT2;NNMT
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7527712110880952,-1.2837263861253487,0.20754716981132076,0.7015575591704294,1.0,3/7,11.61%,CLU;LCAT;SCARB1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.634508040451824,-1.2835412539901738,0.16666666666666666,0.6995671840875188,1.0,5/16,13.48%,GSTP1;GSTM4;AKR1A1;GSTM3;GSTA4
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.634508040451824,-1.2835412539901738,0.16666666666666666,0.6995671840875188,1.0,5/16,13.48%,GSTP1;GSTM4;AKR1A1;GSTM3;GSTA4
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.8106115192425678,1.2833768747620895,0.11764705882352941,0.8802855290679319,1.0,3/6,15.66%,GABRB1;GABRG2;DIAPH1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.8106115192425678,1.2833768747620895,0.11764705882352941,0.8802855290679319,1.0,3/6,15.66%,GABRB1;GABRG2;DIAPH1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.7675586636139851,1.283320415850494,0.18,0.8782264526122984,1.0,2/9,14.47%,NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.8287086133494352,-1.2832218240192985,0.1590909090909091,0.6993707539443849,1.0,3/6,5.47%,PRDX1;MT3;ADPRS
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.46983296651140916,1.282985942945902,0.05454545454545454,0.8779674563982888,1.0,36/149,17.19%,SLC6A15;SLC6A11;KCNQ3;KCNJ11;KCNH7;TRPC4;KCNC4;SLC6A17;SCN8A;SLC24A2;SLC39A14;SLC4A4;HCN3;KCNN3;KCNB2;KCNC2;KCNQ5;HCN1;RHCE;SLC6A6;KCND3;SLC12A1;RYR3;SLC39A11;SCN2A;NALCN;SLC6A7;SLC8A1;SLC8A2;SLC6A8;KCNAB2;TMEM165;ABCC8;KCNH1;SLC6A1;SLC39A13
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.7017947610734532,1.2829406682356475,0.18181818181818182,0.8759248830851706,1.0,4/10,20.35%,MERTK;SPI1;AOAH;IGSF6
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.766419129813336,1.2829326052712953,0.19230769230769232,0.873707787295604,1.0,2/8,10.06%,BAIAP2;GAS2L1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.8412123380470791,1.2827232005614453,0.06896551724137931,0.872101623534254,1.0,1/5,5.58%,FOXP1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.7949667583520719,1.2820974233472058,0.11764705882352941,0.8690713514827407,1.0,1/5,12.65%,MAN1A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.7949667583520719,1.2820974233472058,0.11764705882352941,0.8690713514827407,1.0,1/5,12.65%,MAN1A1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.7949667583520719,1.2820974233472058,0.11764705882352941,0.8690713514827407,1.0,1/5,12.65%,MAN1A1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5107041834716034,-1.2818745364075559,0.0975609756097561,0.7035712020789241,1.0,11/49,10.38%,GPX1;BAD;BEX3;MT3;MALT1;ARL6IP5;PDCD5;DELE1;NGF;IFI6;CD44
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.6192563417078599,-1.2815150098126948,0.1590909090909091,0.7034928492216436,1.0,5/21,12.61%,JUN;TAF11;CTDP1;SAP30;TARDBP
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.8111796128428395,1.2814640899537493,0.2558139534883721,0.8700271795151733,1.0,3/5,10.77%,THRAP3;RORA;FBXW11
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5642999320731148,1.2814458158336584,0.1875,0.8679495345965541,1.0,9/36,14.30%,FECH;RRH;UBE4B;MAPK10;CLOCK;ZRANB3;MSH6;PRIMPOL;DDB2
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8058498077051093,1.28094582362188,0.1346153846153846,0.8688352341685025,1.0,2/10,1.86%,ROBO2;ADAMTS9
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.7822929254212316,1.280804748028961,0.21153846153846154,0.867564010961532,1.0,4/7,14.54%,USP30;NBR1;ATM;MAP1LC3B
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.7541166890414724,-1.280586593334327,0.22727272727272727,0.7054490371306416,1.0,3/7,16.78%,GAS1;PRNP;SNX12
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.5373133421501541,1.2803230983620726,0.07142857142857142,0.8679490222296506,1.0,20/62,14.78%,GLRA1;TPCN2;EDNRA;CKMT2;MYLK;SORBS1;OXTR;SNTA1;CAV3;TTN;TMOD3;VCL;MYOM1;TPM1;NOS1;SGCA;DYSF;MYOM2;SLC8A1;SLC6A8
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.44094806578177365,-1.2801257877312002,0.125,0.7058647658441253,1.0,29/124,13.93%,MT1E;BTG1;JUN;BGN;BCAN;PRDX5;MT2A;PLIN2;GAPDH;GPC4;JMJD6;TIPARP;GBE1;TPST2;WSB1;TPI1;SLC25A1;CAV1;PNRC1;SAP30;TMEM45A;SCARB1;CDKN1C;GPC1;ISG20;GRHPR;XPNPEP1;NCAN;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.6752597616506288,-1.2800898036736674,0.11904761904761904,0.7046037944525188,1.0,3/13,8.15%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.7479563371828514,1.2798999641095334,0.24,0.8681517555490069,1.0,2/9,12.36%,PIP4K2C;PIP4K2A
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.7451293327039357,-1.2797933868433735,0.17647058823529413,0.7042351154771939,1.0,1/5,3.57%,BAG3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.6044376697413975,-1.2794303289035036,0.10810810810810811,0.7044241277233052,1.0,9/29,15.10%,POLR2L;POLR1F;POLR1A;RRN3;POLR2K;POLR2E;GTF2H2;TAF1A;POLR1G
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.7190074262185577,1.279131214582825,0.12727272727272726,0.8699501729933725,1.0,3/13,8.51%,AGMO;PLA2G15;GPAM
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.6598463062781094,-1.2790822211244044,0.16666666666666666,0.7045713119032043,1.0,4/10,13.24%,THY1;MADCAM1;PTN;ZP3
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.4718826436845219,1.2785379953237646,0.029850746268656716,0.8708872178552401,1.0,21/165,7.58%,DOCK5;VSIR;PTPRC;SOX9;NEDD9;IGF1R;FAM107A;SHTN1;AKT2;MYLK;PAK1;ENPP2;NTRK3;SEMA3A;TIAM1;SEMA4B;NSMF;WASHC1;PRKCA;PLET1;GCNT2
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.8311675587592853,-1.2785226847275868,0.24489795918367346,0.705621257267526,1.0,1/5,5.85%,EIF3D
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.800943611347884,1.2783711894243552,0.13043478260869565,0.8697832895440639,1.0,2/7,9.64%,ROBO2;BMP7
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.7378242984710692,1.27818679133902,0.1746031746031746,0.8684169481569523,1.0,3/8,24.36%,SMC5;XRCC3;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7904944371116023,-1.2781108750934573,0.2978723404255319,0.7059706349758764,1.0,3/5,20.76%,MST1;CLK2;PGP
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.8605934361195965,1.2780913945835017,0.1320754716981132,0.866901468043785,1.0,2/5,9.09%,SOX9;CRACD
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6413616195267826,1.2780833216583012,0.1694915254237288,0.8648159137211452,1.0,2/16,6.27%,ERBIN;PARD3
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.8201812587348423,-1.2778313133261872,0.1891891891891892,0.7057255533894812,1.0,5/7,9.96%,GSTP1;MID1IP1;ALOX5;SPHK2;SLC25A33
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.6451162777243796,-1.2777277898397126,0.10416666666666667,0.7048280088116081,1.0,1/15,0.35%,BTC
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.5438681664635394,1.2777252514769053,0.10344827586206896,0.8644689000825506,1.0,15/47,24.22%,PAK1;BAIAP2;CAV3;CRACD;CDC42EP3;VASP;CDC42EP4;PRKCE;FER;FCHSD2;CLASP1;TOGARAM1;NAV3;MAPT;NCK2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.4324755139663804,-1.2776820687301456,0.09302325581395349,0.7036891650693631,1.0,53/270,14.91%,UBB;SIRT2;PSMB6;UBXN1;PSMD8;RPS27A;PSMB4;DERL2;UBC;GID8;CDC26;PSMA7;TNFAIP1;KBTBD6;UBA52;FBXO45;SELENOS;UBE2J1;SPSB3;FOXRED2;FAM8A1;SEC61B;HECTD3;UBXN4;PSMC3;AUP1;PSMC1;PSMD10;PSMD12;ANAPC11;STUB1;YOD1;FBXO44;RNF126;PSMB9;PSME3;TMUB2;DNAJB12;RAD23A;OS9;PSMD2;UCHL1;CUL4B;RNF187;RHBDD2;DMAC2;HSPA5;HSP90B1;PSMD3;PELI1;KBTBD7;UBQLN2;PSMD4
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.809031816977143,-1.2776324036340538,0.21428571428571427,0.7026765146161646,1.0,1/5,4.07%,SH3GL2
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.7189490598459455,1.277376887193296,0.1774193548387097,0.863747819764439,1.0,3/12,7.73%,RASGRF1;ARHGAP24;ARHGAP17
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.5092103579025372,-1.277238580624654,0.11904761904761904,0.7029062239175032,1.0,10/65,6.23%,UBB;RPS27A;CCDC88C;GPC4;UBC;WNT3;SFRP1;VPS35;PORCN;UBA52
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.8143757147815344,-1.277093885622341,0.21428571428571427,0.702222966619468,1.0,2/5,12.79%,PLEKHG5;CORO1B
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.6998590468277563,-1.2768398852459366,0.14,0.7017647400224432,1.0,2/8,5.39%,ZFP36L1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.6908207625177207,1.2766850862472399,0.1509433962264151,0.8657203358929794,1.0,1/15,0.27%,PTPRC
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.7739789155469206,-1.276053062974584,0.20454545454545456,0.702284614168586,1.0,2/5,13.89%,GINS3;MCM4
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.7739789155469206,-1.276053062974584,0.20454545454545456,0.702284614168586,1.0,2/5,13.89%,GINS3;MCM4
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.598721802812598,1.2758914936247383,0.15789473684210525,0.8677492419383983,1.0,7/31,13.77%,CHRM3;HTR1F;ADCY5;AKAP5;P2RY12;AKAP12;ADCY3
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.5866396986993883,1.2757351222612925,0.08064516129032258,0.8665427088364894,1.0,6/27,21.93%,THAP9;WRN;RPA1;XRCC3;HDAC10;RAD54B
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.5194528211733345,1.2755358621173347,0.07017543859649122,0.8653201288504138,1.0,9/61,11.34%,RASGRF1;MMD2;MADD;BCR;ERBIN;ARHGAP17;DENND4B;SYNGAP1;RASGEF1A
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6793004263821145,-1.2754922857782285,0.20930232558139536,0.703177061055619,1.0,4/16,3.66%,MT1E;MT2A;SLC30A10;MT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.500453882437033,-1.2748633499132291,0.08108108108108109,0.7042471017211397,1.0,25/93,14.91%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;SFRP1;UBA52;MAPK13;HAS2;PSMC3;PSMC1;PSMD10;PSMD12;CACTIN;PSMB9;PSME3;IKBKB;PSMD2;TOLLIP;RC3H1;PSMD3;PELI1;PSMD4
prerank,PanglaoDB_Augmented_2021__Microglia,0.635513694357757,1.274794268082692,0.09433962264150944,0.867400809719505,1.0,7/29,14.70%,PTPRC;MERTK;FOS;SPI1;P2RY12;AOAH;IL6R
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.6131465775396712,-1.27433959477184,0.1891891891891892,0.7047919588230735,1.0,1/15,1.47%,RBM22
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.7515776791011815,-1.274221120486168,0.07894736842105263,0.7039537443461226,1.0,1/9,2.45%,TCTA
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.8156499989714958,-1.274119936878127,0.16279069767441862,0.7030385956192022,1.0,2/5,9.09%,ALOX5;FADS1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4682653764105157,-1.2740897199828731,0.075,0.7019671429974068,1.0,21/107,10.81%,SOX4;PSMB6;PSMD8;TMEM9;PSMB4;GID8;PSMA7;CDH3;GSKIP;SFRP1;BAMBI;PSMC3;PSMC1;PSMD10;PSMD12;CAV1;PSMB9;ZBED3;PSME3;LRRK1;SEMA5A
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.5821067398947471,-1.2740655326307644,0.16279069767441862,0.7008397676364525,1.0,4/22,3.92%,PPIF;PPWD1;PPIB;PPIA
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.6087642626976733,-1.273987197552168,0.09090909090909091,0.6998356361859629,1.0,4/25,6.16%,ACTG1;ACTB;ARL6IP5;DNAJA1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.5793229858155317,1.2735166882023454,0.16363636363636364,0.8719112899310205,1.0,1/32,0.26%,VSIR
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.7224301011812334,-1.2730943729010131,0.23529411764705882,0.7020688452624849,1.0,1/8,1.90%,ATF4
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.5377529309764212,-1.272613876614552,0.10526315789473684,0.703165327910448,1.0,10/56,10.47%,BTC;SIRT2;SVIL;RANBP1;WIZ;NPM2;MAP10;RCC2;GIPC1;CENPV
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.7837243258661293,-1.2725785292081933,0.2222222222222222,0.70200425421605,1.0,3/6,20.95%,DACH1;BHLHE41;MAD2L2
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.7521488766716478,1.2723544356393974,0.15384615384615385,0.8765956713537358,1.0,2/8,7.74%,WNT7A;DOCK7
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.7204574806240769,-1.2722684797069639,0.14893617021276595,0.7019326604797624,1.0,2/10,6.15%,KIF25;SYNE2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.5438758502534684,1.2718308522410815,0.10526315789473684,0.877355242108614,1.0,11/62,14.39%,JADE2;MSL3;MRGBP;KAT2B;ING5;SPI1;NAA50;EP400;TADA2A;ACTL6B;MORF4L2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7780342812457919,-1.2708901933428274,0.2222222222222222,0.7048776552571844,1.0,2/6,8.24%,BLVRB;ABCG2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7780342812457919,-1.2708901933428274,0.2222222222222222,0.7048776552571844,1.0,2/6,8.24%,BLVRB;ABCG2
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7429309546046259,1.2705023106180637,0.18032786885245902,0.8829125549148069,1.0,2/7,13.97%,NEDD9;DMTN
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.7360148952215776,-1.270324032034423,0.225,0.7054295881858039,1.0,1/8,0.62%,GSTP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.7201914184932606,-1.2697699764104928,0.1956521739130435,0.7063911154953207,1.0,3/8,22.99%,LAMP1;IL18;HLA-F
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.6887997424023584,-1.2696856983423657,0.21621621621621623,0.705569127251403,1.0,5/9,17.81%,CRAT;OXSM;CROT;GLYATL2;ABHD2
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.7947820460166896,-1.2693933640053792,0.175,0.7053163183011995,1.0,1/5,1.61%,PCBD1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.7167467657365163,1.268666653248903,0.16071428571428573,0.8923054816366695,1.0,7/12,24.22%,CCDC39;TGFBR3;PRKCSH;PROX1;PKD2;COBL;NF1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.8110328279204485,1.2685679540428993,0.13333333333333333,0.8908697393938912,1.0,1/6,0.75%,TMSB4X
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7973338935351777,-1.2678109851861046,0.29545454545454547,0.7099769142878073,1.0,4/6,9.64%,CALM1;SRI;CALM3;CAV1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.4839762085781653,1.2677140579266373,0.0847457627118644,0.8938644007938918,1.0,37/118,19.77%,PCSK2;OLFM3;STMN2;MMD2;ATP2B3;SLC24A2;NTRK3;VWC2L;HSPA12A;HCN1;PRKCA;SNAP25;RNF152;GABRG2;ADGRB3;PROX1;SGIP1;CNTNAP2;NAPB;LSAMP;LIN7A;FAM135B;SCN2A;GRM1;CLVS2;CDH20;ACTL6B;ASTN1;KIF1B;MAGI2;GAD2;SV2B;SEZ6L;CNTNAP5;SYP;UNC79;GABRA1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5199722788897431,1.2673525173896056,0.08888888888888889,0.8938885205466743,1.0,16/63,14.51%,IGF1R;EPHA7;ALK;NLRC5;MERTK;NTRK3;TSPYL2;EMP2;ZNF16;TTN;TYRO3;ZNF622;ROR1;EPHA4;LMTK2;ANKRD54
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.7330566434222477,-1.2673375151052129,0.2608695652173913,0.7104762826413102,1.0,1/7,3.46%,NT5E
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.7125920566691013,1.2673240616634023,0.2,0.8919676584751272,1.0,4/14,13.35%,SHTN1;RIPOR2;BCAS3;RAP1B
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.4943259485154505,1.2667591573739523,0.1016949152542373,0.8925078603212246,1.0,32/114,19.27%,ROBO2;OLFM3;PCLO;STMN2;EPHA7;SULT4A1;MMD2;ATP2B3;NTRK3;GRM3;RBFOX3;GRIK3;SNAP25;NPAS3;ADGRB3;PROX1;HIVEP2;LSAMP;CLVS2;ACTL6B;SLC8A2;ASTN1;KIF1B;NOVA2;ANK2;UNC13A;GAD2;ERC2;DCLK1;CTNND2;SLC12A5;UNC79
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.5266904792081575,-1.266538997529242,0.14893617021276595,0.7117898363791356,1.0,16/58,11.00%,MMP2;BGN;PODN;THY1;PRRX1;FBLN2;FIBIN;IGFBP7;THBS2;PDGFRA;CXCL12;CYBRD1;PTN;AEBP1;SSC5D;ADAMTS2
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.4375718879084339,-1.2665210554332134,0.08108108108108109,0.7106359379480068,1.0,30/134,17.72%,CDKN2C;CCND1;MARCKS;MT2A;ODC1;HSPA8;SQLE;E2F4;H2AZ1;SMC1A;KPNA2;CBX1;SAP30;SNRPD1;ODF2;HMGN2;NCL;GSPT1;PRMT5;SRSF10;SMAD3;HIRA;DR1;NUMA1;UBE2S;TLE3;BUB3;DBF4;LBR;STMN1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.6057282825221589,-1.2664874364506908,0.18604651162790697,0.7095828227221385,1.0,7/30,13.50%,EMC6;SEC61G;SEC61B;GET3;EMC10;MMGT1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.727739616346226,-1.2662871082213956,0.11627906976744186,0.7080469599631027,1.0,3/7,8.15%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.727739616346226,-1.2662871082213956,0.11627906976744186,0.7080469599631027,1.0,3/7,8.15%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.8369302581911934,1.2660912614412656,0.11290322580645161,0.8945132603378417,1.0,1/6,1.11%,SOX9
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.4603486207371146,-1.2658482959185278,0.06976744186046512,0.7083904187939771,1.0,22/116,10.97%,MMP2;BGN;DAPL1;SLITRK2;THY1;PRRX1;DBI;TCEAL7;FIBIN;THBS2;ITM2B;PDGFRA;CXCL12;EDNRB;S100A16;CLU;PTN;CD44;DOK5;FNDC4;SEMA5A;BRINP1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.45806793630751014,1.2657997392620763,0.08620689655172414,0.8941960838267982,1.0,29/145,11.91%,SEC14L5;MYRF;NKX6-2;OPALIN;KIF6;PEX5L;FAM107A;SHISA6;ST18;ZDHHC9;MMD2;MOBP;ASPA;SORBS1;ENPP2;PHYHIP;GFAP;GRM3;ADCY5;PSD2;ATP2B2;ITPR2;SRCIN1;TYRO3;AQP4;NDRG2;SLC25A19;NINJ2;MPPED1
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7484208586615664,-1.2656555242956664,0.2391304347826087,0.7079828601055844,1.0,2/7,2.31%,CFL1;PPIB
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.4413325870212788,-1.2654022140206107,0.08333333333333333,0.7076726657945208,1.0,35/163,12.46%,CDKN2C;SSPN;UQCR10;CD151;IDH1;GPX4;PLIN2;NDUFB7;ARL4A;UBC;MRPL15;UQCRQ;CRAT;JAGN1;CHCHD10;DHRS7;UQCRC1;NDUFA5;VEGFB;GBE1;NDUFS3;DLD;ACLY;PPP1R15B;AIFM1;SLC25A1;ADCY6;GRPEL1;NDUFAB1;CYC1;SCARB1;ESRRA;DHCR7;ACOX1;TALDO1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.7102186854900034,1.2650351766962036,0.125,0.896209309149799,1.0,5/11,23.98%,SNTA1;CAV3;ANK2;KCNQ1;CACNA1D
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.7475019910229861,-1.2647991973737434,0.2222222222222222,0.7088006006687121,1.0,2/7,7.47%,IRF3;PHB2
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7342411591048377,1.2643679304146875,0.1276595744680851,0.8979807793941608,1.0,2/9,9.45%,HEY2;PROX1
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.7702381043072675,-1.2640245712719917,0.3142857142857143,0.7102116092070703,1.0,2/5,15.76%,UBE2L6;ISG15
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.6335299375950147,1.2636326595243785,0.15,0.9004815552032667,1.0,2/18,0.47%,PTPRC;AHR
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.4699099387863993,-1.2634953589619673,0.0,0.7110831325335306,1.0,17/87,11.85%,JUN;PSMB6;PSMD8;CALM1;LAT2;PSMB4;MALT1;PSMA7;LYN;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.6739368882315007,-1.2634338038849522,0.24390243902439024,0.7099691232587857,1.0,1/15,0.66%,HSD17B10
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.5021554930893648,1.2631761595624795,0.12727272727272726,0.9007421285373156,1.0,35/130,17.34%,TLK1;VRK1;AKT2;CAMK1D;RPS6KB2;PRKX;PNCK;PRKCA;RIPK1;PAK2;ATM;SGK1;TNKS;TOP1;TTBK2;TAF1;MAST4;PDPK1;CAMK1;MAPK12;RPS6KA2;PLK2;AKT3;MAPKAPK5;LMTK2;MASTL;CSNK1G1;CAMK2D;CSNK1D;CDC7;VRK2;PRKCE;SRPK2;MKNK1;PRKCZ
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.47083640541276833,-1.2630394137697103,0.11627906976744186,0.7100388057292771,1.0,21/68,15.66%,VANGL1;PSMB6;PSMD8;PSMB4;PSMA7;PRICKLE1;SAPCD2;PSMC3;PSMC1;WNT5A;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PFN1;PSMD3;CDC42;AP2S1;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.705846432915674,1.262958028438371,0.17857142857142858,0.8998058906870143,1.0,5/12,15.43%,FAM161A;DIP2B;PRKAA2;CAMK1;PRKAA1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5578697268791392,1.2629462874655855,0.1206896551724138,0.8978067143600971,1.0,14/48,17.34%,PTPRC;EFNA5;EPHA7;IL5;RELN;ENPP2;PTPRJ;EFNA1;PAK2;DMTN;IL6R;SEMA4D;CNOT7;PRKCZ
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.7537707394560256,1.2628362828287938,0.23076923076923078,0.8964013726171634,1.0,3/9,18.97%,SOCS4;CHMP6;CBLB
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5432605338208231,-1.262700543524763,0.18421052631578946,0.7097282812830318,1.0,8/33,11.72%,STAB2;RPS19;ROMO1;RARRES2;PPP1R11;TNFRSF14;RPL30;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7984852501440678,1.2624499237885554,0.17307692307692307,0.8961690141182573,1.0,3/6,10.22%,NR4A3;SGIP1;NPAS2
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.7852139298754635,-1.2622855920520135,0.19148936170212766,0.7100826312898773,1.0,2/5,13.00%,PTPRF;B2M
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.4200989006577365,-1.2622753288536537,0.0625,0.7089021017366793,1.0,27/202,7.95%,SOX4;UBB;JUN;UTP11;NCSTN;RPS27A;ATF4;FGD3;BAD;UBC;TRIM35;PLEKHG5;SAP18;PNMA1;ARL6IP5;APH1A;IFIT2;SFRP1;PDCD5;DNAJA1;UBA52;MCF2;PHLDA1;SMPD1;NGF;STPG1;CLU
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.7111901798511163,-1.2622245531206973,0.23809523809523808,0.7078956755245885,1.0,1/6,1.46%,UBXN1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.6731097872582579,-1.2620134419570137,0.17073170731707318,0.7073644029275509,1.0,4/13,11.67%,CSTB;CAV1;CST3;FURIN
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.690374326450576,-1.261616838301409,0.21153846153846154,0.7077391825379673,1.0,2/10,5.35%,STOX1;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6878416054012481,1.2612439886903577,0.21666666666666667,0.9011957207831727,1.0,2/12,2.70%,ROBO2;WNT7A
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.6282317067088157,1.2610220225810658,0.16363636363636364,0.9003728539049564,1.0,6/18,17.71%,FGF9;CCDC39;PROX1;LOXL3;FGF1;PDPN
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.5127918355502565,1.2608949621021412,0.16071428571428573,0.8991606908615856,1.0,16/66,17.90%,PCTP;FABP3;PITPNA;SLCO1A2;ABCA2;RXRA;NCOA1;ACSL1;ABCA8;PITPNC1;PITPNB;ABCA10;ATP8A1;SLC51A;AKR1C1;NCOA2
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.4867304618182097,1.2606428515431514,0.047619047619047616,0.8986764715484674,1.0,29/91,19.77%,UNC13C;PCSK2;ST18;MOBP;CACNG2;SLC24A2;ASPA;KCNC2;RBFOX3;MCF2L2;GNG7;HCN1;CNDP1;ATP2B2;SGSM1;PROX1;NAPB;FAM135B;ACTL6B;DPP6;GAD2;CACNB4;KCNT1;SV2B;SEZ6L;CNTNAP5;SYP;KCNQ1;GABRA1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.67566255248039,-1.26046542568746,0.2,0.7104448065771907,1.0,4/16,4.62%,ACTG1;ACTB;PRDX1;CDH3
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.8372043992726668,1.2602391298547577,0.1836734693877551,0.8987504755416649,1.0,3/5,12.98%,PTPRR;TENM3;PTPRG
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.5588973301298248,-1.260219613587912,0.1794871794871795,0.7102498976838028,1.0,5/21,10.56%,CHRNA4;NIPSNAP1;USH2A;P2RX4;GNAS
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.4631411378607063,1.260122643447806,0.028169014084507043,0.8975091716091215,1.0,40/134,25.86%,SYNJ2;INPP4B;PCTP;PIP4K2C;PIP5K1B;PLEKHA4;DGKG;PITPNM2;CDS1;GPAM;INPP4A;DGKZ;INPP5E;PLEKHA2;PIP4K2A;PIK3CD;AGK;MTMR7;MTMR3;IMPA1;ABHD3;GPD1L;LIPH;SLC44A3;TAMM41;DGKD;PI4K2B;STARD7;MTMR9;PIK3CA;PTPN13;PLA2G12A;PIK3R1;CDS2;PIP4K2B;GPAT4;SLC44A1;ABHD8;PIP5K1A;SACM1L
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.5861959907880285,-1.259846128064878,0.13953488372093023,0.7102993175247689,1.0,3/24,2.23%,CALR;RAN;NUP42
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.715694153160007,-1.2596081821447473,0.20930232558139536,0.7101053022988923,1.0,1/8,1.48%,CALR
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.4848733174733734,1.2593877950972583,0.13793103448275862,0.8998609691429824,1.0,24/90,17.12%,NEDD4L;KCNJ13;KCNC4;SLC6A17;SCN8A;SLC4A4;PANX2;LRP2;KCNB2;GRIN1;TMEM63C;SLC6A6;SLC9B2;KCND3;SLC22A4;SGK1;SCN2A;KCNMB4;SLC8A1;PIEZO1;SLC8A2;PIEZO2;ABCC8;KCNH1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6256794120035744,1.259384500545937,0.125,0.8978250845974101,1.0,8/27,17.10%,TULP3;NPHP4;ODAD4;WDR19;RAB29;CSNK1D;BBS4;EHD1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6231321856083698,1.2591991463130634,0.14545454545454545,0.8968187558923011,1.0,3/23,8.42%,BCL9;TGFBR3;PCSK6
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.6216144838896495,1.2583059661933338,0.15517241379310345,0.8996245284227902,1.0,6/22,21.22%,ATP10A;PLSCR4;ATP8B2;ATP8A1;ATP10B;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.7777138685667525,-1.2582954970714482,0.16666666666666666,0.7136856761753212,1.0,2/6,5.59%,PDGFRA;LDLR
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.6177347326165403,-1.2580011862578644,0.14285714285714285,0.7137477833670066,1.0,5/15,21.59%,ESRRB;PTN;WDR43;CNOT3;CNOT1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.6874182496791742,1.2565845204234725,0.2,0.9074153213547415,1.0,4/13,17.12%,SORT1;ADGRB3;NOS1;KCNH1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.5512039474708754,1.2565014708022855,0.12698412698412698,0.9058469683368782,1.0,9/35,16.45%,ROBO2;SHTN1;PLXNA4;TIAM1;MACF1;LIMK1;PLXNA1;SEMA4D;TIAM2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4155782690187904,-1.2562738442419292,0.05555555555555555,0.7180922444106117,1.0,70/274,14.89%,GSTP1;ILF2;NCSTN;C6ORF120;IDH1;ARPC5;CKAP4;SRP14;AGA;PGRMC1;FTL;CSTB;HSPA8;SURF4;YPEL5;EEF1A1;CD63;CAP1;PPIA;GUSB;EEF2;DDOST;RHOG;LPCAT1;CYB5R3;FABP5;ALOX5;GOLGA7;DYNLT1;MAGT1;MOSPD2;ASAH1;CTSC;PA2G4;ALAD;APEH;OSTF1;PRCP;HLA-B;PSMC3;ACLY;PSMD12;TUBB4B;RAB14;HSP90AB1;RAB5B;GRN;GALNS;NEU1;CD44;GM2A;DBNL;CST3;MAN2B1;RAP2C;CAPN1;PSMD2;PGAM1;TOLLIP;LAMP1;B2M;PRDX4;TIMP2;TMBIM1;NIT2;IMPDH2;PSMD3;AP1M1;GYG1;ADA2
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.6363825290930915,-1.2561497571304159,0.19607843137254902,0.7173846909882293,1.0,3/14,3.66%,NOX4;PRDX1;MT3
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7544549434502319,-1.255523751925753,0.3076923076923077,0.7184053904399147,1.0,2/5,6.44%,UBE2D4;RNF6
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.6756632765232835,-1.25501395743201,0.18421052631578946,0.7188854182601829,1.0,5/13,11.59%,SOX4;ASCL1;EDNRB;FN1;SOX8
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.6017890818625241,1.2549495749242585,0.22033898305084745,0.912719321697332,1.0,2/25,2.61%,GLRA1;RACGAP1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.6684718778955344,1.2549397496919188,0.26666666666666666,0.9107627199021566,1.0,4/15,13.35%,SHTN1;RIPOR2;BCAS3;RAP1B
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4136221164739633,-1.2544603706593291,0.05405405405405406,0.7200482480092252,1.0,70/277,14.89%,GSTP1;ILF2;NCSTN;C6ORF120;IDH1;ARPC5;CKAP4;SRP14;AGA;PGRMC1;FTL;CSTB;HSPA8;SURF4;YPEL5;EEF1A1;CD63;CAP1;PPIA;GUSB;EEF2;DDOST;RHOG;LPCAT1;CYB5R3;FABP5;ALOX5;GOLGA7;DYNLT1;MAGT1;MOSPD2;ASAH1;CTSC;PA2G4;ALAD;APEH;OSTF1;PRCP;HLA-B;PSMC3;ACLY;PSMD12;TUBB4B;RAB14;HSP90AB1;RAB5B;GRN;GALNS;NEU1;CD44;GM2A;DBNL;CST3;MAN2B1;RAP2C;CAPN1;PSMD2;PGAM1;TOLLIP;LAMP1;B2M;PRDX4;TIMP2;TMBIM1;NIT2;IMPDH2;PSMD3;AP1M1;GYG1;ADA2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6867879380131763,-1.2544308652333718,0.23255813953488372,0.7189912722309181,1.0,4/15,3.66%,MT1E;MT2A;SLC30A10;MT3
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.7995314985813418,1.2541990480231657,0.18181818181818182,0.9130632312462643,1.0,1/5,2.29%,SLCO1A2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.7653528485801989,1.2535458107979147,0.18518518518518517,0.9146905532754327,1.0,1/9,1.40%,BAIAP3
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.5830237242464482,1.2535098940572464,0.1320754716981132,0.9129029581514875,1.0,5/30,9.17%,SOX9;WNT7A;SLC39A14;ZBTB16;SULF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.587119179667727,-1.2533092179940557,0.15151515151515152,0.7218646580911829,1.0,8/17,25.42%,HIPK1;PHLDA3;DYRK2;AEN;USP28;RPS27L;PML;BAG6
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.4807104425098981,-1.253111817977582,0.06976744186046512,0.7189257178408021,1.0,18/72,15.66%,PSMB6;PSMD8;PSMB4;MALT1;PSMA7;LYN;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2;PSMD3;PSMD4;PRKACA;PSMB2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.4807104425098981,-1.253111817977582,0.06976744186046512,0.7189257178408021,1.0,18/72,15.66%,PSMB6;PSMD8;PSMB4;MALT1;PSMA7;LYN;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2;PSMD3;PSMD4;PRKACA;PSMB2
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.4807104425098981,-1.253111817977582,0.06976744186046512,0.7189257178408021,1.0,18/72,15.66%,PSMB6;PSMD8;PSMB4;MALT1;PSMA7;LYN;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2;PSMD3;PSMD4;PRKACA;PSMB2
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6306749199983167,1.2530203626204492,0.16363636363636364,0.9135233867311036,1.0,3/18,8.94%,SHTN1;MACF1;LIMK1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.8217220740015824,1.2527885155651066,0.14035087719298245,0.9127640570693901,1.0,1/5,0.27%,PTPRC
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.6893448306351037,-1.2527693868256555,0.19047619047619047,0.7190514088926392,1.0,1/12,8.24%,ABCG2
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.6698599198493196,-1.2526336121778414,0.20408163265306123,0.7184269760459966,1.0,3/13,3.66%,SIRT2;PPT1;MT3
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.6990288419897652,-1.252618964252338,0.19047619047619047,0.7173116673022573,1.0,6/10,18.01%,ADRM1;PSMD10;PSMD4;POMP;PSMG1;PSMD11
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.415362797486725,-1.252505126975272,0.05714285714285714,0.7164187004236364,1.0,70/275,14.89%,GSTP1;ILF2;NCSTN;C6ORF120;IDH1;ARPC5;CKAP4;SRP14;AGA;PGRMC1;FTL;CSTB;HSPA8;SURF4;YPEL5;EEF1A1;CD63;CAP1;PPIA;GUSB;EEF2;DDOST;RHOG;LPCAT1;CYB5R3;FABP5;ALOX5;GOLGA7;DYNLT1;MAGT1;MOSPD2;ASAH1;CTSC;PA2G4;ALAD;APEH;OSTF1;PRCP;HLA-B;PSMC3;ACLY;PSMD12;TUBB4B;RAB14;HSP90AB1;RAB5B;GRN;GALNS;NEU1;CD44;GM2A;DBNL;CST3;MAN2B1;RAP2C;CAPN1;PSMD2;PGAM1;TOLLIP;LAMP1;B2M;PRDX4;TIMP2;TMBIM1;NIT2;IMPDH2;PSMD3;AP1M1;GYG1;ADA2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.43471013130754615,-1.2522895262967504,0.10810810810810811,0.7163656786430755,1.0,24/116,14.65%,SOX4;PIWIL2;PCIF1;BRPF3;EEF2;CDH3;MID1IP1;FXR2;NPM2;LDLR;OPN3;EIF3D;P2RX4;CLU;HSP90AB1;GIPC1;EIF4A3;SCARB1;NPM1;PRMT1;DYRK2;SMAD3;PLXNB2;ASIP
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.7500201432279829,-1.2518096707808752,0.24390243902439024,0.7170395150074559,1.0,5/10,19.21%,EMC6;EMC10;MMGT1;EMC4;EMC7
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7586983588056952,1.2510711163444685,0.17647058823529413,0.9209887633169164,1.0,2/5,17.77%,RAB31;APPL2
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.41990140252519803,-1.2509537905700052,0.043478260869565216,0.7189082628440902,1.0,24/224,9.19%,SOX4;CDKN2C;BTG1;NOX4;GSTP1;SIRT2;PODN;FABP7;SMYD2;IGFBP7;BTG3;TMEM115;TNS2;PTPN14;SFRP1;APOD;PDCD5;LYN;SPEG;NGF;FUZ;ATRAID;WNT5A;ZBTB49
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.44127124832514286,1.2506233875670554,0.05084745762711865,0.9216270683093348,1.0,39/163,19.49%,BCL2L11;SEPTIN9;NEDD9;RAPGEF5;TLK1;RACGAP1;TBCD;BCR;KIF3C;TIAM1;SSH2;KLC1;DOCK4;VCL;RANBP9;TUBA4A;TSC1;MID1;TUBD1;SOS1;CDC42EP4;PCNT;ANLN;KIF1B;RASAL2;CSNK1D;CDC27;ARHGEF7;ITSN1;CEP131;RFC1;FARP1;PDLIM5;DST;AKAP13;PKD2;ABL1;PREX1;RABGAP1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5419527641665337,1.2503968413621647,0.0967741935483871,0.9208747885089626,1.0,10/42,18.85%,KCNJ13;KCNJ11;SLC24A2;SLC39A14;SLC12A1;SLC8A1;SLC8A2;SLC6A1;SLC9A9;SLC12A5
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.730704018880541,-1.2502194272727838,0.23529411764705882,0.7203544781783058,1.0,2/5,14.33%,PRNP;RC3H1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.661471056432303,1.249454839397189,0.21052631578947367,0.9239833145854254,1.0,3/13,10.88%,SCEL;BRCA1;RAI2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.7633276623573279,1.249294450052612,0.21568627450980393,0.9228738744897703,1.0,2/7,11.91%,TMSB4X;TAF1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.43894367940992374,-1.2488014237272111,0.10526315789473684,0.7244898367432286,1.0,34/217,9.25%,PPIF;UBB;PTMA;GSTP1;TAF9B;PRDX5;ASCL1;PPT1;RPL10;GPX4;CFL1;RPS27A;UBC;TMBIM6;BAG3;MT3;MALT1;HAX1;NOL3;ZNF830;API5;SFRP1;OPN3;DNAJA1;UBA52;ANXA5;PA2G4;PHB2;NGF;WNT5A;IFI6;PSMD10;FIGNL1;RPS3A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.6260849503272802,1.248186284206602,0.19230769230769232,0.9268705130120753,1.0,2/21,5.22%,PON1;RXRA
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7099135660719424,1.2481356354505233,0.20967741935483872,0.925228986153199,1.0,2/10,4.14%,AKT2;SORBS1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.5434938410630957,-1.2480505282023149,0.2222222222222222,0.7260848575808302,1.0,10/44,12.54%,UBB;GPX1;GABARAPL2;ALAD;PSMC3;HSP90AB1;UFL1;PSME3;RAD23A;UBQLN4
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5548417250497338,1.2478413227422427,0.17391304347826086,0.9248496513400002,1.0,12/45,9.52%,CDH9;CLDN12;CDH7;TLN2;TBCD;CNTNAP1;PKP2;CDH8;CDH12;PRKCA;VCL;PAK2
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.8363356656197823,1.2478216377999287,0.19298245614035087,0.922965220441403,1.0,3/5,15.75%,SNCA;PRKAA1;FGF1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.7833932790923714,1.2475096361371156,0.25,0.9228657742814302,1.0,1/6,3.68%,PAK1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.7120285889932424,1.2472323870670496,0.18518518518518517,0.9224745015090651,1.0,7/11,24.22%,TGFBR3;PRKCSH;PROX1;PKD2;COBL;NIPBL;NF1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.6338865909999493,-1.2464825511508395,0.20408163265306123,0.7305401075984937,1.0,10/19,18.95%,HSPA8;ST13;HSPA13;HSPA14;DNAJB12;HSPA9;HSPA5;SDF2;DNAJC18;HSPA1A
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.8106696925073955,1.246364062851621,0.19230769230769232,0.9206525475921169,1.0,4/5,15.72%,RYR2;RYR3;SLC8A1;GSTM2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.8106696925073955,1.246364062851621,0.19230769230769232,0.9206525475921169,1.0,4/5,15.72%,RYR2;RYR3;SLC8A1;GSTM2
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.8106696925073955,1.246364062851621,0.19230769230769232,0.9206525475921169,1.0,4/5,15.72%,RYR2;RYR3;SLC8A1;GSTM2
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6369107324194972,-1.2463434127662234,0.2,0.728521973350326,1.0,4/17,12.71%,CENPX;SMARCA5;CENPQ;NPM1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6369107324194972,-1.2463434127662234,0.2,0.728521973350326,1.0,4/17,12.71%,CENPX;SMARCA5;CENPQ;NPM1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.5931045495411489,1.2458881637729144,0.18,0.9215056461811156,1.0,8/28,13.63%,PTPRC;SPI1;BCL11A;PRKCA;DOCK8;TRAF3IP3;ETV6;AOAH
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.6783573588019016,1.2458720707184474,0.17543859649122806,0.9196564711917914,1.0,5/16,13.63%,MYLK;SPI1;DOCK8;SERPINB1;AOAH
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.6659700488985331,1.245462939403069,0.24,0.9199502451587616,1.0,3/13,9.13%,RELN;AKAP5;SHANK3
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5025938304180573,1.24534271107689,0.11290322580645161,0.9185153010986503,1.0,32/86,22.04%,LIFR;ADAMTS9;CHST3;EDNRA;ADGRL2;TENM3;SLIT3;TYRO3;PDE10A;TPM1;PRKAA2;AKAP12;PTPRG;APBB2;GJA1;NOVA2;TACC2;ANK2;ALDH7A1;ITSN1;FIGN;ZNF532;TJP1;FARP1;MPDZ;DZIP1;RNF150;ZBTB8A;LIMCH1;MYH10;DIXDC1;PAPPA
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7159539586725925,1.2453284501190263,0.19047619047619047,0.9166459079129725,1.0,2/9,4.14%,AKT2;SORBS1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7523252521350177,1.245023230335049,0.19642857142857142,0.9166001501945592,1.0,3/6,22.39%,RNF213;MAPK1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.7121000924057134,1.245021666334227,0.16071428571428573,0.9108232584916524,1.0,4/10,10.34%,CAMK1D;DAPK2;RIPOR2;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.7121000924057134,1.245021666334227,0.16071428571428573,0.9108232584916524,1.0,4/10,10.34%,CAMK1D;DAPK2;RIPOR2;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.7121000924057134,1.245021666334227,0.16071428571428573,0.9108232584916524,1.0,4/10,10.34%,CAMK1D;DAPK2;RIPOR2;TIRAP
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.46944188941695336,-1.2450063999618095,0.06666666666666667,0.7321628156225867,1.0,15/85,12.26%,TSR1;TBRG4;HDGF;EIF3D;PRPF8;CEP85;NOP14;LSG1;RCC2;RFWD3;NOL6;YBX1;GANAB;ITGA4;SNRNP200
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.417735878466245,-1.2449353619715964,0.09375,0.7311722861375137,1.0,32/221,9.38%,SOX4;UBB;BTG1;JUN;SIRT2;UTP11;NCSTN;RPS27A;ATF4;FGD3;BAD;UBC;TRIM35;PLEKHG5;SAP18;PNMA1;ARL6IP5;APH1A;IFIT2;SFRP1;PDCD5;DNAJA1;UBA52;MCF2;PHLDA1;SMPD1;NGF;STPG1;CLU;SPHK2;AIFM1;GRN
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.6886980878354723,-1.2447876418535406,0.23636363636363636,0.730506709608279,1.0,1/10,0.80%,BICD2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.808779222315267,1.2447788851976342,0.15384615384615385,0.9100698893779289,1.0,2/5,6.29%,CCDC39;ODAD4
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.766906216394996,1.2446717846012507,0.28846153846153844,0.9088846726969245,1.0,2/6,10.76%,XRCC4;LIG3
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.6909080112497988,-1.244292115049215,0.2826086956521739,0.731396110734093,1.0,3/12,8.03%,THNSL2;SEPHS2;SARS1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.7903956536989749,-1.244252803391986,0.21568627450980393,0.7303937039160265,1.0,2/7,5.91%,FGFBP3;PDE3A
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.7009088215111967,1.2441336387595,0.22580645161290322,0.910648678175111,1.0,3/9,26.42%,NLRC4;ENO1;LPCAT3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.612869000309525,-1.2440264886653372,0.18,0.7297859094807588,1.0,4/18,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.5453433464538379,1.2440036131664693,0.18,0.9094106914034209,1.0,11/45,17.17%,VSIR;FOXO1;NEDD4L;ATG7;HACE1;STX5;WWP1;PLK2;WWP2;BARD1;HECW2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.7768585004181521,-1.2439034843156844,0.18181818181818182,0.7291622774116938,1.0,4/6,16.87%,SAPCD2;EPB41;NUMA1;GNAI1
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.767660733681581,-1.2436255131256126,0.24,0.72788550856712,1.0,2/7,5.24%,LIN7B;LIN7C
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.767660733681581,-1.2436255131256126,0.24,0.72788550856712,1.0,2/7,5.24%,LIN7B;LIN7C
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5388860498336325,1.2434120877993258,0.1694915254237288,0.9104708509020727,1.0,10/25,19.17%,SOX9;GADD45A;HABP4;TMEM150C;PIEZO1;PIEZO2;CASP8AP2;IRF1;MAP2K4;MAP3K14
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.6627320758190324,-1.2433898863579087,0.2222222222222222,0.7274269451404699,1.0,4/11,9.48%,LRRC8D;SLC25A4;SLC25A24;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.6588008047305458,-1.2432818822081457,0.20930232558139536,0.726740347637436,1.0,2/11,4.80%,PPIF;PARP1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.7118515760692671,1.2432426055423202,0.18518518518518517,0.9095947354140866,1.0,3/10,18.63%,VAPB;MOSPD3;STX18
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.7705519861357986,1.2432180492045843,0.18461538461538463,0.9078425372156159,1.0,4/7,19.43%,PMS2;MSH6;POLQ;SAMHD1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.8616316053917579,-1.242935789156755,0.07317073170731707,0.7268666329042981,1.0,1/5,2.65%,SYAP1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.45489777998409486,-1.242345574660998,0.05405405405405406,0.7278899564052224,1.0,8/85,5.85%,SOX4;PIWIL2;PCIF1;BRPF3;EEF2;FXR2;NPM2;EIF3D
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.525288419575824,1.2421428043616003,0.10344827586206896,0.9116451157066232,1.0,17/58,19.54%,GRIN2A;BAIAP3;SYT1;CACNG2;SLC24A2;RELN;AKAP5;SHANK3;CACNG8;DLG4;PLK2;SLC8A2;GRIN2B;PRKCZ;STX1B;CACNG5;ADCY1
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.7904848470801044,-1.2421031269809786,0.21428571428571427,0.72736398429939,1.0,4/6,20.68%,GUSB;GBA3;ABHD10;FUCA1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.5359085659754295,-1.2419408869223405,0.11428571428571428,0.7267694916943791,1.0,15/57,14.03%,IPO13;RAN;SNRPB;SNRPD2;PTTG1IP;PRICKLE1;PHB2;SNRPG;PPP1R10;SNRPD1;NUP155;RANBP6;FAM53C;SNRPE;RANBP17
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.5080334048961123,-1.2418010878137744,0.13333333333333333,0.7260892855053472,1.0,5/41,9.03%,CCND1;STOX1;PHB2;RCC2;ANAPC11
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.5671598750294123,1.2412933274158906,0.1724137931034483,0.9140712890417466,1.0,9/39,14.35%,ARFGEF2;GRK4;DNM1;RAB31;ARRB2;SNX25;SNCA;AP2M1;LMTK2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7463026435940592,-1.2412897026727165,0.27450980392156865,0.7266352882369804,1.0,6/8,18.26%,ERN1;FICD;RACK1;HSPA5;COPS5;BAX
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.7951799510716365,-1.2411525079342611,0.22448979591836735,0.7258875712576818,1.0,5/7,15.80%,COPRS;PRMT5;PRMT6;PRMT1;PRDM4
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.4607229454954948,1.2411264289621877,0.08064516129032258,0.9128973487677058,1.0,44/235,17.10%,FHDC1;ABLIM1;INTU;FAM161A;RPGR;NPHP4;SEPTIN6;RAB17;KIF3C;CEP135;DYNC2LI1;CCDC39;RAB8B;IFT172;RABL2B;CCDC57;WDR19;CFAP221;MAK;HAUS2;RAB1A;CCP110;BBS7;INPP5E;TUBA4A;TTBK2;IFT27;HAUS6;DNAH5;HAUS5;PCNT;ASAP1;BBS10;RILPL1;TMEM138;KIAA0586;CEP41;IFT52;CSNK1D;BBS4;ACTR1A;TNPO1;CEP131;EHD1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.6450632764557769,1.2407417147286668,0.13725490196078433,0.9132504374227243,1.0,6/20,17.71%,FGF9;CCDC39;PROX1;LOXL3;FGF1;PDPN
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.5686804339758305,-1.2406076511420452,0.125,0.7268854359480995,1.0,4/39,3.92%,SOX4;BAD;NLGN2;PPIA
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.7152022149271394,1.2402982455190843,0.22641509433962265,0.9137502827531679,1.0,2/12,17.73%,AGMO;PLAAT3
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.5897991849708601,-1.2402302865717205,0.22916666666666666,0.7269054942192696,1.0,8/24,11.61%,LDLR;SOAT1;LIMA1;CLU;CAV1;LCAT;STARD3;SCARB1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.4763285628749687,1.24017439005949,0.1111111111111111,0.91280605204863,1.0,33/110,19.77%,OLFM3;SHISA6;STMN2;SULT4A1;MMD2;ATP2B3;KCNC2;GFAP;GRM3;KCNIP1;PSD2;NRGN;GABRB1;SNAP25;GABRG2;ADGRB3;AQP4;PDE10A;ATXN1;LSAMP;SCN2A;CLVS2;ACTL6B;SLC8A2;ASTN1;LRRTM1;ARHGDIG;GAD2;SLC6A1;SNCB;PLP1;SPOCK1;GABRA1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.7018400209858844,1.24016578825801,0.13793103448275862,0.910998532122192,1.0,4/12,12.68%,LRIF1;RBM15;BRCA1;CDYL
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.6136089189718293,-1.239924911489907,0.20408163265306123,0.7268559762738054,1.0,4/20,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.8041964165851332,-1.2398797589474302,0.1794871794871795,0.7259737346714523,1.0,2/5,15.12%,LYN;TGFBR2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.528726708156405,1.2398449200850947,0.16666666666666666,0.9108370677014761,1.0,8/42,14.49%,FAM117A;WRN;BCL11A;NMI;MPP1;RAB27A;VASP;PIEZO1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6355414349854436,-1.2395225697700514,0.25,0.7262203312607368,1.0,3/15,5.54%,TRMT112;BUD23;RIOK2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.4845213375047259,-1.2392295604875312,0.13953488372093023,0.7261720999152649,1.0,7/64,9.31%,SOX4;UBB;MT3;VPS35;CLU;SLC25A24;CHMP2A
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5489628951522487,1.2390782863350105,0.13793103448275862,0.9133773635357391,1.0,14/52,17.44%,FMO5;MAP3K19;TMCO5A;ALDH1L1;DDO;CCPG1;L3MBTL4;SGK1;PRKAA2;FAM20A;SLC8A1;CFLAR;CHL1;CPEB4
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6609465103378176,-1.239037125102592,0.24444444444444444,0.7256576895192232,1.0,4/11,7.48%,PPT1;SMPDL3A;ASAH1;SMPD1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6886155556970873,-1.2390306792201695,0.2608695652173913,0.724541293073809,1.0,3/11,17.91%,CHAMP1;BUB3;SPDL1
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.8276167313055275,-1.238722386050136,0.20833333333333334,0.7232987135558087,1.0,2/5,14.63%,VPS28;SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.8276167313055275,-1.238722386050136,0.20833333333333334,0.7232987135558087,1.0,2/5,14.63%,VPS28;SNF8
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6025126036984115,-1.2381351603359088,0.2,0.7239591151997649,1.0,3/13,5.46%,CUBN;RBP1;CBR1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.5751741871508079,1.2378751548338176,0.16417910447761194,0.9177227748171318,1.0,7/30,14.80%,EFNA5;TBCD;PLET1;GCNT2;CDKN2A;DMTN;ITGB1BP1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.45587892347879183,-1.2374608388175907,0.12195121951219512,0.7252345139161873,1.0,28/119,11.00%,MMP2;NOX4;BGN;PODN;FBLN5;THY1;CKAP4;COL8A1;PRRX1;FBLN2;FIBIN;RARRES2;IGFBP7;NT5E;COL12A1;NR2F6;THBS2;PDGFRA;CXCL12;CYBRD1;NGF;COL4A4;WIF1;LRRK1;CD44;FN1;SSC5D;ADAMTS2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.6818560229036661,1.237382547815757,0.22448979591836735,0.918573505123115,1.0,5/13,17.17%,NEDD4L;CAV3;CAMK2D;PRKCE;HECW2
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6104271193709615,1.2371871343828647,0.16071428571428573,0.9176309757556624,1.0,4/23,9.17%,SOX9;WNT7A;SLC39A14;SULF1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.6751042672067705,1.2370442144093134,0.2,0.914483995734393,1.0,2/9,5.87%,AHR;ADCY5
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.6751042672067705,1.2370442144093134,0.2,0.914483995734393,1.0,2/9,5.87%,AHR;ADCY5
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.6565122771934389,-1.2370435162077615,0.21621621621621623,0.7254792272200382,1.0,4/10,28.25%,WNT5A;HSPD1;NR1H3;KARS1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.5533532843744707,-1.2367055383845698,0.14,0.7254156266962245,1.0,5/31,4.11%,UBB;BAD;TUSC2;STOX1;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.7241471656861382,-1.2365296151471372,0.22727272727272727,0.7248745092755159,1.0,4/8,21.06%,PPP1R3F;KHK;AKT1;PPP1R3B
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.7125275882562893,1.236139606483488,0.22,0.9172768180080062,1.0,4/10,13.48%,LRIF1;RBM15;BRCA1;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.586843098503953,1.2359615937510486,0.2641509433962264,0.9164531451150486,1.0,10/30,18.90%,RAB29;BCAS3;B3GAT3;STK11;PCNT;PGAP1;CEP131;EHD1;STX18;CEP290
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.8077926582951536,1.2359463318053225,0.1956521739130435,0.9148010474121121,1.0,1/5,1.11%,SOX9
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.672255162505941,-1.2355343625601933,0.22916666666666666,0.7273161897260269,1.0,4/9,12.39%,WASHC2A;VPS35;MICALL1;TOLLIP
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.5850856769899939,-1.2353454902611092,0.20930232558139536,0.7267228026003436,1.0,4/25,9.94%,SIRT2;PARP1;TIPARP;PARP2
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.7978786833641778,1.235178392068848,0.2037037037037037,0.9169629912088836,1.0,1/5,5.61%,PLEKHM1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.7634281568288024,-1.2349952211016808,0.23255813953488372,0.7271332424235333,1.0,5/6,23.37%,TSPO;STARD3;FDX1;STARD3NL;AKR1B1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6206574274243646,1.2347542099894795,0.2,0.9173514569870647,1.0,9/21,24.40%,ATM;BRCA1;BABAM2;DONSON;TAOK1;BRSK1;NOP53;CDC14B;FZR1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.6717106000481886,-1.2347270136016948,0.2826086956521739,0.7269319579376045,1.0,3/11,11.72%,ZDHHC1;PHB2;NLRP1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.7082132369851428,-1.2344387074756027,0.18604651162790697,0.7269852650014073,1.0,3/6,20.98%,PSAT1;PSPH;PHGDH
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6182925221434149,1.2337936402201466,0.18333333333333332,0.9205421693842,1.0,6/18,21.70%,FAR2;ACSBG2;ACSL1;ELOVL2;ACSBG1;ACSL3
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6206812421673432,-1.2336764426984055,0.1875,0.7283064130465436,1.0,4/18,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.6083492126613859,1.2334282693498237,0.1896551724137931,0.9202583097730459,1.0,6/17,17.71%,FGF9;CCDC39;PROX1;LOXL3;FGF1;PDPN
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.6846793108353658,-1.233025693810677,0.20454545454545456,0.7295391755870508,1.0,3/9,14.11%,CALR;HSPA5;HSP90B1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4844625374013254,1.232963046955471,0.15254237288135594,0.9207453534923942,1.0,51/139,25.49%,TLK1;VRK1;AKT2;CAMK1D;RPS6KB2;PRKX;PNCK;PRKCA;PAK2;ATM;SGK1;TNKS;TOP1;TTBK2;TAF1;MAST4;PDPK1;CAMK1;MAPK12;RPS6KA2;PLK2;AKT3;MAPKAPK5;LMTK2;MASTL;CSNK1G1;CAMK2D;GALNT16;CSNK1D;CDC7;VRK2;PRKCE;GALNT13;SRPK2;MKNK1;PRKCZ;POGLUT2;MAPK1;CSNK1G2;BRSK1;PRKD2;EIF2AK3;ATR;MAP3K10;MAP3K12;ULK2;TBK1;CAB39;CAMKV;VRK3;RICTOR
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.6875575096576338,1.2328895147930745,0.21818181818181817,0.9192651614063004,1.0,2/12,9.72%,XRCC4;ATM
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5716956141128816,-1.2327310641116749,0.24,0.7294029072634785,1.0,9/25,18.40%,SMARCA5;TAF7;NAT14;TCEA2;TAF6;PRMT5;PRIM1;TAF13;TBP
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7933624311636436,1.2327120205433548,0.15517241379310345,0.9184505635424264,1.0,3/6,20.44%,UHRF2;UHRF1;ZNF445
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.7530098518100525,1.2326133951044507,0.15217391304347827,0.9170519007704682,1.0,2/6,10.73%,RIPK1;RFTN1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5596653170894945,-1.2320028932644094,0.28205128205128205,0.7310510847823931,1.0,8/33,12.25%,HSD17B10;TM7SF2;SQLE;SC5D;PMVK;MSMO1;DHRS11;DHCR7
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.6112436150980909,-1.2316591694670846,0.21739130434782608,0.7312322590489091,1.0,14/23,24.56%,HSPA8;ST13;HSPA13;HSPA14;DNAJB12;HSPA9;HSPA5;SDF2;DNAJC18;HSPA1A;UGGT1;BAG1;ENTPD5;DNAJB5
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6865276869925265,1.2316133331431403,0.1864406779661017,0.9205252909876389,1.0,5/10,24.47%,IGF1R;GIGYF2;EIF2AK3;PIK3R1;IRS1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.7523444097093877,1.2315942354438336,0.2459016393442623,0.9187735184329456,1.0,3/5,22.39%,RNF213;MAPK1;MAPK3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5417789361692293,1.2312585458930523,0.19642857142857142,0.9188154580327379,1.0,4/37,9.08%,CALCB;ADGRL2;ADCY5;ADGRB3
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6769293514629005,1.2310380840067547,0.2542372881355932,0.9180273506416328,1.0,1/12,1.70%,SRF
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5650739378030163,1.2309765728228979,0.16363636363636364,0.9165726543595418,1.0,7/33,13.76%,TMSB4X;SRPX2;PRKCA;RHOJ;PDPK1;HDAC7;AKT3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7323654666248478,1.2309256605376258,0.28,0.9133466793094639,1.0,3/6,18.70%,CAMTA1;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.7323654666248478,1.2309256605376258,0.28,0.9133466793094639,1.0,3/6,18.70%,CAMTA1;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.7697413377114944,1.2308612601700937,0.13043478260869565,0.9118569509965286,1.0,1/8,2.70%,WNT7A
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6367930312332307,1.2305756052405117,0.21153846153846154,0.9114746240503261,1.0,1/15,0.53%,NDST3
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.6924161493022488,1.2305403294075472,0.24390243902439024,0.9047370193368308,1.0,1/6,12.69%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.6924161493022488,1.2305403294075472,0.24390243902439024,0.9047370193368308,1.0,1/6,12.69%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.6924161493022488,1.2305403294075472,0.24390243902439024,0.9047370193368308,1.0,1/6,12.69%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.6924161493022488,1.2305403294075472,0.24390243902439024,0.9047370193368308,1.0,1/6,12.69%,ELOVL2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.5386318857542781,-1.2304270430470752,0.2,0.7345339975514303,1.0,4/22,11.72%,PANX1;MALT1;WNT5A;NLRP1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7940369862248237,1.2303023883219044,0.22,0.9042507624305477,1.0,1/5,1.68%,NUAK1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.5523358819171921,-1.230286834081663,0.1590909090909091,0.7339386912380511,1.0,3/26,3.70%,GSTP1;PANX1;MALT1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.4715967009886605,1.2302765357457905,0.1,0.9025736506249329,1.0,14/99,9.27%,HOOK1;BAIAP3;EPS15;TBC1D10B;CLTCL1;EMP2;WASHC1;WDR91;RBSN;VPS52;RAB29;RAB6B;SORT1;VTI1A
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.6838445274124201,1.229673993880073,0.16666666666666666,0.9038013982790085,1.0,2/14,2.56%,PTPRC;GPI
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.6431921763537245,-1.2296707766692336,0.17647058823529413,0.7351018175683723,1.0,3/13,8.73%,CCND1;STOX1;RCC2
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.6363270686189942,-1.2293752643532643,0.24489795918367346,0.7354262210335741,1.0,3/14,11.27%,PIH1D1;NOL11;NCL
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.49995057030697937,1.228899869885943,0.11290322580645161,0.906092100457469,1.0,16/92,8.29%,SOX9;LIFR;NUAK1;SRPX2;CHST3;EDNRA;KIAA1217;IRF2;KITLG;SRPX;ARHGEF17;TIMP3;HSPA12A;TEAD1;FKBP9;SH3PXD2B
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6389516348787215,1.2288451985866562,0.22807017543859648,0.9047132344628609,1.0,6/15,21.22%,CAMK1D;RELN;CRTC1;CRTC3;ADCY1;PRKD2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6893237020201881,1.2287110735054025,0.25925925925925924,0.9036483826249009,1.0,1/10,1.11%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.7682294125814986,1.2285939276785602,0.2222222222222222,0.9024334660888229,1.0,4/5,22.75%,PROCR;KNG1;HS3ST5;APOE
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8071148281242473,1.2285199654178751,0.20408163265306123,0.9011376945172983,1.0,3/5,17.49%,LMO3;CLOCK;PER1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6554195791542843,1.2282632834963316,0.2835820895522388,0.9007167407584943,1.0,7/19,14.80%,ROBO2;FAM107A;DUSP22;PHLDB2;BCAS3;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.801441135523326,-1.2281792586890954,0.2857142857142857,0.7382683785142072,1.0,1/6,1.21%,CD151
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.598132821466258,-1.2281781191401926,0.13636363636363635,0.7371713972682724,1.0,6/24,4.52%,SLITRK2;CLSTN2;AGRN;NLGN2;SYNDIG1;EPHB3
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6333284083372708,1.2275120179918153,0.23076923076923078,0.902238255653346,1.0,5/18,20.69%,HTR2C;BEGAIN;SLC8A2;CACNG5;NPTX2
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.781031248308046,-1.2270985319529242,0.28888888888888886,0.7399193779385503,1.0,2/5,4.10%,DBI;RABL3
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.7946825622788769,1.2269262569494237,0.2727272727272727,0.9037370572791106,1.0,1/5,2.70%,WNT7A
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.6272789628457717,-1.2267026457485162,0.21951219512195122,0.7402181157592665,1.0,1/19,0.66%,HSD17B10
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.4733768129388425,-1.2264397735970087,0.10869565217391304,0.7401180122563704,1.0,13/69,9.60%,ZDHHC1;VPS37B;SRP14;ZDHHC6;NACA;ICMT;ZDHHC4;GOLGA7;SSR2;YIF1B;ATAD1;ACBD5;GET3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.724905137616802,1.2264208993441919,0.21818181818181817,0.9044669716165785,1.0,1/9,0.37%,DPYD
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5256795872963262,-1.2263683980676048,0.1509433962264151,0.7392400222314083,1.0,5/31,6.23%,UBB;RPS27A;UBC;PARP1;UBA52
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.8252780447668215,1.2260715432687421,0.1346153846153846,0.9047878407603621,1.0,3/5,12.58%,PLEKHM1;PRKCA;SPP1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7680445428322107,1.2258178175821115,0.22,0.904279508451516,1.0,1/7,0.27%,PTPRC
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.5603335660723321,1.225687471412509,0.2222222222222222,0.9033345446149386,1.0,4/29,5.87%,AKR1C2;AHR;KLF9;ADCY5
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.5451369604600755,1.225397632445663,0.21818181818181817,0.9029318222445492,1.0,8/39,9.52%,CDH9;CDH7;TBCD;CDH8;PVR;CDH12;VCL;PAK2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.6699905506707902,1.2253329281541319,0.265625,0.9016399970645177,1.0,2/19,1.04%,JADE2;MSL3
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.726379958651976,1.2250719759953659,0.26785714285714285,0.8997571032878477,1.0,4/8,19.26%,CACNG2;CACNG8;DLG4;CACNG5
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.726379958651976,1.2250719759953659,0.26785714285714285,0.8997571032878477,1.0,4/8,19.26%,CACNG2;CACNG8;DLG4;CACNG5
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6741761597723432,-1.2246005281027539,0.1891891891891892,0.7451099428039385,1.0,4/12,13.93%,PPP1R15B;UFL1;RACK1;HSPA5
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.6464702652338393,-1.2245862358005486,0.2653061224489796,0.7441611538192056,1.0,4/12,16.45%,MT3;UFL1;PARP2;PARK7
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5893906682868809,1.2244160528163337,0.2,0.9011854255229277,1.0,1/23,0.27%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7426402042448159,1.224293897864699,0.2391304347826087,0.900123193108916,1.0,3/7,21.22%,PIK3CD;MYO1C;PRKD2
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6924850346514004,1.2242145726008835,0.23076923076923078,0.8989649789060273,1.0,2/10,5.94%,AKT2;PLIN5
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5944450198893292,-1.2241143842374083,0.21739130434782608,0.7448470736901224,1.0,4/17,3.92%,PPIF;PPWD1;PPIB;PPIA
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5901273424626815,-1.2240543274001092,0.22448979591836735,0.7439837562561481,1.0,5/25,11.61%,CALM1;S100A1;DHFR;CAV1;SCARB1
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.7020440712523504,-1.2234025089925498,0.23684210526315788,0.7450952525032163,1.0,2/8,11.68%,NOC2L;MTA2
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.4574713412794148,-1.2233880484235022,0.10526315789473684,0.7440371602910496,1.0,22/95,14.91%,VANGL1;PSMB6;PSMD8;CCDC88C;CALM1;PSMB4;PSMA7;PRICKLE1;SFRP1;PSMC3;PSMC1;WNT5A;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PFN1;PSMD3;CDC42;AP2S1;PSMD4
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.8352422424091714,1.222784506933887,0.21153846153846154,0.9026993130212804,1.0,2/5,8.47%,DPAGT1;DHDDS
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.8352422424091714,1.222784506933887,0.21153846153846154,0.9026993130212804,1.0,2/5,8.47%,DPAGT1;DHDDS
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.74744713239667,1.2227381735602891,0.1896551724137931,0.901277823457332,1.0,1/7,5.89%,ADSS2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.6163197633630846,1.2227261455086083,0.14285714285714285,0.8996632037777562,1.0,3/21,4.58%,NEDD9;FAM107A;BAIAP2
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.7121628349365514,1.2227096941180007,0.2641509433962264,0.8980874711384881,1.0,1/10,0.37%,DPYD
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6635103971188274,1.2223504628977482,0.19607843137254902,0.8980818518961655,1.0,2/14,2.42%,BCL2L11;USP13
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7101094070649017,1.2221096703494096,0.22807017543859648,0.8975009530369717,1.0,2/8,11.39%,TMSB4X;NOS1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.7241896431184135,-1.2219883007816283,0.2,0.7475870846626469,1.0,1/10,1.56%,THY1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.7712008191800236,-1.2218729634252894,0.29545454545454547,0.7469048092031646,1.0,1/5,3.39%,SLC30A10
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.7762925379278973,-1.2216722729987592,0.34,0.7465839995431666,1.0,1/5,7.85%,NUDT16L1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.7892150258596164,1.2216184765105507,0.18181818181818182,0.8982347477293078,1.0,4/6,17.35%,UNC13C;SNAP25;UNC13A;STX1B
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.5032837607343541,1.2214553564031252,0.16129032258064516,0.8973936351600603,1.0,9/63,9.45%,DOCK5;SOX9;GPI;ENPP2;FOXP1;PRKCA;SASH1;BCAS3;PROX1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.4812862359661234,-1.2214288928543633,0.15151515151515152,0.7462314916993644,1.0,14/74,12.13%,UBB;VEPH1;RPS27A;PMEPA1;UBC;BAMBI;UBA52;STUB1;HSP90AB1;GIPC1;CAV1;SPRY1;CDKN1C;SLC2A10
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5367734044740691,-1.2213571551993752,0.16666666666666666,0.7455052845712072,1.0,7/32,18.72%,PMEPA1;RPL13A;CLU;HSPA5;CDC42;PARK7;RAF1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.7674368069923612,-1.2212681489454114,0.2553191489361702,0.7446347671267745,1.0,4/5,21.80%,B4GAT1;B3GALT2;B3GALT5;B3GNT7
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.6187425861714446,1.2211704696416101,0.20754716981132076,0.8970460037952955,1.0,5/19,21.22%,ATP10A;ATP8B2;ATP8A1;ATP10B;ATP8B1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.580526066557344,1.22086404859061,0.2,0.8969607228503222,1.0,11/34,11.82%,SYT1;CACNG2;RELN;GRM3;GRIK3;TPRG1L;SHANK3;MAPK8IP2;DGKZ;CACNG8;GRM1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.7001318450419038,-1.220771926754667,0.2127659574468085,0.7450338926200674,1.0,3/10,10.06%,CFL1;KIF25;ZBED3
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7626625296257166,-1.2207224104002097,0.23404255319148937,0.744199020180603,1.0,1/6,2.53%,PPP1R3F
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.6536726265758831,-1.2205818850493766,0.2727272727272727,0.743593335090897,1.0,2/13,3.57%,RBM22;BAG3
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.7407452351322056,-1.2205795695839219,0.3125,0.7425203288353546,1.0,3/5,23.09%,GALE;GALK1;PGM2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.47670957217220483,1.219962874757161,0.11864406779661017,0.8996448897501881,1.0,22/96,16.53%,ROBO2;UNC5D;SHISA6;STMN2;SULT4A1;NTRK3;TMEM132B;KCNIP1;FMN2;SNAP25;CRMP1;NEFL;ADGRB3;LSAMP;CLVS2;ACTL6B;ASTN1;NOVA2;LRRTM1;MAGI2;ANK2;UNC13A
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.6138442913725416,-1.21995777768907,0.17647058823529413,0.7437439267522059,1.0,3/18,8.31%,SIRT2;NGF;EDF1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.6870287940639087,-1.2199256496370234,0.24,0.7427383046175794,1.0,1/8,0.09%,PPIF
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.5536781228234017,-1.2197816010461309,0.1794871794871795,0.7421059890455868,1.0,4/36,6.07%,WDR18;STOX1;PIF1;KPNA2
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.6725707342624347,-1.2194344320585961,0.21428571428571427,0.742215258664113,1.0,2/12,5.21%,RARRES2;PDGFRA
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.5462711701546952,-1.2190327444319928,0.2,0.7423884509244012,1.0,7/25,9.92%,BGN;BCAN;UGDH;B3GAT2;CHST7;XYLT2;CHST15
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.6581916058306858,1.2188436360274415,0.2711864406779661,0.9033925458663656,1.0,2/14,5.07%,GRAMD1C;ABCA2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.48969966948436694,1.2187534753197586,0.10526315789473684,0.9021764205310885,1.0,22/81,16.26%,NUAK1;EFNA5;EPHA7;PLXNA4;FUT2;PRKX;PTPRJ;PRKCA;RIPOR2;EFNA1;ATM;DUSP1;TPM1;EPHA4;CHRD;ADAM22;PLXNA1;ITGB1BP1;SEMA4D;KNG1;ARHGDIG;ADAM10
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.6716606911673724,-1.2187479312889968,0.2826086956521739,0.7421923205697473,1.0,1/9,6.28%,SMDT1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.7696758462367853,1.2186902934142443,0.2391304347826087,0.9008512436637645,1.0,2/5,21.29%,NOS1;SLC39A8
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.39487687428629614,-1.218683368646598,0.08571428571428572,0.7412921763374575,1.0,61/461,9.25%,PPIF;SOX4;UBB;JUN;PTMA;GSTP1;TAF9B;UTP11;NCSTN;PRDX5;ASCL1;PPT1;RPL10;APEX1;CALR;CFL1;RPS27A;ATF4;FGD3;BAD;UBC;TRIM35;TMBIM6;BAG3;PLEKHG5;MT3;SAP18;MALT1;PPIA;PNMA1;ARL6IP5;HAX1;APH1A;NOL3;ZNF830;API5;PAX8;IFIT2;SFRP1;IRF3;OPN3;PDCD5;DNAJA1;UBA52;MCF2;ANXA5;PA2G4;PHLDA1;PHB2;SMPD1;NGF;STPG1;CLU;SIGMAR1;WNT5A;IFI6;PSMD10;FIGNL1;SPHK2;AIFM1;RPS3A
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.7510729398707588,-1.2185353991707006,0.28,0.7407783652686274,1.0,2/5,8.50%,CCNK;PSMC3
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.5742193556614313,-1.218528605899588,0.22727272727272727,0.739755060291882,1.0,5/16,13.20%,CD320;CUBN;ABCG2;SLC2A10;SLC5A6
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.6224306846718594,-1.2183950359209332,0.21428571428571427,0.7391651739160814,1.0,3/15,8.15%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.7465190222370708,-1.2182483649357903,0.25925925925925924,0.7385132750822763,1.0,3/6,4.04%,RAN;RPS15;LTV1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8203794247749774,1.218149033993058,0.22448979591836735,0.9017626134978012,1.0,2/5,12.82%,CDKN2A;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.5603303898629871,-1.2180753001068318,0.2,0.7380858183744587,1.0,4/20,11.72%,PANX1;MALT1;WNT5A;NLRP1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.8149669062114516,1.2179400359764747,0.24,0.9007819244473098,1.0,2/5,16.86%,NTRK3;ANGPT2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8078700650188166,1.2173416161225905,0.1836734693877551,0.9018996617702756,1.0,2/5,12.64%,FOXO1;MLIP
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5382140659756396,-1.2170746216792858,0.20408163265306123,0.7402633945052716,1.0,5/23,6.89%,THY1;MT3;MCF2;RNF6;LINGO1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.763669827639606,1.2170342099293405,0.2222222222222222,0.9019839062925553,1.0,1/7,9.12%,CD59
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.5098597330619872,1.2169804069401842,0.140625,0.9005584370504931,1.0,14/58,17.35%,HDAC4;SLC4A4;PSEN1;POM121C;POM121;SLC2A6;PRXL2C;PFKFB3;NUP93;GAPDHS;PRKAA2;PRKAA1;NCOR1;PFKFB1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6093087308204117,-1.2169009651992067,0.19047619047619047,0.7396761265329924,1.0,4/16,8.91%,GORASP1;RPS7;RPL23;RPL11
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6599157983757837,1.2167707680915714,0.20689655172413793,0.8999715374280187,1.0,7/13,28.97%,PLIN5;FTO;MEST;NFKB1;FBXW7;NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6458032708319101,1.2167388054945354,0.2807017543859649,0.8985866773294574,1.0,5/18,12.57%,HEY2;NEBL;MRTFA;RORA;SGCZ
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.7128203210239128,-1.2163339639102344,0.22916666666666666,0.7404204149771918,1.0,2/8,12.42%,MUS81;ISG20
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.7795478458257228,-1.2162401231862607,0.26,0.7395658158440227,1.0,3/6,14.05%,PIH1D1;ZNHIT3;RUVBL2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.5617614620605795,1.2161105470374158,0.16981132075471697,0.9000498139572396,1.0,3/25,3.26%,PTPRC;WNT7A;LMBR1L
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.6300038409555818,1.2160385839998704,0.17543859649122806,0.898733477952376,1.0,7/19,20.07%,SRF;CCDC39;MICAL2;BBS7;BBS4;PKD2;ENG
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6392648381120705,1.216018620105519,0.16666666666666666,0.8971989494491042,1.0,5/20,16.15%,INTU;KAT2B;SMOC1;RSPO2;ZNRF3
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.75028969693765,-1.2158895074624787,0.2857142857142857,0.7396292999143387,1.0,2/7,5.90%,GSTP1;APOD
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5189704052381197,-1.2150308062765525,0.1724137931034483,0.7413479630149106,1.0,12/33,17.49%,UBB;RPS27A;UBC;PARP1;UBA52;CUL4B;GTF2H2;RFC5;POLD3;FAN1;POLD2;RFC3
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.4614248552788555,1.214762407152338,0.14035087719298245,0.9016755832601667,1.0,21/100,15.24%,ROBO2;PCSK2;UNC5D;OLFM3;STMN2;FAM13C;GNRHR;FMN2;ADGRB3;SULF1;SGIP1;PTPRN;RAB27A;FGF14;LSAMP;MAPK10;CLVS2;RSPO2;PRKG1;ASTN1;MAGI2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5470378816427793,-1.2146061577551044,0.18867924528301888,0.7415976837625423,1.0,7/21,13.10%,SFR1;LOC400499;SFRP1;WBP2;CAV1;GSTM3;AR
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.49781928748643267,1.2144912682672024,0.18333333333333332,0.9013942492683135,1.0,23/72,22.75%,ITPR1;KCNJ11;G6PC2;KCNC2;TTN;PRKCA;SYTL4;SNAP25;ITPR2;MYOM1;GOLPH3L;CLOCK;STX1A;ENSA;ABCC8;RFX3;PPID;TMED10;TGFB2;UNC13B;MYH10;GOLPH3;APOE
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6356792190281765,-1.2143625013051333,0.3018867924528302,0.7413593503009275,1.0,4/16,13.24%,MALT1;HLA-B;B2M;ZP3
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.8120911362949393,-1.2141082018354827,0.2727272727272727,0.7411059853703024,1.0,2/5,9.07%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.6036283335306978,-1.2134596847232488,0.1951219512195122,0.7418566643849213,1.0,3/20,7.71%,ATF4;MT3;CREB3
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6385761044887674,1.2134012256980502,0.18518518518518517,0.9045654131214415,1.0,4/17,9.19%,PEX5L;RNF157;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.5958122586390833,1.212414175485435,0.14814814814814814,0.9077254889890691,1.0,7/21,24.67%,STAT5B;NRCAM;SIN3A;ABL1;APOE;NIPBL;INSR
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.8246469399647874,-1.2123819426030382,0.20454545454545456,0.7431641399822928,1.0,1/6,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.8246469399647874,-1.2123819426030382,0.20454545454545456,0.7431641399822928,1.0,1/6,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.7520757942197789,1.2123369661562446,0.2786885245901639,0.9064410957411457,1.0,3/6,22.39%,RNF213;MAPK1;MAPK3
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7312687721558723,1.211677221096683,0.24528301886792453,0.9082324037347008,1.0,1/7,0.27%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.7077026499938947,1.21148765872481,0.25,0.9075333283272009,1.0,3/8,12.36%,PIP4K2C;WASHC1;PIP4K2A
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.6209221752905949,1.2112501970638527,0.22916666666666666,0.9071034984926427,1.0,7/19,20.90%,DND1;THRAP3;TENT5A;TAF15;MEIOC;NBAS;LARP1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6903315357185345,-1.210915648810919,0.20454545454545456,0.7475931558442144,1.0,2/9,6.72%,GSTP1;LYN
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.6687496792701154,-1.210613257827284,0.21621621621621623,0.7477693998446283,1.0,5/18,6.23%,UBB;RPS27A;UBC;TLR1;UBA52
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.6620650550315985,1.2104884364329276,0.22033898305084745,0.9079844385440923,1.0,2/9,10.06%,KLF9;GAS2L1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.6620650550315985,1.2104884364329276,0.22033898305084745,0.9079844385440923,1.0,2/9,10.06%,KLF9;GAS2L1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.4971058990233042,-1.2103968026540701,0.1891891891891892,0.747400265732702,1.0,11/45,17.34%,BANF1;TRIM35;PPIA;LARP7;IFITM3;SHFL;ISG20;IFIT5;ISG15;SRPK1;TRIM28
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.4448861122285777,1.209842427685432,0.1111111111111111,0.909788839760374,1.0,32/139,16.67%,AHR;BCL2L11;FOXO1;EFNA5;EGLN3;TNFRSF19;BRAT1;DAPK1;DAPK2;GADD45A;AHCYL1;HIP1;RNF152;SEPTIN4;ZBTB16;ARHGEF6;RIPK1;C19ORF12;YARS1;BCL2L13;TRAF7;SCN2A;STK11;CIT;TP63;STK3;CFLAR;FEM1B;IRF1;DAPK3;PRKCE;MAGEH1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.6073558856549738,1.2097552115264971,0.24444444444444444,0.9086254989392039,1.0,3/19,6.82%,FMO5;PON3;TG
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.4663849369869822,-1.209748071030655,0.15217391304347827,0.7489754870199579,1.0,10/57,8.17%,ZDHHC1;VPS37B;GORASP1;ZDHHC6;NACA;ICMT;ZDHHC4;GOLGA7;YIF1B;COX18
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.5252366621306903,-1.2096384525550763,0.20833333333333334,0.7482641523450417,1.0,5/25,13.65%,CALR;CANX;HLA-B;B2M;SAR1B
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.7521348871355328,-1.209594706778865,0.2553191489361702,0.7473842452988756,1.0,2/5,8.15%,CALM1;CALM3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.7095482037384817,-1.2095786947350384,0.2571428571428571,0.7463829110810501,1.0,2/9,8.91%,COPS9;RPL11
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.5861602822539828,-1.209224921500067,0.2,0.7464356787978603,1.0,5/29,11.67%,AURKAIP1;BAD;CTSC;STUB1;FURIN
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.45350341201332933,1.2090645143539545,0.12698412698412698,0.9100180223133006,1.0,20/117,15.60%,PON1;HEY2;SOX9;PCTP;SRF;PTPRR;SPRED2;SPI1;DOCK7;EFNA1;RAB11FIP5;STK11;ACOT11;PTPRG;ACVR1C;GJA1;PROCR;USF3;NOVA2;OVOL2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.480044073872637,1.2086690186771456,0.20689655172413793,0.9103339569023268,1.0,13/66,15.43%,FOXO1;TPCN1;DAPK1;PLEKHF1;DHRSX;MID2;RNF152;PRKAA2;STK11;SVIP;PLK2;BNIP3L;PRKAA1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.6548219482033614,1.2080968311259397,0.3157894736842105,0.9116102255418367,1.0,1/9,1.11%,SOX9
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.7094570771613291,1.2080057945689646,0.3,0.9104826943717499,1.0,4/9,24.75%,AGMO;GPAM;MOGAT1;GPAT4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7539415629201145,1.2075435203647393,0.21311475409836064,0.9107962144721853,1.0,2/8,0.75%,OTUD7B;TMSB4X
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7252254106641649,-1.20751169690618,0.2619047619047619,0.7514752858079178,1.0,4/10,17.91%,CHAMP1;RCC2;BUB3;SPDL1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.559283297215475,1.2072168397636975,0.17543859649122806,0.9107384080453966,1.0,8/31,16.51%,INPP4B;ITPK1;INPP5A;INPP4A;ITPKB;ITPKC;NUDT11;IMPA1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.6966895660851358,1.207104428721762,0.21428571428571427,0.9097105310272601,1.0,4/10,8.66%,ANGPTL4;LMF1;PCSK6;SORT1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.748704562987932,1.2068964931926678,0.26,0.9091781463453582,1.0,2/7,5.94%,AKT2;PLIN5
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.7873713536849642,-1.206884657093653,0.2826086956521739,0.7514278218213115,1.0,3/5,18.58%,KMT5B;BEND3;SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.7873713536849642,-1.206884657093653,0.2826086956521739,0.7514278218213115,1.0,3/5,18.58%,KMT5B;BEND3;SMYD5
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.6413266993949203,1.2068590910626353,0.23214285714285715,0.9077880379367019,1.0,11/15,31.61%,SYNGR2;SNAP25;STX1A;STX1B;SYP;SNAP47;AP3D1;SYNGR1;STX4;STX3;SNAP23
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.8169338413637433,1.2068074829712088,0.16071428571428573,0.9065252238530198,1.0,2/6,2.74%,YWHAH;HSD11B1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.8075590408925798,-1.206776623624714,0.3191489361702128,0.7507045775059652,1.0,1/5,3.66%,NLGN2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7623623194034714,-1.2065252963460702,0.2894736842105263,0.7504900290398264,1.0,2/5,16.82%,CNBP;PKM
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.5627751947037993,-1.2061025739945284,0.17073170731707318,0.7497411171335957,1.0,5/30,3.33%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.5627751947037993,-1.2061025739945284,0.17073170731707318,0.7497411171335957,1.0,5/30,3.33%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7622946973058806,1.205964108741491,0.2708333333333333,0.9085707995678801,1.0,3/5,20.07%,NFATC3;PDCD4;ENG
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.6959731211050563,-1.2053922932321113,0.3333333333333333,0.7511038511951922,1.0,1/6,0.15%,SOX4
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.49153689788992466,1.205199131006553,0.19642857142857142,0.91074690351391,1.0,22/67,23.27%,STMN2;CAMK1D;ALK;TENM3;RELN;NTRK3;CAMK2B;BMP7;ROR1;CAMK1;MAGI2;ARHGAP35;PTK7;ABL2;PLPPR5;CBFA2T2;CAPRIN2;COBL;PACSIN1;LRRC7;APOE;DAB2IP
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.7625699509345869,-1.205134021111567,0.21153846153846154,0.7508135714500231,1.0,6/7,21.97%,SEC61G;SEC61B;HSPA5;SEC62;SEC61A2;SEC61A1
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.727634185670722,1.2050367462345668,0.29411764705882354,0.9099580909259767,1.0,1/7,4.16%,KAT2B
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.43729868924507537,1.2050103793038516,0.11475409836065574,0.9085327119943718,1.0,42/131,23.40%,BAG5;RTN4IP1;STMN2;CAMK1D;RAB17;PAK1;TENM3;RELN;NTRK3;SEMA3A;CAMK2B;PSEN1;RAB29;CRMP1;SRCIN1;SHANK3;PAK2;ROR1;EPHA4;CAMK1;NCS1;SIPA1L1;MAG;MAGI2;ARHGAP35;STX1B;PTK7;GAK;PDLIM5;ABL2;SPOCK1;LPAR1;PLPPR5;CAMSAP2;BRSK1;CBFA2T2;DISC1;LRRC7;APOE;TANC2;DAB2IP;ABI2
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.7108060046292746,1.204862848196803,0.2641509433962264,0.9062120327754389,1.0,3/7,20.49%,STAT5B;JAK1;STAT3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.7108060046292746,1.204862848196803,0.2641509433962264,0.9062120327754389,1.0,3/7,20.49%,STAT5B;JAK1;STAT3
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7766711229946525,-1.204764417608686,0.29545454545454547,0.7509205952289417,1.0,5/5,22.37%,TIMP2;TIMP1;LRP1;DDRGK1;SVBP
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6702049948057122,1.2045335278712035,0.2,0.9060721115684214,1.0,1/8,1.67%,NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7781215956950543,1.2043971465905712,0.23404255319148937,0.9052977117812993,1.0,2/8,8.40%,SOX9;ZBTB16
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7088014766934039,1.2039153243489673,0.24,0.9063370020164411,1.0,4/7,23.33%,RAB29;SNCA;VAMP3;NSF
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5337505662654841,-1.2038507834504286,0.13513513513513514,0.7529462834953946,1.0,9/40,16.45%,HSD17B10;ALOX5;ACSM5;ACLY;OXSM;NDUFAB1;GAMT;ALDH1A2;PARK7
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.46557293825176865,-1.2036891393346185,0.175,0.7524113392104539,1.0,24/94,17.06%,RRAGA;GAPDH;LZTS1;ATP6V0E1;ERN1;ATP6V1G1;VPS35;ATP6V1B2;SCOC;MLST8;ATP6V0E2;LAMTOR4;CAPN1;ATP6V0D1;UCHL1;VPS26B;TBC1D25;SNX5;UBQLN2;EXOC7;PRKACA;LAMTOR5;VPS26A;ATP6V1E1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.7916000531060762,1.2034075244070135,0.1956521739130435,0.9076741755962882,1.0,1/5,2.74%,HSD11B1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5089218596922082,1.2033519605780385,0.0967741935483871,0.9064196217254119,1.0,16/65,13.09%,PTPRC;NEDD9;CRLF1;EFNA5;IL5;RELN;ENPP2;PTPRJ;SRCIN1;EFNA1;PAK2;HES1;EPHA4;PARP9;DLG4;IL6ST
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.6140348166044468,1.2032771605221473,0.2,0.9051992704566469,1.0,3/24,1.64%,AHR;SOX9;HTR2C
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.6639603723890024,1.2032383055992604,0.23728813559322035,0.9038780198462315,1.0,5/12,14.54%,USP30;RB1CC1;NBR1;ATM;MAP1LC3B
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6999243332070879,-1.2029299061525265,0.24489795918367346,0.7535637715677932,1.0,1/8,2.02%,CALM1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.6215831013074558,-1.2026488246728495,0.27906976744186046,0.7525419939397429,1.0,1/10,3.33%,BLOC1S4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.6215831013074558,-1.2026488246728495,0.27906976744186046,0.7525419939397429,1.0,1/10,3.33%,BLOC1S4
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.7330235977857367,1.2025810374551398,0.3018867924528302,0.9055396962967308,1.0,2/6,9.21%,HEY2;MRTFA
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.5665238868061807,-1.2017504597866122,0.15384615384615385,0.7547030958606136,1.0,3/21,7.85%,TRIR;EXOSC8;NUDT16L1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.7010835163584006,-1.2017039679283164,0.2727272727272727,0.7539276822176034,1.0,3/9,12.15%,PODXL2;MADCAM1;ITGA4
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.4562955327215093,-1.2016211273585808,0.15384615384615385,0.7532750463857097,1.0,12/77,6.58%,UBB;JUN;RPS27A;UBC;ZFP36L1;DUSP15;SFRP1;BAMBI;PDE3A;PDCD5;UBA52;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.6608446615248219,1.201486765557843,0.23809523809523808,0.9090039654748755,1.0,4/18,12.19%,PTPRC;GPI;SHLD2;TP53BP1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.7503751729727406,1.201420880147671,0.2916666666666667,0.9078321593371661,1.0,1/6,9.72%,ATM
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.47377429684618344,1.2010007380753573,0.14285714285714285,0.9084067681054585,1.0,28/95,17.83%,OLFM3;NKAIN2;STMN2;SULT4A1;MMD2;ATP2B3;CAMK2B;PHYHIP;PARM1;KCNC2;GFAP;KCNIP1;PSD2;SNAP25;GABRG2;ADGRB3;AQP4;CLVS2;SPTBN4;ACTL6B;HS6ST3;SLC8A2;ASTN1;ANK2;GAD2;ABCC8;SLC6A1;SNCB
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.68300129089164,1.2008919608915163,0.2962962962962963,0.9074033592254077,1.0,2/10,5.94%,AKT2;PLIN5
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5091236344848221,-1.2008505294463172,0.1956521739130435,0.7545676844643496,1.0,8/46,5.66%,MMP2;BGN;FBLN5;FIBIN;IGFBP7;COL12A1;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.5982031852645813,-1.2006027586144457,0.17142857142857143,0.7545478660457151,1.0,3/18,9.31%,VPS37B;TRIM35;CHMP2A
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.7689007956243362,-1.2005917537432718,0.20408163265306123,0.7535364077802382,1.0,3/6,13.35%,PEX11A;MFF;FIS1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.7231963127667964,-1.2005608808751198,0.3269230769230769,0.7526627073978955,1.0,4/6,25.67%,MID1IP1;ABCD2;NR1H2;NR1H3
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.6600058697688752,-1.2000913354909908,0.2391304347826087,0.7533198616305624,1.0,3/11,13.93%,ATF4;QRICH1;HSPA5
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.5257679923003012,-1.2000659617529001,0.16216216216216217,0.7523589905301078,1.0,6/28,5.84%,ZDHHC1;ZDHHC6;SELENOK;ZDHHC4;GOLGA7;PORCN
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.5384940190726121,-1.2000289734949003,0.1702127659574468,0.7514156272669833,1.0,5/46,5.58%,LSM4;LSM7;LSM1;EXOSC8;EDC3
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.7559192102758446,1.200014794082956,0.2391304347826087,0.9100105105315269,1.0,2/8,9.64%,ROBO2;BMP7
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.48055047483679864,-1.1993303501852715,0.225,0.7528628744619106,1.0,13/53,11.97%,SPCS2;GPX1;GSTP1;GSTM4;SEC11C;MMACHC;APEH;SEC11A;AEBP1;HM13;GSTM3;FURIN;ETHE1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.607920871609333,1.1992119144781437,0.20689655172413793,0.9116309689840705,1.0,2/23,2.70%,INTU;WNT7A
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.6037773259406407,1.198528664871002,0.3,0.9135420455550896,1.0,8/25,21.74%,PARN;DND1;THRAP3;TENT5A;TAF15;MEIOC;LARP1;NAF1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.6978021971861927,1.1985050237325054,0.24074074074074073,0.9121379614548168,1.0,4/6,22.39%,ATM;MAPK12;ABL1;MAPK3
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5588490804286962,-1.1982573399134886,0.18421052631578946,0.7556328857413002,1.0,3/23,9.03%,UBE2D4;CDC26;ANAPC11
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6687911570212506,-1.1977478371298196,0.28846153846153844,0.7563561617926612,1.0,4/11,8.97%,ACTG1;ACTB;FUZ;LAMA5
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5523389806007568,1.1977006989344674,0.22807017543859648,0.9142336977911345,1.0,8/32,16.51%,INPP4B;ITPK1;INPP5A;INPP4A;ITPKB;ITPKC;NUDT11;IMPA1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5344307557609494,1.1975118875561004,0.14285714285714285,0.9136575950595696,1.0,13/48,15.70%,MEIS2;NR4A3;KAT2B;SPI1;AGO1;ZBTB16;SIN3A;RBM15;CDK6;KMT2C;CBFB;KMT2A;AGO4
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.7442201003462738,-1.1972936527940148,0.2391304347826087,0.7567355960994246,1.0,4/9,13.22%,VBP1;LDLR;CLU;PFDN1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6934083229939092,1.1972331927847824,0.25,0.9120853963575006,1.0,2/10,11.77%,RPTOR;UBR1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6934083229939092,1.1972331927847824,0.25,0.9120853963575006,1.0,2/10,11.77%,RPTOR;UBR1
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.8018327193227944,1.1972125365983317,0.22,0.9106657469589612,1.0,2/5,3.41%,SLC6A15;SLC6A17
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.44822717517312927,1.1971051341208794,0.08771929824561403,0.9097919473748076,1.0,34/153,15.75%,CARD14;SOX9;IGF1R;EFNA5;AKT2;BRAT1;EPHA7;ALK;MERTK;PAK1;SLC4A4;NTRK3;PSEN1;FGF9;ZNF16;RB1CC1;EFNA1;RIPK1;TYRO3;ZNF622;ROR1;PRXL2C;PFKFB3;WDFY2;EPHA4;GAPDHS;PRKAA2;TNIK;FAM20A;LMTK2;PRKAA1;SEMA4D;ARRB1;FGF1
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.671567470578678,1.1970178576685686,0.3103448275862069,0.9073529001226294,1.0,5/13,16.44%,MREG;RAB17;RAB27A;BBS7;BBS4
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.671567470578678,1.1970178576685686,0.3103448275862069,0.9073529001226294,1.0,5/13,16.44%,MREG;RAB17;RAB27A;BBS7;BBS4
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7414585924021019,1.1968344389333538,0.25,0.9067506979203647,1.0,1/5,2.87%,ST18
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.7690691213344818,1.1966412070280528,0.3469387755102041,0.9061795009642958,1.0,2/6,10.70%,RYR2;HES1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.689758417053759,-1.1965522804570359,0.27906976744186046,0.757945431381024,1.0,1/6,5.46%,CBR1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.7550244837119773,1.1964618798151856,0.26785714285714285,0.9054650264805629,1.0,2/6,14.13%,ATP10A;ASAP1
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.8032079938462026,-1.196388073418279,0.1951219512195122,0.7574173188335546,1.0,4/5,14.79%,NEU1;NEU4;GM2A;NEU3
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5518854311898138,-1.1960172820096144,0.2826086956521739,0.757482894075996,1.0,8/19,13.06%,PGRMC1;TSPO;UROD;ALAD;ABCG2;NFE2L1;UROS;SUCLA2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6824573556597611,1.1957901294188036,0.24074074074074073,0.9068680706446042,1.0,3/10,10.75%,IHO1;RAD18;SMC5
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7407868211872823,-1.195677804695526,0.28125,0.7576222351871691,1.0,1/6,0.89%,FBLN5
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.4793115542401785,-1.1954703939367595,0.18421052631578946,0.7573476968720844,1.0,9/60,12.20%,POLR2L;POLR2J;NUP42;POLR2I;POLR2G;WTIP;POLR2K;NUP155;POLR2E
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.7414874336407425,-1.1952169538942568,0.3125,0.7570886298891403,1.0,1/5,4.07%,SH3GL2
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.6237663080546259,1.1951050675130541,0.2542372881355932,0.9083678778762049,1.0,8/17,26.42%,PLA2G15;ABHD12B;ABHD12;SERINC1;MBOAT2;PLAAT3;PLA2G12A;LPCAT3
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.7277366515875971,1.1948918016104255,0.25,0.9077399810645604,1.0,3/8,16.25%,LMBR1L;DOCK8;CADM1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.7143987816874817,1.1947298863721867,0.22033898305084745,0.9069699016372486,1.0,1/8,2.03%,HDAC4
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.7464658211539227,1.1945610070213875,0.27419354838709675,0.9062166702803496,1.0,2/7,12.09%,SHTN1;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.4804224974365555,1.1945363176142039,0.16666666666666666,0.9048909258680079,1.0,5/85,3.20%,VSIR;PTPRC;OTUD7B;TMSB4X;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.6372294595375498,1.1945060895041208,0.21568627450980393,0.9037128890468911,1.0,2/18,5.22%,PON1;RXRA
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.5633597125225319,-1.194174900070831,0.23529411764705882,0.7596141158622284,1.0,5/23,12.15%,THY1;AGRN;MADCAM1;PTN;ITGA4
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7042191250400347,1.194095326539984,0.3103448275862069,0.9041145722000326,1.0,1/8,2.50%,EGLN3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.7052112608356774,-1.1938838694033018,0.41509433962264153,0.7585778977692539,1.0,4/8,20.62%,BCS1L;SLC25A33;UQCC3;UQCRFS1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.7052112608356774,-1.1938838694033018,0.41509433962264153,0.7585778977692539,1.0,4/8,20.62%,BCS1L;SLC25A33;UQCC3;UQCRFS1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5908108283312051,1.193841017938561,0.25862068965517243,0.903771151408127,1.0,2/18,6.05%,BAZ2A;FOS
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.7853203960574515,-1.1938031516387995,0.30952380952380953,0.7578930992796744,1.0,2/5,6.54%,LDLR;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.7090417427665594,1.1937383563203383,0.2727272727272727,0.902657594211626,1.0,3/7,18.06%,DND1;NCOR1;PPARG
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.7399874048715499,1.1934195628610138,0.359375,0.9026455199417394,1.0,3/6,22.49%,SLIT3;PADI2;ROBO1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.6667204683996888,1.1933535331883645,0.23076923076923078,0.9014802950734283,1.0,3/9,8.66%,SLC2A9;SLC2A6;SORT1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.5968996916773285,1.1931384771869935,0.26,0.9009726019669287,1.0,5/14,24.52%,LRP2;PROX1;DISC1;FZD9;NAP1L1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.7655639872545039,1.1928070845681016,0.2777777777777778,0.8996077414976941,1.0,3/5,20.49%,STAT5B;JAK1;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.7655639872545039,1.1928070845681016,0.2777777777777778,0.8996077414976941,1.0,3/5,20.49%,STAT5B;JAK1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6265821139100248,-1.1928061356889268,0.22916666666666666,0.7603310661779045,1.0,4/11,21.34%,TNFRSF14;PRNP;RC3H1;GPNMB
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.6680752085570709,1.1925371589425562,0.2833333333333333,0.8992468401385214,1.0,2/10,7.86%,TESPA1;RAB29
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.651699640317566,-1.1923863554221232,0.3269230769230769,0.7610066672414095,1.0,2/10,5.35%,CPA1;ALOX5
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7371761735766288,1.1922977947658169,0.3137254901960784,0.8988446895834494,1.0,2/7,12.36%,PLEKHM1;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.7636091144939487,-1.1917766831282752,0.2558139534883721,0.7617681921806032,1.0,2/7,13.93%,PPP1R15B;HSPA5
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.7672568422405517,-1.1916949686215685,0.22727272727272727,0.7611849729229557,1.0,1/5,5.40%,RPL23
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.6905022216369996,-1.191593842383387,0.34,0.7605886942410152,1.0,3/6,23.09%,GALE;GALK1;PGM2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.6337687809280996,-1.191522984964655,0.25,0.7598920631003565,1.0,2/12,3.92%,PPIB;PPIA
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.46781427272178405,1.1915140146813505,0.12962962962962962,0.9007708933907526,1.0,25/92,20.74%,PCSK2;UNC5D;BAIAP3;SHISA6;STMN2;FAM13C;SORBS1;KCNB2;KCNIP1;SNAP25;GABRG2;PROX1;SHC2;MAPK10;ACTL6B;ASTN1;LRRTM1;GAD2;ABCC8;SLC6A1;SPARCL1;LCORL;PPARGC1A;NPTX2;PTPRT
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.6418677591732241,-1.1913917775946339,0.2619047619047619,0.7595170846831849,1.0,3/12,15.14%,RPL23;SET;SMARCD1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.6964501591137531,1.1913514931397842,0.22641509433962265,0.8999733350874669,1.0,1/11,1.60%,IGF1R
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5189374923877129,-1.1913189350919202,0.2222222222222222,0.7588817248055132,1.0,4/23,5.46%,GPX1;GPX4;ALOX5;CBR1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.6825327218094875,-1.1912263086412753,0.23684210526315788,0.7582770104535189,1.0,4/10,14.62%,MRPL44;DGCR8;SMAD3;HNRNPA2B1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.6938595967376429,1.190929956958536,0.30357142857142855,0.9006264133956411,1.0,3/11,5.12%,PTPRC;WNT7A;TCOF1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6918348751902474,1.1909015149945181,0.3230769230769231,0.8993542665802474,1.0,3/9,17.88%,KIAA0319;NUP93;SMAD4
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.6004824185523733,1.190821873618388,0.21568627450980393,0.8982822907799488,1.0,1/20,0.69%,OTUD7B
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.500695565813243,-1.190254687374747,0.23076923076923078,0.7604399374011007,1.0,9/67,8.88%,CCND1;DIPK2A;CALM1;SYAP1;PDGFD;PIH1D1;CALM3;WNT5A;PSMD10
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7327343698617703,1.1899253283444375,0.2641509433962264,0.9007402409107653,1.0,2/7,4.93%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7137882789975074,-1.1897488309304376,0.28205128205128205,0.7613245033112582,1.0,3/8,9.22%,KDSR;SGPP1;SPHK2
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.7583414308039825,-1.1896401742735006,0.3023255813953488,0.7608634264882809,1.0,3/5,20.89%,RBP1;ALDH1A2;RLBP1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.4299850249097676,-1.1895441235284094,0.16279069767441862,0.7602881271006606,1.0,35/174,16.17%,SIRT2;PSMB6;UBXN1;PSMD8;PSMB4;GID8;PSMA7;TNFAIP1;KBTBD6;FBXO45;SPSB3;HECTD3;PSMC3;PSMC1;PSMD10;PSMD12;STUB1;FBXO44;RNF126;PSMB9;PSME3;DNAJB12;RAD23A;PSMD2;UCHL1;CUL4B;RNF187;ERLEC1;PSMD3;PELI1;KBTBD7;PSMD4;PSMB2;PRPF19;VCP
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.5177961357864074,-1.1894202607052853,0.2,0.7596134532248636,1.0,10/36,8.98%,SIRT2;CALM1;ACTB;S100A1;CNP;COX6B1;YWHAQ;CALM3;NDUFS3;ATP5PB
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7089927571433536,1.1889395368288749,0.32075471698113206,0.9038892351960987,1.0,4/8,17.17%,NEDD4L;CAMK2D;PRKCE;HECW2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6968612112153766,-1.188858506254388,0.2619047619047619,0.7603794249555115,1.0,4/8,10.13%,ROMO1;TIMM8B;TIMM13;TIMM22
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.5241893548440494,-1.1886630476844222,0.18181818181818182,0.7601518552586813,1.0,9/38,9.96%,SIRT2;ROMO1;MT3;DHRS4;ALOX5;CBR1;DCXR;SPHK2;SLC25A33
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.4566859176354753,1.1885289228065612,0.15873015873015872,0.9044056697451192,1.0,21/115,16.12%,PTPRC;PTPRB;PTPRR;UBASH3B;DUSP22;PTPRJ;DUSP4;SSH2;PPP2R2C;EYA4;TAB1;DUSP8;DUSP1;FBXW11;STK11;PTPRG;PTPRU;EYA1;EYA2;MTMR7;MTMR3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.7190901222522024,-1.1882138623120129,0.29545454545454547,0.7606711872274358,1.0,3/5,25.67%,GRN;HAVCR2;NR1H3
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7389239376157698,1.1880314470006488,0.2777777777777778,0.904809074549894,1.0,3/5,22.75%,PRKAA2;PRKAA1;APOE
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.5147652073906165,1.1879557842056736,0.24561403508771928,0.9037091359992914,1.0,11/42,12.10%,TMSB4X;LRRC19;SPI1;SASH1;CYLD;BMP7;NMI;CD27;TRIM44;PTP4A3;HDAC7
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7922666801975762,1.1878521784911855,0.32,0.9030430733126004,1.0,2/5,16.60%,PARN;TENT4B
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5712209915085655,-1.1876434321281968,0.2857142857142857,0.7614902035795572,1.0,6/20,9.07%,GABARAPL2;RPS7;RPL23;ALAD;RPL11;HSP90AB1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4059593128079203,-1.1873477422198908,0.10810810810810811,0.7613766121928675,1.0,53/256,15.83%,CUL7;PSMB6;ELOB;SCG3;CKAP4;PSMD8;NUCB1;PSMB4;BTBD6;IGFBP7;ASB18;ICMT;ELOC;RAB1B;CHGB;PSMA7;KBTBD6;RCN1;VWA1;CUL9;SPSB3;ASB1;STT3A;PSMC3;WSB1;PSMC1;PSMD10;PSMD12;FBXO44;COPS7B;COPS2;PSMB9;PSME3;FN1;MFGE8;CST3;PSMD2;CUL4B;DSCC1;SUMF2;COPS6;HSP90B1;KLHL9;PSMD3;TIMP1;KBTBD7;KTN1;PSMD4;RAB11B;SCG2;PSMB2;COMMD1;COPS8
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.49050659071214714,1.1872448524171895,0.19642857142857142,0.9042647874954952,1.0,5/56,4.88%,ITGA2;TNS1;MMP19;SLC39A14;FAM20C
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.622803316403337,1.1870001200448608,0.3018867924528302,0.9037798918158764,1.0,7/19,16.18%,HS3ST4;CHST9;SULF1;CHST8;CHST12;CHST11;CSGALNACT1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.7766868894476584,1.186927752122955,0.2631578947368421,0.9026744311055978,1.0,2/6,3.37%,TPCN2;EPS15
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.7447902608350904,-1.1867398408866507,0.23809523809523808,0.762206936807906,1.0,3/5,19.77%,TGFBR2;IL18;CD81
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.4498599873401396,-1.1865089078085556,0.12195121951219512,0.7621212800978256,1.0,8/77,5.55%,BGN;GSTP1;BCAN;DSEL;UGDH;CNDP2;GSTM4;CHST7
prerank,PanglaoDB_Augmented_2021__T Cells,0.5501680169003882,1.18650540711929,0.18518518518518517,0.9030353771649019,1.0,7/31,12.20%,PTPRC;CD160;CD247;RORA;TRAF3IP3;CREM;MAFF
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.4515467466141871,1.1863843715706757,0.13793103448275862,0.9020997954004277,1.0,17/101,10.83%,SYNJ2;ROBO2;GRIN2A;MDGA1;EPHA7;MEIS2;ADGRL2;SLC6A17;RELN;B3GNT5;GRIN1;ARNT2;SHANK3;PROX1;CNTNAP2;FBXW11;ATXN1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.6031466840863302,-1.1863498334093732,0.2857142857142857,0.7615224458110778,1.0,3/16,8.15%,THY1;CALM1;CALM3
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.3991946473462429,-1.1862345530402043,0.03571428571428571,0.7609963476711621,1.0,46/259,13.28%,COPZ1;IPO13;CALR;RAN;RANGRF;ARL4A;NUP42;PTTG1IP;SNX17;AP4M1;VPS28;SURF4;TMED2;BAG3;RAB1B;RABL3;SYNDIG1;CAMSAP3;ARFIP2;PRICKLE1;VPS35;ERP29;ARL1;CDC37;SCG5;PHB2;COX18;TMED9;RPL11;RAB14;RAB5B;PPP1R10;GIPC1;BCS1L;SLU7;TMED1;CLIP3;STX6;NUP155;RANBP6;VPS26B;NPM1;TBC1D25;RUNDC1;FAM53C;WLS
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.5616346793298443,1.1860681845858732,0.2545454545454545,0.9019376309996537,1.0,4/20,10.70%,MEIS2;CCDC57;PRKCA;HES1
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.7461848990040783,1.1859518584503594,0.2711864406779661,0.8997079202629221,1.0,2/7,18.85%,SLC12A1;SLC12A5
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.7461848990040783,1.1859518584503594,0.2711864406779661,0.8997079202629221,1.0,2/7,18.85%,SLC12A1;SLC12A5
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.4457609102455404,-1.1857263069916564,0.13043478260869565,0.7618940639677297,1.0,7/85,5.39%,MT1E;CDKN2C;BTG1;PPT1;MT2A;MT3;SFRP1
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7673644397642762,-1.1853562276832694,0.3125,0.7622496477004606,1.0,3/5,16.83%,SF3A2;SLU7;SF1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.49164441321628327,-1.1852890142129318,0.23809523809523808,0.7614124737440932,1.0,2/48,0.39%,CDKN2C;CCND1
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5465512620143131,1.1846793883900522,0.22807017543859648,0.9035635197594082,1.0,4/34,6.30%,JADE2;KAT2B;ING5;SPI1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.5683426215273242,-1.1846237993806987,0.2558139534883721,0.7623629425921451,1.0,2/23,0.54%,NR0B1;COL9A3
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.4771933976864086,1.1844381100785386,0.109375,0.9032223226075046,1.0,13/62,12.06%,FOXO1;TBC1D4;AKT2;SLC39A14;SORBS1;KAT2B;RAB10;RAB8B;SORT1;C2CD5;RAB31;TSC1;PDPK1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.630535573577103,-1.184053768778158,0.22448979591836735,0.7621788288693314,1.0,2/15,12.60%,SVIL;TWF1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.630535573577103,-1.184053768778158,0.22448979591836735,0.7621788288693314,1.0,2/15,12.60%,SVIL;TWF1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6061042531873088,-1.1840255085849685,0.2826086956521739,0.761275375109026,1.0,6/19,12.15%,MMP2;COL8A1;COL12A1;FN1;ITGB5;ITGA4
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.7649488781496705,-1.1833161688859968,0.3181818181818182,0.7628839126434772,1.0,2/5,7.73%,SNCAIP;COMT
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.649984115906151,1.1831710196734262,0.288135593220339,0.907279464805648,1.0,2/12,7.04%,HEY2;TTN
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.5644481649045023,-1.1831434395866884,0.24390243902439024,0.7624887889239096,1.0,5/25,5.55%,BGN;BCAN;DSEL;UGDH;CHST7
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.6402725669449529,1.1825393894115357,0.3673469387755102,0.9087745035715266,1.0,8/15,27.47%,PAK1;SASH1;MAP3K5;MAP3K10;DVL2;DAB2IP;TRAF6;TRAF2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.6764309639504997,1.1824620750262405,0.32075471698113206,0.9077190146736592,1.0,4/10,14.47%,PKP2;RYR2;GJA1;SLC8A1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.687495418269727,1.1823436709496637,0.27450980392156865,0.9068162411153516,1.0,2/11,14.47%,NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5631385146089115,-1.182220537384024,0.2558139534883721,0.7645418206322758,1.0,6/24,16.48%,CENPX;SMARCA5;CENPQ;NPM1;HIRA;H3-3A
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.7072541101272293,1.1821788277627066,0.2903225806451613,0.9048290607607222,1.0,1/7,1.00%,RFC4
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.7072541101272293,1.1821788277627066,0.2903225806451613,0.9048290607607222,1.0,1/7,1.00%,RFC4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.4829897787182079,-1.1821427263273927,0.16666666666666666,0.7638646788970649,1.0,6/37,9.64%,PPIF;BAD;RTKN2;NDUFS3;NOC2L;CAV1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.6079385931267476,1.182010678480693,0.23809523809523808,0.9041782722370736,1.0,8/26,14.80%,FAM107A;DUSP22;PHLDB2;PLET1;CDKN2A;BCAS3;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.48848926425533223,1.1819065814811842,0.16,0.9032456489755908,1.0,14/67,12.43%,TPD52L1;TNFRSF19;WNT7A;SEMA3A;GADD45A;DUSP22;SPI1;SH3RF1;SASH1;RIPK1;ZNF622;TIRAP;CD27;MID1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.7445052002637431,1.1816459526871226,0.2982456140350877,0.9032333457787667,1.0,2/5,24.88%,SHMT1;GMPS
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.716394639594038,1.181583688106523,0.34,0.9021432337253392,1.0,2/8,6.33%,NEDD4L;CAV3
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.5995521684452716,-1.1814950486604057,0.22,0.7648446489359212,1.0,4/21,3.86%,SOX4;ZNF488;MT3;HES5
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6861419905520857,1.1814941275637871,0.23214285714285715,0.9012985204110059,1.0,3/12,8.59%,KAT2B;NAA50;NAA16
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.7521363964886437,-1.1814180834346442,0.3404255319148936,0.7641127758406853,1.0,1/5,0.53%,EYS
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.6744553460217193,1.181268747637232,0.2692307692307692,0.9009667725387028,1.0,3/10,11.39%,NEDD4L;CAV3;NOS1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.5210235310121941,-1.180994393989394,0.17073170731707318,0.7645162382582111,1.0,4/32,9.17%,SMYD2;USP51;FXR2;RFWD3
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.49999090866876267,-1.180489500564608,0.21739130434782608,0.7652122005845844,1.0,11/49,14.58%,UBB;RPS27A;UBC;S100A1;TLR1;UBA52;CNPY3;IKBKB;CTSK;HSP90B1;CTSL
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5582003941806303,1.1804819350688334,0.25,0.9028759967727001,1.0,1/28,0.27%,PTPRC
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.7152654482001932,-1.180133078757613,0.3541666666666667,0.7654318210158889,1.0,2/7,13.61%,PPIA;CBLL1
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.7137080496556664,1.1800171044404517,0.2553191489361702,0.9035607802353581,1.0,1/7,0.67%,MYRF
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.4410518185221583,1.1799000284883154,0.16666666666666666,0.9027189682623669,1.0,26/105,17.18%,RAB40A;RAB3A;RAB10;PLEKHF1;MAP7;MRAP;RAB40C;PKP2;TSPAN5;KCNB2;RAB8B;EMP2;CAV3;PACS1;C2CD5;RAB40B;SPTBN4;TNIK;SEC16A;PACS2;ITGB1BP1;DPP6;ANK2;EFR3A;EHD1;DPP10
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.68508751075609,1.1798248299242957,0.24528301886792453,0.9017327528934145,1.0,5/12,16.94%,CD160;PVR;ARRB2;CADM1;KLRD1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5155689420882604,1.1797706355749273,0.2549019607843137,0.9006427749814249,1.0,9/48,11.83%,VSIR;PTPRC;ARFGEF2;PSEN1;FOXP1;PTPRJ;RIPK1;TIRAP;RARA
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5815645522537773,-1.1794662195145866,0.2619047619047619,0.7662922138424485,1.0,5/19,10.20%,LAPTM4B;LEPROTL1;TMEM50B;CHMP2A;TMEM50A
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7096307028219533,1.1790532216248333,0.3090909090909091,0.9019525868212266,1.0,2/7,15.70%,AGO1;AGO4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.5845226869848271,1.179020340539374,0.27692307692307694,0.9007192492017142,1.0,5/28,7.58%,SCEL;CRLF1;CLDN18;DDX3Y;STEAP4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.7302895253523515,-1.1785787337352895,0.3076923076923077,0.7683479667843651,1.0,3/5,16.87%,EPB41;NUMA1;GNAI1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.6869813662798272,1.1782153334148666,0.3191489361702128,0.9027021385741135,1.0,3/8,19.31%,RYR2;TPM1;KCNQ1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.7848143140337304,-1.1781077963821185,0.225,0.7686463219393501,1.0,1/5,5.35%,ALOX5
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.7180584431313948,1.1776549431628789,0.35185185185185186,0.9037115424298464,1.0,1/5,5.83%,KLF9
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.7553173772635041,1.1774520412063683,0.2909090909090909,0.9031958098512457,1.0,2/7,13.32%,SLC24A2;PLK2
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.6092164821373538,1.1767870796053128,0.2545454545454545,0.9045319655419617,1.0,4/20,13.63%,PTPRC;CD247;TRAF3IP3;AOAH
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.7261493708206914,-1.1766941960535584,0.32608695652173914,0.7722497298939662,1.0,3/6,9.40%,SAT1;SAT2;SRM
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.46085918740955,1.1759702452886112,0.18518518518518517,0.906642884767181,1.0,17/82,13.25%,DEPP1;PCSK2;STMN2;RGS4;CNTN3;FAM13C;KCNB2;KCNIP1;SNAP25;ARX;PROX1;SHC2;RAI2;FGF14;MAPK10;ACTL6B;CAMK2N1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5597397363453158,1.1756144987805295,0.24074074074074073,0.9072321258358568,1.0,5/30,10.37%,HOOK1;ARFGEF2;PLEKHF1;DNM1;RAB27A
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.6981515796370488,-1.175117022462815,0.2653061224489796,0.7760245635285921,1.0,3/8,14.05%,PIH1D1;ZNHIT3;RUVBL2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.4466362089046168,-1.1744109802964646,0.175,0.777060522726608,1.0,20/69,15.66%,VANGL1;PSMB6;PSMD8;PSMB4;PSMA7;PRICKLE1;PSMC3;PSMC1;WNT5A;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PFN1;PSMD3;CDC42;AP2S1;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.5240798584508436,-1.1741546080662513,0.23076923076923078,0.7769314951032436,1.0,9/21,18.06%,CALM1;PPIA;SMPD1;CALM3;ANKLE2;BMP2;PPP1R7;PPP2R5A;PIN1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.6209476956195139,1.1741286478047595,0.22727272727272727,0.9122543308255812,1.0,3/13,7.54%,IGF1R;CLEC16A;ETF1
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6716112603540388,1.173632437182329,0.2962962962962963,0.9118368625096807,1.0,5/12,16.44%,MREG;RAB17;RAB27A;BBS7;BBS4
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6716112603540388,1.173632437182329,0.2962962962962963,0.9118368625096807,1.0,5/12,16.44%,MREG;RAB17;RAB27A;BBS7;BBS4
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.6748781684042922,1.1734379494193947,0.3620689655172414,0.9113276882460585,1.0,3/10,15.22%,FOXP1;DMTN;ABCB10
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.5538684632791298,1.1731456241249105,0.22950819672131148,0.9110554837032632,1.0,13/44,21.80%,JADE2;MSL3;ING5;EP400;KANSL3;ACTL6B;MORF4L2;KMT2A;MCRS1;PER1;OGT;MSL2;DMAP1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.6089826061168119,1.1730055848725374,0.25,0.9103529471374203,1.0,6/15,19.13%,CAV3;TTN;PIEZO1;PIEZO2;LHFPL5;PKD2
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.5970479679798082,-1.1729749335297215,0.2826086956521739,0.7797467387251837,1.0,2/13,3.92%,PPIB;PPIA
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.7315016323985466,1.1729005048267147,0.27450980392156865,0.9094567578048551,1.0,2/8,4.93%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5259544449773874,-1.1728880804739317,0.17777777777777778,0.7791453727054656,1.0,12/32,18.63%,ZFP36L1;PTCD2;JMJD6;LARP7;C9ORF78;RBM23;SRSF10;RBM39;SF1;SRPK1;CWC22;SRSF3
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.6560867909057353,-1.1725764837334782,0.2857142857142857,0.7790280441825783,1.0,8/14,14.03%,SURF1;COX19;COX18;SMIM20;COX17;BCS1L;TIMM21;COA5
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.7559461976087922,-1.1724189538332657,0.29545454545454547,0.7785254316974533,1.0,2/5,14.33%,MALT1;RC3H1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.47390463991983695,1.1723468028491317,0.203125,0.9103868688897547,1.0,19/52,24.64%,TBC1D10B;TBC1D13;DYNC2LI1;CDKL1;CYLD;ATG5;CCP110;TBC1D22B;TBC1D8;TBC1D1;ARHGAP35;BBS4;RABGAP1;ATG3;KCTD17;IFT140;TAPT1;TESK1;TBC1D2B
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6290407713913506,-1.1717769712572434,0.22916666666666666,0.7796469704380703,1.0,2/8,6.54%,SYT11;SELENOS
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.707013333145061,-1.1717547179655572,0.36065573770491804,0.7787739408355484,1.0,2/6,13.00%,HLA-B;B2M
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.5611773479017744,-1.1714521089921606,0.25,0.7787811202295911,1.0,8/23,21.92%,CCND1;PHB2;CDC73;AKT1;HYAL1;PAF1;DDRGK1;EZH2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.7326505302316764,1.1711737627506191,0.3448275862068966,0.9136687173744206,1.0,2/6,19.31%,KCND3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6851399135911019,-1.1710862229928707,0.2826086956521739,0.77910345337001,1.0,4/9,16.00%,SPHK2;SAMD8;RACK1;SMPD3
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.6302372346079345,-1.1704965003027386,0.24390243902439024,0.7798903359009133,1.0,4/10,17.46%,PMEPA1;DDX5;AR;RNF14
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.49624837807817523,-1.1703990010385281,0.28205128205128205,0.7792536527148437,1.0,12/32,18.06%,CALM1;PPIA;TIPRL;SMPD1;CALM3;YWHAB;PPP1R16A;ANKLE2;HSP90B1;PPP1R7;PPP2R5A;PIN1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6987781606994615,1.1698068586395014,0.2962962962962963,0.9164167809644197,1.0,5/7,29.45%,NFATC3;PPP3CA;PPP3CC;ADGRB2;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6987781606994615,1.1698068586395014,0.2962962962962963,0.9164167809644197,1.0,5/7,29.45%,NFATC3;PPP3CA;PPP3CC;ADGRB2;NFAT5
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.7448298165964542,1.1688141495067816,0.2909090909090909,0.9191448571547006,1.0,1/5,6.33%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.66440295087867,1.1687920036676507,0.24528301886792453,0.9178945814603784,1.0,1/10,0.75%,TMSB4X
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.57125012909727,-1.1687519998901852,0.22727272727272727,0.7837110998802211,1.0,1/19,1.96%,RPS23
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4989474251539608,1.1686306451658532,0.22033898305084745,0.916983665358728,1.0,7/51,7.07%,CDH9;CDH7;TLN2;PKP2;CDH8;PVR;CDH12
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.628912024620109,1.1685798327876529,0.2962962962962963,0.915830315126228,1.0,2/15,8.18%,DPYD;CRMP1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.5102383806151991,1.1684561831084177,0.28,0.9151438625541175,1.0,9/55,9.42%,EFHC1;DNAH6;MAP3K19;DNAH7;NME9;GFAP;CFAP221;SAXO2;AQP4
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6088527205436105,1.1684250363357682,0.3448275862068966,0.9139578312621233,1.0,5/17,19.22%,DUSP4;DUSP8;DUSP1;PPM1F;DUSP6
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.41105710275587704,-1.1683918627307555,0.17142857142857143,0.7838758663467034,1.0,17/152,8.24%,H4C3;ISCA1;GDE1;TMEM9B;YPEL5;CROCCP2;SLC30A10;ERMAP;TCEA1;BLVRB;HDGF;UROD;LRP10;GLRX5;ALAD;MARCHF2;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.7760934461289268,1.1682743569538625,0.27419354838709675,0.9133273546935171,1.0,4/5,20.18%,JAK1;DMTN;PDPN;ANK3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5951389301750224,-1.1680412297608886,0.24561403508771928,0.7839448934650571,1.0,4/15,12.71%,CCND1;STOX1;RCC2;NPM1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.5894606695140651,-1.1676486351919373,0.3409090909090909,0.7842586128044106,1.0,4/15,10.87%,DHFR;APOD;P2RX4;FLRT3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.6349251552673393,1.1673274795684425,0.24561403508771928,0.9159814325511461,1.0,4/11,16.46%,STMN2;TBCD;SNCA;ARHGEF7
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.7023383781963355,1.1671866680062917,0.2857142857142857,0.9152090191961897,1.0,2/5,23.43%,NEK11;MAP3K12
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.5231849482477494,1.1670601617362963,0.19672131147540983,0.9145666611741282,1.0,8/44,13.77%,CALCB;PRKAR1B;ADCY5;CD247;PRKAR2A;GPR176;PLK2;ADCY3
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.586521797018916,-1.1668755213732338,0.30952380952380953,0.785916667907635,1.0,3/15,6.72%,ARL6IP5;SEMA4C;LYN
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.7613114972199171,-1.1664962821337066,0.32558139534883723,0.7846801185792333,1.0,1/7,0.69%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.7613114972199171,-1.1664962821337066,0.32558139534883723,0.7846801185792333,1.0,1/7,0.69%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.7613114972199171,-1.1664962821337066,0.32558139534883723,0.7846801185792333,1.0,1/7,0.69%,H1-4
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.5521720124194517,-1.1662732371930942,0.2926829268292683,0.784625984494797,1.0,3/18,5.03%,TRIR;NHP2;ERN1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.7056908725166948,-1.1662656553526543,0.3137254901960784,0.7837076619491327,1.0,1/5,7.47%,PHB2
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.4432364681374287,-1.1662298755502325,0.21951219512195122,0.7829129481486689,1.0,16/94,6.83%,MMP2;BGN;PODN;FBLN5;MT2A;SYAP1;FIBIN;RARRES2;IGFBP7;TSPO;TNS2;THBS2;PDGFRA;CXCL12;EPSTI1;TRIP10
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5655621868202354,1.1661049888768036,0.25,0.9170672838579365,1.0,4/25,5.76%,AKT2;SORBS1;GRB10;CLTCL1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6055944531449491,1.1660004213169752,0.36538461538461536,0.916245603466731,1.0,2/18,1.11%,AHR;SOX9
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6052053646713809,-1.1658255422838777,0.2682926829268293,0.7832114187558165,1.0,3/12,9.22%,CALM1;SGPP1;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.7657043022065864,1.1657821415850216,0.2857142857142857,0.9156681646511752,1.0,4/6,21.12%,RAC3;P2RY12;PIEZO1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.38200765803624154,-1.1651117047256672,0.16666666666666666,0.7845856803863988,1.0,54/270,15.10%,SOX4;PIWIL2;POLR2L;RBM22;GAPDH;ATF4;ACTG1;ACTB;POLR1F;PCIF1;MT3;STOX1;EEF2;RPS7;CDH3;FXR2;WNT3;ERN1;RPL23;YAP1;VPS35;EIF3D;SMARCA5;WBP2;PDCD5;ERP29;LIMS1;MED23;POLR1A;NGF;CLU;WNT5A;RPL11;DNMT3B;SPHK2;FN1;DDX5;EIF4A3;POLR2K;SLC2A10;POLR2E;NPM1;LRP3;AR;MYBBP1A;TAF1A;FLOT1;BMP2;SMAD3;PLXNB2;SNF8;DEK;CUX2;POLR1G
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.7615773923252688,-1.1650732855984138,0.3333333333333333,0.7837524518564073,1.0,1/5,0.59%,CUL7
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.6424006810825386,1.164959848095303,0.3559322033898305,0.9179786756857092,1.0,4/11,20.76%,DYNC2LI1;WDR19;DYNC2I1;IFT140
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6582750853393763,1.1646698489512204,0.29850746268656714,0.9178067362312236,1.0,4/9,19.26%,DUSP1;XRCC3;PCID2;LCMT1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.7503786200482545,-1.16459241668339,0.2972972972972973,0.7843173270149378,1.0,1/5,1.74%,PMEPA1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.7114806985154349,1.16427152740436,0.20754716981132076,0.9182819297031164,1.0,1/10,0.35%,HEY2
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.560626381080077,-1.1641973757071429,0.1509433962264151,0.7847065460542411,1.0,4/28,11.61%,NOX4;OAT;AADAT;PYCR1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.653766455739135,1.1641085495095254,0.3103448275862069,0.9175909188493865,1.0,1/11,0.75%,TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7128918287558996,1.1637445212011601,0.3114754098360656,0.9176604783223536,1.0,5/6,28.73%,CPEB3;CPEB4;CPEB2;CPEB1;UNK
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.5997608924491523,-1.1636943923440477,0.32,0.7854162439717306,1.0,7/19,18.86%,P2RX4;CLU;HSP90AB1;CAV1;SMAD3;KHSRP;AKT1
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.6354080150054197,-1.1636248022686988,0.36538461538461536,0.7848133945098519,1.0,3/10,8.71%,LRRC8D;SLC25A4;SLC25A24
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.6885333037579495,1.1634708766092792,0.2807017543859649,0.9173258019592653,1.0,1/8,0.27%,PTPRC
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.5713077697831753,1.1630991121581384,0.2857142857142857,0.9175216240425407,1.0,6/23,14.49%,CARD14;RPS6KB2;SYNGR2;TMEM79;AP1G2;PIEZO1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.49377764961439724,1.1629991707030845,0.2,0.9166088814625033,1.0,9/60,9.45%,PON1;AHR;CYP2E1;PON3;HSD11B1;ZHX2;SLBP;TMEM97;PROX1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.7803368876495567,1.1629787573385995,0.22413793103448276,0.9154094846540549,1.0,2/5,16.95%,PARN;EXOSC10
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6457660704987628,1.1628754477574972,0.328125,0.9144896548451065,1.0,3/10,11.82%,GRM3;GRIK3;GRM1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.7454511922251204,-1.1622794907563077,0.375,0.7878993736282001,1.0,3/5,23.09%,GALE;GALK1;PGM2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.5559842122798425,-1.1621868362620587,0.20930232558139536,0.787161561322631,1.0,2/26,0.54%,NR0B1;COL9A3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.4535720960590186,1.1621274013036844,0.21052631578947367,0.9158795041800126,1.0,10/54,10.14%,EFHC1;DNAH7;ALDH1L1;TMEM213;AGBL4;PDZD2;CFAP221;CCDC30;TMEM150C;RSPH3
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.498015818064923,-1.1618957373782217,0.15217391304347827,0.7875184276852428,1.0,19/58,13.63%,ACTG1;TM7SF2;SQLE;GUSB;FABP5;LDLR;SC5D;PMVK;ANXA5;IDI1;CLU;ACAT2;PNRC1;HMGCS1;TRIB3;ETHE1;DHCR7;PCYT2;CD9
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.4850623984074178,-1.1617110006777402,0.15,0.787235445768797,1.0,15/66,7.54%,MMP2;BGN;PODN;FBLN5;THY1;PRRX1;FBLN2;FIBIN;IGFBP7;TLR1;THBS2;PDGFRA;CXCL12;CYBRD1;MADCAM1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.7223627287995618,-1.1612782233631465,0.30434782608695654,0.7876578614336769,1.0,2/6,10.04%,ESRRB;CDK2AP2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.7284484454156859,1.1612690459513475,0.3103448275862069,0.9168720934918799,1.0,3/8,14.53%,SLC24A2;SLC8A1;SLC8A2
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.7284484454156859,1.1612690459513475,0.3103448275862069,0.9168720934918799,1.0,3/8,14.53%,SLC24A2;SLC8A1;SLC8A2
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.6958180541277125,1.1612027622193812,0.30357142857142855,0.9158928915331725,1.0,1/5,6.30%,SPI1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.6567313582764231,1.161173148238417,0.27450980392156865,0.9147667561283152,1.0,2/15,2.63%,GPI;G6PC2
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.7720423435083682,1.1607751495334908,0.36,0.9151006517241153,1.0,1/6,0.87%,ARFGEF2
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.653303327476197,1.1604570445390296,0.2909090909090909,0.9153092762266026,1.0,4/7,30.64%,DOCK11;DOCK10;NOTCH2;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.5543356805862742,-1.1601902094348693,0.2222222222222222,0.7903370404328076,1.0,9/25,16.45%,UBXN1;GAPDH;CSTB;TIMP4;CST3;TIMP2;TIMP1;LRP1;PARK7
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.626262731680498,1.1601455194789168,0.25862068965517243,0.9154676548960352,1.0,3/15,11.87%,SOX9;ZBTB16;TRPS1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.6976400921498251,1.1600584206158437,0.3148148148148148,0.9145591012160834,1.0,1/7,5.95%,WRN
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.7583290792135318,-1.1598455657731677,0.2,0.7904762155323332,1.0,1/7,1.16%,PPT1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.6019196585984621,-1.15979842208078,0.36585365853658536,0.7896478430392376,1.0,10/23,16.17%,RANGRF;DERL2;SURF4;SELENOS;SEC61B;TMED9;AUP1;OS9;HSP90B1;VCP
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.41217760942506687,-1.1597656038468989,0.10526315789473684,0.7888478944145951,1.0,42/277,9.64%,PPIF;UBB;PTMA;GPX1;GSTP1;TAF9B;PRDX5;ASCL1;PPT1;RPL10;CFL1;RPS27A;UBC;BEX3;TMBIM6;SLC30A10;BAG3;MT3;MALT1;HAX1;NOL3;ZNF830;API5;SFRP1;YAP1;OPN3;DNAJA1;UBA52;QARS1;ANXA5;PTPRZ1;PA2G4;PHB2;NGF;SET;WNT5A;IFI6;PSMD10;FIGNL1;RPS3A;GRN;CAV1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.423358265998927,-1.159753024897052,0.21428571428571427,0.7879837408586622,1.0,28/122,14.91%,SOX4;PSMB6;PSMD8;TMEM9;PSMB4;GID8;PSMA7;CDH3;GSKIP;SFRP1;BAMBI;PSMC3;PSMC1;PSMD10;PSMD12;CAV1;PSMB9;ZBED3;PSME3;LRRK1;SEMA5A;PSMD2;WLS;BMP2;PSMD3;CDC73;WNK2;PSMD4
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.7443749048320288,1.1595140515721623,0.32,0.9153992018481588,1.0,2/6,14.95%,DUSP22;DOCK3
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.5105356855957239,-1.159511244108708,0.225,0.7877949633130273,1.0,2/27,3.68%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5984430402342736,1.15925836249691,0.3148148148148148,0.9150744863905707,1.0,5/15,10.32%,SULT4A1;PPA2;DDO;BPNT1;TPST1
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.7679384169665091,1.1591127927667544,0.3125,0.9143430977934751,1.0,2/5,14.36%,PKP2;DSC2
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.665764071597699,1.1589279267217276,0.2857142857142857,0.9139220414082637,1.0,4/10,19.12%,CAMK2B;SHANK3;DLG4;SYP
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4318660766236873,-1.1589166426318114,0.16216216216216217,0.7885692969065098,1.0,16/86,14.09%,UBB;JUN;RPS27A;UBC;DUSP15;BAMBI;UBA52;STUB1;DDX5;FURIN;ITGB5;FNTA;BMP8B;RGMB;BMP2;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6269752955730046,-1.158913322988754,0.25,0.7876690019296436,1.0,3/15,6.12%,PPIF;BAD;PDCD5
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.6141892627345789,1.1588989940902883,0.32075471698113206,0.9127631326400683,1.0,2/17,7.35%,BCL9;TGFBR3
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.44397955594217164,1.1587155030893006,0.14754098360655737,0.9122223725599958,1.0,31/92,23.74%,SOX9;HTR2C;SLC2A12;KIAA1217;ADGRL2;SHROOM3;CMTM4;CDC42BPB;ARHGEF17;ADCY5;TEAD1;CADPS2;CEP170B;SHC2;CHRD;CDC42EP4;PTPRU;MMP15;SLC13A4;TJP1;FARP1;MPDZ;DIP2C;SLC44A3;UNC13B;COBL;SMARCA1;APOE;DAB2IP;IGFBP5;AGT
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5670723428736112,-1.1583519465431176,0.2608695652173913,0.7884942907313223,1.0,2/23,0.54%,NR0B1;COL9A3
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.7223425165853117,-1.15754018413664,0.36363636363636365,0.7901060948556249,1.0,1/5,2.31%,PPIB
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.6729722535479434,1.1574983208296183,0.2830188679245283,0.9159944823537866,1.0,1/8,1.69%,TMCO5A
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.7050077894993039,1.1570111377448553,0.29411764705882354,0.9169350548701497,1.0,4/6,29.05%,SHANK3;APOE;NLGN1;GPHN
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.5962668794840786,1.156874792051769,0.2982456140350877,0.9163540902777684,1.0,4/16,8.24%,PTPRC;DUSP22;SOCS4;SRCIN1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.687609978672457,1.156768467521078,0.3387096774193548,0.9155055647695032,1.0,4/7,29.50%,ACSL1;SLC27A4;ACSL3;RPS6KB1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6142173556821343,1.1566682435555857,0.29310344827586204,0.9147081997591775,1.0,5/10,20.49%,RORB;MYO7A;CEP290;AGTPBP1;STAT3
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.7000435375321468,-1.1566308985834297,0.3673469387755102,0.7920028842015652,1.0,4/9,22.41%,ARFIP2;CORO1B;WHAMM;ARF1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.7392162804678692,1.1564913293956367,0.3269230769230769,0.9142057943099491,1.0,1/6,0.47%,AHR
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.5121069557570477,1.156459552859125,0.2545454545454545,0.9130468142316176,1.0,10/37,22.24%,PIP4K2C;IL5;CCP110;PIP4K2A;ASAP1;ARHGAP35;BBS4;STX18;KCTD17;TAPT1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6466565523405908,1.156275902113819,0.3559322033898305,0.9125358297340197,1.0,1/9,0.32%,CARD14
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.7415892529731007,1.1562681295037998,0.2542372881355932,0.9113579075401012,1.0,4/5,25.80%,PLA2G15;GPAM;MOGAT1;PNPLA2
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.5869594087444916,1.1562138187525233,0.26229508196721313,0.9104258436437419,1.0,3/22,9.05%,KCNJ13;KCNJ11;SLC12A1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.731496994355676,-1.1560927482420846,0.3125,0.7928202083849082,1.0,2/6,18.86%,NPM1;AKT1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.4737670655172175,-1.155699847356817,0.21052631578947367,0.7931118315399402,1.0,8/46,10.51%,RBM8A;SAP18;SMU1;FXR2;PUF60;RBM15B;MAGOH;DDX5
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.6733542702510737,-1.1555159897161997,0.3409090909090909,0.7927880373918746,1.0,4/8,9.64%,CALM1;SRI;CALM3;CAV1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.47687732569789604,-1.1551490870525227,0.21951219512195122,0.7929483756596292,1.0,9/44,9.64%,HSPG2;AMOTL2;FERMT1;COL12A1;CDH3;YAP1;S100A16;LRIG3;CAV1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.6426322312825122,1.1551332288450369,0.2909090909090909,0.9138710708042761,1.0,1/9,1.11%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.7078204547945957,-1.1550377552138034,0.36538461538461536,0.792377593693216,1.0,4/7,21.06%,SLC30A10;PARK7;ABCD2;PPARA
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5488520451693866,-1.1549352077794577,0.20408163265306123,0.7918081391267247,1.0,5/23,10.15%,GPX1;CYB5R3;CXCL12;MEOX2;ADCY6
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.5876989440826684,-1.1546450955762533,0.2978723404255319,0.7916305695579495,1.0,5/20,9.97%,CIAO2B;ISCA1;ISCU;GLRX5;NUBP2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.6163408880528769,-1.1538162972944737,0.3023255813953488,0.7932219067263991,1.0,2/10,17.55%,PSMC3;PSMC4
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6026226112734702,1.1537908914567883,0.3220338983050847,0.9178516779743011,1.0,8/15,20.49%,ST18;SPI1;JAK1;IL6ST;IL6R;SMAD4;FER;STAT3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.6573740093868629,1.1533553650548922,0.3076923076923077,0.9185825574918199,1.0,1/9,1.60%,IGF1R
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.6965251887516501,-1.1532020843269375,0.35185185185185186,0.7932539342047216,1.0,1/5,5.75%,DUSP3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.6965251887516501,-1.1532020843269375,0.35185185185185186,0.7932539342047216,1.0,1/5,5.75%,DUSP3
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.6464895451731036,-1.1529988978636803,0.27906976744186046,0.7929200118655845,1.0,4/11,16.80%,GMPR2;DGUOK;POLD3;POLD2
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.7322995844289777,1.1529717766497547,0.3541666666666667,0.9187924754316135,1.0,2/6,6.09%,DNAH7;CCDC39
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.4400954064431861,-1.1525856923898288,0.21951219512195122,0.7930657729781284,1.0,17/102,5.99%,MMP2;BGN;PODN;HSPG2;THY1;PRRX1;CSTB;AMOTL2;FIBIN;COL12A1;TNS2;THBS2;PDGFRA;YAP1;CXCL12;PDE3A;SMARCA5
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.5155231144243315,1.1519742532896418,0.22580645161290322,0.9213643991308709,1.0,4/32,5.96%,GRIN2A;IGF1R;PSEN1;GRIN1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.46192084295428226,1.1517825898217111,0.1875,0.9208838960968887,1.0,12/48,11.83%,AKR1C2;ROBO2;NR4A3;ARID5A;KLF9;NCOA1;NSMF;SLIT3;STAT5B;BCAS3;GAS2L1;RARA
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7544767247595,1.1512546669860821,0.32727272727272727,0.9218112271609591,1.0,3/6,23.53%,NNMT;PPARGC1A;ARPP19
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.5456151275682533,-1.151094935525027,0.23809523809523808,0.7966372889509933,1.0,5/24,14.71%,BICD2;ARL1;RAB33B;IFT20;OPTN
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.564015482814642,1.1509874061226384,0.29545454545454547,0.9218596657871149,1.0,4/18,21.58%,SLC4A4;CA2;SLC9A9;SLC4A8
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.43952982427006815,-1.150906369431012,0.1836734693877551,0.7963522778508629,1.0,13/105,6.94%,S100A6;TUBB2B;FABP7;ASCL1;DLL3;SOX21;RND2;INAFM2;S100B;HES5;SEMA5B;LINGO1;PTPRZ1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.7581049865802599,1.1506099599719264,0.2708333333333333,0.9219439458069598,1.0,2/6,6.27%,MYRF;PARD3
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.596523110506711,-1.1505941620886513,0.2765957446808511,0.7964161927446461,1.0,5/19,9.97%,CIAO2B;ISCA1;ISCU;GLRX5;NUBP2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.6331735605099853,1.150078500152039,0.3333333333333333,0.9224830175563655,1.0,4/12,19.12%,SAE1;ATG7;UBA5;DESI2
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6505564317619179,1.1500332205731676,0.32653061224489793,0.9215019667226847,1.0,2/12,8.40%,SOX9;ZBTB16
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.49869381648443184,1.1499063020732387,0.2537313432835821,0.9207026444783533,1.0,8/43,13.77%,CALCB;PRKAR1B;ADCY5;CD247;PRKAR2A;GPR176;PLK2;ADCY3
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5444302272306012,-1.1496410901713205,0.18421052631578946,0.7983094978146853,1.0,6/18,17.25%,GPX1;NT5E;PPAT;PRPSAP1;NT5C;PRPSAP2
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.6011142981480273,1.149592593508613,0.3275862068965517,0.9196701345267209,1.0,2/16,6.05%,BAZ2A;FOS
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.6011142981480273,1.149592593508613,0.3275862068965517,0.9196701345267209,1.0,2/16,6.05%,BAZ2A;FOS
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.6498373612411676,1.1492521923968138,0.29508196721311475,0.9199112690635162,1.0,2/7,6.25%,SCEL;EMP2
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.7473414742996918,-1.1492100560253857,0.3269230769230769,0.7985640579291332,1.0,1/6,6.54%,SELENOS
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.7737585457310265,-1.149060186389439,0.35135135135135137,0.7981881630272203,1.0,1/5,5.35%,ALOX5
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.6496751085834488,-1.149013565938704,0.3673469387755102,0.7973765764560247,1.0,3/9,11.71%,CHRNA4;ACHE;COLQ
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5604811612498322,-1.1489654499981479,0.20512820512820512,0.7966566227494964,1.0,3/14,13.52%,TLR1;CAV1;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.572337159781191,-1.1489419700427739,0.2564102564102564,0.7958614520059774,1.0,3/18,6.72%,TUBB2B;RPS19;LYN
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.7302660904580569,-1.1485770672767501,0.36538461538461536,0.7959893955533813,1.0,1/5,3.66%,NLGN2
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.6691069330976289,1.1482860772430739,0.3090909090909091,0.9226227413648059,1.0,3/9,21.12%,RYR2;KCNQ1;TGFB2
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7154965428525875,1.1480371280055388,0.35714285714285715,0.9224915816939675,1.0,2/7,9.76%,NR4A3;SGIP1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.4480064949001851,1.147926743943103,0.19672131147540983,0.9217209451340714,1.0,15/76,12.06%,FOXO1;TBC1D4;AKT2;SLC39A14;NR4A3;SORBS1;KAT2B;RAB10;PRKAR1B;ADCY5;RAB8B;C2CD5;PRKAR2A;RAB31;PDPK1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.7254348754535093,1.147518962939196,0.28,0.9219581328793031,1.0,3/7,15.43%,ALK;PLIN5;PRKAA1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.5939236875294943,1.1474642536732773,0.3392857142857143,0.9209420397249967,1.0,1/12,2.50%,EGLN3
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.63759774584966,1.1474396256674337,0.2857142857142857,0.9198341825385637,1.0,1/10,3.47%,NNMT
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.5846323397570011,1.1472651500342776,0.28846153846153844,0.9193774848429137,1.0,6/19,19.43%,FOXP1;TIRAP;IRF1;APPL2;TRAF3;SAMHD1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.6809438819082059,-1.1469859154871715,0.2765957446808511,0.8001814774089416,1.0,3/8,13.93%,ATF4;QRICH1;HSPA5
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.6680209445766941,-1.1464224994515906,0.3333333333333333,0.8010063760318814,1.0,2/7,6.16%,HAX1;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.7332188356112614,1.1463737619736039,0.3125,0.9213468832989767,1.0,5/7,20.18%,PKP2;AHCYL1;NOS1;GPD1L;ANK3
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.7015429668096081,-1.145415293202778,0.40476190476190477,0.8033213987628608,1.0,1/5,1.10%,ASCL1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.7119309179424304,-1.1449337101190897,0.3958333333333333,0.8038351508202092,1.0,3/6,18.26%,ARL6IP5;PRELID1;BAX
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6967041662552885,1.1446510111763246,0.3673469387755102,0.9270143265573316,1.0,1/10,1.11%,SOX9
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.49250293650059235,1.1445274386612982,0.2711864406779661,0.9262917853591428,1.0,8/37,16.82%,PCTP;ATP10A;PITPNA;ATP8B2;PITPNC1;PITPNB;ATP8A1;ATP10B
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6295702800360525,1.1444895806722188,0.32,0.925231076366947,1.0,1/10,0.84%,BCL2L11
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.6527519125322093,1.1443953916848273,0.3387096774193548,0.9232465393359379,1.0,2/9,13.02%,PUDP;UCK1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.6527519125322093,1.1443953916848273,0.3387096774193548,0.9232465393359379,1.0,2/9,13.02%,PUDP;UCK1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7884367649482078,1.144301715740263,0.3157894736842105,0.9212139197259619,1.0,2/5,10.48%,SHANK3;CNTNAP2
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7884367649482078,1.144301715740263,0.3157894736842105,0.9212139197259619,1.0,2/5,10.48%,SHANK3;CNTNAP2
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.4428316328266442,-1.1442058283163064,0.2647058823529412,0.804894834018469,1.0,16/96,5.66%,SSPN;MMP2;NOX4;BGN;PODN;FBLN5;THY1;PRRX1;FBLN2;FIBIN;PDGFD;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.5901729681121202,-1.144174088673718,0.3170731707317073,0.8040585074660446,1.0,3/15,6.64%,S100B;H2AZ1;ASPM
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5381688542913383,1.1439919455145648,0.3157894736842105,0.9214131428891978,1.0,11/27,24.65%,PIP4K2C;SOCS4;ITPKB;PIP4K2A;PIK3CD;ITPKC;EFR3A;PI4K2B;PIK3CA;PIK3R1;PIP4K2B
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.5994720609265312,1.1439681148231546,0.2962962962962963,0.9203785385633957,1.0,8/22,19.86%,MMP21;CCDC39;ODAD4;BBS7;DNAH5;DNAH11;PKD2;RFX3
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5050118885079373,-1.1437824302478365,0.28205128205128205,0.8044935130005669,1.0,4/17,14.65%,BLOC1S4;TRAPPC6A;AP1M1;ASIP
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.6855146448563717,-1.1437201412001954,0.3673469387755102,0.8037482926978027,1.0,1/7,3.23%,NOMO3
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.6399179343259473,1.1433805668802104,0.3275862068965517,0.9213220090456236,1.0,9/15,24.60%,TTN;RYR2;TPM1;SLC8A1;CAMK2D;KCNQ1;DMD;PIK3CA;ATP1B1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.5776265006295735,1.1431569665377488,0.29310344827586204,0.9210909348464685,1.0,3/18,2.63%,FOXO1;PCSK2;G6PC2
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.5725480143948802,1.1431279065115263,0.2641509433962264,0.919956410208792,1.0,10/26,26.86%,SRF;CAMK1;MAPK12;PTBP1;ABL1;CTNNA1;RBM4;MAPK11;HDAC9;CDK9
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.5363428654742275,-1.1430033017581358,0.3125,0.8048412815827511,1.0,2/27,0.35%,S100A10;BTC
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.4406437320267425,-1.1427943243197851,0.23076923076923078,0.8045907553749015,1.0,25/72,18.58%,GPX1;POLR2L;ACTB;POLR1F;PHF1;SMARCA5;WBP2;POLR1A;CREBZF;DNMT3B;SPHK2;POLR2K;POLR2E;MYBBP1A;TAF1A;PPHLN1;TDG;DEK;POLR1G;H3-3A;ZNF335;BMI1;MORC2;TBP;SMYD5
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.6559398579458859,1.1423477945378793,0.35294117647058826,0.9214176925198528,1.0,4/12,17.77%,SOX9;BRCA1;NCOR1;APPL2
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.6651450445821434,-1.1416394393553815,0.391304347826087,0.8068808575182927,1.0,3/9,16.17%,COX7A2;SLC25A33;VCP
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6057569734833521,1.1415096382512977,0.2916666666666667,0.9241237878830411,1.0,5/13,18.06%,FABP3;PRKAA2;ADIPOR2;NCOR1;PPARG
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6101649184027544,-1.1413146918065733,0.30434782608695654,0.8070830231631018,1.0,4/12,6.03%,SFR1;LOC400499;SFRP1;WBP2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.5637238243792789,-1.140516999167475,0.35555555555555557,0.8090247348243943,1.0,3/23,6.16%,GSTP1;DUSP3;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5770551477638892,-1.1405032686423922,0.30434782608695654,0.8081409073376178,1.0,3/15,9.64%,G0S2;SFRP1;CAV1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4969175562081396,1.1404306957355062,0.2,0.9271116182952592,1.0,5/48,5.97%,ITGA2;NEDD9;ADAMTS13;ITGBL1;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.642593337509833,-1.1402951817384936,0.3333333333333333,0.8078880837170682,1.0,3/11,13.63%,RANGRF;HSP90AB1;TMEM35A
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6285220884385402,1.1402841123105047,0.328125,0.9264941048010936,1.0,2/15,4.53%,GULP1;SPIRE1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.7141450400038678,-1.140057113896277,0.37777777777777777,0.8077991888101936,1.0,3/5,18.26%,ARL6IP5;PRELID1;BAX
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.5448332377561744,-1.1399580515129062,0.2653061224489796,0.8071832995991228,1.0,4/21,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.7402805880504917,1.1396841450974005,0.3548387096774194,0.9277898986974064,1.0,3/5,22.49%,SLIT3;PADI2;ROBO1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.6118512604084052,1.1392955421066187,0.32727272727272727,0.9283232753852436,1.0,2/13,7.35%,HEY2;TGFBR3
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.7403617306939381,-1.139277793263271,0.3877551020408163,0.8076589377173345,1.0,2/5,21.16%,CDC73;PAF1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.7403617306939381,-1.139277793263271,0.3877551020408163,0.8076589377173345,1.0,2/5,21.16%,CDC73;PAF1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6851578478710953,1.139046498417631,0.3488372093023256,0.9280741667488446,1.0,3/7,24.46%,KDM7A;KDM2B;KDM4C
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5707092559403321,1.138711603017952,0.28846153846153844,0.9282501775334684,1.0,5/24,6.68%,EPHA7;SEMA3A;SEMA4B;SLIT3;UNC5C
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.6282340654725356,-1.1383034831971652,0.4222222222222222,0.8099851632729473,1.0,3/11,7.83%,NCSTN;APH1A;APEH
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.5961621240169508,1.1382111531785375,0.3392857142857143,0.9292621823891346,1.0,1/13,1.00%,RFC4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.6943840341972226,1.138079830768328,0.3157894736842105,0.9286924109637409,1.0,1/5,5.58%,FOXP1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.6050968203495617,1.1373407979080818,0.36,0.9302613245371415,1.0,4/17,16.83%,ATM;RNF138;BRCA1;BARD1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5124713044064245,1.137297137963468,0.30612244897959184,0.9292123136766293,1.0,4/29,8.88%,RAB3A;RAB10;RAB8B;TANGO2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6558633031557147,1.137265669183527,0.2641509433962264,0.9281773487821772,1.0,1/12,4.44%,RAB10
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.744200276229262,1.137091024926424,0.3137254901960784,0.927645971824545,1.0,1/5,1.40%,BAIAP3
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.6349623439833405,-1.1370402763766363,0.36,0.8125061421414205,1.0,3/5,22.08%,NUMA1;CSNK2A2;TPR
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.6945634202643817,-1.137023405826323,0.39622641509433965,0.8117511348891029,1.0,1/6,1.56%,THY1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.5224874470900576,1.1369011940949003,0.32727272727272727,0.9271614181013453,1.0,6/32,8.91%,SLC6A15;SLC6A11;SLC6A17;SLC13A3;SLC6A6;SLC1A4
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.7140334718530953,1.1368285170827526,0.35384615384615387,0.9263373621501382,1.0,1/7,3.55%,TESPA1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.6930259085735054,1.1367839065225689,0.37735849056603776,0.9253452279949564,1.0,2/8,12.50%,VRK1;STX5
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.43130608398437525,-1.1367275543478335,0.20454545454545456,0.8117209773483679,1.0,13/77,5.66%,MMP2;BGN;PODN;THY1;PRRX1;RBP1;FIBIN;IGFBP7;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.6145323111536947,-1.136485127135261,0.2909090909090909,0.8117157960150495,1.0,4/15,6.67%,NOP10;CCT5;NHP2;CCT3
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5396649032917891,1.1363622673702287,0.24489795918367346,0.925805674324724,1.0,4/24,3.14%,SYNJ2;SYT1;WNT7A;RAB3A
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.7199837216607284,-1.1358580117081534,0.3409090909090909,0.8126934471907269,1.0,3/7,14.41%,PPT1;CAV1;CDC42
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.6125231275773759,-1.1357240197262468,0.3333333333333333,0.8121279851278888,1.0,1/15,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.5393980911063359,-1.1356432043648728,0.3269230769230769,0.8115017093830375,1.0,4/28,6.58%,S100A10;THY1;SFRP1;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.5484391675573802,1.1353580110392276,0.3508771929824561,0.9288107711105538,1.0,3/22,6.41%,STMN2;TBCD;SSH2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.7512955490459292,1.1352102414531873,0.2608695652173913,0.9282147844819582,1.0,3/6,18.57%,CDKN2A;PPARG;PDCD4
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.6876663826251719,1.134831209016961,0.3392857142857143,0.9273203512288234,1.0,3/6,13.39%,WASHC1;CDC42EP3;CDC42EP4
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.6876663826251719,1.134831209016961,0.3392857142857143,0.9273203512288234,1.0,3/6,13.39%,WASHC1;CDC42EP3;CDC42EP4
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.5663999098092515,-1.1347340046030745,0.2682926829268293,0.8131335257471326,1.0,6/20,15.62%,HAX1;CXCL12;BRK1;DBNL;PFN1;ARHGAP18
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7704546232817028,1.134543708900281,0.4,0.9273701713917029,1.0,1/5,2.59%,AKT2
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.4886618752316675,-1.134530822015179,0.20454545454545456,0.8128419391485588,1.0,8/34,11.85%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;MCOLN1;ATP6V0E2;ATP6V0D1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.6107736180646833,-1.1342066143022798,0.2926829268292683,0.8130087644679482,1.0,2/15,8.88%,CCND1;PSMD10
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.6571323521374732,1.1341881191548098,0.2807017543859649,0.927611020981042,1.0,5/7,31.94%,DMTN;ARHGEF7;PRKCE;DDR2;PTK2
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.7020156179053436,-1.1340550696216098,0.3673469387755102,0.8126067321277053,1.0,2/6,3.86%,MT3;HES5
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.5240573952557424,1.1339978222935567,0.32608695652173914,0.9274694403870548,1.0,10/38,15.70%,NR4A3;KAT2B;AGO1;ZNF16;SIN3A;RBM15;KMT2C;CBFB;KMT2A;AGO4
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6457543791259757,1.1336549216469534,0.33962264150943394,0.9277768676538308,1.0,4/9,17.88%,FOXO1;CAV3;MLIP;SMAD4
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.631878669677219,-1.133582603371453,0.35185185185185186,0.8130203462932577,1.0,1/5,2.20%,RPS19
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4446732543482157,1.1335101657768532,0.21311475409836064,0.9272097368723062,1.0,23/101,17.93%,FOXO1;AKT2;TPCN1;DAPK1;SLC4A4;PLEKHF1;PSEN1;PLIN5;DHRSX;MID2;RNF152;PRXL2C;PFKFB3;GAPDHS;PRKAA2;STK11;SVIP;PLK2;SNCA;PRKAA1;CNOT7;PFKFB1;DTX3L
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.7007676159772513,1.1334971255734296,0.3469387755102041,0.9261069546700615,1.0,1/6,7.40%,TMOD3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5437027157846162,-1.1333443317919047,0.30434782608695654,0.8127671611613926,1.0,1/17,0.60%,GPX1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.6638411131023603,-1.133235664831979,0.38095238095238093,0.8121819537259595,1.0,3/9,16.45%,SLC25A4;SLC25A5;PARK7
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.6000443087876228,1.1331971279718978,0.29411764705882354,0.9258003109712744,1.0,4/12,21.32%,KAT2B;PBX1;MAML1;MAML3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.5005505976859173,1.1330547390020942,0.3333333333333333,0.925237720867561,1.0,7/36,8.94%,SYT1;NEDD4L;SHTN1;RNF157;CPNE5;MACF1;LIMK1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.6928417712163614,1.1330114490394723,0.29411764705882354,0.9241971859025975,1.0,4/9,23.34%,NNMT;PARP9;NUDT12;PARP10
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7053681709210312,-1.1329393754656258,0.3695652173913043,0.8119917657859874,1.0,3/8,17.91%,CHAMP1;BUB3;SPDL1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.6413151300338638,1.132880270808256,0.31666666666666665,0.9236824899155525,1.0,4/11,24.36%,SMC5;XRCC3;RAD54B;NSMCE2
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.6428960132661652,-1.132829267861709,0.3953488372093023,0.8114332733525715,1.0,6/10,21.12%,PDGFRA;FUZ;EIF4A3;TGFBR2;SOX11;TGFBR1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.7027701133775819,1.1327602792993907,0.3793103448275862,0.9219683086973743,1.0,1/7,2.35%,EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.7027701133775819,1.1327602792993907,0.3793103448275862,0.9219683086973743,1.0,1/7,2.35%,EEFSEC
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.46116866589531813,-1.1326315772414317,0.2558139534883721,0.8111215494852023,1.0,9/56,8.97%,TUBB2B;SALL2;RND2;IGFBPL1;SEMA5B;CXCL12;FBN3;LINGO1;DNMT3B
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.4905711046149837,1.1322795255103877,0.2631578947368421,0.9227338855227281,1.0,26/61,25.03%,CALB1;ALDH1L1;NEBL;MAP7;MACC1;TMEM213;PDZD2;RSPH3;KLHL3;ACOT11;SLC8A1;LPP;GDA;ATP10B;CPEB4;TRHDE;PPARGC1A;SLC16A7;TSC22D2;COBL;ZBTB7C;CACNA1D;ATP1B1;CYP3A5;INSR;KCNJ16
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.4403619825400319,1.1322182091604693,0.24528301886792453,0.9217803475133065,1.0,30/100,19.18%,SOX9;LIFR;NUAK1;CHST3;TNFRSF19;CMTM4;CDC42BPB;ARHGEF17;PHYHIP;GFAP;HSPA12A;TEAD1;ARNT2;SH3PXD2B;TYRO3;CEP170B;NCS1;RBFOX2;CAMK2N1;NAV2;SLC19A1;PTPRU;ZNRF3;SLC13A4;SEMA3B;TJP1;FARP1;MPDZ;DZIP1;DOCK1
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.7192692891428234,-1.1322165083212141,0.39622641509433965,0.8114727542619863,1.0,2/5,8.77%,WNT3;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.7017180791936523,-1.1320446904327122,0.35,0.8110514148150052,1.0,2/7,17.55%,PSMC3;PSMC4
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.5273653189449841,-1.1319410944252515,0.3076923076923077,0.8104841507493926,1.0,10/24,18.06%,CALM1;PPIA;SMPD1;CALM3;HSP90AB1;PPP1R15B;ANKLE2;PPP1R7;PPP2R5A;PIN1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5143527427748392,1.1318977128946568,0.29411764705882354,0.9218028986839474,1.0,10/40,13.87%,SYT1;RAB3A;RAB10;RAB8B;CADPS2;SYTL4;SEPTIN4;RAB27A;CPLX1;SNCA
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.5627938407777239,-1.131778922297436,0.28888888888888886,0.810248163886225,1.0,5/14,18.12%,SELENOS;ZBED3;EIF2B2;KHK;EIF2B1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.6267080995984363,-1.1316667381794692,0.30952380952380953,0.8096219587531579,1.0,9/17,23.11%,CLU;HSP90AB1;MKKS;HSPA4;TMEM35A;PSMG1;HSPA1A;HSPD1;HSP90AA1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.5264192413769477,1.1313692746780628,0.32142857142857145,0.9224995587652293,1.0,8/34,13.41%,CHRM3;TPCN2;INPP5A;RYR2;NOS1;PDPK1;P2RY12;ACKR4
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.6541167782561684,1.130928775494107,0.3709677419354839,0.923073095472672,1.0,5/8,21.70%,SGK1;NRG1;MYO6;KCNQ1;ACSL3
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.725136783763105,-1.1309282225454833,0.35714285714285715,0.8111560032896014,1.0,1/5,0.56%,NOX4
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.5331248525337258,-1.1307144022729465,0.3181818181818182,0.8109078718310562,1.0,9/25,11.85%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;RAB14;MCOLN1;ATP6V0E2;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.49163498565229935,-1.130482887931272,0.2619047619047619,0.8107089616603543,1.0,6/43,9.64%,SOX4;UBXN1;VPS28;DNAJA1;UFL1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5500333294510733,1.1304397680024727,0.2830188679245283,0.9240531551228933,1.0,11/22,31.39%,ADAMTS9;GADD45A;ANGPT2;PPARG;APOE;DAB2IP;FGF2;RGCC;ADGRB1;SP100;ATP2B4
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.492881879483986,-1.1303115952567175,0.2857142857142857,0.8102430198549608,1.0,6/46,7.62%,G0S2;BAD;BAG3;DELE1;HIPK1;NGF
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.7085241495029475,1.1299736844119312,0.3333333333333333,0.924590367886528,1.0,2/7,15.70%,AGO1;AGO4
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.6531070564120841,1.1295421388166993,0.3157894736842105,0.9240241527674795,1.0,8/9,33.74%,STAT5B;JAK1;STAT3;IL7;IRS1;SMARCA4;BRWD1;IRS2
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.6531070564120841,1.1295421388166993,0.3157894736842105,0.9240241527674795,1.0,8/9,33.74%,STAT5B;JAK1;STAT3;IL7;IRS1;SMARCA4;BRWD1;IRS2
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.650239916493474,-1.1294488058311585,0.3157894736842105,0.8110367779475963,1.0,3/9,23.17%,CHMP2A;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.650239916493474,-1.1294488058311585,0.3157894736842105,0.8110367779475963,1.0,3/9,23.17%,CHMP2A;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.6527198386349099,-1.1292996597974452,0.34782608695652173,0.8106447008166989,1.0,1/10,0.15%,SOX4
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.6396706768642448,-1.1292359044622202,0.3673469387755102,0.8099508480479449,1.0,2/9,7.06%,EXOSC8;DXO
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.7353854644022751,1.1292270002051468,0.3392857142857143,0.9241864174311935,1.0,4/7,20.03%,ERC1;KIF1B;ERC2;FCHSD2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.761334248067623,1.1288667660815317,0.3050847457627119,0.9245564925538182,1.0,1/5,9.75%,MAP2K5
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5057055860834712,-1.1288329285200556,0.25,0.8102258394747385,1.0,6/24,12.79%,PLEKHG5;RHOG;PDGFRA;CXCL12;SEMA5A;CORO1B
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.4997345956201724,-1.1287876419994192,0.2631578947368421,0.8094373029565295,1.0,3/30,5.27%,NR0B1;EPHB3;PAX8
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.7429533371603273,-1.1284978932647678,0.4583333333333333,0.809446807380859,1.0,1/5,11.42%,NUP155
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.5532499422187659,1.1283998578139696,0.34545454545454546,0.9251117337163393,1.0,6/18,20.96%,MRAP;AP2M1;DMTN;ITGB1BP1;PPFIA1;PICALM
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.6342826236836855,-1.1282596808583463,0.29545454545454547,0.8092272875159562,1.0,1/9,0.36%,TUBB2B
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.4635100233939765,1.1279952768283896,0.2459016393442623,0.9257421532624491,1.0,19/64,23.98%,GRIN2A;TRPC4;ATP2B3;SLC24A2;GRIN1;RYR3;NALCN;SLC8A1;SLC8A2;TMEM165;GRIN2B;PMPCB;PKD2;ATP2B1;TRPC4AP;SLC24A3;MAIP1;GRIN2D;CACNA1D
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.45674683613710865,1.1272309574407542,0.22727272727272727,0.9276812572103337,1.0,12/60,19.43%,AHR;CD160;FOXP1;PVR;CD247;TIRAP;IRF1;KLRD1;APPL2;TRAF3;BCL6;SAMHD1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.420490017068554,-1.1270805140187137,0.21621621621621623,0.8118978123674183,1.0,15/79,15.69%,UBB;VEPH1;RPS27A;PMEPA1;UBC;BAMBI;UBA52;STUB1;CAV1;SPRY1;SLC2A10;BMP2;SMAD3;TGFBR2;BMPER
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5727189648685836,1.1270297973820476,0.24528301886792453,0.9275218802825672,1.0,3/21,10.70%,PTPRC;OCIAD2;HES1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6631717695397353,1.1269009683946325,0.3137254901960784,0.9256268255891135,1.0,4/11,16.94%,CD160;PVR;CADM1;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6631717695397353,1.1269009683946325,0.3137254901960784,0.9256268255891135,1.0,4/11,16.94%,CD160;PVR;CADM1;KLRD1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6883281169983128,1.1266040880716846,0.41509433962264153,0.9244137478937199,1.0,3/6,17.35%,HDAC4;NCOR1;PFKFB1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6883281169983128,1.1266040880716846,0.41509433962264153,0.9244137478937199,1.0,3/6,17.35%,HDAC4;NCOR1;PFKFB1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.48888911407044017,1.1265160178292664,0.28846153846153844,0.9235763342081363,1.0,7/50,9.72%,HEY2;SOX9;KIAA0319;SPI1;SUZ12;BCL11A;CDK6
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.7181015734862063,1.1259730456771493,0.34,0.9245923196228302,1.0,3/8,15.82%,PRKCA;RIPK1;CSF1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.374401091150027,-1.125779017460572,0.11904761904761904,0.8150436852684133,1.0,40/218,16.67%,UBB;TAF9B;PSMB6;MBD6;PSMD8;RPS27A;PSMB4;ACTB;UBC;USP51;PSMA7;UBA52;ADRM1;JOSD2;PSMC3;PSMC1;PSMD10;PSMD12;YOD1;COPS7B;COPS2;PSMB9;PSME3;RAD23A;PSMD2;UCHL1;AR;COPS6;OTUB1;SMAD3;PSMD3;ACTL6A;PSMD4;CFTR;ACTR8;PSMB2;COPS8;VCP;OTUD5;GPS1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.7200129284465973,1.1257132136897163,0.34615384615384615,0.924513669467354,1.0,2/5,22.92%,MTMR3;MTMR9
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.693856589347427,1.1257112480865044,0.3137254901960784,0.923409113111957,1.0,2/5,19.22%,TTBK2;ABL1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7328293192147444,1.124927362339419,0.43103448275862066,0.9251336756184421,1.0,2/7,13.59%,XRCC4;MSH6
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.7472595483072079,1.1244056465595655,0.41509433962264153,0.925776602771553,1.0,1/5,9.45%,PROX1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.6735404486737621,1.1242635164340782,0.39215686274509803,0.9251803213160392,1.0,6/10,29.45%,INPP5A;NFATC3;PPP3CA;PPP3CC;ADGRB2;NFAT5
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.6326711815836852,-1.1242478891096694,0.32608695652173914,0.8183510117121219,1.0,9/15,22.55%,THY1;DUSP3;FGL1;PRELID1;PRKCQ;HSPD1;GPNMB;METTL3;SPINK5
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6348184114019656,-1.1237875584365833,0.36538461538461536,0.818962983689721,1.0,3/11,13.69%,SYT11;FER1L5;RACK1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.5617660073802204,1.123765251043093,0.3,0.9257894151896043,1.0,10/31,14.77%,SHTN1;DIP2B;SEMA3A;MACF1;KIAA0319;NRCAM;LIMK1;SIN3A;TRIM46;MAG
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.4209235007196889,-1.1234539015348375,0.23529411764705882,0.8191660416982905,1.0,13/80,5.66%,MMP2;BGN;PODN;THY1;PRRX1;FBLN2;FIBIN;RARRES2;NT5E;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.6154129217324698,1.1230899973367787,0.35294117647058826,0.9272237998866057,1.0,2/11,7.28%,KCNJ11;RYR2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.6926524586267183,1.1230408994617749,0.39622641509433965,0.9263276484726584,1.0,2/5,22.49%,SLIT3;ROBO1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.5336821756213445,-1.122998448837526,0.34285714285714286,0.819524348263847,1.0,4/19,5.55%,BGN;BCAN;UGDH;CHST7
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6390590536013165,1.1229276381440585,0.36538461538461536,0.9256371374150579,1.0,4/10,30.19%,MAGI2;ACVR1B;ACVR1;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.698345478311529,1.1228144627623031,0.3877551020408163,0.9248733695723242,1.0,3/5,23.77%,CAV3;SNCA;NFKB1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.706403969341221,1.1227087229079897,0.3877551020408163,0.9231164279376638,1.0,2/7,7.34%,RB1CC1;ATG7
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.706403969341221,1.1227087229079897,0.3877551020408163,0.9231164279376638,1.0,2/7,7.34%,RB1CC1;ATG7
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.5476633701390596,-1.1226856327047041,0.2682926829268293,0.819523006284012,1.0,5/26,14.49%,CCDC88C;SERF2;RAD23A;PRNP;CDC73
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.5695776050176261,1.1226641440463647,0.32653061224489793,0.9221557778485583,1.0,6/18,21.20%,RAB17;CBFB;RAP1B;TJP1;PDLIM5;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.7223191696488387,-1.1224221349564802,0.375,0.8193782667075878,1.0,1/6,1.16%,PPT1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.5578395414061128,-1.122289219999815,0.3617021276595745,0.8188160295020569,1.0,7/17,11.90%,PGRMC1;TSPO;UROD;ALAD;ABCG2;NFE2L1;UROS
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.5679303790090006,-1.121975597803825,0.325,0.8179810265919021,1.0,3/19,2.24%,HSD17B10;SLC25A44;ACAD8
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.5679303790090006,-1.121975597803825,0.325,0.8179810265919021,1.0,3/19,2.24%,HSD17B10;SLC25A44;ACAD8
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.42437294282432975,-1.1217330674632668,0.28888888888888886,0.8177433441828073,1.0,21/113,11.03%,GPR17;CHRNA4;OLIG1;ASCL1;OLIG2;TCEAL6;TCEAL7;CNP;SYNDIG1;LGI3;GPR37L1;PDGFRA;LINGO1;SHC3;HPCA;TMEM179;C1QL1;PTN;NEU4;BRINP1;CLIP3
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.40337171373306735,-1.1216674743751054,0.21212121212121213,0.8170188121418502,1.0,15/128,5.66%,JUN;MMP2;BGN;FBLN5;THY1;PMEPA1;PRRX1;PPIB;FBLN2;NT5E;COL12A1;SAT1;THBS2;SFRP1;CXCL12
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.5810466614899578,-1.1214416633746758,0.27906976744186046,0.8167707785076194,1.0,3/11,19.77%,LAMTOR4;LAMTOR5;CD81
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.6795164093888315,1.121177510640697,0.3469387755102041,0.9265747957563224,1.0,4/8,22.75%,NRCAM;SIN3A;ABL1;APOE
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5854623805372638,1.120829293193052,0.2413793103448276,0.9268673616641486,1.0,7/18,18.76%,SRPX2;MAP2K5;RHOJ;HDAC7;AKT3;ITGB1BP1;JCAD
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5917634717979319,-1.120607639821454,0.21951219512195122,0.8184092513907879,1.0,2/11,7.95%,ALOX5;CLU
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.6296311688987787,1.1203175502292797,0.3269230769230769,0.927509808931809,1.0,1/10,0.27%,PTPRC
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.6258011016203865,1.1202661060124919,0.38596491228070173,0.9266121773820818,1.0,7/10,31.61%,SNAP25;STX1A;STX1B;SNAP47;STX4;STX3;SNAP23
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4462117339335028,1.120000091489334,0.25806451612903225,0.9266599074695834,1.0,11/68,9.13%,CDH9;PCDHB5;CDH7;FBLIM1;TLN2;PKP2;CDH8;CDH12;RAB29;NRCAM;SHANK3
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.7350759901523616,-1.1198545366432573,0.3488372093023256,0.8196058479840579,1.0,1/5,9.72%,CACTIN
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.41604541255197885,1.119716347661386,0.22641509433962265,0.9266440098798446,1.0,24/129,9.42%,GRIN2A;SOX9;OPALIN;SLC6A11;FAM107A;SHISA6;STMN2;ALDH1L1;MMD2;SLC4A4;SORBS1;TMEM132C;PHYHIP;GFAP;ADCY5;KCNIP1;PSD2;TEAD1;SNAP25;DAAM2;ATP2B2;NFATC3;ADGRB3;AQP4
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.7235184364820971,1.1196364139828188,0.38596491228070173,0.9258457029593378,1.0,3/5,16.48%,ABHD12B;ABHD12;ABHD6
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.45169294156031947,-1.1194177302939468,0.2127659574468085,0.8201370752026699,1.0,2/47,0.39%,CDKN2C;CCND1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.40203892227154314,-1.1193520534381132,0.24324324324324326,0.8195439033125024,1.0,23/119,12.30%,COL9A3;MMP2;BGN;FBLN5;BCAN;HSPG2;AGRN;COL8A1;ADAMTS6;VWF;MADCAM1;COL4A4;COL9A2;LAMA5;CD44;FN1;ADAMTS2;FURIN;COLQ;HAPLN1;ITGB5;ITGA4;ADAMTS3
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.4967297234942743,-1.1184221907308747,0.3111111111111111,0.8216095743075149,1.0,2/31,3.66%,S100A10;NLGN2
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.7193729956313067,1.1182713546170246,0.3442622950819672,0.9296962109153505,1.0,2/5,11.09%,SHTN1;RHOJ
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.5150733262472765,-1.1180739702756735,0.2857142857142857,0.8220072247874501,1.0,3/33,5.39%,S100A10;RHOC;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5144432495258957,-1.1178741516100628,0.3055555555555556,0.8216968379921368,1.0,4/23,5.03%,JUN;MMP2;HES5;ERN1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.5333888734378214,1.117718453125175,0.3392857142857143,0.9306578761263574,1.0,5/33,8.14%,MAP3K19;FAM161A;ECT2L;CCDC39;SAXO2
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.6048816874676166,1.1175968154994855,0.38333333333333336,0.9298998288468455,1.0,2/11,2.83%,RMI1;EME2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5063013327755423,-1.1175904325291879,0.2857142857142857,0.821575492106842,1.0,6/30,9.62%,UBXN1;GABARAPL2;ALAD;RPL11;HSP90AB1;GIPC1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.7151956094463019,-1.117565573258995,0.30434782608695654,0.8208192557270555,1.0,2/6,7.83%,TRMT112;APEH
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.48055297439319006,1.1175554853776137,0.26785714285714285,0.9289751566834268,1.0,6/40,10.79%,ARFGEF2;RAB10;MACF1;CCDC93;RAB31;GOLPH3L
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5757005833442365,-1.1174322563862222,0.391304347826087,0.820346595586137,1.0,3/19,5.39%,LOC400499;H2AZ1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.6632663596284755,-1.1172678374069152,0.39622641509433965,0.8199922984590916,1.0,1/9,4.80%,PARP1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6288284326413308,1.1167787511808818,0.3137254901960784,0.931279857961036,1.0,4/8,26.37%,CCDC120;BBS4;HOOK3;NIN
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.48305282922511267,-1.1166551706062169,0.32432432432432434,0.8209988468829563,1.0,4/39,4.66%,MAP7D3;GPX4;MID1IP1;MSRB2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7290450493646644,-1.1165070547979248,0.2826086956521739,0.8205860447025919,1.0,3/5,17.79%,NOP14;KRI1;RPS21
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.7157957395752396,1.116113235548849,0.35714285714285715,0.9326237131588064,1.0,3/5,24.79%,ATG7;ULK2;ATG2B
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.6272790865727574,-1.11573056925437,0.3333333333333333,0.8221866005195048,1.0,1/10,0.46%,BTG1
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.708214207557446,-1.115449367003014,0.39215686274509803,0.8222643317637339,1.0,2/5,22.27%,CBLL1;GRB2
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4823393207102859,-1.1150937533535712,0.2826086956521739,0.8224119581666004,1.0,5/35,6.23%,UBB;RPS27A;UBC;UBE2L6;UBA52
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.6582428982463953,-1.1150792775122171,0.3333333333333333,0.8215911625882689,1.0,2/10,18.34%,CNTN6;ROBO3
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.46336745506434607,-1.114833854996434,0.25,0.8215410993942808,1.0,5/38,6.23%,UBB;RPS27A;UBC;UBE2L6;UBA52
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5684388045424049,1.1147388135630956,0.32653061224489793,0.9362612647840359,1.0,2/15,13.87%,PSEN1;SNCA
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.5732865850513396,-1.1143240043730998,0.3111111111111111,0.8220847704183811,1.0,7/17,20.49%,EIF5;EIF3D;EIF4H;DHX29;EIF4A2;DENR;EIF4B
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.6450138509325037,1.1143176434444284,0.3508771929824561,0.9368000889865177,1.0,3/7,24.08%,IRAK2;IRAK4;TRAF6
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.5444796717230549,-1.1139466129991442,0.3076923076923077,0.8222203427962861,1.0,5/18,14.11%,PPP1R35;TIPRL;GPATCH2;BMP2;HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.628466734238089,1.1136672603078817,0.2692307692307692,0.9379445465856965,1.0,5/10,24.62%,AKT2;PRKCE;PPARG;IRS1;PPM1K
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.7151621044952543,-1.1136305763030105,0.34782608695652173,0.8221697832389548,1.0,1/5,13.69%,RACK1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.7517891273244832,1.1135547788493108,0.42105263157894735,0.9373827858014749,1.0,2/5,16.51%,ITPK1;IMPA1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.7438726115013399,1.113169795973979,0.4807692307692308,0.9379497662331356,1.0,4/5,22.75%,ABCA2;DTX3L;ITCH;APOE
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.37836055248921574,-1.1130913953944348,0.15789473684210525,0.8228503589552325,1.0,35/208,15.66%,UBB;TAF9B;PSMB6;MBD6;PSMD8;RPS27A;PSMB4;ACTB;UBC;USP51;PSMA7;UBA52;ADRM1;ATXN7L3;JOSD2;PSMC3;PSMC1;PSMD10;PSMD12;YOD1;ENY2;PSMB9;PSME3;RAD23A;PSMD2;UCHL1;AR;OTUB1;SMAD3;PSMD3;ACTL6A;PSMD4;CFTR;ACTR8;PSMB2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.5082334941399871,1.112899835447678,0.2692307692307692,0.9378689489929699,1.0,7/31,12.26%,IQSEC2;GRIK5;RELN;BCR;GRIK3;PXK;NRG3
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6359002259001082,1.1126217861574605,0.3559322033898305,0.9378716398972716,1.0,4/14,25.89%,SLC12A1;SLC12A5;ATP1B1;KCNMA1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.70134772898687,1.112137701934247,0.3877551020408163,0.9386857785675534,1.0,4/7,24.22%,MYLK;PROX1;ENG;NF1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.525308745159585,-1.1121332759335978,0.17142857142857143,0.8248973430195734,1.0,9/31,15.10%,POLR2L;POLR1F;POLR1A;RRN3;POLR2K;POLR2E;GTF2H2;TAF1A;POLR1G
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.48443617806279354,1.1121209833686891,0.3442622950819672,0.937638003291147,1.0,5/36,8.21%,SCEL;COL5A1;BCR;ALOX12;TMEM79
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4477733319365021,1.1117814341569419,0.2807017543859649,0.9378173993299934,1.0,19/78,17.17%,FOXO1;NEDD4L;WNT7A;PSEN1;ABCA2;ATG7;RAB1A;RANBP9;HACE1;MAP2K5;STX5;WWP1;PLK2;UHRF1;WWP2;ABCB10;CSF1;BARD1;HECW2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5872739750326095,1.11174900886089,0.375,0.9369078000989212,1.0,2/20,0.72%,HOOK1;KIF1C
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.7033894554432745,-1.1113137712929244,0.38636363636363635,0.8265463884628231,1.0,1/6,3.66%,NLGN2
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.4571624758131008,1.1110742541917524,0.3157894736842105,0.9384959817101745,1.0,18/74,13.97%,GLRA1;AHR;GLRA2;SOX9;HCN3;NSMF;SLC38A9;HCN1;GABRB1;GABRG2;RPTOR;RYR3;BRCA1;TAF1;P2RY12;CPEB3;RAP1B;DMTN
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.6591067355519196,-1.1108089565963608,0.42,0.8272087727774812,1.0,1/5,6.82%,TOMM7
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.4673860982848632,-1.1106366314996905,0.2727272727272727,0.8268875474928115,1.0,19/69,16.17%,DERL2;SELENOS;UBE2J1;FOXRED2;FAM8A1;SEC61B;UBXN4;AUP1;STUB1;YOD1;FBXO44;TMUB2;DNAJB12;OS9;RHBDD2;HSPA5;HSP90B1;UBQLN2;VCP
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.7290234174019118,-1.1105607259750054,0.4090909090909091,0.8262206665713431,1.0,1/5,3.85%,CAP1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.5474630167657667,1.1104873228854597,0.3269230769230769,0.9392633735239082,1.0,3/18,5.07%,FMO5;SEC14L2;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.4797546304550714,1.1102721355760101,0.2727272727272727,0.9388925001790789,1.0,14/47,20.03%,SYNPO2;NTRK3;BAIAP2;BCAS3;LIMK1;CRACD;PROX1;CDC42EP3;VASP;CDC42EP4;PRKCE;ABL1;FER;FCHSD2
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.6335363294966353,1.1101518424619026,0.3469387755102041,0.9382438302062168,1.0,1/9,1.68%,NUAK1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.600699901778728,-1.1097874365488303,0.36363636363636365,0.8276193916884043,1.0,1/14,0.09%,PPIF
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.5599648300484477,1.1094338102154082,0.32075471698113206,0.9399263282793795,1.0,4/18,11.77%,CAV3;RPTOR;RAP1GAP2;PRR16
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.6976126967474549,1.1094079478308156,0.3333333333333333,0.9389484667030729,1.0,1/6,5.94%,PLIN5
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.44103719987507156,1.1089030083566318,0.2962962962962963,0.9398652521418447,1.0,17/57,16.28%,SOX9;CRIM1;SMOC1;NBR1;BMP7;CDK6;RANBP3L;ZHX3;HDAC7;SUFU;CHRD;IL6ST;RORB;TP63;IL6R;SEMA4D;NELL1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.4134525746722384,1.1082480461130624,0.2459016393442623,0.9411086968633351,1.0,29/108,17.18%,RAB40A;RAB3A;RAB10;PLEKHF1;MAP7;MRAP;RAB40C;PKP2;TSPAN5;KCNB2;RAB8B;EMP2;CAV3;WDR19;PACS1;RAB29;C2CD5;RAB40B;LIN7A;SPTBN4;TNIK;SEC16A;PACS2;ITGB1BP1;DPP6;ANK2;EFR3A;EHD1;DPP10
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.5298486929930162,1.107951830768401,0.32727272727272727,0.9409947936102727,1.0,8/26,17.35%,WNT7A;RELN;GRIN1;SHANK3;DLG4;SLC8A2;PRKCZ;STX1B
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6067894914108583,1.1078308908844163,0.375,0.9404301521649882,1.0,2/16,8.73%,SLC4A4;KCND3
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.6978343485972575,-1.1074905117845955,0.3902439024390244,0.8333353094812361,1.0,1/5,8.61%,ACHE
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5128414801952612,1.1074451944161758,0.3125,0.9407268078312823,1.0,7/34,9.11%,PTPRC;PTPRR;SPRED2;LMO3;TIMP3;DUSP4;RANBP9
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.5449942264456298,1.1073448915745434,0.3064516129032258,0.9399592124056537,1.0,5/25,13.97%,AHR;HCN3;HCN1;RAP1B;DMTN
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.7459351366148224,1.1073061436706886,0.38461538461538464,0.9389992633449092,1.0,3/5,19.13%,KCNJ11;ABCC8;PKD2
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.5843219908856849,1.1072707882553174,0.3793103448275862,0.9380618885018295,1.0,3/21,10.37%,SORBS1;GRIN1;RAB27A
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.7234046085807986,-1.1070231544618663,0.38636363636363635,0.8337686646144478,1.0,4/5,22.41%,PLAT;DDR1;AAMP;PARVA
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.5461087875865199,-1.1067575035796575,0.3333333333333333,0.8338907239766061,1.0,4/13,7.66%,GDE1;SMPDL3A;SMPD1;ENPP6
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.6766608438148689,-1.1061556019802776,0.39473684210526316,0.8346212260421457,1.0,3/6,9.40%,SAT1;SAT2;SRM
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6636613080809858,1.1061551758223094,0.40384615384615385,0.9409282959616948,1.0,1/9,1.01%,ITPR1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.4228134046464009,-1.105963564390191,0.28888888888888886,0.8342832423009062,1.0,15/80,14.03%,IPO13;CALR;RAN;PTTG1IP;PRICKLE1;CHCHD10;PHB2;RPF2;RPL11;PPP1R10;MORC3;NUP155;RANBP6;FAM53C;RANBP17
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.6997548891853191,1.1058572945766703,0.3157894736842105,0.9409580230405903,1.0,1/6,2.58%,SPRED2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),-0.671827705394092,-1.105853808292851,0.38461538461538464,0.8338427981765503,1.0,1/5,1.22%,DSEL
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.7015348946333653,1.1057340793640147,0.36,0.9403165152575884,1.0,3/7,16.48%,ABHD12B;ABHD12;ABHD6
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.4260491851084434,-1.1056845837240428,0.23684210526315788,0.8335063000281075,1.0,15/98,8.49%,CCND1;JUN;MMP2;BGN;GPX1;PPT1;GPX4;TSPO;BTG3;SAT1;SC5D;DNAJA1;VDAC2;CLU;IFITM3
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4525485931644512,-1.1056736404799294,0.2564102564102564,0.8326786591827661,1.0,20/60,19.47%,PSMB6;PSMD8;PSMB4;PSMA7;YAP1;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PSMD3;PSMD4;PSMB2;SETD1A;PSMC4;PSMD11;LDB1;PDCD2
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.7378959974910522,1.1056557864102734,0.4032258064516129,0.9396256601360952,1.0,1/6,2.06%,STMN2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.44027774886924387,1.1053370618978926,0.25806451612903225,0.9398495304389163,1.0,16/77,18.05%,RFC4;RMI1;ING5;WRN;TOP1MT;ATM;BRCA1;RPA1;RAD9A;TOP1;HELB;DONSON;CDC7;BARD1;RFC1;ORC2
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6844727006222135,1.1052038000593314,0.36538461538461536,0.9393229080134955,1.0,3/7,16.44%,SOX9;RORB;BBS4
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4517604801062845,-1.105126659225667,0.18604651162790697,0.8334066735362428,1.0,5/47,7.40%,CCND1;JUN;MED10;MED23;MED30
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.5250112926080083,-1.105002413964115,0.3958333333333333,0.8329118431250015,1.0,4/24,10.59%,CCND1;APH1A;WNT5A;SAP30
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.46208395953441633,-1.104894126928118,0.24390243902439024,0.8323838105300702,1.0,18/56,16.17%,UBB;RPS27A;UBC;MALT1;UBA52;ZYG11B;CTSC;CTSF;STUB1;FBXO44;HM13;CUL4B;NGLY1;CTSK;CTSL;ISG15;PRPF19;VCP
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.48121127753261494,1.10474405854943,0.2698412698412698,0.9397794601605549,1.0,4/44,6.98%,PON1;PCTP;ENPP2;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.6383509815024154,1.1045391706064578,0.4107142857142857,0.9394664533187889,1.0,1/9,0.27%,PTPRC
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.4369789449413605,1.1043754538339594,0.19047619047619047,0.9390026303577081,1.0,16/71,11.35%,SHISA6;TNFRSF19;NEBL;AHCYL2;TMEM132C;PRIMA1;PARM1;ADCY5;SH3BGRL2;CDS1;BMP7;SHC2;ITGA9;RAI2;PDE9A;NDRG2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.40975752524921033,1.1036879012424134,0.25396825396825395,0.9406990524077479,1.0,24/124,14.34%,RASGRF1;TBC1D4;TBC1D10B;BCR;TBC1D13;RGS7;NTRK3;TIAM1;ARHGAP24;DOCK11;RANGAP1;DOCK7;SGSM1;BCAS3;RAP1GAP2;DOCK8;RAP1GDS1;TBC1D22B;TBC1D8;TSC1;TBC1D1;ASAP3;ZC3H15;SIPA1L1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6157070815231509,1.1036636250313676,0.36666666666666664,0.9397410421645754,1.0,6/16,24.22%,ROBO2;HES1;PKD2;ENG;ROBO1;NF1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.7098599370921304,1.1036337125384934,0.4,0.938775098281227,1.0,2/6,15.70%,AGO1;AGO4
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.5911193954478363,-1.1033933334024084,0.3333333333333333,0.8358096663361972,1.0,2/13,3.92%,PPIB;PPIA
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.40069042965028145,-1.1033719105857993,0.24242424242424243,0.8350066479370608,1.0,23/120,12.30%,COL9A3;MMP2;BGN;FBLN5;BCAN;HSPG2;AGRN;COL8A1;ADAMTS6;VWF;MADCAM1;COL4A4;COL9A2;LAMA5;CD44;FN1;ADAMTS2;FURIN;COLQ;HAPLN1;ITGB5;ITGA4;ADAMTS3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.6460476213942399,-1.1031563289600974,0.3902439024390244,0.8348759875995907,1.0,1/6,5.69%,VPS35
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.5724269412404828,1.102973626880186,0.36585365853658536,0.9401342612621808,1.0,7/18,22.24%,SEPTIN9;CEP135;CCP110;ARHGAP35;BBS4;KCTD17;TAPT1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5375449565496053,-1.1023360041246795,0.24,0.8363241835908084,1.0,4/20,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.719429891681724,-1.1022940078807084,0.42857142857142855,0.8356138449733688,1.0,3/5,24.13%,STPG1;ACAA2;THEM4
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.7064335954612097,1.1021111584778396,0.4,0.9421634136225479,1.0,3/7,20.94%,FOXP1;NLRP12;TMED10
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.5803857609739225,-1.1020563480523473,0.391304347826087,0.8354602994108054,1.0,4/20,6.12%,RBM22;RAN;BAG3;PDCD5
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.5499640228461276,1.1020545061836997,0.39655172413793105,0.9412582000792438,1.0,9/21,20.74%,ST18;SPI1;JAK1;IL6ST;IL6R;SMAD4;FER;STAT3;PTPRT
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.7334251415490609,1.101871095509595,0.34545454545454546,0.9408160355136136,1.0,1/5,2.58%,SPRED2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.4781903670626704,-1.1018434171507636,0.358974358974359,0.8351825180880009,1.0,6/34,12.54%,PPP4C;USP51;MAGEF1;PARP1;FIGNL1;UBQLN4
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.4918427625478673,1.1018266403638228,0.28,0.9399443536350819,1.0,6/41,3.10%,IL1RAPL2;ROBO2;SRPX2;MDGA1;WNT7A;RAB17
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.6752352282414176,-1.1017591313274961,0.4318181818181818,0.8337585716032709,1.0,2/5,18.23%,DPH2;DPH7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.6752352282414176,-1.1017591313274961,0.4318181818181818,0.8337585716032709,1.0,2/5,18.23%,DPH2;DPH7
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.7111695339838041,1.1015269173304665,0.43137254901960786,0.9399546420528436,1.0,2/5,18.06%,RXRA;PPARG
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.42227736496217594,1.1009685339654105,0.26229508196721313,0.941333458919363,1.0,24/146,13.89%,ROBO2;UNC5D;EFNA5;EPHA7;PLXNA4;DAB1;RELN;SEMA3A;LAMA2;SEMA4B;GRB10;SLIT3;UNC5C;PRKCA;SPTBN5;EFNA1;RANBP9;SHANK3;EPHA4;SPTBN4;PIK3CD;SOS1;VASP;PLXNA1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6313761874803556,1.1001729931815845,0.3584905660377358,0.9430085840057582,1.0,2/11,5.12%,HEY2;TCOF1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.5690349940567951,1.0999481924324237,0.3448275862068966,0.9428958512019099,1.0,3/14,6.33%,WNT7A;RFLNA;CAV3
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6374021733201037,-1.099736651765763,0.4,0.8390145381275509,1.0,3/10,12.15%,PODXL2;MADCAM1;ITGA4
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6407523272442499,-1.0996427320105737,0.4186046511627907,0.8376322442484107,1.0,1/7,1.90%,ATF4
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6407523272442499,-1.0996427320105737,0.4186046511627907,0.8376322442484107,1.0,1/7,1.90%,ATF4
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.46387159664038546,-1.0992617791430233,0.27906976744186046,0.8377140885165637,1.0,5/46,5.35%,GPX1;GSTP1;GPX4;GSTM4;ALOX5
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.5900576939120691,1.0989388615327391,0.41818181818181815,0.9450235612093623,1.0,1/14,0.27%,PTPRC
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.41018234565205847,-1.0988195706755204,0.2391304347826087,0.8381555402641125,1.0,17/93,8.36%,S100A10;BGN;STAB2;PODN;HSPG2;IGFBP7;TNS2;PDGFRA;VWA1;CXCL12;EDNRB;PCDH12;VWF;CD82;MADCAM1;ABCG2;MEOX2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.6783518016305339,-1.0988033275042912,0.4444444444444444,0.8373606314494058,1.0,2/5,6.72%,TLR1;LYN
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.7301920102250377,1.098602589214688,0.37254901960784315,0.9452569510855667,1.0,1/5,3.14%,RAB3A
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.44280089785338994,-1.0984478327334,0.2558139534883721,0.8376220275221048,1.0,11/65,5.66%,MMP2;BGN;PODN;THY1;PRRX1;FIBIN;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.6223042533377189,1.098342163352389,0.41304347826086957,0.9451520537330331,1.0,3/12,11.87%,SOX9;ZBTB16;TRPS1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.6975044326036788,1.0982181583782606,0.40350877192982454,0.9445313577720931,1.0,2/6,9.56%,OXTR;SLC22A4
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.5288533581423436,-1.098131654500878,0.3673469387755102,0.8375802541361478,1.0,4/14,15.20%,NT5E;P2RX4;HSP90AB1;IL18
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.7331144951326071,1.098029721425655,0.39622641509433965,0.9441400162709224,1.0,1/5,1.11%,SOX9
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.4607808416155484,-1.0979830506058914,0.2926829268292683,0.8371466363884401,1.0,8/52,11.54%,RAN;KIF25;SMC1A;TUBG1;MZT1;CTDP1;CHMP2A;KIF18B
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6889507584796575,1.09761861092548,0.3770491803278688,0.9447397214504419,1.0,3/7,16.57%,AKT2;SNCA;PRKCE
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.665024405466675,1.097470101369661,0.35384615384615387,0.9443687904285417,1.0,2/6,5.71%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.7223954324595216,1.0972070256714352,0.4067796610169492,0.9442753172036413,1.0,3/5,19.31%,GJA1;ANK2;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.5417858121004022,1.0971832598639264,0.35185185185185186,0.9433530130615103,1.0,5/16,20.96%,PSEN1;ABCA2;DLG4;ATXN2;PICALM
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.42784595634071554,1.0969754600632446,0.2459016393442623,0.9430538186884732,1.0,31/97,19.33%,LIFR;NUAK1;CHST3;EDNRA;ADGRL2;GULP1;FAM13C;TENM3;HSPA12A;TEAD1;ARNT2;RBFOX2;PTPRG;NAV2;ASAP3;GJA1;PBX1;LRRTM1;ANK2;ALDH7A1;ITSN1;SEMA3B;FIGN;DCLK1;PCDH7;TJP1;PALM;FARP1;MPDZ;DZIP1;PLP1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.6535379574918704,1.096895894679066,0.4375,0.9422333341546711,1.0,4/6,30.64%,DOCK11;DOCK10;NOTCH2;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5522743256862837,1.0967140755002234,0.32,0.9417982878301078,1.0,3/14,12.86%,OTUD7B;SIN3A;SUFU
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.39958461151278407,1.0966795841428139,0.2833333333333333,0.9408433799145889,1.0,31/166,14.80%,PTPRC;TPD52L1;WNT7A;SLC39A14;SORBS1;KAT2B;RELN;ASXL2;NTRK3;ING5;TSPAN5;LMO3;MACF1;GRB10;GRIN1;EMP2;PRKCA;SASH1;SHANK3;SULF1;ZRANB1;LOXL3;TRAF7;TRIM44;DLG4;RSPO2;TUBD1;IL6ST;DMTN;TP63;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.6727510782002705,1.0959368638291758,0.41935483870967744,0.94233470080215,1.0,3/6,26.48%,AKAP5;EHD1;ZDHHC2
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.5007842508276028,1.0957354416888558,0.40350877192982454,0.9419205705633303,1.0,7/31,12.22%,GLRA1;GLRA2;NSMF;SLC38A9;RPTOR;UBR1;CPEB3
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.5196396107852101,1.0957016279383707,0.2692307692307692,0.9409882231025706,1.0,4/25,11.75%,IGF1R;WNT7A;SHANK3;DLG4
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.7241715225699158,1.0954080953037575,0.34615384615384615,0.9411830553732611,1.0,2/5,23.38%,GAD2;PAH
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.3887530118676531,1.0953570542556867,0.23333333333333334,0.940380575795585,1.0,16/131,11.75%,RASGRF1;STMN2;SHTN1;WNT7A;PAK1;CNTNAP1;WHRN;DOCK7;SHANK3;BMP7;SGK1;CNTNAP2;FRYL;EPHA4;MAP4;DLG4
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.4072847732233464,1.094599513494853,0.3125,0.941952209927167,1.0,15/101,8.18%,LIFR;NUAK1;CHST3;EDNRA;KCNJ11;ADGRL2;FAM13C;TENM3;TLN2;ARHGEF17;ADCY5;HSPA12A;TEAD1;ARNT2;CRMP1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6338611520388155,1.0945906340822416,0.32727272727272727,0.9409458326018569,1.0,3/8,30.26%,CSGALNACT1;GFPT1;UGP2
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.4489651716619657,-1.0945467278650405,0.30952380952380953,0.8458758424461073,1.0,10/66,5.66%,MMP2;BGN;PODN;THY1;PRRX1;FIBIN;COL12A1;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.5817430812097377,-1.0931049057687057,0.3191489361702128,0.8494245109662005,1.0,5/11,28.08%,IFITM3;RO60;TPR;IFNAR1;EIF2AK2
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.6741014650257917,-1.0929065995349576,0.4166666666666667,0.8491925169003158,1.0,4/6,13.45%,KRT10;F13A1;FN1;FLG
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.4874077010844742,1.0926248874131776,0.3103448275862069,0.9468778156885121,1.0,18/53,24.32%,GALNTL6;CDC42BPB;PRKCA;OXSR1;TNKS;TAF1;PDPK1;CIT;LMTK2;CAMK2D;GALNT16;GALNT13;ACVR1B;MAPK1;PRKD2;MAP3K10;MAP3K12;TBK1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.513596822391104,1.092470204224641,0.3125,0.9463548706744219,1.0,5/35,6.13%,PTPRC;KLF6;HDAC4;LMBR1L;PTPRJ
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4375603591922341,-1.0920633958080785,0.3170731707317073,0.8506897567017138,1.0,12/46,18.95%,GPX1;GSTP1;NOL3;IFI6;PSME3;AR;TMBIM1;SCG2;PARK7;PEA15;AKT1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.5215913403727398,-1.0911477398705745,0.3,0.8521505930369158,1.0,8/33,13.50%,SIRT2;VBP1;LDLR;EDNRB;CLU;HSP90AB1;PFDN1;PRNP
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.6369826288673732,1.090922203684036,0.38181818181818183,0.9510726109480645,1.0,5/10,18.80%,TDRD9;HSF2BP;MEIOC;SYCP3;MYBL1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.38066652574556453,-1.0907358263136309,0.1724137931034483,0.8524397501950344,1.0,42/234,11.67%,UBB;COL9A3;MAP7D3;NCSTN;FBLN5;RHOC;HSPG2;CD151;MARCKS;RPS27A;CCDC88C;COL8A1;RND2;PPIB;MARCKSL1;UBC;COL12A1;SNCAIP;APH1A;RHOG;CAMSAP3;ITM2B;UBE2L6;MYO1D;UBA52;MAP10;COL4A4;TUBGCP4;COL9A2;FIGNL1;HSP90AB1;CGNL1;ZBED3;WDR73;MFGE8;CST3;ADAMTS2;CLIP3;RHOBTB1;LTBP3;KIF18B;FURIN
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.6515205374564373,1.0906714157041162,0.4528301886792453,0.9510415166239501,1.0,2/6,28.34%,PPARG;THOC5
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.49875837175880045,1.0902444400649927,0.3384615384615385,0.951476090538197,1.0,11/30,27.12%,TRAK1;MYO1H;RAB1A;FBXW11;MYO7A;MYO6;MYO1C;TANC2;CCDC186;SYT4;ACTN4
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5731873151022034,-1.0901271358796145,0.40425531914893614,0.8533177028719116,1.0,3/19,3.57%,RBM22;RAN;BAG3
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.4273570838572463,-1.0897295108815401,0.24390243902439024,0.8536828942484898,1.0,12/82,8.77%,PPIF;MT1E;JUN;ZNF658;MT2A;MT3;SYT11;P2RX4;SMPD1;HPCA;SLC25A24;WNT5A
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.6240365232934248,-1.0892502879421657,0.41509433962264153,0.8541250495536062,1.0,3/8,14.62%,RTRAF;YBX1;HNRNPA2B1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3989480058084762,-1.088936632111952,0.2702702702702703,0.8540895815650849,1.0,22/103,12.11%,EIF5A;PSMB6;PSMD8;TXNDC17;PSMB4;ZFP36L1;PSMA7;SFRP1;ASAH1;LIMS1;HAS2;PSMC3;TNFRSF14;PSMC1;PSMD10;PSMD12;CACTIN;PSMB9;PSME3;IKBKB;PSMD2;TRAF5
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5694243234356268,1.0881664429485143,0.4067796610169492,0.957956065069521,1.0,4/19,6.44%,TTLL6;TTLL4;AGBL4;TTLL5
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.4798484371968599,-1.088147175037502,0.2564102564102564,0.8555162448622752,1.0,3/26,5.24%,LIN7B;CAMSAP3;LIN7C
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.7032645362791146,-1.0878035559321129,0.48717948717948717,0.8556675834376355,1.0,2/5,22.16%,CTDP1;RPRD1B
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5566284678092754,1.0876865127644868,0.4186046511627907,0.9586242867758913,1.0,7/23,17.49%,GADD45A;SPI1;SASH1;CYLD;DUSP1;RELL1;PER1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.7017525947294252,1.0876752008097181,0.4642857142857143,0.95760868906743,1.0,2/6,23.34%,SASH1;PARP10
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5473260914728644,-1.0873554271103618,0.3191489361702128,0.8559954935076666,1.0,1/16,0.37%,CDKN2C
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.5560452753794191,1.0871653826010064,0.375,0.9581985854508002,1.0,5/20,13.97%,AHR;HCN3;HCN1;RAP1B;DMTN
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.37866707413984224,-1.0871527305667987,0.1951219512195122,0.8556932788874992,1.0,34/161,14.11%,IDH1;CALR;GAPDH;ATP5MC1;TM7SF2;PRDX1;DHFR;SQLE;PPIA;TCEA1;LDLR;SC5D;CANX;GBE1;CTSC;IDI1;TUBG1;TPI1;ACLY;PSMD12;FADS1;SEC11A;PSME3;HMGCS1;RPN1;PSAT1;TRIB3;DHCR7;HSPA4;CD9;HSPA9;MCM4;HSPA5;HSP90B1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.5883881143393844,-1.0870325632440083,0.3404255319148936,0.8552151373544317,1.0,1/8,5.46%,CBR1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.450015387877514,-1.0870083463163522,0.3333333333333333,0.8544293266775674,1.0,6/51,6.91%,ZDHHC1;PIGO;ZDHHC6;SELENOK;PORCN;DPM2
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.5337093052520594,1.0870053926928356,0.3584905660377358,0.9577645060546365,1.0,5/20,9.45%,RAB17;GPRC5C;PKP2;EFNA1;PROX1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.566113970858131,-1.0868158749223342,0.375,0.8540194317555571,1.0,4/15,8.15%,SIRT2;CALM1;CADM4;CALM3
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7336857524713565,1.0868145750019538,0.45614035087719296,0.9574951979356499,1.0,1/5,5.36%,HIP1
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.6989494638669104,1.0863277509748137,0.39622641509433965,0.958025564208044,1.0,1/5,2.90%,STAT4
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.708156503864924,-1.0861708050547336,0.4,0.854191094451962,1.0,2/5,16.79%,CAV1;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.708156503864924,-1.0861708050547336,0.4,0.854191094451962,1.0,2/5,16.79%,CAV1;KHSRP
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.44760614782277663,1.0861399400069758,0.2903225806451613,0.9576796115392351,1.0,26/59,28.51%,TBC1D10B;TBC1D13;DYNC2LI1;CDKL1;CYLD;ATG5;TRAPPC12;TBC1D22B;TBC1D8;PLK2;TBC1D1;MTMR3;STX18;RABGAP1;ATXN2;ATG3;IFT140;ALMS1;C10ORF90;TBC1D2B;SENP6;RNF4;RAB5A;C9ORF72;CDKL5;PIKFYVE
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6137714088305337,-1.0860625603547196,0.4,0.8535740441302008,1.0,1/10,1.30%,ARPC5
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.6357910596244046,-1.0859456296556398,0.5106382978723404,0.853034976246033,1.0,2/6,16.85%,VPS11;MSN
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.44798183167097405,1.0858514957450318,0.3090909090909091,0.957776328005509,1.0,21/57,21.22%,SLC6A15;SLCO1A2;SLC13A3;SLC25A48;RXRA;NCOA1;SLC16A10;SLC6A6;SLC1A4;ACSL1;SLC7A11;SLC19A1;SLC38A4;SLC51A;PDPN;AKR1C1;NCOA2;SLC27A4;SLC25A45;SLCO2B1;ATP8B1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.5855879475734321,1.0857804077650441,0.4117647058823529,0.9569899097218008,1.0,3/11,6.09%,EFHC1;DNAH7;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.6159296977201718,1.0857074238745894,0.4,0.9561668118189077,1.0,1/12,1.11%,SOX9
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.6127573235277282,-1.0856734464639861,0.38095238095238093,0.8528914186496941,1.0,5/9,20.49%,EIF5;EIF4H;DHX29;DENR;EIF4B
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.4543958542640302,-1.0854003962028254,0.30303030303030304,0.8529780162944913,1.0,11/51,11.41%,TUBB2B;DLL3;PCGF2;IGFBPL1;SEZ6L2;EFNA2;LINGO1;C1QL1;AADAT;POU3F2;CKB
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.6865132324397427,-1.0853783863461244,0.42857142857142855,0.8522333285579831,1.0,1/6,4.75%,CAMSAP3
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.7130059236456606,1.0849275192795325,0.4772727272727273,0.9575768349306084,1.0,3/7,11.27%,YJEFN3;ARIH2;ETV6
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.6443480891249913,1.0846612725230453,0.3584905660377358,0.9575680182622073,1.0,2/10,6.13%,PTPRC;PTPRJ
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.551066560009664,-1.0846528817852865,0.3829787234042553,0.8536423339281232,1.0,6/19,15.09%,SNRPB;CSKMT;BHMT;GSPT1;PRMT1;VCPKMT
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.523803631936038,-1.0844172314253695,0.4,0.8535860596414989,1.0,1/10,2.42%,ADPRM
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.676821717436898,1.0841692895998198,0.3620689655172414,0.9582950691354736,1.0,2/6,8.56%,AHCYL1;CA2
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6348243591741886,1.0839928444834026,0.4,0.9568932102435256,1.0,3/9,14.80%,EFNA5;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6348243591741886,1.0839928444834026,0.4,0.9568932102435256,1.0,3/9,14.80%,EFNA5;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.4687773242738486,1.0838926147306513,0.3392857142857143,0.956275469878624,1.0,15/48,15.69%,ITPR1;KCNJ11;ATP2B3;AHCYL1;CAV3;RYR2;ATP2B2;ITPR2;RYR3;TPM1;NOS1;SLC8A1;SLC8A2;CAMK2D;ANK2
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.3822246800786305,1.083814411716132,0.19117647058823528,0.9555353188810791,1.0,38/251,11.33%,VSIR;TMSB4X;GNA12;NEDD9;IGF1R;FAM107A;ZMYND8;AKT2;MYLK;PAK1;PLXNA4;ENPP2;NTRK3;SEMA3A;TIAM1;CAMK2B;SEMA4B;DUSP22;PRKX;MACF1;FGF9;PTPRJ;WASHC1;PRKCA;PLET1;SASH1;GCNT2;TCAF1;SRCIN1;VCL;SULF1;HACE1;SRGAP3;ATM;SGK1;TPM1;PHACTR1;EPHA4
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.69704053346907,1.0837408033250617,0.3584905660377358,0.9548632681017761,1.0,3/6,21.95%,SPI1;PLAAT3;KLF7
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.6650184360066603,1.0835329746737272,0.41509433962264153,0.9546104641644948,1.0,3/9,24.60%,KCND3;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5267083073957544,-1.0831695474773297,0.3695652173913043,0.8562340443297314,1.0,2/21,5.50%,H1-4;DACH1
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.6381524349084942,1.083115535337896,0.39285714285714285,0.9550222307029764,1.0,2/8,9.17%,TMEM63C;SULF1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.4159142352119952,1.082988442910493,0.35,0.9544665472118202,1.0,15/101,12.16%,HEY2;YWHAH;SRF;ALK;TCFL5;TIAM1;EMP2;SMOC1;SUZ12;PHLDB2;SLC6A6;CDK6;CBFB;TRPS1;CAMK1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.6052460321759277,-1.0829163243136342,0.3333333333333333,0.8562951863034913,1.0,3/11,12.27%,LDHD;ACBD5;ACOX1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.6414672755727744,1.0819187393004055,0.42857142857142855,0.9573010051652068,1.0,5/8,31.93%,MBOAT2;PLAAT3;PLA2G12A;LPCAT3;LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.6716746167402733,-1.0818723661730376,0.38636363636363635,0.858325970311478,1.0,3/5,31.23%,ANAPC2;CPLX2;EPHB2
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7086300316427541,-1.0817794798753766,0.4090909090909091,0.8576674060073418,1.0,2/5,12.20%,SMC1A;MUS81
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.7041015866253408,1.0814729325783443,0.45454545454545453,0.9575762739508414,1.0,4/5,29.50%,ACSL1;SLC27A4;ACSL3;RPS6KB1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.6946889627755665,1.0814615746629173,0.3673469387755102,0.9566229049569778,1.0,3/6,19.97%,SLC25A48;SLC22A4;SLC25A45
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.6446296086180042,1.0814484967127913,0.41818181818181815,0.9556903998427774,1.0,1/7,0.27%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.5599176303355795,-1.0814023550084328,0.3902439024390244,0.8579116279432575,1.0,2/12,5.15%,BRPF3;NPM2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.4585961358285833,1.0812230567977397,0.3728813559322034,0.9555422749657999,1.0,11/40,19.43%,TMSB4X;LRRC19;BRD4;FOXP1;CYLD;TIRAP;IRF1;APPL2;TRAF3;BCL6;SAMHD1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.6199247540526701,1.0810971566179473,0.4807692307692308,0.954961271441925,1.0,3/8,26.86%,MACROH2A1;MAPK3;CDK9
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.6183489645244432,1.0809910947960069,0.37037037037037035,0.9543532551386056,1.0,1/10,0.75%,TMSB4X
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.4471260481784607,-1.0806449394181958,0.36585365853658536,0.8592513332011423,1.0,5/45,9.21%,SOX4;CCND1;E2F4;RFWD3;PCBP4
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.49426637122740824,-1.0806083278517862,0.38636363636363635,0.8577209051462226,1.0,4/20,5.61%,ZDHHC1;ZDHHC6;ZDHHC4;GOLGA7
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.49426637122740824,-1.0806083278517862,0.38636363636363635,0.8577209051462226,1.0,4/20,5.61%,ZDHHC1;ZDHHC6;ZDHHC4;GOLGA7
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6330223257353969,-1.0802956204765954,0.43478260869565216,0.8579316736127632,1.0,4/8,22.55%,ZFP36L1;PRELID1;METTL3;SPINK5
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.46043214377136416,1.0800141703370816,0.359375,0.9568100995478565,1.0,12/62,10.16%,PTPRC;FOXO1;PTPRR;SPRED2;LMO3;TIMP3;PTPRJ;DUSP4;CAV3;RANBP9;BMP7;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5754977925146171,1.0797650615753343,0.36,0.9567834683173418,1.0,5/17,16.94%,CD160;SPI1;PVR;CADM1;KLRD1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.440758867851068,-1.0793131577042312,0.35,0.8598174608946886,1.0,3/46,1.84%,SIRT2;RAN;BANF1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5796629895463122,-1.0793005261289381,0.4146341463414634,0.859010717937751,1.0,1/11,0.35%,BTC
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.6924423395478007,-1.079088035301937,0.4523809523809524,0.8588312544438758,1.0,3/6,11.41%,GSTM4;CRYZ;GSTM3
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.36927967088408403,-1.078699497413734,0.2857142857142857,0.8591371467556148,1.0,28/134,17.72%,CDKN2C;RAN;SNRPB;RANBP1;EXOSC8;TBRG4;H2AZ1;NOP56;SMC1A;KPNA2;PA2G4;TUBG1;CBX5;KIF18B;GINS3;GSPT1;DSCC1;PRDX4;MCM4;DEK;MELK;POLD3;UBE2S;POLD2;CNOT9;RFC3;LBR;STMN1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5876030722646007,-1.0786257693124497,0.3684210526315789,0.8585272001361895,1.0,4/7,19.74%,CAMSAP3;CDC42;MSN;RAP2A
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.550328535648031,1.0785611130931183,0.421875,0.9597766208190766,1.0,10/20,24.08%,PTPRC;CSF2RA;IL6R;CFLAR;IRF1;FPR3;IGSF6;PTPRE;NFKB1;TRAF6
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.3883792634291612,1.0784359491985134,0.296875,0.9592972912794273,1.0,28/127,17.83%,OLFM3;STMN2;GALNTL6;SULT4A1;MMD2;ATP2B3;CPNE5;PSD2;PRKCA;CHRNB3;SNAP25;CRMP1;NEFL;ADGRB3;CDK14;CALY;CLVS2;ACTL6B;MTUS2;SLC8A2;ASTN1;LRRTM1;NELL1;ERC2;DPP10;LHFPL5;TMEM163;SNCB
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.4115457284235157,1.0783335117291475,0.25,0.9586692161799895,1.0,25/99,15.86%,PTPRC;NEDD9;MMD2;PAK1;RELN;CACUL1;EMP2;RPTOR;SRCIN1;EFNA1;PAK2;BORA;MMD;EPHA4;DLG4;CAMK1;STK11;TNIK;SNCA;SLC8A2;IL6R;STK3;MTCP1;CSF1;TAB2
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.572566077116618,1.078215144354324,0.2909090909090909,0.9580424400983375,1.0,3/11,13.08%,RAB3A;RAB27A;STX1A
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5743268988103891,1.0779620136975987,0.38461538461538464,0.9578372269026091,1.0,5/11,21.12%,TGFBR3;BMP7;NRG1;ENG;TGFB2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5263613506071719,1.0778071305549035,0.39285714285714285,0.957389866403382,1.0,7/26,10.70%,HEY2;ROBO2;ZFPM2;SLIT3;TGFBR3;PROX1;HES1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.352518371490733,-1.0777303345554765,0.19444444444444445,0.8600806471716335,1.0,56/463,10.75%,NR0B1;HSBP1;UBB;CCND1;JUN;ZBTB32;TAF9B;SIRT2;ASCL1;RPL10;SMYD2;CALR;RPS27A;ATF4;ZNF491;UBC;PCGF2;MYT1L;BAG3;ZNF688;HES5;NR2F6;LARP7;PARP1;HDGF;RPL23;DACH1;YAP1;ZFP90;NR2E1;EDNRB;EID1;UBA52;ZNF582;DRAP1;ZNF558;DPF2;TAF7;SARS1;CBX5;CHD3;PSMD10;DNMT3B;NOC2L;ZNF77;CNBP;CAV1;AEBP1;ZNF124;ZBTB21;ZNF557;HSF4;PHF6;DDX5;SAP30;ZNF614
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.4975649781695498,1.0776249613022268,0.3392857142857143,0.9571577889932128,1.0,11/27,22.75%,DGKG;CAV3;LMF1;DGKZ;ABHD12;LYPLA2;ABHD6;PLAAT3;DGKI;DGKD;APOE
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.36194877509588236,-1.0774196038427748,0.25925925925925924,0.8600298102878272,1.0,60/430,10.07%,SOX4;BTC;CDKN2C;BTG1;JUN;NOX4;SIRT2;COPS9;PODN;FABP7;SMYD2;CLEC11A;CALR;DERL2;S100B;ROMO1;PDGFD;IGFBP7;TSPO;RTKN2;GID8;SQLE;STOX1;BTG3;ZFP36L1;HES5;TMEM115;RHOG;TBRG4;TNS2;DUSP15;PDGFRA;PTPN14;SFRP1;RPL23;BAMBI;YAP1;RPS9;PDCD5;IL12RB2;LIMS1;LYN;SAPCD2;CADM4;SPEG;RPS15A;NGF;FUZ;CLU;HAS2;NACC1;COX17;ZBTB49;PTN;SLC25A5;CNBP;UFL1;RNF126;SLC25A33;RAB33B
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5423205964759309,-1.077180742304981,0.38095238095238093,0.859807283270899,1.0,4/20,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6219938396070922,1.0771432516157884,0.4,0.9578199910617559,1.0,2/10,12.36%,PIP4K2C;PIP4K2A
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7160252348844677,-1.076988014861632,0.5106382978723404,0.8596066350344752,1.0,3/5,21.30%,UFL1;HSPA5;DDRGK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.5181165976970153,1.0769486787752909,0.375,0.9574484358632036,1.0,7/28,10.16%,PTPRB;UBASH3B;DUSP22;PTPRJ;DUSP4;DUSP8;DUSP1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.7129807138240094,1.0768646478934536,0.43333333333333335,0.9567338665062792,1.0,2/6,7.86%,WDR19;RAB29
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.47291433932096294,-1.0767844616178266,0.3448275862068966,0.8594278028287075,1.0,7/45,9.36%,AURKAIP1;KIF25;PCGF2;CBX5;CHMP2A;RING1;PPP1R10
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.4311304413747118,-1.076496411259225,0.3333333333333333,0.8594420194374116,1.0,10/48,9.48%,SLC35B4;LRRC8D;ARL6IP5;SLC25A30;PRAF2;SLC1A6;SLC7A8;SLC25A4;SLC25A1;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5851774750150953,1.0764935060800305,0.421875,0.9569118129170379,1.0,4/12,18.57%,CD160;PIAS4;AKR1C3;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.35834848859021595,-1.076322869795931,0.16666666666666666,0.8590925537462064,1.0,34/348,9.31%,SOX4;CDKN2C;BTG1;NOX4;SIRT2;PIWIL2;PODN;FABP7;PPT1;SMYD2;IGFBP7;TMBIM6;MT3;BTG3;RNF167;TMEM115;SYT11;TNS2;PTPN14;ALOX5;SFRP1;VPS35;PDCD5;PLXNA3;LYN;SPEG;NGF;FUZ;CLU;NDUFS3;FER1L5;ZBTB49;SPHK2;CHMP2A
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.5717011352283892,-1.0762282311356544,0.4090909090909091,0.8584766157351398,1.0,1/17,2.86%,TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.5231617333669091,-1.0757223430027358,0.47058823529411764,0.8591001935606808,1.0,5/23,7.58%,GSTP1;ROMO1;DHRS4;CBR1;DCXR
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),0.6273006040314402,1.0755414288764622,0.44,0.9593054585332706,1.0,3/5,16.89%,EMP2;CAV3;PACSIN2
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.46405995850547554,1.0754914129612938,0.36507936507936506,0.9585633947063735,1.0,19/49,23.01%,BAIAP3;RAB3A;TTN;CADPS2;SYTL4;MYOM1;RAB27A;GOLPH3L;STX1A;SNCA;STX1B;RAB9A;PPID;TMED10;TGFB2;UNC13B;MYH10;GOLPH3;CLASP1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.45256457513210435,-1.075441392377415,0.3076923076923077,0.8591253329844466,1.0,10/43,12.83%,MT2A;CALM1;MT3;PEF1;ALG2;CALM3;CAV1;SLC30A4;ATP5F1D;KHK
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.655400160811834,1.07536327982086,0.4,0.9580449280467295,1.0,1/10,1.11%,SOX9
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.4198714717500559,-1.075227300502446,0.3181818181818182,0.8589266681015794,1.0,27/109,15.72%,PSMB6;PSMD8;ODC1;PSMB4;TM7SF2;SQLE;PSMA7;LDLR;SC5D;PMVK;IDI1;EDF1;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;HMGCS1;PSMD2;DHCR7;SIN3B;HDAC3;PSMD3;PSMD4;PSMB2;CERS2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6729504422634135,1.0747504584862568,0.453125,0.9580361851865193,1.0,2/5,5.71%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6729504422634135,1.0747504584862568,0.453125,0.9580361851865193,1.0,2/5,5.71%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.40847766176052586,-1.0744564612108853,0.3673469387755102,0.8603251235409053,1.0,20/82,16.00%,KDSR;PPT1;ARV1;SGPP1;ASAH1;SMPD1;GBA3;SPHK2;NEU1;NEU4;GM2A;SPTLC1;PPP2R1A;SAMD8;TECR;ST6GALNAC3;SUMF2;NEU3;CERS2;SMPD3
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.6457056580613882,1.0744128506159563,0.375,0.9582578378724602,1.0,2/8,11.51%,TOP1MT;TOP1
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.7030709942731754,-1.0743053009459729,0.4716981132075472,0.8599023653824012,1.0,2/5,20.76%,WLS;DDIT3
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.6458711811688199,1.0741533571165036,0.43859649122807015,0.9581104176940186,1.0,2/6,9.32%,MADD;DENND4B
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.653236605645004,-1.0738319366996563,0.5,0.8603197657492578,1.0,3/7,23.51%,DYNLT1;IFIT1;TBC1D20
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.5269919082009422,1.0736382703038925,0.40816326530612246,0.9587458196503581,1.0,6/24,23.23%,PAK1;CAV3;CLASP1;TOGARAM1;NAV3;MAPT
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.4497579644544608,1.0735059077172373,0.2857142857142857,0.9583314965288884,1.0,6/47,3.47%,ITGA2;SCEL;SRPX2;TMEM14A;MYLK;NNMT
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6648624854506241,1.0734964904668625,0.48148148148148145,0.9573943321192642,1.0,2/7,12.52%,DAPK2;STK11
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5652265968538083,-1.0732023383490665,0.30612244897959184,0.8612034229099788,1.0,6/18,11.35%,SMYD2;PTTG1IP;PSMD10;CD44;DDX5;YJU2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.36165184505175,-1.0730102473735692,0.23076923076923078,0.8610567551070284,1.0,42/270,13.28%,COPZ1;ATP6V0A4;PPT1;ARL4A;SNX17;AP4M1;TMED2;RAB26;RAB1B;ATP6V0E1;SCAMP3;RABL3;ARL6IP5;ATP6V1F;SYNDIG1;ARFIP2;ATP6V1G1;GOLGA7;VPS35;ERP29;ARL1;CANX;SCG5;CLU;ATP6V1B2;TMED9;RAB14;RAB5B;CHMP2A;SLU7;TMED1;MCOLN1;SCAMP4;UNC119B;STX6;ATP6V0E2;ATP6V0D1;VPS26B;NPM1;TBC1D25;RUNDC1;WLS
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.642200962114162,-1.0729839652899766,0.4583333333333333,0.8603064697191958,1.0,1/10,2.33%,LGALS3BP
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.5999037030133345,-1.0729694359065447,0.44680851063829785,0.8595258473751646,1.0,3/9,9.48%,ACTG1;ACTB;CGNL1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4845183621711756,1.0727698699602006,0.390625,0.9590105826255797,1.0,6/34,13.59%,BCL2L11;BCL2L2;ATM;BRCA1;MOAP1;MSH6
prerank,MSigDB_Hallmark_2020__Coagulation,-0.4367885030856402,-1.071997888217492,0.25,0.861305764755178,1.0,18/66,15.35%,MMP2;SIRT2;ISCU;S100A1;PEF1;MSRB2;VWF;CLU;FN1;MST1;FURIN;RAPGEF3;CD9;CASP9;CTSK;TIMP1;LRP1;PLAT
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.6929631132102795,1.071927229059359,0.4,0.9608802809221574,1.0,2/7,23.23%,SHANK3;MAPT
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.680539170520218,1.0716262810812982,0.4716981132075472,0.9610242040240511,1.0,2/6,18.57%,PPARG;PDCD4
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.5768656006563304,1.071621530545265,0.3620689655172414,0.9600606576934243,1.0,4/13,7.71%,PYGB;PHKG1;RB1CC1;PYGL
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.5699454558773596,1.0715978235925818,0.29411764705882354,0.9591630467502736,1.0,5/14,24.34%,SCN8A;SCN2A;KCNMB4;ANK3;KCNMB3
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.6053161882368288,-1.0714836742218166,0.4222222222222222,0.8620364226831343,1.0,2/6,15.05%,SARAF;STIM1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.5109586618647292,-1.0707108067639204,0.3333333333333333,0.8634834270501859,1.0,3/22,6.90%,KIF25;DYNLT1;SAPCD2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4976775795215609,-1.0706924013310428,0.35135135135135137,0.8627238430915154,1.0,2/18,4.42%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5859177834442724,-1.0704908731953802,0.3333333333333333,0.8624081528089524,1.0,4/10,13.93%,KDELR1;GPAA1;OS9;HSPA5
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5518465447337193,1.0704206195517723,0.36507936507936506,0.9620569240982634,1.0,4/15,6.33%,YWHAH;NEDD4L;SNTA1;CAV3
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.5039038720301107,1.07039349753903,0.3673469387755102,0.9611773553490692,1.0,12/36,23.23%,STMN2;PAK1;TBCD;CAV3;PRUNE1;SNCA;ABL1;CAMSAP2;CLASP1;TOGARAM1;NAV3;MAPT
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.4482911862010518,1.0701612437521286,0.3333333333333333,0.9610286268082147,1.0,15/53,16.99%,SLC6A15;SYT1;RAB3A;SYN3;SNAP25;NAAA;GABRA2;CPLX1;LIN7A;SLC29A2;STXBP3;STX1A;UNC13A;PPFIA1;GAD2
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5995976931218379,-1.0700938305769188,0.3611111111111111,0.8628613811120454,1.0,1/12,1.05%,DNAAF2
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.6672772150446492,-1.069909009463088,0.45652173913043476,0.8625356389596398,1.0,2/5,21.45%,AEBP1;EFEMP2
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.5677271335208915,1.0696863304390685,0.4339622641509434,0.9618907594119335,1.0,4/14,14.99%,GADD45A;SPI1;SASH1;RELL1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.6109212974215892,1.0696265095152202,0.4153846153846154,0.9592385699687714,1.0,2/10,8.54%,DCAKD;PANK4
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.6109212974215892,1.0696265095152202,0.4153846153846154,0.9592385699687714,1.0,2/10,8.54%,DCAKD;PANK4
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.6109212974215892,1.0696265095152202,0.4153846153846154,0.9592385699687714,1.0,2/10,8.54%,DCAKD;PANK4
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6310993484142835,-1.0696056110367633,0.46808510638297873,0.8624731394306853,1.0,2/8,10.42%,ZNF830;EIF2B2
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.696009226328405,1.0695184839536682,0.43859649122807015,0.95872075900478,1.0,1/5,27.98%,JAM3
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.6694634086521345,1.0694770329915346,0.423728813559322,0.9569461897873879,1.0,1/6,8.97%,DNM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.6694634086521345,1.0694770329915346,0.423728813559322,0.9569461897873879,1.0,1/6,8.97%,DNM1
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.6190342075465878,-1.0694514246893347,0.4,0.8620749026859664,1.0,4/8,19.85%,SMPD1;SHFL;ISG15;IFIT1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.4587110391839844,1.0694013037200114,0.32786885245901637,0.9562152543317176,1.0,10/60,16.67%,PTPRC;IRF2;NLRC5;AGBL4;ATG7;TRIM52;STAT2;BNIP3L;IRF1;CNOT7
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.4968465975410044,1.0690178651829327,0.34545454545454546,0.9564431074710199,1.0,6/22,20.79%,PRKCA;SASH1;NMI;ZCCHC3;POLR3B;POLR3G
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.590734562683846,1.0688933302970052,0.37254901960784315,0.9559306702768067,1.0,5/9,23.27%,ALK;BMP7;COBL;PACSIN1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6002834252951242,-1.068823748474663,0.4222222222222222,0.8630090856977202,1.0,1/9,2.31%,PPIB
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.4942563102891561,-1.0687320544642365,0.34782608695652173,0.861721938207806,1.0,6/21,16.67%,DBI;ACSM5;ACLY;OXSM;CROT;ACOT13
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.4942563102891561,-1.0687320544642365,0.34782608695652173,0.861721938207806,1.0,6/21,16.67%,DBI;ACSM5;ACLY;OXSM;CROT;ACOT13
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4967300638790238,-1.068565248731688,0.4,0.8613258881684993,1.0,8/22,24.92%,CCNK;TCEA2;WDR43;EAF1;LDB1;HMGN1;SUPT5H;KAT7
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.49097469858602877,1.0684023589775218,0.3508771929824561,0.9566360624331622,1.0,9/24,20.18%,YWHAH;NEDD4L;CAV3;FGF14;CAMK2D;PRKCE;HECW2;GPD1L;ANK3
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.41535623199794286,-1.0681595425153045,0.32432432432432434,0.8617349598033991,1.0,7/63,8.39%,COL9A3;CD151;COL8A1;PPIB;COL12A1;COL4A4;COL9A2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.43315711398135887,1.0681070246861963,0.28846153846153844,0.9565026391361032,1.0,16/78,15.82%,LIFR;NEDD9;IGF1R;EPHA7;ALK;MERTK;NTRK3;TYRO3;ROR1;SHC2;EPHA4;PTPRG;IL6ST;LMTK2;PTPRU;CSF1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.5524266192178752,-1.0677745407679797,0.4166666666666667,0.8623728795241999,1.0,2/11,4.42%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.549769487304371,1.0675097917398488,0.3508771929824561,0.9575568810357926,1.0,2/15,2.70%,PCLO;WNT7A
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.6857672271038748,-1.067441480033372,0.36666666666666664,0.8624465488520118,1.0,2/5,19.10%,SFRP1;GREM1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.5245449364395289,-1.0669442416437755,0.33962264150943394,0.8628430210339518,1.0,1/18,1.10%,PRDX5
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4500792717255593,1.0669395464122962,0.31343283582089554,0.9585011889034986,1.0,16/52,21.22%,RAB17;TBC1D10B;TBC1D13;DYNC2LI1;CDKL1;CYLD;ATG5;TBC1D22B;TBC1D8;TBC1D1;DMTN;RABGAP1;ATG3;FER;IFT140;ATP8B1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.37532915629112895,-1.0666344652344728,0.25,0.8627808164104896,1.0,35/167,17.46%,UBB;RPS27A;UBE2D4;PCYOX1;UBC;ELOC;CDC26;RNF167;UBE2L6;UBA52;FBXO45;RNF6;ADRM1;PPP1R11;ANAPC11;STUB1;RNF126;PCYOX1L;OS9;TOLLIP;UBQLN4;RC3H1;PSMD3;RNF168;UBE2I;UBQLN2;ISG15;UBL7;RNF8;UBE2S;BUB3;UBA1;ANAPC2;RNF146;RNF14
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.5832131439466313,-1.0664669081055314,0.41304347826086957,0.8624587750656262,1.0,3/11,9.94%,PARP1;TIPARP;PARP2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.6385755990307793,-1.0664523427557577,0.3695652173913043,0.861711404262955,1.0,2/6,12.32%,DDX5;GPC1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.4177908665395174,-1.066395157845421,0.2972972972972973,0.8610899634335855,1.0,6/65,4.97%,NOX4;PRDX5;HSPG2;HNRNPA0;TUSC2;TLR1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3422206788807033,-1.0662563170110322,0.2647058823529412,0.8606252107805424,1.0,42/405,10.08%,RRAGA;UBB;CUL7;PSMB6;ELOB;PSMD8;RPS27A;UBE2D4;PSMB4;UBC;TRIM35;ELOC;RNF167;UBE2Q2;RNF141;PSMA7;MAGEF1;TNFAIP1;UBE2L6;UBA52;FBXO45;RNF6;RNF112;SELENOS;UBE2J1;CUL9;ASB1;MARCHF2;UBE2Q1;PSMC3;WSB1;PSMC1;PSMD10;PSMD12;ANAPC11;STUB1;RFWD3;CAND2;FBXO44;RNF126;PSMB9;PSME3
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.33236027217261627,-1.0659624644672305,0.19444444444444445,0.8605757029862553,1.0,78/640,10.75%,NR0B1;HSBP1;UBB;CCND1;JUN;ZBTB32;TAF9B;SIRT2;PRDX5;ASCL1;ZNF658;RPL10;SMYD2;CALR;RPS27A;ATF4;TCEAL7;ZNF491;UBC;HSPA8;PCGF2;MYT1L;ZNF12;MT3;SAP18;ZNF688;HES5;NR2F6;LARP7;PARP1;HDGF;PRICKLE1;SFRP1;RPL23;DACH1;YAP1;ZFP90;NR2E1;EDNRB;EID1;LBH;UBA52;QARS1;ZNF582;YWHAQ;LIMS1;DRAP1;PA2G4;ZNF558;DPF2;PHB2;ZBTB33;TAF7;CREBZF;SARS1;CBX5;CHD3;NACC1;SCML1;SET;WNT5A;PSMD10;DNMT3B;RBM15B;NOC2L;RING1;ZNF77;CNBP;CAV1;AEBP1;ZNF124;ZBTB21;ZNF557;HSF4;PHF6;DDX5;SAP30;ZNF614
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.6968075414187413,1.0659495907090069,0.40350877192982454,0.9608082143955301,1.0,1/6,0.46%,AKR1C2
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.5246435815372009,1.0658941716939514,0.4339622641509434,0.9600523426015097,1.0,5/17,13.24%,PCTP;PITPNA;SLC25A19;PITPNC1;PITPNB
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.39053107093652617,-1.0656355565698885,0.3333333333333333,0.8607539883619734,1.0,24/87,19.85%,RAN;GTF2F1;ACTB;TMBIM6;IFIT2;BAMBI;RPL11;CAV1;TRIB3;B2M;FLOT1;EPB41;RACK1;BMP2;LRP1;PRKACA;PARK7;PIN1;BAX;RIPK2;AKT1;AMFR;GOLGA2;IFIT1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.5659352318279842,1.0654155771433245,0.4375,0.9607584150394329,1.0,6/14,24.79%,RB1CC1;ATG7;ATG5;ATG3;ULK2;ATG2B
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.6208063158531892,1.065355150421048,0.43103448275862066,0.9600130402476984,1.0,6/8,26.87%,WDR91;EEF1A2;WDR81;PIK3R1;RBL1;RBL2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.46418381770982187,1.0652276916585934,0.35714285714285715,0.9594658654516184,1.0,13/33,16.99%,SYT1;PCLO;RAB3A;SYN3;SNAP25;NAAA;CPLX1;LIN7A;STXBP3;STX1A;SNCA;UNC13A;GAD2
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6145147385059608,1.0651735164433471,0.42857142857142855,0.9587232409555079,1.0,2/13,5.71%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7296519084581279,1.0651613658785963,0.4727272727272727,0.9578214432317841,1.0,1/6,4.53%,SPIRE1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.6573519906579732,-1.0649274822083326,0.40425531914893614,0.8620487221650819,1.0,1/9,2.52%,ZDHHC6
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.628161253327378,1.0648276226089972,0.4482758620689655,0.9580715379967106,1.0,4/7,30.25%,DNM1;PICALM;AP3D1;DNM3
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.48287142226831997,-1.0647624880978634,0.34146341463414637,0.8618534052563658,1.0,5/36,6.23%,UBB;RPS27A;UBC;UBE2L6;UBA52
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.6402271401209071,1.064562443176977,0.4074074074074074,0.9581519102518254,1.0,3/5,20.18%,CNTNAP1;CNTNAP2;ANK3
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.6275861992719396,1.0644723879078992,0.46153846153846156,0.957457993039187,1.0,2/8,22.08%,DCUN1D2;DCUN1D4
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.5602198230176925,1.0644690871305997,0.46296296296296297,0.9565343183741821,1.0,5/16,24.18%,PRKCSH;MAN2A1;MAN1A1;MAN1C1;ST8SIA1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.6233835066105562,1.0643530067311031,0.4,0.9559854427098127,1.0,1/10,1.70%,SRF
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.4419873757751509,-1.0643493339011434,0.35555555555555557,0.8621332364880412,1.0,5/35,12.02%,RAN;NUP42;NOL6;NUP155;YBX1
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.6447235668287187,1.064346788191317,0.42,0.9550650260425111,1.0,1/8,1.11%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5490507067011509,1.064161300312351,0.3018867924528302,0.9548111515670581,1.0,8/19,23.96%,NLRC5;RIPK1;TRIM44;PARP9;CSF1;PARP14;IL7;UBE2K
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.714537329131488,-1.0640608496389015,0.4090909090909091,0.8620413211225278,1.0,4/5,28.25%,WNT5A;HSPD1;CD226;KARS1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6964863065051065,-1.063909154598233,0.39473684210526316,0.8617538269432221,1.0,3/6,19.08%,DBI;PRELID1;TMEM30A
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.41167482095956404,1.063896951826481,0.2878787878787879,0.9546109013081957,1.0,19/104,10.52%,CORO6;NEDD9;RAC3;NEBL;SPIRE1;BAIAP2;SHROOM3;HIP1;MYO1H;EMP2;RFLNA;MPRIP;TTN;TMOD3;ARHGAP17;RHOBTB2;PROX1;GAS2L1;TPM1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5387090338161293,-1.0638238130490265,0.375,0.8611992413567947,1.0,2/14,6.07%,PPIA;KPNA2
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.7026617415156754,-1.063338695437817,0.5,0.8592269208180867,1.0,1/5,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.7026617415156754,-1.063338695437817,0.5,0.8592269208180867,1.0,1/5,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.7026617415156754,-1.063338695437817,0.5,0.8592269208180867,1.0,1/5,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.7026617415156754,-1.063338695437817,0.5,0.8592269208180867,1.0,1/5,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.6539221690000403,1.0632813842869597,0.4074074074074074,0.9556317662673799,1.0,1/5,10.70%,HES1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.6282112519934502,1.0631297702709903,0.4117647058823529,0.9553515707705266,1.0,4/6,22.75%,FAM107A;EPHA4;ABL1;APOE
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6041384737658665,1.0631021741867346,0.4727272727272727,0.9545245527838134,1.0,1/11,2.03%,HDAC4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.4724541053994875,-1.062971869482024,0.3,0.8593534163986055,1.0,4/26,9.22%,TLR1;MAPK13;WNT5A;SPHK2
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.46453305263927674,1.0622415902191338,0.3620689655172414,0.9563363078858934,1.0,13/32,16.99%,SYT1;PCLO;RAB3A;SYN3;SNAP25;NAAA;CPLX1;LIN7A;STXBP3;STX1A;SNCA;UNC13A;GAD2
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.6503664200979491,1.0621098185887279,0.4897959183673469,0.9558623956237858,1.0,4/8,23.74%,KCNC2;NOS1;APOE;AGT
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.41761243653017655,-1.0619389981144594,0.2564102564102564,0.861670324827828,1.0,11/82,5.66%,MMP2;BGN;THY1;PRRX1;TCEAL7;AMOTL2;FIBIN;TNS2;PDGFRA;SFRP1;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.7103911222598138,1.0617284876451538,0.41304347826086957,0.9560760211561955,1.0,3/7,15.82%,PRKCA;RIPK1;CSF1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.6316862194852445,-1.0616551699555523,0.47058823529411764,0.861528450038014,1.0,3/8,14.05%,PIH1D1;NABP2;RUVBL2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.45146293944662497,-1.0616523586734814,0.2727272727272727,0.8607431004937679,1.0,3/39,4.44%,G0S2;GSTP1;NOL3
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.6769014324814657,-1.0614131119703782,0.5294117647058824,0.8605614938557998,1.0,1/5,10.91%,CST3
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.6693858786694595,1.0613229455347513,0.45454545454545453,0.9564827032984868,1.0,3/6,12.03%,CHAC2;ABHD12B;ABHD12
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.41053813974874503,-1.061246630259235,0.32432432432432434,0.8603598189209095,1.0,10/65,9.25%,CHRNA4;SLC22A17;PCSK1N;ENHO;CAMSAP3;EFNA2;SEMA5B;LINGO1;TMEM179;OGDHL
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.5079877579136761,1.0611746468966505,0.3157894736842105,0.9559836734982641,1.0,5/24,22.88%,XRCC4;RPA1;TNKS;ATRX;ATR
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.601962810920674,-1.0610908524432574,0.35555555555555557,0.8599648983221397,1.0,2/7,17.92%,BMP2;EDA
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.45012664706210265,-1.060580657103707,0.3684210526315789,0.8606804097333945,1.0,11/46,14.67%,BTG1;TRIM35;BTG3;RNF167;BRINP1;TAF6;CDKN1C;GAS1;BMP2;SMAD3;HECA
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.432135738027705,1.0604413694305903,0.36666666666666664,0.9574165781833138,1.0,18/75,16.30%,CARD14;PAK1;NTRK3;PRKAR1B;ADCY5;EMP2;PRKAR2A;PAK2;BORA;TIRAP;PDPK1;STK11;TNIK;ADCY3;STK3;ITGB1BP1;FGF1;NRG1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.5743842679675174,-1.0603601351928105,0.40476190476190477,0.8603672879883079,1.0,2/8,11.62%,SELENOS;TMCO1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.5667115222317088,-1.0600616415677495,0.4423076923076923,0.8603900934642373,1.0,3/10,14.95%,SEPHS2;PSAT1;PSPH
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.573829637618527,1.0600279233120877,0.43478260869565216,0.9578558511248336,1.0,4/14,18.97%,SOCS4;CHMP6;PPARG;CBLB
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6282973860593647,1.059981456373187,0.4482758620689655,0.9570853781378563,1.0,3/10,30.39%,CD27;IL7;ZMIZ1
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.730552772181047,-1.059633094735575,0.45454545454545453,0.8607276069100451,1.0,2/5,8.77%,DNAJC19;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.542542049557708,1.0595441463461963,0.45098039215686275,0.9575328728446493,1.0,7/18,17.35%,WNT7A;RELN;GRIN1;SHANK3;DLG4;PRKCZ;STX1B
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.546581915638878,-1.0594784053417452,0.38,0.8604254365711622,1.0,5/15,22.41%,ARFIP2;BRK1;CORO1B;CYFIP1;ARF1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.48050265095513606,1.0594464736782792,0.36666666666666664,0.956895349920268,1.0,8/37,19.75%,CRIM1;LRP2;VWC2L;CHRD;SMAD4;PPARG;UBE2D3;SMAD5
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.4059602262842406,-1.0594058820823868,0.2894736842105263,0.8597792280076775,1.0,10/89,10.56%,SSPN;PPT1;TMED2;CD63;SCAMP3;SH3GL2;CTSC;RAB14;TMX1;GNAS
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.5025331402646795,-1.0592232663987888,0.36363636363636365,0.8594784603061749,1.0,8/24,18.79%,CSKMT;KMT5B;BEND3;VCPKMT;SETD1A;ZNF335;SMYD5;ANTKMT
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.5821912598831975,1.058850404101061,0.46296296296296297,0.9577090215083368,1.0,5/16,14.80%,EDNRA;GCLC;NOS1;KCNMB4;ITGB1BP1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.3834440277057631,1.0586294543285948,0.3728813559322034,0.957613588852098,1.0,32/182,13.10%,ROBO2;UNC5D;EFNA5;SHTN1;WNT7A;EPHA7;RAB3A;DAB1;RELN;RAB10;BAIAP2;SEMA3A;LAMA2;SEMA4B;GRB10;SLIT3;PARD3;UNC5C;USP9X;PRKCA;SPTBN5;DOCK7;EFNA1;NRCAM;RANBP9;SHANK3;EPHA4;SPTBN4;PIK3CD;SOS1;SLITRK4;VASP
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6269322461077893,1.057929024483294,0.4107142857142857,0.9590352493248532,1.0,3/8,11.08%,HTR2C;KCNC2;PDE9A
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.40955938585265617,1.0575555091435718,0.3898305084745763,0.9591825880170796,1.0,23/111,14.67%,BCL2L11;SOX9;ALK;DAPK1;MADD;DAPK2;NLRC4;HIP1;WRN;FANK1;ANP32E;SEPTIN4;RIPK1;RABGGTB;ATM;SGK1;TOMM70;MOAP1;FBXO11;PPP1R13B;RTKN;TP63;BNIP3L
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.42903999971922846,-1.057541160599608,0.3076923076923077,0.8635182348358851,1.0,9/66,6.72%,MMP2;NCSTN;ARPC5;ACTG1;ACTB;APH1A;EPHB3;EFNA2;LYN
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.4511693948177522,1.0574978780153743,0.3103448275862069,0.9583290180910934,1.0,3/41,2.03%,MSL3;BAZ2A;HDAC4
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.6853771807021031,-1.0573142631384709,0.4888888888888889,0.8632853900191001,1.0,4/6,9.64%,LIN7B;AP4M1;LIN7C;CAV1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.6471704117458242,-1.0569182581212708,0.40476190476190477,0.8627806009487289,1.0,2/8,9.51%,PPT1;ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.6471704117458242,-1.0569182581212708,0.40476190476190477,0.8627806009487289,1.0,2/8,9.51%,PPT1;ABHD17A
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.6425651844281297,1.0564687976226315,0.45454545454545453,0.9606760108055444,1.0,2/7,9.17%,TMEM63C;SULF1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.448440025054775,1.0563576038473537,0.3392857142857143,0.9601005460253156,1.0,14/49,16.04%,YWHAH;SYT1;NEDD4L;NKAIN2;KCNJ13;KCNJ11;CA2;NOS1;PXK;SPTBN4;SYT12;SNCA;WWP2;SYT2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.5331043256549625,-1.0562031389877458,0.4,0.8640610713638155,1.0,4/25,5.90%,RBM22;RAN;BAG3;APOD
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.6459805040307941,1.0561789437469478,0.4444444444444444,0.9597777908239122,1.0,1/6,0.27%,PTPRC
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5586645195481319,1.0561516919021463,0.43636363636363634,0.9589615946221407,1.0,4/15,21.58%,SLC4A4;CA2;SLC39A8;SLC4A8
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.5744397223215959,1.0561447309242953,0.5,0.9580603678636226,1.0,4/11,12.09%,KCNJ11;RYR3;TAF1;P2RY12
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.5016299490890431,1.055983339149769,0.4098360655737705,0.9576107246270955,1.0,3/30,8.93%,KIF1C;TRAK1;NEFL
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.6336251499295438,-1.0559769134415056,0.4489795918367347,0.8639091444527921,1.0,1/9,0.69%,H1-4
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5110127862936731,1.0558680158845848,0.4067796610169492,0.9570150125447496,1.0,1/25,1.17%,BCL9
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.42625180976616966,1.055714275798853,0.3275862068965517,0.9565844958607739,1.0,12/85,9.64%,SOX9;SRF;MEF2D;ZFPM2;KAT2B;NTRK3;MMP21;PKP2;TGFBR3;MICAL2;SH3PXD2B;BMP7
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.599397257658355,1.0551507039416466,0.42,0.9573624917191869,1.0,5/11,24.40%,PROX1;PIEZO1;NRG1;MAML1;EFNB2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.5078438094780634,1.0551235274994868,0.46,0.9565877389814516,1.0,5/25,8.19%,GLRA1;GLRA2;NSMF;SLC38A9;RPTOR
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.6781398361293505,-1.0549452877732861,0.43636363636363634,0.8649331090044041,1.0,4/5,31.51%,HLA-B;HLA-F;HLA-A;HLA-C
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.6781398361293505,-1.0549452877732861,0.43636363636363634,0.8649331090044041,1.0,4/5,31.51%,HLA-B;HLA-F;HLA-A;HLA-C
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.48155019562369245,-1.054882102190495,0.40425531914893614,0.8643388718496873,1.0,5/34,4.52%,SLITRK2;CLSTN2;NLGN2;SYNDIG1;EPHB3
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.5751163684133072,1.0543663919220245,0.4166666666666667,0.9579669451452838,1.0,6/11,31.74%,SLC8A1;SLC6A1;SLC9A9;HCN2;SLC9C1;SLC9A5
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.45291814379735357,1.0541647683531998,0.3620689655172414,0.9577091960364069,1.0,18/60,21.99%,SLC6A17;SLC4A4;SLC13A3;LRP2;ABCA2;SLC6A6;SLC1A4;SLC29A2;SLC8A2;SLC19A1;ATP8A1;SLC6A1;SLC2A3;SLC27A4;SLC16A7;SLCO2B1;SLC4A8;SLC24A3
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.43834377305744676,-1.0539812615228188,0.325,0.8657928461334973,1.0,9/53,9.61%,UBB;RPS27A;UBC;DYNLL2;UBA52;PHB2;AUP1;ACBD5;UFL1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6439249805753893,1.0537413147648458,0.5,0.9581394220676369,1.0,2/8,20.83%,PARD3;DGKD
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.45773199400688624,-1.0535977212419059,0.38095238095238093,0.8661112745375276,1.0,9/33,19.85%,BANF1;IFITM3;SHFL;ISG20;IFIT5;ISG15;SRPK1;MORC2;IFIT1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6783511889736344,-1.0532767114982735,0.42857142857142855,0.8662187746944278,1.0,2/5,11.61%,LCAT;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.6528701744606432,-1.0532181720080558,0.42857142857142855,0.8648033252885118,1.0,3/7,16.00%,SPHK2;RACK1;SMPD3
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6528701744606432,-1.0532181720080558,0.42857142857142855,0.8648033252885118,1.0,3/7,16.00%,SPHK2;RACK1;SMPD3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6133995211519928,1.0531898675852887,0.41818181818181815,0.9590324427176992,1.0,4/8,13.87%,CTBP1;KLF15;BRCA1;SNCA
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.4543575522741329,1.053140762061388,0.3508771929824561,0.9582597808838446,1.0,3/33,8.22%,SYNJ2;PLPP4;PIP4P1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.5782112541280879,-1.0530758940284524,0.40384615384615385,0.8643822169352102,1.0,2/10,2.06%,BTG1;BAD
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.46662896145905564,1.0529039599216417,0.4,0.9581312683637517,1.0,10/57,11.27%,PTPRC;YJEFN3;KITLG;ARIH2;PRKX;ZNF160;TGFBR3;ZBTB16;TIRAP;ETV6
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5704193874530146,-1.0525425328966462,0.42,0.86491009354842,1.0,2/13,1.16%,S100A10;PPT1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6203049751627246,1.0523437141062681,0.46808510638297873,0.9588591005041782,1.0,1/11,2.28%,FMNL3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.6245311899791735,1.052306412572537,0.4696969696969697,0.9580032665171242,1.0,3/9,18.77%,GALNT16;GALNT13;POGLUT2
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.4026510734431533,1.0519012997290156,0.3392857142857143,0.9583282368025655,1.0,25/84,21.70%,MCCC1;CKMT2;ALOX12;PDHA1;NAAA;ACSBG2;GPAM;ACSF2;ACOT11;HLCS;AOAH;SLC6A8;ME2;CPT1A;SLC16A3;AKR1C1;PPARG;ME3;ABAT;CPT1C;SLC27A4;PC;FA2H;LDHA;ACSL3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5315968627921155,1.0516933412435416,0.42592592592592593,0.9579952627993845,1.0,5/20,19.22%,PMS2;RPA1;PMS1;MSH6;ABL1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.5653544962576346,-1.0513624463881655,0.4,0.8677805779543307,1.0,3/11,9.92%,NOP10;NHP2;PUS3
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5184738458995618,-1.0512471707224054,0.3333333333333333,0.8673380187572965,1.0,7/17,20.00%,SIRT2;CACTIN;NFKBIL1;MUL1;PCBP2;LYAR;TRAFD1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.34936448841308465,-1.0503172682082473,0.3,0.8692953590677194,1.0,45/298,10.48%,EIF5A;UBB;CCND1;MMP2;PSMB6;MT2A;CFL1;PSMD8;RPS27A;TXNDC17;AIP;PSMB4;UBC;IL20RA;HSPA8;MT3;PPIA;PSMA7;JAGN1;IFIT2;ALOX5;RPLP0;IRF3;YAP1;CXCL12;UBA52;IL12RB2;CANX;LIMS1;PTPRZ1;NDN;HLA-B;IFITM3;PSMC3;TNFRSF14;PSMC1;IFI6;PSMD10;PSMD12;LAMA5;F13A1;PSMB9;PSME3;CD44;FN1
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6558962155920478,1.0503083709520649,0.4528301886792453,0.9607224238704605,1.0,7/8,33.12%,AGO1;AGO4;TNRC6A;RBM4;TNRC6C;AGO3;AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.6558962155920478,1.0503083709520649,0.4528301886792453,0.9607224238704605,1.0,7/8,33.12%,AGO1;AGO4;TNRC6A;RBM4;TNRC6C;AGO3;AGO2
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.38613183954933017,-1.0502053287314674,0.43243243243243246,0.8687428352242939,1.0,10/76,9.50%,PRDX5;IDH1;PRDX1;TSPO;CRAT;IDI1;PEX11A;SLC25A4;FADS1;CNBP
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.5701246736725123,1.0499544578547477,0.4423076923076923,0.9608563315527775,1.0,5/13,26.60%,SORBS1;PPARG;EEF1A2;APOE;CREBL2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.5616387682788689,-1.04993434713793,0.43478260869565216,0.8687179614206836,1.0,4/12,15.47%,SARS1;AARS1;POP5;DTD1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5625386820172507,1.0498929841982918,0.34,0.9601650374818125,1.0,5/19,21.12%,PARN;CNOT11;CNOT7;SAMD4B;SAMD4A
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.5752847068355855,1.0496906902510896,0.39285714285714285,0.9599423582634786,1.0,5/12,16.33%,PRKAR1B;AKAP5;PRKAR2A;AKAP12;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6136973607551482,1.0495996712690068,0.47540983606557374,0.9592871752525043,1.0,1/7,1.67%,NEDD4L
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.5729571553468609,1.0495777959473656,0.41509433962264153,0.958472088121542,1.0,8/12,35.38%,UFD1;SEC14L1;ZCCHC3;NOP53;ANKRD17;NPLOC4;PUM2;PUM1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.40932600741985015,1.0492857289248367,0.39285714285714285,0.9584634405068935,1.0,14/97,10.68%,PTPRC;IGF1R;EPHA7;PAK1;NTRK3;PTPRJ;CAV3;TGFBR3;PAK2;NBR1;ZNF622;ROR1;DUSP1;TRAF7
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.5982216348694261,-1.0492506807954736,0.425531914893617,0.869695897593223,1.0,1/12,2.86%,TRMT10C
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.6620758694556269,1.0490548746364918,0.3877551020408163,0.9582177940842096,1.0,2/5,23.39%,ATM;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.6266544138573757,1.0490458733175385,0.42592592592592593,0.9573383395141863,1.0,2/9,4.93%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.4826675196690625,1.0489476623029137,0.38181818181818183,0.9568153867595431,1.0,7/34,10.27%,HEY2;SOX9;TGFBR3;FBXL17;LOXL3;BMP7;RANBP3L
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.45274696937369013,-1.0488429194355586,0.41304347826086957,0.8699082945368328,1.0,6/37,13.35%,STOX1;HAX1;VPS35;MFF;PRMT6;FIS1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6807326093885614,1.048409166289368,0.4406779661016949,0.9579478682355134,1.0,3/7,23.64%,UBA5;AGTPBP1;MYCBP2
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.5729124492257718,1.0483105146273248,0.42857142857142855,0.9574421890214646,1.0,5/10,13.87%,CTBP1;SPI1;SIN3A;BRCA1;SNCA
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.6431565429978392,1.0481948040636506,0.48148148148148145,0.9569290269826848,1.0,3/6,21.06%,ADCY3;SLC6A1;BRSK1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.5290515268319631,-1.04819458554541,0.38095238095238093,0.8709924679227253,1.0,1/19,0.35%,BTC
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.6540556431991825,-1.0481663729974748,0.44,0.8687376780419628,1.0,3/6,16.63%,TMED2;TMED9;ARFGAP2
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.6540556431991825,-1.0481663729974748,0.44,0.8687376780419628,1.0,3/6,16.63%,TMED2;TMED9;ARFGAP2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.6540556431991825,-1.0481663729974748,0.44,0.8687376780419628,1.0,3/6,16.63%,TMED2;TMED9;ARFGAP2
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.531942280956669,1.0479464617926024,0.40816326530612246,0.9568713672807488,1.0,3/19,2.52%,NEDD4L;KCNJ13;KCNJ11
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.5995077240820152,-1.0477673366321545,0.38461538461538464,0.8689006041096694,1.0,4/9,18.26%,VPS35;MFF;FIS1;BAX
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5164025051194232,-1.0471156144528913,0.4186046511627907,0.8699710254600874,1.0,5/19,21.08%,IL12RB2;ZP3;IL18;ISG15;HSPD1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5280026027264816,1.0471058436620235,0.4642857142857143,0.9586639492342861,1.0,6/31,9.72%,HEY2;RTN1;UNC5C;CRMP1;NRCAM;CDK6
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.6878070417511317,-1.046690083302732,0.4782608695652174,0.8703691846496648,1.0,2/5,11.85%,ATP6V1G1;ATP6V0D1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.5351122707089206,1.0465175938724813,0.40816326530612246,0.9597222351667878,1.0,5/18,11.69%,GLRA1;GRIN2A;GRIN1;MAPK8IP2;ARRB2
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.664405694649826,-1.046511811177426,0.4444444444444444,0.8700377547642559,1.0,1/6,1.10%,ASCL1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.5101248193684235,1.046493074735333,0.375,0.9588814926793424,1.0,8/19,17.88%,NR4A3;CAV3;PRKCA;PDE9A;MLIP;IL6ST;CAMK2D;SMAD4
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.44471642934264694,-1.046114179679878,0.42105263157894735,0.8696322863180228,1.0,3/43,1.84%,SIRT2;RAN;BANF1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.44471642934264694,-1.046114179679878,0.42105263157894735,0.8696322863180228,1.0,3/43,1.84%,SIRT2;RAN;BANF1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.6374340657535464,-1.0459849501103857,0.4090909090909091,0.8691648382790945,1.0,2/6,8.97%,PIH1D1;DNMT3B
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.49169147333779795,-1.0457253490637297,0.4318181818181818,0.8691889766551506,1.0,2/20,1.90%,SIRT2;ATF4
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.4272592324404652,-1.0455992667904976,0.4,0.868810995307308,1.0,13/57,10.54%,MPDU1;OST4;DDOST;ALG2;MAGT1;DAD1;UBE2J1;OSTC;DPM2;ALG10;STT3A;ALG8;RPN1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.6740805648559923,1.0454799762238596,0.45454545454545453,0.9610697636293969,1.0,3/6,23.74%,ABCA2;APOE;AGT
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.3893981691667189,-1.045042719262371,0.3548387096774194,0.8694428889155447,1.0,20/117,10.06%,GSTP1;SIRT2;THY1;PMEPA1;CALM1;RTRAF;PPIA;SH3GL2;GSKIP;SFRP1;QARS1;LYN;CADM4;CEP85;TAF7;CALM3;PPP1R15B;CAV1;CACTIN;ZBED3
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.6081202469810962,-1.0449622838375263,0.43478260869565216,0.8688793429129407,1.0,3/11,17.90%,MFF;FIS1;SUPV3L1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.3896341828416014,-1.0449410101578367,0.3958333333333333,0.8681505017824669,1.0,19/110,7.19%,SLC22A17;OLIG1;THY1;TCEAL6;TCEAL7;S100B;CNP;BAG3;MT3;SYNDIG1;LGI3;GPR37L1;TNS2;CMTM5;EDNRB;APOD;BCHE;CADM4;CD82
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.560605540786751,1.0447237129009987,0.42105263157894735,0.9625418037750973,1.0,2/14,15.01%,ASPA;MTHFD1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.5257975206035115,-1.0444062200628015,0.3783783783783784,0.8688985893246708,1.0,2/18,7.47%,SMDT1;PHB2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6745239699416631,1.0443352486854929,0.45454545454545453,0.9630735919123388,1.0,1/6,0.27%,PTPRC
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.6397860172718395,-1.0437054749070156,0.46511627906976744,0.8698894749677746,1.0,2/7,4.42%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.6521100688046975,-1.043589579233606,0.48717948717948717,0.8694543244075683,1.0,3/6,11.78%,KDELR1;GPAA1;OS9
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5230269796757255,-1.0427864793848323,0.4523809523809524,0.87068668038854,1.0,3/20,5.34%,RBM22;BAG3;PTPN14
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.5301130731078847,1.0427457552388395,0.38596491228070173,0.9671586815331279,1.0,9/26,23.98%,MYLK;PKP2;AHCYL1;ANK2;GPD1L;ANK3;ATP2B1;SNX4;CACNA1D
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5107933488387314,1.0424531046371788,0.32653061224489793,0.9671922572983279,1.0,5/23,21.58%,SLC4A4;CA2;TMEM165;SLC9A9;SLC4A8
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.4310162478619411,1.0420582146759028,0.35185185185185186,0.9676014121677574,1.0,12/62,13.39%,STMN2;PAK1;SYNPO2;BAIAP2;PSEN1;CAV3;LIMK1;CRACD;PROX1;CDC42EP3;VASP;CDC42EP4
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.7092408166532838,1.0420313772796685,0.4528301886792453,0.9658594760594512,1.0,2/5,23.01%,PHLDB2;CLASP1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.7092408166532838,1.0420313772796685,0.4528301886792453,0.9658594760594512,1.0,2/5,23.01%,PHLDB2;CLASP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.4729276140387272,-1.041701492610537,0.4772727272727273,0.8726765062914751,1.0,5/29,8.15%,SIRT2;CALM1;STOX1;CADM4;CALM3
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4447614728982306,1.0416582924177729,0.3870967741935484,0.9663103505084883,1.0,3/38,7.02%,ROBO2;TENM3;PVR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.658995467656007,-1.0415236651473516,0.42857142857142855,0.8723957520794494,1.0,2/5,9.22%,WNT5A;SPHK2
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.5170488825257168,1.041517838278362,0.3958333333333333,0.964849795007423,1.0,3/17,2.70%,IL1RAPL2;MDGA1;WNT7A
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.5170488825257168,1.041517838278362,0.3958333333333333,0.964849795007423,1.0,3/17,2.70%,IL1RAPL2;MDGA1;WNT7A
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.3646420356073278,-1.0414972520926407,0.3333333333333333,0.8717168946070245,1.0,34/174,14.58%,COL9A3;MMP2;BGN;FBLN5;BCAN;HSPG2;CD151;AGRN;COL8A1;PPIB;COL12A1;ADAMTS6;VWF;MADCAM1;COL4A4;HAS2;COL9A2;LAMA5;CD44;FN1;ADAMTS2;FURIN;COLQ;CAPN1;HAPLN1;ITGB5;ITGA4;ADAMTS3;FLOT1;TIMP2;NCAN;CTSK;TIMP1;CTSL
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.5583943986163409,-1.041284255717474,0.4339622641509434,0.871573444572869,1.0,3/12,9.09%,GSTP1;ALOX5;FADS1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.6406380874156016,1.0411848427668224,0.4230769230769231,0.9650762116647783,1.0,3/8,21.12%,BMP7;HES1;TGFB2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5630907499388202,1.0410681138266806,0.4827586206896552,0.9645225795206704,1.0,5/14,21.70%,ACSBG2;ACSL1;ELOVL2;ACSBG1;ACSL3
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.3895692953578603,1.0410082554372306,0.3448275862068966,0.963845666738449,1.0,20/118,13.25%,PTPRC;HTR2C;PTPRR;SPRED2;EPHA7;NTRK3;LMO3;TIMP3;DUSP4;PRKCA;TGFBR3;GCNT2;RANBP9;ROR1;PRXL2C;TIRAP;TRAF7;ARRB2;DENND2B;CAMK2N1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.4046076708021575,-1.0409684760708688,0.35714285714285715,0.8716437502855494,1.0,15/74,10.52%,BGN;HSPG2;AMOTL2;FIBIN;RARRES2;COL12A1;TNS2;YAP1;CXCL12;S100A16;HAS2;LRIG3;CAV1;FN1;COBLL1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5862744196672679,1.0408591114071193,0.4406779661016949,0.9634845874190684,1.0,1/13,0.27%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.6598021526879935,1.040721100038301,0.46153846153846156,0.9630662703623466,1.0,3/8,12.01%,TMSB4X;XRCC4;ATPSCKMT
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.3814377718134623,1.0405296930154286,0.3392857142857143,0.9627396181658854,1.0,41/120,24.76%,SYNJ2;INPP4B;IGF1R;RGS4;ADGRL2;SCN8A;RXRA;PRKCA;TGFBR3;MAP2K5;DUSP1;GRK5;ATXN1;PIK3CD;APBB2;AKT3;GJA1;SIPA1L1;MAGI2;BHLHE40;CDK13;PRKCE;PPARG;TJP1;PDLIM5;NEK7;LPAR1;SFMBT1;ATP2B1;ATRX;COL5A2;TOGARAM1;NIPBL;IGFBP5;NFKB1;LAMC1;MAP1B;PRDM2;GCNT1;IRS1;BCKDHB
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5006128702348818,-1.0404543451457784,0.41509433962264153,0.8721793656062019,1.0,5/23,10.47%,SIRT2;SVIL;MAP10;GIPC1;CENPV
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5629963557989702,-1.0402049296600928,0.39215686274509803,0.8721327688452272,1.0,3/8,14.33%,SFRP1;LYN;RC3H1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.6195839072787084,-1.0401765492825112,0.45454545454545453,0.8714183506883545,1.0,2/8,8.20%,DHFR;DHFR2
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.5699399018168224,1.04008950469863,0.4827586206896552,0.9631978920827005,1.0,1/12,0.27%,PTPRC
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.39184199363117933,-1.039868414381219,0.32558139534883723,0.8712854484798127,1.0,24/110,12.42%,PPIF;CCND1;ASCL1;UGDH;COX6C;SLC16A1;BTG3;BLVRB;FABP5;CXCL12;OPN3;SCUBE2;GALE;DCXR;MAPK13;PDLIM3;CAV1;CD44;PRKAR2B;FKBP4;CKB;SCARB1;DHCR7;ISG20
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5199579250053779,-1.0397325609380115,0.34146341463414637,0.8709208622585952,1.0,7/23,11.17%,ACTG1;ACTB;PPIA;PDGFRA;FN1;GNAS;TLN1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.5344898882835275,-1.0397089676119182,0.42105263157894735,0.8702479528909078,1.0,3/14,2.92%,ODC1;TMEM9;RARRES2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.4303837437412296,-1.0396423960740837,0.3939393939393939,0.8697401907928238,1.0,3/59,3.37%,CDKN2C;CCND1;DHFR
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.6137547856274151,1.0396140906815723,0.4117647058823529,0.9635398497961039,1.0,3/8,16.57%,NMI;TIRAP;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.5115156145832511,1.0393818214811197,0.38235294117647056,0.9633949622515829,1.0,5/26,12.19%,PTPRC;SHLD2;TIRAP;CD27;TP53BP1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5900220251548651,-1.03897407091658,0.4444444444444444,0.8707368489083941,1.0,2/11,6.61%,CUL7;CUL9
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.4807827434299132,1.0388785157816696,0.4107142857142857,0.9639831238769578,1.0,6/28,8.19%,GLRA1;GLRA2;GRIN1;NSMF;SLC38A9;RPTOR
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.620928192252058,1.038873727749744,0.5,0.9631059781773428,1.0,4/9,16.45%,SPI1;SERTAD2;ARID1B;PADI2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.6269135680291186,1.0386073546085046,0.509090909090909,0.9629947544980136,1.0,2/9,9.80%,RAB1A;PTPRN
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.44340552894789775,-1.0384877774397636,0.37209302325581395,0.8714428993004835,1.0,8/31,17.46%,PMEPA1;DDX54;YAP1;WBP2;DDX5;AR;NCOA4;RNF14
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.6441529683358027,1.0384466440389937,0.4791666666666667,0.9625717107746345,1.0,1/5,16.60%,TENT4B
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6113582509170163,-1.038216569711742,0.46808510638297873,0.8713491467982298,1.0,3/9,19.77%,LDLR;CD9;CD81
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.6926825671973309,1.0380361454052083,0.4838709677419355,0.9629615968103753,1.0,2/5,24.22%,MAPK8IP2;NCK2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.3693305641331767,-1.0378781565800328,0.3695652173913043,0.8715055015307263,1.0,22/117,14.01%,RRAGA;DAPL1;ATF4;HSPA8;GABARAPL2;ATP6V0E1;ATP6V1F;ATP6V1G1;SFRP1;MAP1LC3A;ATP6V1B2;FADS1;RRP8;TFEB;MLST8;ATP6V0E2;LAMTOR4;ATP6V0D1;WDR45B;MYBBP1A;HSPA5;MAP1LC3B2
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.4148740439382464,-1.037794544025244,0.4146341463414634,0.8709412068251619,1.0,17/68,17.73%,CDKN2C;PPIA;SH3GL2;LYN;CADM4;PPP1R15B;CACTIN;ZBED3;CDKN1C;TARDBP;ANKLE2;PRNP;PARK7;DYNLL1;PRDX3;CDKN2D;FBP1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.6219335944125335,1.037488462155323,0.4745762711864407,0.9629858808222869,1.0,6/14,14.80%,FAM107A;DUSP22;PHLDB2;BCAS3;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.6219335944125335,1.037488462155323,0.4745762711864407,0.9629858808222869,1.0,6/14,14.80%,FAM107A;DUSP22;PHLDB2;BCAS3;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.601414235662334,1.0374027566867114,0.43333333333333335,0.962368023292407,1.0,3/9,6.46%,SLC2A12;SLC2A9;SLC2A6
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.515441386174222,-1.0372571532977055,0.35714285714285715,0.8715966799582884,1.0,2/15,9.64%,SYT11;CAV1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.5252843544580457,1.0370318027425713,0.4,0.9627321614576643,1.0,6/14,25.49%,FUT2;DUSP4;OVOL2;LIPH;GOLPH3;QSOX1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.5449890384113665,-1.0364093119932833,0.4230769230769231,0.8730277125895036,1.0,3/12,11.61%,ALOX5;DHRS11;PYCR1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6377936165597025,1.036369005860988,0.5,0.9638306359973488,1.0,3/6,26.56%,NCOR1;STAT3;NCOR2
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.6235404937851882,1.0361946744468944,0.40384615384615385,0.9634503066885793,1.0,4/6,16.26%,FOXP1;DYSF;CSF1;ADAM10
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.47505528267760666,-1.0359947805659147,0.3617021276595745,0.8732779026837484,1.0,3/25,8.34%,MAP7D3;TUBG1;TUBGCP4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.4503506315030076,-1.035894141609701,0.358974358974359,0.8727714556233158,1.0,6/32,9.62%,UBXN1;RPS7;RPL23;RPL11;HSP90AB1;GIPC1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.3706842288798938,-1.0355809563665976,0.3023255813953488,0.8729927450941712,1.0,18/112,12.10%,PSMB6;THY1;PSMD8;LAT2;PSMB4;ERMAP;MALT1;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;EIF2B2;IKBKB;PSMD2;BTN3A3
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.3675674454485177,1.035555171267858,0.3382352941176471,0.9647581013988421,1.0,38/221,15.86%,PTPRC;CARD14;SOX9;EFNA5;AKT2;BRAT1;IL5;MMD2;PAK1;RELN;ENPP2;NTRK3;CACUL1;FGF9;PTPRJ;RB1CC1;DOCK7;RPTOR;EFNA1;RIPK1;PAK2;BMP7;MMD;GDF11;WDFY2;NOS1;BMP8A;CAMK1;TNIK;SNCA;FAM20A;IL6R;MTCP1;SEMA4D;ARRB1;FGF1;CSF1;TAB2
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6545706805320887,1.035431890533303,0.5,0.9642473093183439,1.0,5/8,27.05%,MACF1;SEMA4D;MYO9A;MOV10;NTNG1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.5597583117866084,-1.0354169570916558,0.425531914893617,0.8726976356630972,1.0,2/13,4.14%,FTL;NR2F6
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.6118553701488315,-1.0353432943499101,0.425531914893617,0.8721452379461216,1.0,2/9,9.51%,PPT1;ABHD17A
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.4841448999443406,1.0352641796943687,0.38461538461538464,0.9638757691580623,1.0,4/26,9.17%,SOX9;SH3PXD2B;ZBTB16;SULF1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.47687923034339486,-1.0351216597588297,0.41025641025641024,0.8718799711817714,1.0,4/18,12.27%,SIRT2;MT3;ACBD5;ACOX1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.510962907734703,1.034970707787658,0.39285714285714285,0.9639276511266334,1.0,2/22,4.53%,FAM107A;SPIRE1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.4896835986301289,-1.034726605715497,0.35555555555555557,0.8722061133909955,1.0,2/22,1.16%,SIRT2;PPT1
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.6457999771296293,1.0339100364639324,0.4807692307692308,0.9662456391408549,1.0,1/7,0.27%,PTPRC
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5044000922030314,1.0338853909486496,0.43137254901960786,0.9654756566572241,1.0,3/25,3.67%,PTPRC;CAMK1D;MERTK
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.532928489106822,1.0337322027456817,0.44642857142857145,0.9651611037784268,1.0,7/16,22.38%,PRKAR1B;ADCY5;PRKAR2A;ADCY3;ADCY1;ADCY2;PRKACB
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5730797417707426,1.0336075640278808,0.48,0.9646932004944582,1.0,1/12,0.84%,BCL2L11
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6640498409365994,1.0331257549077457,0.5,0.9652540083437773,1.0,2/7,17.44%,GRIN1;CPEB4
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.46452906714347764,1.0329576755108265,0.42105263157894735,0.9649404977788887,1.0,7/38,10.22%,PTPRR;KIAA1217;ARNT2;SULF1;PROX1;BMP7;BRCA1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.44053544807899914,1.0329350852144106,0.3684210526315789,0.9641832011604455,1.0,3/40,2.03%,MSL3;BAZ2A;HDAC4
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.590752869066711,-1.0327237203358457,0.46153846153846156,0.8764458516308243,1.0,2/10,13.00%,MALT1;B2M
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.5843577566886793,-1.0323124962244963,0.4166666666666667,0.8768436873218024,1.0,3/10,13.46%,CFL1;TWF1;DSTN
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.6425143755721536,1.0322991826712515,0.4166666666666667,0.9652999172257906,1.0,4/6,18.50%,DENND6A;ADAM19;PTPRU;TJP1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.42719476884399765,-1.0320550817261231,0.4166666666666667,0.876746467259761,1.0,2/37,4.84%,SOX4;E2F4
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.6488966649667157,1.0320293295801977,0.5,0.9654388229563835,1.0,3/7,28.51%,RAB20;SYT7;PIKFYVE
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3866053101998878,1.032008506686789,0.35294117647058826,0.9646267050893885,1.0,24/137,12.82%,PTPRC;PTPRB;INPP4B;ITPK1;GPI;G6PC2;EPHA7;ALK;PAK1;PPA2;ACYP1;DUSP4;INPP5A;PLA2G15;PIP4P1;INPP4A;DUSP8;PAK2;PFKFB3;ITPKB;TOP1;PIP4K2A;PIK3CD;GPD2
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5457372893135799,-1.0320044694745751,0.375,0.8761839478638943,1.0,4/13,12.32%,FGFBP3;SPRY1;DSTYK;GPC1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.5171119108252918,-1.031812362765353,0.4375,0.8759450827067061,1.0,3/16,3.86%,ASCL1;CALR;HES5
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.582691475822776,-1.0317315181664248,0.45098039215686275,0.8754126426938639,1.0,4/11,18.02%,ZNF304;PPHLN1;TRIM28;MORC2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4663475199540019,-1.0316810351865406,0.38095238095238093,0.8747674006949401,1.0,3/24,5.03%,JUN;MMP2;ERN1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.45707492926501025,-1.03144877485697,0.38095238095238093,0.8745682058805114,1.0,11/35,14.29%,ROMO1;SEC61G;TIMM23;SEC61B;DNAJC19;TIMM44;AIFM1;GRPEL1;TIMM21;HSPA5;SEC62
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.41595297612628584,-1.0312285244790507,0.42105263157894735,0.8744639391231256,1.0,19/67,16.36%,TUBB2B;DLL3;RND2;IGFBPL1;EFNA2;LINGO1;ACHE;ACLY;TMEM179;OGDHL;POU3F2;GDAP1L1;ZDHHC22;NCAN;FAM171A2;MSI1;SCG2;TMEM59L;CSPG5
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.474424773622716,1.0310593907092926,0.4222222222222222,0.9664967663979706,1.0,4/37,7.18%,ACACB;ABCA2;MKLN1;CNDP1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.40691657514393453,1.0307181340041804,0.38,0.96661010731143,1.0,27/105,19.49%,RASGRF1;RAC3;ARHGAP26;RACGAP1;RELN;BCR;TIAM1;ARHGAP24;ARHGEF17;ARHGAP17;ARHGEF6;SRGAP3;RHOJ;SOS1;ARHGAP31;ARHGDIG;ARHGAP35;TIAM2;ARHGEF7;ITSN1;ARHGAP32;SOS2;ARHGEF4;ARAP2;AKAP13;ARHGAP20;PREX1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.5265425639455086,1.0303097152561727,0.42592592592592593,0.9670928998417327,1.0,1/13,0.41%,CHRM3
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.5804042740806868,-1.0296060041678015,0.44680851063829785,0.8780363691266398,1.0,2/14,4.76%,DBI;LPCAT1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.5976672987317013,-1.0295410621263477,0.46938775510204084,0.8774855235889879,1.0,2/7,4.42%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.4317947007874869,-1.0294659883926383,0.35714285714285715,0.8769827818981869,1.0,12/59,14.03%,IPO13;RAN;PTTG1IP;PRICKLE1;RPL23;KPNA2;PHB2;PPP1R10;NUP155;RANBP6;FAM53C;RANBP17
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.4348615054842437,-1.0292510402311488,0.4090909090909091,0.8760457694415608,1.0,4/33,11.42%,RAN;NUP42;NOL6;NUP155
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.4348615054842437,-1.0292510402311488,0.4090909090909091,0.8760457694415608,1.0,4/33,11.42%,RAN;NUP42;NOL6;NUP155
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.4494018923989156,-1.0290098149221094,0.38,0.8760819603449085,1.0,3/32,5.79%,CHRNA4;C12ORF57;MAGT1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.4405499495524631,1.028829541127614,0.39655172413793105,0.9704892894184994,1.0,12/37,17.71%,PTPRC;SEPTIN6;NR4A3;SPI1;NAAA;ETV6;ADAM19;MACROH2A1;AOAH;CAMK2D;CADM1;PDPN
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5642474985897719,-1.0287653022408096,0.4339622641509434,0.875892403227344,1.0,1/9,6.56%,WTIP
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.33240402615051007,-1.0286262754672524,0.36363636363636365,0.8755528318109431,1.0,49/334,13.99%,SOX4;BTG1;ZNF488;RPL10;SOX21;CALR;ZNF114;ATF4;ESRRB;ZNF460;SPIN2B;PCIF1;HES6;ZNF22;PHF1;RABL3;ZNF92;ZNF676;ZNF257;SLC2A4RG;RNF6;ZNF117;WTIP;DRAP1;MED23;MLF2;CHD3;EDF1;FADS1;RPL6;CNBP;ZNHIT3;TFEB;SAP30;ZSCAN21;ESRRA;MZF1;YBX1;ZNF217;TRAPPC2;DSCC1;ZFPL1;PPP2R1A;PRMT5;MYBBP1A;ASCC2;SRSF10;AKAP17A;BMP2
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.614844196335467,1.028575353493596,0.5454545454545454,0.9704383524854154,1.0,1/6,6.30%,SPI1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.658112029393745,1.0284782087119813,0.4807692307692308,0.9697944280531113,1.0,2/7,14.47%,TTN;SLC8A1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.5772120570114269,-1.0284357016577217,0.4489795918367347,0.8753358717079339,1.0,3/12,12.71%,BANF1;RBM15B;NPM1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.6331044926059886,-1.0283495702006824,0.4666666666666667,0.8747440735198523,1.0,5/11,19.10%,SFRP1;ATRAID;SOX8;BMP2;GREM1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.3984288327223466,1.0281879791042052,0.3968253968253968,0.9697762266848549,1.0,9/91,4.93%,ROBO2;STMN2;CAMK1D;PLXNA4;TENM3;RELN;NTRK3;TIAM1;CAMK2B
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.4059992029274554,-1.0280730386236303,0.4473684210526316,0.8747624571237114,1.0,8/60,9.64%,UBB;PTTG1IP;CENPX;MALT1;PRICKLE1;PSMD10;STUB1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5339020410182274,1.0278738768352864,0.4,0.9697260560115345,1.0,5/14,15.47%,NR4A3;PRKCA;PDE9A;IL6ST;CAMK2D
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.5234385072207735,-1.0277139639980661,0.46511627906976744,0.8749493684444734,1.0,5/19,15.92%,ZFP36L1;SGPP1;CTSK;CTSL;NUMA1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.5266844328327868,-1.0272195686200147,0.4230769230769231,0.8753885943260609,1.0,2/12,6.72%,RARRES2;LYN
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.5749757979557144,1.027034731273278,0.4576271186440678,0.9712186821629092,1.0,4/11,10.16%,RIPOR2;DOCK8;OXSR1;DUSP1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.6468334074944443,-1.0267386016660787,0.4782608695652174,0.8759205749250827,1.0,1/7,4.18%,JMJD6
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4327552442852631,1.0266876498560522,0.423728813559322,0.9712232295915512,1.0,5/49,7.87%,HEY2;SOX9;SRF;AGO1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.3467823704117161,1.0265563770757935,0.3392857142857143,0.9707490172172468,1.0,62/324,16.83%,TMSB4X;RFC4;PEX5L;GNA12;NUAK1;PIP4K2C;RMI1;RAC3;ARHGAP26;RACGAP1;PAK1;PIP5K1B;DAPK2;BCR;NTRK3;TIAM1;ING5;ARHGAP24;ARHGEF17;PRKAR1B;WRN;ARHGAP17;AKAP5;PIP4P1;ARHGEF6;CYLD;PRKAR2A;SRGAP3;PAK2;TAF3;ATM;SGK1;BRCA1;RPA1;RAD9A;RHOJ;TAF1;PRKAA2;PDPK1;PIP4K2A;STK11;SOS1;AKAP12;TNIK;BANP;MAPKAPK5;PPP1R13B;TP63;ANKRD54;STK3;ARHGAP31;PRKAA1;FGF1;ARHGDIG;TAF15;ARHGAP35;TIAM2;ARHGEF7;VRK2;ITSN1;ARHGAP32;BARD1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.41011358674042614,1.0265507359604589,0.43333333333333335,0.9699248661592587,1.0,19/81,18.32%,CALCB;CAMK1D;IL5;GPRC5C;NRIP2;PTPRJ;TG;RYR2;ZBTB16;SGK1;NOS1;CPEB3;TENM2;ARHGDIG;NUDT11;BARD1;SNCB;MFSD6;EFHD1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5033796724895758,1.0265261958882812,0.42857142857142855,0.969173853573868,1.0,6/27,8.27%,SOX9;SRF;FOS;SPI1;TEAD1;NFATC3
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.5531432758773559,1.026356284161196,0.4909090909090909,0.9687822787935666,1.0,3/15,16.00%,RFC4;LIG3;GINS1
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.6273106270067591,1.0261446274460353,0.5333333333333333,0.9685583664285854,1.0,1/6,4.34%,TTLL4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.6102665897279758,1.0260349781584466,0.4909090909090909,0.9679138082537639,1.0,3/10,22.65%,MAPK1;MAPK3;DENND10
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.5838941382356211,-1.0259670064160633,0.3902439024390244,0.8772923540745248,1.0,2/6,10.48%,CXCL12;FN1
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.614254974690817,1.0258649095312715,0.5384615384615384,0.9675640569295507,1.0,2/8,12.56%,NEIL2;NEIL1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5160999872843807,-1.0256695251012151,0.40540540540540543,0.8772618735005675,1.0,4/23,4.62%,ATF4;PPIA;NOL3;GPR37L1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.5213495495830516,1.02563816415933,0.4406779661016949,0.9674290346364732,1.0,7/20,21.20%,AKT2;TCAF1;C2CD5;DMTN;ITGB1BP1;ANK3;MYO1C
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.4261723875540965,-1.0254636642158363,0.4,0.8771195387931557,1.0,16/58,15.83%,PSMB6;PSMD8;PSMB4;MALT1;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;PSMD2;PSMD3;PSMD4;PSMB2;COPS8
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.6005130513814667,-1.0254600048923823,0.4,0.8764183815766943,1.0,2/8,10.64%,MT3;MKKS
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.4968738180848093,-1.025359459152674,0.42,0.8760256162171461,1.0,5/23,10.38%,IDH1;SQLE;SOAT1;LCAT;STARD3
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.5159325027519984,1.0250813542481352,0.4126984126984127,0.9681816531264199,1.0,3/20,10.04%,GUK1;REXO2;NMNAT2
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.689210622728754,-1.0250237725077171,0.5434782608695652,0.8761637274311505,1.0,2/5,15.89%,NLGN2;LRRC4
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.617446645536794,1.0248612435019584,0.5185185185185185,0.9678642513000689,1.0,5/8,32.75%,NOS1;CAMK2D;SESTD1;BIN1;CACNB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.4614558819959905,-1.0247469875540636,0.3958333333333333,0.8760878367000868,1.0,7/46,6.67%,RBM22;RAN;BAG3;CCT5;LARP7;YAP1;CCT3
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4554556869288678,1.0247044421511518,0.423728813559322,0.9674762203743048,1.0,12/41,22.70%,SOX9;USP9X;TGFBR3;BMP7;BMP8A;SMAD4;PDCD4;SMAD5;ENG;TGFB2;MAPK3;RUNX2
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.5569063800794923,1.0246175600695107,0.4406779661016949,0.9668992084669839,1.0,3/12,6.46%,SLC2A12;SLC2A9;SLC2A6
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.6023192975780601,1.0245854437666757,0.543859649122807,0.9652827734297659,1.0,1/15,0.48%,JADE2
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.6023192975780601,1.0245854437666757,0.543859649122807,0.9652827734297659,1.0,1/15,0.48%,JADE2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.4388255856607701,1.024532586127958,0.4444444444444444,0.9646067195877681,1.0,10/51,11.07%,PON1;NEDD4L;AKT2;CAMK1D;MERTK;RXRA;C2CD5;SGK1;RAB27A;CALY
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4221845663649746,1.0244818853693198,0.43859649122807015,0.9639318435399201,1.0,8/75,7.79%,PTPRC;SYT1;RAB17;RAB3A;RAB10;HIP1;RAB8B;SEPTIN4
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.6393158218688005,-1.024373661336565,0.5,0.8761049394565369,1.0,2/6,8.45%,GPR37L1;PRCP
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.41161009061878334,-1.0243656154777856,0.4074074074074074,0.8754168033669096,1.0,10/54,5.66%,MMP2;BGN;PODN;FIBIN;RARRES2;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.5669897867511533,1.0240129731559893,0.48214285714285715,0.9644147506676194,1.0,4/10,27.70%,AKR1C1;AKR1C3;RDH11;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.494981642507686,1.024012364317908,0.38461538461538464,0.9635761291452998,1.0,8/27,23.39%,CTBP1;BRCA1;NOS1;TADA2A;ARRB1;PPARGC1A;MAPK3;NIPBL
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.6236891788647211,-1.0238429385686982,0.6153846153846154,0.8761390600922337,1.0,2/6,14.41%,PARP1;CDC42
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.5981188645034329,-1.023738274138047,0.5227272727272727,0.8756928906821582,1.0,2/7,6.44%,UBE2D4;RNF6
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.47750556764811813,-1.0236571283435056,0.5135135135135135,0.8753029947267483,1.0,4/29,7.08%,SALL2;ASCL1;PAX8;HIPK1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.4053512367667895,1.0235789224995282,0.4666666666666667,0.9639956709082916,1.0,27/95,19.54%,OLFM3;STMN2;SULT4A1;KCNB2;GRIK3;CADPS2;SNAP25;GABRG2;SRCIN1;MAPK8IP2;CALY;SCN2A;CLVS2;ACTL6B;HS6ST3;SLC8A2;ASTN1;NOVA2;LRRTM1;UNC13A;GAD2;ERC2;ABCC8;SNCB;CTNND2;SYP;ADCY1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.5903268426899023,1.0235431394694554,0.4909090909090909,0.9632216498701052,1.0,2/8,4.75%,GRIN2A;NLRC4
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5502619522262128,1.023376264822181,0.48214285714285715,0.9629272595633341,1.0,4/12,10.32%,SULT4A1;BPNT1;PAPSS2;TPST1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.33459797546812164,-1.0231867867271767,0.23684210526315788,0.875635122190524,1.0,51/328,9.96%,SOX4;BTC;CCND1;TAF9B;SIRT2;COPS9;CLEC11A;CALR;RPS19;DERL2;S100B;ROMO1;PDGFD;RTKN2;GID8;MT3;STOX1;ZFP36L1;HES5;RHOG;CDH3;TBRG4;FXR2;PDGFRA;SFRP1;RPL23;BAMBI;CXCL12;RPS9;IL12RB2;LYN;P2RX4;SAPCD2;PA2G4;RPS15A;TENM4;LMAN2;HAS2;NACC1;COX17;WNT5A;ACLY;PSMD10;HSP90AB1;PTN;GRN;SLC25A5;CNBP;UFL1;CAV1;SLC25A33
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5075322448508219,-1.02303108971222,0.40476190476190477,0.874598822133418,1.0,1/22,0.78%,CPSF1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5075322448508219,-1.02303108971222,0.40476190476190477,0.874598822133418,1.0,1/22,0.78%,CPSF1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.3932936341096762,1.022610597029127,0.4,0.9643646921943516,1.0,15/125,7.58%,VSIR;NEDD9;IGF1R;FAM107A;AKT2;MYLK;PAK1;NTRK3;SEMA3A;TIAM1;SEMA4B;WASHC1;PRKCA;PLET1;GCNT2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.5129638486923367,-1.0225625686361615,0.4090909090909091,0.8751152216187044,1.0,3/21,5.70%,RARRES2;EPHB3;EDNRB
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.4562239958874651,1.0224050746517863,0.38181818181818183,0.9641324396998808,1.0,13/28,21.22%,SLC6A11;SLCO1A2;RXRA;NCOA1;SLC6A8;SLC51A;SLC16A3;AKR1C1;NCOA2;SLC27A4;SLC16A7;SLCO2B1;ATP8B1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.6409429547710045,1.0222964652705073,0.5384615384615384,0.9635955918418859,1.0,3/6,25.51%,MTHFD1;SHMT1;MTHFD2
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.6580658669727184,-1.022240044866024,0.5,0.8753911027407636,1.0,4/7,18.74%,CLU;STUB1;DNAJB12;DNAJC18
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.6127115747927073,-1.021880108846517,0.5128205128205128,0.8757217932732878,1.0,2/6,8.73%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.6749377622803396,-1.0218292559019058,0.46153846153846156,0.8751040417958579,1.0,1/6,5.85%,EIF3D
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.6232068314872574,1.0217872309986196,0.5161290322580645,0.9642082831475249,1.0,2/5,25.42%,ARHGAP44;GRIPAP1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5342157698288453,1.0217220405414273,0.4230769230769231,0.9635629999192044,1.0,7/22,10.70%,HEY2;ROBO2;ZFPM2;SLIT3;TGFBR3;PROX1;HES1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.4001713167657889,-1.0212505215518675,0.4318181818181818,0.8759493650474096,1.0,10/48,14.20%,SIRT2;CALM1;ESRRB;CALM3;CDK2AP2;KIF18B;RACK1;ENTR1;ZFYVE26;KLHL9
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.3844616048111494,1.0211213465306745,0.4090909090909091,0.964751876714315,1.0,24/141,14.80%,INTU;LIFR;RGS4;TULP3;GNG4;GRK4;YJEFN3;UBASH3B;IRAK2;TSPYL2;CAV3;GNG7;SULF1;MAPK8IP2;FBXL17;RORA;GRK5;RGS12;TSPAN12;CBFB;ANKRD54;SLC8A2;RGS5;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.4048071883597086,1.0210514742590144,0.3548387096774194,0.9641072374281409,1.0,9/70,8.94%,SYT1;NEDD4L;SHTN1;BRAT1;RNF157;CPNE5;MACF1;RPTOR;LIMK1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5549316619698644,-1.0209483885641952,0.425531914893617,0.8760858406736759,1.0,4/12,13.99%,PTPRZ1;TENM4;PTN;BMP2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.5600273934700256,1.0207653955291205,0.4576271186440678,0.9640710759791912,1.0,5/12,15.47%,NR4A3;PRKCA;PDE9A;IL6ST;CAMK2D
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.5371803440320466,1.0204561968162318,0.4074074074074074,0.9643072788595545,1.0,4/20,8.91%,SLC6A15;SLC6A17;SLC6A6;SLC1A4
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.39532437825386285,1.02003108011496,0.3709677419354839,0.9647685032754423,1.0,20/108,16.30%,AKR1C2;IGF1R;AKT2;KITLG;LRP2;NTRK3;HIP1;FGF9;PTPRJ;GCNT2;NRG4;ARRB2;PDPK1;P2RY12;PIK3CD;NRG2;ITGB1BP1;MAGI2;FGF1;NRG1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.3933054128084821,-1.0198831042765937,0.4,0.8779938889924146,1.0,11/70,9.64%,PPIF;CALM1;PEF1;ALG2;SYT11;SMPD1;HPCA;CALM3;SLC25A24;WNT5A;CAV1
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.35685442555434393,-1.0195411822059834,0.3488372093023256,0.878275232619949,1.0,13/108,10.50%,SSPN;BTG1;MT2A;ARL4A;LGALS3BP;IFIT2;UBE2L6;EPSTI1;SRI;HLA-B;IFITM3;PSMB9;SLC25A28
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.5884043161098361,1.0195316887008035,0.5294117647058824,0.9651745683662575,1.0,1/9,2.21%,KLF15
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.6663694162334793,-1.0194424047315247,0.5555555555555556,0.8777953980313097,1.0,1/6,7.82%,TAF7
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5598706837081925,-1.0190955551192997,0.5,0.877801710392345,1.0,3/14,11.49%,SFRP1;ULK3;EVC
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.3518242819314955,-1.018718547733157,0.45161290322580644,0.8782289269345441,1.0,41/207,18.36%,UBB;CHRNA4;APEX1;RPS27A;RAN;UBC;NT5E;PARP1;ADPRS;NABP2;SMC1A;KPNA2;UBA52;MPG;CNBP;PARP2;KMT5B;MUS81;LTO1;RAD17;NPM1;MCM4;RFC5;TDG;ENDOV;PRIM1;POLD3;WDHD1;FAN1;VCP;PARK7;POLD2;SUMO1;DBF4;TRIM28;RFC3;POLG;SUPV3L1;EXD2;TOP3B;UBE2N
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.44975988302346714,-1.0185627119842815,0.4444444444444444,0.8779057327357865,1.0,3/26,3.05%,PIWIL2;RAN;NIFK
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3288723429106046,-1.0181792029672332,0.358974358974359,0.8781129185407825,1.0,46/302,13.99%,SOX4;BTG1;ZNF488;SOX21;CALR;ZNF114;ATF4;ESRRB;ZNF460;SPIN2B;HES6;ZNF22;PHF1;ZNF92;ZNF676;ZNF257;SLC2A4RG;RNF6;ZNF117;WTIP;DRAP1;MED23;MLF2;CHD3;EDF1;FADS1;RPL6;CNBP;ZNHIT3;COPS2;TFEB;SAP30;ZSCAN21;ESRRA;MZF1;YBX1;ZNF217;TRAPPC2;ZFPL1;PPP2R1A;PRMT5;MYBBP1A;ASCC2;SRSF10;AKAP17A;BMP2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6440675309385039,-1.0181575108105023,0.5094339622641509,0.8774708665601902,1.0,2/6,13.99%,CDH3;BMP2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.5305229955962883,1.017298168767144,0.43636363636363634,0.970786913262669,1.0,7/17,24.22%,COL5A1;TENM3;AGTPBP1;STAT3;COL5A2;NIPBL;NF1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.4412313698679123,-1.017066854507215,0.4222222222222222,0.8795112962949669,1.0,4/41,6.23%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.5535658053577249,1.0168805220025146,0.4576271186440678,0.9713111741765252,1.0,2/12,10.33%,WRN;RPA1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5845069007223702,1.0166159827743362,0.5102040816326531,0.9712380387039995,1.0,2/10,9.64%,FTO;BMP7
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.559031383322655,1.0164580258910876,0.45,0.9709328256544227,1.0,4/11,17.93%,PARP9;HMBOX1;MED25;DTX3L
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6541433823247148,1.0163119092476458,0.5079365079365079,0.9705430665852459,1.0,2/5,16.71%,PRIMPOL;SRPK2
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.4908572098006696,1.0159777269276873,0.4827586206896552,0.9706253123958845,1.0,6/34,13.77%,DCAKD;ADCY5;ADSS2;PANK4;PAPSS2;ADCY3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5732243790812135,1.0156954582758009,0.4827586206896552,0.9706070543010046,1.0,3/10,13.89%,PLXNA4;SEMA3A;PLXNA1
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),0.6592218268171381,1.0153153299043958,0.5098039215686274,0.9710747890100195,1.0,3/5,27.70%,RDH12;RDH11;CYP1B1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.5732348686638181,1.0149444086359858,0.47619047619047616,0.9713336344928927,1.0,4/10,30.16%,PUDP;UCK1;HPRT1;UCK2
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.49939264018770146,1.0147211491783914,0.417910447761194,0.9711608089916193,1.0,6/18,26.88%,CPEB3;ZC3H14;CPSF6;CPEB1;CDK9;NELFE
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5415055186511349,1.0143412788141013,0.4,0.9715037744847596,1.0,1/19,0.28%,UNC13C
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),-0.6163776023684263,-1.0140784497113016,0.5087719298245614,0.8863054561325104,1.0,2/7,5.21%,EPHB3;PDGFRA
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.5584649221535751,1.0138507228011275,0.42592592592592593,0.9722151538201775,1.0,2/13,9.64%,ROBO2;BMP7
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5409782324281678,1.013848362350644,0.46153846153846156,0.9713968235530106,1.0,6/11,19.45%,CEP135;PTP4A3;KIAA0586;SCFD1;CEP290;GAPVD1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.6892209570106501,1.0138149869034925,0.5094339622641509,0.9706489521354331,1.0,3/7,16.26%,RAB29;RAB40B;ADAM10
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.5143790731234917,1.0135318616671192,0.4642857142857143,0.970699808789749,1.0,3/16,10.00%,FMO5;ABCA2;RORA
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.36954716629882267,1.0132575319967942,0.36065573770491804,0.9706509812957176,1.0,16/127,12.46%,PTPRC;TPD52L1;IGF1R;HTR2C;NTRK3;PTPRJ;PRKCA;GCNT2;ZNF622;ROR1;PRXL2C;TIRAP;TRAF7;ARRB2;MID1;DENND2B
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4885939573251526,-1.0132034991696872,0.45454545454545453,0.8881988082994624,1.0,3/12,12.30%,CD63;CADM4;ADAMTS3
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.4730120773139263,1.0129338762804023,0.46774193548387094,0.9706634756390323,1.0,8/31,15.58%,GRK4;CAV3;DNM1;RAB31;ARRB2;SNCA;AP2M1;ARRB1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.4577532053128503,1.0127827738276631,0.4,0.9702935279714157,1.0,6/38,10.03%,ABLIM1;PITPNA;RPGR;EYA4;RABGGTB;CRYBG3
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.3986374846963584,-1.012707603653279,0.4489795918367347,0.888860813033876,1.0,19/81,14.84%,DERL2;SELENOS;UBE2J1;FOXRED2;FAM8A1;SEC61B;UBXN4;AUP1;STUB1;YOD1;FBXO44;TMUB2;DNAJB12;OS9;ERLEC1;RHBDD2;HSPA5;HSP90B1;UBQLN2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.4776551336779241,1.0123408978990553,0.43103448275862066,0.9706043394828285,1.0,7/25,12.16%,YWHAH;NKAIN2;PKP2;AHCYL1;SNTA1;NOS1;SPTBN4
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.5160218710706084,-1.0122632883203366,0.38636363636363635,0.8893762888289417,1.0,3/15,12.34%,PPP1R35;YWHAB;GPATCH2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.48680859799488463,-1.012220982690366,0.41025641025641024,0.8887463982852936,1.0,3/16,4.97%,G0S2;NR2F6;TLR1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.44168285760684667,1.0122168056820324,0.45454545454545453,0.9701587116951482,1.0,27/54,27.72%,RNF157;SH3RF1;RAD18;UBE3D;TRIM52;UHRF2;BRCA1;DDB2;UHRF1;WWP2;OBI1;DTX3L;UBE2D3;RNF213;RNF115;ITCH;SH3RF3;NFX1;RNF10;RNF11;TRAF6;CNOT4;PRKN;RNF220;TRAF2;RNF4;MARCHF5
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.5967333973261567,1.0121030633758472,0.5161290322580645,0.9697519812934586,1.0,1/6,5.94%,PLIN5
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.6039452532983414,1.0117632561754257,0.5192307692307693,0.9699786143808682,1.0,1/8,4.53%,SPIRE1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6092584786997101,1.0117145048373721,0.5,0.9693442350130262,1.0,1/6,6.28%,RFLNA
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5149174761639832,-1.0117126669532948,0.5454545454545454,0.8893337417318021,1.0,4/23,8.50%,MAGEF1;CTSC;CLU;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.4674654683431283,-1.0116024449297338,0.375,0.8888862824536218,1.0,2/26,0.56%,BTC;NOX4
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.35277950999293933,-1.0113496025485835,0.41304347826086957,0.8888382547790069,1.0,28/102,18.76%,PSMB6;THY1;PSMD8;PSMB4;ERMAP;MALT1;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;EIF2B2;IKBKB;PSMD2;BTN3A3;RC3H1;PSMD3;PSMD4;PSMB2;PSMC4;PRKCQ;PSMD11;EIF2B1;UBE2N;RIPK2;BTN2A1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.46887049856814633,-1.0112797702784553,0.45098039215686275,0.8882923220854351,1.0,4/33,6.23%,UBB;RPS27A;UBC;UBA52
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.5187830992816604,-1.0109826977737317,0.47619047619047616,0.888344367461249,1.0,3/18,8.61%,EXOSC8;NOP14;KRI1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.5258555237925607,1.0109784030511402,0.43859649122807015,0.9708416645516205,1.0,8/17,21.22%,SLCO1A2;RXRA;NCOA1;SLC51A;AKR1C1;NCOA2;SLCO2B1;ATP8B1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.5796237440781453,-1.0109753209796175,0.42857142857142855,0.8876279607132963,1.0,2/8,14.61%,GMPR2;DGUOK
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.41735598580530464,1.0107374602359203,0.4423076923076923,0.9705573822900361,1.0,13/53,13.87%,FOXO1;SOX9;ABCA2;RXRA;FOXP1;ERBIN;STAT5B;TIRAP;NOS1;PAQR7;RARA;SPP1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.6395707417839627,-1.0105392350714464,0.5957446808510638,0.8879514278010532,1.0,2/7,8.40%,SFRP1;ATRAID
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4306678205040781,-1.0104550837071415,0.425,0.8874530927216002,1.0,9/64,9.38%,PPT1;ATF4;SLC30A10;MT3;VPS35;PTPRZ1;NGF;SET;GRN
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.5035228385178221,-1.010290969108202,0.4489795918367347,0.8871178800190576,1.0,5/12,25.31%,CST3;IL18;GPNMB;CEACAM1;RUNX1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.6107219222306082,-1.0100992043463886,0.5217391304347826,0.8868192484809778,1.0,1/8,3.98%,MYH3
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.5532156890810958,-1.0097898189250682,0.45,0.8868992361931287,1.0,4/10,19.74%,CAMSAP3;CDC42;MSN;RAP2A
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.4421455535290993,1.0096206174464126,0.4107142857142857,0.9730768706167631,1.0,12/38,22.70%,USP9X;TGFBR3;BMP7;BMP8A;CHRD;SMAD4;PDCD4;SMAD5;ENG;TGFB2;MAPK3;RUNX2
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.4016299547834603,-1.0095969824549464,0.3939393939393939,0.8866822243413027,1.0,5/46,9.96%,TAF9B;DERL2;SFRP1;PSMD10;SLC25A33
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.6239033091046691,1.0095408841933724,0.48148148148148145,0.9725103360226554,1.0,4/10,18.18%,WNT7A;TMEM79;RILPL1;SIPA1L3
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5375071553142525,-1.0095036327355547,0.43478260869565216,0.8861779163212407,1.0,4/12,19.77%,MALT1;B2M;IL18;CD81
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.6579089107426404,-1.0093509061743438,0.5576923076923077,0.8858450683942691,1.0,2/5,3.57%,DIPK2A;BAG3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.4134711690647737,-1.0092265803736966,0.44680851063829785,0.8854409575445439,1.0,7/65,4.52%,S100A6;SLITRK2;ACTB;S100B;DHFR;MAP1S;EPHB3
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3782230758729962,-1.009164162603603,0.358974358974359,0.8848850490253434,1.0,28/116,16.55%,PSMB6;PSMD8;CCDC88C;PSMB4;PSMA7;PRICKLE1;SFRP1;FUZ;PSMC3;PSMC1;WNT5A;PSMD10;PSMD12;CAV1;PSMB9;PSME3;TLE4;PSMD2;KLHL12;BMP2;RUVBL2;AMER2;PSMD3;PSMD4;PTPRO;PSMB2;TLE6;TLE3
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.43360898630994693,-1.0091532092274953,0.4107142857142857,0.8842225075624801,1.0,6/51,7.74%,UBB;RPS27A;UBC;ZFP36L1;UBA52;MAPK13
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.5554305318913415,-1.009071741270941,0.4,0.8837400841498242,1.0,1/9,6.72%,LYN
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.3675288529582306,-1.0089481749523086,0.38095238095238093,0.8833747266686786,1.0,31/133,15.94%,PSMB6;PSMD8;CCDC88C;PSMB4;PSMA7;PRICKLE1;SFRP1;FUZ;PSMC3;PSMC1;WNT5A;PSMD10;PSMD12;WIF1;CAV1;PSMB9;PSME3;TLE4;HMGXB4;PSMD2;KLHL12;RACK1;BMP2;RUVBL2;AMER2;PSMD3;PSMD4;LRP1;PTPRO;PSMB2;TLE6
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.6422018742641856,-1.0089074940060934,0.54,0.8821277266615096,1.0,1/5,5.97%,SOAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.6422018742641856,-1.0089074940060934,0.54,0.8821277266615096,1.0,1/5,5.97%,SOAT1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.3765110360801637,1.008883118349176,0.42105263157894735,0.973757388414577,1.0,30/119,15.24%,GRIN2A;OPALIN;FAM107A;SHISA6;ALDH1L1;MMD2;SLC4A4;NTRK3;GFAP;GRM3;KCNIP1;PSD2;SEPTIN4;ATP2B2;NPAS3;KCND3;ADGRB3;AQP4;BAALC;LSAMP;MAPK10;SCN2A;CLVS2;CDH20;CDC42EP4;GJA1;ASTN1;KIF1B;DPP6;MAGI2
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.6640844052819893,1.0087789450816733,0.5106382978723404,0.9733427910699949,1.0,1/5,5.95%,WRN
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.493362374541814,1.008722904796106,0.4666666666666667,0.9726790270802325,1.0,4/17,15.08%,EYA4;MAP2K5;EYA1;EYA2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.5124734967011605,1.0086280447802525,0.509090909090909,0.9721071565468345,1.0,7/26,10.68%,TPD52L1;MADD;DAPK2;ING5;CYLD;MAPK8IP2;TRAF7
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6193962046169643,-1.0084667517605315,0.5555555555555556,0.8826569726911927,1.0,2/7,14.71%,TOMM7;OPTN
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5186455730260883,1.008330088404091,0.49019607843137253,0.9721485122003983,1.0,8/18,25.80%,DGKG;PLA2G15;GPAM;DGKZ;DGKI;DGKD;MOGAT1;PNPLA2
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.5966153596492078,-1.0077711506148992,0.5111111111111111,0.8839076837228428,1.0,1/8,1.67%,CCDC88C
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5588426549117113,-1.0076014843866503,0.48,0.8836862096761803,1.0,4/12,18.02%,ZNF304;PPHLN1;TRIM28;MORC2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.6685660797720344,1.0074870801687492,0.49122807017543857,0.9735794721077585,1.0,2/5,19.95%,PMPCB;MIPEP
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.40400438579744113,-1.0073080978671618,0.45454545454545453,0.8838390220882582,1.0,16/61,20.00%,SIRT2;ALOX5;VPS35;DUSP3;SELENOS;CACTIN;FNDC4;NFKBIL1;CERS2;ENPP3;TNFAIP6;MUL1;PCBP2;TEK;LYAR;TRAFD1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.4010361246825123,-1.0072734086418333,0.3902439024390244,0.8831998355235665,1.0,9/50,11.89%,BTG1;VEGFB;HIPK1;WNT5A;GRN;EMC10;SEMA5A;RAPGEF3;ZNF304
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5986609936689062,1.0072496731789233,0.4423076923076923,0.9734535118407118,1.0,3/10,20.69%,BEGAIN;CACNG5;NPTX2
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5301566870557416,1.00717242360427,0.3877551020408163,0.9728602832666794,1.0,2/17,1.38%,ACACB;FABP3
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.4993927113003115,-1.0069818172600715,0.42105263157894735,0.8832372331727353,1.0,3/15,8.73%,TMED2;FICD;RCC2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.5573100058666791,1.0069661182615153,0.4528301886792453,0.9726447279637986,1.0,3/11,13.09%,CRLF1;JAK1;IL6ST
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.49033317993738407,1.0068538031347911,0.42424242424242425,0.9721209074707879,1.0,8/20,20.18%,TMSB4X;RELN;SHANK3;ATPSCKMT;ANK2;GSTM2;PKD2;ANK3
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4335524321168396,1.0068239699406836,0.4482758620689655,0.9714249719741151,1.0,13/41,19.70%,YWHAH;BAG5;STMN2;SEMA3A;RAB29;CRMP1;EPHA4;MAG;GRIN2B;STX1B;GAK;SPOCK1;LPAR1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.4277808462431528,1.0068021878280844,0.5,0.9706851040541719,1.0,9/49,14.95%,SAE1;POM121C;POM121;RANGAP1;BCL11A;NUP93;STX1A;PIAS4;EYA1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.44124179852322687,-1.0061713719067913,0.4117647058823529,0.8843937087260917,1.0,2/21,5.39%,GPX1;SFRP1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),0.6153758143202949,1.0060530663002092,0.5094339622641509,0.9718461567032519,1.0,1/7,4.75%,NLRC4
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.42618260934502583,1.0060395136515266,0.4791666666666667,0.9710696550939203,1.0,9/46,13.84%,RFC4;PARN;PARM1;CCT8;CCT6A;ATM;TNKS;HMBOX1;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.6449764015690795,-1.005956410121456,0.4782608695652174,0.8842348516990703,1.0,2/8,7.67%,VDAC2;STPG1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5428012326982359,-1.0058856758792718,0.475,0.8837126585536864,1.0,8/17,16.17%,DERL2;SELENOS;SEC61B;AUP1;HM13;OS9;HSP90B1;VCP
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.5616509371851341,1.005800804138137,0.5,0.9707667024507525,1.0,3/11,17.79%,BRD4;CDK13;CDK12
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),0.6142982545907243,1.0056934314112185,0.5245901639344263,0.9702994718119454,1.0,1/7,7.14%,ENTPD3
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.5103780377861705,-1.0054481054880346,0.5111111111111111,0.8841659984706952,1.0,5/15,9.09%,GSTP1;GPX4;GSTM4;ALOX5;FADS1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6377757129538946,-1.0054442059871485,0.5,0.8834676051069743,1.0,1/5,4.20%,HAX1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.4702597476253388,-1.0053528310256135,0.3488372093023256,0.8830180298877166,1.0,7/27,11.17%,ACTG1;ACTB;PPIA;PDGFRA;FN1;GNAS;TLN1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.40307101314351584,-1.0052864525913896,0.46153846153846156,0.8825780037900954,1.0,4/72,3.57%,HSBP1;NUP42;HSPA8;BAG3
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.5265931534893626,-1.0049689203504748,0.4594594594594595,0.882624488741342,1.0,2/12,7.75%,HPCA;SRI
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5575591963245111,1.0048272863722743,0.45098039215686275,0.9719060270963954,1.0,3/11,5.07%,MYRF;CNTNAP1;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.44467041418663367,1.0046714744156227,0.56,0.9714760150543257,1.0,17/44,19.70%,HTR2C;GPR18;EDNRA;ADCY5;GRIN1;CAV3;RYR2;DLG4;GRM1;ACKR4;SLC8A1;KNG1;SPPL3;ABL2;ABL1;FPR3;LPAR1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.3794255136130135,-1.0045649036623763,0.4666666666666667,0.8830062919527238,1.0,19/90,13.99%,SOX4;BCAN;DLL3;PPIB;RPL13;PRDX1;HES5;COL9A2;WNT5A;RAB33B;CD44;GNAS;EVC;HAPLN1;TRAPPC2;EXTL1;NCAN;BMP8B;BMP2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.40801267180898315,1.0043791173838021,0.41379310344827586,0.9715771852510795,1.0,17/82,16.30%,AKR1C2;IGF1R;AKT2;KITLG;LRP2;HIP1;FGF9;PTPRJ;GCNT2;NRG4;PDPK1;P2RY12;PIK3CD;NRG2;ITGB1BP1;FGF1;NRG1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.6599212189517941,-1.003997790953405,0.4634146341463415,0.8839519197782407,1.0,1/6,15.62%,PLA2G4C
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.6136314371432352,1.003763570808236,0.5862068965517241,0.972424714321553,1.0,1/7,12.82%,PIK3CD
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5601973498118283,1.0034798790762136,0.41818181818181815,0.9724578029143937,1.0,1/11,0.41%,CHRM3
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.395068501978494,-1.0032921256825384,0.4186046511627907,0.8850106195453501,1.0,17/75,12.11%,EIF5A;PSMB6;PSMD8;TXNDC17;PSMB4;PSMA7;LIMS1;PSMC3;TNFRSF14;PSMC1;PSMD10;PSMD12;PSMB9;PSME3;IKBKB;PSMD2;TRAF5
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.5423078467062749,-1.003287388274121,0.5294117647058824,0.8843330136160871,1.0,2/11,4.62%,ZFP36L1;CDH3
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.6416858256712186,-1.0032180436967986,0.475,0.8837884471285891,1.0,2/5,13.94%,CAV1;WNT7B
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.6518529965759219,1.0030559578029645,0.5660377358490566,0.9728038608857428,1.0,2/5,26.86%,MAPK3;CDK9
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.5353487916062913,1.0030114354849575,0.45454545454545453,0.9721440291699628,1.0,8/18,22.38%,PRKAR1B;ADCY5;PRKAR2A;AQP4;ADCY3;ADCY1;ADCY2;PRKACB
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.3951407606237616,1.0025793721996776,0.3548387096774194,0.972452572335533,1.0,4/86,3.86%,RASGRF1;BCL2L11;ITPR1;TTC23L
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5122258840208911,-1.002515101177005,0.4594594594594595,0.885003030674278,1.0,2/16,7.40%,JUN;MED30
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5249508209368021,1.0020706165088902,0.4,0.9730802942645488,1.0,9/22,26.60%,ZNF16;STAT5B;ANKRD54;ABCB10;ACVR1B;STAT3;FOXO3;MAPK11;FAM210B
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5689880842529604,-1.001836126123322,0.5,0.8858643269167076,1.0,3/13,5.03%,JUN;MMP2;ERN1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6469352483484299,1.0016780640230725,0.5185185185185185,0.9734321317807862,1.0,4/7,28.25%,VAMP1;SNCA;VAMP3;STXBP1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.6676192289204426,-1.0013625587435058,0.5813953488372093,0.8862590555869292,1.0,1/5,7.37%,REC8
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.6298571016639747,1.0010250454031375,0.5471698113207547,0.9745182047913349,1.0,4/6,32.17%,CD247;PYHIN1;KLRC4-KLRK1;GPR171
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.6116392915269473,1.000617641083774,0.543859649122807,0.9748312041349861,1.0,5/8,19.64%,SLC1A4;SLC19A1;SLC6A8;PDPN;MGST1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.5881652868533223,-1.0006108583928601,0.5098039215686274,0.8874951673394215,1.0,3/9,15.20%,PRNP;RC3H1;IL18
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.5804692461436981,-1.0004807257218242,0.4,0.8870817171268762,1.0,1/7,5.27%,PAX8
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.3932277409365461,-1.0001468686337824,0.4594594594594595,0.8872118554454403,1.0,5/48,8.88%,CCND1;CALR;DUSP3;RPS15A;PSMD10
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.385442675310154,1.0001250119358474,0.4482758620689655,0.975477148825132,1.0,10/82,13.24%,SOX9;BAZ2A;HDAC4;PAK1;KAT2B;CECR2;SATB2;TOP1;TADA2A;ACTL6B
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.3858908158784902,1.0000361194529792,0.4918032786885246,0.9748485269795649,1.0,19/83,15.86%,PTPRC;CAMK2N2;MMD2;UBASH3B;RELN;CACUL1;TSPYL2;CAV3;TTN;TAB1;PAK2;MMD;PDPK1;CAMK2N1;SNCA;ANKRD54;ITGB1BP1;CSF1;TAB2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.40027211082971925,-0.9999480509684003,0.3611111111111111,0.8870617809442297,1.0,4/58,5.39%,S100A10;RHOC;ACTG1;SFRP1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.603253340702852,0.9996277975204297,0.543859649122807,0.9753010507403272,1.0,3/9,11.06%,DGKG;PLA2G15;DGKZ
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4528303439125757,-0.9988314537245245,0.475,0.8893076528995683,1.0,9/38,12.15%,AMOTL2;SEMA5B;SEMA4F;SEMA4C;CENPV;SEMA5A;SOX8;AMOT;ITGA4
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.5828908791391628,-0.9983299097805861,0.5384615384615384,0.889855111691642,1.0,3/9,16.85%,NT5E;ITGA4;MSN
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6451549261378521,0.9980111766825843,0.5714285714285714,0.9789092231447507,1.0,4/6,31.35%,AP2M1;PICALM;RAB5A;ALS2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5041200351529981,-0.9979284715408042,0.4444444444444444,0.8903406087483878,1.0,3/16,8.15%,CALM1;STOX1;CALM3
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4619105625918434,-0.9976212783679324,0.4230769230769231,0.8905025968412495,1.0,3/19,13.13%,SYT11;ERP29;PNKD
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.6233586779166022,0.9972550724310907,0.5084745762711864,0.9803326381901956,1.0,1/7,1.86%,ADAMTS9
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.5323171178350827,-0.997186415530699,0.4489795918367347,0.8911001469976018,1.0,1/10,1.56%,THY1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.3858712026529744,0.9970993948732187,0.42857142857142855,0.9799530233621111,1.0,8/91,11.57%,RASGRF1;STMN2;FAM161A;DOCK7;CNTNAP2;TPM1;FRYL;MAP4
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.6210975638641326,0.9969899193383953,0.5263157894736842,0.9794634189656629,1.0,4/6,35.72%,DNM1;PICALM;DNM3;DNM2
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.3405035874460387,-0.9967135495920295,0.42,0.8916532210239649,1.0,39/189,16.17%,SOX4;PSMB6;PSMD8;CCDC88C;TMEM9;PSMB4;GID8;PSMA7;CDH3;PRICKLE1;GSKIP;SFRP1;BAMBI;FUZ;PSMC3;PSMC1;WNT5A;PSMD10;PSMD12;CAV1;PSMB9;ZBED3;PSME3;LRRK1;TLE4;SEMA5A;PSMD2;KLHL12;WLS;BMP2;RUVBL2;AMER2;PSMD3;WNK2;PSMD4;PTPRO;PSMB2;TLE6;VCP
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.6362618736601806,0.9967004970307218,0.5,0.9793724799273937,1.0,1/5,3.41%,SLC6A17
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.39733933081999423,-0.9963637326255685,0.358974358974359,0.8918921374131124,1.0,14/64,13.65%,SURF4;STOX1;SYT11;CAMSAP3;VPS35;TMED9;RAB33B;CENPV;MFF;PRMT6;TBC1D25;VPS11;FIS1;SAR1B
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.6212614534579615,0.9962770056149814,0.5873015873015873,0.9795761655248443,1.0,3/5,16.48%,ABHD12;LYPLA2;ABHD6
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.5689291916595198,0.9961487705806626,0.46296296296296297,0.9791027747408907,1.0,3/9,9.45%,NEBL;TTN;PROX1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3933985989058611,-0.996134882218424,0.4528301886792453,0.8917045794137292,1.0,9/44,10.26%,GPX4;GSTM4;ALOX5;ACSM5;FADS3;ACLY;FADS1;OXSM;NDUFAB1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3377524979297167,-0.9961201058123044,0.41935483870967744,0.8910307140588296,1.0,49/231,18.36%,UBB;CHRNA4;APEX1;UBXN1;RPS27A;UBC;CENPX;PARP1;ADPRS;NABP2;SMC1A;SMARCA5;KPNA2;UBA52;ALKBH2;MPG;RFWD3;PARP2;KMT5B;RAD23A;DDX1;CUL4B;MUS81;GTF2H2;RAD17;NPM1;TDP2;PRMT6;ASCC2;RFC5;TDG;RNF168;ENDOV;ACTR8;COMMD1;POLD3;WDHD1;RNF8;FAN1;VCP;PARK7;POLD2;SUMO1;TRIM28;RFC3;CDKN2D;EXD2;ABRAXAS1;UBE2N
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.4741728986612604,0.9960550664072221,0.41379310344827586,0.9785346044446015,1.0,3/26,3.47%,SCEL;NEDD9;NNMT
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.5844403841913203,0.9959845492692664,0.5434782608695652,0.9779232934207772,1.0,1/7,2.70%,WNT7A
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.48469083738274965,-0.9959346337108272,0.4888888888888889,0.8907659711773263,1.0,2/17,4.42%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.5105276453692873,0.9959105725859215,0.4528301886792453,0.9773570028500664,1.0,7/20,24.00%,CAMK1;MAPK12;NRG1;ABL1;CTNNA1;RBM4;MAPK11
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.6783093346988671,-0.9954214690931186,0.5918367346938775,0.8912651086641445,1.0,1/5,0.31%,S100A10
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.6241351553687532,-0.9952032073657202,0.5116279069767442,0.8911653067503866,1.0,1/6,16.17%,VCP
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4671005160113249,0.9947284596374,0.45454545454545453,0.980127717909584,1.0,4/37,2.47%,DOCK5;NEDD9;EFNA5;RAC3
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.5420165469376419,0.9945369438804134,0.52,0.9799268646361882,1.0,4/12,21.20%,NPHP4;CBFB;TJP1;MYO1C
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.5417157434745494,-0.9945218081678291,0.5294117647058824,0.8921484581429762,1.0,4/13,14.41%,BAG3;CAMSAP3;CLIP3;CDC42
prerank,PanglaoDB_Augmented_2021__Acinar Cells,-0.5748312299860153,-0.993888063492023,0.4772727272727273,0.8929829441986322,1.0,2/12,2.92%,CPA1;RARRES2
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5651577310473158,0.9937565656442061,0.4528301886792453,0.9812416150753722,1.0,4/9,20.72%,ADCY5;ADCY3;ADCY1;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6111129152164572,-0.9936715728864821,0.5121951219512195,0.8928993458665101,1.0,1/5,6.27%,LIMA1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.5913652827362794,-0.993598787969382,0.4634146341463415,0.892392400998248,1.0,1/8,5.11%,CYB5R3
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.3359466772891693,-0.9935832723381325,0.37142857142857144,0.8917653374771222,1.0,57/292,17.55%,SIRT2;PSMB6;UBXN1;VPS37B;PSMD8;UBE2D4;PSMB4;VPS28;GID8;ELOC;CDC26;RNF167;PSMA7;TNFAIP1;KBTBD6;UBE2L6;FBXO45;RNF6;SPSB3;ADRM1;PPP1R11;HECTD3;PSMC3;PSMC1;PSMD10;PSMD12;ANAPC11;STUB1;RNF126;PSMB9;PSME3;RAD23A;OS9;PSMD2;UCHL1;TOLLIP;UBQLN4;RNF187;RC3H1;PSMD3;PELI1;RNF168;UBE2I;KBTBD7;UBQLN2;PSMD4;PSMB2;UBL7;RNF8;VCP;UBE2S;BUB3;UBA1;ANAPC2;RNF146;RNF14;PSMC4
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.40916825374105287,-0.9934123994830879,0.4722222222222222,0.8914585142573972,1.0,8/49,6.58%,S100A10;THY1;ACTG1;CAMSAP3;SFRP1;DUSP3;APOD;LIMS1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6009995020653954,-0.993250680779311,0.5319148936170213,0.8911004286004871,1.0,1/7,0.67%,SIRT2
prerank,MSigDB_Hallmark_2020__Myogenesis,0.38435153482589285,0.993129046967516,0.5079365079365079,0.9824298956115803,1.0,25/112,15.67%,ABLIM1;TPD52L1;FABP3;CKMT2;MEF2D;AKT2;MYLK;SORBS1;DAPK2;SYNGR2;CAMK2B;LAMA2;CAV3;MYOM1;ACSL1;NOS1;PTP4A3;SGCA;DENND2B;MAPK12;NAV2;MYOM2;SLC6A8;LARGE1;BHLHE40
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6278792115063463,0.9927115693083348,0.5185185185185185,0.982724636177244,1.0,2/5,16.33%,WHRN;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3932834026732449,-0.9926797887174982,0.40425531914893614,0.891811250714602,1.0,13/66,16.45%,DBI;PPIA;SH3GL2;LYN;CADM4;PPP1R15B;CACTIN;ZBED3;YWHAB;TARDBP;PRNP;BEX4;PARK7
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.6048423348499812,-0.9926723125675475,0.4489795918367347,0.8904509948699109,1.0,5/11,18.86%,P2RX4;CLU;HSP90AB1;SMAD3;AKT1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.6048423348499812,-0.9926723125675475,0.4489795918367347,0.8904509948699109,1.0,5/11,18.86%,P2RX4;CLU;HSP90AB1;SMAD3;AKT1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.4776494244252917,0.9923266978108021,0.4782608695652174,0.9829312712231116,1.0,1/25,0.27%,PTPRC
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.43259263543664006,0.9921636296263879,0.49056603773584906,0.9825538484648902,1.0,12/42,13.06%,PON1;PON3;ACSS3;SORBS1;EYA4;PCSK6;ARX;PROX1;ACSL1;ABCA8;ELOVL2;CHRD
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.412789597558283,-0.9921440364679341,0.4418604651162791,0.8911606796890781,1.0,15/69,14.03%,IPO13;RAN;PTTG1IP;PRICKLE1;PHB2;CLU;ATAD1;ACBD5;PPP1R10;NUP155;HSPA4;RANBP6;FAM53C;FIS1;RANBP17
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.49209769383821717,0.9921149554874966,0.509090909090909,0.9818999890370386,1.0,3/23,5.94%,FABP3;SORBS1;PLIN5
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.45433178344437825,-0.9919930030610113,0.43243243243243246,0.8907268898487831,1.0,9/31,15.98%,SOX4;ERN1;SELENOS;ZBED3;EIF2B2;KHK;RACK1;PRKACA;ZNF236
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.5482993323527019,-0.9919100123902437,0.5,0.8903109299099229,1.0,3/7,20.98%,PSAT1;PSPH;PHGDH
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.5955776074630715,-0.9913967210944972,0.5,0.8908732969800149,1.0,1/5,3.66%,MT3
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.5074716919440414,-0.9912982927397953,0.5,0.8904664308091542,1.0,5/12,21.06%,YAP1;SEMA5A;SCG2;TEK;PPARA
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.47740438646272837,0.9910111241289791,0.45454545454545453,0.9841392465927764,1.0,6/22,22.30%,ATP2B3;RYR2;SLC8A1;SLC8A2;ATP2B1;MAIP1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.6690508021390374,0.990913300380083,0.5869565217391305,0.9836089053774266,1.0,5/5,33.12%,AGO1;AGO4;MOV10;AGO3;AGO2
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.5625017901739108,0.9908767956704,0.52,0.9829194098872642,1.0,3/8,17.79%,CDK7;CDK13;CDK12
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.3797300309748527,0.9906763047769679,0.4603174603174603,0.9826089186719762,1.0,22/113,13.87%,GTPBP2;TMSB4X;SYT1;PCLO;RAB3A;RAB10;SYNGR2;TIMP3;TTN;SYTL4;SNAP25;ARHGAP17;HABP4;TMEM79;VCL;RAB11FIP5;RAB31;CPLX1;TUBA4A;SYT12;STX1A;SNCA
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.557502381810114,0.990296222629561,0.5,0.9826111659668182,1.0,6/11,25.98%,ABCA2;RANBP9;TMED10;PICALM;APOE;FLOT2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.42483965761611775,-0.9900332301439452,0.4897959183673469,0.8928860188363452,1.0,6/26,13.17%,RHOC;RND2;RHOG;IKBKB;RHOBTB1;EPB41L3
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.44379412337959623,-0.9899377888798104,0.4722222222222222,0.8924268978530457,1.0,5/45,5.39%,SIRT2;BAD;MT3;ZFP36L1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.6131060173765461,0.9898390297943979,0.5084745762711864,0.9831793434348989,1.0,2/6,16.46%,ENPP2;ARHGEF7
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.5991420815672519,0.9897759519977911,0.4897959183673469,0.9825576518005387,1.0,3/7,20.34%,ATP2B3;SLC8A2;ATP2B1
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.5531535815525114,0.9894861126403302,0.5094339622641509,0.9827265452495272,1.0,2/9,11.64%,SLC25A19;SLC29A2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.6294637902718772,-0.9894693411446915,0.45,0.8929688349400585,1.0,2/5,11.89%,PIH1D1;ZNF304
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.5319639779574651,-0.9894172805814176,0.4528301886792453,0.8924249152280211,1.0,5/13,22.08%,ZNF304;PPHLN1;TRIM28;MORC2;TPR
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.5247049358525472,-0.9893913206273192,0.5581395348837209,0.8917879165713231,1.0,7/15,16.17%,DERL2;SELENOS;SEC61B;AUP1;OS9;HSP90B1;VCP
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.5330158203543066,0.9890765254522169,0.47368421052631576,0.983047169066618,1.0,4/13,10.16%,RIPOR2;DOCK8;OXSR1;DUSP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.6057488900590994,0.9887659371698142,0.4727272727272727,0.9828971775586384,1.0,1/7,0.85%,PTPRB
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3296948517236554,-0.9887424550542181,0.5142857142857142,0.8925679578990725,1.0,28/266,10.08%,UBB;PSMB6;PSMD8;RPS27A;UBE2D4;PSMB4;UBC;CDC26;RNF167;UBE2Q2;PSMA7;KBTBD6;UBE2L6;UBA52;RNF6;UBE2J1;UBE2Q1;PSMC3;WSB1;PSMC1;PSMD10;PSMD12;ANAPC11;STUB1;FBXO44;RNF126;PSMB9;PSME3
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.4862024648832999,0.9885530787332877,0.4838709677419355,0.9827474258452359,1.0,1/26,0.27%,PTPRC
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3755923067491684,-0.9885393081552469,0.4594594594594595,0.8922898297048103,1.0,14/73,12.32%,MMP2;BGN;HSPG2;PRRX1;AMOTL2;COL12A1;TNS2;YAP1;NGF;ACHE;CAV1;FN1;CAPN1;GPC1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.6078837866870666,-0.9882978742253313,0.5365853658536586,0.8923187570919081,1.0,1/5,5.53%,CHCHD10
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.6039795526436076,-0.9882403220639634,0.4666666666666667,0.8918454848838813,1.0,2/5,4.42%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5472330988218376,0.9878943588160378,0.543859649122807,0.9839554219145704,1.0,1/10,0.27%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.5151656835040391,0.9875529130391053,0.45614035087719296,0.9839998704022189,1.0,6/17,21.20%,AKT2;TCAF1;C2CD5;ITGB1BP1;ANK3;MYO1C
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.547464709722786,0.9875481324918106,0.5102040816326531,0.983215181510351,1.0,4/12,23.75%,TOP1MT;TOP1;ABL1;MTERF1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.3673881729689135,-0.9875078044732329,0.3953488372093023,0.892946292089211,1.0,15/77,13.00%,EIF5A;THY1;RPS19;TLR1;RPS9;EIF3D;LYN;ACHE;AARS1;RPS3A;EIF3J;IKBKB;RPL9;NPM1;B2M
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.46423696835554795,0.9872701470080986,0.45652173913043476,0.983202520761754,1.0,9/26,22.39%,PARN;PARM1;TNKS;HMBOX1;MAPKAPK5;NEK7;MAPK1;NAF1;MAPK3
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.4887510052189403,0.9870865655955294,0.4807692307692308,0.9829307595866987,1.0,4/22,5.96%,GRIN2A;IGF1R;PSEN1;GRIN1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.6172641802876648,-0.9870438717345297,0.5526315789473685,0.8928246497455306,1.0,1/8,0.67%,SIRT2
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.6172641802876648,-0.9870438717345297,0.5526315789473685,0.8928246497455306,1.0,1/8,0.67%,SIRT2
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6207645998592162,0.9870230956615875,0.5510204081632653,0.9823645560237343,1.0,2/8,9.72%,SPRED2;ATM
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.6347029666505395,0.9869813438632242,0.5454545454545454,0.9816986437135683,1.0,4/7,33.24%,ENG;NF1;PGM5;POGLUT1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.3760150809432284,-0.9866691176231502,0.4634146341463415,0.8929973135834741,1.0,16/61,15.84%,E2F5;PIF1;PARP1;SET;RCC2;DNMT3B;RFWD3;PHF6;NCL;PPAT;NPM1;ERCC6L;KNTC1;MCM4;BEND3;WDHD1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.5926379730350373,0.9864394958599888,0.5192307692307693,0.9824124726763487,1.0,4/6,32.83%,MVK;PHYH;PDSS2;PDSS1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.3915670962338602,0.9864264504377673,0.5192307692307693,0.9816973547331787,1.0,23/89,19.27%,PCSK2;UNC5D;OLFM3;STMN2;SULT4A1;ENPP2;KCNB2;KCNIP1;SNAP25;ARX;PTPRN;CALY;CLVS2;ACTL6B;SLC8A2;ASTN1;LRRTM1;UNC13A;GAD2;ABCC8;CTNND2;SYP;UNC79
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4439737018003319,-0.9863618259049497,0.45454545454545453,0.8929068696019222,1.0,3/37,5.39%,S100A10;RHOC;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.6066387724931862,-0.9861803387080537,0.625,0.892841979887455,1.0,1/7,1.06%,RHOC
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.6330444919987822,0.98597985565363,0.5555555555555556,0.9821878056791066,1.0,3/6,33.84%,SPSB4;PRKN;XIAP
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.548010520402551,-0.9859721077517056,0.45652173913043476,0.8926501964739534,1.0,6/11,25.31%,AEBP1;SLC2A10;LRP1;DDR1;EFEMP2;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6346347307118824,0.9859341897668132,0.6212121212121212,0.9807470069922315,1.0,2/5,17.94%,XRCC3;PCID2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6346347307118824,0.9859341897668132,0.6212121212121212,0.9807470069922315,1.0,2/5,17.94%,XRCC3;PCID2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.48123302927386097,0.9859036615319929,0.5,0.9800354696957836,1.0,11/31,22.49%,ROBO2;KAT2B;TSPAN5;IL6ST;TP63;ITGB1BP1;MAML1;STAT3;TGFB2;MAML3;ROBO1
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.5777153635468069,0.9854578968681607,0.5172413793103449,0.9797083310559488,1.0,4/10,21.30%,ALOX12;TMEM79;TP63;FA2H
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.5777153635468069,0.9854578968681607,0.5172413793103449,0.9797083310559488,1.0,4/10,21.30%,ALOX12;TMEM79;TP63;FA2H
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5958163993498244,-0.9854184607115498,0.5333333333333333,0.8934738695603989,1.0,2/5,14.85%,SULT1C4;ALDH2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.4559016979012178,0.9854120646778247,0.5,0.9790349748444644,1.0,6/27,13.61%,EME2;MMS22L;WRN;ZGRF1;ZRANB3;PRIMPOL
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.5226596781751252,-0.9847620388424807,0.46153846153846156,0.8945583540069686,1.0,4/12,21.48%,LARP7;RNF168;RNF8;HEXIM1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.6570143251363864,-0.9845700545907691,0.54,0.8943488167913024,1.0,1/5,3.82%,ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.5921815843990353,0.9844932721198613,0.5094339622641509,0.9808580673633127,1.0,1/8,2.58%,SPRED2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.5085734098773926,0.9844100266216298,0.5151515151515151,0.9803059753561746,1.0,2/16,5.02%,BRAT1;TRAK1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5312109105126606,0.9842192716650853,0.5294117647058824,0.9800608460629702,1.0,4/11,17.81%,WHRN;PIEZO2;ADGRV1;LHFPL5
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.6541617929600709,0.9838237046133158,0.6122448979591837,0.9804206945467795,1.0,2/5,23.35%,BNIP3L;AFG1L
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.561783446072572,0.9836873697659727,0.5714285714285714,0.9799697500710434,1.0,3/12,13.87%,RNF157;MRAP;SNCA
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.6341686535624004,-0.9836605132847985,0.5111111111111111,0.8952970389907888,1.0,2/6,13.73%,PRNP;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.6341686535624004,-0.9836605132847985,0.5111111111111111,0.8952970389907888,1.0,2/6,13.73%,PRNP;DYRK2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.45775228395964734,0.98362576859602,0.43103448275862066,0.9792709555255413,1.0,5/31,9.64%,HEY2;SOX9;TGFBR3;LOXL3;BMP7
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.42888522638546045,0.9835856291177794,0.47540983606557374,0.9786371228743665,1.0,15/47,24.32%,CDC42BPB;PRKCA;OXSR1;TNKS;TAF1;PDPK1;CIT;LMTK2;CAMK2D;ACVR1B;MAPK1;PRKD2;MAP3K10;MAP3K12;TBK1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.5786694207132935,0.9835657087830622,0.5625,0.977897926477962,1.0,4/9,16.73%,ACACB;PRKAA2;ACACA;CPT1A
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.41715492198762016,0.9834835404351878,0.5254237288135594,0.9774149478322797,1.0,18/61,21.99%,SLC6A17;SLC4A4;SLC13A3;LRP2;ABCA2;SLC6A6;SLC1A4;SLC29A2;SLC8A2;SLC19A1;ATP8A1;SLC6A1;SLC2A3;SLC27A4;SLC16A7;SLCO2B1;SLC4A8;SLC24A3
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.43614273812398924,-0.983450756221766,0.39473684210526316,0.8951127027781702,1.0,2/32,3.68%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.4243309000820981,0.9832423816000931,0.47058823529411764,0.977279617578266,1.0,5/39,9.80%,RAB3A;RAB10;RAB8B;TANGO2;PTPRN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.5160339035464154,0.983068692354852,0.54,0.9769605780105011,1.0,5/15,25.50%,MRAP;AP2M1;PPFIA1;PICALM;CLTC
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6244902319075064,0.9828855723388026,0.58,0.9760273552844169,1.0,1/8,1.11%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6244902319075064,0.9828855723388026,0.58,0.9760273552844169,1.0,1/8,1.11%,SOX9
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.48365849014606993,-0.9828500061333241,0.48,0.895989763847902,1.0,3/17,8.15%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.5574336887680722,0.982535256689763,0.47368421052631576,0.9762040529816989,1.0,5/9,33.06%,ZC3H14;BARD1;CDK9;NELFE;RNF20
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.409450335038011,0.9819370779074028,0.5614035087719298,0.9770715530833054,1.0,9/73,8.29%,HEY2;SOX9;SRF;ZFPM2;KAT2B;NTRK3;PKP2;MICAL2;SH3PXD2B
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.4009237726318588,-0.9815326791037713,0.3939393939393939,0.8983297644870668,1.0,6/57,11.37%,SOX4;MT3;VPS35;CLU;CHMP2A;DCPS
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.3886030244157572,-0.9815012779026454,0.5,0.8977147113633532,1.0,13/102,11.42%,HSBP1;ATF4;NUP42;HSPA8;BAG3;USP51;ALOX5;HSP90AB1;CHCHD2;VASH1;FKBP4;MLST8;NUP155
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.3701925881275697,0.9814273394308214,0.47297297297297297,0.9777685891904028,1.0,25/133,16.37%,CARD14;SOX9;EFNA5;FAM161A;AKT2;BRAT1;NNMT;PAK1;NTRK3;FGF9;NSMF;RB1CC1;ATG7;EFNA1;RIPK1;WDFY2;CAMK1;SVIP;TNIK;CAMTA1;FAM20A;SEMA4D;ARRB1;FGF1;CSNK1D
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.487849031018216,-0.9813479415143462,0.5609756097560976,0.8973946731265449,1.0,1/23,0.15%,SOX4
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6116510054707734,-0.9813447379642406,0.574468085106383,0.8967224673788845,1.0,2/5,9.84%,CXCL12;BRK1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.63686703604399,-0.981241567431041,0.5681818181818182,0.8962945800066728,1.0,1/5,7.01%,CADM4
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.46980813984100844,0.9809851304585099,0.46938775510204084,0.9781899470907736,1.0,9/26,15.58%,CTBP1;SPI1;BRCA1;NOS1;CAMK1;TADA2A;SNCA;KMT2A;ARRB1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.49160965637216647,0.9809534369804959,0.5,0.977520169374548,1.0,2/20,0.64%,SCEL;MLANA
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.5139689787525407,-0.980921565686462,0.5217391304347826,0.8963368253041388,1.0,3/16,9.35%,PPT1;ACLY;SLC25A1
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5365646517336806,0.9808768734198497,0.5192307692307693,0.9769639114291367,1.0,2/10,7.40%,PRKCA;SASH1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.5381720694472807,0.9805010105829666,0.46551724137931033,0.977110959973515,1.0,5/13,19.13%,MMP21;BBS7;DNAH5;DNAH11;PKD2
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4227710544039344,0.9800665838837661,0.4642857142857143,0.9774823871223817,1.0,8/54,5.63%,FOXO1;IGF1R;AKT2;SLC39A14;SORBS1;BAIAP2;ATP6V1E2;GRB10
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.5856885128626927,0.9795762537832593,0.525,0.9780636436169756,1.0,5/12,24.64%,KAT2B;BRCA1;PLK2;ALMS1;C10ORF90
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.5457815142666275,-0.9794645135311362,0.4782608695652174,0.8992525004130175,1.0,4/10,12.12%,DHFR;ASAH1;SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5807565718080212,0.9794336966842052,0.48148148148148145,0.9776348347305595,1.0,2/11,12.16%,FAM161A;CAMK1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.4541115158599577,0.9792506349631518,0.45454545454545453,0.9773467432764178,1.0,7/28,17.40%,VRK1;RB1CC1;KLC1;STX5;MCTS1;UBA5;MRRF
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4692436015154676,-0.9789254511266418,0.4782608695652174,0.899878462734208,1.0,4/21,9.64%,ACTG1;ALOX5;CADM4;CAV1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.4096050407396111,-0.9787927096601702,0.4864864864864865,0.8995247826577455,1.0,9/55,9.46%,CD320;CUBN;ALDH1L2;DHFR;FLAD1;CYB5R3;MMACHC;DHFR2;PCCB
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.4305661335702923,-0.9786777472041852,0.4186046511627907,0.8991465537019113,1.0,12/57,14.03%,IPO13;RAN;PTTG1IP;PRICKLE1;LAMP5;PHB2;PPP1R10;NUP155;LAMP1;RANBP6;FAM53C;RANBP17
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.5436557037751013,-0.9784671724394449,0.5,0.8982749367973775,1.0,2/9,14.80%,GBE1;GYG1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.5436557037751013,-0.9784671724394449,0.5,0.8982749367973775,1.0,2/9,14.80%,GBE1;GYG1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.5421484718946201,0.9780553342893047,0.5084745762711864,0.9799559536333337,1.0,2/10,19.95%,PMPCB;MIPEP
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),-0.6088992354346419,-0.9775769921187095,0.5208333333333334,0.8996082088616694,1.0,3/8,18.69%,NLGN2;NLGN4Y;NLGN3
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.6356609850533618,0.9775618829432192,0.5490196078431373,0.9804426051981286,1.0,4/6,17.05%,RAB3A;CBLN2;ERC1;ERC2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.4421504242873046,-0.9772454938334802,0.4791666666666667,0.8996060695716125,1.0,3/25,5.70%,SIRT2;MT3;EDNRB
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.4936585924574899,-0.9771973855606695,0.4444444444444444,0.8990209917769584,1.0,4/16,14.58%,ZFP36L1;SGPP1;CTSK;CTSL
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.3416051469718004,-0.9769639892751473,0.41935483870967744,0.8989610407163654,1.0,23/114,15.84%,DNAAF2;GPX4;CLTB;VBP1;COX7A2;MID1IP1;ADRM1;NSG2;CLU;RPL38;HSP90AB1;AIFM1;EIF4H;CHMP2A;MKKS;DNAJB12;HSPA4;TMEM35A;SMAD3;AP2S1;PSMD4;POMP;PSMG1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6538027205452825,0.976919625884844,0.5555555555555556,0.9815363232633855,1.0,2/5,9.16%,TTN;MYOM1
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6359605783505238,0.9769036652517058,0.6071428571428571,0.98083422836891,1.0,3/6,24.49%,GPAM;TAMM41;CDS2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.5445160539694648,0.976890028794945,0.48,0.9800913631145585,1.0,3/11,12.01%,MYRF;PARD3;ATPSCKMT
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.633594948267312,0.9768697402895334,0.6363636363636364,0.9793496433733208,1.0,2/7,24.60%,ANK2;ATP1B1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5528799409626557,0.976702357547623,0.5737704918032787,0.9790408897800745,1.0,2/11,10.59%,EME2;RAD9A
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5471525726858706,0.9764998579478843,0.5,0.9789205188658373,1.0,4/10,20.72%,ADCY5;ADCY3;ADCY1;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4593229404136551,0.9763002692580715,0.5185185185185185,0.9785777994917222,1.0,5/29,13.87%,RAB3A;CADPS2;SYTL4;RAB27A;SNCA
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.4317072482945951,0.9761797906983999,0.5370370370370371,0.9781313745052153,1.0,8/38,15.08%,SPIRE1;EYA4;FMN2;BRCA1;NPAS2;BABAM2;EYA1;EYA2
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5067170249031772,-0.9761584263982225,0.4878048780487805,0.9002981628872007,1.0,4/11,18.86%,DNAJA1;COX18;ISG15;AKT1
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.4547144409389887,0.97604431580385,0.43636363636363634,0.9777134092479184,1.0,5/29,9.52%,CLDN18;TBCD;PARD3;VCL;PAK2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.642542406723781,0.9759746115858741,0.5319148936170213,0.9771989512196383,1.0,1/5,4.86%,KDM7A
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.6155621957056782,-0.9757843390714537,0.52,0.9005032489478125,1.0,2/5,15.36%,CAV1;EXOC7
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.4261201107572773,-0.9753870839497109,0.5208333333333334,0.9008906985753917,1.0,12/44,21.34%,HSD17B10;ACAT2;ACOX1;CROT;ACADS;ACAA2;PEX13;ABCD2;ADIPOR1;MECR;ECHDC1;CYP4V2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.41660569706563333,-0.9749559417991079,0.46511627906976744,0.9014352160644677,1.0,6/31,14.69%,RPS19;LYN;SLC25A5;UFL1;HSPA9;RPS14
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.5463864781811882,-0.9748841381723554,0.5476190476190477,0.9010171974681928,1.0,3/12,9.96%,PARP1;SLC25A4;SLC25A33
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.646918591615774,0.9748534742256239,0.5714285714285714,0.9794584200793409,1.0,2/7,13.35%,STXBP3;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5832335262349485,0.974736451608695,0.5396825396825397,0.9790681088968765,1.0,3/8,18.57%,CD160;AKR1C3;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.5886299215589339,0.974628843118685,0.5957446808510638,0.9786645509790641,1.0,2/6,22.28%,HES1;RNF10
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.3843808065219226,-0.9745719774794489,0.4857142857142857,0.9010305987526426,1.0,18/82,11.51%,TUBB2B;RPL23A;PCGF2;SOWAHA;NKX2-2;SEZ6L2;CAMSAP3;EFNA2;DUSP15;VWA1;YAP1;LINGO1;LRIG3;C1QL1;HNF4G;FLRT3;CKB;PTPRF
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.6075106982179356,0.9745315950038466,0.5652173913043478,0.9782339428687327,1.0,2/6,5.07%,NECAB1;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.5126953029317175,0.9745274919595053,0.48,0.9774998808778004,1.0,9/21,24.65%,PIP4K2C;GRB10;PIP4K2A;PRKCZ;APPL2;SLC27A4;PTPRE;IRS1;PIP4K2B
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.6112492167736756,0.9743835769009734,0.5652173913043478,0.9770915395164494,1.0,2/7,5.03%,MYRF;CNTNAP1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5186384283073886,-0.9742569617889203,0.5405405405405406,0.9010936514493606,1.0,7/13,27.97%,LARP7;RNF168;RNF8;HEXIM1;SUPT5H;NELFB;NELFCD
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.3990268316495143,-0.9742554914672845,0.42857142857142855,0.9004286376844534,1.0,14/59,16.82%,BTG1;S100A1;VEGFB;HIPK1;WNT5A;GRN;EMC10;SEMA5A;RAPGEF3;ZNF304;STIM1;BMPER;CHRNA7;PKM
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.5462956553647303,-0.974069194973005,0.4634146341463415,0.900334981144842,1.0,2/9,8.09%,PHB2;DNAJC19
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.5497691513510018,0.9739642714097502,0.56,0.9773118208687691,1.0,1/13,0.37%,DPYD
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.3519316029430787,0.9737263093283816,0.4838709677419355,0.9771249123696618,1.0,16/108,15.07%,RASGRF1;SRF;STMN2;ALK;TENM3;TBCD;DOCK7;CNTNAP2;FRYL;MAP4;THOC2;ACTL6B;TENM2;LGI4;ATXN10;PBX1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.6335654120378456,0.973665565108378,0.5,0.9765386356646452,1.0,1/5,6.01%,SNTA1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5150658937565193,-0.973516348796275,0.6086956521739131,0.9009188017227018,1.0,3/11,17.85%,CAV1;PPP2R1A;ADIPOR1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.6062623873967031,0.9734060652540343,0.5873015873015873,0.9757540439780913,1.0,2/7,14.80%,GCLC;ITGB1BP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.6062623873967031,0.9734060652540343,0.5873015873015873,0.9757540439780913,1.0,2/7,14.80%,GCLC;ITGB1BP1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5132943636948206,-0.9728364592688389,0.5294117647058824,0.901798911879004,1.0,4/15,17.78%,GAPDH;NLRP1;ATN1;ERBB3
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5682182085738203,-0.9727431254814047,0.4888888888888889,0.9013662826593044,1.0,2/9,5.91%,SH3GL2;PDE3A
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.4096840514541193,0.9725089969908037,0.4909090909090909,0.9773975990697765,1.0,1/55,0.16%,PON1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5033938731373372,0.9723445334263325,0.44642857142857145,0.9771014214935111,1.0,6/14,15.74%,BAG5;NLRC5;EMP2;ATM;HMBOX1;FEM1B
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.4958547884507187,0.9722622106223408,0.5,0.9766203545947749,1.0,2/14,8.09%,ADAMTS9;FBXO6
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.5699087572990179,-0.9718719011279757,0.5128205128205128,0.9028134683073146,1.0,2/7,14.84%,CAV1;UBQLN2
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.42369848559588563,0.9714792960815268,0.5272727272727272,0.9779577064482676,1.0,7/42,12.94%,SYT1;RAB3A;RAB10;RAB8B;SEPTIN4;CPLX1;KCNMB4
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.33196025111313876,0.9714411482878128,0.5151515151515151,0.9773122237376214,1.0,54/305,14.27%,CHRM3;IL1RAPL2;ROBO2;INTU;IGF2BP3;RAPGEF5;EFNA5;HDAC4;CRIM1;ARHGAP26;NRSN2;PCDHB12;PCDHB5;IGF2BP2;SCN8A;MOBP;MERTK;APBA2;RELN;B3GNT5;TRAK1;BPNT1;RBFOX3;NRGN;TEAD1;ARNT2;RAB29;CRMP1;ZBTB16;NRCAM;LIMK1;TYRO3;SHANK3;PROX1;FBXL17;CHST8;NPAS2;HES1;ATXN1;GDF11;LSAMP;ZIC4;NINJ2;DLG4;SCN2A;WWP1;RBFOX2;HPCAL4;ACTL6B;NAV2;ADAM22;ACVR1C;ATXN10;IGSF8
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.5199925409166403,0.9712911626541421,0.6,0.9768389392842008,1.0,9/14,27.98%,RAC3;EFNA1;P2RY12;ITGB1BP1;TGFB2;PDE3B;PTPN11;CYP1B1;JAM3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.5765699730860376,0.9712882297086505,0.52,0.9760994699887547,1.0,2/9,6.54%,BAIAP3;SYN3
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.4280749220992414,-0.9710603475254855,0.5208333333333334,0.9040855722337767,1.0,9/27,9.32%,SIRT2;ASCL1;HES6;HES5;WNT3;YAP1;PTPRZ1;TENM4;PTN
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.3709168228737024,0.970620458058498,0.5384615384615384,0.9773032388764862,1.0,15/102,10.00%,FKBP5;CLDN12;CHST3;KIAA1217;ADGRL2;ZDHHC9;SLC39A14;ARHGEF17;PLIN5;TEAD1;KCTD3;FKBP9;CEP170B;TSPAN9;RORA
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.4098446388428762,-0.9704517513649557,0.5116279069767442,0.9049772323610461,1.0,2/28,4.42%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.5198881670738503,0.9701961990337669,0.55,0.9777056942544342,1.0,1/14,0.50%,CMTR1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.520062545364085,0.9701030488761044,0.5084745762711864,0.977178917529397,1.0,3/13,7.71%,PYGB;PHKG1;PYGL
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.6288393911214385,0.9699390540532223,0.5925925925925926,0.976816687112437,1.0,1/8,1.11%,SOX9
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.6065792749449286,-0.969936063517746,0.5111111111111111,0.9055550770220434,1.0,1/6,3.66%,MT3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.6810456215065598,0.9699124815808463,0.6,0.9761754724246491,1.0,2/5,18.57%,PPARG;PDCD4
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.5249056937832977,-0.9693509101429771,0.4583333333333333,0.9061731636109449,1.0,3/14,6.76%,PTTG1IP;VPS35;CTSC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.5533156282561366,-0.9686717600160104,0.5238095238095238,0.9072419947387771,1.0,2/7,9.64%,RANGRF;CAV1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.5852726075056898,-0.9685174640829144,0.5365853658536586,0.9069470965807335,1.0,2/8,10.81%,LIMA1;SEMA5A
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.46055464014316155,0.9684763896393702,0.5517241379310345,0.9793843896286624,1.0,4/24,10.27%,PTPRC;SH3PXD2B;SULF1;RANBP3L
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.4634262992316277,0.9684351797992586,0.43548387096774194,0.9787762448758766,1.0,8/28,14.63%,SLC39A14;LRP2;SNAP25;SLC6A6;SLC22A4;SLC29A2;NEURL1B;SLC19A1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.47897527947260193,0.9681866891121234,0.46296296296296297,0.9785227416704714,1.0,2/24,10.00%,FMO5;RORA
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.3663935812310598,-0.9681703013558294,0.46153846153846156,0.9071856173130344,1.0,5/49,6.88%,ATP6V0A4;TIMM8B;TIMM13;USH2A;P2RX4
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.5582319392596102,0.9672481235733655,0.5,0.9803360035276781,1.0,2/11,9.28%,STMN2;KIF19
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.5332256095956727,0.9668980077519891,0.5192307692307693,0.9805367873359415,1.0,7/14,22.38%,PRKAR1B;ADCY5;PRKAR2A;ADCY3;ADCY1;ADCY2;PRKACB
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.40825534357895016,-0.9667950827482954,0.5294117647058824,0.9097836073932755,1.0,8/52,9.15%,TRMT112;TRMT5;BUD23;TRMT10C;PCIF1;TRMT10A;HENMT1;RBM15B
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5469106810822701,0.9667391889144251,0.5094339622641509,0.9802553849185974,1.0,1/9,1.61%,BAG5
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.4466497518908614,0.9661489646169704,0.5306122448979592,0.9811273476901734,1.0,14/40,27.47%,TPD52L1;PAK1;SASH1;MAP3K5;FGF1;ROBO1;MAP3K10;DVL2;DAB2IP;TRAF6;NEK10;IL34;FLT1;TRAF2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.4493232048977103,0.965883997706733,0.5087719298245614,0.9810221247390679,1.0,7/31,12.05%,EFNA5;FAM107A;STMN2;PHLDB2;CYLD;GAS2L1;PRKAA2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.575500005479973,0.9656282840231528,0.5510204081632653,0.9809170594253422,1.0,1/8,1.30%,MCCC1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.5817966318888543,0.9654450994926398,0.5510204081632653,0.9806565152607482,1.0,2/7,13.87%,PDPK1;SNCA
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.4921430393525059,0.965434432297174,0.575,0.9799433251132788,1.0,2/20,4.22%,CMTR1;PUS7
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.4167640075516891,0.9653601281880485,0.46551724137931033,0.9793866045141519,1.0,7/51,7.79%,EFHC1;SEPTIN9;RACGAP1;SEPTIN6;SPIRE1;CECR2;SEPTIN4
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3897221303955274,-0.9653310085676147,0.5428571428571428,0.9128363203547835,1.0,10/61,11.48%,SIRT2;ELOB;PRICKLE1;ZYG11B;CLU;PSMD10;STUB1;CAV1;RAD23A;TRIB3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.44075657347821634,-0.9652864962286419,0.5238095238095238,0.9123172897883497,1.0,7/26,11.83%,VEPH1;IGFBP7;IGFBPL1;SCG5;SRI;GRK2;MTCH1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5557878032592641,0.9650799146738115,0.5769230769230769,0.9794383619464067,1.0,3/8,18.06%,RXRA;RARA;PPARG
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.3283002096497217,-0.9649603718889562,0.5,0.912297745250166,1.0,31/204,13.79%,ELOB;TSPAN4;GORASP1;BAD;ST13;NIFK;TMED2;RAB1B;HES5;PEF1;NOL3;CHCHD10;YAP1;CXCL12;GPAA1;CTSC;TRAPPC2L;WDCP;TRAPPC6A;TUBGCP4;CAND2;TLE4;FN1;DBNL;DNAJB12;KLHL12;TRAPPC2;PPP2R1A;MAGI1;SAR1B;KNTC1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.6023845623974675,0.9648358867189949,0.5714285714285714,0.9792741512782625,1.0,1/5,6.82%,TG
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.5407005865711765,0.9647857984680789,0.5849056603773585,0.9786652426856344,1.0,1/8,7.87%,CDKN2A
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.6349179404296373,0.9642928278729366,0.5555555555555556,0.9792091889652463,1.0,4/5,36.52%,HS6ST3;HS3ST5;HS6ST2;HS6ST1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.4826690545567692,-0.9641189133805923,0.49019607843137253,0.9134383584176723,1.0,6/24,15.16%,OAT;AADAT;ALDH4A1;PYCR1;NIT2;RIMKLA
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5358798489596741,0.9637821838999355,0.56,0.979617694827991,1.0,5/13,18.99%,DENND6A;ADAM19;PTPRU;TJP1;PPM1F
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5451541803403889,0.9637374348165253,0.53125,0.9789897102637367,1.0,1/9,2.08%,CHST3
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.6271642423485748,0.9636349208268172,0.625,0.9785374187348804,1.0,1/5,8.59%,NAA16
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.49767150052263753,0.9632647724121022,0.5333333333333333,0.9787843168323127,1.0,4/13,20.72%,ADCY5;ADCY3;ADCY1;ADCY2
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.6526701722453477,0.9632006132628977,0.6326530612244898,0.9782388879355154,1.0,2/5,5.24%,CHRM3;AHCYL1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.443636752212588,0.9631966744576018,0.47692307692307695,0.9775266045310598,1.0,9/33,19.43%,PTPRC;NLRC5;SLIT3;STAT2;CCDC3;PADI2;CNOT7;PPARG;SAMHD1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.5119508676584488,0.9629685530081307,0.5357142857142857,0.9772576813229554,1.0,5/15,27.28%,HDAC4;PIEZO1;MAML1;HDAC9;DMPK
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5436105625496405,0.9627734799115971,0.58,0.9769958531339481,1.0,4/15,16.73%,ACACB;PRKAA2;ACACA;CPT1A
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4725539186628392,-0.9626388402009538,0.47368421052631576,0.9166019755554949,1.0,5/29,11.05%,BTC;SH3GL2;DUSP3;RNF126;SPRY1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.6349301955487892,-0.9621579614392837,0.5952380952380952,0.9164670948362242,1.0,1/5,0.27%,AURKAIP1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.6349301955487892,-0.9621579614392837,0.5952380952380952,0.9164670948362242,1.0,1/5,0.27%,AURKAIP1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.5279022168785991,0.9619928936462462,0.5490196078431373,0.978193193899699,1.0,7/15,22.38%,PRKAR1B;ADCY5;PRKAR2A;ADCY3;ADCY1;ADCY2;PRKACB
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3753890052032341,0.9613830391158207,0.48214285714285715,0.9789942476728112,1.0,12/96,6.19%,FOXO1;IGF1R;TBC1D4;AKT2;SLC39A14;SORBS1;KAT2B;RAB10;BAIAP2;ATP6V1E2;GRB10;RAB8B
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.36631274787018236,0.9612556729203788,0.5,0.9786448535831951,1.0,12/106,13.73%,SOX9;BAZ2A;HDAC4;PAK1;PHF19;KAT2B;SPI1;SATB2;TOP1;TADA2A;ACTL6B;PRDM16
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.5724385026673974,-0.9610358360418096,0.5476190476190477,0.9186603648724178,1.0,1/8,3.66%,MT3
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.5445100687205982,0.9608122841436846,0.5306122448979592,0.9791239026467545,1.0,5/15,23.34%,NNMT;NMNAT2;PARP9;NUDT12;PARP10
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.5989936229488818,0.9606675085271758,0.5714285714285714,0.9780197832457997,1.0,3/5,24.48%,CCDC39;DNAH11;CFAP43
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.5989936229488818,0.9606675085271758,0.5714285714285714,0.9780197832457997,1.0,3/5,24.48%,CCDC39;DNAH11;CFAP43
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6466613233063983,-0.9605192066366741,0.6086956521739131,0.9194666054056991,1.0,3/5,32.09%,CRCP;BRF1;BDP1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.46293033102463177,-0.9604998461180033,0.4375,0.918864433040654,1.0,1/23,0.16%,RPS2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6179275097121,0.9604803130717409,0.5517241379310345,0.9777454199327473,1.0,2/7,13.08%,SYT1;STX1A
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.4858076589089827,0.9604057181634397,0.5319148936170213,0.9772118312746312,1.0,2/16,4.38%,SCEL;BCR
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5358122152547358,0.9602975358276542,0.5294117647058824,0.9766790278831202,1.0,2/12,3.95%,TRPC4;SLC39A14
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.5261114402209277,-0.9601539584931988,0.5769230769230769,0.9189946947339355,1.0,2/13,8.01%,MRPL44;HENMT1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.6232518794671089,0.9600584478938308,0.6415094339622641,0.9765458504979796,1.0,2/5,17.77%,ADIPOR2;APPL2
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.5277871015736697,-0.9598061363367916,0.6046511627906976,0.9192303609503839,1.0,1/11,5.39%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3598441381047133,-0.9597652432249455,0.525,0.9186621344975306,1.0,4/90,3.45%,NR0B1;COMMD6;TCEAL7;HES6
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.5368600589237347,-0.9596261914427149,0.5238095238095238,0.9183623870129819,1.0,1/11,2.19%,MRPL44
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.6004339113433178,0.9593785519040592,0.5576923076923077,0.9776815844746497,1.0,4/6,34.27%,SHMT1;GMPS;CTPS2;CTPS1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.42806553847446466,-0.9591184298105819,0.40625,0.9189708265885911,1.0,16/56,23.11%,POLR2L;GAPDH;IRF3;POLR2K;POLR2E;FLOT1;CRCP;ISG15;DHX33;RIPK2;POLR3D;HSPD1;RELA;OAS3;POLR2F;HSP90AA1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.5764416585238192,-0.9587689127953856,0.5897435897435898,0.9191896307614601,1.0,1/5,3.66%,NLGN2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.6196157623873868,0.9584837767952671,0.5806451612903226,0.9790811552403317,1.0,1/5,8.91%,SLC1A4
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.483390274498242,0.9583996704878337,0.5,0.9785949731952278,1.0,8/21,24.60%,PKP2;KCND3;SLC8A1;ANK2;KCNQ1;DMD;CACNA1D;ATP1B1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.46215137021285574,0.958363371581657,0.5106382978723404,0.9779570627694074,1.0,8/33,10.91%,SLC6A15;SLC6A17;SLC25A48;SLC38A9;SLC16A10;SLC6A6;SLC1A4;SLC7A11
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.586725988096244,0.9579154045811555,0.5283018867924528,0.9783201638123917,1.0,2/5,32.69%,GNB3;PANK2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.5823341786521383,-0.9578105290873598,0.5588235294117647,0.920597825081454,1.0,1/5,5.69%,VPS35
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.6078149462116413,0.9573514596779414,0.5576923076923077,0.9791195328905027,1.0,5/6,38.12%,SHANK3;ERBB4;ZSWIM6;SALL1;RAPGEF2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.4944510987075327,-0.957271264410343,0.5897435897435898,0.9213408206107057,1.0,1/16,2.06%,BAD
prerank,MSigDB_Hallmark_2020__Androgen Response,0.3795645500107835,0.9572162695940608,0.5357142857142857,0.9786810387430458,1.0,11/87,10.02%,FKBP5;INPP4B;LIFR;SRF;MERTK;SORD;MAP7;STEAP4;MAK;CDK6;SGK1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.6195020746852945,0.9571102109079824,0.6226415094339622,0.9782035346629183,1.0,3/6,20.18%,RYR3;SNCA;ANK3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.37223483720279504,-0.9571052961121844,0.4878048780487805,0.9211856906428476,1.0,17/76,15.66%,PSMB6;PSMD8;PSMB4;PSMA7;PSMC3;PSMC1;PSMD10;PSMD12;FBXO44;PSMB9;PSME3;PSMD2;CUL4B;DMAC2;PSMD3;PSMD4;PSMB2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.4606729343419977,-0.9568742772764327,0.5,0.9210065569664488,1.0,4/23,13.50%,SEC61G;SEC61B;COX18;PRNP
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.40799555315824015,-0.956784272539706,0.5142857142857142,0.9205694433921802,1.0,8/41,11.93%,CCDC88C;PPIB;MT3;RABL3;LYN;CADM4;FN1;PPP1R16A
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.577894470572876,0.9566959869673132,0.5961538461538461,0.9778973054093927,1.0,4/8,27.01%,SORBS1;PRKCZ;IRS1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.577894470572876,0.9566959869673132,0.5961538461538461,0.9778973054093927,1.0,4/8,27.01%,SORBS1;PRKCZ;IRS1;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.35300265475760995,0.9565886571053299,0.5666666666666667,0.9773950416852937,1.0,24/119,15.60%,FOXO1;SOX9;CRIM1;SPRED2;MEIS2;COL5A1;ZFPM2;PKP2;SUZ12;EFNA1;ZBTB16;NBR1;BMP7;CDK6;RORA;RANBP3L;HES1;HDAC7;SUFU;CHRD;RORB;USF3;SEMA4D;OVOL2
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.4534307244099647,0.9563025718570173,0.4745762711864407,0.9774338273309848,1.0,4/27,6.60%,AEBP2;PHF19;SPI1;SUZ12
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.5685375340675053,-0.9560574694632797,0.5084745762711864,0.9217699764322116,1.0,3/6,12.71%,RAN;LSG1;NPM1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.50888928870626,0.955466405733484,0.5660377358490566,0.9787696901897502,1.0,4/14,11.46%,CACNG2;RELN;SHANK3;CACNG8
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.36263812310905236,0.9552201447858024,0.5178571428571429,0.9786692464057077,1.0,20/123,12.22%,SOX9;SRF;ALK;RELN;ENPP2;SPIRE1;CAMK2B;PSEN1;FOXO6;PHLDB2;TMEM79;SLC6A6;ZBTB16;SHANK3;BMP7;SHLD2;DLG4;CAMK1;TP53BP1;CPEB3
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.4334674218542759,0.9549836781039097,0.5737704918032787,0.9786412721566323,1.0,6/40,12.86%,INTU;TULP3;FBXL17;RORA;TUBD1;SUFU
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5057728676996789,0.9545074042483251,0.5833333333333334,0.9792112158004959,1.0,6/13,26.64%,SLC22A4;SLC25A19;SEC14L1;PDZK1;SLC44A1;SLC25A29
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.5153795259155363,0.9541665467854215,0.5573770491803278,0.9793404559914027,1.0,3/16,14.39%,MSL3;EP400;MORF4L2
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.5214223391928906,0.9541595064773423,0.5806451612903226,0.9786494406300837,1.0,5/15,22.51%,USP30;CHCHD3;GDAP1;MIGA2;MFN1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.46653221738632505,-0.9539682589767599,0.4864864864864865,0.9259584234294623,1.0,2/16,3.37%,ESRRB;DHFR
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.5196860906801033,-0.9538255047250785,0.5476190476190477,0.9255750623155649,1.0,2/10,12.61%,HNRNPA0;TARDBP
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5199765934633689,0.9535556744418873,0.543859649122807,0.9796180414108876,1.0,5/12,23.14%,TTN;SLC8A1;NRG1;AKAP13;CBY1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.4918957397398873,-0.9531390611861409,0.5609756097560976,0.9265521539452917,1.0,1/21,0.35%,BTC
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.43184574406962,0.9531359343925928,0.515625,0.9800939107395807,1.0,14/38,24.46%,GADD45A;FBXO6;ATM;CDC5L;RAD9A;CLOCK;TP53BP1;DONSON;ABL1;MYO6;USP10;ATRX;ATR;HINFP
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.3311869699563774,-0.9528939270493972,0.5135135135135135,0.9266111712105405,1.0,37/243,9.96%,SOX4;S100A6;BTC;COPS9;CLEC11A;CALR;BAD;DERL2;S100B;ROMO1;PDGFD;RTKN2;GID8;STOX1;HES5;RHOG;TBRG4;PDGFRA;SFRP1;RPL23;BAMBI;YAP1;RPS9;IL12RB2;LYN;SAPCD2;RPS15A;HAS2;NACC1;COX17;WNT5A;PTN;GRN;SLC25A5;CNBP;UFL1;SLC25A33
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),-0.5828618170982965,-0.9527970530007197,0.6666666666666666,0.9261478143816564,1.0,3/10,18.69%,NLGN2;NLGN4Y;NLGN3
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.5905356158486832,-0.9523020615088787,0.5909090909090909,0.9267048636844611,1.0,1/5,3.68%,PIH1D1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.36769043844064914,-0.9517284012905772,0.6216216216216216,0.9273493764054177,1.0,8/67,11.54%,RAN;KIF25;SMC1A;REC8;TUBG1;SET;CHMP2A;KIF18B
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.49353354243900943,-0.9517188363898273,0.5,0.9267501802036782,1.0,2/16,9.64%,SVIL;CAV1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.42948051590280206,0.9516894483315566,0.4897959183673469,0.9832465243633479,1.0,11/38,24.22%,TMSB4X;GADD45A;PRKCA;PDPK1;AKT3;ANGPT2;PPARG;MAP2K3;PRKD2;APOE;NF1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.594380872277032,-0.9516147706574304,0.5588235294117647,0.9263040733318461,1.0,3/7,15.11%,DBI;PRELID1;LRP1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5247292431338457,-0.9511231856143731,0.5918367346938775,0.9267153019914351,1.0,2/7,15.20%,LYN;IL18
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.6141963619077828,-0.951037886826574,0.5365853658536586,0.9263578657732217,1.0,1/5,3.31%,LRRC8D
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.35499779923445607,0.9510165990018137,0.5483870967741935,0.9842162376935649,1.0,44/149,23.46%,HOOK1;ARFGEF2;BAG5;SYNGR2;PLEKHF1;VAPB;CAV3;SPTBN5;RAB29;BCAS3;RAB1A;TANGO2;DNM1;HACE1;NUP93;TRAPPC12;GOLPH3L;ATP8B2;SMPD4;FAM174B;SEC16A;DYSF;CSNK1D;ARHGEF7;GAK;TJAP1;SYP;ANK3;USP8;HOOK3;FBXW8;TMED10;ATP8B1;EIF2AK3;SEC31A;GOLPH3;PI4K2B;ARHGAP21;GOLGA8M;ARFGEF1;PLEKHM2;CLASP1;SNX33;VPS51
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.6144708881168054,-0.9509781775926585,0.5416666666666666,0.9245461266381867,1.0,3/5,8.23%,XYLB;DCXR;AKR1A1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.6144708881168054,-0.9509781775926585,0.5416666666666666,0.9245461266381867,1.0,3/5,8.23%,XYLB;DCXR;AKR1A1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.6144708881168054,-0.9509781775926585,0.5416666666666666,0.9245461266381867,1.0,3/5,8.23%,XYLB;DCXR;AKR1A1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.424643612471414,0.9504999110017235,0.5714285714285714,0.9849230756794233,1.0,8/46,15.08%,WRN;EYA4;USP9X;BRCA1;NPAS2;BABAM2;EYA1;EYA2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.5270873419760091,-0.9504190792375943,0.5094339622641509,0.925212440101256,1.0,3/11,12.79%,ARFIP2;LIMA1;CORO1B
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.5511370510583208,0.9503727417137569,0.5,0.9845576274717994,1.0,2/11,9.72%,RELN;CDK6
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.5749995370536081,0.950359602053613,0.5961538461538461,0.9838793924677213,1.0,1/7,9.08%,ADGRB3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.3676708168439692,-0.9503190683885222,0.5641025641025641,0.9248573438851629,1.0,11/78,11.12%,PPT1;CD320;CUBN;SCAMP3;ARL6IP5;SLC50A1;ABCG2;CHMP2A;ABCA6;GM2A;SCAMP4
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.6034556064168457,-0.9500209803669819,0.6086956521739131,0.924917020415239,1.0,2/6,6.88%,EDNRB;P2RX4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.580312793493193,-0.9499078594095418,0.5869565217391305,0.9244671060049399,1.0,2/6,8.65%,CXCL12;TNFRSF14
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.5155250840460341,0.9493574203725889,0.6363636363636364,0.9855242089238411,1.0,2/12,9.17%,PCSK6;SULF1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.5138153211945194,0.9493132581004647,0.5208333333333334,0.9849440246256218,1.0,5/24,16.04%,SYT1;RAB3A;RAB27A;SYT12;SYT2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.4694453876040526,0.9491254025223886,0.578125,0.9847424464309673,1.0,4/22,10.87%,HEY2;HABP4;SIN3A;TNKS
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.46250136325910257,0.9491025238478088,0.5081967213114754,0.9840530143515311,1.0,7/26,11.75%,PTPRC;NEDD9;RELN;SRCIN1;EFNA1;EPHA4;DLG4
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.40553096650812337,-0.9489512297873245,0.575,0.9259032561884208,1.0,14/45,21.06%,SIRT2;ALOX5;VPS35;SELENOS;CACTIN;FNDC4;ENPP3;TNFAIP6;MUL1;PCBP2;TEK;LYAR;TRAFD1;PPARA
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.48037386709009766,0.9487708394859117,0.5084745762711864,0.9841905703249535,1.0,3/15,11.75%,WNT7A;SHANK3;DLG4
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.5827131400214494,0.948739641906768,0.5365853658536586,0.9835805170324627,1.0,1/6,15.01%,MTHFD1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.28517664095369993,-0.9484212398030175,0.6956521739130435,0.9264946966592664,1.0,160/1384,12.09%,NR0B1;FIZ1;HSBP1;SOX4;EIF5A;UBB;GMEB2;CCND1;JUN;ZBTB32;SALL2;TAF9B;SIRT2;LAGE3;OLIG1;ASCL1;ZNF658;RPL10;SMYD2;SOX21;APEX1;CALR;E2F5;RPS27A;ZNF426;GTF2F1;ATF4;AGRN;PRRX1;DACH2;OLIG2;ZNF491;UBC;ESRRB;PCGF2;MYT1L;ZNF12;RTRAF;ELOC;HES6;ZNF22;ZNF821;SAP18;ZNF761;NKX2-2;ZNF688;HES5;TCEA1;ZNF333;NR2F6;JMJD6;HAX1;ZNF584;WIZ;BEX1;LARP7;PARP1;E2F4;IER2;HDGF;H2AZ1;ZNF300;PAX8;RPL23;ZNF699;GABPB2;DACH1;CKAP2;IRF3;YAP1;ZFP90;NR2E1;EDNRB;MED10;GALR1;EID1;ZNF525;SLC2A4RG;SMARCA5;WBP2;UBA52;ZNF582;ZNF649;MED19;DRAP1;MED23;MED29;CCNK;ATXN7L3;ZNF558;MED30;DPF2;CREB3;ZBTB33;TAF7;CREBZF;ZNF726;SARS1;CBX5;CHD3;NACC1;MEOX2;PSMC3;ZNF317;ZNF574;ZXDB;WNT5A;CTDP1;PSMD10;DNMT3B;ZNF667;HNF4G;RFX5;ZBTB49;NOC2L;ZNF77;CNBP;CHCHD2;CAV1;RXRB;AEBP1;ENY2;ZNF446;ZNF480;ZNF124;ZNF320;ZBED3;ZBTB21;TFEB;ZNF557;HSF4;PHF6;DDX5;SAP30;ZNF614;NFE2L1;ZNF260;POU3F2;IKBKB;ZNF677;ZNF701;ATMIN;TRIB3;HES4;TAF6;CCNL1;SOX8;USF2;ZSCAN21;MTA2;ESRRA;ZNF665;MYNN;ZNF304;ZNF208;LITAF;MZF1;YBX1;ZNF32;ZNF217
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5374925375547686,-0.94805227826299,0.5106382978723404,0.9266245405623232,1.0,1/8,5.35%,ALOX5
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5112780050803463,0.9478862644697721,0.5925925925925926,0.9847703337404042,1.0,4/12,31.77%,OVOL2;TMC4;SLC9A8;TSPAN8
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.40329188823977213,0.947884979584874,0.5,0.9840633916487026,1.0,10/49,17.07%,PON1;PLA2G15;ABHD12;PIGH;SMPD4;AGK;SERINC1;PIGX;ABHD6;ABHD3
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),-0.5938257949980591,-0.9477602500969328,0.6086956521739131,0.926619246365982,1.0,3/9,18.69%,NLGN2;NLGN4Y;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.4573856433842243,-0.9472933949033614,0.5121951219512195,0.927185125818441,1.0,3/35,3.57%,RBM22;RAN;BAG3
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.5191348057369448,-0.9471160063093013,0.6097560975609756,0.9270208975960761,1.0,2/17,9.64%,CALM1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.5545178076439156,-0.9470410122271411,0.5757575757575758,0.9265558787702983,1.0,2/7,12.46%,SPHK2;LAMP1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.4273049788001907,0.9468902562358635,0.515625,0.9856337842709079,1.0,7/35,11.95%,STAT4;STAT6;TGFBR3;STAT5B;SORT1;STAT2;TSC1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.37868744745888994,-0.9468233509857219,0.5384615384615384,0.9264081590049156,1.0,10/85,9.31%,PPT1;CD320;CUBN;SLC7A10;LRRC8D;SCAMP3;ARL6IP5;SLC7A8;ABCG2;CHMP2A
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.3577499133196524,0.9464041250411915,0.5344827586206896,0.986190952687999,1.0,28/99,23.40%,NEDD4L;EFNA5;PAK1;NSMF;EMP2;PHLDB2;SRCIN1;ADGRB3;SHANK3;ZRANB1;PAK2;STAT2;EPHA4;TSPAN12;TNIK;SIPA1L1;SEMA4D;ARHGAP35;HECW2;BCL6;PDLIM5;BRSK1;BCL9L;FMNL2;TANC2;CLASP1;MAPT;ABI2
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.5544944408160262,-0.9462252626552929,0.6078431372549019,0.927217814589519,1.0,7/12,20.92%,VBP1;LDLR;CLU;PFDN1;CHRNA7;PFDN2;PFDN4
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.5721576259024891,0.9460604284903341,0.603448275862069,0.986281054306314,1.0,1/9,1.49%,CTBP1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.5731254533400226,-0.9459080373124638,0.5555555555555556,0.9272358390804422,1.0,2/5,21.55%,RIPK2;CHMP5
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.5363923732094062,0.9457818899475205,0.6428571428571429,0.9862157153319382,1.0,1/11,7.14%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.434869207176127,-0.9457345502682974,0.5,0.9268904694236351,1.0,2/23,6.16%,HSPA8;DNAJA1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.5008722792644937,-0.9455760728254636,0.5789473684210527,0.926569267475774,1.0,5/14,16.85%,PTTG1IP;VPS35;ATRAID;VPS11;MSN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.5411034408680973,0.9455272036566368,0.5535714285714286,0.9860987363311186,1.0,2/9,6.33%,NEDD4L;CAV3
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.3684908151938241,-0.9455123505902366,0.575,0.9260828653535043,1.0,20/85,11.00%,MMP2;BGN;PODN;HSPG2;THY1;PRRX1;FIBIN;IGFBP7;COL12A1;TNS2;THBS2;PDGFRA;CXCL12;P2RX4;WNT5A;PARD6G;CD44;FN1;SSC5D;ADAMTS2
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.5511031510312318,-0.9454515095868766,0.6304347826086957,0.9256050299963833,1.0,3/8,16.45%,GPR37L1;PYCR1;PARK7
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.6059959441232176,0.9454499290058689,0.5555555555555556,0.9842130252809903,1.0,3/5,24.36%,SMC5;MACROH2A1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.6059959441232176,0.9454499290058689,0.5555555555555556,0.9842130252809903,1.0,3/5,24.36%,SMC5;MACROH2A1;NSMCE2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.6059959441232176,0.9454499290058689,0.5555555555555556,0.9842130252809903,1.0,3/5,24.36%,SMC5;MACROH2A1;NSMCE2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4308873676034649,-0.9454457501638277,0.5714285714285714,0.9249782010275805,1.0,5/23,15.34%,PPT1;ACLY;SLC25A1;TECR;HSD17B12
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.3888347473724373,0.9448851758543104,0.5483870967741935,0.9849876652947076,1.0,9/60,9.82%,VSIR;MYRF;PCSK2;ADAMTS13;C1RL;PSEN1;PCSK6;APH1B;PHEX
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.55959067617852,-0.9448390872978235,0.6444444444444445,0.9260131566873165,1.0,2/6,9.84%,CXCL12;BRK1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.4471350351578559,-0.9445222592008985,0.5348837209302325,0.9262285895160525,1.0,5/25,9.51%,CFL1;LZTS3;VPS35;WNT5A;ABHD17A
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5595860213088844,0.9444122615212789,0.6101694915254238,0.985310146124137,1.0,1/8,6.79%,ZC3H12B
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.5884152134253534,0.9439929844164878,0.631578947368421,0.985561338004371,1.0,1/6,11.65%,AK3
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.5365347654722925,-0.9438986115382347,0.58,0.9270647031738776,1.0,5/9,18.40%,GTF2A2;TAF7;TAF11;DR1;TBP
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.469859302447605,-0.9438418952980079,0.6041666666666666,0.9265721439676827,1.0,5/25,5.93%,LOC400499;DHFR;ARL6IP5;SFRP1;TIPARP
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.41278541151643977,-0.9437967418996766,0.5,0.9260096288064753,1.0,2/26,3.35%,RPL10;PCIF1
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.4598393778272032,0.9437495816425595,0.6382978723404256,0.9855547935441443,1.0,2/19,1.55%,SYNJ2;SYT1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.4951680608607837,-0.9436671351426922,0.5918367346938775,0.9257616626041135,1.0,1/13,0.75%,PIWIL2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5098422854846378,0.9435202366487483,0.5370370370370371,0.9847771191029828,1.0,4/13,15.08%,EYA4;MAP2K5;EYA1;EYA2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.5098422854846378,0.9435202366487483,0.5370370370370371,0.9847771191029828,1.0,4/13,15.08%,EYA4;MAP2K5;EYA1;EYA2
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.5434433498087825,0.9430816959921563,0.660377358490566,0.985233440243991,1.0,1/7,7.87%,CDKN2A
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.49348268285170305,0.9430484215267423,0.5319148936170213,0.9846561050542711,1.0,1/12,6.19%,CECR2
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.5089849696218192,-0.9429865877092811,0.575,0.9266819881263052,1.0,3/9,8.65%,CXCL12;APOD;TNFRSF14
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.4192539055236196,-0.9429743722830504,0.5476190476190477,0.9260344116146866,1.0,6/41,10.75%,IDH1;ALDH1L2;DHFR;DHFR2;ACLY;AADAT
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.40033800572960115,-0.9428618566439988,0.5,0.9257008438913995,1.0,8/47,14.84%,EMC6;GABARAPL2;RAB1B;MAP1LC3A;ULK3;WDR45B;MAP1LC3B2;UBQLN2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.3613143073239837,0.9427738599029309,0.5689655172413793,0.9845989325942811,1.0,19/96,11.27%,HEY2;SRPX2;EDNRA;SVEP1;COL5A1;NNMT;ITGBL1;SRPX;TIMP3;PTPRJ;SMOC1;FKBP9;MICAL2;TMTC2;SULF1;APH1B;CHST12;ITGA9;PLSCR4
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.5756445283540845,0.9425442872515393,0.5925925925925926,0.9844585487687199,1.0,3/8,9.19%,PKIG;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.41743237546110645,0.942157130245709,0.5283018867924528,0.9847921539946015,1.0,7/43,8.65%,MDGA1;RELN;SEMA3A;KIAA0319;SH3RF1;USP9X;NRCAM
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.40504442069225494,0.9417253216612694,0.5666666666666667,0.9850357144776967,1.0,12/59,15.75%,TMSB4X;GPI;FOXP1;PRKCA;SASH1;BCAS3;PROX1;PDPK1;PIK3CD;AKT3;ITGB1BP1;FGF1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.45172456313026726,-0.9417124198734742,0.47619047619047616,0.927651808469634,1.0,3/25,9.31%,VPS37B;VPS28;CHMP2A
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.5621422891679206,-0.9416649137648316,0.5625,0.9270674439493438,1.0,2/6,21.15%,CHMP2A;FNBP1L
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.6205963547914339,0.9412186826134129,0.5925925925925926,0.9855602450959264,1.0,3/5,30.67%,SNX33;CARMIL1;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.4939066079065536,-0.9410102340292826,0.5625,0.9280930102326487,1.0,1/14,0.43%,GPR17
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.4039065868049463,-0.940991898712092,0.5526315789473685,0.9274935407372082,1.0,5/37,13.63%,JUN;HAX1;CD44;ITGA4;CD9
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.47423364424989883,0.9408967620818534,0.5873015873015873,0.9856304156108845,1.0,4/26,11.78%,RRH;GADD45A;RAD9A;CLOCK
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.34981518098766906,-0.9407853473996506,0.5952380952380952,0.9273161257108091,1.0,17/106,11.89%,BTG1;HSPG2;THBS2;ALOX5;SFRP1;VEGFB;HIPK1;SARS1;WNT5A;RNH1;GRN;EMC10;SEMA5A;VASH1;AMOT;RAPGEF3;ZNF304
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.5485345007945015,-0.940573580281264,0.5869565217391305,0.9272013170240664,1.0,1/10,1.48%,CALR
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.4909227245765072,0.9403823116369259,0.5932203389830508,0.9862240147041436,1.0,5/19,14.10%,NDST3;HS3ST4;SULF1;B3GAT3;HS6ST3
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5446671968275506,0.9403562280638786,0.5901639344262295,0.9856045800800588,1.0,3/9,13.58%,CLEC16A;CALCOCO2;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5551471199395718,0.9403225576180064,0.5517241379310345,0.9850051455669347,1.0,1/9,3.98%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5209582114046571,-0.9402809518031188,0.5714285714285714,0.9272891957230691,1.0,1/11,1.56%,THY1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.3731429381462481,0.9402736025441548,0.559322033898305,0.9844575238120515,1.0,13/82,16.26%,LIFR;SRF;HDAC4;IRAK2;TIMP3;PRKCA;CALCOCO2;RIPK1;IL6ST;SNCA;IL6R;YTHDC2;ADAM10
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.3334843324722673,-0.9402056022339683,0.5142857142857142,0.9268087114564076,1.0,19/186,9.31%,UBB;BTC;PPT1;ARPC5;CLTB;RPS27A;ACTG1;ACTB;STON2;UBC;HSPA8;SH3GL2;LDLR;UBA52;TRIP10;COX18;WNT5A;FER1L5;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.4699371874003854,0.9401889207443753,0.543859649122807,0.9839616053518354,1.0,2/18,4.40%,GLRA1;CFAP69
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.5557557439514081,0.9400717269743057,0.5932203389830508,0.9835300050693583,1.0,2/7,15.83%,DMTN;ENPP4
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.42381820761598044,-0.9400541839691016,0.5333333333333333,0.9265622556716574,1.0,7/45,9.38%,PPT1;SLC30A10;MT3;PTPRZ1;NGF;SET;GRN
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.6103222759109723,-0.9399037178406432,0.5714285714285714,0.9262928217344656,1.0,2/5,16.45%,NONO;PARK7
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5289381506061157,-0.9398674336501921,0.5918367346938775,0.9257674192502078,1.0,3/11,16.35%,CTDP1;CHMP2A;UBE2S
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.5035215776568792,-0.9397720175084732,0.5,0.9253048449455497,1.0,5/15,17.81%,YAP1;WBP2;CAV1;CATSPERD;ABHD2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.3608537893332821,0.939573395845599,0.6304347826086957,0.9840907888807316,1.0,19/101,14.47%,RFC4;IGF1R;PARN;EPHA7;ALK;MERTK;NTRK3;PARM1;ZNF16;TYRO3;ZNF622;ROR1;TNKS;EPHA4;HMBOX1;MAPKAPK5;DCUN1D2;LMTK2;SERINC1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.29761646462959307,-0.9394768904366735,0.75,0.9253703996255174,1.0,68/576,12.02%,FIZ1;SOX4;EIF5A;UBB;JUN;SALL2;SIRT2;LAGE3;ASCL1;APEX1;E2F5;RPS27A;GTF2F1;ATF4;AGRN;UBC;ESRRB;RTRAF;TCEA1;JMJD6;HAX1;BEX1;LARP7;PARP1;E2F4;IER2;H2AZ1;ZNF300;PAX8;GABPB2;CKAP2;IRF3;YAP1;MED10;GALR1;SMARCA5;WBP2;UBA52;MED19;DRAP1;CCNK;MED30;DPF2;CREB3;TAF7;MEOX2;PSMC3;WNT5A;HNF4G;RFX5;ZBTB49;CNBP;CHCHD2;RXRB;ZBED3;TFEB;POU3F2;IKBKB;ATMIN;TAF6;SOX8;USF2;ZSCAN21;ESRRA;ZNF304;LITAF;MZF1;YBX1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.38950086783122717,-0.9393135054386407,0.6363636363636364,0.9252730753559066,1.0,10/61,11.48%,SIRT2;ELOB;MAGEF1;PRICKLE1;ZYG11B;CLU;PSMD10;STUB1;RAD23A;TRIB3
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.3231322286985084,-0.9391094813049268,0.5365853658536586,0.9251371532767281,1.0,11/63,12.36%,CIAO2B;NCSTN;ISCA1;APH1A;MAGEF1;STUB1;AEBP1;NDUFAB1;FURIN;ADAMTS3;NAA40
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5710075193347732,0.9389311023032868,0.559322033898305,0.9851336184152905,1.0,2/7,13.63%,ALOX12;PRKG1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.4504656482787687,-0.938917435602605,0.5853658536585366,0.9249240077764114,1.0,5/26,6.73%,GPX1;GSTP1;CNDP2;GSTM4;MMACHC
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4341253552549991,0.9388817532708564,0.5769230769230769,0.9845687834215252,1.0,14/29,24.14%,SYNJ2;SYT1;DNM1;STX1A;SNCA;SYT2;ITSN1;SNCB;GAK;PICALM;DNAJC6;PACSIN1;ITSN2;OPHN1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.6159694447229842,0.9388785608415025,0.6037735849056604,0.9838842021204328,1.0,2/6,9.87%,PTPRN;RAB11FIP5
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.5336699624336012,-0.9388776050308378,0.4888888888888889,0.9244171970799085,1.0,2/5,19.36%,WNT5A;NOXA1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.5213385099896385,-0.9387663773743015,0.5128205128205128,0.9240270420098493,1.0,2/10,8.49%,PPIA;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3716187419827572,0.9383089238705609,0.6153846153846154,0.9848108678188012,1.0,10/75,12.46%,PTPRC;HTR2C;NTRK3;PRKCA;GCNT2;ROR1;PRXL2C;TIRAP;ARRB2;DENND2B
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.35140033933842674,-0.9378837654331093,0.5365853658536586,0.9254682759776648,1.0,14/95,13.14%,CDKN2C;SIRT2;CCDC88C;NUP42;LYN;CADM4;FN1;IKBKB;NUP155;CDKN1C;PGAM1;RAD17;AR;ANKLE2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.3688382179835472,0.9378569996928908,0.5344827586206896,0.9853687891341646,1.0,14/85,14.95%,HDAC4;SAE1;KAT2B;POM121C;POM121;RANGAP1;BCL11A;ESCO1;LOXL3;NUP93;ATPSCKMT;STX1A;PIAS4;EYA1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.5293042940036509,0.9377546943074867,0.6065573770491803,0.984894003286311,1.0,3/10,17.12%,ADGRB3;NOS1;KCNH1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.479665095707427,0.9375824725538817,0.5357142857142857,0.9847172228631149,1.0,10/24,25.35%,BBS10;CSNK1D;BBS4;TMEM216;CEP290;DISC1;ARL13B;CEP250;TOGARAM1;C2CD3
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5008661266267498,0.9374054414651889,0.5686274509803921,0.9844585039637689,1.0,4/13,15.51%,ACACB;MVK;ACSS1;ACACA
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.4483128069160414,0.9373684878408195,0.5517241379310345,0.9838210930140509,1.0,6/29,18.48%,KAT2B;CAV3;BRCA1;CCP110;SMAD4;SCFD1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5215110588808373,0.93733811090589,0.49122807017543857,0.983159319707099,1.0,2/12,12.56%,NEIL2;NEIL1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.3379688596982255,-0.9373135023440724,0.5757575757575758,0.9262899415352385,1.0,29/177,15.94%,G0S2;CFL1;GAPDH;BAD;RPS19;PPIB;ESRRB;FABP5;PAX8;BAMBI;ACHE;WNT5A;PTN;CAV1;ZBED3;GNAS;GLIPR2;MST1;KMT5B;SOX8;FLOT1;BMP2;SMAD3;HDAC3;LRP1;TGFBR2;IL18;NUMA1;TLE6
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.33920529204401373,-0.9372256473166465,0.5333333333333333,0.9258607307471968,1.0,19/111,15.95%,GSTP1;KDSR;GSTM4;LPCAT1;SGPP1;SLC25A15;AKR1A1;ACHE;SPHK2;LCAT;GAL3ST4;GSTM3;FURIN;SPTLC1;SAMD8;GSTA4;PLA2G4C;CERS2;TYW5
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.32558437743377744,-0.9371007966812425,0.6136363636363636,0.9255785846095768,1.0,26/262,7.62%,ATP6V0A4;MMP2;SIRT2;NCSTN;POLR2L;POLR2J;ARPC5;GTF2F1;POLR2I;ACTG1;ACTB;PDGFD;RARRES2;CLNK;POLR2G;ATP6V0E1;ATP6V1F;APH1A;EPHB3;EFNA2;ATP6V1G1;PDGFRA;VEGFB;LYN;SHC3;NGF
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5340394283371165,0.9369157186400348,0.6111111111111112,0.983482633997847,1.0,1/9,4.86%,KDM7A
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.41405712793968275,-0.9368649669542077,0.45,0.9254509037696951,1.0,5/32,11.05%,BTC;SH3GL2;DUSP3;RNF126;SPRY1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5141799612835088,0.9367465039613648,0.5714285714285714,0.983175062957319,1.0,3/11,17.35%,HDAC4;NCOR1;PFKFB1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.5643405423043039,0.9367171875274266,0.6140350877192983,0.982578122851499,1.0,2/6,11.18%,SEMA3A;PHACTR1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.41419933778266516,-0.9366911974215627,0.5853658536585366,0.9253003025687484,1.0,2/32,9.31%,CHAMP1;CHMP2A
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.5569402306471675,-0.9365921065848251,0.5555555555555556,0.9249191091430259,1.0,1/8,0.75%,PIWIL2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.47401537330223287,0.9365652976139439,0.5306122448979592,0.9822338366835611,1.0,3/15,20.65%,CECR2;ACVR1C;ACIN1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6227403157833928,0.9364672409328557,0.631578947368421,0.9817579148549953,1.0,3/5,36.24%,CAMK2D;PLN;PDE4D
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.36868804401067945,-0.9364003367921327,0.46511627906976744,0.9247844553142479,1.0,11/67,11.48%,SIRT2;ELOB;PRICKLE1;ZYG11B;CLU;TMEM259;PSMC3;PSMD10;STUB1;RAD23A;TRIB3
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.3923792860384221,0.9363783647533783,0.5757575757575758,0.9813455230245549,1.0,11/63,13.77%,CALCB;PRKAR1B;ADCY5;SPI1;TYRO3;CD247;PRKAR2A;GPR176;NMI;PLK2;ADCY3
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.2904845345928567,-0.936185724564943,0.7857142857142857,0.9246653515740588,1.0,98/755,13.28%,FIZ1;SOX4;EIF5A;UBB;JUN;SALL2;SIRT2;H1-4;LAGE3;ILF2;ASCL1;SFR1;APEX1;E2F5;RPS27A;GTF2F1;ATF4;AGRN;UBC;ESRRB;RTRAF;MT3;HES5;TCEA1;JMJD6;HAX1;RHOG;BEX1;PARP1;E2F4;IER2;H2AZ1;ZNF300;PAX8;SFRP1;GABPB2;CKAP2;CHCHD10;BAMBI;IRF3;YAP1;ZFP90;MED10;GALR1;LBH;SMARCA5;WBP2;UBA52;RNF6;MED19;DRAP1;HNRNPAB;CCNK;ATXN7L3;MED30;DPF2;CREB3;TAF7;EDF1;MEOX2;PSMC3;WNT5A;HNF4G;RFX5;ZBTB49;NAT14;CAND2;CNBP;CHCHD2;RXRB;ENY2;ZBED3;TFEB;POU3F2;IKBKB;AFAP1L2;ATMIN;TAF6;SOX8;USF2;ZSCAN21;ESRRA;QRICH1;CDKN1C;ZNF304;LITAF;MZF1;YBX1;H1-10;MYRFL;RNF187;NPM1;JUND;BRD7;AR;ZNF711;ZP3;PITHD1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.43445834538728256,0.9361725751356754,0.5079365079365079,0.9811850019086715,1.0,4/33,7.22%,SOX9;HDAC4;IRAK2;PRKCA
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.4461287239633486,-0.9356231265267382,0.4883720930232558,0.9253295149973921,1.0,4/20,7.74%,ARL6IP5;PRAF2;SLC1A6;SLC7A8
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.48880952004202743,-0.9355776023937654,0.5227272727272727,0.9248342616978324,1.0,5/14,9.62%,LRRC8D;ARL6IP5;PRAF2;SLC1A6;GIPC1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.4592004893004582,-0.935539376203505,0.5217391304347826,0.924270683011425,1.0,5/15,9.98%,BEX3;MT3;DELE1;NGF;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.5772946915286172,0.9355032739481737,0.5714285714285714,0.9821547574093678,1.0,2/5,21.25%,MACROH2A1;NOP53
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5957792955815748,0.9354641134098277,0.5862068965517241,0.9815735583201419,1.0,2/5,16.44%,RORB;BBS4
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4723943852233401,0.935443780488134,0.5576923076923077,0.9809743572268137,1.0,6/20,21.12%,BMP7;GDF11;BMP8A;SMAD4;ENG;TGFB2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.5591563458275869,0.9353993923800169,0.5454545454545454,0.9804010467222902,1.0,6/10,37.90%,RAB27A;KIF5A;KIF5C;SYNJ1;DNM2;SPG11
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5442673702068076,0.935069953189625,0.56,0.9804921629031306,1.0,3/7,10.32%,SULT4A1;BPNT1;TPST1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.5354886090399296,-0.9348076931487013,0.5405405405405406,0.9254317678326242,1.0,1/10,4.82%,ARV1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.5010728204956728,-0.9347836988222448,0.7209302325581395,0.9248379248757599,1.0,5/16,6.88%,MT1E;ZNF658;MT2A;MT3;P2RX4
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.35677896859355307,-0.9346083505965515,0.5365853658536586,0.9246580621365987,1.0,12/63,9.25%,GPC4;PCGF2;SOWAHA;SH3GL2;SEZ6L2;CAMSAP3;DUSP15;VWA1;LINGO1;SCG5;SLC7A8;OGDHL
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3905186190060023,0.9340104977850665,0.6229508196721312,0.9822535990895132,1.0,6/65,5.63%,ACACB;IGF1R;CAMK1D;STAT6;OXTR;GRB10
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.5448774594341363,0.9339571327058155,0.5961538461538461,0.981724357530497,1.0,3/6,16.89%,EMP2;CAV3;PACSIN2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.30904269700446735,-0.9337096227764391,0.6153846153846154,0.9264587764075477,1.0,25/311,9.61%,RRAGA;UBB;CUL7;ELOB;RPS27A;UBE2D4;NUP42;UBC;TRIM35;ELOC;UBE2Q2;MAGEF1;TNFAIP1;UBA52;FBXO45;RNF6;SELENOS;CUL9;ASB1;MARCHF2;ANAPC11;STUB1;RFWD3;CAND2;UFL1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.5769112626086641,0.9337062207316753,0.5849056603773585,0.9815832051931316,1.0,3/7,24.60%,KCND3;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.39440521875059176,-0.9335398503939738,0.5681818181818182,0.9250245843167233,1.0,10/54,13.65%,GORASP1;TMED2;RAB1B;PEF1;CTSC;TRAPPC2L;TRAPPC6A;KLHL12;TRAPPC2;SAR1B
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.39440521875059176,-0.9335398503939738,0.5681818181818182,0.9250245843167233,1.0,10/54,13.65%,GORASP1;TMED2;RAB1B;PEF1;CTSC;TRAPPC2L;TRAPPC6A;KLHL12;TRAPPC2;SAR1B
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.39440521875059176,-0.9335398503939738,0.5681818181818182,0.9250245843167233,1.0,10/54,13.65%,GORASP1;TMED2;RAB1B;PEF1;CTSC;TRAPPC2L;TRAPPC6A;KLHL12;TRAPPC2;SAR1B
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.6145279406501538,-0.9334911037581687,0.631578947368421,0.9244715685164854,1.0,1/6,1.84%,ODC1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.41723568455471305,-0.9333574168950239,0.44680851063829785,0.9241174266539186,1.0,5/25,14.57%,GAPDH;MT3;TIMP4;TIMP2;TIMP1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.42542649155141343,0.9332959840500428,0.5666666666666667,0.981979179395847,1.0,11/41,16.30%,SRF;WNT7A;RAB3A;PAK1;MACF1;SYTL4;TPM1;DYSF;CFLAR;FGF1;NRG1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6297877497496007,-0.9332274079765533,0.5853658536585366,0.9237409212562534,1.0,2/6,20.76%,TPI1;PGP
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.5649594320948167,0.9328979642834839,0.6363636363636364,0.982231108171514,1.0,2/9,12.09%,PLEKHM1;P2RY12
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.5007876154376063,0.9324326638534944,0.5789473684210527,0.982420341670493,1.0,4/10,23.46%,SHANK3;FBXW11;BBS4;VPS51
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.5678423155523591,-0.9323457084238945,0.6078431372549019,0.9253586769512756,1.0,2/7,11.61%,ALOX5;PYCR1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.45852434842988143,-0.9323219605256843,0.4782608695652174,0.9247765169362342,1.0,2/21,2.80%,VPS37B;VPS28
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4723548534302682,-0.9316310650192009,0.5,0.9257682250092911,1.0,1/12,1.66%,RAN
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.5800131711123834,0.9316294680300409,0.5740740740740741,0.9837744144694012,1.0,5/6,39.59%,ZCCHC3;ANKRD17;PUM2;PUM1;USP15
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.45280119988707235,0.9316053590527736,0.5081967213114754,0.9831778243642162,1.0,12/30,27.01%,PIP4K2C;SORBS1;GRB10;PIP4K2A;PRKCZ;OGT;SLC27A4;PTPRE;IRS1;PIP4K2B;SIK2;PTPN11
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.5106828980650375,-0.9310954928187578,0.5652173913043478,0.9264548186866748,1.0,5/11,18.40%,GTF2A2;TAF7;TAF11;DR1;TBP
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3247658945214088,0.9309526035774702,0.6612903225806451,0.9840193157204571,1.0,48/312,17.20%,FHDC1;ABLIM1;INTU;VPS37C;FAM161A;RPGR;SEPTIN6;RAB17;RAB8B;IFT172;RABL2B;CCDC57;WDR19;RB1CC1;CFAP221;ATG7;TMOD3;CDS1;SH3PXD2B;MAK;HAUS2;RAB1A;ATG5;TNKS;BBS7;INPP5E;TTBK2;HAUS6;DNAH5;HAUS5;PCNT;ANLN;ASAP1;RILPL1;MAP1LC3B;TMEM138;KIAA0586;PACS2;CEP41;IFT52;CHMP6;CSNK1D;BBS4;VPS37A;NCOR1;CEP131;EHD1;STX12
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.41298303221998767,0.9308357314325142,0.5789473684210527,0.9836036889787763,1.0,10/49,11.69%,TMSB4X;NLRC5;IRAK2;ERBIN;SPI1;CDKN2A;CYLD;BMP7;MAP2K5;ARRB2
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.39228294875243236,0.9308348603429222,0.5254237288135594,0.9829276726976912,1.0,9/56,10.90%,YWHAH;ALK;MMD2;TIAM1;NRCAM;SIN3A;BMP7;HES1;MMD
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.3443043986022931,-0.9303338679472873,0.475,0.9274971714670306,1.0,4/51,6.33%,ATP6V0A4;TIMM8B;TIMM13;USH2A
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.3785326303241726,-0.930272719156285,0.5405405405405406,0.9270061479710044,1.0,8/69,9.31%,UGDH;LRRC8D;JMJD6;NOL3;RNF112;WDCP;ALAD;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.37004811815395355,0.9301762719670537,0.5737704918032787,0.9837365565888047,1.0,20/66,24.41%,PLEKHM1;DOCK11;WASHC1;RIPOR2;BCAS3;CCP110;CDC42EP3;P2RY12;CDC42EP4;TENM2;ANLN;ARHGAP35;BBS4;PALM;PLPPR5;KCTD17;TAPT1;PIK3CA;ABI2;PIK3R1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.46091422011450445,0.9300068645469951,0.639344262295082,0.983396437597112,1.0,6/25,10.62%,PTPRC;GPR18;GNG7;SLC12A1;TRAF3IP3;CD27
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.5646574298908785,-0.9299342563746611,0.6296296296296297,0.9272736745944247,1.0,1/6,6.33%,USH2A
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.3290151293713292,-0.9294078845055634,0.5,0.9279952641195709,1.0,19/135,10.74%,S100A10;BTG1;JUN;RPL18;ISCU;ZFP36L1;DNTTIP2;SAT1;PTPN14;CD82;CCNK;DCXR;CTSF;RRP8;RPL36;EI24;PHLDA3;ANKRA2;GM2A
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.5774498877182073,0.9293754162038583,0.6166666666666667,0.984253494946549,1.0,3/6,28.07%,UBA5;CDKN2B;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.5890691214718986,0.9293026438084575,0.5862068965517241,0.9837337946306961,1.0,2/6,13.63%,ALOX12;PRKG1
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),-0.6208977609348014,-0.9292780778894912,0.6730769230769231,0.9276941146091983,1.0,1/5,5.21%,PDGFRA
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5751293207843653,0.9288010675855808,0.6181818181818182,0.9842488827426058,1.0,3/8,21.00%,ST3GAL1;CSGALNACT1;GFPT1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.5498905499342711,-0.9287264001934777,0.625,0.9284825183064802,1.0,2/8,11.85%,ATP6V1G1;ATP6V0D1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.5731434889274285,0.9287207569324691,0.6,0.983791775381224,1.0,4/6,40.96%,PRKN;EIPR1;ATP9A;LRRK2
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.42869603693224445,0.9287005738148035,0.5555555555555556,0.9831559688154284,1.0,4/37,6.13%,PTPRC;KLF6;HDAC4;PTPRJ
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3756616911377018,-0.9286350636765935,0.5,0.9281436542754403,1.0,6/47,7.62%,SIRT2;ZFP36L1;PDGFRA;PIK3C2G;PLCL2;NGF
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5332935218118501,-0.9284161925805943,0.5348837209302325,0.9279789734326658,1.0,4/12,18.91%,H2AZ1;SFRP1;RUVBL2;SSTR1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.34905066463987405,-0.9281467630580734,0.45714285714285713,0.9280485098096779,1.0,18/92,15.11%,STAB2;PPT1;HSPG2;CALR;CLTB;CUBN;LDLR;CANX;CAV1;MICALL1;GRK2;SCARB1;LRP3;CD9;HSP90B1;CTSL;AP2S1;LRP1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.30761109959693833,-0.9279906540162545,0.6923076923076923,0.9277483377568165,1.0,22/156,14.39%,NR0B1;CALR;TMBIM6;TNS2;SFRP1;APOD;QARS1;LYN;CADM4;SMPD1;ULK3;WIF1;CACTIN;YWHAB;HMGXB4;SPRY1;SLC2A10;GPC1;TMBIM1;RACK1;BMP2;NFKBIL1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.36440527487359564,-0.9278290130504827,0.5483870967741935,0.9275013360433517,1.0,15/74,11.17%,SCG3;CALM1;LGALS3BP;RARRES2;CD63;BRPF3;VEGFB;LYN;ANXA5;VWF;CLU;F13A1;FN1;PCYOX1L;TLN1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.33147585926211465,-0.9277298133617664,0.5483870967741935,0.9271492040222747,1.0,38/245,13.28%,COPZ1;RRAGA;BICD2;FBLN5;ARL4A;SNX17;AP4M1;SEPTIN3;TMED2;CD63;RAB1B;RABL3;SYNDIG1;ARFIP2;VPS35;ERP29;ARL1;SCG5;ARMCX3;COX18;TMED9;WNT5A;RAB14;RAB5B;ABHD17A;SLU7;TMED1;CEP68;STX6;AMOT;WDR45B;VPS26B;NPM1;CORO1B;TBC1D25;RUNDC1;EPB41L3;WLS
prerank,MSigDB_Hallmark_2020__Apical Junction,0.3576548381552151,0.927453266364187,0.6527777777777778,0.985586002699403,1.0,12/129,8.74%,THBS3;PTPRC;ITGA2;YWHAH;SKAP2;AKT2;CLDN18;BAIAP2;CDH8;PPP2R2C;ARHGEF6;VCL
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.35173172358099913,-0.9273384640411737,0.6046511627906976,0.9272868625255948,1.0,7/81,7.51%,JUN;CCDC88C;NUCB1;RUNDC3A;ARFIP2;RASSF1;SHC3
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.4774174927771748,-0.9272824414772357,0.5121951219512195,0.9267472743586405,1.0,2/17,5.03%,SOX4;ERN1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.415563828877999,0.9269445055425274,0.5344827586206896,0.9861169437673084,1.0,14/38,27.31%,IGF1R;RELN;EPHA4;ABL2;ABL1;FER;MAPK3;ABI2;AATK;ERBB4;INSR;EPHA3;DDR2;FLT1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.4874655514338676,0.9268034380327203,0.52,0.9857770572430254,1.0,4/14,16.24%,ADGRB3;ACTL6B;LGI4;B4GALT5
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.39545425400384865,0.926756731292907,0.5862068965517241,0.9852094653207584,1.0,11/52,20.07%,CRIM1;LRP2;VWC2L;PCSK6;SULF1;CHRD;SMAD4;PPARG;UBE2D3;SMAD5;ENG
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.3497334970539843,-0.9266467925646167,0.5384615384615384,0.9276368042183161,1.0,9/84,8.34%,ELOB;TSPAN4;ST13;NIFK;HES5;CHCHD10;YAP1;GPAA1;TUBGCP4
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4917603215438472,0.926460285779619,0.5769230769230769,0.9851479745516942,1.0,2/12,13.25%,CDKN2A;CAMK2N1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.5678055281834173,0.9263381641721364,0.64,0.9847848093566548,1.0,2/8,9.13%,WNT7A;SHANK3
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.4925490226662152,-0.9261100570726217,0.6,0.928359859515494,1.0,1/10,3.63%,SMPDL3A
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),-0.5488509745383165,-0.9259381133305229,0.6097560975609756,0.9281735031971367,1.0,1/8,0.67%,SIRT2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4863415981601271,-0.925716468914488,0.5,0.9280699268027421,1.0,4/11,7.57%,ITM2A;ITM2B;SOAT1;ITM2C
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.5649518824593047,0.925224609829582,0.5964912280701754,0.986834560867773,1.0,4/9,21.12%,WNT7A;TGFBR3;SMAD4;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.3994206086404216,-0.9251373868448215,0.5434782608695652,0.9288812144350935,1.0,13/53,18.86%,RANGRF;VPS28;SYT11;YAP1;HSP90AB1;CENPQ;TMEM35A;ENTR1;NUMA1;LAMTOR5;PARK7;MEAK7;AKT1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.5548178903481311,0.9251046516338537,0.582089552238806,0.9864276927737685,1.0,5/10,18.59%,TIAM1;DAAM2;ZNRF3;CSNK1D;RNF213
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.4971772532147597,-0.9249262116892737,0.574468085106383,0.9288522308211252,1.0,6/15,23.51%,CAV1;NPM1;FLOT1;MUL1;IFIT1;COLEC12
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.37874353101860586,-0.9249153283219032,0.5625,0.9282542182470229,1.0,7/40,10.10%,GPX4;GDE1;LPCAT1;PLPPR2;SMPD1;FADS1;LCAT
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.6203905789078291,0.9248874861045563,0.6458333333333334,0.986224188313498,1.0,1/6,1.11%,SOX9
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.46312810430242146,-0.9244928335361304,0.48936170212765956,0.9285848631254827,1.0,5/13,17.81%,GDE1;ENPP6;PLA2G4C;GPCPD1;ABHD2
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.530765391852729,-0.924454069714068,0.5909090909090909,0.9280476487363153,1.0,1/6,2.71%,SLC7A10
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5280433584751951,0.9243834515962157,0.5909090909090909,0.9868562174147202,1.0,1/11,2.08%,CHST3
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.5514981863118641,0.9241245230466483,0.5849056603773585,0.9867324848933635,1.0,2/6,11.18%,LRP2;PHACTR1
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.4698623388342935,-0.9240233460590321,0.5897435897435898,0.9282957901387687,1.0,1/14,2.45%,TCTA
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5082411940102676,0.9238625953352161,0.5111111111111111,0.9866763861495204,1.0,3/13,10.77%,TMEM201;DOCK7;FBXW11
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.45434398064503057,0.9237993337857803,0.5409836065573771,0.9862035843552966,1.0,6/24,22.29%,ZNF385B;STK11;PPP1R13B;MYO6;USP10;ATRX
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.626348345986259,0.9229349868693173,0.6491228070175439,0.9879792806507931,1.0,4/5,36.20%,IL7;PTK2B;ZNF675;RAB3D
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.45051669772133357,0.9228869391157023,0.5882352941176471,0.9874266664851046,1.0,3/29,11.43%,OTUD7B;SIN3A;PARP9
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.5870017033842013,0.9228771039136535,0.625,0.9867708168181522,1.0,1/5,3.25%,DAPK1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5010637031627683,0.9226982559959289,0.5,0.986519280901979,1.0,8/20,24.65%,PIP4K2C;GRB10;PIP4K2A;PRKCZ;SLC27A4;PTPRE;IRS1;PIP4K2B
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5792708102192266,0.922595039024019,0.5636363636363636,0.9860787245544057,1.0,3/5,34.23%,GOLPH3;VPS13C;VPS13D
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.5927680679352725,0.9225541274127278,0.6271186440677966,0.9854861563085054,1.0,1/5,13.84%,MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5212748686058151,-0.9220623032745662,0.6111111111111112,0.9315224689844036,1.0,3/10,6.67%,CCT5;LARP7;CCT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5212748686058151,-0.9220623032745662,0.6111111111111112,0.9315224689844036,1.0,3/10,6.67%,CCT5;LARP7;CCT3
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5623201835477419,0.9220153352279542,0.603448275862069,0.9861937207152158,1.0,1/8,18.04%,RYK
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.48554508491687776,-0.9219777085392507,0.58,0.9310742239107772,1.0,1/18,0.15%,SOX4
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.45490977615512224,0.9214505552864122,0.5636363636363636,0.986869850681173,1.0,5/17,15.75%,SEC14L2;ABCA2;SREBF1;PRKAA1;FGF1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.4902003623848988,0.9213345553798272,0.5714285714285714,0.986454613318148,1.0,4/14,13.63%,PYGB;PHKG1;PYGL;AOAH
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.5437358633591324,-0.9213297823629885,0.5128205128205128,0.9320351697651573,1.0,2/8,7.73%,SNCAIP;COMT
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4760283787972609,-0.9212861399129372,0.5882352941176471,0.9314903566011719,1.0,3/23,7.97%,SNRPB;LSM1;SNRPG
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.5845860841614251,-0.921283270126246,0.6222222222222222,0.9308792800933335,1.0,1/8,3.76%,STOX1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.4885020414166017,-0.9212817751891378,0.5510204081632653,0.9302690145695799,1.0,2/11,8.41%,UBXN1;TMEM259
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.4416214077365199,0.9211228949002733,0.5614035087719298,0.9861982188091347,1.0,7/25,15.76%,FBXO6;ATM;CDC5L;RAD9A;CLOCK;TP53BP1;DONSON
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.6295867158187212,0.9209984012957211,0.6538461538461539,0.9857657410817116,1.0,4/5,28.25%,NAPB;STX1B;UNC13B;STXBP1
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.5853709757112943,-0.9209450442713547,0.64,0.9303136724418186,1.0,2/6,13.99%,PAX8;BMP2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.38253372311650524,0.9206532942209218,0.5416666666666666,0.9859418093475114,1.0,16/44,22.88%,PARN;CCT8;CCT6A;STN1;ATM;TNKS;HMBOX1;MAPKAPK5;GNL3L;TENT4B;EXOSC10;NEK7;MAPK1;NAF1;MAPK3;ATR
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.45752600685464595,0.9202783068562194,0.5833333333333334,0.9861844720934724,1.0,5/22,17.49%,FBXL17;CLOCK;CRTC1;BHLHE40;PER1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.5521368261751595,-0.9202662609720901,0.5227272727272727,0.931205084565269,1.0,1/9,1.72%,GORASP1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.6177372609990766,-0.9201260416273458,0.6190476190476191,0.9310115187744386,1.0,1/5,17.90%,SUPV3L1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.38654525355208524,-0.9200059286200818,0.5652173913043478,0.9306698420740436,1.0,4/49,6.90%,EMC6;GABARAPL2;RAB1B;MAP1LC3A
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.5829414818438161,0.9199738655992737,0.5666666666666667,0.9862446645866245,1.0,1/5,23.67%,ULK2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.6007214314711223,0.9194173893191877,0.5957446808510638,0.9869054491080432,1.0,4/6,31.94%,STAT3;PIK3R1;JAK2;PTK2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.4941346923896733,-0.9193615501653292,0.5609756097560976,0.9308101926611154,1.0,2/11,15.14%,SET;SMARCD1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.4941346923896733,-0.9193615501653292,0.5609756097560976,0.9308101926611154,1.0,2/11,15.14%,SET;SMARCD1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.48924829878520637,0.9192074924143098,0.6,0.9866619106620708,1.0,4/18,18.50%,PTPRR;ARNT2;ADAM10;MBNL1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.5466334790752029,0.918673606516131,0.5932203389830508,0.9873275890268182,1.0,5/10,24.22%,AKAP5;NOS1;MAPK3;CACNA1D;NF1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.39034738980302286,0.9183704321191097,0.5571428571428572,0.9874716275509146,1.0,11/60,15.43%,BRAT1;GADD45A;XRCC4;ATM;BRCA1;RAD9A;BABAM2;CLOCK;STK11;EYA1;PRKAA1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.4973787920739461,-0.9180271262597661,0.5945945945945946,0.9330087801182365,1.0,2/8,21.37%,TUBB4B;TUBB
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.40091075225004047,-0.9179094931067825,0.5106382978723404,0.9326518896712173,1.0,5/38,7.95%,THY1;SLC30A10;ALOX5;LYN;CLU
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.5279465870950504,-0.9178205558278832,0.5813953488372093,0.9322437128325868,1.0,3/10,7.50%,LRRC8D;SLC25A30;SLC1A6
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.5605965647088964,0.9175699889908377,0.6666666666666666,0.9885836584587463,1.0,1/8,3.95%,SLC39A14
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.4616353765514451,0.9171217819549176,0.6271186440677966,0.9890048311663177,1.0,1/28,0.35%,HEY2
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.5517366984292689,0.9170620704215828,0.6,0.9885129375774437,1.0,2/7,15.22%,DMTN;ABCB10
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.5242596112626993,0.9170493756363801,0.6071428571428571,0.9878707253867401,1.0,2/9,16.25%,EMP2;CADM1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4170398651021387,0.9168218055328446,0.6379310344827587,0.9877121705882635,1.0,7/38,15.08%,EYA4;UBR5;BRCA1;NPAS2;BABAM2;EYA1;EYA2
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.40879290409549024,0.9166744945928454,0.5666666666666667,0.9874271768924809,1.0,8/40,15.08%,SPRED2;EYA4;ATM;BRCA1;NPAS2;BABAM2;EYA1;EYA2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.48336076819305596,0.9166036732193263,0.5094339622641509,0.9869255928835404,1.0,2/12,5.07%,SEC14L2;ABCA2
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.6022430767286304,0.9162696854887872,0.66,0.9870570856576175,1.0,2/5,12.42%,SRF;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.4460238926137017,-0.9160857729354847,0.575,0.9358852543659166,1.0,4/22,6.88%,RARRES2;PDGFRA;DUSP3;P2RX4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4529460697171189,-0.9158446620211795,0.6521739130434783,0.9357930036328463,1.0,2/13,8.15%,CALM1;CALM3
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.3946666420839896,0.9149756193154697,0.6346153846153846,0.9893672551590358,1.0,10/45,16.24%,ADAMTS9;ADAMTS13;PRKCSH;FBXO6;PCSK6;ENGASE;MAN2A1;MAN1A1;LARGE1;B4GALT5
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.48203918164874354,-0.9149691616081919,0.6078431372549019,0.937139835178789,1.0,6/16,11.20%,CALM1;C12ORF57;P2RX4;SRI;CALM3;GRK2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3666417099400657,0.9145596839891045,0.6727272727272727,0.9895510827411359,1.0,27/82,20.74%,FAM107A;SHISA6;STMN2;SORBS1;TMEM132C;PRIMA1;PHYHIP;GFAP;ADCY5;KCNIP1;GRIK3;DAAM2;AQP4;SHC2;NDRG2;CCDC3;LGI4;SORCS1;ASTN1;ANK2;CHL1;SLC6A1;DCLK1;PLP1;SPARCL1;INTS6;PTPRT
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.5296146783229269,-0.9144987756457302,0.6153846153846154,0.937526218490086,1.0,3/9,7.50%,ARL6IP5;PRAF2;SLC1A6
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.4241012028160971,0.913906905600207,0.5,0.990353791020974,1.0,5/39,11.78%,GADD45A;WRN;ATM;RAD9A;CLOCK
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.4703439670992904,0.9138479249967072,0.6271186440677966,0.9897918595118802,1.0,2/20,4.69%,MAP3K19;FUT2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.444814291085106,-0.9137461364725263,0.5714285714285714,0.9386195737079309,1.0,6/22,18.48%,ATP5F1A;ALOX5;CAV1;VASH1;SCG2;AIMP1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.37230124257995423,-0.9135619392836004,0.6086956521739131,0.9383932035525542,1.0,11/61,13.65%,GORASP1;TMED2;RAB1B;PEF1;CTSC;TRAPPC2L;TRAPPC6A;SEC23B;KLHL12;TRAPPC2;SAR1B
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.591116891933471,0.9134999260965538,0.6739130434782609,0.9899270154326146,1.0,1/5,2.37%,TMEM14A
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.48685170180279624,-0.9127580745529121,0.6595744680851063,0.9396023122026046,1.0,4/13,17.90%,MFF;FIS1;CSPG5;SUPV3L1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.47905367517674324,-0.9126303014820681,0.5853658536585366,0.939390304431355,1.0,4/24,11.24%,PIGO;GPAA1;DPM2;PIGF
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.33250689145416257,0.9126162295164323,0.6666666666666666,0.9912377877061267,1.0,20/181,8.19%,DRAM1;DEPP1;FOXO1;ITPR1;TPCN2;PIP4K2C;USP13;TPCN1;DAPK1;DAPK2;PLEKHF1;ATP6V1E2;GFAP;DHRSX;MID2;SLC38A9;WASHC1;RB1CC1;RNF152;RPTOR
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.5938993531359767,0.9125616023467557,0.6415094339622641,0.990700367811954,1.0,4/5,40.58%,ST3GAL1;ST6GAL1;ST3GAL2;ST3GAL4
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.3579927602330581,0.9124153677364837,0.7068965517241379,0.9903493814168491,1.0,16/101,13.79%,FHDC1;BAG5;VRK1;SPTBN5;RAB29;BCAS3;RAB1A;TANGO2;VTI1A;HACE1;TRAPPC12;GOLPH3L;ATP8B2;STX5;FAM174B;SEC16A
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.5437503021083644,0.9118333668046543,0.6226415094339622,0.9911244232954864,1.0,4/8,31.75%,SRP54;COBL;NIPBL;PKD1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.5030654454893806,-0.9117340395116432,0.5909090909090909,0.9409867369365175,1.0,2/10,13.33%,CRAT;CROT
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.3855002853818929,0.9112010542694721,0.6046511627906976,0.992048016233263,1.0,13/56,12.63%,GRIN2A;CNTN3;MYLK;FAM13C;SLC4A4;ENPP2;PROX1;SGIP1;FGF14;RHOJ;GABRA2;LSAMP;ABCA8
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.37862890433683877,-0.9111158481648569,0.6666666666666666,0.9417069702117868,1.0,2/51,4.84%,SOX4;E2F4
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.47575479661832465,-0.9110875349053708,0.5555555555555556,0.9411416506180508,1.0,4/18,6.67%,NOP10;CCT5;NHP2;CCT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.5680609815271844,0.9110586998692779,0.6153846153846154,0.9917147722977204,1.0,2/5,30.30%,CEP250;MARK4
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.6246865956655065,0.9110390488955006,0.6666666666666666,0.9911190614724388,1.0,1/5,5.58%,FOXP1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.36827179210560235,-0.9110194371627783,0.6341463414634146,0.9407091157648436,1.0,12/56,17.81%,HSD17B10;ACAT2;ACBD5;PCCB;ACOX1;CROT;ACADS;ACAA2;PEX13;GLYATL2;ABCD2;ABHD2
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.6019434794162697,0.9107677596451292,0.639344262295082,0.9911750007280032,1.0,2/6,18.19%,ME2;ME3
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5204455132518984,0.9107362177429452,0.6481481481481481,0.9905804326045174,1.0,2/10,2.91%,IGF2BP3;IGF2BP2
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.43494226928630897,-0.9107004054188599,0.5925925925925926,0.9408416355395313,1.0,11/32,15.11%,PPT1;CD151;VPS28;SMPD1;CLU;CLIP3;B2M;FLOT1;CBLL1;CDC42;LRP1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4305450625426283,-0.9105842489591067,0.4888888888888889,0.9405124294353036,1.0,4/25,6.29%,GSTP1;PPIA;DUSP3;QARS1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.4156312171963232,-0.9104918649707412,0.7058823529411765,0.9401836533847715,1.0,6/19,18.42%,LAPTM4B;RAB1B;IFT20;UBQLN2;SCARB2;NPRL3
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.5591214890168206,0.9104517856908321,0.6071428571428571,0.9905591298868734,1.0,3/6,39.98%,USP1;USP15;USP47
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.4350284156282285,0.9104228766687066,0.5230769230769231,0.9900015080938265,1.0,10/25,20.18%,GRIN1;CNNM2;TMTC2;LETM2;SLC12A1;SNCA;FAM20A;SLC8A1;SLC12A5;ANK3
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.42137219041040747,0.9103661992465731,0.6296296296296297,0.989533953286324,1.0,5/37,8.37%,CHRM3;MAP7;SH3BGRL2;CDS1;EFNA1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.3990363451296409,-0.9103029124657401,0.5681818181818182,0.9399723732381876,1.0,9/35,14.62%,CFL1;AIP;PPIA;RPLP0;IL12RB2;TALDO1;HSPA9;CDC42;HNRNPA2B1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.3956820122359703,-0.9102104584982476,0.5813953488372093,0.9395712594514073,1.0,5/37,12.71%,RAN;NUP42;NOL6;NUP155;NPM1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.37661267746914584,-0.910084414452097,0.6136363636363636,0.9392948898211572,1.0,10/52,14.41%,CALM1;SVIL;MAP10;CALM3;GIPC1;CENPV;ENTR1;ZFYVE26;KLHL9;CDC42
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.42408423473723805,0.909837102868709,0.6428571428571429,0.9900549741102582,1.0,8/36,10.68%,BCL2L11;TPD52L1;ING5;SEPTIN4;RIPK1;CYLD;PAK2;TRAF7
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.5210311825918134,-0.9098038579584813,0.6078431372549019,0.9393109750255183,1.0,1/8,2.92%,RARRES2
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.4796496202167294,-0.9096867213053855,0.5740740740740741,0.9389767537919562,1.0,2/16,5.91%,BAD;PDE3A
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.5652993768813668,0.9089784373058836,0.6346153846153846,0.9913128180918059,1.0,2/8,7.34%,FOXO1;ATG7
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.5125648623785265,-0.9087705406201264,0.5789473684210527,0.9406120414117278,1.0,1/8,2.95%,CDHR1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.43068775459660624,-0.9086689516218661,0.6136363636363636,0.9402118157268723,1.0,6/32,11.91%,GSTP1;DNAJA1;LYN;SMPD1;SPRY1;UCHL1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.371828722850926,0.9086645593211811,0.6,0.9914040349573505,1.0,8/67,11.24%,PTPRC;IRF2;NLRC5;AGBL4;ZDHHC11;ATG7;TRIM52;STAT2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.474609580415171,0.9085581143962462,0.5789473684210527,0.9910615239796936,1.0,1/19,1.70%,SRF
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.3516640497308932,0.9085076518404958,0.7068965517241379,0.9905354487943218,1.0,23/123,13.36%,ABLIM1;FKBP5;TPD52L1;SEC14L2;IGF1R;MREG;ITPK1;RAB17;TIAM1;FOS;SYBU;PAPSS2;SLC1A4;MPPED2;HES1;RAB31;RARA;MAST4;SYT12;ELOVL2;IL6ST;RPS6KA2;NAV2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.47415779536674135,0.9081693281013683,0.5789473684210527,0.9905380155799652,1.0,1/11,2.21%,KLF15
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.2911350907690563,0.9079515663070961,0.8055555555555556,0.9903805189384495,1.0,167/754,21.12%,PTPRC;CHRM3;PTPRB;FBXO31;CTBP1;NUAK1;TLK1;PTPRR;VRK1;HIF3A;NEK3;EGLN3;AKT2;GRK4;RAB3A;DAPK1;EVA1A;MERTK;PAK1;DAPK2;BCR;FBXL4;FUT2;FAM20C;B3GNT5;CAMK2B;CDC42BPB;PRKAR1B;PTPRJ;DUSP4;SSH2;TSSK3;CDKL1;NEURL2;PRKCA;ATG7;GCNT2;CDK19;PRKCSH;FBXO6;TAB1;ZBTB16;MAK;FBXL13;RAB1A;LIMK1;RABGGTB;DUSP8;CD247;ATG5;PAK2;CDK14;OXSR1;ATM;CDK6;ENGASE;PHEX;JAK1;PSMD6;MAN2A1;SGK1;SPSB4;DUSP1;CDK7;MAP3K9;GRK5;FBXW11;TNKS;KLHL3;PARP9;MAPK10;PXK;RARA;TAF1;PRKAA2;PDPK1;CAMK1;PIGH;STK11;SPP1;PIK3CD;PTPRG;TNIK;FBXL5;PLK2;HLCS;PRKG1;PGAP1;AKT3;ACVR1C;FBXO11;PSMB5;ST3GAL1;DDB2;FAM20A;LMTK2;SIK3;STK3;PTPRU;LARGE1;WWP2;NIM1K;PRKAA1;CAMK2D;MTMR7;MAP3K5;MCRS1;FEM1B;KNG1;CSF1;MMP15;UBXN7;MTMR3;DAPK3;ANO8;B4GALT5;ADAM10;CSNK1D;VRK2;CDK13;PRKCE;SRPK2;MKNK1;PSMA4;CDK17;STK17A;PRKCZ;STK17B;MGAT1;CDK12;RYK;ASB16;PPP2R5C;DCLK1;UBE2D3;ASB3;NEK4;FBXL18;PPM1F;NEK7;USP6;ABL2;ABL1;DUSP6;LCMT1;NEK11;ATG3;MAML1;SPARCL1;ACVR1B;PPP2R5E;FER;TF;MAPK1;HS3ST5;PIGU;FEM1C;FBXW8;FN3KRP;CSNK1G2;PTPRT;TAOK1;DCAF6;STK24;BRSK1;PTPRE;TGFB2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.34181715085388303,-0.9078075463959238,0.5714285714285714,0.9415601235329693,1.0,12/73,10.15%,BTC;HSPG2;AMOTL2;IL20RA;RTKN2;COL12A1;YAP1;S100A16;COL4A4;LRIG3;LAMA5;ADCY6
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.507892285944085,-0.9077860685411112,0.5849056603773585,0.9409778354937834,1.0,2/8,12.67%,ZNF830;RAD17
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.4594655604082678,-0.9076401297422816,0.6078431372549019,0.940672712760472,1.0,2/14,10.75%,OAT;AADAT
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.3994646064440771,-0.9072539384583173,0.5777777777777777,0.9409131772062908,1.0,9/33,14.62%,CFL1;AIP;PPIA;RPLP0;IL12RB2;TALDO1;HSPA9;CDC42;HNRNPA2B1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5451578381083165,0.9071358611159449,0.6888888888888889,0.9916687495303973,1.0,3/10,14.36%,PKP2;RYR2;DSC2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.560644264314049,0.9071107741403508,0.6470588235294118,0.9911022120461637,1.0,1/7,8.37%,EFNA1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.5166353491291404,-0.9070836290501096,0.574468085106383,0.9406884014577609,1.0,2/7,14.75%,WARS2;TARS2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.49545007342897096,0.906987416018658,0.5818181818181818,0.9907257444667978,1.0,2/13,9.18%,NR4A3;C2CD5
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.3327549931546855,0.9064430831718379,0.6515151515151515,0.991195277106077,1.0,34/152,17.18%,RAB40A;RAB3A;RAB10;PLEKHF1;MAP7;MRAP;RAB40C;PKP2;TSPAN5;KCNB2;RAB8B;EMP2;CAV3;WDR19;PACS1;RAB29;SH3PXD2B;SHANK3;C2CD5;RAB40B;RFTN1;LIN7A;DLG4;SPTBN4;TNIK;SEC16A;PACS2;ITGB1BP1;DPP6;MAGI2;ANK2;EFR3A;EHD1;DPP10
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3449895425511706,-0.9063328792834792,0.5405405405405406,0.9418360196322049,1.0,22/82,17.47%,SIRT2;ELOB;UBXN1;PRICKLE1;ZYG11B;CLU;PSMD10;RPL11;STUB1;HSP90AB1;UFL1;GIPC1;RAD23A;TRIB3;UBQLN4;RACK1;COMMD1;VCP;PARK7;SUMO1;RNF14;ARAF
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.42391682185772833,-0.9063057346042765,0.6153846153846154,0.9412917129671808,1.0,2/20,3.82%,BTG1;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.3966952113231168,0.9059514399123666,0.6065573770491803,0.9917941890791763,1.0,18/47,22.55%,TTN;SYTL4;RAB29;BCAS3;MYOM1;GOLPH3L;B3GAT3;PCNT;CNST;CEP131;CEP290;PPID;TMED10;TGFB2;UNC13B;MYH10;ACSL3;GOLPH3
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.43859709388098445,-0.905202366932741,0.5918367346938775,0.9431769982201528,1.0,4/21,7.74%,ARL6IP5;PRAF2;SLC1A6;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.4347695005994435,-0.9050253817569329,0.5098039215686274,0.9429296031274664,1.0,4/19,12.34%,PPP1R35;TIPRL;PPP1R11;GPATCH2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.35233600860609765,0.9049416345141976,0.631578947368421,0.993531967834403,1.0,5/65,4.57%,SOX9;IGF1R;PIP4K2C;PIP5K1B;NTRK3
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.5685974921790724,-0.9045901071094501,0.6470588235294118,0.9432618111703879,1.0,1/6,1.66%,RAN
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.5333352521894312,0.9045107129214116,0.6666666666666666,0.9938807280137741,1.0,3/13,14.13%,SOX9;PIK3CD;GJA1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.3966841325800382,-0.9044086728374687,0.5116279069767442,0.9430580989647354,1.0,8/37,13.61%,UBB;ERMAP;UROD;ALAD;CD44;UROS;ITGA4;EPB41
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.31088866735048265,0.904215986509504,0.8,0.9939105836229879,1.0,39/326,12.60%,HEY2;AHR;MYRF;FOXO1;KLF6;SOX9;YWHAH;SEC14L2;HDAC4;WNT7A;BRD4;ING5;PSEN1;RXRA;THRAP3;FOS;NCOA1;FANK1;TEAD1;ARNT2;NPAS3;ZBTB16;NAA16;BMP7;RORA;BRCA1;NPAS2;YAF2;HES1;FBXW11;TRIM44;NOS1;PARP9;CLOCK;RARA;FUBP3;TP53BP1;SPP1;TASP1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.5490954851593434,0.9037378752082932,0.6551724137931034,0.9944118698957977,1.0,3/7,19.41%,SORT1;SLC2A3;SLC27A4
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5776261739396107,-0.9033552590953543,0.6585365853658537,0.9448072087523202,1.0,1/6,7.01%,CADM4
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.3673672263425147,0.9032754154062987,0.6461538461538462,0.9948712763131684,1.0,19/84,16.30%,TMSB4X;AKT2;PLXNA4;ENPP2;PRKX;MACF1;FGF9;SRCIN1;NRG4;HACE1;CDK6;SGK1;TTBK2;NRG2;PLXNA1;DIAPH1;FGF1;DAPK3;NRG1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.5911577632290468,0.903172090454859,0.6379310344827587,0.9944531158111564,1.0,3/6,17.10%,RIPOR2;CFLAR;EHD1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3895087328338638,-0.9028447085791867,0.6170212765957447,0.9453832829379457,1.0,3/39,1.48%,S100A10;CUL7;CALR
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.4225798754088081,0.902739323225818,0.6140350877192983,0.994800142126589,1.0,2/25,4.57%,TMSB4X;NTRK3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5273074848108799,-0.902655043238273,0.6071428571428571,0.9450919290024536,1.0,3/7,19.11%,BMP2;GREM1;SOX6
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.4493954165806397,0.9024913690641708,0.5535714285714286,0.9947058639849463,1.0,9/25,26.60%,ZNF16;STAT5B;ANKRD54;ABCB10;ACVR1B;STAT3;FOXO3;MAPK11;FAM210B
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.37102326210709907,-0.9024566708490906,0.6170212765957447,0.9449092162419916,1.0,8/49,9.76%,RAN;BAD;DBI;SULT1C4;ACSM5;TPST2;ACLY;OXSM
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.4790226079763351,-0.9023766441343147,0.6326530612244898,0.9445680507389257,1.0,5/17,13.00%,MALT1;TNFRSF14;WNT5A;SPHK2;B2M
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.6002618642714644,0.9023149002628368,0.68,0.9944531043380642,1.0,3/5,37.17%,DOCK3;NTRK2;BDNF
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5856422964133875,0.9022766609608693,0.6470588235294118,0.9938660596557973,1.0,2/5,16.34%,UBR5;RNF169
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.38559802788523995,0.9022313223140999,0.6206896551724138,0.9932973766720757,1.0,12/56,15.75%,ADAMTS9;GPI;FOXP1;EMP2;PRKCA;SASH1;BCAS3;PROX1;RHOJ;PIK3CD;ITGB1BP1;FGF1
prerank,PanglaoDB_Augmented_2021__Basophils,-0.3737428946466887,-0.9021952823115892,0.65,0.9442705747186805,1.0,8/39,10.38%,GPC4;IGFBP7;PLEKHG5;SNCAIP;LAMA5;FADS1;F13A1;CD44
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.38236570903909517,0.901880731587083,0.6153846153846154,0.9934271038442325,1.0,9/56,9.45%,ITGA8;TBCD;RELN;SPI1;RADIL;SRCIN1;EFNA1;TYRO3;PROX1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.5397370334259015,-0.901466239503754,0.6153846153846154,0.9455871355689363,1.0,1/8,15.62%,PLA2G4C
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.4824565878764555,0.9011777105261451,0.6521739130434783,0.9943476271990774,1.0,4/11,23.14%,SORT1;NRG1;AKAP13;CBY1
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.5503045996963046,0.9007891041967021,0.6538461538461539,0.9945350581204412,1.0,3/7,8.91%,SLC6A17;SLC6A6;SLC1A4
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.45225193901728117,-0.9007410413948462,0.65,0.9463836637287215,1.0,4/25,10.48%,CD151;THY1;RCC2;FN1
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.5490723107995261,0.900705218725434,0.5882352941176471,0.9940493341946973,1.0,3/6,15.69%,CAV3;DYSF;ANK2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.3819086620161148,0.9005247855959552,0.625,0.9937104292741082,1.0,8/48,8.37%,BAG5;STMN2;SEMA3A;KIAA0319;BCL11A;RAB29;CRMP1;EFNA1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.3191745737982588,-0.9003375046549229,0.7894736842105263,0.9466611605446807,1.0,19/118,11.81%,GPX4;CKAP4;PLIN2;ODC1;ARL4A;S100A1;NT5E;SMPDL3A;SYT11;PRAF2;P2RX4;PHLDA1;IFITM3;RNH1;CD44;GLIPR2;DCPS;FURIN;CDKN1C
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.5637430917333055,-0.9000121539091719,0.64,0.9467585525572085,1.0,3/7,18.75%,GBA3;B3GALT2;B4GALT3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.422726387986295,0.9000068479737661,0.6363636363636364,0.9941316624448242,1.0,3/22,10.39%,ZER1;FBXL17;UFD1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.4948926730905172,0.8999485092661212,0.5789473684210527,0.9936588205773378,1.0,2/9,5.07%,SEC14L2;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.5537305917594797,-0.8997939262304075,0.6222222222222222,0.9466905568086155,1.0,2/5,9.22%,PIH1D1;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.5980903849441871,0.8995815713705442,0.7017543859649122,0.9936826747587428,1.0,3/5,26.94%,PDPN;CLASP1;DDR2
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.5237736323443422,-0.8993947820237046,0.6222222222222222,0.9468165281695724,1.0,3/8,11.90%,UGDH;FADS1;UROS
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4319805179000387,0.8991611905211645,0.6363636363636364,0.9939981249142582,1.0,5/20,10.52%,HEY2;PKP2;TGFBR3;PROX1;TPM1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.3514136100106561,0.8989791733680128,0.703125,0.9937652634897666,1.0,10/90,10.08%,TMSB4X;LRRC19;BRD4;FOXP1;RIPK1;TYRO3;CYLD;MVK;RORA;NMI
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.41523801692198425,0.8989600064258666,0.6290322580645161,0.9931832010091977,1.0,6/43,4.36%,KCNJ11;GPI;BRAT1;G6PC2;SLC39A14;SORD
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.4753595397252365,0.8989104463624663,0.6727272727272727,0.9926251731985708,1.0,3/12,18.18%,BMP7;TRERF1;AKR1C3
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5160869513519519,0.8987502949671735,0.5636363636363636,0.9923645571982526,1.0,2/6,23.23%,FYCO1;MAPT
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.5864118768316829,-0.8987421592875475,0.675,0.9477819469988336,1.0,1/7,1.16%,PPT1
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.5388278273875223,0.8986720155573573,0.6349206349206349,0.9919007940623956,1.0,4/8,33.16%,ST3GAL1;NPL;ST6GAL1;GNPDA2
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.49610654331239246,-0.8986309622355942,0.6382978723404256,0.9473907071568002,1.0,1/12,1.52%,GDE1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.37789337418009156,0.8984010725569597,0.6779661016949152,0.9918152799207388,1.0,14/68,15.17%,GLRA1;SLC25A18;SLC24A2;PANX2;KCNN3;GRIN1;TMEM63C;GABRB1;SLC12A1;LASP1;SLC8A1;PIEZO1;SLC8A2;PIEZO2
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.4358984528403301,0.8979948398545373,0.6101694915254238,0.9921247049088715,1.0,5/20,13.84%,SRF;SPI1;CDKN2A;SMC5;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3247373392656698,-0.8978882287552858,0.7631578947368421,0.9483186894799044,1.0,9/87,8.15%,S100A10;RHOC;THY1;AGRN;CALM1;SFRP1;LIMS1;GBA3;CALM3
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.4745262729896942,0.897788735477937,0.5576923076923077,0.9920333542383781,1.0,4/13,21.84%,PPP2R2C;DUSP1;PPM1F;PPP3CA
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.40014611133015043,0.8975147455713293,0.6341463414634146,0.9920059082659939,1.0,12/30,22.88%,PARN;CCT8;CCT6A;ATM;TNKS;HMBOX1;MAPKAPK5;NEK7;MAPK1;NAF1;MAPK3;ATR
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.48606156226086666,0.8974445369446845,0.6458333333333334,0.9915322711595486,1.0,1/12,2.52%,KCNJ11
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.370705154107327,0.8972547438156913,0.5918367346938775,0.9913314383159813,1.0,13/63,14.11%,ITPR1;EFNA5;KCNJ11;G6PC2;KCNC2;ADCY5;PRKCA;SNAP25;ITPR2;BMP8A;CLOCK;STX1A;ENSA
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.33749284523355494,0.8964634156723209,0.7142857142857143,0.9923752238969297,1.0,20/117,16.28%,PTPRC;AHR;IGF2BP3;IGF2BP2;PSEN1;FOXP1;MKLN1;SORT1;TOB2;PROX1;ZUP1;CDK6;TRIM44;FUBP3;ADNP;SLC8A1;SLC8A2;NOVA2;MTMR3;NELL1
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.532096224715265,-0.896339199619922,0.675,0.9512867662039103,1.0,1/6,12.46%,LAMP1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.4861042463933247,-0.8962772563978074,0.5853658536585366,0.95078667059136,1.0,2/8,13.89%,ZNF830;MCM4
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4556508956456335,0.8961558108696486,0.6491228070175439,0.9924286057718498,1.0,3/26,2.47%,DOCK5;NEDD9;RAC3
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),-0.5146901273175704,-0.896099423414647,0.5806451612903226,0.9505232703665034,1.0,1/14,0.67%,SIRT2
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.44953654149121264,-0.8960168617607699,0.5813953488372093,0.9500600429720948,1.0,6/24,18.61%,CENPX;SMARCA5;CENPQ;NPM1;RNF8;ZNHIT1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5205782393258109,0.895907744845854,0.5416666666666666,0.9922507063562732,1.0,2/8,10.38%,PRELP;GLB1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.4582913463930968,0.8958059057394895,0.6181818181818182,0.9918939586905533,1.0,11/22,22.96%,ACACB;FABP3;ACSL1;PRKAA2;ACACA;CPT1A;PPARG;SLC27A4;ACSL3;APOE;PRKAG2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3783058164598088,-0.8955620281189229,0.6521739130434783,0.950304674659051,1.0,6/64,3.53%,S100A6;SLITRK2;ACTB;S100B;CDHR1;MAP1S
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.41726816729236926,0.894790615672067,0.6578947368421053,0.9933676896991216,1.0,12/28,22.88%,PARN;CCT8;CCT6A;ATM;TNKS;HMBOX1;MAPKAPK5;NEK7;MAPK1;NAF1;MAPK3;ATR
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.36818783478549044,-0.8946250905968969,0.6326530612244898,0.9518698164472899,1.0,7/54,9.92%,TRMT112;TRMT5;OSGEP;TRMT10A;ADAT2;AARS1;PUS3
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.51246628689815,-0.8944382725688687,0.6764705882352942,0.9516706127069743,1.0,2/7,13.69%,IFI6;RACK1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.533857086666579,-0.8942430075636895,0.5957446808510638,0.9515073148740785,1.0,2/5,6.29%,MT3;ASAH1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.4835676836962958,0.8941943739129272,0.6557377049180327,0.9941587671486286,1.0,1/12,0.46%,AKR1C2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.37448645100895667,-0.8934894802341014,0.6,0.9521071280015319,1.0,7/51,10.44%,ARPC5;ACTG1;ACTB;LYN;HSP90AB1;BRK1;MYO10
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.37448645100895667,-0.8934894802341014,0.6,0.9521071280015319,1.0,7/51,10.44%,ARPC5;ACTG1;ACTB;LYN;HSP90AB1;BRK1;MYO10
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5825738279547332,0.8933006431874744,0.6551724137931034,0.9955715182055885,1.0,4/5,41.42%,PRKN;ADAM9;LRRK2;D2HGDH
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.410497126686012,0.8932954810930442,0.6166666666666667,0.9949485158732265,1.0,7/26,8.89%,CHRM3;YWHAH;NEDD4L;AHCYL1;CAV3;TCAF1;RIPK1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.38387453612399275,0.893294895354827,0.6666666666666666,0.9943205489391446,1.0,11/55,17.89%,XRCC4;ATM;BRCA1;SMC5;LIG3;BABAM2;TP53BP1;PIAS4;POLQ;BARD1;RIF1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.38806709743991674,-0.8929633704248041,0.6410256410256411,0.9526555552212539,1.0,8/45,11.56%,NOP10;JMJD6;ADAT2;HENMT1;AARS1;RBM15B;PUS3;TSR3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.4641789942272276,0.8926618933403209,0.68,0.9951320239369777,1.0,3/25,4.36%,KCNJ11;BRAT1;SORD
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.503593844095956,-0.8926254852617015,0.5897435897435898,0.9528761162600832,1.0,1/9,0.39%,CCND1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.5436951400114471,0.892327875621383,0.6101694915254238,0.995396130143691,1.0,6/8,31.68%,SERTAD2;ARID1B;PADI2;ARID1A;ZMIZ1;ZMIZ2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.5451711931945741,-0.8921716326859052,0.5909090909090909,0.9532101237482906,1.0,1/5,5.97%,SOAT1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.47798866643074533,0.892159309496643,0.6206896551724138,0.9951081642388832,1.0,1/13,2.42%,USP13
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.40977794550512053,-0.8918940995560108,0.6744186046511628,0.953266676033046,1.0,7/32,12.34%,CSTB;TMED2;PPP1R35;FICD;RCC2;CST3;GPATCH2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.5787534960622664,0.8918345482110897,0.64,0.9951077443315617,1.0,2/5,16.35%,PUS7;PUS10
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.43039145284884217,-0.89175701993888,0.574468085106383,0.9530604980270814,1.0,4/27,8.86%,PPT1;CD63;CLU;ATAD1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.5050357956396629,0.8917107291120159,0.6,0.9947858874689338,1.0,2/10,8.59%,NAA50;NAA16
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.5044432409238394,0.8917053075991045,0.5517241379310345,0.9941661507755711,1.0,3/9,19.77%,GABRG2;GABRA2;GABRA1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.5159605551007316,-0.8915697952230501,0.6458333333333334,0.9528120146674658,1.0,2/8,12.05%,CAMSAP3;ITGB5
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.38188009114007526,0.8910753092188999,0.7076923076923077,0.9948083886754975,1.0,9/54,8.37%,CHST3;EDNRA;SVEP1;COL5A1;SRPX;TIMP3;TEAD1;FKBP9;NRG4
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3116091723463012,-0.8909974231430055,0.6,0.953315375306059,1.0,27/221,9.79%,UBB;CCND1;MMP2;MT2A;RPS27A;GAPDH;UBC;IL20RA;HSPA8;ZFP36L1;HAX1;PTPN14;ALOX5;SFRP1;CXCL12;UBA52;ASAH1;IL12RB2;RPL13A;PTPRZ1;NDN;MAPK13;HAS2;WNT5A;LAMA5;CACTIN;F13A1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.4575290271458322,0.890654681294364,0.6326530612244898,0.9950086762985667,1.0,4/15,11.53%,CEP135;CCT8;CCT6A;PTP4A3
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.472070332968647,0.890106216789536,0.6078431372549019,0.995575136755134,1.0,4/17,16.04%,SYT1;ARHGAP17;SYT12;SYT2
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.49438924317273547,0.889675659598489,0.6,0.9958490688455546,1.0,3/12,9.19%,PKIG;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.486851217311513,-0.8894849597165309,0.6041666666666666,0.9564397053021105,1.0,3/16,14.19%,PIH1D1;RUVBL2;PPHLN1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.5614753051974627,0.8893273021198046,0.6326530612244898,0.9959511092565818,1.0,1/5,6.97%,ZNF16
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.5040529246053349,-0.888980756971764,0.675,0.9569543002171929,1.0,2/13,6.74%,MT3;GBE1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.3787239215547173,0.8888240526203764,0.6037735849056604,0.9965501871353111,1.0,10/59,8.05%,CALCB;TPCN2;HTR2C;ATP2B3;SLC24A2;SLC39A14;VAPB;SLC30A9;RYR2;ATP2B2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.4352472307360982,-0.888740318807359,0.5217391304347826,0.9568313626754994,1.0,7/21,8.80%,SF3B5;RHOG;BLVRB;RASSF1;YIF1B;TRAPPC6A;CNPY3
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.4163596798936021,0.888517231867788,0.6530612244897959,0.9966859214042512,1.0,5/25,8.51%,FABP3;CAV3;AGMO;LMF1;GPAM
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5179648598962139,-0.8884820478851997,0.6382978723404256,0.9568217324195036,1.0,2/9,5.26%,ARL6IP5;GSKIP
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.4289853562013567,-0.8883981179961499,0.627906976744186,0.9564092639037981,1.0,3/21,15.20%,PIF1;PPP1R10;SMG5
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.34654907821345277,0.8883690473378445,0.6785714285714286,0.9963820189751997,1.0,10/70,12.66%,TIAM1;PSEN1;MACF1;GRB10;DAAM2;SULF1;ZRANB1;CDK14;CBFB;RSPO2
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.5652255668296526,-0.8882257268424835,0.75,0.9561880188307784,1.0,1/5,3.92%,PPIA
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.5782060484241616,0.8880933411040579,0.6612903225806451,0.9963750945472974,1.0,3/6,39.31%,MYO7A;NRXN1;CDH23
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5490579919820852,-0.8880165369864004,0.6808510638297872,0.9561082253988666,1.0,2/7,6.13%,KRT10;SGPP1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.3543885253032649,0.887684955669797,0.6666666666666666,0.9966588862268698,1.0,12/75,14.27%,BAIAP3;TBC1D10B;CLTCL1;WASHC1;RBSN;VPS52;RAB29;RAB6B;VTI1A;STX5;ERC1;VPS54
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.4005531735777509,-0.8875083820604617,0.6666666666666666,0.9564517848522069,1.0,4/28,8.15%,THY1;CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.46882599051350665,-0.8874541196982357,0.6896551724137931,0.956019437351747,1.0,7/18,21.86%,AUP1;STUB1;RNF126;DNAJB12;VCP;DNAJC18;UGGT1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.47917416529155366,-0.8874158768414983,0.6428571428571429,0.955510134603793,1.0,3/21,11.24%,PIGO;DPM2;PIGF
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.5517631498133947,-0.8872035994691598,0.6756756756756757,0.9553464764912244,1.0,1/5,13.99%,BMP2
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.49113920082327267,0.8870515752929701,0.603448275862069,0.9974094375942459,1.0,2/12,12.09%,EDNRA;P2RY12
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.3894657232372868,-0.8868039183263102,0.5531914893617021,0.9556826149623285,1.0,4/31,11.33%,CALM1;PDGFD;CALM3;RAP2C
prerank,MSigDB_Hallmark_2020__Complement,0.33209553797690744,0.8867010304904326,0.7213114754098361,0.9975157385705997,1.0,17/116,12.92%,GCA;PCLO;IRF2;ZFPM2;PSEN1;DGKG;GNB4;RBSN;L3MBTL4;CA2;DOCK4;CD59;PHEX;PREP;MAFF;GPD2;HPCAL4
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.4756586659553532,-0.8864282624007974,0.65,0.9559128504761599,1.0,1/14,0.48%,ZDHHC1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.3585775203611041,-0.8862871173732683,0.6,0.9556368049565183,1.0,11/49,15.11%,CD151;SNX17;STON2;SYT11;SMPD1;RAB5B;CLIP3;FLOT1;CBLL1;AP2S1;LRP1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5382083230253871,0.886286516690327,0.5862068965517241,0.9978096553852679,1.0,1/5,13.58%,FYCO1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5204782381322506,0.8857193216023622,0.6153846153846154,0.9983647495063173,1.0,3/10,8.46%,NTRK3;BAIAP2;BCAS3
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.493573277380398,0.8855372121854154,0.6326530612244898,0.9981349979701898,1.0,2/12,10.00%,ANGPTL4;RORA
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.594204051278934,0.88553053575984,0.7142857142857143,0.9968988719765639,1.0,1/5,8.87%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.594204051278934,0.88553053575984,0.7142857142857143,0.9968988719765639,1.0,1/5,8.87%,PAPSS2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.3799353356250657,-0.8854480909547152,0.627906976744186,0.9568149218434896,1.0,6/39,4.82%,HSD17B10;CYP3A43;CUBN;TSPO;DHRS4;ARV1
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.3322285978750714,0.8854230886843231,0.7272727272727273,0.9965230125161306,1.0,12/98,8.29%,AHR;MLANA;SOX9;SRPX2;CHST3;SRPX;TIMP3;TEAD1;PRKCA;FKBP9;SASH1;SH3PXD2B
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.38434875576573035,-0.885339951703407,0.6511627906976745,0.9564895250834569,1.0,5/29,9.64%,SLC7A10;SLC16A1;SLC25A30;SLC7A8;SLC38A10
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.4717751870525614,-0.8850602474484288,0.575,0.9562697527479986,1.0,1/11,3.21%,ERH
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.5415531017654249,0.8849609400440497,0.72,0.9968617899327323,1.0,1/7,4.94%,PSEN1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4676999602020602,-0.8847729354551777,0.5961538461538461,0.9562044773057226,1.0,5/12,17.53%,PPIA;POLD3;POLD2;RFC3;CDKN2D
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.331463500692735,-0.8846765942966641,0.6521739130434783,0.9557679808344839,1.0,8/55,7.82%,GSTP1;THY1;RTRAF;PPIA;GSKIP;QARS1;CEP85;TAF7
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.5721037021470101,-0.8844054579365582,0.675,0.9557311056832665,1.0,3/5,33.93%,NKAP;HLA-A;PNP
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5469726248215574,0.8841619547384201,0.68,0.9980384783713514,1.0,2/8,8.31%,STAT6;STAT5B
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.47060338919514166,0.8840686922938887,0.6,0.9976173243192269,1.0,4/12,23.33%,RAB29;SNCA;VAMP3;NSF
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.5048651929772268,-0.8835663475342934,0.5740740740740741,0.9568627695010563,1.0,2/7,5.27%,FABP7;FABP5
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.5672837513007822,0.8835173833329745,0.6862745098039216,0.9982489626137451,1.0,2/5,14.47%,EDNRA;SLC8A1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.4490888979739317,0.883404259006618,0.6071428571428571,0.9979073569262029,1.0,5/19,16.04%,SYT1;SYT12;STXBP3;STX1A;SYT2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.552171443435776,-0.8833821887402147,0.6666666666666666,0.956643449827644,1.0,4/7,21.34%,DUSP3;FGL1;SOX11;GPNMB
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.3883017290325383,-0.8832518823138878,0.5526315789473685,0.956312591791763,1.0,2/26,5.03%,RBM22;ERN1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5705807443277582,0.8832296276958501,0.6825396825396826,0.9977356862963581,1.0,3/5,35.80%,ITCH;TANK;OTUD4
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.351364045722355,0.8831651904131119,0.6666666666666666,0.9972536594680138,1.0,9/86,7.40%,HEY2;DRAM1;TNS1;EDNRA;ARID5A;LAMA2;TIMP3;NRGN;SASH1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3353752832902122,-0.8830614102949731,0.6590909090909091,0.9560519848923545,1.0,6/106,3.70%,RHOC;GAPDH;S100B;TMEM9B;PLEKHG5;MALT1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.596714696871947,0.8830579477904339,0.6938775510204082,0.9968907419220134,1.0,2/5,16.79%,ATPSCKMT;ZFHX2
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.5029117366862558,0.8830003916891234,0.631578947368421,0.9964267626832667,1.0,2/7,9.30%,DHDDS;MVK
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.40407755761358954,0.8829354938624958,0.6379310344827587,0.9959577257943409,1.0,7/47,8.49%,EFNA5;FAM107A;RAC3;PAK1;BAIAP2;ARHGAP17;RHOBTB2
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),-0.5458648888562125,-0.8828194352851362,0.6571428571428571,0.9560220272426906,1.0,1/9,0.67%,SIRT2
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.4984833858928881,0.882168383059088,0.6379310344827587,0.9971283792598703,1.0,2/11,9.87%,PTPRN;RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.37671645152125166,0.8819290318431152,0.6724137931034483,0.9970760473710614,1.0,16/62,19.43%,TMSB4X;GRK4;LRRC19;NMT1;BRD4;FOXP1;CYLD;CAMKMT;TIRAP;P2RY12;IRF1;APPL2;TRAF3;BCL6;USP14;SAMHD1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.31232741490206506,-0.8817284495162461,0.8780487804878049,0.9578893594822607,1.0,26/213,10.12%,UBB;BTC;PSMB6;PSMD8;RPS27A;CALM1;PSMB4;UBC;ICMT;MT3;ZFP36L1;PSMA7;PDGFRA;PEBP1;GOLGA7;UBA52;SHC3;MAPK13;PSMC3;PSMC1;PSMD10;PSMD12;ABHD17A;PSMB9;PSME3;YWHAB
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.3521827434448863,0.8816719677344416,0.7049180327868853,0.9969900266755254,1.0,15/74,14.80%,PTPRC;PTPRB;CAMK2N2;UBASH3B;GADD45A;CAV3;TAB1;SRCIN1;PAK2;PDPK1;CAMK2N1;MACROH2A1;SNCA;SLC8A1;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5073901858660886,-0.8816175094644024,0.5909090909090909,0.9575306662345027,1.0,3/8,18.74%,WIZ;DBF4;DBF4B
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.31071198183556253,-0.8815843402630812,0.7804878048780488,0.957019155335389,1.0,23/124,13.65%,IDH1;MT2A;PGRMC1;UGDH;TMBIM6;HES6;CNDP2;SLC46A3;GSTM4;BLVRB;CBR1;DHRS7;SSR3;DCXR;COMT;CSAD;LCAT;ACP2;PYCR1;ACOX1;CROT;DHRS1;SAR1B
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.38807399813222304,-0.8809280896795367,0.5833333333333334,0.9578310971214735,1.0,6/46,8.77%,PPIF;SYT11;SMPD1;HPCA;SLC25A24;WNT5A
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3625908337523064,0.8807552432253525,0.6833333333333333,0.998405229040786,1.0,31/99,23.58%,TPD52L1;CEP135;CCDC57;HAUS2;FBXL17;CDK14;BORA;CCP110;CDK7;FBXW11;TUBA4A;HAUS6;HAUS5;PCNT;ENSA;CEP41;MASTL;CSNK1D;ACTR1A;CEP131;CEP290;LCMT1;BRSK1;TAF2;CEP250;PPP1R12B;ALMS1;CLASP1;ARPP19;CEP70;CDKN2B
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.5487648400345789,-0.8804955637783692,0.6,0.9581828111942412,1.0,2/6,5.59%,LAPTM4B;LDLR
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.4183885905168579,0.880456711215816,0.6226415094339622,0.9985263797226364,1.0,3/23,3.51%,YWHAH;SCN8A;CACNG2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5179097952357644,0.8802687387886581,0.62,0.9982543177604547,1.0,4/12,9.42%,CABYR;CCDC39;ODAD4;AQP4
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.4289936522373562,0.8800764511446318,0.6363636363636364,0.9980948273136163,1.0,8/23,17.26%,SOX9;RAB17;GPRC5C;EFNA1;AQP4;SPP1;OVOL2;ALPL
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.4470086939060216,0.8800171637709792,0.6122448979591837,0.9976046505444316,1.0,2/18,1.11%,MYRF;SOX9
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.5188411036400487,0.8798616056105909,0.7017543859649122,0.9973168518351766,1.0,2/10,11.41%,KCNJ11;BMP8A
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.5149908816187396,-0.8797394587241264,0.6222222222222222,0.9592920267395234,1.0,4/8,21.23%,MST1;CLK2;PGP;ACMSD
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.5755139442601995,0.8796289060909434,0.6666666666666666,0.9971862449596449,1.0,2/5,20.49%,AGTPBP1;STAT3
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.49371087448171647,0.8794443029612652,0.7192982456140351,0.9970278108809727,1.0,1/11,0.43%,SCEL
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.47334924696644287,0.8791539773512139,0.7,0.997110128863463,1.0,7/13,38.57%,NUP93;NUP205;NUP153;NUP133;NUP98;RTN4;NDC1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.5096858525165423,-0.8790317356381695,0.75,0.9602191865118334,1.0,2/9,10.64%,UGDH;MKKS
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.35087319573719267,-0.8786443164214043,0.6666666666666666,0.9605826571149505,1.0,9/48,12.85%,LPCAT1;ALOX5;ACSM5;ACLY;FADS1;OXSM;NDUFAB1;DHRS11;PCYT2
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.26090628042574177,-0.8784628857702357,1.0,0.9603904262908596,1.0,201/1410,14.11%,NR0B1;SOX4;GMEB2;BTG1;JUN;ZBTB32;SALL2;ZNF488;SIRT2;ILF2;POLR2L;OLIG1;ASCL1;ZNF658;SFR1;SOX21;CALR;E2F5;ZNF114;ZNF426;ATF4;PRRX1;DACH2;OLIG2;TCEAL7;ZNF491;ESRRB;ZNF460;HSPA8;MYT1L;ZNF12;SPIN2B;DHFR;ELOC;HES6;ZNF22;ZNF821;MT3;SAP18;ZNF761;NKX2-2;ZNF688;HES5;PHF1;ZNF333;NR2F6;JMJD6;ZNF584;WIZ;RHOG;ZNF92;ZNF676;E2F4;HDGF;ZNF300;ZNF257;PRICKLE1;PAX8;SFRP1;ZNF699;DACH1;BAMBI;IRF3;YAP1;ZFP90;NR2E1;EID1;ZNF525;LBH;SLC2A4RG;SMARCA5;WBP2;QARS1;RNF6;ZNF582;ZNF649;ZNF117;YWHAQ;WTIP;LIMS1;DRAP1;HNRNPAB;MED23;MED29;PA2G4;MLF2;CCNK;ATXN7L3;ZNF558;MED30;DPF2;PHB2;CREB3;ZBTB33;TAF7;CREBZF;ZNF726;CBX5;CHD3;NACC1;EDF1;SCML1;MEOX2;ZNF317;ZNF574;SET;ZXDB;WNT5A;ZNF667;FADS1;HNF4G;RFX5;RBM15B;ZBTB49;NAT14;RING1;CAND2;RPL6;ZNF77;CNBP;RXRB;RRP8;ZNHIT3;ENY2;ZNF446;ZNF480;ZNF124;ZNF320;ZBTB21;TFEB;ZNF557;HSF4;PHF6;DDX5;SAP30;ZNF614;NFE2L1;TCEA2;ZNF260;POU3F2;IKBKB;ZNF677;ZNF701;AFAP1L2;ATMIN;POLR2K;TRIB3;HES4;CCNL1;SOX8;USF2;ZSCAN21;ESRRA;ZNF665;QRICH1;CDKN1C;MYNN;ZNF304;ZNF208;LITAF;MZF1;YBX1;ZNF32;ZNF217;ZNF302;GTF2H2;ZNF791;TRAPPC2;ZFPL1;MYRFL;RNF187;ZNF48;NPM1;PPP2R1A;PRMT5;PRMT6;JUND;ZBTB14;BRD7;AR;ZNF808;ZNF711;MYBBP1A;ZP3;PITHD1;ASCC2;ZNF454;ZNF740;ZNF239;RBM23;RGMB;ZNF567;SRSF10;TADA1;AKAP17A;BMP2;ZNF384;RUVBL2;ZNF337;SMAD3;HDAC3
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.3681493213593433,0.8783422950748623,0.7090909090909091,0.9982490185923724,1.0,7/48,11.17%,WNT7A;PCDHB5;RAB29;GABRG2;NRCAM;SHANK3;GABRA2
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.47377099641560594,-0.8781998992328586,0.6666666666666666,0.9603510329971989,1.0,2/11,6.88%,RARRES2;P2RX4
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5218767647777989,0.8780064042485202,0.6721311475409836,0.998431053438205,1.0,1/8,2.61%,RACGAP1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.4818192323045817,0.8774877117132667,0.6909090909090909,0.9989590688590336,1.0,3/15,11.33%,ABCA2;EFNA1;EPHA4
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.5025054603402915,-0.8774262456960155,0.7142857142857143,0.9615802548163287,1.0,1/5,14.92%,BAHD1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.3586588191113404,-0.8769257187571174,0.6486486486486487,0.961900419013082,1.0,4/36,11.42%,RPS19;CHMP2A;WDR73;NUP155
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.4551011132926457,-0.8769011175166015,0.5675675675675675,0.9614170624681369,1.0,1/10,3.09%,TRIM35
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3379377292014551,-0.8766406693894689,0.7073170731707317,0.9613771327158327,1.0,18/68,18.74%,CUL7;CALM1;USP51;SFRP1;CUL9;CEP85;CALM3;PRMT5;TXLNG;ENTR1;ZFYVE26;KLHL9;CDC42;NUMA1;DBF4;CSNK2A2;PIN1;DBF4B
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.5717625073400288,0.8761702639555463,0.6833333333333333,1.0,1.0,1/5,22.75%,APOE
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.5856249648871059,0.8761680707865722,0.6363636363636364,1.0,1.0,2/5,33.79%,SLC8B1;PLN
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.5239276812885024,-0.8760834192566996,0.6923076923076923,0.9618282137599934,1.0,3/8,15.12%,PDGFRA;EIF4A3;TGFBR2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.5262150805247197,0.8755627914631883,0.6666666666666666,1.0,1.0,4/9,20.83%,DGKG;DGKZ;DGKI;DGKD
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.5607663832919368,0.8753827983512803,0.6666666666666666,1.0,1.0,2/5,14.78%,CKMT2;SLC6A8
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.5338560923910735,-0.8752741970320992,0.6739130434782609,0.9628592363854326,1.0,2/8,19.10%,BMP2;GREM1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.3617391902629997,0.8751079774492666,0.6724137931034483,1.0,1.0,31/100,23.58%,TPD52L1;CEP135;CCDC57;HAUS2;FBXL17;CDK14;BORA;CCP110;CDK7;FBXW11;TUBA4A;HAUS6;HAUS5;PCNT;ENSA;CEP41;MASTL;CSNK1D;ACTR1A;CEP131;CEP290;LCMT1;BRSK1;TAF2;CEP250;PPP1R12B;ALMS1;CLASP1;ARPP19;CEP70;CDKN2B
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.4619271214792059,-0.8750819001053348,0.625,0.9626872696862415,1.0,1/17,0.48%,ZDHHC1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.4164194897228273,-0.8750746651979396,0.6511627906976745,0.962122090667461,1.0,2/26,2.80%,VPS37B;VPS28
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4252211847003831,-0.8748601508563619,0.627906976744186,0.9620197685449364,1.0,6/26,9.32%,THY1;GORASP1;DYNLT1;MCF2;LINGO1;PTN
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.48751798589169415,0.874695655769085,0.673469387755102,1.0,1.0,5/11,13.87%,CTBP1;BRCA1;AASS;MACROH2A1;SNCA
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.39564407744273916,0.8745988509573701,0.6538461538461539,1.0,1.0,15/42,25.89%,NEDD4L;KCNN3;KCNIP1;CAV3;KCNMB4;DPP6;WWP2;KCNAB2;DPP10;KCNQ1;CACNA1D;KCNMB3;KCNJ16;CAB39;KCNMA1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.4455378988835185,0.8745570345054109,0.6304347826086957,1.0,1.0,5/14,9.06%,PARN;IHO1;USP9X;FMN2;TOB2
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.5313842947496381,0.874496629810061,0.7,0.999950341601687,1.0,2/6,27.23%,SENP1;SENP6
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4556408521481016,0.8743980457901822,0.6065573770491803,0.9995362870378608,1.0,4/15,19.43%,NLRC5;STAT2;CNOT7;SAMHD1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.5882718818836428,0.8742680735009931,0.7058823529411765,0.9979703386173681,1.0,1/5,14.62%,UHRF1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.5882718818836428,0.8742680735009931,0.7058823529411765,0.9979703386173681,1.0,1/5,14.62%,UHRF1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.5882718818836428,0.8742680735009931,0.7058823529411765,0.9979703386173681,1.0,1/5,14.62%,UHRF1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.45159036373276107,0.8738057442746958,0.6615384615384615,0.9983667794047254,1.0,3/14,14.13%,SLC22A4;ABCA8;GJA1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.4306953226158078,0.8737785121168988,0.6875,0.9978111108087904,1.0,3/23,5.14%,ROBO2;SEMA3A;SEMA4B
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.31478404429933643,-0.8737287579947142,0.8,0.9637581868295223,1.0,13/150,10.07%,CDKN2C;BTG1;TAF9B;PPT1;DERL2;MT3;SFRP1;NDUFS3;PSMD10;SPHK2;SLC25A33;EI24;RAB33B
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.3751241873497874,-0.872850829095594,0.7105263157894737,0.9650811011286315,1.0,11/59,16.92%,GSTP1;HNRNPA0;SELENOS;WNT5A;CACTIN;SCARB1;NFKBIL1;CDC73;PELI1;OTUD5;PRDX3
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.5638131640921262,0.8728002235842731,0.7017543859649122,0.9988624520357258,1.0,3/6,34.05%,PEX16;ZFAND6;LONP2
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.5638131640921262,0.8728002235842731,0.7017543859649122,0.9988624520357258,1.0,3/6,34.05%,PEX16;ZFAND6;LONP2
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.5126474219139504,0.8722611324738856,0.5892857142857143,0.9994230559289919,1.0,4/8,33.06%,ZC3H14;CDK9;NELFE;RNF20
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.38284557822560367,-0.8722067395836497,0.55,0.9657758353380004,1.0,9/32,16.29%,ODC1;TMEM9;LDLR;VPS35;HSP90AB1;FURIN;PM20D2;SNF8;CHRNA7
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.5510992490771169,-0.8722003666938204,0.58,0.9652104950727143,1.0,2/6,14.05%,PIH1D1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.4671291490596043,-0.8720414942018826,0.696969696969697,0.9648659051301426,1.0,4/14,22.77%,IRF3;RIPK2;HSPD1;HAVCR2
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5361259429227643,-0.8719608031848893,0.6744186046511628,0.9644392670884444,1.0,1/7,1.10%,ASCL1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.4370873458730302,-0.8717635097136873,0.6458333333333334,0.9642810172649783,1.0,3/16,15.20%,PIF1;CENPV;SMG5
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.5398623240966811,0.8714764599128404,0.6666666666666666,1.0,1.0,3/5,23.23%,PRKAA2;PRKAA1;MAPT
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.3713346236566012,0.8709169299630919,0.6140350877192983,1.0,1.0,5/66,5.58%,PTPRC;IGF2BP3;IGF2BP2;LRRC19;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.4897952972870432,0.8709107087974095,0.5769230769230769,1.0,1.0,3/9,24.48%,TSPYL2;ATR;PDS5A
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.3475280868892199,0.8703589556742646,0.6875,1.0,1.0,15/80,14.95%,SOX9;LIFR;CHST3;ADGRL2;PRTG;TENM3;HSPA12A;EYA4;TEAD1;PRKAA2;MID1;RBFOX2;PTPRG;PTPRU;EYA1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.41864493974895056,-0.8702028063104372,0.6086956521739131,0.9672461436124496,1.0,2/26,3.32%,SIRT2;HNRNPA0
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.4863746417282515,-0.8698735134177102,0.6326530612244898,0.9672784479049139,1.0,1/10,5.34%,PTPN14
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.3510476107072128,-0.8696390879333589,0.725,0.9670364830594866,1.0,8/47,14.88%,NUP42;COX7A2;SPHK2;SLC25A33;NUP155;PGAM1;FIS1;BEND3
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.46255719169239407,-0.8694332016858716,0.6444444444444445,0.9669249934645654,1.0,1/13,1.30%,ARPC5
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.40442504793186673,-0.8694070989325842,0.6585365853658537,0.9663617140202906,1.0,6/27,10.12%,NCSTN;MT3;APH1A;MID1IP1;CAV1;YWHAB
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.4584554070990194,0.869301272272066,0.6779661016949152,1.0,1.0,1/21,0.35%,HEY2
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.5217289919373977,0.8690219719720672,0.6981132075471698,1.0,1.0,2/6,22.97%,MTHFD1;PLOD2
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.4552662782881969,-0.8682742115086238,0.6222222222222222,0.9683105709595777,1.0,2/19,3.62%,ACTG1;FERMT1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.3587933759367462,-0.8682414396744499,0.8333333333333334,0.9677950065439609,1.0,7/47,10.95%,ZFP36L1;SFRP1;ASAH1;SMPD1;HAS2;CACTIN;IKBKB
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5460094433564926,-0.8682007006258571,0.7142857142857143,0.9673005753821375,1.0,2/6,8.73%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.4848425939457991,0.8680415366328227,0.6833333333333333,1.0,1.0,1/9,10.12%,NUP93
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.563287369225509,0.8679375751541109,0.7096774193548387,1.0,1.0,3/5,42.35%,NLGN4X;LRRK2;TMEM25
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.53602084340995,-0.8674454999349198,0.6470588235294118,0.9684734312384228,1.0,1/6,2.02%,CALM1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.5797083802446339,0.8670182471663104,0.7413793103448276,1.0,1.0,2/5,26.37%,SEC16A;GBF1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.49503335890934586,0.8669505105238986,0.6825396825396826,1.0,1.0,1/8,0.46%,AKR1C2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.5665176778893027,-0.8669469278643009,0.6511627906976745,0.9688461564004781,1.0,2/6,14.09%,CDH3;SMAD3
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.47425718798896427,0.8667240739449348,0.6730769230769231,1.0,1.0,6/13,27.05%,MACF1;DLG4;MYO9A;DVL2;MOV10;NTNG1
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.5261655828574002,-0.8663728275607577,0.6511627906976745,0.9694299209778552,1.0,5/10,6.88%,MT1E;ZNF658;MT2A;MT3;P2RX4
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.3205519876881302,-0.865736100580585,0.725,0.9704084315084276,1.0,21/141,14.81%,GSTP1;RHOC;GAPDH;S100B;TMEM9B;PLEKHG5;MALT1;WNT5A;SPHK2;UFL1;CACTIN;TSPAN6;IKBKB;DDX1;LITAF;TRAF5;WLS;IFIT5;PELI1;OPTN;TRAF4
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.4988640435630449,-0.8656399632340496,0.5531914893617021,0.9700433816906662,1.0,4/7,22.35%,WIZ;DBF4;DBF4B;TIPIN
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.5671911765210045,0.8651825684870501,0.6739130434782609,1.0,1.0,2/6,14.47%,EDNRA;SLC8A1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4223685164350812,-0.8651497033913665,0.58,0.9705844953969602,1.0,3/16,8.15%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.39600799671856257,0.8651132776016973,0.6949152542372882,1.0,1.0,4/32,5.96%,GRIN2A;DAPK1;NLRC4;GRIN1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.34899542239951137,0.8650352157603074,0.671875,1.0,1.0,6/78,7.02%,AHR;KLF6;SLC4A4;PSEN1;IRAK2;PVR
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.5290646908826413,-0.8647971350371398,0.6451612903225806,0.9707574393640716,1.0,3/7,15.62%,SQLE;AUP1;PLA2G4C
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5588702881821087,-0.8645579108423912,0.6486486486486487,0.9706921153452492,1.0,1/7,0.39%,CCND1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.32276930815035676,0.8645215918741559,0.8727272727272727,1.0,1.0,24/181,11.23%,IL1RAPL2;MYRF;SYNJ2;ROBO2;GRIN2A;SOX9;MDGA1;EPHA7;MEIS2;ADGRL2;SLC6A17;RELN;B3GNT5;GRIN1;ARNT2;ZBTB16;NRCAM;PROX1;LOXL3;CHST8;NPAS2;CNTNAP2;ATXN1;ZIC4
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.5323738033808078,-0.864516974228683,0.6382978723404256,0.9701986258278501,1.0,2/6,5.53%,NLGN2;CHCHD10
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.4100455350894195,0.8642317730588722,0.6129032258064516,1.0,1.0,7/31,20.70%,SPIRE1;FMN2;SHLD2;PARP9;RIF1;DTX3L;MMS19
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.33691872407880497,0.864108355960355,0.8103448275862069,1.0,1.0,31/144,18.32%,OLFM3;SYT1;STMN2;EPHA7;KCNH7;SULT4A1;LINGO2;RELN;SNAP25;RIPOR2;CRMP1;NEFL;ADGRB3;SRGAP3;RNF138;CNTNAP2;TRIM44;CLVS2;ACTL6B;GNL3L;ELAVL2;ASTN1;KIF1B;ANK2;NRG1;GALNT13;SLC25A36;ERC2;TMEM163;SNCB;DCLK1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.43099725665117944,0.8636926810967163,0.7,1.0,1.0,7/27,16.31%,DND1;THRAP3;TIRAP;TENT5A;SYNCRIP;TAF15;MEIOC
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.5722038454326587,0.8635184488807519,0.7258064516129032,1.0,1.0,2/5,33.16%,NPL;GNPDA2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.5722038454326587,0.8635184488807519,0.7258064516129032,1.0,1.0,2/5,33.16%,NPL;GNPDA2
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.4212423055603717,0.863144616064914,0.6724137931034483,1.0,1.0,6/25,18.90%,RAB29;BCAS3;B3GAT3;PCNT;CEP131;CEP290
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.40405717723254964,-0.863055502711409,0.6829268292682927,0.9729665739840545,1.0,6/26,9.09%,CALM1;TIPRL;PPP1R11;CALM3;HSP90AB1;PPP1R15B
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.4091881811146746,0.862715729143386,0.7049180327868853,1.0,1.0,5/33,4.88%,FOXO1;ZDHHC9;ZDHHC14;KAT2B;ING5
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.4989259572450261,0.8624487417612345,0.6129032258064516,1.0,1.0,2/9,15.37%,ITPKB;ITPKC
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.4752378981421167,0.8622726560347912,0.6964285714285714,1.0,1.0,6/16,29.07%,RAP1B;SLC4A8;RAB3GAP1;RAB5A;NLGN1;DTNBP1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.41695351857902074,0.8621531279207414,0.6875,1.0,1.0,4/30,11.33%,ABCA2;RTN1;EFNA1;EPHA4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.4257860142950989,-0.8617183850369566,0.7608695652173914,0.9750658175949,1.0,4/20,9.64%,RANGRF;CALM1;CALM3;CAV1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.5717506134854833,0.8615589272586697,0.7291666666666666,1.0,1.0,1/5,3.20%,NLRC5
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.4021542714080941,-0.8613981524912498,0.6226415094339622,0.9752083846944446,1.0,2/20,5.50%,PIF1;DACH1
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.579248822993001,-0.8613687437509908,0.6956521739130435,0.9746794517467591,1.0,1/5,7.91%,FUZ
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.5027887923338682,0.8610501717974367,0.6875,1.0,1.0,2/9,10.00%,ANGPTL4;RORA
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.34783651187975756,-0.861047268473667,0.6818181818181818,0.9747678641578365,1.0,6/58,6.58%,AGRN;ACTG1;ACTB;NLGN2;RAB39B;LIMS1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.33380681133934603,-0.8610171886088577,0.717948717948718,0.9742262907961563,1.0,9/103,6.89%,TUBB2B;ASCL1;DLL3;RND2;IGFBPL1;PHF1;EFNA2;SEMA5B;LINGO1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.3672257104772356,-0.8608520401833817,0.7111111111111111,0.9739967363918256,1.0,4/44,7.01%,BTC;RPS19;LYN;CADM4
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3605122115062977,0.8605785412489912,0.660377358490566,1.0,1.0,3/51,4.90%,IGF2BP3;IGF2BP2;HNRNPH2
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.4090360976334366,-0.8601533856818441,0.5714285714285714,0.974897166771355,1.0,2/23,5.03%,SOX4;ERN1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.41072467318585554,0.859974363359345,0.631578947368421,1.0,1.0,4/28,10.70%,HEY2;TGFBR3;PROX1;HES1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.4318578748098291,-0.8599447664553691,0.7659574468085106,0.9747553729208184,1.0,2/16,5.37%,HES5;C12ORF57
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.34055222477071523,0.8599314553800753,0.7049180327868853,1.0,1.0,18/92,15.66%,AHR;NR4A3;HCN3;ADCY5;HCN1;GABRB1;GABRG2;RYR3;RORA;BRCA1;TAF1;P2RY12;SPP1;RAP1B;ADCY3;DMTN;LCOR;DIAPH1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4735474762292174,-0.8598886992951956,0.5869565217391305,0.9742691653644769,1.0,3/14,9.64%,THY1;P2RX4;CAV1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.37411548848270537,-0.8598081568211806,0.6,0.9738645734976975,1.0,13/49,18.86%,BTC;SH3GL2;DUSP3;IFI6;RNF126;SPRY1;AFAP1L2;CDC42;NEU3;TGFA;CNOT9;RHBDF1;AKT1
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.575627925621494,-0.8597940698296493,0.6808510638297872,0.9733052549966072,1.0,1/5,3.66%,MT3
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5121862406892546,-0.8596799956166244,0.65,0.9729152187048548,1.0,2/8,7.41%,CCDC88C;EPDR1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.47753673841813865,0.8593030691198414,0.7,1.0,1.0,2/11,11.65%,NMNAT2;AK3
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.4304458143101326,-0.8592276490455225,0.7073170731707317,0.9732805662265799,1.0,3/19,4.10%,SOX4;ZFP36L1;RABL3
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.4093559515979314,0.859217166050258,0.8043478260869565,1.0,1.0,7/24,19.12%,SPI1;ALOX12;PROX1;TSPAN9;AOAH;PPARG;SYP
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.5827486273647349,0.8589968975013295,0.7450980392156863,1.0,1.0,2/5,8.71%,VAPB;MOSPD3
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.5091638921117273,0.8586597752612855,0.6491228070175439,1.0,1.0,3/7,6.65%,PON1;PON3;ALOX12
prerank,MSigDB_Hallmark_2020__Glycolysis,0.32065248558898685,0.858437408991782,0.75,1.0,1.0,17/138,11.97%,NDST3;SOX9;EGLN3;COL5A1;PYGB;MERTK;GCLC;ANGPTL4;PKP2;BPNT1;SDHC;PYGL;CHST12;TPST1;AK3;B3GAT3;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.530994770922939,-0.8583002491045357,0.7083333333333334,0.9748310562994911,1.0,3/6,23.56%,HIF1AN;CEACAM1;TMEM100
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.43726119110607353,0.8582403317849836,0.639344262295082,1.0,1.0,2/18,4.57%,STMN2;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.5546319765463814,-0.8582359698186803,0.7,0.9743600198143526,1.0,1/5,6.16%,DNAJA1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.3215623176320819,-0.8581434066705964,0.7446808510638298,0.9739433741811611,1.0,14/115,8.77%,TUBB2B;OLIG1;ASCL1;OLIG2;MYT1L;HES6;HES5;WNT3;IER2;YAP1;RNF112;ITM2C;TUBB2A;WNT5A
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.4979248777218914,0.8578491207530499,0.6521739130434783,1.0,1.0,2/8,14.06%,PARN;ST3GAL1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.4454848164675827,-0.8577889729880176,0.673469387755102,0.9740180903982544,1.0,4/18,17.91%,DYNLT1;SAPCD2;NUMA1;SPDL1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.32981703768519166,-0.8574052330196225,0.7021276595744681,0.9741531979761008,1.0,4/64,5.91%,POLR2L;GAPDH;IRF3;UBE2L6
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.4019240464788488,-0.8569672662673968,0.7,0.9745635028891829,1.0,3/24,6.82%,UBL5;PDCD5;TOMM7
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.4119573373259835,-0.8569416626832319,0.6304347826086957,0.9740067801588221,1.0,2/27,2.51%,ASCL1;BTBD6
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.27779840416351737,-0.8567046135903554,0.925,0.9738532061976191,1.0,32/321,9.33%,NR0B1;JUN;SIRT2;ASCL1;ZNF658;CALR;TCEAL7;HSPA8;ZNF12;MT3;SAP18;PRICKLE1;SFRP1;DACH1;EID1;LBH;QARS1;YWHAQ;LIMS1;PA2G4;DPF2;PHB2;ZBTB33;TAF7;CREBZF;CBX5;NACC1;SCML1;SET;WNT5A;RBM15B;RING1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.5539498380050804,0.8566891618644675,0.7333333333333333,1.0,1.0,1/5,12.82%,PIK3CD
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.447002457545528,0.8566592807398198,0.6851851851851852,1.0,1.0,6/17,20.42%,NDST3;B3GAT3;HS6ST3;CSGALNACT1;EXTL3;HS3ST5
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.4253253499521087,-0.8566209702164015,0.6530612244897959,0.9734517668796244,1.0,4/10,14.67%,MAGT1;NIPA2;MMGT1;NIPA1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.4245490685497093,0.8560851801931504,0.6727272727272727,1.0,1.0,2/24,4.38%,SCEL;BCR
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.3472674010499773,0.8559968664689735,0.6792452830188679,1.0,1.0,9/73,7.40%,MLANA;LIFR;EDNRA;SVEP1;KIAA1217;LAMA2;TIMP3;FKBP9;SASH1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.4142955634465388,0.8559880844382637,0.6296296296296297,1.0,1.0,1/26,1.11%,SOX9
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.37599089755750326,0.8559145134748488,0.6379310344827587,1.0,1.0,11/45,16.45%,ROBO2;PAK1;PLXNA4;TIAM1;PAK2;EPHA4;PLXNA1;SIPA1L1;MAG;ARHGAP35;TIAM2
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.4585914640856662,-0.855702019251905,0.725,0.9751345141195539,1.0,5/16,19.77%,PHB2;CLU;ZP3;C5;CD81
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.27782129271291267,-0.855634295108201,0.975,0.974719396963519,1.0,39/383,9.33%,NR0B1;JUN;SIRT2;ASCL1;ZNF658;CALR;GAPDH;DBI;TCEAL7;HSPA8;ZNF12;PCIF1;DHFR;MT3;SAP18;FXR2;PRICKLE1;SFRP1;DACH1;EID1;LBH;QARS1;SELENOS;YWHAQ;LIMS1;RPL13A;PA2G4;DPF2;PHB2;ZBTB33;TAF7;CREBZF;CBX5;NACC1;SCML1;SET;WNT5A;RBM15B;RING1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.35581851137646653,-0.8556198237993343,0.6923076923076923,0.9741508589782234,1.0,5/38,8.72%,FARSA;QARS1;WARS2;SARS1;AARS1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.3761426909267088,-0.855283278613055,0.6666666666666666,0.9743387466617802,1.0,3/43,5.35%,SOX4;BAD;ALOX5
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.5063207424970672,-0.8549309689282502,0.6170212765957447,0.9745932506736613,1.0,4/8,16.45%,AGA;MAN2B1;NGLY1;PARK7
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.3561612980811032,0.8547975253448508,0.7230769230769231,1.0,1.0,7/64,4.14%,EFNA5;CHST3;EDNRA;ADGRL2;FBLIM1;TENM3;SRPX
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.5025376395830574,0.8546548814958005,0.6842105263157895,1.0,1.0,3/9,16.95%,PARN;TENT4B;EXOSC10
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.3727528806145205,-0.8546042411504544,0.6,0.9746470496307602,1.0,3/35,7.51%,BTC;SLC30A10;SHC3
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.4870686263565538,0.8544918065731291,0.7192982456140351,1.0,1.0,5/11,17.71%,ALOX12;PRKCA;PRKG1;DMTN;PDPN
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.3264602282328319,-0.8544753826937763,0.8857142857142857,0.9743135719505022,1.0,9/88,9.99%,CDKN2C;BTG1;PPT1;MT3;SFRP1;RNF6;NDUFS3;SPHK2;EI24
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.3595654705030266,-0.8544149087662176,0.6808510638297872,0.9738804096978693,1.0,13/54,14.09%,SIRT2;SYAP1;RARRES2;ZFP36L1;ALOX5;SFRP1;YAP1;WNT5A;PTPRQ;TRIB3;LRP3;BMP2;SMAD3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.48330278518516123,-0.8540420752344968,0.65,0.9741745895786953,1.0,1/11,5.59%,LDLR
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.5498231702680121,0.8539199646466484,0.6909090909090909,1.0,1.0,2/5,33.06%,CDK9;RNF20
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.5057823349149098,-0.8533529489063505,0.6666666666666666,0.9751481651143971,1.0,1/7,6.72%,LYN
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4553014486864436,0.852350630023955,0.6551724137931034,1.0,1.0,5/16,18.68%,CDYL;YTHDC2;MEIOC;BBS4;SYCP3
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.3281836223815498,0.8522818255495535,0.7636363636363637,1.0,1.0,16/122,11.27%,CDH9;TNS1;ADAMTS9;EDNRA;HSD11B1;MEIS2;SYNPO2;SLC4A4;ENPP2;LAMA2;PAPSS2;ROR1;DUSP1;ITGA9;LSAMP;PLSCR4
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.4193385477948127,0.8522056480657467,0.6875,1.0,1.0,6/20,31.44%,PRKAA2;ADIPOR2;PRKAG2;MITF;SIRT5;JAK2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.47628785438866944,0.8521904222755686,0.7121212121212122,1.0,1.0,2/15,3.55%,VSIR;TESPA1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.43899303251424737,0.8518422230680303,0.6724137931034483,1.0,1.0,4/14,24.54%,RAB1A;SEC24A;SEC31A;SEC23A
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.44306918061623024,0.8517221751666259,0.7111111111111111,1.0,1.0,3/16,13.63%,ADAMTS9;FBXO6;AOAH
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.4021453464386459,-0.8516645843970194,0.5952380952380952,0.9780120837369608,1.0,10/22,18.86%,CSTB;TIMP4;CST3;GAS1;PRNP;TIMP2;TIMP1;PLAT;SNX12;AKT1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.5604640377198191,0.8516015600998157,0.6666666666666666,1.0,1.0,2/7,25.89%,ATP1B1;KCNMA1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.4569894981762228,-0.8514469673830906,0.6153846153846154,0.9779505044664174,1.0,2/15,4.59%,CHRNA4;SYT11
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5278418890582162,-0.8514303255914808,0.7045454545454546,0.9768103659127148,1.0,1/8,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5278418890582162,-0.8514303255914808,0.7045454545454546,0.9768103659127148,1.0,1/8,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.42995071409376256,-0.8510347064022272,0.6481481481481481,0.9771682069212628,1.0,4/17,12.12%,CYB5R3;ASAH1;SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.2876465056784097,-0.8509471654561699,0.8823529411764706,0.9767486874024237,1.0,31/198,14.09%,CDKN2C;CCND1;JUN;SIRT2;GADD45GIP1;CALR;CDC26;RNF167;USP51;TBRG4;ERN1;SFRP1;RPL23;RNF112;RASSF1;RPS15A;FIGNL1;HSP90AB1;ZBTB49;RRP8;BRINP1;AFAP1L2;RAD23A;TAF6;TARDBP;JUND;MYBBP1A;TXLNG;RACK1;BMP2;SMAD3
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.42715940863001595,0.8508451189839182,0.5892857142857143,1.0,1.0,3/16,12.09%,ARHGAP24;PLEKHM1;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.45812764413297624,-0.8507826271769439,0.6481481481481481,0.9765486708559518,1.0,2/9,12.02%,SLC30A10;YBX1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.4419544629590784,-0.8507484428663127,0.7804878048780488,0.9760371576530588,1.0,3/15,16.00%,CHMP2A;SNF8;SMPD3
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.5455059418106779,-0.8507430016614778,0.7346938775510204,0.9754732198138751,1.0,4/7,31.79%,KDM5C;KDM5D;KDM1B;RIOX2
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.49713076501229947,-0.8507385868243215,0.6097560975609756,0.9749099485678819,1.0,1/5,1.96%,CUBN
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.44653152935688384,0.8501958529998889,0.7384615384615385,1.0,1.0,5/15,25.35%,CSNK1D;BBS4;CEP131;HOOK3;C2CD3
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.4150701349744574,-0.8501829228516932,0.6341463414634146,0.9755126161539677,1.0,2/18,4.59%,CHRNA4;SYT11
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.4561205775567403,0.8497930630801209,0.7083333333333334,1.0,1.0,2/13,12.56%,NEIL2;NEIL1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3219153610666284,-0.8497235289429855,0.8536585365853658,0.9758895954565471,1.0,12/69,12.67%,PCSK1N;SCG3;ARL4A;PEBP1;IL12RB2;SCG5;PARP2;TLE4;COIL;GSTM3;TALDO1;RAD17
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.4942633277296441,0.8495803158677709,0.6724137931034483,1.0,1.0,3/9,17.71%,ENPP2;ARHGEF7;PDPN
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.39402836337601743,0.8491999486028221,0.7454545454545455,1.0,1.0,2/25,1.86%,PON1;PON3
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.3953688064300894,-0.849096768257746,0.6956521739130435,0.9766364612759463,1.0,4/17,16.87%,EFNA2;HNF4G;CFTR;GNAI1
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.48661962798567987,-0.8490620371657789,0.675,0.9761134875879143,1.0,3/7,9.76%,CRAT;PCCB;OXSM
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.44117564550694977,-0.8489411058732372,0.6511627906976745,0.9757826829543783,1.0,1/13,1.66%,RAN
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4117912039240981,0.8488329211945058,0.65,1.0,1.0,5/22,19.70%,EDNRA;NTRK3;P2RY12;ABL2;LPAR1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.38342520573866323,-0.8485978014614598,0.6818181818181818,0.9758417491225339,1.0,3/29,5.03%,SOX4;LRRC8D;ERN1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.35859642850676304,-0.8483514236355032,0.6521739130434783,0.9756896260747797,1.0,12/34,21.82%,H1-4;SMARCA5;NOC2L;H1-10;NPM1;BAHD1;H3-3A;H2AX;ANP32B;KAT6B;PAF1;ASF1A
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.47818396261952245,0.8482783382953225,0.62,1.0,1.0,2/10,11.64%,SNAP25;SLC29A2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4785923627562759,-0.848124169709404,0.6304347826086957,0.9756497733532841,1.0,3/15,10.38%,THY1;HAS2;CD44
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.5664792156956864,-0.8479221681562107,0.7368421052631579,0.9755308906940355,1.0,3/5,6.29%,GSTP1;PPIA;QARS1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.5189571015887738,-0.8478603487562324,0.6470588235294118,0.975102612255042,1.0,1/8,0.67%,SIRT2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.41045686811096793,0.84784923418545,0.6612903225806451,1.0,1.0,5/20,11.06%,TESPA1;CD160;PTPRJ;RAB29;DGKZ
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.4812131987506838,-0.8477493938874364,0.6585365853658537,0.974740656725529,1.0,1/7,2.11%,CHAMP1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.4725508650719941,-0.8476163806485305,0.723404255319149,0.9744185948144659,1.0,1/9,1.05%,DNAAF2
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.5036479289434764,0.8475003922108236,0.6271186440677966,1.0,1.0,2/9,11.75%,PCLO;DLG4
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4103848024713919,-0.8472172499354167,0.6097560975609756,0.9745571098122537,1.0,3/20,6.63%,FTL;MT3;CYBRD1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.48449836215655573,-0.8471296742785185,0.5813953488372093,0.9741829696974169,1.0,1/7,3.62%,FERMT1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.46496176990618543,0.8470987943404306,0.6785714285714286,1.0,1.0,6/16,24.22%,GADD45A;DMTN;GPD1L;PPM1F;DMD;NCK2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.31987115955673,-0.8464954549716882,0.8,0.9747679872314066,1.0,12/100,9.99%,VPS37B;VPS28;GABARAPL2;DYNLL2;TOMM7;MAP1LC3A;ULK3;YOD1;ACBD5;MTMR14;CHMP2A;EI24
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.4528715478792011,-0.8463826768908465,0.627906976744186,0.9743679108517125,1.0,2/9,16.85%,VPS11;MSN
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.5548020526400925,-0.8463519656987673,0.7045454545454546,0.9738502427273835,1.0,1/5,4.18%,JMJD6
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5419420641022689,-0.8463252929843891,0.7307692307692307,0.9733200699625021,1.0,5/8,21.34%,DUSP3;FGL1;AKT1;PPARA;GPNMB
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.4541419396789987,-0.8462670904238703,0.7446808510638298,0.9728822339870324,1.0,3/15,8.20%,ALDH1L2;DHFR;DHFR2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3333561385288735,0.8462628728747137,0.7903225806451613,1.0,1.0,15/114,8.90%,ITGA2;SOX9;PTPRR;AKT2;WNT7A;HSD11B1;ITGBL1;RELN;MAP7;ANGPTL4;FGF9;CSF2RA;SNAP25;CA2;TSPAN13
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.3993155058058998,0.8460187997974291,0.68,1.0,1.0,11/31,23.98%,MYLK;CAMK2B;CAV3;PLPP4;NOS1;ANK2;PKD2;ATP2B1;HOMER1;BCL2;CACNA1D
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.5281801300171955,0.8456823843328448,0.6938775510204082,1.0,1.0,2/6,9.46%,ATG7;ATG5
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.3393405099658262,0.8456540429929387,0.7619047619047619,1.0,1.0,12/69,14.12%,BCL2L11;ZNF385B;ITPR1;BCL2L2;ATM;ZNF622;BRCA1;SCN2A;MOAP1;STK11;MSH6;PPP1R13B
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.5264342637033983,-0.8455908190072002,0.6909090909090909,0.9736758192742548,1.0,2/6,8.24%,SLC16A9;ABCG2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3984360393280524,-0.8450276599978572,0.6444444444444445,0.9741740173569089,1.0,5/25,14.62%,MRPL44;SNIP1;DGCR8;SMAD3;HNRNPA2B1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.36979624387926524,0.8447231187998377,0.711864406779661,1.0,1.0,5/37,10.00%,FABP3;ABCA2;CAV3;TMEM97;RORA
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.36979624387926524,0.8447231187998377,0.711864406779661,1.0,1.0,5/37,10.00%,FABP3;ABCA2;CAV3;TMEM97;RORA
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.3810236774060456,-0.8446610923041036,0.8181818181818182,0.9743708054962646,1.0,6/28,18.79%,DNAJC30;GAS1;LAMP1;RAB11B;NUMA1;ANTKMT
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.47715727732105107,0.8445446899032337,0.6949152542372882,1.0,1.0,6/15,14.47%,GRIN1;CNNM2;TMTC2;SNCA;FAM20A;SLC8A1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.38420634775234425,-0.8445367883511475,0.6170212765957447,0.9741163843375152,1.0,5/29,10.87%,SH3GL2;SEMA5B;HSP90AB1;SEMA5A;FLRT3
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.4004797896011168,-0.8442464849057084,0.6829268292682927,0.9740974164019585,1.0,5/27,15.62%,HAX1;CAMSAP3;DBNL;PFN1;ARHGAP18
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.3793834890220982,0.8441748525277077,0.6607142857142857,1.0,1.0,8/36,12.25%,ROBO2;ITGA8;PRKX;ZBTB16;SULF1;PROX1;BMP7;IFT27
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.44760968012430863,-0.8441180820058171,0.717948717948718,0.973778167563212,1.0,1/11,4.16%,PTCD2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.34357513417101476,0.8440496835428178,0.75,1.0,1.0,10/80,7.37%,LIFR;NUAK1;CHST3;EDNRA;ADGRL2;KITLG;TENM3;SRPX;TEAD1;FKBP9
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.4036474933319477,0.8439489162664174,0.7111111111111111,1.0,1.0,4/22,13.76%,NUAK1;CDKN2A;CDK6;AKT3
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.46210413254443244,0.8438963670311803,0.7272727272727273,1.0,1.0,4/13,32.41%,INTS10;INTS6;INTS12;INTS3
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.5266985939416237,-0.8438665821352913,0.6052631578947368,0.9738638109928429,1.0,2/7,13.13%,SYT11;PNKD
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.35414402613288004,-0.8435447924510415,0.6744186046511628,0.974066727928862,1.0,14/40,17.90%,TBRG4;NOP56;FARSA;PA2G4;SRM;NIP7;MRTO4;NPM1;MYBBP1A;MCM4;WDR43;TFB2M;CBX3;SUPV3L1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.44580806968646364,0.8435303734277895,0.7192982456140351,1.0,1.0,5/17,18.57%,TAFA5;TPM1;PRKG1;PPARG;PDCD4
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.513787606118486,0.8433847945158326,0.6896551724137931,1.0,1.0,2/7,13.19%,ODAD4;DNAH5
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.504348194845188,0.8433064197996648,0.6296296296296297,1.0,1.0,1/7,0.95%,FOXO1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.36549253583922087,0.8432927748851788,0.6481481481481481,1.0,1.0,4/40,4.86%,YWHAH;SAE1;NMT1;ARIH2
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.5360051971977633,0.843022363024296,0.625,1.0,1.0,2/6,17.54%,PUS7;TRUB2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.42565677127870627,0.842674426457708,0.62,1.0,1.0,2/17,7.35%,HEY2;TGFBR3
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.3721792778683155,-0.8425783155232083,0.65,0.9755597629194582,1.0,3/36,8.12%,PPT1;TXN2;ADO
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4848900955194833,0.8425610810940855,0.6567164179104478,1.0,1.0,4/13,17.93%,SHLD2;PARP9;RIF1;DTX3L
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.48116299915763694,-0.8424132790908101,0.64,0.975357643129624,1.0,1/10,2.32%,ACTG1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.44831161258397434,0.8418987432178048,0.75,1.0,1.0,4/17,11.33%,ABCA2;EFNA1;RANBP9;EPHA4
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.473412423246956,-0.8417362580565781,0.725,0.9761647104989457,1.0,1/8,2.11%,CHAMP1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.4059397101978633,0.8413779241349769,0.639344262295082,1.0,1.0,6/21,30.84%,SNX25;AP2M1;ZNRF3;CLTC;NEDD4;KIF16B
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.38948709231076717,0.841376592011759,0.6923076923076923,1.0,1.0,8/31,15.66%,EFNA5;FAM107A;MACF1;PHLDB2;CYLD;PRKAA2;PRKAA1;DIAPH1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.431943046285288,0.8413302585016534,0.7192982456140351,1.0,1.0,5/17,25.35%,CSNK1D;BBS4;CEP131;HOOK3;C2CD3
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.3259258470699365,-0.8411463352607774,0.8918918918918919,0.9767041117612433,1.0,9/75,9.31%,FTL;AP4M1;HSPA8;BLOC1S4;SCAMP3;SH3GL2;GOLGA7;RAB14;CHMP2A
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.5066983034140526,-0.8410494610274202,0.6595744680851063,0.9764041526289364,1.0,3/6,16.22%,EDNRB;SOX8;SOX10
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.5184010082813448,-0.8409045391739208,0.7083333333333334,0.9761305334742827,1.0,3/7,23.86%,MSN;AKT1;STK10
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.3664548168017752,0.8407283355135708,0.803921568627451,1.0,1.0,6/63,6.30%,PTPRC;TNS1;PLXDC2;KITLG;ARID3A;SPI1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.34737387358942423,-0.8404120127602277,0.75,0.976467694159257,1.0,9/62,9.38%,PPT1;ATF4;SLC30A10;MT3;PTPRZ1;NGF;SIGMAR1;SET;GRN
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.45858098177705403,0.8403036968225492,0.6491228070175439,1.0,1.0,5/12,31.15%,ITPKB;ITPKC;CYP27A1;FGF2;PPIP5K2
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.4951646680973746,0.8402717593173766,0.7413793103448276,1.0,1.0,5/8,23.21%,GRM3;AKAP5;ADGRV1;PALM;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.4951646680973746,0.8402717593173766,0.7413793103448276,1.0,1.0,5/8,23.21%,GRM3;AKAP5;ADGRV1;PALM;GNAI3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3941362910451514,-0.8402642690757272,0.7435897435897436,0.9761878645593121,1.0,3/22,6.39%,SIRT2;ZFP36L1;PIK3C2G
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.5231406692478883,-0.839753875377152,0.6666666666666666,0.9767192048863269,1.0,2/6,23.00%,BHMT;ADI1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.5597476101183646,-0.8396373271957224,0.6888888888888889,0.976387689376665,1.0,1/5,13.52%,FLOT1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.42316970839155205,-0.8390845797753926,0.6086956521739131,0.9769636548164575,1.0,1/12,4.42%,SYNDIG1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.4831436957845149,-0.8389979939133497,0.7,0.976548199281222,1.0,1/7,7.01%,CADM4
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.3198562487261073,-0.8385941178513769,0.851063829787234,0.9768192329524067,1.0,7/117,4.52%,UBB;S100A6;SLITRK2;ACTB;S100B;MAP1S;EPHB3
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.42316356539742445,-0.8385894902874388,0.6938775510204082,0.9762555749991739,1.0,2/23,6.16%,GSTP1;DNAJA1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.44510957289896946,-0.8385714055131284,0.6041666666666666,0.975724888784632,1.0,2/13,7.01%,MT3;CADM4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4332151728640647,-0.8385296299521937,0.7777777777777778,0.975227117297129,1.0,6/19,11.80%,ATF4;SELENOK;ERN1;AIFM1;TRIB3;QRICH1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.4653671148369713,-0.8382884297828642,0.7142857142857143,0.9751431593084527,1.0,3/12,21.08%,IRF3;RIPK2;HSPD1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.43409439278995693,-0.8382053267586649,0.6511627906976745,0.9746785616559726,1.0,2/11,8.49%,LARP7;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.5452770684951422,-0.8378877628025948,0.7083333333333334,0.9748207464892196,1.0,1/5,3.82%,ZFP36L1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.5472207850381301,0.8377804535342063,0.75,1.0,1.0,2/5,28.55%,ASH1L;SETD2
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.4884157352934873,0.8377685461814711,0.7222222222222222,1.0,1.0,6/9,23.76%,ALK;CCDC3;PRKAA1;NCOR1;PDE3B;ASXL3
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.43023704524738904,-0.8377645644370424,0.6818181818181818,0.9744535546130905,1.0,5/14,20.63%,DDX54;DDX5;AR;NCOA4;TADA3
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.43272181434917,-0.8376492476978464,0.7142857142857143,0.9741447630851928,1.0,5/17,17.25%,GMPR2;PPAT;PRPSAP1;DGUOK;PRPSAP2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.38171856711432606,0.837408659214488,0.6935483870967742,1.0,1.0,10/32,20.76%,KIF3C;DYNC2LI1;IFT172;WDR19;IFT27;IFT52;TNPO1;CEP131;DYNC2I1;IFT140
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.30586011706518346,0.8371307737482138,0.921875,1.0,1.0,25/172,15.75%,CARD14;SOX9;EFNA5;AKT2;BRAT1;EPHA7;PAK1;NTRK3;BRD4;TSPYL2;FGF9;RB1CC1;TTN;EFNA1;RIPK1;BMP7;STAT2;WDFY2;SPTBN4;TNIK;FAM20A;ANKRD54;SEMA4D;ARRB1;FGF1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.44033032971735037,-0.8368441841453045,0.6956521739130435,0.9752785126265164,1.0,1/16,0.67%,MAP7D3
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.5697829649121662,0.8368408180369936,0.7735849056603774,1.0,1.0,2/5,33.06%,CDK9;RNF20
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.3773960893129542,0.8364443378537324,0.7272727272727273,1.0,1.0,9/42,11.18%,KIAA1217;RAB17;SLC2A9;GPRC5C;CDS1;EFNA1;AQP4;HES1;PHACTR1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.4677244127218908,-0.8363990058721862,0.6346153846153846,0.9750983501486414,1.0,1/9,5.11%,CYB5R3
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.4677244127218908,-0.8363990058721862,0.6346153846153846,0.9750983501486414,1.0,1/9,5.11%,CYB5R3
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.5131061092948372,-0.8359178453200977,0.625,0.9754583318394547,1.0,4/7,25.13%,TSPAN6;MUL1;PCBP2;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.5194481288855037,-0.8353253507995493,0.5813953488372093,0.9760812674582235,1.0,3/6,18.74%,WIZ;DBF4;DBF4B
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.3819857656046892,0.8352409101732414,0.7592592592592593,1.0,1.0,9/35,17.71%,GNA12;SHTN1;LIMK1;RHOJ;CDC42EP3;CDC42EP4;RTKN;ARHGDIG;PDPN
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.439701546988274,0.8352134611185202,0.7096774193548387,1.0,1.0,5/20,11.33%,VSIR;GRIN1;EFNA1;APH1B;EPHA4
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4097869671569111,0.8350848849809344,0.6666666666666666,1.0,1.0,6/26,11.93%,NDST3;CHST9;CHST8;CHST12;B3GAT3;CHST11
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.42472076895380506,0.8347529751839247,0.7358490566037735,1.0,1.0,1/19,0.84%,BCL2L11
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.303669240276959,-0.8346597949066309,0.7741935483870968,0.976831887409579,1.0,25/153,15.35%,MMP2;CUL7;NCSTN;CPA1;MALT1;CNDP2;APH1A;CTSC;RNPEP;CTSF;APEH;PRCP;AEBP1;HM13;VASH1;FURIN;NLRP1;CAPN1;ADAMTS3;PM20D2;XPNPEP1;CTSK;CTSL;MMP17;PLAT
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.5473110848149518,-0.8344302002798656,0.6829268292682927,0.9767732043556192,1.0,2/5,22.33%,MUL1;OAS3
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.5415053378526737,-0.8342967523687648,0.7111111111111111,0.9764388488341824,1.0,3/5,21.97%,SEC61B;SEC61A2;SEC61A1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.43547455166616633,-0.834051254137146,0.6981132075471698,0.9758609572394703,1.0,4/17,12.13%,HSP90AB1;GIPC1;CDKN1C;SLC2A10
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.43547455166616633,-0.834051254137146,0.6981132075471698,0.9758609572394703,1.0,4/17,12.13%,HSP90AB1;GIPC1;CDKN1C;SLC2A10
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.4595849313653928,-0.8339671838337958,0.6875,0.9755212939955228,1.0,2/12,8.37%,SURF4;TMED9
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.4768350547434105,0.8338472502980796,0.7307692307692307,1.0,1.0,4/9,22.29%,BRCA1;RIF1;ZNF274;ATRX
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.36818889217445605,-0.833631205161187,0.7380952380952381,0.9756490658198667,1.0,6/43,14.78%,MALT1;CTSC;CTSF;CTSK;CTSL;AP2S1
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.5499445642676155,0.833497776188093,0.7547169811320755,1.0,1.0,3/5,25.01%,CA2;ATP8B1;PDZK1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.3069981720882138,0.8333951352779807,0.8666666666666667,1.0,1.0,21/141,12.10%,OTUD7B;TMSB4X;ITPR1;RNF157;DGKG;PTPRJ;SPI1;CAV3;BCL2L2;RIPK1;CYLD;BMP7;PDE10A;RORA;NMI;DUSP1;ARRB2;UBR1;TSC1;PRKAA2;HDAC7
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.3262189323046937,0.8333443296824192,0.7833333333333333,1.0,1.0,16/105,15.69%,LIFR;STMN2;EDNRA;ADGRL2;FAM13C;ADCY5;CRMP1;SHC2;MAPK10;CCDC3;PRKG1;PAMR1;GJA1;ASTN1;PBX1;ANK2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.38066894604020496,0.8331624458061363,0.7,1.0,1.0,14/34,28.99%,FABP3;ABCA2;PRKAA2;PRKAA1;PPARG;ADCK1;APOE;TLCD3B;ABHD8;FBXW7;PNPLA2;THADA;NR1D2;PNPLA8
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.347791281721034,-0.8330780166420642,0.65,0.9760964048125996,1.0,2/37,3.82%,POLR2G;ZFP36L1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.5082268396355106,-0.8328928768668453,0.6046511627906976,0.9758977817794194,1.0,2/8,9.32%,PIWIL2;PTN
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.40464234284968015,-0.8325564788361305,0.7142857142857143,0.9759229291160118,1.0,5/22,14.65%,ATXN7L3;RING1;CUL4B;CDC73;RNF168
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.31771278637319,0.8325280340988244,0.8545454545454545,1.0,1.0,13/93,15.08%,MSL3;BAZ2A;HDAC4;MRGBP;NAA50;EYA4;SIN3A;HLCS;MORF4L2;TRERF1;UHRF1;EYA1;EYA2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.356415835058172,-0.8325103360961114,0.7,0.975475681040515,1.0,3/38,4.66%,CFL1;SVIL;MSRB2
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.387719210432387,0.8322200882749294,0.75,1.0,1.0,5/27,19.13%,KCNJ11;SLC25A19;SFXN3;ABCC8;PKD2
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.3150359624396928,-0.831858798344025,0.8181818181818182,0.9760943522445849,1.0,11/65,9.53%,ROMO1;CD63;MT3;RAB1B;DHRS4;PAX8;CBR1;DCXR;ACLY;ATAD1;CHCHD2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.36613099649869774,-0.8317596938199854,0.7142857142857143,0.9756793958368958,1.0,11/47,13.00%,GPX1;BAD;ZFP36L1;SFRP1;YAP1;LIMS1;GRN;RAB33B;CDKN1C;ZNF304;B2M
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4142215661242228,0.8315126555303124,0.7746478873239436,1.0,1.0,1/18,0.27%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.4839686972952981,-0.8313007704348283,0.6829268292682927,0.9759403907124725,1.0,4/10,16.45%,ATF4;RACK1;NONO;PARK7
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.37889754198637837,-0.830998651501334,0.6382978723404256,0.9759017541265745,1.0,3/30,6.82%,UBL5;HAX1;TOMM7
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.4433163543746042,0.8306897212753706,0.6909090909090909,1.0,1.0,5/14,11.07%,EPS15;HIP1;FCHO1;SGIP1;CALY
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.5172604909311017,0.830578507204844,0.7857142857142857,1.0,1.0,1/6,1.73%,TLK1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.48843417346607076,0.8304443805494447,0.7142857142857143,1.0,1.0,1/7,9.87%,RAB11FIP5
prerank,MSigDB_Hallmark_2020__Apical Surface,0.3896535227351512,0.8303528519010503,0.6206896551724138,1.0,1.0,5/31,4.14%,EFNA5;MDGA1;CRYBG1;CD160;SRPX
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.4510954985119796,-0.8293732384806315,0.6744186046511628,0.9783137674866719,1.0,5/12,23.51%,CAV1;FLOT1;MUL1;IFIT1;COLEC12
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.5352247534505044,-0.829274543781127,0.7555555555555555,0.9779493862757831,1.0,1/6,1.60%,PLIN2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.3696242823316399,-0.829191072526708,0.7083333333333334,0.9775663444608284,1.0,4/24,13.73%,HES5;HIPK1;ULK3;DYRK2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3519064244370465,-0.8281029101729166,0.7741935483870968,0.9792425577942626,1.0,11/44,20.15%,PPT1;HSPA8;FBXO44;NEU4;CUL4B;NGLY1;PRPF19;VCP;DENND3;MANBA;DDI2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.41285440934060774,0.8279760151868971,0.6721311475409836,1.0,1.0,10/26,25.89%,KCNN3;NOS1;KCNMB4;ANK2;KCNQ1;ANK3;KCNMB3;PDZK1;KCNJ16;KCNMA1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4083283431046071,-0.8278764679879559,0.717948717948718,0.9790116361896376,1.0,3/17,17.75%,HAX1;PARK7;CSNK2A2
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.42728395891572096,0.8271470139047546,0.6923076923076923,1.0,1.0,3/18,8.74%,CLDN12;LAMA2;VCL
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.34797562040079977,0.827021215514367,0.7719298245614035,1.0,1.0,11/53,17.45%,FUT2;B3GNT5;CHST9;GCNT2;CHST8;CHST12;CHST11;LARGE1;CSGALNACT1;B4GALT5;MGAT1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.4131783615463896,0.8269793316375188,0.6666666666666666,1.0,1.0,5/25,13.81%,LRP2;STAT5B;MAP2K5;NOS1;ACVR1C
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.4427963523421473,-0.8265119358304235,0.6153846153846154,0.980561497325141,1.0,1/11,3.82%,ZFP36L1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.4427963523421473,-0.8265119358304235,0.6153846153846154,0.980561497325141,1.0,1/11,3.82%,ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.342885981356392,0.8257566830759546,0.7704918032786885,1.0,1.0,12/54,23.74%,CRIM1;LRP2;VWC2L;SULF1;CHRD;SMAD4;PPARG;UBE2D3;SMAD5;DAB2IP;TRIM33;AGT
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.2739373788893889,-0.825703759467203,1.0,0.9817377035328171,1.0,35/318,11.05%,CUL7;HSD17B10;CFL1;THY1;GORASP1;FGD3;KIF25;CFAP61;SURF4;TMED2;PPIA;PTCD2;HAX1;PARP1;CHCHD10;ARL1;RNF112;WTIP;PHB2;LMAN2;PEX11A;SNX11;TMED9;AUP1;RAB14;CHMP2A;CHCHD2;CAV1;BCS1L;SLC25A33;NIPSNAP2;WDR73;TMED1;ODF2;MCOLN1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.32314576874022705,0.8252760602969846,0.8253968253968254,1.0,1.0,8/83,13.64%,EFHC1;SGO2;RANGAP1;XPO1;TNKS;MAP4;PLK2;PCNT
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),0.5468701228186286,0.8252322478358154,0.8235294117647058,1.0,1.0,3/5,35.66%,CDKN2B;PDK2;USF1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.30944098932936687,0.8251490557044004,0.8275862068965517,1.0,1.0,40/129,26.87%,HEY2;PSEN1;FOXP1;SPI1;AGO1;PARP9;DLG4;TAF1;PRKAA2;CCDC3;WWP2;PRKAA1;OVOL2;AGO4;ZNF148;ADAM10;CNOT7;ATXN2;ENG;PC;PICALM;TGFB2;SLC24A3;SFMBT2;PARP14;ROBO1;TNRC6A;APOE;MAPT;PARP10;NFKB1;HINFP;TNRC6C;FBXW7;FLOT2;MOV10;SETDB1;PRKN;RBL1;RBL2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.39172804996971633,0.8249601999472842,0.7647058823529411,1.0,1.0,5/29,11.06%,CYP2E1;DGKG;ALOX12;PLPP4;DGKZ
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.33914592723540027,-0.8249462229936566,0.8108108108108109,0.9826781322182248,1.0,12/35,18.36%,RPS7;MAGEF1;RPL23;CLU;RPL11;UFL1;RAD23A;UBQLN4;COMMD1;ARAF;CSNK2A2;RPL5
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.5074672801245645,0.8249449904535906,0.6981132075471698,1.0,1.0,3/8,16.24%,ST6GALNAC5;ST3GAL1;B4GALT5
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.4241983951808577,0.824936255840436,0.7037037037037037,1.0,1.0,2/14,9.72%,WRN;ATM
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.4552279026919749,-0.8248022039444048,0.7647058823529411,0.9824205905516861,1.0,3/16,12.56%,MRPL44;HENMT1;SNIP1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.4583425422614591,0.8247997871866682,0.7017543859649122,1.0,1.0,2/14,10.34%,FOXP1;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.42065285991751805,0.8247860043378284,0.6923076923076923,1.0,1.0,1/16,0.26%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.42065285991751805,0.8247860043378284,0.6923076923076923,1.0,1.0,1/16,0.26%,VSIR
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.533644427736226,0.8247653663982004,0.7307692307692307,1.0,1.0,2/6,28.93%,CDC27;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.533644427736226,0.8247653663982004,0.7307692307692307,1.0,1.0,2/6,28.93%,CDC27;TACC3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.4327041431068342,-0.8247390801890191,0.7555555555555555,0.9819924494592988,1.0,3/15,8.20%,ALDH1L2;DHFR;DHFR2
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.45092631648626696,-0.8245571036950289,0.6944444444444444,0.9818431222818321,1.0,2/14,9.64%,SVIL;CAV1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.46325107821253136,-0.8244373786708087,0.6956521739130435,0.981523266050696,1.0,2/11,6.07%,KRT10;FARSA
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4239844547673052,-0.8243571230059877,0.675,0.9810963548048578,1.0,1/12,3.33%,POLR2G
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.4466445873134568,0.8242796583427333,0.7096774193548387,1.0,1.0,2/13,8.54%,DCAKD;PANK4
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.42539802490291967,-0.8242245153364878,0.7073170731707317,0.9807772796891804,1.0,3/11,8.77%,CXCL12;TNFRSF14;WNT5A
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.41344115561304806,0.8240913591357565,0.7962962962962963,1.0,1.0,3/23,9.64%,SOX9;ZBTB16;NBR1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.4488988215221462,-0.8238739704753497,0.6756756756756757,0.9808498738131575,1.0,6/10,31.52%,HIRA;H3-3A;ASF1A;CABIN1;RBBP4;SUPT16H
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.3899898005353651,0.8238329498428513,0.6935483870967742,1.0,1.0,7/21,20.18%,KCNIP1;NOS1;DPP6;KCNAB2;ANK2;DPP10;ANK3
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.4584505947765492,0.8235047062810501,0.7083333333333334,1.0,1.0,4/11,31.11%,TRNT1;INTS6;ERI1;INTS12
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.4540389070337876,-0.8234328417692801,0.6851851851851852,0.9811494705822854,1.0,1/11,1.60%,PLIN2
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.336777005607516,0.8233878196280597,0.7777777777777778,1.0,1.0,17/90,13.97%,NEDD9;PCLO;FMNL3;RAC3;CNTNAP1;CDC42BPB;CECR2;MICAL2;RHOBTB2;SPRYD3;RANBP9;ZRANB1;TPM1;BRWD3;MAST4;TNIK;DMTN
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.4331700653120458,-0.823306281586333,0.6538461538461539,0.9808624257188876,1.0,6/11,31.73%,CAV1;CSNK1A1;DVL1;LRP6;PPP1CA;AXIN1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.4524309528138623,0.8232631658421831,0.7164179104477612,1.0,1.0,1/10,0.37%,DPYD
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.5437393438645346,0.8228690914669982,0.8103448275862069,1.0,1.0,2/6,16.45%,DUSP1;PADI2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.41387031765191923,0.8225854221340999,0.7678571428571429,1.0,1.0,3/22,7.10%,SEMA3A;SLIT3;USP9X
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4606818013246944,-0.8222177361277335,0.7045454545454546,0.9824029376125258,1.0,2/8,5.39%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.387595890233927,0.822204469912374,0.7384615384615385,1.0,1.0,1/24,1.18%,PCTP
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.4924310476160144,0.8220309544944806,0.7241379310344828,1.0,1.0,1/8,5.97%,ERBIN
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2608050082256877,-0.8217285650641037,1.0,0.9827389405393352,1.0,94/661,14.33%,SOX4;BTG1;GPX1;ZNF488;ASCL1;SOX21;CALR;ZNF114;ATXN7L3B;ATF4;ACTG1;ESRRB;ZNF460;SPIN2B;HES6;ZNF22;ERMAP;MT3;PCBP3;STOX1;ZFP36L1;PHF1;SH3GL2;FAM50A;RPS7;ZNF92;CDH3;ZNF676;WNT3;ZNF257;SFRP1;RPL23;YAP1;VPS35;SLC2A4RG;TIPARP;PDCD5;ERP29;RNF6;ZNF117;WTIP;LIMS1;DRAP1;HNRNPAB;MED23;LYN;MLF2;NGF;CLU;CHD3;EDF1;ATRAID;WNT5A;RPL11;DNMT3B;FADS1;PCBP4;RPL6;CNBP;CACTIN;ZNHIT3;TFEB;FN1;ANKRA2;SAP30;ANXA7;ZSCAN21;ESRRA;MZF1;YBX1;ZNF217;BTN3A3;SLC2A10;TRAPPC2;ZFPL1;TARDBP;RNF187;PPP2R1A;NOVA1;PRMT5;LRP3;AR;ZNF711;MYBBP1A;ASCC2;RO60;RACK1;SRSF10;AKAP17A;BMP2;SMAD3;TDG;PCBP1;RC3H1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.47861578183093856,-0.8216011289980351,0.7037037037037037,0.9824200180710242,1.0,2/6,13.50%,VPS35;PRNP
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.3467293042809842,0.8215608854997488,0.7222222222222222,1.0,1.0,12/50,15.43%,FOXO1;FAM107A;WRN;ATG7;CLEC16A;RPTOR;GAS2L1;TSC1;PRKAA2;MAP1LC3B;SREBF1;PRKAA1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.4447334501777592,0.8212565683130395,0.7254901960784313,1.0,1.0,3/17,6.27%,MYRF;NKX6-2;PARD3
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.33544585978458086,0.8203899486867077,0.7796610169491526,1.0,1.0,20/87,19.26%,UNC5D;SOX9;PCLO;SULT4A1;MMD2;GRIK3;MAPK8IP2;HES1;RHBDL3;CLVS2;SLC8A2;ASTN1;NOVA2;ANK2;UNC13A;GALNT13;ERC2;SNCB;CTNND2;CACNG5
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4607226098267104,-0.8202687953095319,0.6739130434782609,0.9843156038212161,1.0,2/7,5.39%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.5226056123654312,0.8202549727524504,0.7636363636363637,1.0,1.0,2/5,5.37%,PAK1;LMO3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.39982670095817135,-0.8201469464982843,0.6808510638297872,0.9839458614399951,1.0,4/21,8.15%,CALM1;P2RX4;SRI;CALM3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.4900233851866569,-0.8200523168692027,0.6938775510204082,0.9835514009766975,1.0,1/6,20.01%,GRAMD4
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.553252160698462,-0.819874839267525,0.7636363636363637,0.9834148472296975,1.0,1/5,11.61%,PYCR1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.5063594517342664,0.8198119840381336,0.72,1.0,1.0,3/7,21.12%,NRG1;ENG;TGFB2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.46694576497478957,0.8196736628894289,0.7,1.0,1.0,1/11,4.75%,NLRC4
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.4873668801230425,0.8195869832600434,0.6862745098039216,1.0,1.0,3/8,9.52%,TBCD;VCL;PAK2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3230539734573901,-0.8195167327226683,0.7777777777777778,0.9834918342019481,1.0,15/73,13.69%,CALR;GAPDH;CSTB;PCIF1;DHFR;FXR2;EDNRB;RPL13A;ATRAID;CST3;EIF4A3;NCL;YBX1;MRPL13;RACK1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.39652221139730637,-0.8195156170554283,0.625,0.9829414750333964,1.0,3/29,2.43%,CUL7;GORASP1;LZTS1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3826634413950588,0.8194409355337853,0.6923076923076923,1.0,1.0,11/21,32.68%,PSEN1;NCS1;BRSK1;DISC1;HOMER1;ZNF804A;NTNG1;ULK4;CTNNA2;CAMK2G;IL1RAPL1
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.4850874763965253,0.8191523486702368,0.7358490566037735,1.0,1.0,1/6,15.01%,MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.43359158083865557,-0.8183250155734476,0.660377358490566,0.9847175644660243,1.0,2/10,12.02%,SLC30A10;YBX1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.5342389611789049,-0.8182542243140816,0.6808510638297872,0.9837488252050179,1.0,1/6,0.67%,SIRT2
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.5342389611789049,-0.8182542243140816,0.6808510638297872,0.9837488252050179,1.0,1/6,0.67%,SIRT2
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.49257692717346135,-0.8181410140985155,0.6326530612244898,0.9834186023840683,1.0,2/5,10.15%,SFRP1;ADCY6
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.543503581808461,0.8180446898506974,0.7454545454545455,1.0,1.0,2/5,32.07%,HIBADH;HIBCH
prerank,PanglaoDB_Augmented_2021__Platelets,0.3628601389271944,0.8178284910653326,0.7543859649122807,1.0,1.0,13/52,16.26%,ITGA2;MAP3K7CL;SPI1;ALOX12;NRGN;SH3BGRL2;CA2;P2RY12;SMOX;RAP1B;AOAH;ATP8A1;ADAM10
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.47736760588287175,-0.8176047579051801,0.631578947368421,0.983914421064684,1.0,3/6,24.20%,ADAT2;METTL3;NUDT16
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.450296427762379,-0.8175884288382524,0.7083333333333334,0.9834094291681487,1.0,1/13,3.98%,MYH3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.48394757189656307,0.8174140951506909,0.7391304347826086,1.0,1.0,2/7,16.33%,WHRN;ADGRV1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.45043874847063736,0.81731572438604,0.7543859649122807,1.0,1.0,1/13,0.75%,TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.3480802601256747,-0.8168575265421074,0.7777777777777778,0.9842733395699792,1.0,8/37,16.67%,GSTP1;ATF4;PLCL2;NOVA1;FIS1;TFE3;TLE3;ACOT13
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.37179670413081123,-0.8168485110502305,0.7777777777777778,0.9837749550278084,1.0,7/24,17.46%,SFRP1;RNF6;DDX5;AR;PARK7;H3-3A;RNF14
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.43984470465427766,0.8167574506689405,0.6595744680851063,1.0,1.0,4/15,17.16%,SLC6A6;SLC22A4;SFXN3;SLC6A1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.288568897332048,0.8167537193647281,0.9142857142857143,1.0,1.0,31/205,15.82%,VSIR;HEY2;SOX9;NTRK3;PSEN1;FGF9;AGO1;TTN;UBR5;RAB29;MYOM1;BMP7;ATM;MAP2K5;BRCA1;RAB27A;ARRB2;FUBP3;PIK3CD;CAMK2N1;ADAM19;SNCA;GJA1;MAGI2;PRKAA1;ARRB1;OVOL2;ANK2;AGO4;FGF1;CSF1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.4545615103325309,0.8167072897947154,0.7592592592592593,1.0,1.0,1/9,8.19%,RPTOR
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.4152118879263361,0.8166969248134324,0.6785714285714286,1.0,1.0,2/15,8.10%,RPS6KB2;HABP4
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.33839591613975506,-0.8165528934266159,0.8571428571428571,0.9838138658350809,1.0,9/52,15.72%,KDSR;SGPP1;ASAH1;SMPD1;SPHK2;SPTLC1;SAMD8;B4GALT6;CERS2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.4853657159357602,0.8164748751223716,0.7,1.0,1.0,2/9,5.07%,CNTNAP1;ABCA2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.4631817216265457,-0.8162709686368143,0.6923076923076923,0.9837778810100912,1.0,1/11,2.47%,ACTB
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4313773516949284,0.8161464338856848,0.7307692307692307,1.0,1.0,1/11,7.87%,CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.3382507876473161,0.8160870989228229,0.7368421052631579,1.0,1.0,4/55,4.68%,ROBO2;PLXNA4;LRP2;TIAM1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.3619984538415652,0.8160709252729876,0.7833333333333333,1.0,1.0,21/48,31.58%,BAIAP2;SSH2;CRACD;CDC42EP3;VASP;CDC42EP4;PRKCE;FER;FCHSD2;ARFGEF1;ABITRAM;NCK2;SSH1;CARMIL1;RASA1;BIN1;PTK2B;CTTN;VIL1;EVL;ARHGAP28
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.35801628626714066,0.8158359238958279,0.8035714285714286,1.0,1.0,11/54,14.80%,EFNA5;PLXNA4;TBC1D10B;WRN;FBXW11;EPHA4;NOS1;PRKG1;PLXNA1;SIPA1L1;ITGB1BP1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.5386214965991598,-0.8156926334905402,0.7317073170731707,0.9842718453021032,1.0,1/5,9.03%,DHODH
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.3698754806107046,0.8156882992368083,0.7017543859649122,1.0,1.0,2/24,8.94%,BAG5;LIMK1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.392363177965091,-0.8156839307884972,0.813953488372093,0.9837371851721929,1.0,4/19,8.24%,TSPO;LRRC8D;VDAC2;ABCG2
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.4395973270778511,0.8154207845970064,0.7115384615384616,1.0,1.0,3/13,9.72%,MEIS2;ZBTB16;CDK6
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.36290026304267603,-0.8147255946588062,0.6304347826086957,0.985071308408542,1.0,3/29,6.58%,THY1;FBLN2;LIMS1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4148593493684401,0.8146932026471331,0.711864406779661,1.0,1.0,7/16,23.88%,NLRC5;JAK1;PARP9;PPARG;PARP14;PIAS1;IFNGR2
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.38306854790911704,0.8146552549693391,0.7719298245614035,1.0,1.0,2/32,3.00%,SRF;YJEFN3
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.5326148884692596,0.814535739862865,0.7580645161290323,1.0,1.0,3/5,42.15%,MAPT;LRRK2;DNM1L
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.5122546198098239,-0.8141773835185327,0.717391304347826,0.9855699555520375,1.0,3/7,26.41%,RO60;TPR;IFNAR1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.4032218193691453,-0.8139678801591468,0.7083333333333334,0.9854149087149895,1.0,5/19,19.85%,MT3;TMBIM1;TIMP1;PHPT1;IFIT1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.3916547942572749,-0.8137351458269748,0.6216216216216216,0.9852849016099775,1.0,6/18,16.48%,SIRT2;RRP8;CENPV;BEND3;BAHD1;H3-3A
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.41648210130722485,-0.8131895665923914,0.7254901960784313,0.9857080392389541,1.0,1/11,12.85%,PCYT2
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.5063408349589387,0.8131216794645135,0.8333333333333334,1.0,1.0,2/8,8.19%,CLEC16A;RPTOR
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.4799254841019085,0.8131129294589933,0.7741935483870968,1.0,1.0,1/9,5.07%,ABCA2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.4045499992855236,0.8126345807852589,0.7777777777777778,1.0,1.0,3/17,15.24%,SORT1;SOS1;MAGI2
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.327157250147526,0.8121891826825851,0.7868852459016393,1.0,1.0,11/67,16.02%,CMTR1;IRF2;TMEM140;NMI;NCOA7;STAT2;PARP9;TENT5A;PROCR;CSF1;IRF1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.41312992755740574,0.812025906641447,0.6785714285714286,1.0,1.0,4/20,16.89%,RAC3;RHOJ;P2RY12;PACSIN2
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.49735026379862735,-0.8119826695441404,0.65,0.9875590189499147,1.0,1/7,16.08%,SLC25A46
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.41777206529891503,0.811807985451128,0.6842105263157895,1.0,1.0,5/21,14.70%,CRLF1;HES1;PARP9;IL6ST;IL6R
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.452354310457017,-0.811528997718738,0.7333333333333333,0.9878314701715167,1.0,1/11,9.36%,PPP1R10
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.4385982558986291,-0.8114023393262464,0.75,0.9875267246407472,1.0,1/8,8.77%,WNT5A
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.5317539283502635,0.8113744980878635,0.8,1.0,1.0,3/5,23.74%,NTRK3;ZDHHC17;AGT
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.43756358416447483,0.8109743586606412,0.6779661016949152,1.0,1.0,6/15,19.83%,ASPA;DDO;AASS;SLC25A21;ALDH7A1;CRYM
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.5699820457433882,0.8107999539980885,0.7916666666666666,1.0,1.0,2/5,6.30%,CTBP1;SPI1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.3789470453494005,0.8104150954988973,0.7592592592592593,1.0,1.0,4/25,6.29%,CABYR;DNAH7;CCDC39;ODAD4
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.5291708345616356,0.8098912743805671,0.7377049180327869,1.0,1.0,3/5,38.94%,CTBS;GNPDA2;CHIT1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.39343591677482426,-0.8098787227387572,0.6923076923076923,0.9899378037615332,1.0,2/25,8.77%,CALM1;WNT5A
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.45988400486300096,0.8097047100186184,0.7111111111111111,1.0,1.0,1/11,1.11%,SOX9
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.44503817095562853,-0.8090135655549423,0.7843137254901961,0.9908529050574191,1.0,3/8,15.72%,PTN;GRN;CERS2
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.4716778767735465,0.808659804423106,0.7719298245614035,1.0,1.0,6/12,27.36%,KCNJ11;BMP8A;KLF7;IRS1;PRKN;PIM3
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.44592642504631586,0.8085043770860122,0.7192982456140351,1.0,1.0,3/10,11.83%,RXRA;SPI1;RARA
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.4117847909809743,-0.8083862599296163,0.7045454545454546,0.9915997870886075,1.0,1/20,0.89%,FBLN5
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.449569192763621,-0.8083075063795573,0.6875,0.9911760338742758,1.0,2/8,6.69%,CXCL12;VEGFB
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.38010481178007116,-0.8078199034403428,0.6875,0.9914270286225643,1.0,4/17,14.21%,PARP1;MPG;PARP2;TDG
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.45476811214531865,0.8073203402708525,0.673469387755102,1.0,1.0,4/11,15.43%,FAM107A;RPTOR;PRKAA2;PRKAA1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3397333642938653,-0.8069021244570519,0.8163265306122449,0.9925865953358923,1.0,7/52,10.44%,ARPC5;ACTG1;ACTB;LYN;HSP90AB1;BRK1;MYO10
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.34740857045340545,0.8068384865905311,0.7413793103448276,1.0,1.0,12/52,21.32%,YJEFN3;KAT2B;TSPAN5;IL6ST;TP63;ITGB1BP1;WWP2;ARRB1;MAML1;STAT3;TGFB2;MAML3
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.41235110966754196,-0.8067198436784413,0.8367346938775511,0.9924039891708808,1.0,3/14,10.95%,TIPRL;PPP1R11;IKBKB
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.39091131085289116,0.8059047958943995,0.7288135593220338,1.0,1.0,13/23,32.28%,WASHC1;WDR91;P2RY12;WDR81;DAB2IP;PIK3R1;IRS1;FLT1;ATG14;FGF2;PTK2B;PTK2;AMBRA1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.32324164199493766,0.8054181566640264,0.8620689655172413,1.0,1.0,13/64,19.36%,GALNTL6;B3GNT5;TRAK1;TMTC2;GALNT15;TMTC4;ST3GAL1;LARGE1;GALNT16;B4GALT5;GALNT13;POGLUT2;OGT
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4282547112769258,-0.8052257121043209,0.8148148148148148,0.9944572355517272,1.0,4/14,9.96%,SLC30A10;ALOX5;SPHK2;SLC25A33
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.49717038249721124,-0.8047342569208401,0.725,0.9949836300413044,1.0,1/7,0.46%,BTG1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.31079149865665906,-0.8047307076027477,0.8285714285714286,0.9944422021413349,1.0,14/77,13.12%,GAPDH;AMOTL2;PCGF2;NLGN2;COL12A1;SEZ6L2;YAP1;GNA11;FSHR;ADCY6;MCAM;PTPRF;GPC1;MAGI1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.31466044177519437,0.8044492324982512,0.8888888888888888,1.0,1.0,24/143,17.61%,FSTL5;GRAMD1C;PCLO;EFNA5;NRSN2;KCNC4;CARNS1;ARFGEF3;HSPA12A;SYBU;SRCIN1;DUSP8;CEP170B;MAPK8IP2;MORN4;SPTBN4;NCS1;PACRG;PTPRU;CERS5;CMIP;NRG1;ABHD3;DNAJB14
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.3001803156735552,0.8040018827104988,0.9253731343283582,1.0,1.0,25/175,13.35%,GLRA1;AHR;GLRA2;FOXO1;SOX9;DAPK1;NR4A3;HCN3;KCNC2;FOS;NSMF;SLC38A9;HCN1;RPTOR;RYR3;ATM;RORA;TIRAP;TPM1;ERCC6L2;TAF1;P2RY12;CPEB3;RORB;RAP1B
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.3202128947957129,0.8039065741934203,0.8596491228070176,1.0,1.0,14/94,10.09%,KIF1C;SOX9;TNS1;MRO;KITLG;GPRC5C;FAM20C;ANGPTL4;ARHGEF17;TIMP3;FKBP9;TSPAN9;SHC2;PFKFB3
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.4670547324676064,0.8037943470579298,0.7647058823529411,1.0,1.0,2/9,6.33%,NEDD4L;CAV3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.44255674596896355,0.8037775684194643,0.723404255319149,1.0,1.0,3/12,17.88%,BRCA1;KMT2A;SMAD4
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.4013480210970075,-0.8030713442084388,0.7346938775510204,0.9969286997265003,1.0,4/21,17.91%,DYNLT1;SAPCD2;NUMA1;SPDL1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.41388085251326057,-0.8028366981726257,0.7105263157894737,0.9967195594126419,1.0,4/16,15.91%,RING1;CUL4B;RNF168;RNF8
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.5054125658131889,0.8027432826356443,0.7368421052631579,1.0,1.0,2/5,18.16%,FOXP1;BCL6
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.47246548762194795,0.8027410440483451,0.7407407407407407,1.0,1.0,2/6,19.87%,GDF11;MEST
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.5108700899427023,0.8026095708898526,0.7454545454545455,1.0,1.0,1/5,0.45%,GLRA1
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.4892141463999625,0.8021571897404317,0.7647058823529411,1.0,1.0,2/6,23.27%,NOP53;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.36695192044959124,-0.8021242185580711,0.627906976744186,0.9973174603460331,1.0,4/26,9.62%,UBXN1;RPL11;HSP90AB1;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.33517666944562413,-0.8020044667638877,0.7872340425531915,0.9970406259224791,1.0,11/57,13.22%,VBP1;HSPA8;MID1IP1;CAMSAP3;LDLR;LIMA1;CLU;CLIP3;TWF1;PFN1;PFDN1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.4026466771389469,0.8013043611338218,0.7758620689655172,1.0,1.0,5/21,23.13%,FBXL17;CRTC1;BHLHE40;PER1;RBM4
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.4744512454888429,0.8012947123421585,0.6379310344827587,1.0,1.0,2/8,11.33%,SEMA3A;EPHA4
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.43735188923953394,0.8012024823250534,0.7894736842105263,1.0,1.0,9/19,24.60%,TTN;RYR2;TPM1;NOS1;SLC8A1;KCNQ1;DMD;PIK3CA;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.4253917646573405,-0.8011653876788658,0.7555555555555555,0.9979637559057319,1.0,1/12,1.60%,PLIN2
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.3854486916067297,0.8009122349433071,0.7796610169491526,1.0,1.0,8/27,17.35%,HDAC4;ALK;AZIN2;FMN2;BANP;PRKAA1;NCOR1;PFKFB1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4498797983952966,0.8008520906325661,0.7258064516129032,1.0,1.0,2/12,3.31%,ALG6;DPAGT1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.3921324832905838,0.8005018443850904,0.7924528301886793,1.0,1.0,1/13,4.94%,PSEN1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3467621162601975,0.8004281831445981,0.8421052631578947,1.0,1.0,3/42,4.57%,SOX9;IGF1R;NTRK3
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.3361775816580138,0.8002044693802363,0.76,1.0,1.0,5/58,9.60%,AKR1C2;SOX9;VCL;PROX1;LOXL3
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.42972091286516534,0.8001928631564559,0.6792452830188679,1.0,1.0,2/14,11.09%,RAC3;RHOJ
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.4361566861377001,-0.7998057544315511,0.775,0.9998020339820954,1.0,7/17,12.48%,BAD;ROMO1;TIMM8B;TIMM13;COX18;TIMM22;HSPA4
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.3684880191548592,-0.7997258945926315,0.7714285714285715,0.9993706587332769,1.0,2/23,3.34%,RANGRF;CD63
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.5010616978121593,0.7995005287867929,0.7884615384615384,1.0,1.0,4/6,23.14%,NRG1;AKAP13;TGFB2;CBY1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.519922470661719,0.7986448290228293,0.8035714285714286,1.0,1.0,4/8,19.31%,SGK1;KLHL3;AKR1C3;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3944782398504321,-0.7984650331062749,0.76,1.0,1.0,3/23,11.95%,ERN1;VEGFB;GAS1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.32279025484077906,-0.7982274005808023,0.8863636363636364,1.0,1.0,12/82,11.41%,TUBB2B;BCAN;GNG3;NLGN2;NGB;LINGO1;CADM4;HPCA;TMEM179;BRINP1;CLIP3;CKB
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.437129124204017,0.7977459421679663,0.7741935483870968,1.0,1.0,5/17,22.51%,USP30;CHCHD3;GDAP1;MIGA2;MFN1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.36862249716085915,-0.7976440944941782,0.7692307692307693,1.0,1.0,4/33,5.39%,SYAP1;RARRES2;ZFP36L1;SFRP1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.34403858420377426,-0.797572821964505,0.7674418604651163,1.0,1.0,2/26,3.37%,GCNT4;GXYLT2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.5112443763913949,-0.7975679532572622,0.7291666666666666,1.0,1.0,2/6,6.72%,PDGFRA;LYN
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.3965566679221363,0.7973372304659166,0.7755102040816326,1.0,1.0,8/21,20.20%,MDGA1;RAB17;CAMK2B;EPHA4;SLITRK4;PDLIM5;ABL1;ABHD17C
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.5147233198797956,-0.7972742604696825,0.7540983606557377,1.0,1.0,1/6,22.22%,ERCC8
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.4112909126372871,0.7972578734523431,0.8695652173913043,1.0,1.0,8/21,30.07%,KDM7A;KDM6A;KDM2B;KDM4C;KDM3A;UTY;PHF2;KDM4D
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.3939227812210113,-0.7970936889121965,0.7291666666666666,1.0,1.0,4/21,5.75%,SYAP1;EEF1A1;ZFP36L1;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.4898414955921342,0.7970094799410439,0.6727272727272727,1.0,1.0,1/8,6.74%,PHLDB2
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.38858753004603935,-0.7970053748939051,0.7674418604651163,0.9999381249899727,1.0,2/18,1.21%,RHOC;CD151
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.4700735867713327,-0.7969806296256247,0.8421052631578947,0.9989515814014034,1.0,4/9,18.92%,REC8;SYCE1;TEX11;P3H4
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.4700735867713327,-0.7969806296256247,0.8421052631578947,0.9989515814014034,1.0,4/9,18.92%,REC8;SYCE1;TEX11;P3H4
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.3740254783045098,0.7967247073995606,0.7777777777777778,1.0,1.0,4/24,13.87%,SYT1;RAB29;DLG4;SNCA
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.45406681007018745,0.7965726034526689,0.7454545454545455,1.0,1.0,3/9,27.70%,GTPBP3;ELP3;TRMT9B
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.4030568907082617,0.7962653851651587,0.7288135593220338,1.0,1.0,2/16,4.14%,AKT2;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.3913066031057936,-0.7957795491246747,0.8095238095238095,1.0,1.0,3/24,13.00%,FXR2;WNT5A;B2M
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.38657064820476494,-0.7957547490815339,0.7380952380952381,0.999774324506829,1.0,5/32,13.69%,GSTP1;HIPK1;IKBKB;CLIP3;RACK1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4898234615533581,0.7957371937444637,0.7857142857142857,1.0,1.0,3/10,9.21%,GRK4;NMT1;CAMKMT
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.37591118886667385,0.7950118330248187,0.7741935483870968,1.0,1.0,7/24,15.76%,FBXO6;ATM;CDC5L;RAD9A;CLOCK;TP53BP1;DONSON
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.30518049438474726,0.7948754258522055,0.9710144927536232,1.0,1.0,19/109,14.80%,YWHAH;SAE1;AKT2;NMT1;ARIH2;PSEN1;UBR5;TCAF1;RAB29;AKAP5;BCAS3;C2CD5;B3GAT3;CAMK1;PCNT;SEC16A;PPP1R13B;TP63;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.464208393181842,-0.7946752172360516,0.6949152542372882,1.0,1.0,3/6,22.10%,APOD;CABP1;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.464208393181842,-0.7946752172360516,0.6949152542372882,1.0,1.0,3/6,22.10%,APOD;CABP1;RAB23
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.329417561485395,0.794624417660378,0.8214285714285714,1.0,1.0,8/58,10.76%,RMI1;MMS22L;WRN;RNF138;BRCA1;RPA1;SMC5;LIG3
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.31823492210099735,0.7945197174813481,0.8545454545454545,1.0,1.0,21/77,20.14%,PON1;PON3;ALOX12;PLA2G15;NAAA;ACSBG2;GPAM;ACSL1;ACSF2;ADIPOR2;ACOT11;AOAH;ACACA;CPT1A;ACSM6;PPARG;ACSBG1;CPT1C;LIPH;SLC27A4;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.5475665887533332,-0.7943138004118518,0.8222222222222222,1.0,1.0,2/5,22.25%,DDIT3;RELA
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.5503343410974532,0.7942473943571662,0.8113207547169812,1.0,1.0,1/5,7.54%,CLEC16A
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.4241899705636222,-0.7931428019437379,0.7450980392156863,1.0,1.0,1/18,0.59%,CUL7
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.4351348530695436,-0.7929804654950551,0.6976744186046512,1.0,1.0,2/9,17.73%,SELENOS;FBP1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.344024369820521,-0.792794954613817,0.8367346938775511,1.0,1.0,6/42,11.70%,HSPG2;THBS2;ALOX5;SARS1;VASH1;AMOT
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.3533422082322035,0.7926694672206276,0.7719298245614035,1.0,1.0,6/39,12.02%,HEY2;WNT7A;LRP2;DOCK7;HES1;PRUNE1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.466889399000951,-0.7921332261848832,0.7297297297297297,1.0,1.0,2/8,11.33%,RAB1B;RAP2C
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.4488036929604871,0.7917732624118572,0.6862745098039216,1.0,1.0,2/7,2.08%,HTR2C;GPR18
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.47887490060639015,-0.7917327395684415,0.717948717948718,1.0,1.0,1/8,3.66%,NLGN2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.29638194231722786,0.7910666130417425,0.9,1.0,1.0,18/151,12.19%,CARD14;SRF;HDAC4;CAMK1D;ALK;RELN;NLRC4;IRAK2;MID2;FANK1;TAB1;RIPK1;TRIM52;ROR1;TIRAP;CLOCK;TAF1;TP53BP1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.3703813249912883,-0.7910366827086578,0.7254901960784313,1.0,1.0,2/26,6.56%,RAN;WTIP
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.4594039011803556,-0.7910330169669614,0.7209302325581395,1.0,1.0,4/10,19.31%,ALKBH2;MPG;ASCC2;MGMT
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.4594039011803556,-0.7910330169669614,0.7209302325581395,1.0,1.0,4/10,19.31%,ALKBH2;MPG;ASCC2;MGMT
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.4893870014772839,-0.7909081408990808,0.7708333333333334,1.0,1.0,1/7,0.15%,SOX4
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.41645115734265187,-0.7906426830841754,0.6944444444444444,1.0,1.0,1/15,1.48%,VEPH1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.457691848966449,-0.7903679588055802,0.7692307692307693,1.0,1.0,2/8,13.89%,GINS3;MCM4
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.3973073927095896,0.7900762278919883,0.7169811320754716,1.0,1.0,5/20,14.07%,SYNPO2;LIMK1;SHANK3;TSC1;ASAP3
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5084704659665702,0.7900708974792161,0.7547169811320755,1.0,1.0,1/6,7.12%,UBR5
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3669731734356811,0.7899552980592254,0.7833333333333333,1.0,1.0,6/29,15.76%,EME2;MMS22L;WRN;ZRANB3;PRIMPOL;DONSON
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.457210088246093,-0.7897637796179824,0.8125,1.0,1.0,1/7,4.88%,ZNF830
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.5019236252606535,-0.7892285776615755,0.6511627906976745,1.0,1.0,2/7,11.20%,SRI;GRK2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.31052097688135055,-0.7890727515053546,0.8888888888888888,1.0,1.0,12/75,9.76%,ATF4;DBI;ALDH1L2;DHFR;PLAAT1;ACSM5;SMPD1;DHFR2;NIT1;PCCB;AEBP1;OXSM
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.5013928969208756,0.7890465436756333,0.75,1.0,1.0,2/8,6.30%,CTBP1;SPI1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.3372356188632012,0.7888234478676863,0.8636363636363636,1.0,1.0,8/59,13.79%,SHTN1;RAB10;VAPB;MOSPD3;STX5;STX1A;SMPD4;SEC16A
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3540708513402152,0.7888016263726952,0.8070175438596491,1.0,1.0,3/45,4.44%,AKR1C2;AKT2;RAB10
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.4318592549416166,0.7887138351086235,0.7833333333333333,1.0,1.0,3/11,17.94%,NUP93;THOC2;PCID2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.427484365617235,-0.7885937487343507,0.7674418604651163,1.0,1.0,1/9,3.46%,NT5E
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.38066131700984485,0.7882712708291595,0.7678571428571429,1.0,1.0,6/26,17.53%,ACACB;MCEE;ACSF2;ACOT11;ACACA;ACSM6
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.42320727356817855,-0.7882535123489359,0.8245614035087719,1.0,1.0,2/12,4.20%,ZFP36L1;HAX1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.456989564494508,0.7882286289933962,0.8461538461538461,1.0,1.0,4/13,32.41%,INTS10;INTS6;INTS12;INTS3
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.3756204116939889,-0.788187366924127,0.7333333333333333,1.0,1.0,4/22,9.35%,PPT1;ALOX5;ACLY;SLC25A1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.4967527176598619,0.787934070154927,0.7878787878787878,1.0,1.0,1/6,3.88%,UBASH3B
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.4652531593426703,-0.78785325061077,0.8292682926829268,1.0,1.0,2/8,11.03%,RHOG;RHOBTB1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.348194324760152,-0.7878403439348863,0.8444444444444444,1.0,1.0,4/26,8.75%,SLC30A10;MT3;SLC31A1;COX17
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.4347844427924813,0.7875561984566111,0.803921568627451,1.0,1.0,2/11,11.29%,SLC9B2;SLC39A11
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.4733896769713945,-0.7874776416455784,0.68,0.9999139402173471,1.0,3/5,21.30%,UFL1;UFC1;DDRGK1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.4733896769713945,-0.7874776416455784,0.68,0.9999139402173471,1.0,3/5,21.30%,UFL1;UFC1;DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.4733896769713945,-0.7874776416455784,0.68,0.9999139402173471,1.0,3/5,21.30%,UFL1;UFC1;DDRGK1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.4108516412195278,-0.7873105077022788,0.7441860465116279,0.9995816076055697,1.0,1/17,0.60%,GPX1
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.5286939928315783,0.7869702618260114,0.8070175438596491,1.0,1.0,1/5,11.08%,PDE9A
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.30693005406613244,-0.7865422595150457,0.9111111111111111,1.0,1.0,2/52,3.68%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.3598235483413571,-0.7864334512244348,0.825,0.9999342910651215,1.0,6/30,14.71%,GORASP1;RAB26;GOLGA7;GORASP2;RILPL2;OPTN
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.3423364823968418,-0.7862523830396062,0.8536585365853658,0.9997046565528245,1.0,5/43,12.78%,KDSR;SGPP1;SPHK2;SPTLC1;SAMD8
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.4186872988582584,-0.785981770607817,0.8,0.9995713807981758,1.0,3/14,9.38%,ACTG1;PTN;GRN
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.4975868671234328,-0.7854729189735367,0.7857142857142857,1.0,1.0,2/7,6.03%,YAP1;WBP2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.3792153975993834,0.7853984912946863,0.8679245283018868,1.0,1.0,9/27,27.04%,ITGA8;SULF1;PROX1;IFT27;CEP290;TGFB2;AGT;PYGO2;PCSK5
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.39699027353889826,-0.7853110565510288,0.75,0.9996652938511532,1.0,3/20,4.75%,MAP1S;MID1IP1;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.3003054416514341,0.7852285831106666,0.9047619047619048,1.0,1.0,17/118,15.45%,RASGRF1;EFNA5;PLXNA4;TBC1D10B;RGS7;DOCK11;BCAS3;DOCK8;RAP1GDS1;EPHA4;PRKG1;PLXNA1;ASAP3;ZC3H15;SIPA1L1;ITGB1BP1;SEMA4D
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.4830548935476658,0.7851718183878859,0.7358490566037735,1.0,1.0,2/8,29.29%,SREBF1;ARHGEF10L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.4830548935476658,0.7851718183878859,0.7358490566037735,1.0,1.0,2/8,29.29%,SREBF1;ARHGEF10L
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.3727811005695058,-0.785028860052033,0.7555555555555555,0.99958023226255,1.0,3/21,10.07%,PDGFRA;FUZ;RAB33B
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.41894894132152655,0.7850200114071825,0.8545454545454545,1.0,1.0,2/17,4.52%,YWHAH;NMT1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.41894894132152655,0.7850200114071825,0.8545454545454545,1.0,1.0,2/17,4.52%,YWHAH;NMT1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.3957284444110603,-0.7848742840318239,0.7,0.9992974533701429,1.0,1/17,1.66%,RAN
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.33723535959594186,-0.7847859524096232,0.8461538461538461,0.998895157022819,1.0,4/53,5.35%,SOX4;BAD;LRRC8D;ALOX5
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5084589220889782,0.7845859293445432,0.8,1.0,1.0,4/7,24.28%,SNCA;TF;BCL2;ACO1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.47591303415995784,0.7842632712271568,0.84,1.0,1.0,4/8,22.75%,DMTN;KNG1;ENPP4;APOE
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.3966785684989218,0.784211419519811,0.7931034482758621,1.0,1.0,3/22,11.41%,KCNJ11;RAB11FIP5;BMP8A
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.5338377797191411,0.7838528228673144,0.7857142857142857,1.0,1.0,2/5,17.10%,RIPOR2;EHD1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.4391901489779747,-0.783790786025406,0.6818181818181818,1.0,1.0,2/9,13.24%,MADCAM1;ZP3
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.42154749472712855,0.7837705782174403,0.75,1.0,1.0,8/17,22.71%,RBSN;ARMH3;STX5;STX18;MAPK1;CAMSAP2;MAPK3;PDE4DIP
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.38241849650378174,-0.7836234991797792,0.7346938775510204,0.9998273839539717,1.0,2/20,4.80%,PIF1;PARP1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.2934078551271447,-0.7835167828438124,0.8695652173913043,0.9994733000105068,1.0,19/108,14.09%,SIRT2;SYAP1;EEF1A1;ZFP36L1;ERN1;SFRP1;DUSP3;PDE3A;PDCD5;LIMS1;HAS2;WNT5A;CD44;DSTYK;GAS1;CORO1B;RACK1;BMP2;SMAD3
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.35437602427596393,-0.78323761247742,0.7555555555555555,0.9994543732790427,1.0,6/31,16.80%,APEX1;PARP1;LTO1;POLD3;H3-3A;POLD2
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.3763823178561732,0.7831978660975478,0.8421052631578947,1.0,1.0,6/21,19.36%,PHF19;BRCA1;KMT2A;SMAD4;RIF1;OGT
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.3435719433669112,0.7831274581970269,0.8387096774193549,1.0,1.0,2/41,2.70%,BCL9;WNT7A
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.34919074220360735,-0.7829985653059953,0.7547169811320755,0.9993996166108425,1.0,10/30,17.71%,APEX1;PARP1;ADPRS;MPG;RFC5;TDG;POLD3;POLD2;RFC3;POLG
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.3388730284963732,-0.7829742529617716,0.8378378378378378,0.9988910587667168,1.0,10/37,14.57%,NCSTN;GAPDH;APH1A;TIMP4;PSMB9;PSME3;FURIN;PRELID1;TIMP2;TIMP1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.3609889378757888,-0.7827518842094018,0.8536585365853658,0.9987769738077187,1.0,6/28,5.60%,ASCL1;RPS19;HES6;HES5;WNT3;YAP1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.34073176850318243,-0.7823814119041094,0.9090909090909091,0.9988896984975723,1.0,5/39,6.29%,GSTP1;PPIA;ARL6IP5;SEMA4C;QARS1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.406406218859258,0.7823475968395343,0.7924528301886793,1.0,1.0,3/20,4.22%,MYRF;SOX9;RELN
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.48060878903756765,0.782096024596939,0.8076923076923077,1.0,1.0,2/7,15.33%,KMT2C;KMT2A
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.4045350303763825,-0.7817915689902649,0.6904761904761905,0.9987036078889164,1.0,4/11,10.75%,DLD;PIPOX;PHYKPL;AADAT
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.4045350303763825,-0.7817915689902649,0.6904761904761905,0.9987036078889164,1.0,4/11,10.75%,DLD;PIPOX;PHYKPL;AADAT
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.4940560250033109,-0.7812566262531297,0.8,0.9990186948576949,1.0,1/5,13.99%,BMP2
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.3488125057431538,0.7811835998441103,0.7843137254901961,1.0,1.0,5/48,9.17%,ADAMTS9;YJEFN3;CD160;AGO1;SULF1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.33791642709068737,0.7811217844977189,0.8518518518518519,1.0,1.0,5/43,9.72%,SOX9;KLF9;TGFBR3;SULF1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.4116078572482892,-0.7810555187077566,0.7441860465116279,0.99887508101379,1.0,3/10,20.60%,BRK1;CYFIP1;WHAMM
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.3740625064611208,-0.7810359667162649,0.7884615384615384,0.9983805904266173,1.0,7/21,18.86%,SYAP1;TIPRL;EIF4EBP2;MLST8;MEAK7;NPRL3;AKT1
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.5071509766237282,0.7808589321614076,0.86,1.0,1.0,2/5,24.60%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.5071509766237282,0.7808589321614076,0.86,1.0,1.0,2/5,24.60%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.5071509766237282,0.7808589321614076,0.86,1.0,1.0,2/5,24.60%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3605142831931266,0.7806114687857202,0.9253731343283582,1.0,1.0,5/38,8.99%,ITGA8;RADIL;SRCIN1;EFNA1;TYRO3
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.5017928148830347,-0.7804527837159946,0.7380952380952381,0.9986834543104953,1.0,1/5,4.52%,EPHB3
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.4496065314534534,-0.7804464324702015,0.7254901960784313,0.99815987301754,1.0,3/9,16.45%,PRMT5;PRMT1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.40008746411657486,0.7804169195906314,0.8064516129032258,1.0,1.0,9/22,26.74%,PHLDB2;SHANK3;PAK2;PPFIA1;TJP1;CLASP1;PIK3R1;ARHGAP6;PRKN
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.4958450065729903,0.7802978684363095,0.8043478260869565,1.0,1.0,2/11,8.31%,STAT6;STAT5B
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.2827863515522712,-0.7802817411197452,1.0,0.997892274767427,1.0,11/105,11.89%,JUN;CFL1;PLEKHG5;RHOG;RASSF1;SHC3;BRK1;DBNL;RAP2C;RAPGEF3;ZNF304
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.45281518578230395,-0.7802385916105102,0.66,0.99742310055302,1.0,1/5,4.84%,E2F4
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.4792547910952598,0.7801379060668469,0.711864406779661,1.0,1.0,2/5,27.13%,CPSF6;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.4792547910952598,0.7801379060668469,0.711864406779661,1.0,1.0,2/5,27.13%,CPSF6;NRDE2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.39927073700738736,0.7801071870613258,0.8260869565217391,1.0,1.0,2/12,12.92%,SORT1;SOS1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.4910346615637825,0.780007785421173,0.75,1.0,1.0,1/6,8.43%,KLC1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.3725353888575388,-0.7794993610865856,0.813953488372093,0.9980225249578999,1.0,5/22,11.70%,AMOTL2;YAP1;YWHAB;DCHS1;AMOT
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3586720554518029,0.7794770158309904,0.875,1.0,1.0,13/38,26.58%,NEDD4L;SLC4A4;AQP4;KLHL3;TENT4B;PPARG;ADCK1;SLC4A8;TLCD3B;ABHD8;FBXW7;PNPLA2;THADA
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.44460820365002807,-0.7793377684620263,0.6486486486486487,0.9977376318588028,1.0,1/6,3.62%,FERMT1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.4509701400374813,-0.7792907410450298,0.76,0.9972811389966671,1.0,1/9,1.82%,RANGRF
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.33758685299414426,-0.7791609967121995,0.8666666666666667,0.9969850899253534,1.0,6/42,14.09%,PMEPA1;FURIN;CDKN1C;FNTA;BMP2;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.403438649924038,-0.7789414234076527,0.7608695652173914,0.9969262080648216,1.0,2/12,11.89%,CAV1;ZNF304
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.5139543682691629,0.7788916276700786,0.803921568627451,1.0,1.0,1/5,7.78%,TCAF1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2902430128789556,0.778515664989227,0.9436619718309859,1.0,1.0,19/174,11.75%,SOX9;NEDD9;PCLO;FAM107A;SKAP2;RAC3;WNT7A;FBLIM1;BAIAP2;PKP2;PARD3;WDR19;TEAD1;CD247;RANBP9;HES1;RHOJ;LIN7A;DLG4
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.3343210324398947,-0.7782622152102924,0.9393939393939394,0.9973586018298686,1.0,6/40,15.20%,RPS19;MAPK13;WNT5A;GRN;ZP3;IL18
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.3927351355744255,-0.7781427504757661,0.75,0.9970097445591936,1.0,4/10,21.34%,LYN;RC3H1;SOX11;GPNMB
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.37057677570744785,-0.7780060058425933,0.8292682926829268,0.996684903247236,1.0,6/21,16.45%,MT3;PPIA;WNT5A;MLST8;IL18;PARK7
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.3758087527554522,0.7779006684300195,0.8269230769230769,1.0,1.0,6/22,19.31%,PKP2;KCND3;DSC2;CAMK2D;ANK2;KCNQ1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.4134475820689504,-0.7778141213455068,0.6956521739130435,0.9963840399140926,1.0,4/12,15.05%,SLC30A10;SRI;EPB41;STIM1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.45886299042132483,0.777767681222859,0.8070175438596491,1.0,1.0,4/8,31.19%,STX1B;ARHGAP44;GRIPAP1;STX3
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.3392540125937264,-0.7770917987083547,0.9,0.9970461327777496,1.0,7/31,10.97%,ASCL1;WNT3;LYN;WNT5A;TMEM161A;RXRB;BRINP1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4254421282376516,0.7770358652389117,0.7222222222222222,1.0,1.0,3/15,9.56%,SLC6A6;SLC1A4;SLC22A4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.4096415850872904,0.7768561182444773,0.7333333333333333,1.0,1.0,2/12,13.02%,PUDP;UCK1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.45984192335600393,0.776699230192613,0.7454545454545455,1.0,1.0,2/7,13.89%,PLXNA4;PLXNA1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.4876365981920665,0.7764954812504,0.8305084745762712,1.0,1.0,3/7,15.82%,P2RY12;MTUS1;CSF1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.4984263980731504,0.7758065999158912,0.7377049180327869,1.0,1.0,3/6,24.22%,AKAP5;CACNA1D;NF1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.27408845348717825,0.7757951639974635,1.0,1.0,1.0,44/265,19.43%,BCL2L11;FOXO1;RFC4;FBXO31;BRAT1;PAK1;PSEN1;GADD45A;FOXP1;WRN;UBR5;FMN2;RAD18;BCL2L2;FBXO6;ATM;BRCA1;RPA1;RAD9A;SMC5;BABAM2;TAF1;TP53BP1;MOAP1;STK11;ZRANB3;MAPK12;HELB;MSH6;XRCC3;DDB2;MASTL;POLQ;RNF169;FANCC;BARD1;RIF1;DTX3L;BCL6;SPDYA;NEK4;ABL1;CHCHD6;SAMHD1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3894382738579035,-0.7756954311696868,0.7962962962962963,0.9981558440598723,1.0,3/18,12.33%,PARP1;CUL4B;GTF2H2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3894382738579035,-0.7756954311696868,0.7962962962962963,0.9981558440598723,1.0,3/18,12.33%,PARP1;CUL4B;GTF2H2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.3773586945766704,-0.7752507779786728,0.7142857142857143,0.9984562770780085,1.0,3/12,8.61%,NCSTN;APH1A;ACHE
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3043067315713397,-0.7742837076238432,0.875,0.9996345020875594,1.0,15/92,13.52%,UBB;RPS27A;UBC;RTKN2;MALT1;PPIA;UBA52;CLU;WNT5A;CAV1;IKBKB;TRAF5;NPM1;AR;FLOT1
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.48349542266311996,-0.7742497037392424,0.8571428571428571,0.9991975617485488,1.0,1/9,3.60%,EXOSC8
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.29986894035509987,0.7741856930041917,0.953125,1.0,1.0,7/99,7.58%,MGAT4C;ALG6;DPAGT1;FUT2;B3GNT5;TRAK1;GCNT2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.3884996582103304,0.7740035158812116,0.7868852459016393,1.0,1.0,3/21,7.71%,PYGB;PHKG1;PYGL
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.32150658222885736,-0.7737447137454689,0.7631578947368421,0.9993556826470087,1.0,7/76,5.93%,SIRT2;ODC1;TMEM9;VPS28;EEF1A1;RAB26;TIPARP
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.39878865751638637,-0.773643939759658,0.8125,0.9990193764332801,1.0,2/14,8.86%,CD63;ATAD1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.3284095965073959,-0.7734204623399519,0.8717948717948718,0.9988010425849039,1.0,2/37,3.35%,RPL10;PCIF1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.38102765159085455,-0.7732514985981246,0.7619047619047619,0.998500647261196,1.0,2/16,4.75%,FERMT1;CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.3605985898356674,0.7732133811025617,0.7647058823529411,1.0,1.0,8/40,13.06%,RAC3;PTPRJ;PRKCA;ATM;TPM1;EPHA4;P2RY12;CHRD
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.4294241393901522,0.7731654934126907,0.8035714285714286,1.0,1.0,4/12,23.98%,PKP2;CAMK2D;PIK3CA;CACNA1D
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.32391073805892445,0.7730089658524978,0.859375,1.0,1.0,16/61,19.65%,CHRM3;AKT2;RABGGTB;PHEX;PIGH;FBXO11;ST3GAL1;WWP2;MCRS1;MMP15;UBE2D3;USP6;ABL2;ABL1;LCMT1;ATG3
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.38456908521937794,-0.772875458360702,0.7450980392156863,0.9986118034555259,1.0,4/24,13.52%,PPT1;CLU;B2M;FLOT1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.48856837709167344,0.7726193534071161,0.7592592592592593,1.0,1.0,3/6,28.17%,PTPRT;NFKB1;ST3GAL6
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.4778344338820758,-0.7725248687659262,0.7619047619047619,0.9986523824146809,1.0,1/6,3.68%,PIH1D1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.34492693900105326,0.7724732838816442,0.8163265306122449,1.0,1.0,4/36,6.27%,MYRF;SCN8A;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.3670376312125183,0.7723534421003779,0.8275862068965517,1.0,1.0,3/34,3.07%,EFHC1;RACGAP1;SEPTIN6
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5247866767036028,-0.7723348025657243,0.7619047619047619,0.9983760113785796,1.0,1/5,4.76%,LPCAT1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.26928376148337696,0.7718463706677867,1.0,1.0,1.0,35/316,12.09%,PTPRC;AKR1C2;BCL2L11;SOX9;IGF1R;TNFRSF19;AKT2;KITLG;RELN;LRP2;LRRC19;NTRK3;BRD4;HIP1;FGF9;PTPRJ;MID2;SLC38A9;SASH1;GCNT2;SEPTIN4;RPTOR;NRG4;RIPK1;TRIM52;ZNF622;ROR1;NMI;TIRAP;CD27;TRAF7;TRIM44;PTP4A3;PDPK1;P2RY12
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.37844539404485394,0.7716993127285842,0.7719298245614035,1.0,1.0,3/27,7.86%,PTPRC;LMBR1L;RAB29
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.37521982388207664,0.7716288703488962,0.7894736842105263,1.0,1.0,5/24,13.79%,RAB10;MACF1;RAB31;GOLPH3L;SEC16A
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.42993788135268307,-0.7715778561710597,0.8085106382978723,0.9990794825298772,1.0,2/10,11.61%,SOAT1;SCARB1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.40062055361907445,0.7714091780284172,0.8235294117647058,1.0,1.0,2/15,12.33%,BCL2L2;MOAP1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.402908209562686,0.7712477438759013,0.7540983606557377,1.0,1.0,4/16,11.75%,PCLO;PAK2;JAK1;DLG4
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.37949920705874085,-0.7706573867313526,0.7446808510638298,1.0,1.0,3/14,16.81%,IFITM3;SHFL;XAF1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.33855040367660594,-0.7696896583133616,0.8913043478260869,1.0,1.0,10/45,15.11%,RAN;BAMBI;RPL11;CAV1;TRIB3;B2M;FLOT1;EPB41;BMP2;LRP1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.4597776224786643,0.7695511008594484,0.7857142857142857,1.0,1.0,2/6,22.75%,ABL1;APOE
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.3255351193306838,0.7694517628248481,0.8305084745762712,1.0,1.0,3/53,4.45%,AHR;IRF2;SYNGR2
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4321764049704966,0.7691684538600883,0.8928571428571429,1.0,1.0,3/15,8.47%,ALG6;DPAGT1;DHDDS
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.40490143504850074,0.7689527466158983,0.7884615384615384,1.0,1.0,4/20,7.18%,SRF;FOS;SPI1;TEAD1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.39457263237567164,-0.7688663950245226,0.8392857142857143,1.0,1.0,2/12,10.99%,RARRES2;MST1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.5044588890872028,0.7687621302770714,0.8297872340425532,1.0,1.0,1/7,10.16%,DUSP1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.363168580473945,0.7685061888360154,0.8688524590163934,1.0,1.0,7/29,14.34%,RELN;CAMK2B;SRCIN1;EFNA1;SHANK3;EPHA4;SIPA1L1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),0.4247046360871267,0.7682939198493672,0.8225806451612904,1.0,1.0,1/14,0.26%,VSIR
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.44125121907995224,0.7681918132891582,0.7169811320754716,1.0,1.0,1/10,0.84%,BCL2L11
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.36395733008693587,-0.7680792588229847,0.7317073170731707,1.0,1.0,6/26,11.59%,SEMA5B;SEMA4F;SEMA4C;FN1;SEMA5A;SOX8
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.34259771216071055,0.767891380362097,0.8,1.0,1.0,10/32,22.96%,NUAK1;PRKAA2;NIM1K;PRKAA1;MTMR3;CPEB4;BRSK1;EIF2AK3;FOXO3;PRKAG2
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.3807483536351194,0.7677091378557458,0.82,1.0,1.0,3/19,15.43%,WRN;ATM;PRKAA1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3193607459635916,-0.7674031791767336,0.8653846153846154,1.0,1.0,4/42,4.42%,NCSTN;ASCL1;HES5;APH1A
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.4095312744671964,0.7673635643634732,0.7719298245614035,1.0,1.0,6/18,19.71%,RANGAP1;SUFU;DMTN;ITGB1BP1;BARD1;BAG4
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.5266811180337884,0.7673436532755229,0.8085106382978723,1.0,1.0,1/5,8.10%,HABP4
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.43958640813208927,0.7672235841752535,0.7457627118644068,1.0,1.0,5/11,22.85%,KCNB2;TPM1;DAPK3;PPP1R12B;ENO1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.48693028474398087,0.7669500929391734,0.8269230769230769,1.0,1.0,2/6,17.34%,RARA;PRKCZ
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.5137357365128656,0.7668087613916809,0.8113207547169812,1.0,1.0,3/5,41.47%,FER;AFDN;PLEKHA7
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3496678238954077,0.7667383491529743,0.8596491228070176,1.0,1.0,4/37,10.12%,POM121C;POM121;SLC2A6;NUP93
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.42524251230859406,0.7665409766375401,0.71875,1.0,1.0,4/15,18.57%,CD160;PDPK1;AKR1C3;PDCD4
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.4125042127579237,-0.7663446587174659,0.7872340425531915,1.0,1.0,1/10,6.21%,SLC25A30
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.4125042127579237,-0.7663446587174659,0.7872340425531915,1.0,1.0,1/10,6.21%,SLC25A30
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.49136914652379743,-0.7662437816626192,0.7727272727272727,1.0,1.0,2/6,11.51%,PTN;PTPRF
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.3558967809479426,0.7662431032688225,0.8,1.0,1.0,9/24,20.18%,GCNT2;DENND6A;BMP7;JAK1;ADAM19;PIEZO1;PTPRU;TJP1;ANK3
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.2887790777233127,0.7662197469185361,0.9841269841269841,1.0,1.0,24/121,16.83%,RFC4;NUAK1;RMI1;ING5;WRN;PIP4P1;TAF3;ATM;SGK1;BRCA1;RPA1;RAD9A;TAF1;PRKAA2;PDPK1;PIP4K2A;STK11;BANP;MAPKAPK5;PPP1R13B;TP63;PRKAA1;TAF15;BARD1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3775914676118535,-0.7659471215461825,0.7272727272727273,1.0,1.0,6/15,24.07%,LYN;CACTIN;NFKBIL1;GRAMD4;LGR4;GPR108
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.4722372033508645,0.7658224964670322,0.8,1.0,1.0,2/8,10.00%,ABCA2;RORA
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.36367055694315775,0.7654414770912069,0.7636363636363637,1.0,1.0,4/23,17.35%,BAIAP3;CPLX1;KCNMB4;STX1B
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.34476006900993517,0.765002277499851,0.9166666666666666,1.0,1.0,6/33,16.48%,PCTP;DOCK7;STK11;ACOT11;NOVA2;ABHD6
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3845199337945713,0.7649155024848042,0.7547169811320755,1.0,1.0,5/21,18.06%,GADD45A;MAP2K5;ITGB1BP1;ANGPT2;PPARG
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.3988754146129219,0.7647656957070564,0.7636363636363637,1.0,1.0,3/16,8.37%,HEY2;SLIT3;EFNA1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3807990918041065,0.7646944946650948,0.8360655737704918,1.0,1.0,6/27,16.67%,CRLF1;HES1;PARP9;IL6ST;IL6R;CNOT7
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.29071165794221804,-0.7644553842624789,0.9111111111111111,1.0,1.0,18/80,18.26%,RHOC;FERMT1;PIH1D1;PARP1;CLU;PSMC3;STUB1;BRK1;CUL4B;GTF2H2;RACK1;ISG15;DHX33;VCP;PARK7;SUMO1;PSMC4;BAX
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.4050266220139719,-0.7644257105746565,0.6938775510204082,1.0,1.0,1/13,3.43%,LSM1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.32575657944389363,0.7643968350717903,0.9032258064516129,1.0,1.0,8/70,11.39%,ROBO2;LRP2;NCOA1;SLIT3;ZNF16;STAT5B;MAP2K5;NOS1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.3425656541218391,0.7639301687108168,0.8928571428571429,1.0,1.0,13/41,23.33%,COL5A1;RAB3A;CAV3;SYTL4;PLSCR4;DYSF;ANK2;PACSIN2;ANK3;FA2H;PACSIN1;SNX33;NSF
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.3518205717642408,-0.7638982478611214,0.7608695652173914,1.0,1.0,14/31,20.65%,MMP2;CD44;FURIN;CAPN1;FLOT1;TIMP2;CTSK;TIMP1;CTSL;MMP16;HTRA1;CAPNS1;PLG;BMP1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.3518205717642408,-0.7638982478611214,0.7608695652173914,1.0,1.0,14/31,20.65%,MMP2;CD44;FURIN;CAPN1;FLOT1;TIMP2;CTSK;TIMP1;CTSL;MMP16;HTRA1;CAPNS1;PLG;BMP1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.4161445967260569,-0.7635844725025385,0.875,1.0,1.0,4/15,19.77%,PHB2;CLU;C5;CD81
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.4161445967260569,-0.7635844725025385,0.875,1.0,1.0,4/15,19.77%,PHB2;CLU;C5;CD81
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.4478678254329592,-0.7635504474015351,0.7111111111111111,1.0,1.0,2/7,6.58%,CD63;LIMS1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.4432284506189891,-0.7633893739374555,0.7959183673469388,1.0,1.0,1/8,1.05%,DNAAF2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3809603668852561,-0.7633090474525573,0.8837209302325582,1.0,1.0,6/19,23.39%,ALOX5;APOD;CHID1;ABCD2;PPARA;IL17D
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3675951176035802,-0.7631823960366589,0.8048780487804879,1.0,1.0,1/23,0.37%,CDKN2C
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.49888852772422376,-0.7630900331413899,0.7692307692307693,1.0,1.0,2/5,18.26%,CASP9;BAX
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.43712228274143927,-0.7630535575301548,0.7619047619047619,1.0,1.0,3/9,12.64%,PIWIL2;HENMT1;PIWIL4
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.49810390110234676,-0.7628243329724205,0.7333333333333333,1.0,1.0,1/5,7.50%,POLR1A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3662922313615682,0.7624890536692549,0.8125,1.0,1.0,1/29,0.86%,ZNF385B
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.2973536896213956,-0.7624754641506135,0.9347826086956522,1.0,1.0,6/71,7.91%,PODN;THY1;SFRP1;DACH1;DUSP3;FUZ
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.4705160515597241,0.7623037764663282,0.7291666666666666,1.0,1.0,1/7,10.46%,RAP1GDS1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.37196347993403517,0.76163931545215,0.8064516129032258,1.0,1.0,2/18,3.98%,NEDD4L;SLC4A4
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.3936606915021041,0.7613812055711876,0.8571428571428571,1.0,1.0,1/15,2.61%,RACGAP1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.4763127034159921,-0.7609939933223276,0.723404255319149,1.0,1.0,1/5,8.77%,WNT5A
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.4559014849057958,-0.7606708675214657,0.76,1.0,1.0,1/7,9.03%,DHODH
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.49789274153915214,0.7602109365280105,0.8148148148148148,1.0,1.0,1/5,14.80%,ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.45089998310659674,0.7598278825527989,0.7735849056603774,1.0,1.0,5/7,36.49%,STAT3;EIF4G1;AGO2;TNRC6B;EIF4ENIF1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.45089998310659674,0.7598278825527989,0.7735849056603774,1.0,1.0,5/7,36.49%,STAT3;EIF4G1;AGO2;TNRC6B;EIF4ENIF1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3785243916188421,-0.7594888706235867,0.825,1.0,1.0,1/22,0.37%,CDKN2C
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.34369749917877035,-0.7593896910141589,0.8936170212765957,1.0,1.0,11/36,16.00%,ASAH1;SMPD1;GBA3;NEU1;NEU4;GM2A;ST6GALNAC3;SUMF2;NEU3;B4GALT6;SMPD3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.4809117565062727,-0.7590436425646419,0.7674418604651163,1.0,1.0,2/5,6.54%,CXCL12;SELENOS
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.28481172263145604,0.7586532089891437,0.9833333333333333,1.0,1.0,35/154,19.43%,SOX9;SRF;KITLG;MMD2;ASXL2;TIAM1;LMO3;GCNT2;RIPOR2;CDS1;SLC6A6;ZBTB16;NRCAM;SIN3A;BMP7;RANBP3L;MMD;WDFY2;ZHX3;CAMK1;MAPK12;IL6ST;MACROH2A1;GJA1;TP63;IL6R;CSF1;NELL1;PDPN;PCP4;SMAD4;PPARG;AAMDC;ABL1;LRRC8A
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.388894687183109,0.7585327089544103,0.7966101694915254,1.0,1.0,1/16,2.31%,TUFT1
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.4095867726563773,-0.7585273626866971,0.75,1.0,1.0,1/8,2.06%,BAD
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.44215596816793185,-0.7582748211547068,0.7142857142857143,1.0,1.0,4/7,25.67%,LRP1;PPARA;NR1H2;NR1H3
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.390981411456794,0.7581826878047722,0.8846153846153846,1.0,1.0,2/20,4.92%,ALG6;B3GNT5
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.2933298856380027,0.7581677525202275,0.9322033898305084,1.0,1.0,18/92,15.24%,PTPRR;ZMYND8;DUSP22;PTPRJ;PHLDB2;TCAF1;VCL;SULF1;SRGAP3;TPM1;EPHA4;PTPRG;CHRD;ACVR1C;GJA1;ITGB1BP1;PTPRU;MAGI2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.3462398620110625,0.7580521238808268,0.8367346938775511,1.0,1.0,5/34,11.75%,WNT7A;SHANK3;MAPK8IP2;PHACTR1;DLG4
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.3894760010718769,-0.7580068848375401,0.8679245283018868,1.0,1.0,3/17,14.73%,WTIP;NEK8;MOB3B
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.4619353280761975,-0.7578696242336042,0.7446808510638298,1.0,1.0,1/6,9.17%,RFWD3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4832926413203236,0.7578257816869272,0.8333333333333334,1.0,1.0,4/6,30.21%,PDE3B;CYP1B1;JAM3;WNK1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.4331578777148481,0.7570956082607954,0.7719298245614035,1.0,1.0,5/10,23.21%,GRM3;AKAP5;ADGRV1;PALM;GNAI3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.43717440383630546,-0.7569022614394931,0.8444444444444444,1.0,1.0,1/6,2.06%,BAD
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.37383947307360066,0.7567906076851696,0.847457627118644,1.0,1.0,4/24,14.77%,DIP2B;KIAA0319;TRIM46;MAG
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.3093589752799073,-0.7564693358178337,0.918918918918919,1.0,1.0,4/46,6.07%,HSD17B10;KIF25;KRT10;FARSA
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.3618479555061187,0.7563569456776705,0.7666666666666667,1.0,1.0,2/17,5.87%,EDNRA;ADCY5
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.42384230585989513,0.7561537288577365,0.7903225806451613,1.0,1.0,3/11,10.70%,OPALIN;DAAM2;HES1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.4046067023166607,-0.7560737665213033,0.8181818181818182,1.0,1.0,5/17,26.16%,CHMP2A;TARDBP;NSFL1C;CHMP7;TOR1B
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.33364333997635953,-0.7556894749569558,0.8367346938775511,1.0,1.0,7/44,10.38%,MT2A;GAPDH;IRF3;RPL13A;HLA-B;WNT5A;CD44
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.3455549242176831,-0.7554482211974409,0.8292682926829268,1.0,1.0,2/25,6.53%,CLTB;CANX
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3527729717526046,-0.75529647906634,0.7906976744186046,1.0,1.0,3/23,11.11%,USP51;NUDT16L1;KMT5B
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.3696704665316826,-0.7552610724614477,0.8888888888888888,1.0,1.0,4/20,17.70%,PEX11A;MFF;FIS1;ABCD2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.3330858571431454,0.7545893311401932,0.8181818181818182,1.0,1.0,9/37,20.79%,TYRO3;NMI;TIRAP;PARP9;IRF1;APPL2;SAMHD1;POLR3B;POLR3G
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.45918285121239133,-0.7545229935365714,0.7777777777777778,1.0,1.0,2/8,7.52%,B3GAT2;XYLT2
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.309277458560402,-0.7543043479584071,0.8780487804878049,1.0,1.0,8/66,9.59%,PRDX5;IDH1;RBP1;IDI1;PEX11A;PIPOX;FADS1;ABCA6
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.45909233358513923,0.7541923187192244,0.7636363636363637,1.0,1.0,3/7,23.77%,CSF1;AGT;NFKB1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.42671402992765894,0.7539802540248532,0.75,1.0,1.0,1/8,2.87%,ST18
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3938498287611575,0.7536675439248509,0.7843137254901961,1.0,1.0,4/18,15.60%,SPRED2;EFNA1;USF3;OVOL2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.3974965839023864,-0.7534469680531614,0.7692307692307693,1.0,1.0,2/11,4.53%,ICMT;AGBL1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3735783718033464,0.7534375555510724,0.8148148148148148,1.0,1.0,5/24,12.09%,HTR2C;GPR18;GNA14;GRM1;P2RY12
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.34458545172641536,0.7533971660430885,0.8545454545454545,1.0,1.0,7/30,15.14%,MEF2D;LAMA2;CAV3;CHD2;SGCA;MAPK12;LARGE1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.47227133055280435,0.7532613021368639,0.8135593220338984,1.0,1.0,2/6,29.25%,NTNG1;PXDN
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.47225058199707026,0.7532363264269499,0.8431372549019608,1.0,1.0,1/6,23.78%,KDM2B
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.3232645635536029,-0.7531423930939537,0.8181818181818182,1.0,1.0,5/35,8.72%,FARSA;QARS1;WARS2;SARS1;AARS1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.34145198976971824,-0.75310635913738,0.8333333333333334,1.0,1.0,9/35,16.35%,UBE2D4;STUB1;RNF126;TRAF5;PELI1;RNF168;RNF8;PRPF19;UBE2S
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.4571863098532735,0.7529324881507014,0.8076923076923077,1.0,1.0,1/6,5.77%,DOCK11
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.47537055731450706,0.7527111827030234,0.8148148148148148,1.0,1.0,2/6,13.23%,UFD1;SEC14L1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.36664678875325146,0.7526111402717607,0.8,1.0,1.0,6/24,18.50%,ADAMTS9;JAK1;RHOJ;PDPK1;FGF1;TJP1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.35783936504299196,-0.7523921316445568,0.8571428571428571,1.0,1.0,5/24,6.44%,MT3;SEMA5B;SEMA4F;SEMA4C;RNF6
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.5084232812357163,0.7522166842977648,0.8863636363636364,1.0,1.0,1/5,11.33%,EPHA4
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.42751899291241824,0.752166205031684,0.7307692307692307,1.0,1.0,3/10,27.28%,IRF1;UBE2K;PYHIN1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.4409044340147237,0.7520797341422489,0.8125,1.0,1.0,1/8,9.87%,RAB11FIP5
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.46056130291149244,0.7520787291031578,0.8214285714285714,1.0,1.0,1/9,6.41%,MID2
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.45533941720896437,-0.7515121979869406,0.7954545454545454,1.0,1.0,1/7,0.67%,SIRT2
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3257042062326729,0.7512345112655807,0.82,1.0,1.0,10/36,22.39%,PARN;PARM1;ATM;TNKS;HMBOX1;MAPKAPK5;NEK7;MAPK1;NAF1;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.4690708809481723,0.7511674960532227,0.8367346938775511,1.0,1.0,1/8,3.96%,RNF157
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.30827385111853467,0.7510703098699602,0.9180327868852459,1.0,1.0,9/63,13.76%,SOX9;WNT7A;NR4A3;FGF9;PRKCA;PROX1;PTPRN;PIK3CD;AKT3
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.42667227629867854,-0.7509295858510959,0.7894736842105263,1.0,1.0,1/8,7.62%,NGF
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.4196633442564139,-0.7508782630499554,0.7555555555555555,1.0,1.0,1/9,1.06%,RHOC
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.3280235825004548,0.7507020454292975,0.8888888888888888,1.0,1.0,6/39,12.56%,RFC4;NEIL2;WRN;RPA1;LIG3;NEIL1
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.4733716410290121,0.7505849782151016,0.8823529411764706,1.0,1.0,3/6,17.88%,CAV3;MLIP;SMAD4
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.4359162014186093,-0.7505547808732366,0.7906976744186046,1.0,1.0,1/8,1.91%,FGD3
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.3843590114517583,-0.7505249338256058,0.8222222222222222,1.0,1.0,4/12,14.57%,CD63;LIMS1;SLC2A10;TIMP1
prerank,PanglaoDB_Augmented_2021__Monocytes,0.34792726238154514,0.7505089570150585,0.864406779661017,1.0,1.0,3/33,7.97%,PTPRC;SPI1;NAAA
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.35343472505737905,-0.7504563245251349,0.8181818181818182,1.0,1.0,4/22,17.70%,SLC27A6;ACOX1;TECR;ABCD2
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.4358386408948293,0.7503881801256324,0.8,1.0,1.0,1/9,8.29%,SH3PXD2B
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.4465310743264388,-0.7499216693998463,0.7209302325581395,1.0,1.0,2/7,17.85%,CAV1;ADIPOR1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.5087944665756946,0.7496683925227274,0.819672131147541,1.0,1.0,3/5,20.18%,PEX16;SERINC1;ANK3
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.3829475858050345,0.7496405135437972,0.7547169811320755,1.0,1.0,10/17,34.18%,AGO1;AGO4;CNOT7;TNRC6A;TNRC6C;MOV10;NRDE2;AGO3;AGO2;TNRC6B
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.4427606679598235,0.7495165655176069,0.7704918032786885,1.0,1.0,1/6,8.98%,RABGGTB
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.3353438247931644,0.7494584098513616,0.8727272727272727,1.0,1.0,5/28,12.94%,YWHAH;SCN8A;GNA14;SCN2A;KCNMB4
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.33116059251867824,0.7492896949560187,0.875,1.0,1.0,9/49,11.96%,EFNA5;MACF1;EMP2;PLET1;CDKN2A;VCL;CDK6;TSC1;PLEKHA2
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.5354597693170718,-0.7492703049554046,0.825,1.0,1.0,3/5,13.52%,THY1;CD44;FLOT1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.39007646898818515,-0.7492376032629644,0.8604651162790697,1.0,1.0,5/14,14.53%,ASAH1;CDC37;STUB1;FLOT1;PELI1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.33457312279534746,-0.748808793515053,0.813953488372093,1.0,1.0,7/32,12.11%,PEF1;SEMA5B;SEMA4F;SEMA4C;SEMA5A;SOX8;KLHL12
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.3256472795932651,-0.7484353148418271,0.9210526315789473,1.0,1.0,10/36,19.63%,RANGRF;RHOG;CLIP3;EPB41;ZDHHC8;LRP1;NUMA1;GNAI1;AKT1;WNK3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.4588055155332339,-0.7484187573368556,0.8085106382978723,1.0,1.0,1/7,5.24%,LIN7C
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.4500993767443551,-0.7481503482144387,0.8444444444444444,1.0,1.0,3/8,12.12%,ASAH1;SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.4500993767443551,-0.7481503482144387,0.8444444444444444,1.0,1.0,3/8,12.12%,ASAH1;SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.3127042749170239,-0.7473761116015989,0.925,1.0,1.0,8/55,10.84%,HSD17B10;SLC25A44;ACAD8;DLD;PIPOX;PHYKPL;AADAT;ALDH4A1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.35432865109535494,0.7473341654287369,0.864406779661017,1.0,1.0,9/30,25.33%,ARHGAP24;RIPOR2;SYNGAP1;ARHGAP35;ABL2;TGFB2;DAB2IP;ARHGAP44;STMN3
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.4143068573684803,-0.7471182473406222,0.7647058823529411,1.0,1.0,2/9,6.90%,GABARAPL2;MAP1LC3A
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.4143068573684803,-0.7471182473406222,0.7647058823529411,1.0,1.0,2/9,6.90%,GABARAPL2;MAP1LC3A
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.36120273773261735,-0.7469679873911049,0.8936170212765957,1.0,1.0,1/21,3.30%,NME3
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.2861979206654037,0.7469600152134146,0.953125,1.0,1.0,26/120,21.84%,PTPRC;PTPRB;PTPRR;PTPRJ;DUSP4;SSH2;PLPP4;TAB1;DUSP8;DUSP1;FBXW11;STK11;PTPRG;PTPRU;MTMR7;MTMR3;ALPL;PPP2R5C;PPM1F;DUSP6;PPP2R5E;PLPPR5;PTPRT;PTPRE;PPP4R2;PPP3CA
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.40162919381300577,0.7467020873691329,0.8035714285714286,1.0,1.0,4/14,13.87%,CAV3;NOS1;PXK;SNCA
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.4428661112429488,0.7465592040555119,0.78,1.0,1.0,1/5,23.23%,MAPT
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.3544048689261248,-0.746549566503636,0.7777777777777778,1.0,1.0,6/25,16.79%,LSM1;PRPF8;SLU7;SMNDC1;SRSF10;KHSRP
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4944174442180399,-0.7465037972589652,0.7916666666666666,1.0,1.0,2/5,21.06%,AKT1;PPARA
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.25570081946551054,-0.7462574627274063,1.0,1.0,1.0,22/151,16.45%,POLR2L;GAPDH;ATF4;MALT1;TLR1;IRF3;IL12RB2;MAPK13;TNFRSF14;WNT5A;SPHK2;AFAP1L2;POLR2K;POLR2E;ZP3;FLOT1;IL18;CRCP;ISG15;DHX33;LAMTOR5;PARK7
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.3730101093129222,0.7462027149391335,0.76,1.0,1.0,1/17,6.19%,CECR2
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.40945933852641736,0.7458624214905848,0.7307692307692307,1.0,1.0,7/12,37.71%,CPSF6;NRDE2;SETD2;IWS1;NUP153;NSUN2;NCBP2
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.3277402582807285,0.7458553011417859,0.9615384615384616,1.0,1.0,10/57,11.46%,ITPR1;TRPC4;LRP2;NIPAL2;PSEN1;SLC30A9;RYR2;ATP2B2;RYR3;CACNG8
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4217929627376075,-0.7455367227955642,0.8723404255319149,1.0,1.0,4/10,21.06%,APOD;CHID1;ABCD2;PPARA
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.4438373979827987,-0.7455256799731437,0.8181818181818182,1.0,1.0,1/8,1.92%,AGRN
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.48968514871894536,0.74548288868502,0.7959183673469388,1.0,1.0,2/6,3.49%,HEY2;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.37371664296701557,0.7453039491593505,0.8653846153846154,1.0,1.0,10/24,26.74%,CAV3;SSH2;SHANK3;SMAD4;TJP1;ARFGEF1;CLASP1;PIK3CA;SSH1;PRKN
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.3344800370886408,0.7452964122433707,0.8727272727272727,1.0,1.0,7/61,8.49%,EFNA5;FAM107A;RAC3;PAK1;BAIAP2;ARHGAP17;RHOBTB2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.3690796062713081,-0.7452047677494777,0.8666666666666667,1.0,1.0,3/17,10.12%,TIPRL;PPP1R11;YWHAB
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.30617309367269024,0.745185624927467,0.9152542372881356,1.0,1.0,10/79,9.52%,EFNA5;FAM107A;RAC3;PAK1;BAIAP2;PHLDB2;ARHGAP17;RHOBTB2;CYLD;PAK2
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.35406010072444194,0.7449992399798824,0.8360655737704918,1.0,1.0,7/24,20.60%,OTUD7B;RIPK1;RORA;PER1;TLE1;NLRP12;USP10
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.3797663356162393,0.7446577570469767,0.8833333333333333,1.0,1.0,6/24,20.14%,AKT2;CALCOCO2;C2CD5;FYCO1;STX18;PPARGC1A
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.47647224571557273,0.7445705348063608,0.8166666666666667,1.0,1.0,1/6,14.70%,IL6R
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.3507368545729509,-0.7442225107350331,0.825,1.0,1.0,3/21,5.75%,ACTG1;CAMSAP3;DUSP3
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.3371675657200723,-0.7438142290955494,0.8723404255319149,1.0,1.0,7/37,15.91%,ACTB;SMARCA5;CHD3;MTA2;ACTL6A;ACTR8;RNF8
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.4212688721012876,-0.7438074669840317,0.7884615384615384,1.0,1.0,3/7,20.65%,ZDHHC8;PRKACA;BMP1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.44212317628720743,-0.7437825268080034,0.7435897435897436,1.0,1.0,1/9,2.47%,ACTB
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.3592190826840448,-0.7436692463068958,0.7297297297297297,1.0,1.0,4/18,16.85%,RAB1B;RAP2C;RAPGEF3;MSN
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.4114097885401426,-0.7436376225695126,0.85,1.0,1.0,4/13,12.12%,SGPP1;ASAH1;SPHK2;SPTLC1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.28395712941901075,-0.7435947448851883,0.9090909090909091,1.0,1.0,18/101,14.55%,OLIG2;TCEAL7;PDGFD;HES5;SYNDIG1;SEMA5B;PTPRZ1;SHC3;PTN;DOK5;BRINP1;SPRY1;FAT3;NOVA1;NCAN;TMEM35A;TSPAN11;PTPN5
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.3945950113424961,-0.7435541667393296,0.7804878048780488,1.0,1.0,4/19,10.81%,SEMA5B;SEMA4F;SEMA4C;SEMA5A
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.43762961350542706,-0.7430275590768767,0.75,1.0,1.0,1/7,6.39%,PIK3C2G
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.32691732145687613,-0.7430049061601877,0.8536585365853658,1.0,1.0,6/29,11.95%,GAPDH;ATF4;TPI1;SLC25A1;G6PC3;PGAM1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.45740633401226205,-0.7428966138321834,0.82,1.0,1.0,2/7,13.99%,PAX8;BMP2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.4644005079879703,0.7426881860820458,0.8113207547169812,1.0,1.0,1/6,13.55%,AGK
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.31676923912590066,-0.7422513470516499,0.95,1.0,1.0,13/52,19.67%,ATP5F1A;ALOX5;VEGFB;WNT5A;CAV1;EMC10;SEMA5A;VASH1;BMP2;SCG2;AIMP1;AKT1;TEK
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.4854802255038339,0.7422182875986681,0.8245614035087719,1.0,1.0,2/5,30.02%,JCAD;FGF2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.31876755158119735,0.7419380173758949,0.8775510204081632,1.0,1.0,17/50,32.18%,BAIAP2;SULF1;PAK2;SHC2;DOCK1;PRKD2;PIK3CA;DAB2IP;MAPK11;NCK2;PIK3R1;FLT1;ITGAV;PTK2B;MAPKAPK2;PTK2;VAV2
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.3972763082678448,0.7419061421940487,0.7894736842105263,1.0,1.0,4/11,19.41%,FABP3;ACSL1;PPARG;SLC27A4
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.4825010361426827,0.7418838842801572,0.8103448275862069,1.0,1.0,3/5,32.16%,LOXL3;LOXL2;SUMF1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.37048614448704376,-0.74169714845828,0.8372093023255814,1.0,1.0,1/14,1.90%,ATF4
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.39733515894767946,0.7415031645422255,0.8679245283018868,1.0,1.0,2/12,10.93%,NNMT;AASS
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.3225102268222424,0.7414375663891674,0.9384615384615385,1.0,1.0,15/50,25.45%,SPRED2;TIAM1;PHLDB2;GCNT2;EFNA1;USF3;OVOL2;PDPN;SMAD4;TGFB2;BCL9L;CLASP1;DAB2IP;LOXL2;EPHA3
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.44969557620055733,-0.7407449701445095,0.717948717948718,1.0,1.0,3/5,16.85%,AR;NCOA4;MSN
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.44969557620055733,-0.7407449701445095,0.717948717948718,1.0,1.0,3/5,16.85%,AR;NCOA4;MSN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.36023637758730837,0.7401180867657374,0.8703703703703703,1.0,1.0,2/23,4.52%,YWHAH;NMT1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.4263014472070104,0.7398623419363677,0.8431372549019608,1.0,1.0,1/10,7.35%,TGFBR3
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.41598914659419356,-0.7395457185333962,0.8222222222222222,1.0,1.0,1/10,3.63%,SMPDL3A
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.3941039549489538,0.7393838033041178,0.8703703703703703,1.0,1.0,3/16,6.29%,DNAH7;CCDC39;ODAD4
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.30181957618661337,0.7393445514065544,0.9393939393939394,1.0,1.0,12/90,9.15%,PIP4K2C;KIAA1217;GCLC;GPRC5C;CMTM4;CDC42BPB;ARHGEF17;PARM1;CADPS2;FKBP9;CDS1;CEP170B
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.3449403327586421,-0.7392632226154303,0.8461538461538461,1.0,1.0,14/33,22.99%,IFIT2;IRF3;HLA-B;IFITM3;IFI6;ISG20;IFIT5;ISG15;XAF1;IP6K2;IFIT1;TYK2;OAS3;HLA-F
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.3449403327586421,-0.7392632226154303,0.8461538461538461,1.0,1.0,14/33,22.99%,IFIT2;IRF3;HLA-B;IFITM3;IFI6;ISG20;IFIT5;ISG15;XAF1;IP6K2;IFIT1;TYK2;OAS3;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.3356825012947684,0.7391434826574791,0.819672131147541,1.0,1.0,3/43,2.47%,DOCK5;NEDD9;RAC3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.37778848427960365,-0.738551977950719,0.8775510204081632,1.0,1.0,3/17,7.62%,BAG3;DELE1;NGF
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.33602558407119554,0.7385012371406301,0.8793103448275862,1.0,1.0,4/38,10.12%,POM121C;POM121;SLC2A6;NUP93
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.45236346674222844,-0.7378089276735847,0.8367346938775511,1.0,1.0,2/8,9.38%,CLU;GRN
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.45610711872320214,0.7376577815982441,0.7884615384615384,1.0,1.0,1/9,2.59%,AKT2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.39603442911199876,-0.7369317175941271,0.825,1.0,1.0,4/15,10.81%,SEMA5B;SEMA4F;SEMA4C;SEMA5A
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.31602154946583394,-0.7363690117492678,0.925,1.0,1.0,2/32,2.21%,HSD17B10;KIF25
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.2920228364168634,0.736203114017533,0.9508196721311475,1.0,1.0,21/114,14.13%,LIFR;ADGRL2;KITLG;GULP1;PRTG;FBLIM1;TENM3;SHROOM3;PARD3;TEAD1;SH3PXD2B;CD59;COL4A5;ROR1;HES1;MID1;RBFOX2;PTPRG;IL6ST;NAV2;GJA1
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.47334083180059083,-0.7356207622727403,0.7755102040816326,1.0,1.0,1/5,3.70%,MALT1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.4051462082084276,-0.7355318062836292,0.868421052631579,1.0,1.0,2/11,15.72%,ALOX5;CERS2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.38333052295462733,0.7352616729776339,0.8235294117647058,1.0,1.0,6/24,20.90%,PPIE;VAPB;CNOT7;SRPK2;PPID;LARP1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.3694236072235707,0.7352439124766681,0.8771929824561403,1.0,1.0,1/19,3.03%,TRPC4
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.33653567015395,0.7350140067720223,0.864406779661017,1.0,1.0,8/34,20.04%,RXRA;FOXP1;SPI1;RARA;PIK3CD;CSF1;PPARG;SRP54
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.34860674006991194,0.7344798059766742,0.8867924528301887,1.0,1.0,6/29,11.53%,LRRC19;SASH1;NMI;CD27;TRIM44;PTP4A3
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.38045391464271866,-0.7340798053100477,0.813953488372093,1.0,1.0,5/13,15.20%,SIRT2;IKBKB;PGAM1;RAD17;SMG5
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.29538473992773334,0.734030940669756,0.953125,1.0,1.0,12/79,13.77%,CALCB;PRKAR1B;ADCY5;TYRO3;CD247;PRKAR2A;MVK;GPR176;RORA;PLK2;AOAH;ADCY3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.4210082185633958,-0.73334609166048,0.8695652173913043,1.0,1.0,1/9,3.14%,TMBIM6
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.36265519042851063,0.7333433619258931,0.8245614035087719,1.0,1.0,6/16,28.97%,CSF1;PPARG;AGT;NFKB1;NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.3161518017845067,-0.7331120045156267,0.9230769230769231,1.0,1.0,4/40,5.70%,RPL10;PCIF1;VPS35;EDNRB
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.34683675240351813,0.7330102110460596,0.8412698412698413,1.0,1.0,3/37,7.18%,HEY2;KITLG;TEAD1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.4019458371711158,-0.7329713138394448,0.7954545454545454,1.0,1.0,2/11,5.75%,THY1;DUSP3
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.46416131795969584,0.7327826132782849,0.7924528301886793,1.0,1.0,1/5,22.85%,ENO1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.432322132633743,0.7324282653409306,0.8723404255319149,1.0,1.0,1/8,7.02%,PVR
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.36766281766941306,0.7320698706400579,0.8085106382978723,1.0,1.0,4/15,20.96%,MRAP;AP2M1;PPFIA1;PICALM
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.4437785443421755,0.7319660984792564,0.7758620689655172,1.0,1.0,5/7,39.59%,ZCCHC3;ANKRD17;PUM2;PUM1;USP15
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.4333126028609619,0.7318127216560427,0.8333333333333334,1.0,1.0,3/12,17.89%,SHLD2;TP53BP1;RIF1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.3018388659353087,0.7316332631962763,0.9393939393939394,1.0,1.0,13/69,17.18%,YWHAH;AKT2;SORBS1;NMT1;TCAF1;AKAP5;C2CD5;PDPK1;PPP1R13B;TP63;ITGB1BP1;PRKCE;DPP10
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.3736532207166851,-0.7311047666960202,0.9302325581395349,1.0,1.0,2/15,3.82%,LRRC8D;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.3978521348472315,-0.7310805495016157,0.7872340425531915,1.0,1.0,2/12,8.97%,PHF1;DNMT3B
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.37085756762046246,-0.730817243825772,0.8048780487804879,1.0,1.0,3/16,13.19%,CAV1;ZNF304;MYBBP1A
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.3369385119605306,-0.7307010489276267,0.9318181818181818,1.0,1.0,3/29,9.62%,FERMT1;PLEKHG5;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.3551131296358727,0.7305994568663302,0.8666666666666667,1.0,1.0,7/26,17.89%,UBR5;SHLD2;TP53BP1;HELB;POLQ;RNF169;RIF1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.35571697857088375,-0.7304671459043809,0.8095238095238095,1.0,1.0,1/20,3.46%,NT5E
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.2631501693897491,-0.7300230759580815,1.0,1.0,1.0,20/100,16.87%,GSTP1;WNT3;H2AZ1;SFRP1;SELENOS;LYN;WNT5A;SPHK2;CACTIN;ADCY6;BRINP1;AR;WNT7B;RUVBL2;NFKBIL1;CDC73;CFTR;NCOA4;MSN;GNAI1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.35095264887921235,0.7298705683838226,0.8360655737704918,1.0,1.0,9/27,23.05%,STMN2;TBCD;TTBK2;SNCA;ATXN7;TAOK1;CAMSAP2;CLASP1;NAV3
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.31857592550853575,0.729463041011995,0.9482758620689655,1.0,1.0,11/54,14.47%,GADD45A;PKIG;PRKAR1B;PTPRJ;CAV3;CDKN2A;PRKAR2A;BMP7;DUSP1;MACROH2A1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.38517787682688687,0.7293465141094925,0.7272727272727273,1.0,1.0,3/14,18.06%,PDPK1;AKT3;PPARG
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.30305940794726166,0.7290193714453116,0.9615384615384616,1.0,1.0,14/77,14.26%,BCL2L11;IGF1R;NEDD4L;ATP10A;RELN;CAMK2B;SHANK3;BMP7;TIRAP;CALY;CAMK1;SNCA;ASAP1;GNL3L
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.43200800965021513,-0.728894921563193,0.7804878048780488,1.0,1.0,3/7,21.07%,MUS81;MCM4;MCM7
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.46464980565316394,-0.7288756032142069,0.864406779661017,1.0,1.0,2/6,9.09%,FADS3;FADS1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.3788122454744948,-0.7281619001077334,0.8157894736842105,1.0,1.0,3/11,23.17%,CHMP2A;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.3007026104537732,-0.7278727354922154,0.95,1.0,1.0,9/47,17.27%,BANF1;PPIA;IFITM3;SHFL;RAD23A;ISG20;IFIT5;ISG15;SRPK1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.42785627115502645,0.7278106897043147,0.8524590163934426,1.0,1.0,3/8,31.72%,TAMM41;PNPLA8;LCLAT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.3584042712069692,0.7277444325903111,0.8679245283018868,1.0,1.0,6/20,15.69%,PKP2;CAV3;RYR2;DSC2;CAMK2D;ANK2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.2850111462812457,-0.727719921649017,0.9714285714285714,1.0,1.0,5/58,8.77%,UBB;VPS35;CLU;SIGMAR1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.3001654398950569,0.7276926255823836,0.8688524590163934,1.0,1.0,13/68,18.70%,PON1;TIAM1;PSEN1;HES1;PARP9;RARA;TAF1;HMBOX1;STK3;MED25;DTX3L;PPARG;SPPL3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.41175908871819455,-0.7272810339396132,0.8235294117647058,1.0,1.0,2/11,13.52%,SNCAIP;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.33471599718609657,-0.7271698851671742,0.8461538461538461,1.0,1.0,8/30,18.06%,SIRT2;ATRAID;TIMP4;CST3;TIMP2;TIMP1;SNX12;PIN1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.3593610772472688,-0.7269903405890582,0.9347826086956522,1.0,1.0,2/16,5.27%,FABP7;FABP5
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.48572922336050883,0.7269543875205494,0.8275862068965517,1.0,1.0,2/5,22.16%,PPARG;PARP14
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.48572922336050883,0.7269543875205494,0.8275862068965517,1.0,1.0,2/5,22.16%,PPARG;PARP14
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.43868990565622895,-0.7264269324815184,0.75,1.0,1.0,1/8,5.21%,PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.3343447113110121,-0.7262575797160032,0.8863636363636364,1.0,1.0,6/32,18.87%,GABARAPL2;DYNLL2;PFN1;DNAJC24;DYNLL1;CHTOP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3580227271355948,-0.7262443271583959,0.8636363636363636,1.0,1.0,2/16,8.15%,CALM1;CALM3
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.29997741166921454,-0.726170844013983,0.9069767441860465,1.0,1.0,7/34,16.92%,RPS19;LYN;SLC25A5;UFL1;HSPA9;RPS14;PRDX3
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.2703036357062287,-0.7261235060598904,1.0,1.0,1.0,11/81,13.00%,HSD17B10;KIF25;JMJD6;RNF112;ALAD;SIGMAR1;CHMP2A;CRYZ;MCOLN1;PRMT1;B2M
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.38810545313919403,-0.725635847983735,0.8703703703703703,1.0,1.0,5/17,11.59%,ACTG1;ACTB;LIN7C;LAMA5;SOX8
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.4540460567021992,0.7254144234516006,0.8333333333333334,1.0,1.0,3/5,20.96%,EFNA1;EPHA4;PICALM
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.43947286308053457,-0.7251492328147636,0.75,1.0,1.0,1/5,6.17%,ATCAY
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.3032846170214822,-0.7247275203168876,0.9111111111111111,1.0,1.0,14/50,21.82%,H1-4;SMARCA5;SET;H1-10;NPM1;SMARCD1;RNF8;H3-3A;ZNHIT1;H2AX;ANP32B;KAT6B;PAF1;ASF1A
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.3215789392927038,0.7246541766832371,0.8983050847457628,1.0,1.0,6/42,11.22%,FBXO31;EME2;ATM;BRCA1;RAD9A;BABAM2
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.4579918917993441,0.7246494270859846,0.8596491228070176,1.0,1.0,2/7,6.69%,GCLC;CHAC2
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.4579918917993441,0.7246494270859846,0.8596491228070176,1.0,1.0,2/7,6.69%,GCLC;CHAC2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.4282763171019399,0.724333655145626,0.7884615384615384,1.0,1.0,2/8,9.72%,RIPK1;ATM
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.45080213903743316,-0.7240303467304792,0.813953488372093,1.0,1.0,5/5,54.94%,SNRPC;PSIP1;SRSF12;PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.3937161435945056,0.7238288471327421,0.7843137254901961,1.0,1.0,4/15,16.95%,STN1;GNL3L;TENT4B;EXOSC10
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.37663902760067347,-0.7237459966775959,0.8695652173913043,1.0,1.0,2/15,8.03%,ATF4;SARS1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.4505573393913265,0.7232589546131296,0.8571428571428571,1.0,1.0,1/6,18.04%,RYK
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3181281876080437,-0.7231060959914203,0.9444444444444444,1.0,1.0,3/42,7.62%,UBB;MAP1S;NGF
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.3442612972774454,0.7225921848313538,0.7543859649122807,1.0,1.0,3/26,5.14%,PLXNA4;SEMA3A;SEMA4B
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.41414135272470276,-0.7221289965402564,0.8055555555555556,1.0,1.0,1/8,1.90%,ATF4
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.452116418370804,0.7221074585676408,0.8113207547169812,1.0,1.0,2/5,27.10%,MAGI2;IQGAP1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.452116418370804,0.7221074585676408,0.8113207547169812,1.0,1.0,2/5,27.10%,MAGI2;IQGAP1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.44195951027988156,0.7220712052837301,0.8775510204081632,1.0,1.0,3/8,12.09%,RYR3;TAF1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.3642580119870974,-0.7220343101843065,0.8809523809523809,1.0,1.0,5/19,14.05%,PIH1D1;WBP2;SPHK2;BRD7;RUVBL2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.3910803908990086,0.7216175874615145,0.8703703703703703,1.0,1.0,2/12,10.87%,ATM;TNKS
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.4324078930494951,0.7215600456937526,0.7924528301886793,1.0,1.0,3/11,17.89%,SHLD2;TP53BP1;RIF1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.35236411062299866,0.7214787325754719,0.9152542372881356,1.0,1.0,2/23,3.49%,FOXO1;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.36184699877545723,-0.7214663354206444,0.7674418604651163,1.0,1.0,1/10,9.03%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.36184699877545723,-0.7214663354206444,0.7674418604651163,1.0,1.0,1/10,9.03%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.36184699877545723,-0.7214663354206444,0.7674418604651163,1.0,1.0,1/10,9.03%,ANAPC11
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.36306580148688683,-0.7214535584773766,0.7954545454545454,1.0,1.0,3/18,12.52%,MT3;COQ10A;SDHAF4
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.456121005900727,-0.7211311193793065,0.8085106382978723,1.0,1.0,2/5,22.20%,ENPP3;DCTD
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.43889986631670974,-0.7207900191117039,0.8478260869565217,1.0,1.0,3/6,34.59%,CMPK1;AK8;AK5
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.433381676254181,0.7207478649923378,0.8,1.0,1.0,3/9,13.09%,STAT4;JAK1;IL6ST
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.38566386095304195,-0.7207076085819064,0.8043478260869565,1.0,1.0,2/12,14.84%,NEU3;UBQLN2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.44371657754010696,-0.7206905067452807,0.8333333333333334,1.0,1.0,5/5,55.65%,TTPA;PLEKHA3;GLTP;CERT1;PLEKHA8
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.3744668669035014,-0.7205481599094942,0.8421052631578947,1.0,1.0,1/14,3.33%,POLR2G
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.27043647186176134,-0.7203378976786565,0.975,1.0,1.0,14/70,14.09%,BAD;BEX3;MALT1;ARL6IP5;PDCD5;NGF;AIFM1;NLRP1;MTCH1;FIS1;PRR7;RACK1;CASP9;SMAD3
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.30795368597197514,-0.7195556601614024,0.9024390243902439,1.0,1.0,7/58,11.91%,GSTP1;PDGFD;LYN;SMPD1;SPRY1;TRIB3;UCHL1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.34061054670219193,-0.7194341258295002,0.8409090909090909,1.0,1.0,1/15,4.59%,SYT11
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.38008384069594126,0.7194338866520366,0.8518518518518519,1.0,1.0,5/11,22.39%,CAMK1D;MPP1;CSF1;MAPK1;MAPK3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.40313055857510527,-0.7191676069335713,0.7916666666666666,1.0,1.0,5/10,29.07%,TALDO1;DERA;PGM2;PGLS;RPIA
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.4725668738219248,0.7188228383737121,0.8360655737704918,1.0,1.0,1/6,4.39%,MCEE
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.3533565793412399,-0.7187957128134403,0.8157894736842105,1.0,1.0,3/15,18.22%,RPF1;MPHOSPH6;C1D
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.4077681234644158,0.7187945808107268,0.7966101694915254,1.0,1.0,2/12,12.82%,SLC25A18;GPD2
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.35817662432936664,-0.7182951699345765,0.8723404255319149,1.0,1.0,1/14,2.45%,TCTA
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.4477015677413612,0.7182623323640114,0.8148148148148148,1.0,1.0,4/5,25.83%,ALDH7A1;CHDH;SLC44A1;DMGDH
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.37588024393265573,0.7180350320906679,0.90625,1.0,1.0,1/16,1.61%,BAG5
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.4065443400438642,0.7176840037247265,0.8846153846153846,1.0,1.0,3/10,15.30%,CAMK1D;IL6R;MTUS1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.3012560110061495,-0.7174730600687408,0.9574468085106383,1.0,1.0,2/45,5.19%,GPR17;TNFAIP1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.43251565002746145,0.7174291878510232,0.8181818181818182,1.0,1.0,1/9,4.06%,TENM3
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.3737901061455531,-0.7173862204593365,0.86,1.0,1.0,2/16,8.97%,PIH1D1;DNMT3B
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.2946165591562995,0.7172185975936501,0.9423076923076923,1.0,1.0,17/72,18.06%,ACACB;RXRA;NCOA1;NFYC;GPAM;SIN3A;MVK;RORA;CCDC3;MACROH2A1;SREBF1;ACACA;LACTB;BBS4;NCOR1;NCOA2;PPARG
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3773115094841737,-0.7171200701695672,0.7647058823529411,1.0,1.0,2/14,5.21%,PDGFD;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.3947412514575723,-0.7167971547242672,0.8703703703703703,1.0,1.0,2/13,5.63%,PKIB;NABP2
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.41154069516811337,-0.7164143280298417,0.8333333333333334,1.0,1.0,3/13,12.40%,SMC1A;REC8;DSCC1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.2614017606740246,-0.7163915957962886,0.9210526315789473,1.0,1.0,24/130,18.36%,SFR1;UBXN1;PAXX;PARP1;NABP2;SMARCA5;KPNA2;AP5Z1;RFWD3;PARP2;DDX1;TDP2;ZFYVE26;RNF168;ACTR8;RNF8;FAN1;PRPF19;VCP;SUMO1;REV3L;EXD2;ABRAXAS1;UBE2N
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.4409756274185423,-0.716200929515849,0.8367346938775511,1.0,1.0,1/6,3.93%,BRPF3
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.3057575719960866,0.7160978320339205,0.9454545454545454,1.0,1.0,10/60,17.17%,FOXO1;NEDD4L;ATG7;HACE1;STX5;WWP1;PLK2;WWP2;BARD1;HECW2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.39232313189797885,-0.7160188665156572,0.8627450980392157,1.0,1.0,2/10,16.83%,GNPNAT1;UAP1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.39232313189797885,-0.7160188665156572,0.8627450980392157,1.0,1.0,2/10,16.83%,GNPNAT1;UAP1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.39232313189797885,-0.7160188665156572,0.8627450980392157,1.0,1.0,2/10,16.83%,GNPNAT1;UAP1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.4185056294213171,0.7158286043418839,0.8235294117647058,1.0,1.0,1/9,8.74%,VCL
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.41550745622594076,-0.7153797149203002,0.782608695652174,1.0,1.0,2/8,8.75%,SLC31A1;COX17
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.40562276144542253,0.715316872373965,0.8333333333333334,1.0,1.0,6/14,32.30%,RORA;FOXK2;PDK2;PRKN;GNB3;FOXK1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.4551804964533212,-0.7151621865613964,0.8269230769230769,1.0,1.0,2/6,16.45%,NONO;PARK7
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.37697523789760246,-0.7149163887422562,0.7777777777777778,1.0,1.0,5/15,18.90%,VPS35;MFF;FIS1;RALBP1;MUL1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.30749778934369476,0.7147308325784627,0.9298245614035088,1.0,1.0,8/50,13.26%,SOX9;PTPRR;ERBIN;PRKCA;NRG4;PDPK1;SOS1;NRG2
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.3212495487569022,-0.7141362437774962,0.8913043478260869,1.0,1.0,3/32,7.08%,SALL2;HES5;HIPK1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.42016071925449017,0.714076412740262,0.8135593220338984,1.0,1.0,3/12,17.89%,SHLD2;TP53BP1;RIF1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.32471403764326606,-0.7139745419490412,0.918918918918919,1.0,1.0,12/38,22.53%,ERN1;DXO;NUDT16L1;RNH1;DDX5;MRTO4;RC3H1;SUPV3L1;HSPA1A;NBDY;METTL3;LSM2
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.31758034602385504,0.7133228506873325,0.9322033898305084,1.0,1.0,5/45,8.16%,RAB17;EPS15;WASHC1;VPS52;CCDC93
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.43566942551934823,0.7132897368994614,0.8301886792452831,1.0,1.0,5/10,30.21%,NOS1;ANK3;DMD;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.4627625705157153,0.7132045228406849,0.8727272727272727,1.0,1.0,1/5,3.26%,LMBR1L
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.48038970973153594,0.7131463834338057,0.8541666666666666,1.0,1.0,3/5,38.88%,F8;A2M;KLKB1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.35194271565114055,0.7131094987673594,0.9056603773584906,1.0,1.0,5/23,15.85%,PAK1;GPAM;BRCA1;CBFB;UBA5
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.41385003817609567,-0.713042326536768,0.8235294117647058,1.0,1.0,2/10,6.67%,CCT5;CCT3
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4672910130842288,0.7129173887622028,0.8596491228070176,1.0,1.0,3/8,17.10%,RIPOR2;CAMK1;EHD1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.4406869776929967,0.7128010873275687,0.8412698412698413,1.0,1.0,3/9,18.63%,PGAP1;SCFD1;STX18
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.44964577132116224,0.7127565047574488,0.8571428571428571,1.0,1.0,1/5,9.13%,SHANK3
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.43527874536186717,-0.7125850913345698,0.8409090909090909,1.0,1.0,3/8,17.25%,PPAT;PRPSAP1;PRPSAP2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.28497077367694423,0.7118004793792516,0.9814814814814815,1.0,1.0,6/72,5.41%,IGF2BP3;IGF2BP2;ZNF540;DAPK1;PUS7;RTN1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.41397372008633926,-0.7117668931593505,0.8571428571428571,1.0,1.0,3/10,13.52%,THY1;CD44;FLOT1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3921137056024293,0.7117134171349219,0.7931034482758621,1.0,1.0,1/12,5.89%,ADSS2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.4578728860719195,0.7112621387824117,0.88,1.0,1.0,2/7,12.82%,CDKN2A;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4375414940958269,-0.7111568909025704,0.8947368421052632,1.0,1.0,3/10,12.32%,FUZ;SPRY1;GPC1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.4669327993054881,-0.7109762319890147,0.8260869565217391,1.0,1.0,2/5,11.79%,NLRP1;CAPN1
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.4195116206303285,0.7108831234541741,0.8604651162790697,1.0,1.0,1/8,9.64%,BMP7
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.35704591471924596,-0.7108661738637048,0.8775510204081632,1.0,1.0,6/22,17.81%,YAP1;WBP2;CAV1;AR;CATSPERD;ABHD2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4111161797595869,0.7108659867305824,0.8360655737704918,1.0,1.0,2/10,13.76%,PDPK1;AKT3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.3722667833059332,-0.7105972095197967,0.8478260869565217,1.0,1.0,2/13,8.15%,CALM1;CALM3
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.37370790821762173,0.7105274213255032,0.875,1.0,1.0,1/9,2.70%,WNT7A
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.3622787891774201,0.7105074262775664,0.7962962962962963,1.0,1.0,5/16,13.38%,ENPP2;PLA2G15;ABHD12B;ABHD12;SMPD4
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.3194283288085399,0.7099773894318848,0.8840579710144928,1.0,1.0,6/35,13.97%,RAB17;DOCK11;RIPOR2;BCAS3;TENM2;DMTN
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.36020231632993294,-0.7097403973781938,0.82,1.0,1.0,5/19,14.41%,SVIL;MAP10;GIPC1;CENPV;CDC42
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.43858384409683837,0.709058596878987,0.8771929824561403,1.0,1.0,4/6,27.02%,GLDC;SHMT1;RIDA;GLYAT
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.24900647132024684,-0.7087683622637221,1.0,1.0,1.0,33/236,12.90%,CALR;GAPDH;TMBIM6;PCIF1;DHFR;STOX1;PHF1;SH3GL2;SYT11;FXR2;ERN1;SFRP1;YAP1;TIPARP;ERP29;RPL13A;PPP1R11;DXO;ASB1;CREBZF;NUDT16L1;RNH1;DNMT3B;CENPV;RPS13;ANXA7;EIF4A3;NCL;YBX1;SLC2A10;TARDBP;MRPL13;LRP3
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.4199564301252302,0.7087618899186012,0.9,1.0,1.0,5/6,45.60%,PRMT7;PCGF3;DNMT3A;PCGF5;MECP2
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.4604121770997744,-0.7086726882411912,0.8205128205128205,1.0,1.0,1/5,11.18%,ATP5F1D
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.3439006869361333,-0.7083625467157072,0.9024390243902439,1.0,1.0,7/21,15.72%,ASAH1;SMPD1;SPTLC1;SAMD8;ST6GALNAC3;B4GALT6;CERS2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.34724165631046944,-0.7081710819489976,0.8333333333333334,1.0,1.0,2/21,7.08%,SALL2;HIPK1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.3537443684675345,-0.7078155451305946,0.8421052631578947,1.0,1.0,4/13,25.40%,CHMP2A;CHMP5;CHMP7;RHOA
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.29930988458874125,-0.7074980791034311,0.918918918918919,1.0,1.0,8/52,15.11%,RANGRF;ACTB;RHOG;CLIP3;AR;TMBIM1;ZDHHC8;LRP1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.3284511372313291,0.7074259768495593,0.9454545454545454,1.0,1.0,3/28,9.43%,EFNA5;MACF1;ZRANB1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.2713568727662219,0.707199653212559,0.95,1.0,1.0,18/94,18.81%,UNC13C;PCDHB5;CBLN2;PSEN1;RAB29;NRCAM;SHANK3;APBB2;SNCA;SLC8A2;UNC13A;PPFIA1;SLC6A1;CACNB4;SNCB;RYK;CTNND2;FARP1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.4507904809412838,-0.7070329143101539,0.7837837837837838,1.0,1.0,1/7,9.03%,DHODH
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.3703011052341691,-0.7064373886476323,0.8780487804878049,1.0,1.0,5/22,11.25%,GAPDH;RPL13A;IFITM3;WNT5A;SHFL
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.4183975655092084,0.7062331487829783,0.8727272727272727,1.0,1.0,1/9,6.13%,PTPRJ
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.457549708751826,0.7060430132195337,0.847457627118644,1.0,1.0,3/8,14.49%,FBLIM1;RAP1B;PIEZO1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.34193481738759507,0.7060011888431933,0.9152542372881356,1.0,1.0,5/24,11.24%,STAT4;STAT6;ERBIN;STAT5B;STAT2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.382278568265334,-0.7057340820701306,0.82,1.0,1.0,1/14,3.66%,NLGN2
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.41381915524315704,0.7056182452279589,0.8148148148148148,1.0,1.0,1/11,5.02%,TRAK1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3187699734668507,0.7055890406350748,0.9464285714285714,1.0,1.0,5/42,13.73%,POM121C;POM121;SLC2A6;NUP93;PRDM16
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.3188218987147275,-0.7052168476532036,0.8292682926829268,1.0,1.0,6/35,17.78%,ARL6IP5;SYT11;FER1L5;RACK1;SNX12;ERBB3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4593733497104224,-0.704366446655453,0.8367346938775511,1.0,1.0,1/6,3.66%,MT3
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.4504139999027781,-0.704350479629856,0.8,1.0,1.0,3/5,23.41%,RC3H1;RELA;HRAS
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.4370927186098734,-0.7036389949394846,0.813953488372093,1.0,1.0,1/7,7.62%,NGF
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3924520686254402,0.7036306643954608,0.8936170212765957,1.0,1.0,1/12,2.37%,TMEM14A
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.4566401358246561,0.7029391801966625,0.8541666666666666,1.0,1.0,1/5,4.75%,NLRC4
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.3339837316679849,-0.7026074074493246,0.9318181818181818,1.0,1.0,5/29,9.64%,SLC7A10;LRRC8D;SLC1A6;SLC7A8;SLC38A10
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.4677173180815594,-0.7023460037296345,0.8703703703703703,1.0,1.0,2/5,7.50%,LRRC8D;SLC1A6
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.3905800647105557,-0.7022459938591563,0.8571428571428571,1.0,1.0,3/14,20.50%,PDGFRA;PLAT;PLG
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.3610780224282391,-0.7018099669884426,0.8888888888888888,1.0,1.0,1/11,5.37%,C12ORF57
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.4002233484830392,0.7014299590496155,0.8524590163934426,1.0,1.0,1/8,8.59%,NAA16
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4145341913390945,-0.7004946796608039,0.7884615384615384,1.0,1.0,2/9,6.67%,CCT5;CCT3
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.33777587820140836,0.6999190950379378,0.8793103448275862,1.0,1.0,6/24,24.64%,CENATAC;PLK2;XRCC3;CEP131;ALMS1;C10ORF90
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.4080486663547028,-0.6998900164591828,0.7959183673469388,1.0,1.0,6/6,59.22%,CMPK1;AK8;AK5;AK4;CMPK2;PNKP
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.43577585205638836,-0.6997048101829935,0.7924528301886793,1.0,1.0,1/5,4.80%,PARP1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.35077595025429925,-0.6991735779501975,0.8775510204081632,1.0,1.0,7/20,23.98%,PHB2;PSME3;CDC73;PAF1;DDRGK1;EZH2;ID2
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.406053836423227,-0.6988636687580905,0.8333333333333334,1.0,1.0,1/7,3.66%,MT3
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.3812043458539334,0.6987336891994643,0.875,1.0,1.0,6/14,24.52%,PROX1;APPL2;TAFA1;FZD9;KDM2B;NAP1L1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.33877776019340783,-0.6987057248568194,0.8648648648648649,1.0,1.0,5/20,14.69%,CFL1;KIF18B;TWF1;DSTN;STMN4
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.4345294502281937,0.6986890375027954,0.7843137254901961,1.0,1.0,4/7,38.12%,AKAP13;PDE4D;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.35343306229382565,0.6985286335836871,0.8813559322033898,1.0,1.0,4/32,4.36%,GPI;G6PC2;SLC39A14;SORD
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.2966599629305559,0.6984604714347094,0.9285714285714286,1.0,1.0,11/43,21.58%,SLCO1A2;SLC4A4;SLC2A6;CA2;SLC25A19;SLC19A1;LRRC8A;MGST1;SLCO2B1;SLC39A8;SLC4A8
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3292430268942672,-0.6983808919472779,0.9361702127659575,1.0,1.0,2/17,9.03%,RIOK2;ANAPC11
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.3284267038073104,0.6978081508745689,0.9285714285714286,1.0,1.0,10/28,24.40%,ATM;BRCA1;CHFR;BABAM2;DONSON;TAOK1;BRSK1;NOP53;CDC14B;FZR1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.3766349368159241,0.6977484756565338,0.896551724137931,1.0,1.0,5/14,28.97%,PPARG;PNPLA2;NFKBIA;TTC39B;ITGAV
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.428875195047693,-0.6974393761866473,0.825,1.0,1.0,2/5,28.08%,DHX33;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3958900076218907,0.6973804527803976,0.875,1.0,1.0,1/14,1.61%,BAG5
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.3539978994198631,0.6971146815319017,0.8846153846153846,1.0,1.0,2/16,5.03%,MYRF;CNTNAP1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.29294563876904073,0.697080440848546,0.96,1.0,1.0,6/61,10.34%,BCL2L11;SYNPO2;PRKCA;LIMK1;BMP7;TIRAP
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.4120373551823216,0.697070539929501,0.8518518518518519,1.0,1.0,3/11,14.28%,TTN;TPM1;MYOM2
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.383835392911218,-0.6969028576810242,0.85,1.0,1.0,2/13,6.11%,FERMT1;S100A16
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.34969253103589504,0.6968512816633502,0.9107142857142857,1.0,1.0,3/14,19.22%,NTRK3;ABL2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.4125796458103188,-0.6967531172315165,0.7777777777777778,1.0,1.0,1/8,1.48%,CALR
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.44715467525595454,0.6964613860597355,0.8076923076923077,1.0,1.0,1/5,9.09%,CRACD
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.30694024974036943,-0.6961992130449407,0.9333333333333333,1.0,1.0,2/36,4.80%,APEX1;PARP1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.34709219305905553,0.6957677174444187,0.8666666666666667,1.0,1.0,7/21,19.22%,NTRK3;BAIAP2;BCAS3;DAPK3;TJP1;ABL2;ABL1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.35753751675674267,-0.6956855337389071,0.8333333333333334,1.0,1.0,3/10,20.51%,BTN3A3;IL18;JAG1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.382988870637263,0.6948856212344303,0.9090909090909091,1.0,1.0,5/16,17.71%,SLC25A18;SLC13A3;GJA1;SLC19A1;PDPN
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3373338017780735,-0.6945781324709884,0.9591836734693877,1.0,1.0,2/19,7.55%,CALM1;HPCA
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.3258196671647534,0.6944962682202583,0.8852459016393442,1.0,1.0,10/34,18.19%,GPI;NR4A3;ENO4;PDHA1;GAPDHS;ME2;PFKL;SLC16A3;PFKFB1;ME3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.4286885669133786,0.6944728243058436,0.8214285714285714,1.0,1.0,2/8,24.00%,TIRAP;MAPK11
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.36240270463330837,0.6943890239711157,0.8548387096774194,1.0,1.0,2/15,5.07%,YJEFN3;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.43432134732211436,-0.6941338253282379,0.7924528301886793,1.0,1.0,3/5,21.06%,MKKS;NENF;PPARA
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.4093715748105846,-0.693878396773484,0.8837209302325582,1.0,1.0,1/10,5.54%,RIOK2
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.4309232744383022,0.6938534064082468,0.8235294117647058,1.0,1.0,3/7,24.14%,PROX1;AGTPBP1;OPHN1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.3453083247487234,0.6938359948302815,0.8771929824561403,1.0,1.0,4/21,16.24%,PRELP;GLB1;ST3GAL1;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.4102061959489631,-0.6934484599625592,0.8,1.0,1.0,2/6,19.63%,WNK2;WNK3
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.4673412461028211,0.6934387886202265,0.8596491228070176,1.0,1.0,1/5,8.31%,STAT5B
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.3867561015934469,-0.6934141506760362,0.9090909090909091,1.0,1.0,1/10,2.29%,MPDU1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.3867561015934469,-0.6934141506760362,0.9090909090909091,1.0,1.0,1/10,2.29%,MPDU1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.3590926764256579,0.6933990021670238,0.8947368421052632,1.0,1.0,2/18,14.69%,TTN;NCAPH2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.332120577026748,0.693295041632525,0.8852459016393442,1.0,1.0,6/23,20.33%,DOCK11;RIPOR2;BCAS3;TENM2;PALM;PLPPR5
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.4375115835499498,0.6930250104104828,0.875,1.0,1.0,2/5,25.80%,PPARG;PNPLA2
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.35878141465241686,0.692994977183843,0.9344262295081968,1.0,1.0,7/19,24.91%,PHLDB2;PAK2;PPFIA1;TJP1;CLASP1;PIK3R1;ARHGAP6
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.34078866833389787,-0.6926086482690688,0.9473684210526315,1.0,1.0,6/20,22.71%,PEX11A;MFF;FIS1;MUL1;MTFR1L;ACOT8
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.3028974953692219,0.6921315722826187,0.9636363636363636,1.0,1.0,6/44,14.67%,PIP4K2C;CALCOCO2;PRKAA2;PIP4K2A;FYCO1;BNIP3L
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.43234481229995547,-0.6917890291451916,0.85,1.0,1.0,1/6,11.18%,ATP5F1D
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.4069484325880667,-0.6916717709517829,0.8409090909090909,1.0,1.0,2/5,14.21%,ALKBH2;TDG
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.4030774703765644,-0.6913836497334149,0.8444444444444444,1.0,1.0,2/6,21.07%,MCM4;MCM7
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.3196601723803226,-0.6905611298151656,0.8936170212765957,1.0,1.0,4/21,17.90%,PIF1;DDX1;HNRNPA2B1;SUPV3L1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.4151208494940799,0.6903484272943162,0.8253968253968254,1.0,1.0,5/8,24.38%,EFNA1;EPHA4;NELL1;DAB2IP;RGP1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.39508217209921853,-0.690329771516682,0.88,1.0,1.0,3/9,13.02%,PPCS;ACLY;PDHB
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.4189036378354333,0.6903144478562139,0.8333333333333334,1.0,1.0,3/7,20.96%,EFNA1;EPHA4;PICALM
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.4519798025704932,-0.6901185875287208,0.8809523809523809,1.0,1.0,1/6,2.75%,ROMO1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.4452674077526836,0.6898450772232061,0.8444444444444444,1.0,1.0,2/6,19.13%,BMP7;PKD2
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.3948705545802443,0.6892102048085383,0.8627450980392157,1.0,1.0,4/10,20.83%,DGKG;ADGRV1;GPD1L;DGKD
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.4386999802592276,0.6886576545600364,0.8571428571428571,1.0,1.0,1/7,8.74%,VCL
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.3545541390888608,0.6882726648209262,0.9152542372881356,1.0,1.0,6/21,20.86%,SOX9;ATM;RORB;PTK7;ABL2;ADNP2
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.32376431949180806,0.6882219885434283,0.94,1.0,1.0,4/26,9.53%,MAN2C1;FUT2;ST6GALNAC5;MAN2B2
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.3669492145351755,0.6878598875957341,0.8870967741935484,1.0,1.0,3/16,20.42%,MID2;TRIM62;HS3ST5
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.3366122139906748,0.6875192536824972,0.8305084745762712,1.0,1.0,2/18,4.38%,SORBS1;BCR
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.41752191266281274,-0.6875082220525647,0.8571428571428571,1.0,1.0,1/7,4.80%,PARP1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.3136953076602681,0.6872455657366044,0.9591836734693877,1.0,1.0,7/38,15.41%,FUT2;B3GNT5;ABCA2;GLB1;SMPD4;PGAP1;ESYT1
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.35063330269994786,0.6871701341212503,0.8983050847457628,1.0,1.0,6/19,20.79%,NLRC5;SPI1;NMI;TRIM62;POLR3B;POLR3G
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.2708210356536799,0.6869342376408212,1.0,1.0,1.0,31/106,24.14%,BAG5;FAM107A;RAB17;HIP1;GFAP;TMEM97;RPTOR;SGK1;NRG3;STK11;RUFY2;SLITRK4;RAP1B;BBS10;SEMA4D;CAMK2D;PACSIN2;TJP1;ABL2;ABL1;SPOCK1;ITCH;CAMSAP2;PICALM;PACSIN1;APOE;WFDC1;NUBP1;DAB2IP;AGT;OPHN1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.3181912000471291,-0.6866717876206406,0.9487179487179487,1.0,1.0,1/23,2.43%,LZTS1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.3658715261238412,0.686458790339552,0.9047619047619048,1.0,1.0,4/15,18.99%,AKT2;P2RY12;CCDC25;PPM1F
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.4039622521415136,0.6864504110244897,0.8076923076923077,1.0,1.0,2/8,15.14%,ST6GALNAC5;LARGE1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.4188503570061169,0.6862252811329871,0.82,1.0,1.0,2/5,16.44%,ADCY3;BBS4
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.43814689530461837,0.6858258748333869,0.803921568627451,1.0,1.0,3/5,26.64%,SLC22A4;PDZK1;SLC25A29
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.44063371550828734,0.6855188989137091,0.8333333333333334,1.0,1.0,2/5,18.16%,FOXP1;BCL6
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.37427507186866105,-0.6853598123696413,0.9047619047619048,1.0,1.0,3/10,11.75%,PIH1D1;SPHK2;RAPGEF3
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.36621739827941546,0.684940216250966,0.8421052631578947,1.0,1.0,2/16,8.49%,GULP1;RHOBTB2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.4003581544125554,0.684753669115449,0.7959183673469388,1.0,1.0,2/10,13.63%,TPM1;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.2912394828433471,0.6842399201907914,0.9838709677419355,1.0,1.0,8/56,14.13%,IGF1R;STAT6;OXTR;GRB10;ACSL1;ADIPOR2;PRDM16;GJA1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.2792590819084858,0.6842056786089882,1.0,1.0,1.0,11/70,16.42%,RMI1;MMS22L;WRN;RNF138;BRCA1;RPA1;SMC5;LIG3;XRCC3;POLQ;CDC7
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4219938383675109,0.6835917545591282,0.8833333333333333,1.0,1.0,1/8,8.89%,RIPK1
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.4128254067755395,0.6834458686781493,0.8490566037735849,1.0,1.0,3/9,12.94%,SYT1;RYR2;KCNMB4
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.37674575947889444,-0.6831991303684531,0.8163265306122449,1.0,1.0,2/8,19.24%,BRK1;CYFIP1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.41375108629903246,0.6829732760823399,0.8333333333333334,1.0,1.0,3/6,19.36%,PHF19;MACROH2A1;OGT
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.45245062315913354,-0.6824852273310703,0.8823529411764706,1.0,1.0,1/5,13.72%,ENTR1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.46036096256684494,-0.681851644891101,0.8444444444444444,1.0,1.0,5/5,53.99%,DCLRE1C;DCLRE1A;TFIP11;TERF2;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.26827971150512475,0.6814225730342812,0.9818181818181818,1.0,1.0,19/77,21.54%,IGF2BP3;IGF2BP2;ZNF540;DAPK1;PUS7;FTO;TSC1;CPEB3;SYNCRIP;GIGYF2;DAPK3;CNOT7;CPEB4;SAMD4B;LARP1;SAMD4A;CPEB2;EIF2AK3;CPEB1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.43524793119559557,0.6806253765748187,0.8596491228070176,1.0,1.0,1/5,11.95%,TSC1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.36626849220999436,-0.6805898319405099,0.8409090909090909,1.0,1.0,5/10,26.31%,SAR1B;TMEM30A;CD81;GCC2;INSIG1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.3482777465826027,0.6804970925316436,0.9574468085106383,1.0,1.0,3/16,15.14%,TMTC2;TMTC4;LARGE1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.3817452357071213,-0.6804865975027812,0.8541666666666666,1.0,1.0,10/10,61.86%,RRAGD;LARS1;SESN3;EIF2AK4;SESN1;SESN2;RRAGB;MTOR;GCN1;IMPACT
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.369613656235521,0.6803740243885523,0.8620689655172413,1.0,1.0,7/17,23.05%,STMN2;TTBK2;ATXN7;TAOK1;CAMSAP2;CLASP1;NAV3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.3392184783002042,0.6799085531696402,0.9310344827586207,1.0,1.0,8/26,27.29%,KCNN3;KCNMB4;ANK2;KCNQ1;KCNMB3;KCNJ16;KCNMA1;DLG1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.2894395666485671,-0.679678912167446,0.9375,1.0,1.0,3/31,9.33%,PCGF2;CBX5;RING1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.42788853634442553,0.6794721300559758,0.8771929824561403,1.0,1.0,2/7,9.94%,PRKCA;JAK1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.3418638606096487,-0.6793943370091894,0.8775510204081632,1.0,1.0,8/15,26.15%,CHCHD10;MORC3;HSPA5;AKT1;PML;SUPT7L;TAF8;ARL2BP
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.3242333926144089,0.6790900066837177,0.9137931034482759,1.0,1.0,4/23,16.25%,TENM3;PVR;TENM2;CADM1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.34430729763894424,0.6786460715237445,0.9272727272727272,1.0,1.0,1/18,1.55%,SYT1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.3244606766968645,-0.6780321542063034,0.972972972972973,1.0,1.0,2/15,5.70%,CAP1;EDNRB
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.3184730451107497,-0.6780154219269722,0.9512195121951219,1.0,1.0,5/25,15.76%,ALOX5;ATRAID;PTN;BMP2;ISG15
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.3184730451107497,-0.6780154219269722,0.9512195121951219,1.0,1.0,5/25,15.76%,ALOX5;ATRAID;PTN;BMP2;ISG15
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.46845304223455164,0.677974105984943,0.9019607843137255,1.0,1.0,1/5,5.93%,TIMP3
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.39056814439436505,0.6779670128508053,0.9354838709677419,1.0,1.0,3/12,13.11%,PLA2G15;GPAM;SERAC1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.36540947661667006,-0.6777443494304254,0.8363636363636363,1.0,1.0,2/11,6.67%,CCT5;CCT3
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.38669895726728826,0.6772635446492368,0.9649122807017544,1.0,1.0,3/11,14.09%,RAB3A;SYTL4;DYSF
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.4070561378900491,0.6772035824689262,0.8771929824561403,1.0,1.0,1/11,0.46%,AKR1C2
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.35381178333847807,-0.6769236779320318,0.8333333333333334,1.0,1.0,2/12,11.24%,DPM2;PIGF
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.37295409875326735,0.676419776233128,0.8793103448275862,1.0,1.0,2/11,14.70%,FOXP1;IL6R
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3805909515138599,-0.675892154902593,0.8823529411764706,1.0,1.0,3/7,19.67%,SEMA5A;SCG2;TEK
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.38153561816481907,0.6753768745994032,0.7592592592592593,1.0,1.0,2/10,7.85%,ABCA2;ST6GALNAC5
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.39737358239958326,-0.6752725939636601,0.7777777777777778,1.0,1.0,4/8,16.00%,SMPDL3A;SMPD1;SAMD8;SMPD3
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.35729662177973653,-0.6752147131552513,0.9285714285714286,1.0,1.0,2/15,6.15%,MYO1D;SYNE2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.4054504400533809,-0.6749684440058766,0.813953488372093,1.0,1.0,4/7,25.40%,STARD13;RBPJ;RHOB;RHOA
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3472937791156462,0.6748403309474246,0.9032258064516129,1.0,1.0,2/16,11.65%,ADSS2;AK3
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.3246018964979674,0.6747852513667989,0.9423076923076923,1.0,1.0,5/29,10.90%,MMD2;NRCAM;SIN3A;PROX1;MMD
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.38979848673250594,-0.6747617208086699,0.8372093023255814,1.0,1.0,2/8,9.94%,PARP1;PARP2
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.34972384241351495,0.6744501283736964,0.847457627118644,1.0,1.0,3/17,16.24%,PRELP;ST3GAL1;B4GALT5
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.3330789978743497,-0.6739960220406913,0.8478260869565217,1.0,1.0,1/13,2.93%,GABARAPL2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.3567357327319647,-0.6739679504531337,0.9166666666666666,1.0,1.0,6/13,24.08%,IFI6;RHBDF1;RBPJ;CEACAM1;RHBDF2;LGMN
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.391941940968547,0.6739270268732653,0.8431372549019608,1.0,1.0,5/10,30.61%,SLIT3;TGFB2;ZFPM1;ACVR1;MDM4
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.40256272556842115,0.6738562251466937,0.8983050847457628,1.0,1.0,1/9,5.89%,ADSS2
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.4067039274283347,0.6738489333864197,0.8181818181818182,1.0,1.0,1/7,10.70%,HES1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.28524764350300663,0.673265730803506,1.0,1.0,1.0,12/70,15.69%,ITPR1;TRPC4;SLC24A2;PSEN1;RYR2;ATP2B2;RYR3;CACNG8;NALCN;SLC8A1;SLC8A2;ANK2
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.38181616255917283,-0.6726310164323727,0.9230769230769231,1.0,1.0,8/12,29.72%,RC3H1;KHSRP;NUDT21;GTPBP1;CNOT1;UPF1;ZC3HAV1;PRR5L
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.34521386550633704,-0.6724986267771976,0.8095238095238095,1.0,1.0,6/15,21.34%,SFRP1;RNH1;VASH1;BMPER;ADGRA2;GPNMB
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.3610871202706221,0.6724653817897583,0.9148936170212766,1.0,1.0,5/21,15.49%,TTN;TMOD3;TPM1;MYOM2;CFLAR
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.43745589410413205,-0.6720622764877511,0.84,1.0,1.0,2/5,17.70%,ACOX1;ABCD2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.3912075789478364,-0.6718537284746688,0.9137931034482759,1.0,1.0,1/9,5.63%,NABP2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.38703861150327107,0.6717326053043242,0.8833333333333333,1.0,1.0,5/11,24.60%,SLC8A1;CAMK2D;GSTM2;PIK3CA;ATP1B1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.26367034895682584,0.671461493376739,1.0,1.0,1.0,8/105,13.64%,EFHC1;SGO2;RANGAP1;XPO1;TNKS;MAP4;PLK2;PCNT
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.288355016107217,-0.6710162061198368,1.0,1.0,1.0,5/36,12.72%,BRPF3;NPM2;DSCC1;RAD17;PPP2R1A
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.2794036713449367,-0.6708764937283521,1.0,1.0,1.0,3/32,9.33%,PCGF2;CBX5;RING1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.33516458925793713,-0.6708580540137528,0.8823529411764706,1.0,1.0,2/18,6.27%,PDGFRA;ARL1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.3312578437863444,0.6707657361859889,0.9322033898305084,1.0,1.0,7/28,26.74%,AKT2;RORA;OGT;FOXK2;IRS1;PDK2;PRKN
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.36225778325326163,-0.6705525499805949,0.8627450980392157,1.0,1.0,1/9,6.69%,VEGFB
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.3925999656591531,0.6702593540052202,0.9183673469387755,1.0,1.0,2/9,16.71%,HABP4;SRPK2
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.35588489280402524,-0.6702507606079572,0.8717948717948718,1.0,1.0,4/13,14.57%,TIMP4;FURIN;TIMP2;TIMP1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.38726761006946586,0.6696808727963656,0.8666666666666667,1.0,1.0,5/10,24.60%,SLC8A1;CAMK2D;GSTM2;PIK3CA;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.4200597283925417,0.668984986761664,0.9074074074074074,1.0,1.0,1/5,2.70%,WNT7A
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.42511221804413163,0.6689337723632443,0.8769230769230769,1.0,1.0,2/5,29.38%,ACTN4;MITF
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3448435552319755,0.66848415721903,0.9180327868852459,1.0,1.0,5/15,18.89%,FUT2;AGMO;AGK;SERINC1;CERK
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.352123824496442,-0.6684368421620346,0.9210526315789473,1.0,1.0,2/11,15.36%,CAV1;EXOC7
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.3646295941403838,0.6682291082445383,0.8727272727272727,1.0,1.0,3/11,20.14%,NR4A3;PPARG;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.26005084269398693,-0.6679339027126059,1.0,1.0,1.0,16/81,19.26%,RHOC;HSPA8;PIH1D1;CLU;BRK1;ANKRA2;SAR1B;RACK1;HSPA5;CDC42;VCP;PARK7;SUMO1;BAX;RAF1;SLF2
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.349888399976078,-0.6676261939110478,0.8888888888888888,1.0,1.0,3/9,16.45%,ISCU;STIM1;PARK7
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.39330460337445944,0.6669220446756726,0.8412698412698413,1.0,1.0,2/10,13.35%,TNIK;RAP1B
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.39330460337445944,0.6669220446756726,0.8412698412698413,1.0,1.0,2/10,13.35%,TNIK;RAP1B
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.3582788975222806,-0.6663332523213082,0.9347826086956522,1.0,1.0,2/15,9.64%,SVIL;CAV1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.33109229367126664,-0.6662654202696691,0.9166666666666666,1.0,1.0,5/16,17.81%,YAP1;WBP2;CAV1;CATSPERD;ABHD2
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.3589411547736486,0.6661519112438987,0.8870967741935484,1.0,1.0,6/15,19.13%,KCNC2;GRIN1;TMEM120B;GRIN2B;CPSF6;PKD2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.34649833288720966,-0.6654180965922626,0.925,1.0,1.0,5/17,14.53%,CDC37;SLC25A4;STUB1;FLOT1;PELI1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.4325824744390711,0.6648825122017571,0.8867924528301887,1.0,1.0,1/5,4.32%,LRP2
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.348481995906564,0.6647993591378255,0.9642857142857143,1.0,1.0,7/15,32.32%,BORA;CLTC;SENP6;RNF4;TACC3;FSD1;ANKRD53
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.3339318004500603,-0.6646111787064816,0.9090909090909091,1.0,1.0,3/23,9.07%,BTC;CDC37;STUB1
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.3178928103672825,0.6640673951824971,0.9672131147540983,1.0,1.0,11/31,30.37%,PIP4K2C;PIP4K2A;MTMR3;SCFD1;PIP4K2B;RAB3GAP1;RAB5A;C9ORF72;PIKFYVE;TBC1D12;SMCR8
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.41954017137341065,0.6632682452015561,0.8596491228070176,1.0,1.0,2/6,16.73%,SLC25A19;SLC25A36
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.38901604841087234,-0.6632054280893245,0.9090909090909091,1.0,1.0,3/9,16.45%,GPR37L1;PYCR1;PARK7
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.39129645122764545,0.663134389778813,0.9607843137254902,1.0,1.0,3/9,29.20%,SIN3A;ATRX;MIER1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.3286739229972288,0.6625167851090773,0.9473684210526315,1.0,1.0,10/29,24.00%,SPI1;ZNF16;STAT5B;CDK6;ANKRD54;ABCB10;ACVR1B;STAT3;FOXO3;MAPK11
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.29534838244748907,-0.6621690186672236,0.9285714285714286,1.0,1.0,8/30,21.00%,SMC1A;MAP10;MZT1;ABRAXAS1;KIF3B;GOLGA2;BCCIP;MAP9
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.3085652034070602,-0.6619824737860445,0.9166666666666666,1.0,1.0,5/27,15.94%,CFL1;RAB14;ZBED3;TDG;TLE6
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.3904672772244134,-0.6618163346404909,0.8723404255319149,1.0,1.0,6/6,60.98%,ABCC10;SLCO3A1;ABCC11;ABCC4;ABCC1;ABCC3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.33129597751600565,0.6616181373207211,0.8627450980392157,1.0,1.0,4/27,9.87%,NEDD4L;ABCA2;CAV3;RAB11FIP5
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.4067853540370277,-0.6612255211577777,0.8,1.0,1.0,1/5,16.17%,VCP
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.3453431503275657,0.6611823027789038,0.8979591836734694,1.0,1.0,2/14,8.66%,EPS15;SORT1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.40869586523754453,-0.6607555166282011,0.7884615384615384,1.0,1.0,4/5,37.62%,RYR1;CAV2;SKI;SELENON
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.40869586523754453,-0.6607555166282011,0.7884615384615384,1.0,1.0,4/5,37.62%,RYR1;CAV2;SKI;SELENON
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.3655993047663614,-0.6601447007968823,0.8043478260869565,1.0,1.0,6/6,63.46%,METTL4;MTRES1;ALKBH1;MTG2;NSUN3;MTG1
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.3738736205900748,-0.6599311517500019,0.825,1.0,1.0,1/9,9.17%,RFWD3
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.3725867229344839,-0.6593508223573119,0.9130434782608695,1.0,1.0,2/9,20.51%,BTN3A3;JAG1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.29410916572843193,0.658990000113835,0.9473684210526315,1.0,1.0,16/33,31.94%,RELN;TPST1;EPHA4;ABL2;ABL1;FER;ABI2;ERBB4;INSR;EPHA3;DDR2;FLT1;PTK2B;EGFR;JAK2;PTK2
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.39936064363163304,-0.6588892687187671,0.851063829787234,1.0,1.0,1/6,5.63%,NABP2
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.33821061751590564,0.6588735052021966,0.9056603773584906,1.0,1.0,2/19,10.29%,ARHGAP24;CCP110
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.2915839751804437,0.6583449891472978,0.9649122807017544,1.0,1.0,3/28,10.39%,NLRC5;CYLD;UFD1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.2841286157343615,0.6579920367076169,0.9423076923076923,1.0,1.0,11/50,19.80%,NEDD4L;ARIH2;UBR5;RNF152;HACE1;KLHL3;UBE2H;DTX3L;UBE2D3;RNF115;ITCH
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.3389270033949994,-0.6570178755043405,0.9523809523809523,1.0,1.0,3/20,6.27%,MID1IP1;CAMSAP3;LIMA1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.3299999209048254,0.6569668335583598,0.9193548387096774,1.0,1.0,3/19,13.32%,SLC24A2;GRIK3;PLK2
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.3379243747521362,-0.6567161693131106,0.8541666666666666,1.0,1.0,3/15,18.62%,ERP29;SNX12;RHBDF1
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.32562353032060476,0.6563576008542665,0.95,1.0,1.0,4/17,21.37%,ANGPTL4;RAB20;CEBPD;RDH12
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.3391885207703369,-0.6549628320367563,0.8857142857142857,1.0,1.0,6/16,17.83%,GAPDH;TPI1;PGAM1;PKM;ADPGK;PGK1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.4239600224542537,0.6548278802383438,0.9259259259259259,1.0,1.0,4/7,32.65%,PFKL;GFPT1;HK1;PFKP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.38076530123950003,-0.6545886025270786,0.875,1.0,1.0,6/11,21.92%,PHB2;NPM1;CDC73;PAF1;DDRGK1;EZH2
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.37780409463156805,-0.6541237653693196,0.75,1.0,1.0,2/6,19.13%,NUP155;LDB1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.30104168453281194,0.6540580394485961,0.9344262295081968,1.0,1.0,10/31,27.25%,DGKG;GPAM;DGKZ;GPD1L;LIPH;DGKD;PLA2G12A;GPAT4;ABHD8;PLD2
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.2962275815407107,0.6539166887200658,0.96,1.0,1.0,3/37,8.89%,ADAMTS9;FBXO6;RIPK1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.34955305637687734,-0.6539128477398742,0.9761904761904762,1.0,1.0,5/19,21.16%,ATXN7L3;CDC73;RNF8;UBE2N;PAF1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.3361764582803138,0.6537868770516386,0.9122807017543859,1.0,1.0,2/11,12.69%,ACSL1;ELOVL2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.36237682362813994,0.6534114770294782,0.9074074074074074,1.0,1.0,1/10,2.70%,WNT7A
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.34866121810796546,-0.653315115889546,0.8367346938775511,1.0,1.0,1/8,7.47%,PHB2
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.4054812834224599,-0.652469574847043,0.9302325581395349,1.0,1.0,5/5,59.47%,AGPS;GNPAT;FAR1;DHRS7B;PEX7
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.4054812834224599,-0.652469574847043,0.9302325581395349,1.0,1.0,5/5,59.47%,AGPS;GNPAT;FAR1;DHRS7B;PEX7
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.35658144633101874,0.6520121457952445,0.890625,1.0,1.0,2/15,15.91%,NUP93;TMEM43
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.3411925906421428,-0.6515633616986998,0.9333333333333333,1.0,1.0,2/17,5.63%,DACH1;NABP2
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.32472693393778457,-0.6512991158639165,0.9090909090909091,1.0,1.0,2/18,5.63%,PKIB;NABP2
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.285582460749503,0.6509001461409529,0.9259259259259259,1.0,1.0,4/32,9.46%,USP30;RB1CC1;ATG7;ATG5
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.395098738143859,-0.6502184034782205,0.9148936170212766,1.0,1.0,2/8,13.99%,HES5;BMP2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.33984175978942044,0.6496079575483014,0.9090909090909091,1.0,1.0,4/17,16.83%,RANGAP1;TAF3;BBS4;BARD1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.37197889846133303,0.6495541176938524,0.9583333333333334,1.0,1.0,2/12,11.84%,FOXP1;CBFB
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.2854332517284745,-0.6494537576064615,0.9444444444444444,1.0,1.0,7/27,15.72%,SLC25A15;ASAH1;SMPD1;FURIN;SPTLC1;SAMD8;CERS2
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.40117714386514713,0.6488949431990619,0.8181818181818182,1.0,1.0,2/6,16.26%,OXSR1;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.40117714386514713,0.6488949431990619,0.8181818181818182,1.0,1.0,2/6,16.26%,OXSR1;ADAM10
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.3539111551387109,0.6485906078831605,0.9420289855072463,1.0,1.0,2/15,6.69%,GCLC;CHAC2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.38755250812663605,0.6483253231841043,0.8947368421052632,1.0,1.0,2/8,9.66%,RBM15;OXSR1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.33117293763394307,0.6476875194537918,0.9814814814814815,1.0,1.0,7/26,17.35%,GPI;MAN2C1;ENO4;MAN2B2;GAPDHS;PFKL;PFKFB1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),-0.42620330393610484,-0.6471204071352115,0.7692307692307693,1.0,1.0,1/5,6.25%,GPAA1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.32305040284454245,0.6470543390232025,0.9636363636363636,1.0,1.0,2/19,7.97%,PLA2G15;NAAA
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.4069442914271238,0.6468092871705939,0.8888888888888888,1.0,1.0,3/7,27.66%,ADCK1;PRKN;HUWE1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.3907154461752116,0.6467967915139251,0.9272727272727272,1.0,1.0,2/9,14.09%,NMI;DYSF
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.2683943160656624,0.6465573268379129,1.0,1.0,1.0,18/69,25.17%,PAK1;NTRK3;DOCK7;RPTOR;NOS1;SPTBN4;CAMK1;SNCA;DMTN;MTCP1;GPD1L;PPM1F;PRKD2;CAPRIN2;DMD;NCK2;TBK1;BCAR3
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.32721615592904396,-0.646412673563645,0.9411764705882353,1.0,1.0,3/16,10.78%,RHOG;BRK1;DBNL
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.3224516571757235,0.6461995889862179,0.9137931034482759,1.0,1.0,3/21,17.69%,TULP3;SUFU;HHIP
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.4061563800606418,-0.646021282859891,0.9473684210526315,1.0,1.0,2/9,5.75%,THY1;DUSP3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.3053967932025339,0.6460116219547358,0.9649122807017544,1.0,1.0,4/29,9.81%,SPIRE1;UBR5;FMN2;SHLD2
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.3711343555272494,0.6459607162347738,0.8333333333333334,1.0,1.0,3/10,15.76%,LIG3;ZRANB3;DONSON
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.36873183499159234,0.6459601937403703,0.921875,1.0,1.0,4/11,21.54%,CPEB3;CPEB4;CPEB2;CPEB1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.39919563008503334,-0.645703274224034,0.8888888888888888,1.0,1.0,2/8,20.14%,PARK7;P4HB
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3387425932373283,-0.6453235087385768,0.8478260869565217,1.0,1.0,1/13,3.86%,HES5
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.3953357987821102,-0.6445998396982134,0.8085106382978723,1.0,1.0,2/6,9.38%,FER1L5;GRN
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.29357678977710433,-0.6444901404642562,0.98,1.0,1.0,5/31,13.00%,MT2A;IRF3;HLA-B;CD44;B2M
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.3511595887983158,-0.6441702019655327,0.9090909090909091,1.0,1.0,1/9,2.67%,AP4M1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.36629064495406155,0.64332014758567,0.9047619047619048,1.0,1.0,5/16,17.89%,SHLD2;TP53BP1;HELB;POLQ;RIF1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3341441619832256,0.6432182734817227,0.9344262295081968,1.0,1.0,7/16,33.35%,WASHC1;DCUN1D2;ITCH;PRKN;ZMIZ1;UBQLN1;EPAS1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.35362991899415197,-0.6423533572428686,0.9148936170212766,1.0,1.0,4/8,21.15%,MICALL1;BIN3;WHAMM;FNBP1L
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.3861395052284041,0.6417845193360397,0.9148936170212766,1.0,1.0,3/7,23.23%,PRKAA2;PRKAA1;MAPT
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.2905745386253279,-0.6413612092079973,1.0,1.0,1.0,7/27,21.12%,PMEPA1;BMP8B;BMP2;BMPER;PIN1;GREM1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.35285223249989084,-0.6412303738346686,0.9375,1.0,1.0,3/12,19.89%,PTN;ZNF335;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.40903246150496786,-0.6404024655392462,0.8627450980392157,1.0,1.0,2/7,9.07%,LDLR;HSP90AB1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.30078816662087704,0.6400563333352324,0.9491525423728814,1.0,1.0,10/32,27.25%,DGKG;GPAM;DGKZ;GPD1L;LIPH;DGKD;PLA2G12A;GPAT4;ABHD8;PLD2
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.3259098525972667,0.6396705795913479,0.9636363636363636,1.0,1.0,5/20,17.04%,GNG7;CD27;MAN1A1;ATXN8OS;ABCB9
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.30757995555001694,0.6394134049274329,0.9454545454545454,1.0,1.0,3/18,16.37%,CCDC57;RANBP9;CSNK1D
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.2392201853838639,-0.6393156710289523,1.0,1.0,1.0,24/164,17.53%,CDKN2C;CCND1;SSNA1;TUBA1A;PHLDA1;TUBG1;CTDP1;TUBB4B;CHMP2A;ODF2;PRKAR2B;PPP1CB;GSPT1;CUL4B;PPP2R1A;HAUS8;OPTN;MELK;PRKACA;UBE2S;DCTN3;DYNLL1;DBF4;CDKN2D
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.3099312138126028,-0.6388232785243356,0.9473684210526315,1.0,1.0,1/24,3.53%,MAP1S
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.3537352257694539,-0.6387840757223663,0.8478260869565217,1.0,1.0,3/7,21.08%,RNF168;RNF8;HSPD1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.3401727223592338,0.6377984946516517,0.9166666666666666,1.0,1.0,1/10,12.69%,ELOVL2
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.3401727223592338,0.6377984946516517,0.9166666666666666,1.0,1.0,1/10,12.69%,ELOVL2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.2848742685097858,-0.6374613108716433,0.9722222222222222,1.0,1.0,6/35,15.11%,RANGRF;RHOG;CLIP3;RACK1;ZDHHC8;LRP1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.33858614585365576,0.6370787938808514,0.9629629629629629,1.0,1.0,2/13,7.67%,CAV3;PLPP4
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.387505816422099,0.6370488556439095,0.9272727272727272,1.0,1.0,2/11,16.84%,RIPK1;NCOR1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.3825034717522501,-0.6367875451865116,0.8888888888888888,1.0,1.0,2/7,15.11%,UNC119B;LRP1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.3242513034378699,-0.6366603720947042,0.9069767441860465,1.0,1.0,4/18,21.16%,BRK1;CDC42;CYFIP1;AKIRIN1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.37899140811442783,0.6366002307740835,0.9302325581395349,1.0,1.0,6/9,31.93%,MBOAT2;PLAAT3;PLA2G12A;LPCAT3;PNPLA8;LPCAT4
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3077022178961353,0.6363999549900791,0.9642857142857143,1.0,1.0,6/31,18.38%,RAD18;UBE3D;UHRF1;OBI1;DTX3L;UBE2D3
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3730216275033106,-0.6361629296861641,0.8913043478260869,1.0,1.0,1/8,5.27%,PAX8
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.29481533531733867,0.6360489830894959,0.9821428571428571,1.0,1.0,7/36,21.06%,EFNA5;ADCY5;TRIM46;CAMK2D;PPM1F;FER;BRSK1
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.3589547112952285,-0.6360273488264191,0.8235294117647058,1.0,1.0,3/9,22.95%,SLC25A33;TFB2M;TEFM
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.30044679509930217,0.6353645205122234,0.9682539682539683,1.0,1.0,5/29,18.98%,SYBU;NEFL;FBXW11;KIF1B;DST
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.34101546802797283,0.6350042627532254,0.9259259259259259,1.0,1.0,3/13,18.70%,CAMTA1;PTBP1;SPPL3
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.33320874360374303,0.6349354240588011,0.8923076923076924,1.0,1.0,3/15,22.51%,THRAP3;DAZAP1;CELF3
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.3097457004885656,-0.6348721756879157,0.98,1.0,1.0,3/26,7.91%,PRICKLE1;SEMA4C;FUZ
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.3097457004885656,-0.6348721756879157,0.98,1.0,1.0,3/26,7.91%,PRICKLE1;SEMA4C;FUZ
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.31494149796218884,0.6346964776169574,0.9565217391304348,1.0,1.0,3/20,15.14%,TMTC2;TMTC4;LARGE1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.30471744794117356,0.63456373722211,0.9454545454545454,1.0,1.0,5/26,21.25%,PTPRJ;ARRB2;MAGI2;PPP2R5C;NOP53
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.35023389757704704,0.6335702672676328,0.8620689655172413,1.0,1.0,4/13,21.20%,MYO1H;MYO7A;MYO6;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.3087922746827534,-0.6335627220234463,0.9347826086956522,1.0,1.0,2/22,10.51%,WTIP;DDX5
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.39905975654382575,-0.632839524619583,0.8888888888888888,1.0,1.0,1/6,12.81%,FNTA
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.39332351363415946,0.6327840348223294,0.9047619047619048,1.0,1.0,2/8,13.87%,PTPRJ;SNCA
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.3858885760573836,-0.6324159743136442,0.825,1.0,1.0,2/5,9.23%,LYN;NOC2L
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.35087098051246146,-0.6321786118816854,0.9130434782608695,1.0,1.0,5/13,15.85%,SLC30A10;MT3;SLC30A4;SLC39A6;SLC39A7
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.29824638819719984,0.6321549272840423,0.9107142857142857,1.0,1.0,4/27,11.24%,NLRC5;TYRO3;NMI;STAT2
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.34228554189469423,-0.6317507981783201,0.9090909090909091,1.0,1.0,3/12,22.95%,SLC25A33;TFB2M;TEFM
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.42748320159846676,0.6312797694204098,0.9347826086956522,1.0,1.0,2/6,8.56%,AHCYL1;CA2
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.2683535296235232,0.6312427884675552,1.0,1.0,1.0,20/82,23.58%,NPHP4;CEP135;HAUS2;CCP110;TUBA4A;TTBK2;HAUS6;HAUS5;PCNT;CEP41;CSNK1D;ACTR1A;CEP131;TMEM216;CEP290;CC2D2A;CEP250;ALMS1;CLASP1;CEP70
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.3753981344120684,0.6309777876796934,0.9245283018867925,1.0,1.0,2/8,20.49%,PRKCZ;STAT3
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2722428634434442,0.6309048752041507,1.0,1.0,1.0,11/53,21.12%,KIAA0319;SULF1;BMP7;NUP93;GDF11;BMP8A;STK11;SMAD4;ACVR1B;ENG;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.26630981006708215,-0.6308007129692095,1.0,1.0,1.0,11/44,21.12%,VEGFB;WNT5A;EMC10;SEMA5A;ITGA4;BMP2;SCG2;AKT1;TEK;SP1;TGFBR1
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.3957982196334149,0.6304434176538043,0.8620689655172413,1.0,1.0,2/7,15.01%,LOXL3;MTHFD1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3426023917681812,-0.6304293534148913,0.9782608695652174,1.0,1.0,3/14,15.20%,PARP1;HNRNPA2B1;SMG5
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.35071579528521435,-0.630242620050706,0.9069767441860465,1.0,1.0,1/7,12.72%,PPP2R1A
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.2898345038204557,0.6299744892138726,0.9827586206896551,1.0,1.0,9/35,24.47%,IGF1R;PITPNM2;PIK3CD;KCNH1;OGT;PIK3CA;GAB2;PIK3R1;IRS1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.34709235370118036,-0.629237882687133,0.8611111111111112,1.0,1.0,4/11,16.79%,ZFP36L1;TARDBP;RC3H1;KHSRP
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.350317275350882,-0.629066096479054,0.9433962264150944,1.0,1.0,3/13,8.57%,SQLE;PPIA;AUP1
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.3957444918329224,0.6279396930609835,0.9245283018867925,1.0,1.0,2/6,9.45%,WNT7A;PROX1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.3116717487226607,0.6277395228245707,0.9803921568627451,1.0,1.0,1/19,3.68%,PAK1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.3777325827250323,-0.6276028302300035,0.8596491228070176,1.0,1.0,2/8,19.89%,ZNF335;CX3CL1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.30520716295427863,-0.6275865516303678,0.9302325581395349,1.0,1.0,3/12,17.95%,EFNA2;OSTM1;SNX10
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.38197896824243904,0.627373148178485,0.8958333333333334,1.0,1.0,2/6,17.77%,GRB10;APPL2
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.4038610425968079,-0.6271833203194035,0.8571428571428571,1.0,1.0,1/7,3.27%,EEF1A1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),-0.41395849460616363,-0.6270928465233215,0.8541666666666666,1.0,1.0,4/5,29.24%,B3GALT2;B4GALT3;GAL3ST1;UGT8
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),-0.41395849460616363,-0.6270928465233215,0.8541666666666666,1.0,1.0,4/5,29.24%,B3GALT2;B4GALT3;GAL3ST1;UGT8
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3903111457117885,-0.6255811223081406,0.8867924528301887,1.0,1.0,3/9,21.30%,LAMTOR5;PARK7;DDRGK1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.31324117389975487,0.6251455482460303,0.9411764705882353,1.0,1.0,5/27,13.55%,DPAGT1;DHDDS;GPAM;ABCA8;AGK
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.3791103044516804,-0.6247748153088584,0.9130434782608695,1.0,1.0,2/5,13.02%,DLD;PDHB
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.39356555338908605,0.6245817595926106,0.9444444444444444,1.0,1.0,4/5,40.86%,ATG14;AMBRA1;BECN1;GPS2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.32836742085353227,-0.6242391964004325,0.8666666666666667,1.0,1.0,2/10,14.09%,FN1;SMAD3
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.3772324478877657,0.6241812985068006,0.88,1.0,1.0,5/12,27.49%,MAPK12;NRG1;MBNL1;HINFP;PLEKHM3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.3599802704169838,0.6239432905484803,0.9193548387096774,1.0,1.0,5/9,28.79%,FOXP1;NCOR1;NCOR2;PIAS2;SMARCA4
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.3075159131695886,-0.6233899653604693,0.8780487804878049,1.0,1.0,5/17,17.70%,ATAD1;ACBD5;FIS1;PEX13;ABCD2
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.31808273706706625,0.6232587877658476,0.9827586206896551,1.0,1.0,5/17,32.18%,SPP1;COL5A2;ITGAV;PTK2;VAV2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.3431091811754794,-0.623055093643073,0.9491525423728814,1.0,1.0,1/12,6.56%,WTIP
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.35470467024030305,-0.6229925043974865,0.8863636363636364,1.0,1.0,3/10,19.77%,SAR1B;TMEM30A;CD81
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.3582926835104731,0.6228378108180705,0.9354838709677419,1.0,1.0,5/10,40.96%,SCFD1;SMCR8;MTM1;CHMP4B;LRRK2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.30097344140743065,0.6226799154182775,0.9824561403508771,1.0,1.0,9/29,23.74%,BAG5;GFAP;RAP1B;BBS10;TJP1;APOE;DAB2IP;PARP10;AGT
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.3723480765466825,-0.6221913536680947,0.9607843137254902,1.0,1.0,3/9,16.71%,CST3;LRP1;DDR1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.3919576743610602,0.6215552431393276,0.9791666666666666,1.0,1.0,4/7,20.65%,FOXP1;CDK6;CSF1;ACIN1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.37163783855517296,-0.6209972422705127,0.9318181818181818,1.0,1.0,1/6,12.71%,NPM1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.28902430676904256,0.6207394627583404,0.9074074074074074,1.0,1.0,1/15,5.72%,RGPD3
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.25868100309826225,-0.6205879786433134,1.0,1.0,1.0,12/64,16.64%,SSNA1;TUBA1A;TUBG1;TUBB4B;ODF2;PRKAR2B;NPM1;PPP2R1A;HAUS8;PRKACA;DCTN3;DYNLL1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.3475168971344962,-0.6203331194722813,0.926829268292683,1.0,1.0,2/7,15.91%,RNF168;RNF8
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.31399154497443804,-0.6202808313897642,0.95,1.0,1.0,4/16,15.11%,RHOG;RHOBTB1;SCARB1;LRP1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.33525895508520026,-0.6199488858010405,0.9,1.0,1.0,5/11,20.11%,RFK;PPAT;IMPDH2;PFAS;LHPP
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.27891216623765047,-0.6198971067214618,1.0,1.0,1.0,7/28,20.64%,LPCAT1;TPI1;FADS1;PCYT2;IP6K2;AGPAT5;AGPAT3
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.33042039540789786,-0.6198705910539014,0.9148936170212766,1.0,1.0,3/15,13.50%,ATF4;GRN;PRNP
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.40574791182602976,-0.6194694706017394,0.9166666666666666,1.0,1.0,3/6,28.29%,NIT2;SIRT4;CAD
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.3103078310139388,0.6193294397226532,0.9661016949152542,1.0,1.0,5/19,19.64%,RACGAP1;SLC6A6;SLC25A19;SLC13A4;MGST1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.3206961324096762,-0.6191615583951646,0.875,1.0,1.0,1/10,15.11%,LRP1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.39044117647058824,-0.61903380336703,0.9574468085106383,1.0,1.0,5/5,60.98%,ABCC10;ABCC11;ABCC4;ABCC1;ABCC3
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.28860780361892974,-0.6189871195453661,0.9574468085106383,1.0,1.0,5/22,17.70%,ATAD1;ACBD5;FIS1;PEX13;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3449192146219135,0.6189794934278723,0.8888888888888888,1.0,1.0,2/13,8.94%,BAG5;LIMK1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.37610828307117933,0.6180257582620419,0.8723404255319149,1.0,1.0,6/8,43.06%,KIF5A;KIF5C;DLG2;MAP1A;HSPB1;MAPK8IP3
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.37610828307117933,0.6180257582620419,0.8723404255319149,1.0,1.0,6/8,43.06%,KIF5A;KIF5C;DLG2;MAP1A;HSPB1;MAPK8IP3
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.37610828307117933,0.6180257582620419,0.8723404255319149,1.0,1.0,6/8,43.06%,KIF5A;KIF5C;DLG2;MAP1A;HSPB1;MAPK8IP3
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.4067002617571782,-0.6173679417476169,0.8571428571428571,1.0,1.0,1/5,3.86%,HES5
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.4067002617571782,-0.6173679417476169,0.8571428571428571,1.0,1.0,1/5,3.86%,HES5
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.32468062696911587,-0.6171451305559689,0.9459459459459459,1.0,1.0,5/15,17.83%,GAPDH;TPI1;PGAM1;PKM;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.32468062696911587,-0.6171451305559689,0.9459459459459459,1.0,1.0,5/15,17.83%,GAPDH;TPI1;PGAM1;PKM;PGK1
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.3919545335645009,0.6170832249146411,0.875,1.0,1.0,4/6,37.95%,AKR1C3;SIRT5;DGKQ;H6PD
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.2651552095482536,-0.616939118764132,0.9782608695652174,1.0,1.0,6/36,12.48%,LRP10;MAPK13;OSTF1;LITAF;ISG20;CDC42SE1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.28703591950402707,-0.6166643437557773,0.9622641509433962,1.0,1.0,3/26,9.36%,PKIB;NABP2;PPP1R10
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.2795874170579452,0.6164113277800957,0.9830508474576272,1.0,1.0,4/32,15.89%,DND1;FTO;CPEB3;GIGYF2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.3478659626952825,0.6163627864231639,0.9482758620689655,1.0,1.0,4/11,31.93%,PRDM16;LOXL2;SETDB1;EZH1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.3703740724842997,0.616354640673536,1.0,1.0,1.0,3/9,18.97%,PTPRJ;SNCA;CBLB
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.3392395211747629,0.616283106543931,0.9,1.0,1.0,1/7,11.39%,NOS1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.27103164798050117,0.6156406032527496,1.0,1.0,1.0,8/53,14.84%,PAK1;NTRK3;DOCK7;RPTOR;NOS1;CAMK1;SNCA;MTCP1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.33953490568240485,0.6153630484265469,0.9137931034482759,1.0,1.0,1/10,7.35%,TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.31035074252880096,-0.6152993360392084,0.925,1.0,1.0,4/19,9.64%,CXCL12;P2RX4;SPHK2;CAV1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.3639109994880917,-0.6152522281150855,0.9555555555555556,1.0,1.0,2/9,10.81%,EPHB3;SEMA5A
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.3967309429510486,0.615025469281239,0.8679245283018868,1.0,1.0,1/5,10.77%,FBXW11
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3690981006503138,0.6142712845527001,0.9629629629629629,1.0,1.0,6/11,32.75%,SLC8A1;ANK2;CACNA1D;HCN2;CACNA1C;CACNB2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.3658960700127529,-0.614151317729485,0.8372093023255814,1.0,1.0,2/6,9.38%,LYN;GRN
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.3985017834222815,0.6140028337146038,0.8913043478260869,1.0,1.0,1/5,7.36%,SLC16A10
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.34670173158966067,-0.6134384290834188,0.9787234042553191,1.0,1.0,5/12,15.85%,SLC30A10;SLC30A4;SLC39A10;SLC39A6;SLC39A7
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.3077833209916967,0.6130509930489927,0.9454545454545454,1.0,1.0,2/24,5.58%,NR4A3;FOXP1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.3046498160313683,0.6123959822566354,0.9107142857142857,1.0,1.0,2/18,10.46%,C19ORF12;RAP1GDS1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.2729475808271499,-0.6119098898233413,1.0,1.0,1.0,5/24,17.70%,ATAD1;ACBD5;FIS1;PEX13;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.3885432728258277,-0.6116586555759151,0.8604651162790697,1.0,1.0,1/5,19.28%,RBPJ
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.39597978714099247,0.6114375458499999,0.9433962264150944,1.0,1.0,2/6,21.70%,CNST;ACSL3
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.33636093388874116,0.6114357717042879,0.9230769230769231,1.0,1.0,4/12,24.79%,RB1CC1;UBA5;ULK2;ATG2B
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.2911762112017282,0.6112015219065965,1.0,1.0,1.0,3/25,13.92%,RPTOR;RAP1GAP2;AP2M1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.28249946358928973,-0.6108518889369462,0.9777777777777777,1.0,1.0,8/35,14.01%,GABARAPL2;MAP1LC3A;PHB2;FUNDC2;WDR45B;FIS1;CTSK;MAP1LC3B2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.37077090345147,0.6107613697782164,0.9074074074074074,1.0,1.0,2/7,16.26%,OXSR1;ADAM10
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3024488736648785,0.6104649530539037,0.9642857142857143,1.0,1.0,3/21,17.79%,BRD4;CDK13;CDK12
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.34578777954193235,-0.6095180901127989,0.9459459459459459,1.0,1.0,1/11,3.82%,ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.32236542010890357,0.6094959930179723,0.8888888888888888,1.0,1.0,3/12,16.83%,RANGAP1;SUFU;BARD1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.3412399722798831,-0.6093234734840391,0.9111111111111111,1.0,1.0,2/11,10.81%,EPHB3;SEMA5A
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.29154567075438476,0.6086830011166392,0.9206349206349206,1.0,1.0,8/31,21.30%,ABCA2;PLA2G15;SMPD4;AGK;CERS5;CERS6;CERK;FA2H
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.32981175425861053,0.6077071443198473,0.9433962264150944,1.0,1.0,2/12,10.52%,TTN;TPM1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.32981175425861053,0.6077071443198473,0.9433962264150944,1.0,1.0,2/12,10.52%,TTN;TPM1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.27722323040303143,-0.6075935273315641,1.0,1.0,1.0,6/30,15.76%,ALOX5;ATRAID;WNT5A;PTN;BMP2;ISG15
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.3585623501838182,-0.6063171675762685,0.8717948717948718,1.0,1.0,1/7,9.22%,SPHK2
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.41697776977211015,0.6059384420522007,0.9615384615384616,1.0,1.0,1/6,3.98%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.379828049331046,0.6059312912154456,0.8947368421052632,1.0,1.0,1/6,10.73%,RFTN1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.3407236162850148,-0.6056775003890321,0.9387755102040817,1.0,1.0,3/7,21.88%,PLAT;DDR1;AAMP
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.23286539847730636,-0.6053647084797122,1.0,1.0,1.0,9/80,14.11%,CALR;CFL1;DUSP3;NGF;YWHAB;GRK2;TRIB3;PFN1;HSP90B1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.41970126700576726,-0.6053212916382527,0.925,1.0,1.0,1/5,4.44%,NOL3
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.36416060391775906,0.6050971857679505,0.9423076923076923,1.0,1.0,1/7,15.01%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.3920148314967796,0.605002046174151,0.9508196721311475,1.0,1.0,2/7,16.37%,PLEKHA4;CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3288874257527573,-0.6044654991947332,0.9347826086956522,1.0,1.0,1/11,3.86%,HES5
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.36242987157696943,0.6043641457923878,0.8653846153846154,1.0,1.0,1/8,13.48%,MACROH2A1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.34915557450326906,-0.6040936227381365,0.9047619047619048,1.0,1.0,1/10,5.63%,NABP2
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.3731891806162606,0.6039884270863083,0.9090909090909091,1.0,1.0,1/6,10.04%,NMNAT2
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.3882636588635101,0.6034823672636992,0.9375,1.0,1.0,1/5,21.22%,ATP8B1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.27643761289245006,-0.6034523291240301,1.0,1.0,1.0,8/26,21.48%,LARP7;CDC73;RNF168;RNF8;WDR43;EAF1;LDB1;HEXIM1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.26684494315227747,0.6033677842845919,0.9811320754716981,1.0,1.0,15/49,23.23%,EGLN3;NLRC4;HIP1;RIPK1;BCL2L13;SNCA;CFLAR;CASP8AP2;PPARG;SENP1;NLRP12;EIF2AK3;ROBO1;APAF1;MAPT
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.2834858695130726,0.6031175670211568,0.9636363636363636,1.0,1.0,12/29,24.40%,EPHA7;FOS;SNCA;MAP3K5;SRPK2;GRIN2B;PICALM;TGFB2;FOXO3;MAPT;NF1;EFNB2
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.25473115994427986,-0.6026074882406508,1.0,1.0,1.0,14/56,21.00%,SMC1A;MZT1;TUBGCP4;GOLGA8A;HAUS8;HDAC3;NUMA1;GOLGA8B;ABRAXAS1;KIF3B;STARD9;GOLGA2;BCCIP;MAP9
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.3781135167042561,0.6025115948903115,0.9848484848484849,1.0,1.0,1/7,7.58%,STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.3781135167042561,0.6025115948903115,0.9848484848484849,1.0,1.0,1/7,7.58%,STEAP4
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.34770383493772966,0.6024801586833588,0.9814814814814815,1.0,1.0,1/8,5.07%,ABCA2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.28784180761689243,-0.6024089963458069,1.0,1.0,1.0,6/19,21.76%,MID1IP1;TRIB3;ADIPOR1;NR1H2;WDTC1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.35597924839406003,-0.6020924898281531,0.918918918918919,1.0,1.0,1/7,6.43%,DPH2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.3854479512717002,0.6018544209068983,0.8478260869565217,1.0,1.0,1/5,10.29%,CCP110
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.3461102096869728,-0.6013134589128606,0.9130434782608695,1.0,1.0,3/7,21.84%,GTF2H2;CHTOP;MSH3
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.3485639112910929,0.6012837297109481,0.9354838709677419,1.0,1.0,1/12,4.30%,ENOX2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.30938791022458634,-0.6008836599727798,0.9583333333333334,1.0,1.0,2/14,10.65%,TMBIM6;RPS13
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.3549299738194988,0.6008275673418538,0.9803921568627451,1.0,1.0,4/11,23.64%,SPTBN4;B4GALT5;ARHGAP35;MYCBP2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.3405157475765391,-0.6008242647633504,0.9148936170212766,1.0,1.0,2/7,14.53%,SLC25A4;PELI1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.3405157475765391,-0.6008242647633504,0.9148936170212766,1.0,1.0,2/7,14.53%,SLC25A4;PELI1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.27052049117366755,-0.6002853957238476,0.9767441860465116,1.0,1.0,10/29,21.76%,OPN3;CAV1;MST1;TRIB3;KHSRP;CLK2;PGP;ACMSD;WDTC1;CEACAM1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.3324041596469233,-0.5999818478173957,0.9130434782608695,1.0,1.0,1/9,9.01%,TUBB4B
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.29480603290096347,-0.5997665838304687,0.9795918367346939,1.0,1.0,3/29,7.91%,PRICKLE1;SEMA4C;FUZ
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.3961241653531712,-0.5996469211591477,0.8888888888888888,1.0,1.0,2/6,13.33%,BHMT;CROT
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.28776816250406023,0.5994064661766404,0.9642857142857143,1.0,1.0,2/21,11.24%,SPIRE1;STAT2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.29355544609005824,-0.5992388396778844,1.0,1.0,1.0,3/17,13.58%,ABCG2;SLC5A6;SLC14A2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.26408584577045774,-0.5989792021427345,1.0,1.0,1.0,9/24,22.33%,CDC37;WNT5A;HSP90AB1;CACTIN;ISG15;MUL1;USP18;METTL3;OAS3
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),-0.39609793398563026,-0.5988119492322036,0.9111111111111111,1.0,1.0,4/6,29.24%,B3GALT2;B4GALT3;GAL3ST1;UGT8
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.31077233392934306,-0.5982148364271548,0.9574468085106383,1.0,1.0,4/14,12.13%,PDGFRA;FUZ;WNT5A;SLC2A10
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.3004542024968809,-0.5978469847974385,0.9361702127659575,1.0,1.0,1/19,3.86%,HES5
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.3849101361584657,-0.597745688210242,0.8809523809523809,1.0,1.0,2/6,16.28%,KMT2B;SETD1A
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.34920796831074713,0.5977413632108566,0.9375,1.0,1.0,4/10,30.19%,ACVR1C;ACVR1B;ACVR1;ACVR2A
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.3135904383718858,0.5977045307899187,0.9666666666666667,1.0,1.0,8/16,27.28%,CAV3;TPM1;KCNMB4;CAMK2D;KCNQ1;AGT;CELF2;DMPK
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3357988798870582,-0.5972719257002701,0.9777777777777777,1.0,1.0,4/10,16.45%,GPR37L1;PYCR1;RACK1;PARK7
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.35227008496456574,0.5969452629659229,0.8703703703703703,1.0,1.0,1/8,8.97%,RAB20
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.34499561618375807,-0.5964472113764957,0.9583333333333334,1.0,1.0,2/8,15.11%,UNC119B;LRP1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.26708986361347875,-0.5959033971401316,0.9791666666666666,1.0,1.0,7/41,18.06%,GPC4;PARP1;HSP90AB1;GPC1;RAB11B;VCP;PIN1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.3145893238740739,-0.5948875157834368,0.9512195121951219,1.0,1.0,3/15,16.85%,GSTM3;RAPGEF3;MSN
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.3034956908828728,0.5946915394058689,1.0,1.0,1.0,1/20,3.47%,NNMT
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.3459503274844754,0.5945353292183095,0.9183673469387755,1.0,1.0,4/13,23.01%,PHLDB2;KNG1;APOE;CLASP1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.3719113822848603,-0.5944639213542257,0.8913043478260869,1.0,1.0,1/5,7.75%,SRI
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.38807698885012915,0.5941842005072794,0.9333333333333333,1.0,1.0,1/6,3.12%,ALK
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.36354137927083563,-0.5935730340035746,0.9166666666666666,1.0,1.0,5/8,14.79%,GBA3;NEU1;NEU4;MAN2B1;NEU3
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.33346609759947615,0.5933683084327016,0.9180327868852459,1.0,1.0,2/9,25.50%,AP2M1;CLTC
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.33346609759947615,0.5933683084327016,0.9180327868852459,1.0,1.0,2/9,25.50%,AP2M1;CLTC
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.2664701883476033,0.5933041062211205,1.0,1.0,1.0,6/29,16.28%,BMP7;ZHX3;IL6ST;TP63;IL6R;NELL1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.388848603198508,0.5929528022345941,0.9166666666666666,1.0,1.0,1/5,19.13%,PKD2
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.3654610062638368,0.5929407300093171,0.8867924528301887,1.0,1.0,3/8,16.44%,ADCY3;OR3A2;BBS4
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.32090881293770296,0.5924206955209745,0.9655172413793104,1.0,1.0,2/10,19.52%,DLG4;ATXN2
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.38099671391023887,0.5922012121956881,0.9074074074074074,1.0,1.0,1/5,11.39%,NOS1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.40477644564005116,0.592186025922273,0.9310344827586207,1.0,1.0,1/5,20.49%,STAT3
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.3156767276159884,0.5920013363271953,0.9354838709677419,1.0,1.0,2/16,14.36%,PKP2;DSC2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.3414364082324481,0.5915560779063704,0.9090909090909091,1.0,1.0,3/8,23.19%,CD59;TGFB2;DVL2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.28583582811945146,0.5911906007015622,0.95,1.0,1.0,8/32,25.89%,KCNN3;KCNMB4;ANK2;KCNQ1;KCNMB3;ATP1B1;KCNJ16;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.3985852494484472,0.590520519549156,0.9215686274509803,1.0,1.0,1/5,5.93%,TIMP3
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.3848038376933213,0.5903243093044956,0.95,1.0,1.0,2/5,38.16%,EIF4G1;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.25397501045420323,-0.5902358209192683,1.0,1.0,1.0,7/35,15.34%,MT3;CLU;WNT5A;PRR7;PRNP;LRP1;ZNF746
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.32973570407801156,-0.5900218703198749,0.868421052631579,1.0,1.0,1/10,6.16%,DNAJA1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.2615414879086705,0.5899508907892456,1.0,1.0,1.0,13/46,23.45%,MMD2;BORA;MMD;CAMK1;TRIM46;KIAA0586;CEP290;PPM1F;USP8;RAB9A;PICALM;PLEKHM2;TESK1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.295875821656734,0.5892430878597216,0.9636363636363636,1.0,1.0,3/16,20.39%,IHO1;SYCE2;SYCP2
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.3504906354844687,-0.5890934854720304,0.9302325581395349,1.0,1.0,1/6,15.19%,ALDH1A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.24338186135147535,0.5890810138674505,1.0,1.0,1.0,4/63,8.43%,RACGAP1;KIF3C;OSBPL1A;KLC1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.3283670470073392,0.5887087218276618,0.9310344827586207,1.0,1.0,5/17,17.35%,GPI;ENO4;GAPDHS;PFKL;PFKFB1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.2898498801684192,0.5881698151616099,0.9838709677419355,1.0,1.0,9/23,25.33%,STMN2;GAS2L1;PRUNE1;ABL1;CAMSAP2;CLASP1;MAPT;MAP1B;STMN3
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.39427643702296344,0.5875244367389668,0.9245283018867925,1.0,1.0,1/5,11.84%,CBFB
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.3937747325314304,-0.5872471013898973,0.9411764705882353,1.0,1.0,1/5,15.11%,LRP1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.3403248526651306,0.5868529562178992,0.9,1.0,1.0,2/8,30.30%,CEP250;MARK4
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.3072499101337492,-0.5864962536098492,0.9523809523809523,1.0,1.0,4/10,19.67%,ERN1;SEMA5A;BMPER;TEK
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.24100221724682871,0.5861626845845003,1.0,1.0,1.0,4/65,8.43%,RACGAP1;KIF3C;OSBPL1A;KLC1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.36729259387050567,0.5861449403410218,0.95,1.0,1.0,1/7,7.28%,RYR2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3251707299580753,-0.5856488878410174,0.9743589743589743,1.0,1.0,2/9,11.61%,LDLR;SCARB1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.2695981261598269,0.5851575078670748,0.9629629629629629,1.0,1.0,6/25,19.52%,MKLN1;ARRB2;DLG4;MAGI2;ARRB1;ATXN2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.28632405109089787,-0.5849024158951666,1.0,1.0,1.0,3/30,11.24%,PIGO;DPM2;PIGF
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.3024908247906082,-0.5842790627902458,0.975,1.0,1.0,4/15,21.55%,CHMP2A;NPM1;NAT10;CHMP5
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.3178693046695486,-0.5842164727515814,0.9361702127659575,1.0,1.0,2/16,7.91%,PDGFRA;FUZ
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.3789689254706385,0.5837402739437726,0.9482758620689655,1.0,1.0,2/6,24.40%,TGFB2;EFNB2
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.36439994397175296,-0.5818479707260633,0.9534883720930233,1.0,1.0,1/6,7.75%,SRI
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.30779741596160987,-0.581438958315557,0.9245283018867925,1.0,1.0,3/11,17.62%,TBCCD1;CDC42;ARCN1
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.3920727269441488,-0.5809385313730888,0.9444444444444444,1.0,1.0,1/5,4.64%,PLAAT1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.2504248780340631,-0.5807205529847869,0.9782608695652174,1.0,1.0,6/35,15.76%,ALOX5;ATRAID;PTN;TXLNG;BMP2;ISG15
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.2921729105787545,-0.5797056057613349,0.9767441860465116,1.0,1.0,5/19,22.08%,CHMP2A;NUMA1;HSPA1A;CHMP5;TPR
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.29394712499533815,0.5791630752319095,0.94,1.0,1.0,2/15,15.89%,FTO;GIGYF2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.35505370944180126,0.5786256817593957,0.9583333333333334,1.0,1.0,2/6,17.34%,RARA;PRKCZ
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.3718342569827262,0.5782969914025932,0.9830508474576272,1.0,1.0,2/5,23.27%,ERC1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.3706567175728827,0.5781321467928968,0.9538461538461539,1.0,1.0,1/5,3.72%,PHF19
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.3059083137799793,-0.5772026515488798,0.9787234042553191,1.0,1.0,6/18,17.78%,NGF;GSTM3;SOX8;GPC1;SOX10;ERBB3
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.35579379134395284,-0.5771037474971772,0.9555555555555556,1.0,1.0,2/10,12.50%,PORCN;WDR45B
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.30646810811210173,-0.5769653652732487,0.9285714285714286,1.0,1.0,6/14,23.58%,CAV1;FLOT1;MUL1;IFIT1;COLEC12;SLC3A2
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.35762176823251113,0.5769388531832996,0.9534883720930233,1.0,1.0,2/8,17.77%,GRB10;APPL2
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.31460934067308166,-0.576529492943564,0.9047619047619048,1.0,1.0,4/11,25.65%,CUL4B;POLD3;XPC;XPA
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.2686259744588987,0.5765248889098311,0.9701492537313433,1.0,1.0,6/28,21.72%,TIAM1;GCNT2;PDPN;SMAD4;TGFB2;BCL9L
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.2888188886382623,-0.5763029404557105,0.94,1.0,1.0,1/9,15.12%,ACADS
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.2771206198176417,0.576198929333234,1.0,1.0,1.0,3/22,12.42%,SORBS1;PRKAA2;ADIPOR2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.33465392690665563,-0.5755014339170593,0.9782608695652174,1.0,1.0,1/8,17.68%,SNAPC5
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.30033844230355444,-0.5748983720647379,0.9545454545454546,1.0,1.0,1/17,5.21%,PDGFRA
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.37282796561588694,0.5745292052439852,1.0,1.0,1.0,1/7,13.61%,PRIMPOL
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.2947880972807169,0.5730269097946735,0.9183673469387755,1.0,1.0,3/12,16.30%,OXTR;ARHGAP35;NRG1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.293278739783423,0.572753978055346,0.9642857142857143,1.0,1.0,6/15,31.19%,WWP2;ARRB1;FBXW7;HEY1;TSPAN15;EGFR
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.2849074076203924,0.5715562540677764,0.9574468085106383,1.0,1.0,1/16,5.41%,RTN1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.276610499925262,0.5713890371939956,1.0,1.0,1.0,6/25,26.84%,ENPP2;ARHGEF7;PIK3CA;ABI2;PIK3R1;CARMIL1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.33843582887700535,-0.5702175633264465,0.9130434782608695,1.0,1.0,5/5,66.17%,ZDHHC5;SLC15A2;BIRC2;SLC15A4;XIAP
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2902175756341245,0.5699023986161218,0.9830508474576272,1.0,1.0,4/17,15.47%,PSEN1;RAP1GDS1;PACS2;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.30691772502042947,0.5698968626564699,0.9666666666666667,1.0,1.0,6/20,25.01%,TCAF1;ANK2;ANK3;DMD;ATP1B1;PDZK1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.30443003850621575,-0.5694887553765516,0.9787234042553191,1.0,1.0,5/16,21.14%,NLGN2;LRRC4;NLGN4Y;NLGN3;DNAJA3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.3388691872263737,0.5691748387267469,0.9814814814814815,1.0,1.0,1/10,10.22%,BRCA1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.3177971248079339,-0.5689675386305436,0.9814814814814815,1.0,1.0,1/11,10.56%,COQ10A
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.3177971248079339,-0.5689675386305436,0.9814814814814815,1.0,1.0,1/11,10.56%,COQ10A
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.3013132936323849,-0.5687449123632323,0.9761904761904762,1.0,1.0,2/12,11.61%,LDLR;SCARB1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.3476812605237205,-0.5679219063009967,0.9473684210526315,1.0,1.0,2/6,15.91%,RNF168;RNF8
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.32333444297293523,-0.5678810594414458,0.9761904761904762,1.0,1.0,3/10,14.41%,CD44;TWF1;CDC42
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3165582576633472,0.5678400383070537,0.9591836734693877,1.0,1.0,3/14,19.14%,RIPOR2;ARHGAP35;ABL2
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.37568197095413125,-0.567794629314594,0.9111111111111111,0.9999015570629581,1.0,2/5,13.52%,CAV1;FLOT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.23276784977462872,0.567286050150035,1.0,1.0,1.0,4/66,8.43%,RACGAP1;KIF3C;OSBPL1A;KLC1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.3797612139130411,0.5666542310718788,0.9833333333333333,1.0,1.0,2/5,15.58%,ARRB2;ARRB1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3385586854624767,0.5663932384806523,0.9464285714285714,1.0,1.0,2/8,14.80%,MAP2K5;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.32494669930465503,-0.5663483434044813,0.9534883720930233,1.0,1.0,1/12,3.36%,S100A1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.346947034963361,-0.5658073262818818,0.9574468085106383,0.9998170476429242,1.0,1/6,6.72%,LYN
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.3255776864842213,0.56474771610077,0.9811320754716981,1.0,1.0,5/8,25.83%,SMOX;ALDH7A1;CHDH;SLC44A1;DMGDH
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.2856330008955348,0.5646987194871689,0.9272727272727272,1.0,1.0,3/14,17.77%,TYRO3;IRF1;APPL2
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.31987469812837055,0.564342405640787,0.9310344827586207,1.0,1.0,1/11,9.72%,ATM
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.31987469812837055,0.564342405640787,0.9310344827586207,1.0,1.0,1/11,9.72%,ATM
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.31987469812837055,0.564342405640787,0.9310344827586207,1.0,1.0,1/11,9.72%,ATM
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.31987469812837055,0.564342405640787,0.9310344827586207,1.0,1.0,1/11,9.72%,ATM
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.30480174082296774,-0.5641913686636183,0.9722222222222222,1.0,1.0,2/11,13.52%,LYN;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.23000477848050196,0.5636788313101802,1.0,1.0,1.0,12/63,20.79%,PRKCA;SASH1;RIPK1;NMI;P2RY12;SNCA;ZCCHC3;PDCD4;PPM1F;NLRP12;POLR3B;POLR3G
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.3048307135830571,-0.5632687438580235,0.925,0.9999897525175265,1.0,4/14,22.08%,CHMP2A;HSPA1A;CHMP5;TPR
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.31918159032851556,0.5627529281878515,0.96,1.0,1.0,5/15,18.45%,FOXP1;NMI;SNCA;DYSF;CRTC3
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3541512870288036,0.5625708787580292,0.9387755102040817,1.0,1.0,3/6,31.72%,PLAAT3;PLA2G12A;LCLAT1
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.286707457597397,-0.5620287296825772,0.9565217391304348,1.0,1.0,3/12,19.45%,MCOLN1;RAB11B;HYAL1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.3157181114408635,-0.5617087184817618,1.0,0.9996630056815549,1.0,3/13,12.11%,PEF1;SOX8;KLHL12
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.3202367385835656,-0.5587657088061921,0.9285714285714286,1.0,1.0,4/10,25.42%,AUP1;VCP;UGGT1;BAG6
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.31611077281268524,-0.5582592075802043,1.0,1.0,1.0,4/14,17.25%,NMNAT1;PPAT;PRPSAP1;PRPSAP2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.34085245084160215,0.5570540662739805,0.9206349206349206,1.0,1.0,1/6,17.93%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.34085245084160215,0.5570540662739805,0.9206349206349206,1.0,1.0,1/6,17.93%,DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.34085245084160215,0.5570540662739805,0.9206349206349206,1.0,1.0,1/6,17.93%,DTX3L
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.311447753490151,0.5565832356193876,0.9310344827586207,1.0,1.0,2/11,11.57%,CCP110;MAP4
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.33952804331840364,-0.556157911150864,0.8809523809523809,1.0,1.0,6/6,66.07%,CTCF;RAD21;DDX11;RB1;CTNNB1;WAPL
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.3210205284258474,-0.5560073239579505,0.9534883720930233,1.0,1.0,2/9,18.04%,ADAT2;URM1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.2920350719206762,0.5557668981325906,0.9824561403508771,1.0,1.0,5/17,26.15%,HIP1;DGKD;AGT;BCAR3;DOK1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.3432192473042359,0.5553345087056152,0.9565217391304348,1.0,1.0,1/9,13.48%,MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.35434207168049253,0.5547199173862047,0.9523809523809523,1.0,1.0,4/8,31.13%,CRACD;CARMIL1;WASHC2C;VIL1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.2701186107047085,0.5544175702980797,0.9795918367346939,1.0,1.0,7/18,30.48%,RTN1;PICALM;APOE;FLOT2;RTN2;BIN1;NTRK2
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.33541863491919055,-0.5537278628797419,0.9545454545454546,1.0,1.0,1/6,10.40%,DCHS1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.2670704978517458,0.5529491776013901,1.0,1.0,1.0,3/25,11.53%,PRKX;EMP2;PTP4A3
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.29572291273409335,-0.5528396249961373,0.9803921568627451,1.0,1.0,1/12,10.56%,COQ10A
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.3476966624010045,0.5520046490955629,0.9259259259259259,1.0,1.0,2/5,32.11%,C17ORF75;WDR11
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.31203301288736884,-0.5514196168698348,0.9166666666666666,1.0,1.0,5/8,29.55%,PTN;IL17D;RUNX1;PURB;PRKCB
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.2875998758260785,-0.5509030026741955,1.0,1.0,1.0,3/15,16.85%,VPS11;SNX12;MSN
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.3366563472251587,0.5505318357084145,0.9298245614035088,1.0,1.0,3/9,32.88%,RGCC;CIITA;LARP6
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.3205188206191081,-0.5503622985419294,0.9636363636363636,1.0,1.0,8/8,67.97%,FGFR3;LRP6;SFRP4;SKI;FGFR2;LRP5;BMPR2;BMPR1B
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.328267591613989,0.5499020534695797,0.9821428571428571,1.0,1.0,2/8,16.45%,RIPOR2;PADI2
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.330009972521898,0.5495518037799972,0.9423076923076923,1.0,1.0,1/7,7.54%,ETF1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.2695977156812695,0.5491584570839103,0.9491525423728814,1.0,1.0,10/19,32.28%,DGKZ;P2RY12;EEF1A2;IRS1;FLT1;ATG14;FGF2;PTK2B;PTK2;AMBRA1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.309442649902412,0.5491279395516161,0.9692307692307692,1.0,1.0,1/10,4.44%,RAB10
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.3470402742936167,0.5489462403804553,0.9473684210526315,1.0,1.0,2/7,17.40%,MCTS1;MRRF
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.36709856346142766,-0.5487971596665433,0.9736842105263158,1.0,1.0,1/6,4.53%,AGBL1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.31374242735242364,-0.548424035219995,0.9,0.9997883527920415,1.0,2/7,19.63%,WNK2;WNK3
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.33952804331840364,-0.5472660914718523,0.96,0.9997633115250006,1.0,6/6,66.07%,SETMAR;ERCC4;TERF2;ERCC1;TERF2IP;WAPL
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.2375072305048429,0.5464651962483721,1.0,1.0,1.0,8/46,20.79%,RIPK1;NMI;NPAS2;SNCA;PDCD4;NLRP12;POLR3B;POLR3G
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.3388567135010515,-0.5457216971750893,0.9130434782608695,0.9998153967649593,1.0,1/5,5.37%,C12ORF57
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.3252391224282766,-0.5454618742447706,0.9166666666666666,0.9994772610465976,1.0,1/5,6.88%,P2RX4
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.3324528837737465,0.5451539025757474,0.9655172413793104,1.0,1.0,1/6,9.13%,SHANK3
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.2997903726860291,-0.5446654051058221,0.9347826086956522,0.9993368275787088,1.0,1/8,10.07%,RAB33B
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.32382711831415334,-0.5435239245217043,0.9767441860465116,0.9988590799704604,1.0,1/8,17.57%,PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.32382711831415334,-0.5435239245217043,0.9767441860465116,0.9988590799704604,1.0,1/8,17.57%,PDPR
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.2846040507111644,-0.5427897899564202,1.0,0.9986373441314588,1.0,2/12,11.61%,LDLR;SCARB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.342496857218481,-0.5420123972015081,0.9090909090909091,0.9983965718123934,1.0,1/5,9.36%,PPP1R10
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.30592445574686133,0.5413875040805673,0.9807692307692307,1.0,1.0,2/9,13.63%,ALOX12;PRKG1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.31252387384548186,-0.541086153890017,0.9545454545454546,0.998242488729924,1.0,1/10,5.93%,TIPARP
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.31255475829092166,0.5390436224202056,0.9824561403508771,1.0,1.0,3/9,28.97%,PPARG;NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.3306591790346303,-0.5380077088497942,0.9761904761904762,0.9988185242452533,1.0,7/7,66.96%,EPB41L4B;PTEN;MAP4K4;IQSEC1;MTOR;ADAM9;MAPRE2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.28411781983973355,0.5374222192334593,0.9682539682539683,1.0,1.0,3/18,10.34%,RAB1A;RIPK1;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.33640535423059353,0.5373967525321501,0.9454545454545454,1.0,1.0,1/5,20.07%,ENG
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.31309154885711676,-0.5364092275196437,0.9772727272727273,0.9989236186988668,1.0,1/8,11.67%,FURIN
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.333739801674132,-0.5356256731438985,0.9722222222222222,0.9987263219949036,1.0,3/10,21.16%,CDC73;RNF8;PAF1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.3257751055105786,0.5340137326322857,0.9387755102040817,1.0,1.0,3/8,24.60%,KCND3;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.3211194208232181,0.5338248000963906,0.9591836734693877,1.0,1.0,3/7,20.14%,ALOX12;ADIPOR2;PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.3067083809726516,-0.5334055991021174,1.0,0.9990136283328208,1.0,5/12,22.77%,DUSP3;FGL1;GPNMB;CEACAM1;HAVCR2
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.28004905911767336,-0.529607848685502,0.9787234042553191,0.9995595825408599,1.0,3/11,17.05%,BEND3;SETD1A;ZNF335
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.3198419644892312,-0.5295578685219436,0.9782608695652174,0.9991322377000985,1.0,1/7,8.77%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3278107334979109,0.5290166042421856,1.0,1.0,1.0,5/10,30.21%,ANK3;DMD;ATP1B1;ACTN4;WNK1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.33063707467076675,-0.52847456159776,0.9795918367346939,0.9990118327656062,1.0,6/6,66.96%,EPB41L4B;MAP4K4;IQSEC1;MTOR;ADAM9;MAPRE2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.30478432427629354,-0.5277944051007158,1.0,0.9988149197734985,1.0,2/9,19.37%,BMP2;SOD1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.27566282460026303,-0.527640867480822,0.9473684210526315,0.998426729409109,1.0,5/15,21.20%,MFF;FIS1;SLC25A46;MUL1;MTFR1L
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.35310028804215987,0.5271011519247458,0.92,1.0,1.0,4/5,30.86%,SLC16A10;CRYM;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.35310028804215987,0.5271011519247458,0.92,1.0,1.0,4/5,30.86%,SLC16A10;CRYM;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.32682112749257564,0.5270282336381261,0.9642857142857143,1.0,1.0,3/6,35.95%,SETD2;IWS1;NSUN2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.32682112749257564,0.5270282336381261,0.9642857142857143,1.0,1.0,3/6,35.95%,SETD2;IWS1;NSUN2
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.26189903433884426,0.5265072232324732,1.0,1.0,1.0,1/20,5.65%,THRAP3
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.3355060348453654,0.5259136671974769,0.9215686274509803,1.0,1.0,2/5,24.85%,ARFGEF1;ALG10B
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.3356217264038487,-0.5258817018100973,0.9473684210526315,0.9983785411882509,1.0,5/8,32.74%,RPS27L;MAD2L2;ING4;KAT5;TP53
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.2582708022216177,-0.5248766233928563,1.0,0.9982204068296445,1.0,5/23,21.16%,BRK1;TWF1;CDC42;CYFIP1;AKIRIN1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.3235884893963936,0.5248703729113037,0.9824561403508771,1.0,1.0,1/7,9.45%,PROX1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.3043732707635503,-0.5242338809815974,1.0,0.9980098271725107,1.0,6/9,31.29%,B2M;HLA-F;TAP1;ERAP1;HLA-A;ERAP2
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.3060622011706696,0.523235148206827,0.9838709677419355,1.0,1.0,2/10,21.54%,CPEB3;CPEB1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.31181233596561253,0.5231380161416818,0.9818181818181818,1.0,1.0,1/9,6.74%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.3105592295019918,0.5216177408170284,0.9322033898305084,1.0,1.0,3/9,26.18%,TRIM44;IL7;IFIH1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.32425546602936733,0.5214166080829812,0.9622641509433962,0.9998911326283302,1.0,2/7,32.30%,ATRX;RTF2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.3092539292117787,0.5209105481538797,0.9433962264150944,0.9995867557479259,1.0,3/13,32.30%,ATRX;ATP2B4;RTF2
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.26739008633204886,-0.5206582669885684,1.0,0.9985591254996004,1.0,2/21,11.11%,PARP1;KMT5B
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.3292017584271129,0.5199114921013674,0.9814814814814815,0.9994336214263309,1.0,2/6,16.94%,ARRB2;KLRD1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.33401631477034843,0.5190319298881478,0.9701492537313433,0.9992315641860806,1.0,2/6,28.86%,ADARB2;APOBEC2
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.3285202510677184,0.5184438498947691,0.9814814814814815,0.9989580158972494,1.0,2/5,17.34%,RARA;PRKCZ
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.3117799869815372,0.5178731261189984,0.9482758620689655,0.9986733857937743,1.0,3/7,33.79%,SESTD1;BIN1;PLN
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.33239889131357647,-0.5174171505021229,1.0,0.9989790053080856,1.0,2/6,19.13%,PRMT1;LDB1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.30368076306797975,0.5168666557076153,0.9811320754716981,0.9985284243633713,1.0,2/7,27.13%,NAF1;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.35144300711199533,-0.5168258724207984,1.0,0.9986967630033976,1.0,2/5,19.13%,PRMT1;LDB1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.3315510199573903,0.5131934063478968,0.98,0.9989448437238843,1.0,2/5,26.74%,UBE2K;PRKN
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.30701298715622305,0.5118522338503012,0.9811320754716981,0.9988337774743281,1.0,3/7,27.29%,CLASP1;LIMK2;DLG1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.2699251136667558,-0.5113098964627396,0.9791666666666666,0.9997270267986242,1.0,9/9,73.03%,NID1;COL4A1;NTN4;LAMB4;NTNG2;LAMB1;PXDN;NTNG1;FLRT2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.3004461332619845,0.5066710279936271,0.9833333333333333,0.9994379084403373,1.0,3/9,19.31%,GJA1;ANK2;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.2483528349119437,-0.5064931352925104,1.0,1.0,1.0,7/24,23.11%,IRF3;FLOT1;ISG15;RIPK2;POLR3D;OAS3;HSP90AA1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.2515233133733569,0.5044893283283275,1.0,0.9994057344439816,1.0,4/23,21.86%,KMT2C;KMT2A;OGT;KDM6A
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.2882961509743815,-0.504459184567145,1.0,1.0,1.0,2/7,17.96%,ACHE;DAGLA
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.25103554608035644,-0.5035684782813058,1.0,1.0,1.0,2/13,15.20%,PPP1R16A;SMG5
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.2780152863702544,-0.5034137094978807,0.975609756097561,0.9999378025518239,1.0,2/9,14.84%,CAV1;UBQLN2
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.24620731864051987,-0.5014988379899541,1.0,0.9999844323909575,1.0,3/13,22.08%,EIF4EBP2;PAIP2;TPR
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.3102236762961693,0.5007410397025746,0.9807692307692307,0.999757166164427,1.0,2/5,37.01%,PRMT7;DNMT3A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.33020523003533375,-0.49932896358481843,0.9607843137254902,1.0,1.0,1/5,14.09%,SMAD3
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.3069191080419075,-0.498401601707031,0.9722222222222222,0.9998872654092492,1.0,2/11,9.07%,CDC37;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.3039379554723541,-0.4979106077382739,1.0,0.9995438916473207,1.0,8/8,69.63%,RUNX1;TGFB1;HDAC2;CREB3L1;TGFB3;SUCO;LARP6;RGCC
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.31385824870208834,0.49765266059055246,0.9811320754716981,0.9999165959052304,1.0,1/6,21.12%,TGFB2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.2864063855301789,0.4964291079009266,0.9807692307692307,0.9997151777331114,1.0,2/10,21.26%,BMP7;NR3C2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.31734822279213604,0.496338624108566,0.98,0.9993223764861047,1.0,1/6,10.22%,BRCA1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.23964767717771943,0.49524943855308257,1.0,0.9990613030755839,1.0,3/25,18.05%,RPA1;CDC7;ORC2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.31027734534030993,-0.4944665366406071,0.9772727272727273,0.9999423804518924,1.0,2/8,14.11%,HAS2;HDAC3
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.30266385109862004,0.4922709643953123,0.98,0.9991532070445155,1.0,1/6,26.16%,NUF2
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.3408353332170063,-0.49134721622666544,0.95,1.0,1.0,1/5,18.38%,SLC7A1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.30735601849101213,-0.49061369536322424,0.9629629629629629,0.9996070871908135,1.0,1/6,16.48%,H3-3A
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.30735601849101213,-0.49061369536322424,0.9629629629629629,0.9996070871908135,1.0,1/6,16.48%,H3-3A
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.2962064169932198,-0.4888750465734336,0.9772727272727273,0.9996442078872945,1.0,3/5,24.84%,SCARB2;TMEM30A;ATP8A2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.2965430283720151,0.48826442273620396,1.0,0.9994888637523545,1.0,1/9,13.59%,MSH6
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.298187846747728,0.48642230456179175,0.9629629629629629,0.9993705332073762,1.0,3/7,28.03%,ARHGAP21;COPG1;STK25
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.2852669265091736,0.4835125258424061,0.9821428571428571,0.9994509503478947,1.0,2/8,30.56%,DUSP6;DUSP9
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.2742782167241018,0.4825632702350735,0.9824561403508771,0.9992203370401953,1.0,4/8,39.49%,DNAJB1;HSPA2;DNAJB6;SACS
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.3022575115249435,-0.48143806475476314,1.0,1.0,1.0,1/8,6.74%,GBE1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.29549222657466795,0.4785799987369631,0.9836065573770492,0.9993569247699251,1.0,2/9,13.35%,PLK2;RAP1B
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.24511546806969103,-0.4777447317860153,1.0,1.0,1.0,3/18,17.73%,CGNL1;SPRY1;FBP1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.2160473048255891,-0.477697634096294,0.975,1.0,1.0,7/27,22.08%,CHMP2A;NUMA1;GNAI1;HSPA1A;MAP9;CHMP5;TPR
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.3185105729740261,-0.4753039940198011,1.0,1.0,1.0,1/5,9.03%,DHODH
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.26742738827379503,0.47392882389767627,0.9636363636363636,0.9996543676910513,1.0,5/11,34.61%,SUFU;PKD2;NFKBIA;PKD1;KEAP1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.2067214289700393,-0.4689121297016896,1.0,1.0,1.0,8/32,23.11%,IRF3;CACTIN;FLOT1;ISG15;RIPK2;POLR3D;OAS3;HSP90AA1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.3081962829255248,-0.467612340157863,0.972972972972973,1.0,1.0,7/7,69.20%,RPS27L;ING4;KAT5;TP53;RPS6KA6;SP100;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.28257567146640167,-0.4672664161255671,0.9583333333333334,1.0,1.0,3/5,28.17%,RELA;HRAS;ZSWIM8
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.27739944727898863,0.4644442694598654,0.9795918367346939,1.0,1.0,2/8,17.34%,RARA;PRKCZ
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),0.30653538946683107,0.4636785412216445,0.9807692307692307,1.0,1.0,2/5,23.98%,ANK2;CACNA1D
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.32045454545454544,-0.4625575919537846,0.9787234042553191,1.0,1.0,5/5,67.97%,FGFR3;MEF2C;INPPL1;BMPR2;BMPR1B
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.2560533738894026,0.4561731972070418,0.9830508474576272,1.0,1.0,2/11,19.80%,TRAF3;ITCH
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.2662441570440973,-0.4557803310277086,1.0,1.0,1.0,5/7,31.29%,B2M;TAP1;ERAP1;HLA-A;ERAP2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.28106067961249637,-0.4547257976302767,1.0,1.0,1.0,1/7,12.97%,VPS11
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.2512789824187766,0.45383528839876747,1.0,1.0,1.0,3/10,23.74%,ABL2;ABL1;AGT
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.2320132320434029,0.452300693126781,0.9855072463768116,1.0,1.0,3/18,22.47%,TIRAP;IL6R;IL7
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.2632220400784034,0.45070389678785333,0.9636363636363636,0.9999962090641155,1.0,3/10,24.60%,KCND3;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.27755041088794097,-0.44242402648394324,0.9655172413793104,1.0,1.0,1/6,16.20%,PEX13
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.26788340687257656,-0.4420220370618773,1.0,1.0,1.0,7/7,73.23%,ERCC8;APLF;TDP1;LIG4;ERCC6;SIRT1;APTX
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.26524064171122996,-0.4418374630926368,1.0,1.0,1.0,5/5,73.49%,NR1H2;NR1H3;PTPN2;ITGAV;NFKBIA
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.2767379679144385,-0.43894146558862546,1.0,1.0,1.0,5/5,72.34%,LNPK;TMEM33;ATL3;RAB3GAP2;RAB3GAP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.263484868715247,-0.43780417971339824,1.0,1.0,1.0,3/7,21.12%,TGFBR2;JAG1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.28140051588535947,0.4374246284470967,0.9841269841269841,1.0,1.0,3/7,29.59%,ENG;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.24089055291836597,-0.43562585230248363,1.0,1.0,1.0,8/8,75.93%,RELA;ZDHHC21;RHOA;ETS1;FUT9;IRAK1;NFAT5;TRAF6
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.26099967867398177,-0.4353731850358874,1.0,1.0,1.0,1/5,18.98%,PFAS
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.2529950022281964,-0.43409264384381574,0.9791666666666666,1.0,1.0,2/7,25.53%,TGFBR2;COL4A1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.2588811554109822,-0.4338506714799625,0.9743589743589743,1.0,1.0,1/6,14.09%,SMAD3
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.2856368424827416,0.4287021747742445,1.0,1.0,1.0,2/5,33.12%,ACVR1B;AGO2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.3016606123208813,0.42845650199632995,1.0,1.0,1.0,3/5,29.59%,ENG;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.2571902791189845,-0.42225714501655826,1.0,1.0,1.0,1/6,16.17%,VCP
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.27375149880491284,0.4220915795760435,1.0,1.0,1.0,4/6,39.24%,PDZK1;STK39;ANO6;P2RX7
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.2327862885616844,0.41688527821306937,1.0,1.0,1.0,2/12,18.06%,EHD1;PPARG
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.26554352186121144,-0.41668377417780145,0.9791666666666666,1.0,1.0,7/7,73.46%,MORC2;MPHOSPH8;RESF1;TOP2B;TASOR;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.24123894357062947,-0.4163815562532353,1.0,1.0,1.0,2/9,19.41%,WDR45B;WDR45
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.2569400997528703,-0.41591163347249277,1.0,1.0,1.0,2/11,14.89%,HSP90AB1;B4GALT6
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.2536970899153754,0.4146607022785462,1.0,1.0,1.0,3/8,23.45%,NLRP12;ENG;TESK1
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.26552577043920045,-0.4130262576611984,0.9583333333333334,1.0,1.0,6/6,73.46%,MORC2;MPHOSPH8;RESF1;TASOR;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.26286860692065905,0.41246989560125136,0.9795918367346939,1.0,1.0,3/5,33.75%,PRDM5;SETDB1;SUV39H2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.26047807422396874,0.4124567539964539,0.9807692307692307,1.0,1.0,2/8,28.30%,PPARG;TTC39B
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.18669534525247178,-0.4070435079522468,1.0,1.0,1.0,6/24,21.06%,BMP2;AKT1;PLG;JAG1;MAD2L2;PPARA
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.261234681745833,-0.40424585397221885,0.9767441860465116,1.0,1.0,1/5,16.85%,MSN
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.21686565440764796,-0.3973043024062493,1.0,1.0,1.0,4/13,25.31%,BMP2;SMAD3;EFEMP2;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.24368997218564165,0.3882063852133316,1.0,1.0,1.0,2/7,30.38%,PPM1F;RGCC
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.22290566290031422,-0.3867902149465358,1.0,1.0,1.0,8/8,77.73%,DDI2;KAT7;DDX11;FMR1;BLM;SPIDR;RTF2;ATRX
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.24013043281735458,0.38648033996691794,1.0,1.0,1.0,2/6,29.64%,ATXN2;CNOT2
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.228636751425781,0.38435525487489347,1.0,0.999870744277402,1.0,2/9,21.25%,PRDM16;NOP53
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.26235676303285105,-0.3821047273127644,0.9795918367346939,0.9997818405540094,1.0,2/5,26.99%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.26235676303285105,-0.3821047273127644,0.9795918367346939,0.9997818405540094,1.0,2/5,26.99%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.26235676303285105,-0.3821047273127644,0.9795918367346939,0.9997818405540094,1.0,2/5,26.99%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.2595588235294118,-0.3813925589430408,1.0,0.9989703507827674,1.0,5/5,74.06%,DPM3;DPY19L2;DPY19L1;DPY19L3;DPY19L4
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.2595588235294118,-0.3813925589430408,1.0,0.9989703507827674,1.0,5/5,74.06%,DPM3;DPY19L2;DPY19L1;DPY19L3;DPY19L4
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.19566223667042235,0.37865943958113585,1.0,0.9996418541395442,1.0,3/16,22.47%,CBFB;ABL1;IL7
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.2382124276548701,0.36972507559008816,1.0,0.9995022935353873,1.0,5/8,40.11%,EHD1;INPP5F;EIPR1;ARHGAP1;ATP9A
